<SEC-DOCUMENT>0001628280-20-015862.txt : 20201106
<SEC-HEADER>0001628280-20-015862.hdr.sgml : 20201106
<ACCEPTANCE-DATETIME>20201106080114
ACCESSION NUMBER:		0001628280-20-015862
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		76
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201106
DATE AS OF CHANGE:		20201106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ocugen, Inc.
		CENTRAL INDEX KEY:			0001372299
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36751
		FILM NUMBER:		201292449

	BUSINESS ADDRESS:	
		STREET 1:		5 GREAT VALLEY PARKWAY
		STREET 2:		SUITE 160
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		484-328-4698

	MAIL ADDRESS:	
		STREET 1:		5 GREAT VALLEY PARKWAY
		STREET 2:		SUITE 160
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HISTOGENICS CORP
		DATE OF NAME CHANGE:	20060810
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ocgn-20200930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:b98bd97b-267b-467c-adde-600f3c3e2154,g:859d45a4-db6c-4e83-b642-d8014a2143ca,d:c4b88770ebf34f5b9ff4444c3fcf406a--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ocgn="http://www.deitaxonomy.com/20200930" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ocgn-20200930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80L2ZyYWc6MjdlZTg2NTQ3OTI4NDQ5ZDhmYzM3ZmZhZjFmNWY4MjcvdGFibGU6NTQwNGRjODM4Y2U1NGRmN2I1ODFhNTRiMGQ1MTYzNWIvdGFibGVyYW5nZTo1NDA0ZGM4MzhjZTU0ZGY3YjU4MWE1NGIwZDUxNjM1Yl8xLTEtMS0xLTA_e0c61455-3b3a-4709-85ab-1036036459a3">0001372299</ix:nonNumeric><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80L2ZyYWc6MjdlZTg2NTQ3OTI4NDQ5ZDhmYzM3ZmZhZjFmNWY4MjcvdGFibGU6NTQwNGRjODM4Y2U1NGRmN2I1ODFhNTRiMGQ1MTYzNWIvdGFibGVyYW5nZTo1NDA0ZGM4MzhjZTU0ZGY3YjU4MWE1NGIwZDUxNjM1Yl8yLTEtMS0xLTA_69a8be51-4f1c-40a2-8ade-d0b7a0a3c8c6">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80L2ZyYWc6MjdlZTg2NTQ3OTI4NDQ5ZDhmYzM3ZmZhZjFmNWY4MjcvdGFibGU6NTQwNGRjODM4Y2U1NGRmN2I1ODFhNTRiMGQ1MTYzNWIvdGFibGVyYW5nZTo1NDA0ZGM4MzhjZTU0ZGY3YjU4MWE1NGIwZDUxNjM1Yl8zLTEtMS0xLTA_6bb39445-dd34-41c9-80c1-82b0c6a890e4">2020</ix:nonNumeric><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80L2ZyYWc6MjdlZTg2NTQ3OTI4NDQ5ZDhmYzM3ZmZhZjFmNWY4MjcvdGFibGU6NTQwNGRjODM4Y2U1NGRmN2I1ODFhNTRiMGQ1MTYzNWIvdGFibGVyYW5nZTo1NDA0ZGM4MzhjZTU0ZGY3YjU4MWE1NGIwZDUxNjM1Yl80LTEtMS0xLTA_12e98aee-3076-454e-8b38-7105f6299772">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80L2ZyYWc6MjdlZTg2NTQ3OTI4NDQ5ZDhmYzM3ZmZhZjFmNWY4MjcvdGFibGU6NTQwNGRjODM4Y2U1NGRmN2I1ODFhNTRiMGQ1MTYzNWIvdGFibGVyYW5nZTo1NDA0ZGM4MzhjZTU0ZGY3YjU4MWE1NGIwZDUxNjM1Yl81LTEtMS0xLTA_644b869e-0eb4-4c20-a775-4b0a064eef6c">false</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i4b761e61f7dd46ec849abd0bd8bb9544_D20200101-20200930" decimals="4" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNy9mcmFnOjYzNmJhODY3ODRiNTRjYTg5ZTA1ODFkNjFhNTY3MDU0L3RhYmxlOjg2ODg3MDVlNDNkNDQ1YWM4MTBiYWRkNDU3MWIwZmI0L3RhYmxlcmFuZ2U6ODY4ODcwNWU0M2Q0NDVhYzgxMGJhZGQ0NTcxYjBmYjRfMy0xLTEtMS0w_a1255c8b-c3de-46f2-acb2-fc48c24c64f4">0.0167</ix:nonFraction><ix:nonNumeric contextRef="i93fa98ddee794faabb3a0a08669c9b82_D20200101-20200930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2MTk_eb512e86-ca54-4b51-8e50-01fc17d11c9f">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i0cae5296d90e425585c0c15306000032_D20200101-20200930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2MjU_8897e6c7-9303-4adc-88de-47d481ae6e6d">P3Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="ieded657d1fda48e6b4c81175703563eb_I20200615" decimals="4" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81OC9mcmFnOjcwOTY4ZjYyZmZmNzQ2N2FiZjhjYjBlNzc5MTY4NTc3L3RhYmxlOjEwY2RmZjBlYWU5NjRmOWQ4NzI4YTJiN2VmZDY3NzgxL3RhYmxlcmFuZ2U6MTBjZGZmMGVhZTk2NGY5ZDg3MjhhMmI3ZWZkNjc3ODFfMC0wLTEtMS0w_2469c958-b145-4389-b4a3-afa770d75e80">0.3333</ix:nonFraction><ix:nonNumeric contextRef="i6eb84a90f81044ad8ec2490494674494_D20190101-20191231" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjgzOQ_9250eb5b-b0ea-4f42-8cf2-a98505654eac">P18M</ix:nonNumeric><ix:nonNumeric contextRef="i98e284c9e1a54ade9b9c47c38c6b72d3_I20200930" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTk1_ae9976e8-4e79-4b4b-95fa-b8c561425fb1">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI3NQ_32d25827-fc2b-4183-a751-56c09cccc2ae">us-gaap:OtherLiabilities</ix:nonNumeric><ix:nonNumeric contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI3NQ_939a82e3-172c-4a98-a538-b4e48e03f315">us-gaap:OtherLiabilities</ix:nonNumeric><ix:nonNumeric contextRef="i6f2dc86eba1043a4b6a426c058150999_I20201009" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF8xNjQ5MjY3NDQ2MzEx_c0cab281-7ade-48be-8c4a-31582fcb7c9d">P7Y</ix:nonNumeric><ix:nonNumeric contextRef="i6f2dc86eba1043a4b6a426c058150999_I20201009" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF8xNjQ5MjY3NDQ2MjU0_e2515411-dba9-46d7-a836-2bb32ea59544">P5Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ocgn-20200930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="id9b6720c14554b3da72ba7b6c4c2146e_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i336430b025bf42ab979315995a7658d8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98e43846e414426d8a674b5b72c8ca6d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd20a7846d8b4fc39d7c932264bb4ea1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9993a23cdf354d4e9040dbf206654bd0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f8723a3bb064fb19050f09d0f6f3be8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28157047c72a40388b8efc8371f6fcd9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i609c16341b0b455fb5cb9f1944534389_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88dcd54d5b2b41e98760d2603e2e5b19_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15660c6077044e16863b22305e9f8bf4_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66618942a356454490c353406b315661_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f1a10afb95b4de09f391c08ee58cb4a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4a740be98724d9e987038a54f18720a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31ecd93cc7af4dbaa563d03c878f6d01_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9669856efb5d4178a3b37eabd7255b5f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dc4b283ea42412298190a0bb1c42842_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i394152742f2b46919b80f9aac6e0bdae_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i328e36f86432406a9c2335a6a30ed14e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff5a8b4ad96a4423b5a5d8703b80fd89_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d76dbaad2e54a01a5508dc7b046d2a2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SubscriptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c5385b73d594d0cb6109dbeb0dd402f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SubscriptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d3447d3ea544b67af6beab734e24ec1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SubscriptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84ec37475ad1407b8afd9d013bad577a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ATMTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7f4e1ed546c4dd3bbdecfae1575602d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ATMTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafb9f9ece2254e5d96200b89c04d05ae_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ATMTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3761ade97814636b361bfcc7c6b79e1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c8324876bb7424fb4a9c74dbd244211_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5848bd936cb84e5c9b92ed98dc5efc4c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21e4bdc375dc4ba88ea91dac7663985e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0da0e17b44c4d069cb3178f2bcee63e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6525b0b5dc1b4d65ad83f61508bd23f7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18aa74b3c07a4d74a32c957095f16197_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9d5479720a7404bb1a1908a324dc51e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia40e42f6afba4d05aafce4ad7747ba3b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ATMTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifec1223b1319497b93668a034608cb1c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ATMTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c44d34b710b4e7e85a02e804db3124f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ATMTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2890f5772ae94a0baf3455349ee0ef1e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b195f0612774af0ac040960b61f8f93_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i893354ca24b44aea8098609fe2707967_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcec84ede62e484c81eb25c7fadbd8fb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fd67196ac9e4ddcbc7f6a1fe73988b1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id192bd6eec634f2999ed2c6284506bd2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib39682b0589a4563bb7ca6600d2c74bb_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if64358bdad2f49bb80ab64f710d95a09_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ecffe72ae39480a8cc4dea5b165a9a9_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cb32b18dd0a4067962fc9ab0625c09c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2c738591a314487b302f77f09e6912a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e8e99c2015f49bb951bff3956b8fa43_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bd3fa288f1e4b63accc8a222321ed39_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64c7a1ac8ad047eca985cb5ee6a0d2c2_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac9335d486854d3084e445a33994b49e_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6958ed5917474f8296be96a2f1c58358_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0540cef311b94b2cb1eaf0f5cb846d7c_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd37dadabb2844f9a10e911cb83f43c0_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i544370edaa6242a58ab1c22527f96140_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ec2583968c54b76b5925cc04d32749f_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9d5c4839f734f9d8af158d6419bc025_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83bb706036a64f5ea79f154273a0ebe0_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23ac27353df346c9933361da82476672_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f2c719325c44e12b2d5790a34483527_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8aafdea70ac54f0092cc97d32f96a3a5_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5a973efc1294d12ba97fd0f51a25d4a_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i856b691e765e44f8afa4a464a1e78d9e_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83267470589c49dabfad039edd942ede_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i604296e53c7c4e829ae539a464ee39bf_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ba87472b7a74f70b1be08aa590ce293_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i428aecd8c23f42019007455d1a246411_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92496e8c334d48b585f951d94a716b85_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ac0b7a5cf8e4897b11c2a3631e77ac0_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c82191e545a466984e92701810a3a95_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0884c1459fe43f596eee437b5363a5a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ReverseAssetAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7760c1095dda43128a60a00128e94a57_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ReverseAssetAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a53906430b5411ea8116131d4c97f45_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ReverseAssetAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f73b959d8e14b9098644555fbd773bb_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:PreMergerFinancingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01d87cc2a4764d93ac0bdd0a8c59cb83_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:PreMergerFinancingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e43eec18c794fc481f0826a92482fc5_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:PreMergerFinancingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87973e4eacbb4326a84eb1f0a491f757_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08862f2fb8e94c82b2e2dcbf7ad2b49f_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c1260fccbd4436ba5f9ed5d97ed88be_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7b469aa758f4755afe661f5ed2d8bf5_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bd31c10c4a3492e971d2489a2155990_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dc6aea499224e54b008c9eab809c76d_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff87527ea3fc46fdacb3342226f9f0f9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>ocgn:segment</xbrli:measure></xbrli:unit><xbrli:unit id="orphan_drug_designation"><xbrli:measure>ocgn:orphan_drug_designation</xbrli:measure></xbrli:unit><xbrli:unit id="clinical_trial"><xbrli:measure>ocgn:clinical_trial</xbrli:measure></xbrli:unit><xbrli:context id="id9576326dbf84d1db30189e963d4195f_D20210701-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i4b761e61f7dd46ec849abd0bd8bb9544_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ocgn:HistogenicsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c3c6f97b8e34fa1acfc3dcfa2747a64_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:EB5ProgramBorrowingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93fa98ddee794faabb3a0a08669c9b82_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cae5296d90e425585c0c15306000032_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32e5f294ab464b6d83e4148060068867_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48a7b850f34d4e93a932a1250a70dcdc_I20191004"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="series"><xbrli:measure>ocgn:series</xbrli:measure></xbrli:unit><xbrli:context id="ie03e503b087545748223eb40f7381d1f_D20191004-20191004"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-04</xbrli:startDate><xbrli:endDate>2019-10-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1524a036f48541e08e32da279b7f7398_D20191004-20191004"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-04</xbrli:startDate><xbrli:endDate>2019-10-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0feccca0bf2b43a1a54176fe040b711e_D20190508-20190508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ocgn:HistogenicsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-08</xbrli:startDate><xbrli:endDate>2019-05-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf034182282345c38684657f3ac357ca_D20191031-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ocgn:HistogenicsCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-31</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3cf544d14484496ac45a00e1654a708_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ocgn:HistogenicsCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f29b990abbf4758b5d2b15e35483711_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie506a5cab5e247de846540df1b463305_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59df5d0c89234b009956f4c9f8f30808_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f62ded661e54fefb3a9fd8f2ba1bb64_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i538b5af19f0f4c5b8fc4c537c4a489d5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc346fbec3d24dd58a12ad9d869ecfb2_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2380e13fd027491a936f449e6aa74829_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76069125bcf9493eba6f0ce4826c29c2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc8d8f8a93fc45e4b628285d72bb142a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesAWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i468172d3afbc4db09fe88fcad9e0d420_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesAWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25dbded407394e83baa18d6851c893f9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesAWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97cd3bc630954c2b9bcbbddafafde030_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesAWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb251e6b072448dfa91521c08d3b3479_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e6b2ef153df4c9788cd72ba0651ecfd_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad1b963da04845bd956aea311c52d499_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65d9eeb822d646fb9f1053229278fa42_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i402e841332864f65bad74eba8425cb79_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb41ad76fece4484ae14bc550e4c9795_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfc7128277d343d4a99ba1fe8819b89d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7d146e73e6e42e3a301e33bac8cd8ed_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id67b6ca4f8b24a43beb2890f097dc5c2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ocgn:AdvaiteIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibac481b8f449420f822e23ad5e256c76_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ocgn:AdvaiteIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="employee"><xbrli:measure>ocgn:employee</xbrli:measure></xbrli:unit><xbrli:context id="i2cc0ad28c5724aca9234dcc6309e44c1_D20200615-20200615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-15</xbrli:startDate><xbrli:endDate>2020-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib65216302269446e88de6bdca0d4d78d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3d9be1e13f34b61b21f7829259b9c08_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd5fda4627a342a0982c1661cf0a687a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife4854f917da4de9b27b201328eadc2a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1851644d82bf4fb2b634fbb231dff413_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c0ebd16833c4d9fb7640ffa8d1c822f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74b18383221c462a91314443a371c7b1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7c6f3716ee34faa9aa88da0c9ae7781_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3de6dd9388504be191f7056b17d3e22e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieded657d1fda48e6b4c81175703563eb_I20200615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i705cda31adfa47b8bf226fde1fda52d5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ControlledEquityOfferingSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7205f6b303a46ca881e1f5b3771db48_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ControlledEquityOfferingSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6788e535d4e547eaad37605b59a5e359_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ControlledEquityOfferingSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i641bb5999b314e3e9ff26b630c0802c5_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ControlledEquityOfferingSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84a2946964c741a8929a7e3b1f4d5681_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ControlledEquityOfferingSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3798aebd55684549850d5b6934cb938f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ControlledEquityOfferingSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c39808114c84938bdbf2cfbe7968dba_I20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SubscriptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i891a1948cbf344f09e76772040e3fa8e_D20200606-20200606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SubscriptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-06</xbrli:startDate><xbrli:endDate>2020-06-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36e49ecbf9c640919597478a362dc2c5_I20200606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SubscriptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b93323e957a4ce9b32abd082822d3d0_D20190405-20190405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SubscriptionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-05</xbrli:startDate><xbrli:endDate>2019-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i954c5746ce5b45d1a940c37f489ee070_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id35de39551be499fbe3da2455d22798c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f6eb732ec634b628ad24bc33e7f1a58_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43ef6579c4fd4fce993710b539ee1478_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if855a3da2e6d45e0828572b9b374ebc3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:EB5ProgramBorrowingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae6ba8a4f7f84d6da2219724a513733f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:EB5ProgramBorrowingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib962316dd8ec4a45b707ea8ffe2cfdca_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d689227ca8e441da7199a43bf5eb16a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82bf19a1e632417380b5fe0e427dd9b7_I20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i202e82a2e6574f9395b0475edfae9fc0_I20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ca8387e786e470e94c2d428dd8b08be_I20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8e397ca8e294216950367c054054ea4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idafa3d9adff54d838525f6e345d7b222_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa36c601f8de4816bb5ac175ca991a52_D20201001-20201106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-11-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89af07cba55243ada1a697e372c93c26_I20160930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:EB5ProgramBorrowingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i616e252088514e97a1bc3f1b262dcd7b_D20160901-20160930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:EB5ProgramBorrowingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-09-01</xbrli:startDate><xbrli:endDate>2016-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b78b94d3f034ec7b1df0ad282714b18_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:EB5ProgramBorrowingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b4ea6a10d05450090d47b47a43bceac_I20200326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:EB5ProgramBorrowingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2e106364d89410d8fa73ea0a7ada5a2_I20190521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:SeniorSecuredConvertibleNotesMay2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec5ace5a1a5d48d78f81c3898beaf7cf_I20190628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:SeniorSecuredConvertibleNotesJune2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fe0b042d77c45bc9e7880606282df26_I20190927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:SeniorSecuredConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a8ac0202f094c9288e4af258c9a7d6c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:SeniorSecuredConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b33f5ec1c0e4138ae4e880885651fb9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:SeniorSecuredConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9836b63cfe2f4fe7b7c0325bd22c222e_I20190404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertiblePromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba956723fd0740239620e5f29bcb4ca7_I20190516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-05-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5d139f20a3148c98c5a49fbdcb7bc19_D20190516-20190516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-16</xbrli:startDate><xbrli:endDate>2019-05-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a9a7d47ff164922b47b9474737d5697_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleNotesBoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97a56e3f53224d4ab82457b6f444f1f4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleNotesBoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e196fac2ce14f69a9c7145fc6153460_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c95e5d478a04f07aafab89ce80821a5_I20180131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtJanuary2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92b0bfa510874f698e53c5abd86cfac8_I20180131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtJanuary2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ocgn:ConvertibleDebtConversionFeatureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f4bd0c993144352beacd61bd76c907a_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtJune2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1ef8269ce6849a8bbaaf6f1dd81d930_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtJune2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ocgn:ConvertibleDebtConversionFeatureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07700165b6f44737af43f19cf18c3b61_I20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtNovember2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic60fd8eff73747ec9eaa1854872d27d4_I20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ocgn:ConvertibleDebtConversionFeatureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtNovember2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8441ef9a2d3446daa0a9a5e613555095_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtDecember2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia31f6d3314ac41ffb1c478548ad440f7_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ocgn:ConvertibleDebtConversionFeatureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtDecember2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5349b87b7d764f64a46780bb66baca10_I20190131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtJanuary2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10b818c696fa4a59b0fd450672c2f045_I20190131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ocgn:ConvertibleDebtConversionFeatureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtJanuary2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83b69bf96efa4d168b3abf899bb9cc37_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtFebruary2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c4f1fd7901c4793a17e268f79e0bcd9_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ocgn:ConvertibleDebtConversionFeatureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtFebruary2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29b4f949ec244c099e380923e5e22554_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ocgn:ConvertibleDebtConversionFeatureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eb84a90f81044ad8ec2490494674494_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10c8c2503acb440f996a2813e4f347ab_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9f2b124c93c4651bbb19190ff92d0ef_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebb9183c07544982815cbf0318070f47_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8eb7409e74724c4aab7c90a052528902_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2954e2e8a8d4d55987f92e0a1378c69_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f3b2b81985349648981b7c33c6a0e02_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica44cf11121f47e6b6dc2650b6be2704_I20190405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:November2018AndDecember2018NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73acee8636ae4ab98d80f2c562867e27_I20190405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:January2019AndFebruary2019NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fa755318529457aba279a74293b8181_I20190405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7122180f242946d99ad29848b79e37be_I20190405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bebf4b2ec794a58aac7839dd043db44_D20190405-20190405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-05</xbrli:startDate><xbrli:endDate>2019-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia96a5be04b654077a75d8375d8a5d905_D20190405-20190405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-05</xbrli:startDate><xbrli:endDate>2019-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc5453f20d4e4f35b4a834519b122ec4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic43825ac7a304ddf9c2216ba906f7289_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i087644c141fc4d80854025dc438c16bd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3df75069d5314c0b83c03d93eff49c3b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i162d13dc4b1545c696e798ebac5d4a90_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i792572cf35bb4b92b612e3ff5498a49a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic13576b5389d4b328a17a5d499ac4d69_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c53be1af7724b3faa590b77e842c7b7_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c8969ef77c1411c9bf6a611f2e2d36e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bae26e5ec3b4d6e959ffe614c098254_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ocgn:A2014PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ocgn:A2019PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie94bd56836134356a2b42c3d02bcd7b8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ocgn:A2014PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i132e89b796c1407695971319916c5052_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ocgn:A2019PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i112d9bfb269247e5a5787276fb3cd7ac_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ocgn:A2019PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i627461cada754117a3daf3d544a3877f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ocgn:A2019PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ocgn:A2019PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98e284c9e1a54ade9b9c47c38c6b72d3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic33f61dc175243c98786068416fad0db_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2693db88967c4ff0a47ea33524803019_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e5809e665eb4fa1bf1cecdf798b302a_I20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesAWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4bee8b3a2e3430a8cbcbb7923b89e24_I20190927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72db3f74703449b199225c6a20600560_D20190927-20190927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-27</xbrli:startDate><xbrli:endDate>2019-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37caa52256c84c01ad82bb794238bc10_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2639027910494f379046945f8a7d2bb9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa4ad77ecf7d4e6a9604ede41d7878a1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id84738694cfc4f48a8223bc4775059da_I20190927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41a7cddac3e8403d8a7b1b226753c6a6_I20191105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c449ee518aa4087bceac3f599d60b71_I20190927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e0e42f7805b40a7b369cb9a38e27242_D20190927-20190927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-27</xbrli:startDate><xbrli:endDate>2019-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0391e6dd13e64542b9e6ef240aa2d783_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09974af4f9294df7b673d1888259b853_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc6f5729ecb242e484fb2d858d328ec4_I20190927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dd696ce560e4f74960fe7452fda5bd9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief05580895fc46368234c7da5575be31_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if33032b532e54016bf273bdc3dc87946_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e68dccda8164000aaf8c597ab10b628_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9c4014ea1664b28a89cbda4056472d5_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d3016329c854e379eb39ead2fc7f7d1_D20200422-20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:WarrantsExchangedForCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-22</xbrli:startDate><xbrli:endDate>2020-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5a1d88348ac442ca29916a0b2a044b7_D20200422-20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesAWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-22</xbrli:startDate><xbrli:endDate>2020-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida7ba91283944cbaa8a66a0e1a833edb_D20200421-20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesAWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-21</xbrli:startDate><xbrli:endDate>2020-04-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5deeae01bef4c8e81884c72f6a8ce9d_I20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia83d0c6aaf90427c82faff7bf369406a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:FormerOcugenWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d1becb9d0b64817a37cabf28da5d1ee_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:FormerOcugenWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9adecc5943843fd91836c9fb0e2c80e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:FormerOcugenWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f2dc86eba1043a4b6a426c058150999_I20201009"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86c757f96f724d6b8aaa688ac26a295e_D20201009-20201009"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001372299</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-09</xbrli:startDate><xbrli:endDate>2020-10-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="numberofrenewaloptions"><xbrli:measure>ocgn:numberOfRenewalOptions</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_1"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">___________________________________________________________</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzA3_5a9e0755-b44f-42d1-839b-372e37d07f70">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">___________________________________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6ODQ5MTEwOGNjNGMxNDMxYWFmYjQ3YTQ1YzZiMzVmYjYvdGFibGVyYW5nZTo4NDkxMTA4Y2M0YzE0MzFhYWZiNDdhNDVjNmIzNWZiNl8wLTAtMS0xLTA_7ddb30a1-6dbf-4ba9-841f-bfbcca63d7a5">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV83MTQ2ODI1NTgyOTA1_cb647f0b-ace7-489c-8dcd-5a1dc843a479">September 30, 2020</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6ZWNiMGVjZGM0NDRlNDU3NTkyNmFjMDFjNDAzNTkyMGUvdGFibGVyYW5nZTplY2IwZWNkYzQ0NGU0NTc1OTI2YWMwMWM0MDM1OTIwZV8wLTAtMS0xLTA_a16f4b33-9ff1-4bb9-8f70-9c27f36dfba2">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzAz_a9fd2248-b6ea-4e2f-9f33-a380fd51b41b">001-36751</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">___________________________________________________________</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzA4_bc00191c-365b-4f39-bb0c-6991e03fd7db">OCUGEN, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">___________________________________________________________</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6ZTA3MWZiNDViNGFiNGY4Mzk2MzgxZDgzMjk3MWZhZTgvdGFibGVyYW5nZTplMDcxZmI0NWI0YWI0ZjgzOTYzODFkODMyOTcxZmFlOF8wLTAtMS0xLTA_d21afb73-56bb-4fde-b165-76d5b46bb2fd">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6ZTA3MWZiNDViNGFiNGY4Mzk2MzgxZDgzMjk3MWZhZTgvdGFibGVyYW5nZTplMDcxZmI0NWI0YWI0ZjgzOTYzODFkODMyOTcxZmFlOF8wLTEtMS0xLTA_bdcc12ab-224c-4a02-b6d2-bc42fbddc9d4">04-3522315</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzA5_6cda0d5a-9d49-451e-a538-6a363bb9fdf4">5 Great Valley Parkway</ix:nonNumeric>, <ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzEy_9e729cdf-a2b5-4a4d-a44c-b97ea59dbcd8">Suite 160</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzA0_429cc035-3ead-4f9e-888b-eb803d198466">Malvern</ix:nonNumeric>, <ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzE0_715e2ebc-b2b9-4204-8145-0c169fe4a0be">Pennsylvania</ix:nonNumeric> <ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV81NDI_dc429b65-9a73-4232-b419-ff75bffe15d4">19355</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV82MDc_3464ea65-0ab5-4a16-9260-9d0f6e3d421f">484</ix:nonNumeric>) <ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzE1_c0543009-8698-460e-84a3-7bb517e1e664">328-4701</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">___________________________________________________________</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b)&#160;of the Act</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.551%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Title of each class</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Trading<br/>symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Name of each exchange<br/>on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6ZjBiN2RhN2ZiYzQzNDFiMGI4Nzk3NmViN2UwMWMwOWUvdGFibGVyYW5nZTpmMGI3ZGE3ZmJjNDM0MWIwYjg3OTc2ZWI3ZTAxYzA5ZV8xLTAtMS0xLTA_01427a38-2708-409c-b485-3436786330f9">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6ZjBiN2RhN2ZiYzQzNDFiMGI4Nzk3NmViN2UwMWMwOWUvdGFibGVyYW5nZTpmMGI3ZGE3ZmJjNDM0MWIwYjg3OTc2ZWI3ZTAxYzA5ZV8xLTItMS0xLTA_1f55f834-1921-498c-9c10-d9cfb0d116fe">OCGN</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6ZjBiN2RhN2ZiYzQzNDFiMGI4Nzk3NmViN2UwMWMwOWUvdGFibGVyYW5nZTpmMGI3ZGE3ZmJjNDM0MWIwYjg3OTc2ZWI3ZTAxYzA5ZV8xLTQtMS0xLTAvdGV4dHJlZ2lvbjo4MjRiNjZlYzFhNTI0ZTVlYjhjMzFjZWIyZTc1NjgyNF80_cb5d2835-0ae7-4a03-90b6-69b5766acabf">The Nasdaq Stock Market LLC</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(The Nasdaq Capital Market)</span></div></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),  and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzEw_e58e15bd-8f34-43a2-83de-b9a511c1d33a">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzEx_fffbcd61-4d98-4b97-b26e-934912a97302">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.633%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6Njk4NTEyNDQ1NjQzNGY4OWI2MjBkNWVhZTI4ODYyMGIvdGFibGVyYW5nZTo2OTg1MTI0NDU2NDM0Zjg5YjYyMGQ1ZWFlMjg4NjIwYl8xLTAtMS0xLTA_a0d752be-d19b-4c29-848d-4faae2b50d71">Non-accelerated Filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6Njk4NTEyNDQ1NjQzNGY4OWI2MjBkNWVhZTI4ODYyMGIvdGFibGVyYW5nZTo2OTg1MTI0NDU2NDM0Zjg5YjYyMGQ1ZWFlMjg4NjIwYl8xLTMtMS0xLTA_16f62144-9d8b-4fac-9ed5-a4fc9947a219">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Emerging&#160;growth&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6Njk4NTEyNDQ1NjQzNGY4OWI2MjBkNWVhZTI4ODYyMGIvdGFibGVyYW5nZTo2OTg1MTI0NDU2NDM0Zjg5YjYyMGQ1ZWFlMjg4NjIwYl8yLTMtMS0xLTA_6d76a311-c44f-43e3-8d6c-aca5a9bbeea5">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B)&#160;of the Securities Act.&#160;&#160;&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;<ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzA2_3bdefdd4-8143-4af8-8ab5-f4df48f7a128">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;30, 2020, there were <ix:nonFraction unitRef="shares" contextRef="id9b6720c14554b3da72ba7b6c4c2146e_I20201030" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMjE5_af355a16-bede-4424-8a52-2a33543203d7">162,026,473</ix:nonFraction> outstanding shares of the registrant&#8217;s common stock, $0.01 par value per share.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt"><span><br/></span></div></div></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OCUGEN, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT ON FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2020</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.686%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_13">PART&#160;I&#8212;FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_16">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_16">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_19">Condensed Consolidated Balance Sheets as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_19">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_19"> 30, 2020 and December 31, 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_22">Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_22">nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_22"> months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_22">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_22"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_25">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) for the three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_25">nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_25"> months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_25">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_25"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_28">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_28">nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_28"> months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_28">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_28"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_76">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_76">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_76">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_103">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_103">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_103">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_106">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_106">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_106">34</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_109">PART&#160;II&#8212;OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_109">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_112">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_112">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_112">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_115">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_115">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_115">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_118">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_118">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_118">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_121">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_121">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_121">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_124">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_124">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_124">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_127">Item&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_127">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_127">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_130">Item&#160;6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_130">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_130">36</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_133">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_133">37</a></span></div></td></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context otherwise requires, references to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221; in this report refer to Ocugen, Inc. and its subsidiaries, and references to &#8220;OpCo&#8221; refer to Ocugen OpCo, Inc., the Company&#8217;s wholly owned subsidiary.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form&#160;10-Q may contain forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), about Ocugen and its subsidiaries. These forward-looking statements are intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, and can be identified by the use of forward-looking terminology such as &#8220;believes&#8221;, &#8220;expects&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;could&#8221;, &#8220;should&#8221;, &#8220;projects&#8221;, &#8220;plans&#8221;, &#8220;goal&#8221;, &#8220;targets&#8221;, &#8220;potential&#8221;, &#8220;estimates&#8221;, &#8220;pro forma&#8221;, &#8220;seeks&#8221;, &#8220;intends&#8221; or &#8220;anticipates&#8221; or the negative thereof or comparable terminology. Forward-looking statements include discussions of strategy, financial projections, guidance and estimates (including their underlying assumptions), statements regarding plans, objectives, expectations or consequences of various transactions, and statements about the future performance, operations, products and services of Ocugen and its subsidiaries. We caution our stockholders and other readers not to place undue reliance on such statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should read this report and the documents filed by the Company with the SEC completely and with the understanding that our actual future results may be materially different from what we currently expect. Our business and operations are and will be subject to a variety of risks, uncertainties and other factors. Consequently, actual results and experience may materially differ from those contained in any forward-looking statements. Such risks, uncertainties and other factors that could cause actual results and experience to differ from those projected include, but are not limited to:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risk that Ocugen continues to incur significant losses from operations and continues to incur net losses;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risk that Ocugen may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which health epidemics and other outbreaks of communicable diseases, including the recent outbreak of a novel strain of the coronavirus which causes a serious respiratory condition known as COVID-19 could disrupt Ocugen's business and operations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the uncertainties associated with the clinical development and regulatory approval of product candidates, including potential delays in the commencement, enrollment and completion of clinical trials;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to the inability of the Company to obtain sufficient additional capital to continue to advance these product candidates and its preclinical programs;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainties in obtaining successful clinical results for product candidates and unexpected costs that may result therefrom;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to the failure to realize any value from product candidates and preclinical programs being developed and anticipated to be developed in light of inherent risks and difficulties involved in successfully bringing product candidates to market and the risk that products will not achieve broad market acceptance; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the other risk factors discussed under the heading &#8220;Risk Factors&#8221; contained in the Annual Report on Form 10-K filed with the SEC on March 27, 2020 (the "2019 Annual Report"), in the Quarterly Report on Form 10-Q filed with the SEC on May 8, 2020, and in any other documents Ocugen files with the SEC.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should assume that the information appearing in this report is accurate as of its date only. Because the risk factors referred to above could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. Further, any forward-looking statement speaks only as of the date on which it is made. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. All written or oral forward-looking statements attributable to us or any person acting on our behalf made after the date of this report are expressly qualified in their entirety by the risk factors and cautionary statements contained in this report. Unless legally required, we do not undertake any obligation to release publicly any revisions to such forward-looking statements to reflect events or circumstances after the date of this report or to reflect the occurrence of unanticipated events.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_16"></div><div><span><br/></span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_19"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OCUGEN,&#160;INC.</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMy0xLTEtMS0w_dd8d4995-6dfc-456f-8592-2e3459ecc513">19,105,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMy0zLTEtMS0w_43590bac-b622-48ce-9184-7e16fc9b2428">7,444,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNC0xLTEtMS0w_1df691c7-256e-4d19-90cb-5ec0374182be">652,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNC0zLTEtMS0w_d28b2a12-935b-4086-a8f9-32f8880ab0cb">1,322,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:zerodash" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNS0xLTEtMS0w_6cd416e3-6f87-43a6-a378-c50c2d06f878">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNS0zLTEtMS0w_00db3b5f-14d6-46b6-9323-793f4c651ccb">7,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNi0xLTEtMS0w_36fbadca-d0de-4bfb-9aac-44b65304ff11">19,758,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNi0zLTEtMS0w_5835f946-2462-42af-82b4-e34ab4c7c2ff">15,766,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNy0xLTEtMS0w_1eb796b9-bdc0-44d4-84eb-d50fc62f85f6">214,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNy0zLTEtMS0w_70913877-0546-4eb6-9c93-b654c56ae01c">222,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfOC0xLTEtMS0w_0deaf608-9b25-44ba-b825-dd9db8f444c5">151,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfOC0zLTEtMS0w_4ad0e26d-1bea-4e1f-a971-e9c549c9d15b">151,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfOS0xLTEtMS0w_f2a9ccdc-6a13-40be-940c-f564ef032847">415,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfOS0zLTEtMS0w_65e422f3-cc0e-4077-b3d9-9efc96da4cb3">667,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTAtMS0xLTEtMA_0e610fb9-6cec-42a8-ba42-e31c6b7a5c37">20,539,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTAtMy0xLTEtMA_9c992799-8c29-49f2-bf22-40b9d7a857f7">16,807,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTMtMS0xLTEtMA_d38e014e-5fd2-4e2b-b500-e01c496931a9">222,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTMtMy0xLTEtMA_6753ecb7-e657-4bea-946d-72a6c5b5d314">1,895,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTQtMS0xLTEtMA_23e1c75a-dc7d-4f6f-8326-0f13f6ea951e">2,333,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTQtMy0xLTEtMA_79ac7c66-c246-4941-b182-7979cca22ee9">2,270,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTUtMS0xLTEtMA_92b38b4f-9b1e-4258-8402-f1a45f4fd59a">1,210,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:zerodash" name="us-gaap:ShortTermBorrowings" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTUtMy0xLTEtMA_71c61994-0138-4896-a770-52e875b5b80a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTYtMS0xLTEtMA_b1a7a804-2666-4cda-a02b-479fbfdaf2ed">164,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTYtMy0xLTEtMA_19fad6e1-decf-4813-8815-f59978db351d">172,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTctMS0xLTEtMA_3ac3a004-832e-41f3-8817-dbf97d8c0ae4">199,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTctMy0xLTEtMA_32b86be6-7b90-4fe2-b685-eef5bb9a37d8">205,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTgtMS0xLTEtMA_50d1649a-95a0-4972-9e7c-e6a1e7b49204">4,130,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTgtMy0xLTEtMA_4d716eb2-4d6a-4fa9-9ae1-25f1dab680f6">4,543,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligation, less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjAtMS0xLTEtMA_7b0bef14-429a-4aed-9474-f7cebd52c3fa">42,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjAtMy0xLTEtMA_92b7a272-3ca9-4a86-85e9-305d8a0a21ec">163,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjEtMS0xLTEtMA_794bcbb3-d27d-48d0-a54c-d4d5b39030e7">1,944,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjEtMy0xLTEtMA_6833dfdf-4bd3-4be6-a06a-cf6a447b3560">1,072,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:zerodash" name="us-gaap:OtherLiabilitiesNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjItMS0xLTEtMA_0cb8d086-02be-4310-8087-161b525aadf6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjItMy0xLTEtMA_c3f9f6e7-a4d5-4bad-bba2-f70e06d4b62a">9,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjMtMS0xLTEtMA_8fd0d354-51f5-4844-9297-7af2cc171437">1,987,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjMtMy0xLTEtMA_783ad40d-b090-4d61-bb84-70b7f2cf07b2">1,245,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjQtMS0xLTEtMA_f151bd47-d6f3-4fed-9b98-57d50b2c86a6">6,117,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjQtMy0xLTEtMA_c33ac690-ffe6-4dee-82bd-7b8a3d82fe5f">5,789,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 11)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjUtMS0xLTEtMA_ab9cd5cd-d919-4ace-840f-a3fa45986c33"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjUtMy0xLTEtMA_1980226d-fe66-4716-973a-2e54a8dc9256"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzMz_2330f818-8e51-464b-ae12-dfcdc2b90d3d"><ix:nonFraction unitRef="usdPerShare" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzMz_e3442711-63b2-472f-909f-f5e040cf82c1">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzQ3_5f8ce1a2-1f61-4ba7-9a3b-556bd99e68ea"><ix:nonFraction unitRef="shares" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzQ3_8ad982fb-2ced-4189-b604-811396b7b3db">10,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzY5_1d8a2869-516b-445b-8bcf-d78cc6627d24"><ix:nonFraction unitRef="shares" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzY5_22b03d8f-227b-4c28-b696-586ce3b5ce95"><ix:nonFraction unitRef="shares" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzY5_40b05ce5-9cc5-4b07-87ab-0e0355202c4f"><ix:nonFraction unitRef="shares" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzY5_b1fc9df3-ae5c-47dd-9993-523cb5fa887e">seven</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at September&#160;30, 2020 and December&#160;31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMS0xLTEtMA_226e8a7e-7590-48a6-95db-f2b2d8eaf099">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMy0xLTEtMA_16f9cf94-b982-46d6-9c64-10a864d1255c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1XzE4_3468769f-fae9-4c13-a598-cb52913ce00b"><ix:nonFraction unitRef="usdPerShare" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1XzE4_9c4d05ae-23d1-40c5-b341-728484078063">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1XzMy_b73ab170-0b2c-4835-ba58-7f7d72298183"><ix:nonFraction unitRef="shares" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1XzMy_c9a65608-fe6d-434d-87ac-896b4fbe707c">200,000,000</ix:nonFraction></ix:nonFraction> authorized; <ix:nonFraction unitRef="shares" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1XzQ3_d45a33c8-6276-48ea-bfd8-ad5ffb36719d">162,147,973</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1XzU0_c6035af3-6ef4-4722-9bb8-e830d002d9f7">52,746,728</ix:nonFraction> shares issued at September&#160;30, 2020 and December&#160;31, 2019, respectively; <ix:nonFraction unitRef="shares" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1Xzk5_5653a4e3-bddf-4de2-97c9-7e48f08a68c7">162,026,473</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1XzEwNg_47e1015c-0c7d-46c6-adae-ea02b11e92e4">52,625,228</ix:nonFraction> shares outstanding at September&#160;30, 2020 and December&#160;31, 2019, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMS0xLTEtMA_f75a2e5b-70c0-4d68-81a9-91a2df789002">1,621,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMy0xLTEtMA_23fcbdae-c487-4a13-a615-8c6c82bb387d">527,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock, at cost, <ix:nonFraction unitRef="shares" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockCommonShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmVlMjA3YTVmYTk0NTRjNGE5NGFkYmNmZmYzYjM2YTU4XzI5_1bda7c35-dba9-4992-99f4-b37c6c5bdefb"><ix:nonFraction unitRef="shares" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockCommonShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmVlMjA3YTVmYTk0NTRjNGE5NGFkYmNmZmYzYjM2YTU4XzI5_7664b0c9-3e4d-42b7-90f0-a2e7591e5710">121,500</ix:nonFraction></ix:nonFraction> shares at September&#160;30, 2020 and December&#160;31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjktMS0xLTEtMA_50a3ccb0-69e1-43b7-96b1-75c900109098">47,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjktMy0xLTEtMA_76822ff4-5c0c-4f48-b48d-2ee036f6dd9d">47,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzAtMS0xLTEtMA_f68ff825-d7d5-4b2e-99ae-0c01608db6f0">82,359,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzAtMy0xLTEtMA_42052fa9-bd69-4c7c-ba8a-a3d6eb828c36">62,018,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzEtMS0xLTEtMA_d8ac7205-e417-4efd-9b7a-c51594239f69">69,511,465</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzEtMy0xLTEtMA_21ef4f7d-c213-4ad9-906a-7d4661e7edd0">51,479,824</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzItMS0xLTEtMA_0f7e6960-e018-4d95-ad8e-d6e19b00d9bb">14,421,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzItMy0xLTEtMA_1bc07c42-77ac-459a-a818-7bf4f1bb1ca5">11,018,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzMtMS0xLTEtMA_8ccbf760-5979-4a3f-9718-27bae85070de">20,539,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzMtMy0xLTEtMA_21941542-fad2-4bc0-9172-2f29f181def4">16,807,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OCUGEN,&#160;INC.</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMy0xLTEtMS0w_75d83e8a-e1ad-423f-a59f-56102370e375">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMy0zLTEtMS0w_f63a4ea7-c8d4-4a4e-91f1-97400af88da2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMy01LTEtMS0w_11493ce0-8cb4-4859-ac9f-79d083fc818b">42,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMy03LTEtMS0w_4c628bc0-d699-4e04-be7d-01ad386158da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:Revenues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNC0xLTEtMS0w_e16dce20-783c-4cc5-ba8f-41eddc2bec2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:Revenues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNC0zLTEtMS0w_d0ef148f-564c-4b2f-9ee8-a00351fb9d6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNC01LTEtMS0w_b1efbba6-fd78-4684-84a5-43adf737b084">42,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:Revenues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNC03LTEtMS0w_69ae3712-1e17-45f6-92ec-a6dab141ae84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNi0xLTEtMS0w_01a8d579-f97c-40f9-811b-96c0dcbed9e3">1,477,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNi0zLTEtMS0w_9fd0cd28-e937-4a60-86b2-289f01a805a8">1,305,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNi01LTEtMS0w_9a8e739e-d3e9-46db-b118-05248198c32e">4,759,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNi03LTEtMS0w_dc6af499-d59a-49f4-80d9-2d0ab34dcb03">6,338,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNy0xLTEtMS0w_e90df425-0acf-4de6-bd0c-274e68edba53">7,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNy0zLTEtMS0w_61016a21-6c30-4466-bf26-610042cb306e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNy01LTEtMS0w_44838579-a759-488e-91d9-ea21d1faa48e">7,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNy03LTEtMS0w_656a9373-17fb-4daa-8d3b-d71d82fb1220">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOC0xLTEtMS0w_dda6fc11-ff0b-465e-9b4e-f92e47d1d906">1,704,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOC0zLTEtMS0w_dc9f100b-2fd9-4626-925e-8d0a63a61849">1,408,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOC01LTEtMS0w_97ff3626-0f2c-4576-b967-1915d6257325">5,760,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOC03LTEtMS0w_f34ee613-934e-4b37-924c-c2a38d766456">3,544,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOS0xLTEtMS0w_d6b28b30-53b6-4f87-937e-d70b2992c4cc">10,181,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOS0zLTEtMS0w_92d06b18-025c-4016-8c2f-9793756f3f8a">2,713,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOS01LTEtMS0w_96b6a419-79ed-47ca-a553-3baa0de9ca3b">17,519,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOS03LTEtMS0w_fe0edbb5-7b63-4fed-a950-eced75b5702a">9,883,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTAtMS0xLTEtMA_c0ee4dca-a5fc-4526-853b-45faedcd7d74">10,181,980</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTAtMy0xLTEtMA_f7c253dd-c13e-4e4a-a868-6d74245b7ad4">2,713,811</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTAtNS0xLTEtMA_6542e5c6-42ca-4b8a-b338-806760dfef75">17,477,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTAtNy0xLTEtMA_1d2abdd6-3e25-420f-b893-c998453fdff2">9,883,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTItMS0xLTEtMA_d3293719-0865-47f5-a0bc-d227eabb2e95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTItMy0xLTEtMA_a5944aed-1cfd-4e41-98b4-2ad8ace0b5fd">18,512,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTItNS0xLTEtMA_7fbee6aa-c6ae-417b-8ee8-dd1b9a9a98e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTItNy0xLTEtMA_6b245f36-4e12-4b91-9a80-ed7f574ebd74">19,896,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt conversion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:zerodash" name="ocgn:GainsLossesOnConversionOfDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTMtMS0xLTEtMA_70a01538-7c78-4c19-8e64-ccd596f0ce93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:zerodash" name="ocgn:GainsLossesOnConversionOfDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTMtMy0xLTEtMA_1ae8aa2a-0a24-41e0-835e-86a5c2aad51e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:zerodash" name="ocgn:GainsLossesOnConversionOfDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTMtNS0xLTEtMA_43898244-c7a6-4b5d-a1ff-69824da3deaf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="ocgn:GainsLossesOnConversionOfDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTMtNy0xLTEtMA_230f5fb2-014d-479b-b424-2fd8a9f322c6">341,136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" name="us-gaap:InvestmentIncomeInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTQtMS0xLTEtMA_1d169ece-2b94-4c26-9ed9-a313c6baba57">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" name="us-gaap:InvestmentIncomeInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTQtMy0xLTEtMA_585f4b8e-a133-47b5-9361-a4bb6cae910d">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" name="us-gaap:InvestmentIncomeInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTQtNS0xLTEtMA_ad3f1fe0-f13e-4720-aea5-bf97c12f5271">594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTQtNy0xLTEtMA_f1ca1fd2-a9cb-4a1f-ac15-bf91b537342f">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTUtMS0xLTEtMA_60674d24-e350-47c5-b72a-993a473d1cad">291,909</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTUtMy0xLTEtMA_abd1e343-b345-4185-827f-18115e1d188f">796,141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTUtNS0xLTEtMA_d1702f9f-b074-4f65-8410-211d7932f997">554,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTUtNy0xLTEtMA_cf5db233-d292-475b-b36d-b089e06b27fe">1,753,172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTYtMS0xLTEtMA_3ef3b64a-ebf8-401d-89b2-d8f96f33f7bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTYtMy0xLTEtMA_6e18d051-f4ef-4ad7-9b59-19da753162ee">751,261</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTYtNS0xLTEtMA_bea945c3-3c6c-4a57-90b0-eab61513924b">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTYtNy0xLTEtMA_34c27295-30ba-480e-9372-8cdab07b3a30">751,493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTctMS0xLTEtMA_21d70997-e9c2-4891-b5f4-16daaf3060cd">291,867</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTctMy0xLTEtMA_44d31c21-9806-4ce7-96a0-80df302b8764">20,059,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTctNS0xLTEtMA_0c35729a-7d46-4313-90ce-836b1aa4a2be">554,294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTctNy0xLTEtMA_89dbdaa4-ec84-482a-9d62-0e506cc2fa50">22,741,320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTgtMS0xLTEtMA_f39ff86b-e5f5-4d72-8a03-c5206b0b2432">10,473,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTgtMy0xLTEtMA_a277f8ae-d5ba-476c-9ac6-4bf82021e65f">22,773,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTgtNS0xLTEtMA_1a239651-46e5-44ff-81f0-01aafd5ffa89">18,031,641</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTgtNy0xLTEtMA_85e132b4-64b8-420d-a0c0-4f2a40027464">32,624,697</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividend related to Warrant Exchange</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:PreferredStockDividendsAndOtherAdjustments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTktMS0xLTEtMA_c35abf8d-2d5e-416c-9248-f11fbcb46aa4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:PreferredStockDividendsAndOtherAdjustments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTktMy0xLTEtMA_451847c8-7d9b-40bf-ac2f-3e85482edca3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PreferredStockDividendsAndOtherAdjustments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTktNS0xLTEtMA_ada8ddfb-faaf-4a06-9657-9237f68e823b">12,546,340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:PreferredStockDividendsAndOtherAdjustments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTktNy0xLTEtMA_77f1062a-ac98-41a6-847a-b30a8d3d4048">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjAtMS0xLTEtMA_e693c6ec-fe9d-48e1-8978-1c5059404395">10,473,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjAtMy0xLTEtMA_115e9260-0b9d-44a6-b8d9-aa560861a13f">22,773,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjAtNS0xLTEtMA_2b739099-9b4c-4eaf-912b-b8abc4fa0e3b">30,577,981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjAtNy0xLTEtMA_f3a8031a-44a5-48a8-85fc-0c37a28ea35b">32,624,697</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in calculating net loss per common share &#8212; basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjItMS0xLTEtMA_966ac592-7b36-463e-b565-afff1ed2de53">141,591,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjItMy0xLTEtMA_e08c280f-bb58-4953-b940-c314a6adfac7">6,411,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjItNS0xLTEtMA_71006fb1-bc94-4ae4-af3a-23fa76faf536">92,764,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjItNy0xLTEtMA_d650297b-d7c6-40a8-b3e1-805dd1505066">5,839,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share of common stock &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjMtMS0xLTEtMA_643f3ad2-56a4-45b8-b5ca-0203e7a5b4d8">0.07</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjMtMy0xLTEtMA_956e6a0c-e8bd-433f-b78b-87ec9849a410">3.55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjMtNS0xLTEtMA_18d86f32-d6e8-44f0-81e1-50e229d1806c">0.33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjMtNy0xLTEtMA_86ca969f-39ab-47b7-a38c-46c2ffd4997e">5.59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjUtMS0xLTEtMA_3dfb509d-ed0a-4d78-a54e-03e3e3759609">10,473,847</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjUtMy0xLTEtMA_41c7eb3e-a1c2-4983-9e4c-8b37fc4c359c">22,773,281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjUtNS0xLTEtMA_7cc9079b-1665-42bf-81ba-001ec3ea9b30">18,031,641</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjUtNy0xLTEtMA_d0ce2427-4714-4b47-927a-6ff6e2114c50">32,624,697</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjctMS0xLTEtMA_99daaaaf-d947-4fb2-9bf8-8384593cb26c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjctMy0xLTEtMA_a4fc18d8-b37c-4a37-b659-8e0c9f389314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjctNS0xLTEtMA_60c1e28b-ed91-4d83-80ed-7f82cc4d4d2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjctNy0xLTEtMA_eaaa189f-73d1-4637-bae1-dbc47b0adaff">451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjgtMS0xLTEtMA_26d08803-73fb-4b0b-a941-9799ade2a171">10,473,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjgtMy0xLTEtMA_5f1f4a74-4de1-4367-a7f1-223a0b4ee1f7">22,773,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjgtNS0xLTEtMA_3cb5546b-45c6-4e5f-a370-083418104456">18,031,641</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjgtNy0xLTEtMA_413eaba8-d4a2-408b-b854-51ceee27e299">32,625,148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OCUGEN,&#160;INC.</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.537%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.189%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Income (Loss)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98e43846e414426d8a674b5b72c8ca6d_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMi01LTEtMS0w_5cf0d292-3df6-4bd4-b19b-08417a7e7825">52,746,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e43846e414426d8a674b5b72c8ca6d_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMi03LTEtMS0w_6cf6941a-fa33-41e6-b52c-39499f1b28c8">527,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd20a7846d8b4fc39d7c932264bb4ea1_I20191231" decimals="INF" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMi05LTEtMS0w_da49646f-8613-43c2-8ba8-d3dc084613b8">47,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9993a23cdf354d4e9040dbf206654bd0_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMi0xMS0xLTEtMA_54720cbb-463a-4973-b328-6e19d986a6ec">62,018,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f8723a3bb064fb19050f09d0f6f3be8_I20191231" decimals="0" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMi0xMy0xLTEtMA_e31ded79-1298-4510-b39b-59b5cbeee2c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28157047c72a40388b8efc8371f6fcd9_I20191231" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMi0xNS0xLTEtMA_f36ef2cb-64b0-47ee-9fa8-3a83f3d96ef9">51,479,824</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMi0xNy0xLTEtMA_81bb788b-14b5-4efe-b298-493299989b97">11,018,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i609c16341b0b455fb5cb9f1944534389_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMy0xMS0xLTEtMA_603a4879-bb05-47dd-b76b-cc971b591c40">222,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88dcd54d5b2b41e98760d2603e2e5b19_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMy0xNy0xLTEtMA_4f8e3bb9-7e72-4292-b8b1-6a54c29bf3db">222,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15660c6077044e16863b22305e9f8bf4_D20200101-20200331" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNC0xNS0xLTEtMA_3969048b-ff1e-4222-bf89-2fb377c5e764">3,943,819</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88dcd54d5b2b41e98760d2603e2e5b19_D20200101-20200331" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNC0xNy0xLTEtMA_e9162dbf-b1ee-4466-9545-92b2c16f123d">3,943,819</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66618942a356454490c353406b315661_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNS01LTEtMS0w_d3db942c-09e7-4829-8e76-5c0989ea9f2f">52,746,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66618942a356454490c353406b315661_I20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNS03LTEtMS0w_63b160c8-3faf-480f-bba8-23dc4e7fd125">527,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f1a10afb95b4de09f391c08ee58cb4a_I20200331" decimals="INF" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNS05LTEtMS0w_5858f5b3-a534-4a00-ae89-106fbbc4ae63">47,864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4a740be98724d9e987038a54f18720a_I20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNS0xMS0xLTEtMA_422f827b-04f6-4cd0-ab0a-423d39f8d7c3">62,241,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31ecd93cc7af4dbaa563d03c878f6d01_I20200331" decimals="0" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNS0xMy0xLTEtMA_7d3a76eb-0b5d-4086-8d21-f98aa82e05ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9669856efb5d4178a3b37eabd7255b5f_I20200331" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNS0xNS0xLTEtMA_1ee43c1f-84ae-4373-beb1-37e4c852a561">55,423,643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dc4b283ea42412298190a0bb1c42842_I20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNS0xNy0xLTEtMA_f647fb3d-d0fd-4798-bcf5-a62fe30252b5">7,297,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394152742f2b46919b80f9aac6e0bdae_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNi0xMS0xLTEtMA_d0909744-5bc4-49b8-b4ad-2a0671b43b1e">149,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i328e36f86432406a9c2335a6a30ed14e_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNi0xNy0xLTEtMA_6ae179c7-090f-4c5c-84f0-c84fee822a12">149,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrant Exchange</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff5a8b4ad96a4423b5a5d8703b80fd89_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNy01LTEtMS0w_f43e113a-155c-4899-835d-43b472a8d398">21,920,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff5a8b4ad96a4423b5a5d8703b80fd89_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNy03LTEtMS0w_96d99b71-a226-41f2-828a-b904dd4771d4">219,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394152742f2b46919b80f9aac6e0bdae_D20200401-20200630" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNy0xMS0xLTEtMA_239d5803-455f-4514-8739-c54ff3a8483b">5,197,084</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i328e36f86432406a9c2335a6a30ed14e_D20200401-20200630" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNy0xNy0xLTEtMA_af9c6a43-d861-4c7f-a727-97c36e1f75e7">4,977,876</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for subscription agreements and warrant exercises</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d76dbaad2e54a01a5508dc7b046d2a2_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOC01LTEtMS0w_b089f9e0-25ff-473f-9e6b-2a9a4886f6a6">1,328,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d76dbaad2e54a01a5508dc7b046d2a2_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOC03LTEtMS0w_4ff7de06-f01b-4fb2-bd4f-100193979fed">13,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c5385b73d594d0cb6109dbeb0dd402f_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOC0xMS0xLTEtMA_c27e48ab-9113-443d-82bc-70c5245819ca">318,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d3447d3ea544b67af6beab734e24ec1_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOC0xNy0xLTEtMA_468ad7c1-62e3-402b-86ce-87877c2a0287">331,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">At-the-market common stock issuance, net of $<ix:nonFraction unitRef="usd" contextRef="i84ec37475ad1407b8afd9d013bad577a_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOS0wLTEtMS0wL3RleHRyZWdpb246OWZmMGM5YjI3NDI5NDEwMmIyMDFlN2YzZDk4ODJlZDBfNDg_dac565ae-d96e-4ce9-993e-ded4de44f170">0.7</ix:nonFraction>&#160;million of commissions and equity issuance costs</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7f4e1ed546c4dd3bbdecfae1575602d_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOS01LTEtMS0w_1530f6e9-e00b-4d61-8309-efc44a423657">59,132,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f4e1ed546c4dd3bbdecfae1575602d_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOS03LTEtMS0w_e2e51f3f-04a5-4b41-ac20-1863cffda0fb">591,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafb9f9ece2254e5d96200b89c04d05ae_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOS0xMS0xLTEtMA_7422941f-ca18-47f6-b5d0-1970c9c111e5">14,845,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84ec37475ad1407b8afd9d013bad577a_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOS0xNy0xLTEtMA_cd51840c-a3b9-4a58-a769-8db92d3568fb">15,436,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3761ade97814636b361bfcc7c6b79e1_D20200401-20200630" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTAtMTUtMS0xLTA_505afa39-dc72-4b8f-b2b8-17ee192f2df2">3,613,975</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i328e36f86432406a9c2335a6a30ed14e_D20200401-20200630" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTAtMTctMS0xLTA_f351cd9e-989a-4716-9d8f-bc863b37cc41">3,613,975</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c8324876bb7424fb4a9c74dbd244211_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTEtNS0xLTEtMA_ba928e3d-447a-4228-8e9e-bc36293abd4a">135,128,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c8324876bb7424fb4a9c74dbd244211_I20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTEtNy0xLTEtMA_4632d845-a123-4c36-b27e-093d414b238d">1,351,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5848bd936cb84e5c9b92ed98dc5efc4c_I20200630" decimals="INF" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTEtOS0xLTEtMA_0e535c2e-eff9-46fe-9faf-a1690f04ae71">47,864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21e4bdc375dc4ba88ea91dac7663985e_I20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTEtMTEtMS0xLTA_3802c8d7-a875-4167-b50e-3f59b4349245">72,357,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0da0e17b44c4d069cb3178f2bcee63e_I20200630" decimals="0" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTEtMTMtMS0xLTA_49f5f5f4-420b-4087-baa0-a4f1317ff91c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6525b0b5dc1b4d65ad83f61508bd23f7_I20200630" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTEtMTUtMS0xLTA_d9a63688-533f-4e5a-bb9a-315f6251842d">59,037,618</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18aa74b3c07a4d74a32c957095f16197_I20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTEtMTctMS0xLTA_6cc9627a-7ecf-4520-8d1a-34e5d9f60e5b">14,623,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d5479720a7404bb1a1908a324dc51e_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTItMTEtMS0xLTA_eb23c322-16cc-46b2-ace1-395ce21919b1">126,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTItMTctMS0xLTA_69352188-2a0a-402e-b0b9-3e882d4bd972">126,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">At-the-market common stock issuance, net of $<ix:nonFraction unitRef="usd" contextRef="ia40e42f6afba4d05aafce4ad7747ba3b_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTMtMC0xLTEtMzcvdGV4dHJlZ2lvbjpiOTg2MmFlYzcwMDA0YzRhOTJhMDdjY2NiNzdmY2ZhOF8xMDk5NTExNjI3ODg4_226c480e-78a4-4c98-9a7e-029befb87e19">0.4</ix:nonFraction>&#160;million of commission and equity issuance costs</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifec1223b1319497b93668a034608cb1c_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTMtNS0xLTEtMzM_4dc96e93-98fe-45ce-a202-6e4627697935">27,019,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifec1223b1319497b93668a034608cb1c_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTMtNy0xLTEtMzM_f6e22649-9bf5-49fd-8d04-f374c27f1c19">270,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c44d34b710b4e7e85a02e804db3124f_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTMtMTEtMS0xLTMz_0b238359-d878-40f6-85da-4fbe982c96eb">9,875,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia40e42f6afba4d05aafce4ad7747ba3b_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTMtMTctMS0xLTMz_401c26ef-ca29-4a4d-87d8-422bafb83802">10,146,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2890f5772ae94a0baf3455349ee0ef1e_D20200701-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTMtMTUtMS0xLTA_06d4cb5f-57bd-4c22-89fd-5b384f981f68">10,473,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTMtMTctMS0xLTA_c930be02-a669-48a0-8f3a-5b5a61bb1f1b">10,473,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b195f0612774af0ac040960b61f8f93_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTQtNS0xLTEtMA_bd64b9e5-b985-4c5c-9f0f-a8249f176072">162,147,973</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b195f0612774af0ac040960b61f8f93_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTQtNy0xLTEtMA_ce6780d3-c3cd-4863-9acd-7a0e0be190e5">1,621,480</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i893354ca24b44aea8098609fe2707967_I20200930" decimals="INF" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTQtOS0xLTEtMA_25c0a65d-babc-4ff4-836e-08ca1019fea5">47,864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcec84ede62e484c81eb25c7fadbd8fb_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTQtMTEtMS0xLTA_e5be5645-b75a-4151-ae29-9ca684e205b3">82,359,494</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fd67196ac9e4ddcbc7f6a1fe73988b1_I20200930" decimals="0" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTQtMTMtMS0xLTA_4f6017a0-cabd-4bd2-80a0-bb0bea381d99">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id192bd6eec634f2999ed2c6284506bd2_I20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTQtMTUtMS0xLTA_25a9c709-e4cc-418d-b4f9-7b05680b5236">69,511,465</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTQtMTctMS0xLTA_ff397534-7ec4-4c8e-ab59-20998c2e2ad6">14,421,645</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OCUGEN,&#160;INC.</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT) (CONTINUED)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.042%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Income (Loss)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib39682b0589a4563bb7ca6600d2c74bb_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMi0xLTEtMS0w_f30e5125-8fcd-4ee8-a2a9-eee8960c6401">4,960,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib39682b0589a4563bb7ca6600d2c74bb_I20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMi0zLTEtMS0w_e4a37d98-0dfb-4e89-80d5-597c5966d52d">49,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if64358bdad2f49bb80ab64f710d95a09_I20181231" decimals="INF" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMi01LTEtMS0w_9f147a67-0866-432d-b825-f7c2445201c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecffe72ae39480a8cc4dea5b165a9a9_I20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMi03LTEtMS0w_66c6614c-9a05-490c-85e0-090b6a1b293f">18,477,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cb32b18dd0a4067962fc9ab0625c09c_I20181231" decimals="0" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMi05LTEtMS0w_6db2e1f3-66d4-46c4-a67b-e5bdab6ddc6c">451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2c738591a314487b302f77f09e6912a_I20181231" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMi0xMS0xLTEtMA_f4bf0fd1-de3a-44c0-aaa2-b76da0f802cc">31,237,194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e8e99c2015f49bb951bff3956b8fa43_I20181231" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMi0xMy0xLTEtMA_c5a75f43-5c55-465e-ab96-513b450e4759">12,709,539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd3fa288f1e4b63accc8a222321ed39_D20190101-20190331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMy03LTEtMS0w_7b616f4b-cc19-414a-b633-42e29c549de8">415,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64c7a1ac8ad047eca985cb5ee6a0d2c2_D20190101-20190331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMy0xMy0xLTEtMA_4ad25ff4-30f9-44c7-beec-dcf1838f03b9">415,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac9335d486854d3084e445a33994b49e_D20190101-20190331" decimals="0" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNC05LTEtMS0w_60dac18a-bceb-4abd-994d-c52fa102b24c">282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64c7a1ac8ad047eca985cb5ee6a0d2c2_D20190101-20190331" decimals="0" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNC0xMy0xLTEtMA_8e686025-e136-4f23-92e7-56d4a384832c">282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6958ed5917474f8296be96a2f1c58358_D20190101-20190331" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNS0xMS0xLTEtMA_79474c27-00fd-4aab-b2b0-3cf6af757692">6,312,606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64c7a1ac8ad047eca985cb5ee6a0d2c2_D20190101-20190331" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNS0xMy0xLTEtMA_49285a48-5517-4d1f-ad63-f452a682b7be">6,312,606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0540cef311b94b2cb1eaf0f5cb846d7c_I20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNi0xLTEtMS0w_4c38acf9-2f05-4826-b049-6e3147682062">4,960,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0540cef311b94b2cb1eaf0f5cb846d7c_I20190331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNi0zLTEtMS0w_1e0d7554-8ad4-4d60-a454-5b5e4ccdcaaf">49,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd37dadabb2844f9a10e911cb83f43c0_I20190331" decimals="INF" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNi01LTEtMS0w_d44d4537-6083-4c04-8e15-03e7f2873bb9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544370edaa6242a58ab1c22527f96140_I20190331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNi03LTEtMS0w_431946b1-9631-4596-afbe-86900f067750">18,892,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec2583968c54b76b5925cc04d32749f_I20190331" decimals="0" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNi05LTEtMS0w_6bbc5019-7404-45dc-8ab7-7db52f289288">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9d5c4839f734f9d8af158d6419bc025_I20190331" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNi0xMS0xLTEtMA_9ecfda2d-454e-410e-9d11-cc281f03a762">37,549,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83bb706036a64f5ea79f154273a0ebe0_I20190331" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNi0xMy0xLTEtMA_34f2c2a4-3848-43ff-9b09-f8555fa67cd9">18,607,225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ac27353df346c9933361da82476672_D20190401-20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNy03LTEtMS0w_a785ec32-208b-4cd1-bea4-15feb1734de0">111,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2c719325c44e12b2d5790a34483527_D20190401-20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNy0xMy0xLTEtMA_0f7df3ed-4cbf-4e38-8074-de8402409600">111,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8aafdea70ac54f0092cc97d32f96a3a5_D20190401-20190630" decimals="0" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfOC05LTEtMS0w_2a0efdb6-63e0-4225-8734-8d5107c438a6">169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2c719325c44e12b2d5790a34483527_D20190401-20190630" decimals="0" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfOC0xMy0xLTEtMA_d12fecb7-9229-42bf-8e12-907a619fe521">169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Conversion of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5a973efc1294d12ba97fd0f51a25d4a_D20190401-20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfOS0xLTEtMS0w_29f50417-f0f4-4d2c-a2cc-ad251dbc06d0">1,125,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a973efc1294d12ba97fd0f51a25d4a_D20190401-20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfOS0zLTEtMS0w_b268c984-8dbf-4e02-877f-f700b0b869ac">11,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ac27353df346c9933361da82476672_D20190401-20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfOS03LTEtMS0w_5e4ae3dc-4cea-473e-8db8-42e360855259">13,968,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2c719325c44e12b2d5790a34483527_D20190401-20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfOS0xMy0xLTEtMA_3b57d191-1382-436c-abe3-173d977601b1">13,979,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5a973efc1294d12ba97fd0f51a25d4a_D20190401-20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTAtMS0xLTEtMA_570ac778-d9fb-437d-81ee-4b5e2412c70f">157,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a973efc1294d12ba97fd0f51a25d4a_D20190401-20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTAtMy0xLTEtMA_7407349e-28e3-4e50-b069-b1aef41edb19">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ac27353df346c9933361da82476672_D20190401-20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTAtNy0xLTEtMA_d3f0cc62-3ee1-4cf4-bd74-09116c6dd2b3">1,947,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2c719325c44e12b2d5790a34483527_D20190401-20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTAtMTMtMS0xLTA_8da56311-52fe-40fd-9b1d-ff32a450e54c">1,948,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i856b691e765e44f8afa4a464a1e78d9e_D20190401-20190630" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTEtMTEtMS0xLTA_7075a36f-95b8-4e21-8fe8-616f23e4955d">3,538,810</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2c719325c44e12b2d5790a34483527_D20190401-20190630" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTEtMTMtMS0xLTA_f4482302-2ff4-4883-bbe2-aeac729cb6b2">3,538,810</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i83267470589c49dabfad039edd942ede_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTItMS0xLTEtMA_da074e63-2a1c-4bfc-943a-5582ed3ef6b4">6,243,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83267470589c49dabfad039edd942ede_I20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTItMy0xLTEtMA_96450235-0015-4faf-98e8-2396e1740313">62,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604296e53c7c4e829ae539a464ee39bf_I20190630" decimals="INF" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTItNS0xLTEtMA_750dd02a-5ab1-4f16-865f-0ca38d9a4870">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba87472b7a74f70b1be08aa590ce293_I20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTItNy0xLTEtMA_d31e89da-0358-4c10-bc22-fc95827d3283">34,920,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i428aecd8c23f42019007455d1a246411_I20190630" decimals="0" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTItOS0xLTEtMA_432548b1-7ad0-42f2-b0a8-e208865b4dd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92496e8c334d48b585f951d94a716b85_I20190630" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTItMTEtMS0xLTA_015749c0-1813-4c06-8f6b-47652bd53419">41,088,610</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ac0b7a5cf8e4897b11c2a3631e77ac0_I20190630" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTItMTMtMS0xLTA_0f9d2318-d6cd-4724-bf2e-d1acc307a13c">6,105,723</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c82191e545a466984e92701810a3a95_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTMtNy0xLTEtODI_47c45d8d-f231-4976-adaf-1da89cf7b1c2">193,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTMtMTMtMS0xLTgy_0dda3811-0e14-4d9d-b700-01f5300f5668">193,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of stock for reverse asset acquisition, net of $<ix:nonFraction unitRef="usd" contextRef="ib0884c1459fe43f596eee437b5363a5a_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTQtMC0xLTEtNTgvdGV4dHJlZ2lvbjpjYzA3Yjg2ZWJkMDI0YjVjYmZhYzFjODM1NTQ1ODAxY18xMDk5NTExNjI3ODY5_1e0ae699-88ad-4b53-bfaa-44ab7069416d">5.0</ix:nonFraction>&#160;million of costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7760c1095dda43128a60a00128e94a57_D20190701-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTQtMS0xLTEtODI_177d07bf-2e90-49f6-9b06-02445a6b67e4">1,576,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7760c1095dda43128a60a00128e94a57_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTQtMy0xLTEtODI_1b9115e9-a649-49d1-80f2-ca42aeb936e7">15,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a53906430b5411ea8116131d4c97f45_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTQtNy0xLTEtODI_7861e29d-045f-49e9-997a-15ca6ac8cf73">2,325,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0884c1459fe43f596eee437b5363a5a_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTQtMTMtMS0xLTgy_53ad25b3-c391-4330-ab29-f3a6557eaaec">2,341,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under Pre-Merger Financing, net of $<ix:nonFraction unitRef="usd" contextRef="i2f73b959d8e14b9098644555fbd773bb_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTUtMC0xLTEtNTgvdGV4dHJlZ2lvbjpiOGJlNWVkYjM2YzM0MmI2OTE2ODFjMzlhYzEyYzE2MF8xMDk5NTExNjI3ODcz_eea71e58-384d-478e-9e97-3c3d8d49ba2f">1.8</ix:nonFraction>&#160;million of costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01d87cc2a4764d93ac0bdd0a8c59cb83_D20190701-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTUtMS0xLTEtODI_3af9bcfa-00d8-46e0-82b1-f31aa0516dfd">2,192,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d87cc2a4764d93ac0bdd0a8c59cb83_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTUtMy0xLTEtODI_019c68ec-a7f2-401d-892a-2b248c4d3b76">21,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e43eec18c794fc481f0826a92482fc5_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTUtNy0xLTEtODI_4eb669bc-1878-424e-92ac-d5ed542db7ea">13,229,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f73b959d8e14b9098644555fbd773bb_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTUtMTMtMS0xLTgy_d4bf2f02-a560-4ef9-a565-86396e4812f1">13,251,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87973e4eacbb4326a84eb1f0a491f757_D20190701-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTYtMTEtMS0xLTgy_84290494-5513-4ced-a01d-46dd995674fe">22,773,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTYtMTMtMS0xLTgy_c8e8ea81-5813-4464-8938-d8356a3444c1">22,773,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at September 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i08862f2fb8e94c82b2e2dcbf7ad2b49f_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTctMS0xLTEtODI_827640f4-c21e-4273-9ba0-f4304bbcfe15">10,013,605</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08862f2fb8e94c82b2e2dcbf7ad2b49f_I20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTctMy0xLTEtODI_49012d64-4aa1-4108-925b-56474de1d84a">100,136</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c1260fccbd4436ba5f9ed5d97ed88be_I20190930" decimals="INF" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTctNS0xLTEtODI_06027a25-327b-49cd-9583-e2794999d80a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7b469aa758f4755afe661f5ed2d8bf5_I20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTctNy0xLTEtODI_accc5237-2ec2-4c21-922a-ef35190f67d3">50,668,493</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bd31c10c4a3492e971d2489a2155990_I20190930" decimals="0" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTctOS0xLTEtODI_c9bf1a73-16ff-4635-9c4b-83de52eae501">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dc6aea499224e54b008c9eab809c76d_I20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTctMTEtMS0xLTgy_4eab62aa-ae5e-40db-9699-55f6b6eb88aa">63,861,891</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff87527ea3fc46fdacb3342226f9f0f9_I20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTctMTMtMS0xLTgy_a933500f-dafc-4004-889f-bde5ab97ba5c">13,093,262</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OCUGEN,&#160;INC.</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMy0xLTEtMS0w_42406fe5-08a1-48b2-b60c-31da1ea626e0">18,031,641</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMy0zLTEtMS0w_201885b6-0bee-41e7-92ea-47622a3bc043">32,624,697</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNS0xLTEtMS0w_2e1cae96-0461-4fe2-8566-742eb8b7bd3f">57,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNS0zLTEtMS0w_eb55a2b8-a501-4789-8b69-42d3e6138ef5">34,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="ocgn:NonCashInterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNi0xLTEtMS0w_8262651d-1d04-4196-be3e-f4720a834306">554,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="ocgn:NonCashInterestExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNi0zLTEtMS0w_eabf43fd-08c1-4ea4-bd12-dc4f8b691e88">1,718,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="ocgn:NoncashLeaseExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNy0xLTEtMS0w_08017a28-9fe3-4787-8407-b1619b2ccc36">142,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="ocgn:NoncashLeaseExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNy0zLTEtMS0w_70916d78-ce02-4fc7-85ab-b7da5175f79d">202,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfOC0xLTEtMS0w_e956761a-27f6-4f3d-baef-c8700f2b4ad5">7,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfOC0zLTEtMS0w_e36c3c36-d410-4f6a-aafd-cd05546cb211">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfOS0xLTEtMS0w_3b51d234-5d48-42a1-8399-7acd85a3bd09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfOS0zLTEtMS0w_0b1fa8eb-20a2-43b6-88c6-27cb45234455">19,896,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTAtMS0xLTEtMA_b7a44d0f-cd77-4534-ae84-6243c7920303">498,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTAtMy0xLTEtMA_b4e6ca0d-3553-480e-8a0f-f7ccdb51dcb0">720,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt conversion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:zerodash" name="ocgn:GainsLossesOnConversionOfDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTEtMS0xLTEtMA_91177f01-472e-475d-b32f-85d8fccd0a82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="ocgn:GainsLossesOnConversionOfDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTEtMy0xLTEtMA_99f84522-1402-4e0e-a3d4-ab6b48871292">341,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherNoncashIncomeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTItMS0xLTEtMA_fb25cfea-72c6-4741-a834-a55f4bff359d">165,609</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:OtherNoncashIncomeExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTItMy0xLTEtMA_51c24b7b-e572-4085-a620-da26ba10a73a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTQtMS0xLTEtMA_322b1289-8f50-4b22-b30b-ceef9fbdb8b5">794,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTQtMy0xLTEtMA_430b9c63-a266-4c03-beb7-93e99c6887bc">280,838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTYtMS0xLTEtMA_f9ee6d3d-ad4e-4407-b68b-01f1ca3f012c">1,133,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTYtMy0xLTEtMA_639b0f54-aad1-464a-a589-191ddb0a13cf">2,044,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="ocgn:IncreaseDecreaseInLeaseObligations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTctMS0xLTEtMA_8f3d4368-803d-4d97-a1ab-45231a4cc659">143,834</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="ocgn:IncreaseDecreaseInLeaseObligations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTctMy0xLTEtMA_1b47086a-7534-42c2-8d22-598b155ac639">202,338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTgtMS0xLTEtMA_c2355388-f5f9-4a47-82fc-54ce07cad8e5">10,426,453</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTgtMy0xLTEtMA_492e2255-5c33-449a-be31-786ce02f23b5">8,149,359</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjAtMS0xLTEtMA_eb1828bd-13de-47ff-88d8-91ce8ff929b6">55,488</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjAtMy0xLTEtMA_33d89cca-109e-4a7b-a89e-d085fe3e4566">2,067</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of reverse asset acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjEtMS0xLTEtMA_fc7070e1-49b2-425f-8b61-b377c831619c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjEtMy0xLTEtMA_c3585b17-c648-4179-bdae-c6bb1c68287c">2,334,063</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjItMS0xLTEtMA_6c58daf7-6e40-461e-ae36-9552406d7535">55,488</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjItMy0xLTEtMA_94e10a7a-bce6-41be-b06b-6d56ffd0b585">2,336,130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease principal payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjQtMS0xLTEtMA_9b6cbabb-2d71-41b7-87fe-058bd328a5ef">17,892</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjQtMy0xLTEtMA_ba1b3ac9-1091-4466-9ec4-76c0ef8e43ed">16,985</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjUtMS0xLTEtMA_0d7689ac-3efc-4c56-9007-36f7c90c90a8">26,692,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjUtMy0xLTEtMA_9b570d0f-d93a-4e0a-9a5a-9c298f672ed6">999,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of equity issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjYtMS0xLTEtMA_fa135fa2-3ed0-4ab9-affd-92be421eeb0f">1,083,990</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjYtMy0xLTEtMA_c3877028-c0ae-4f8f-94ec-ab31647bdf0d">649,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjctMS0xLTEtMA_4f9369e3-8c42-4a87-bc70-8672e2739a40">921,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjctMy0xLTEtMA_42e0f859-61c7-4873-a75c-2a9b4c184fa8">6,800,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfFinancingCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjgtMS0xLTEtMA_2665cc9a-dcb0-45e7-8da8-9fd9ec666b7c">5,740</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfFinancingCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjgtMy0xLTEtMA_2b1ce09f-778b-4552-93a4-9cebda725a30">122,262</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfOtherDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjktMS0xLTEtMA_ec0ff976-0b99-47c5-8b2d-f3dc2255ffb4">4,362,271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfOtherDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjktMy0xLTEtMA_1c2c1e01-ddaa-465c-bb44-09f85e8aa8f7">5,290,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from Pre-Merger Financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:zerodash" name="ocgn:ProceedsFromPreMergerFinancingFinancingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzAtMS0xLTEtMzc4_3e27cd24-ef76-4300-be81-0092b9285a42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="ocgn:ProceedsFromPreMergerFinancingFinancingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzAtMy0xLTEtMzc4_920a4bb1-28f5-4478-a934-b0e16e05ae99">22,437,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzAtMS0xLTEtMA_3b8c15b9-20b7-4e07-975a-0ddec1b7b1df">22,143,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzAtMy0xLTEtMA_3daed63c-3d7d-4ca2-bb21-868251115038">24,158,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect of changes in exchange rate on cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzEtMS0xLTEtMA_1c1f1b80-0d04-4939-822c-d09aa08d44dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzEtMy0xLTEtMA_0e28f499-5aa7-4d9f-a3a6-0a3610bfef95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzItMS0xLTEtMA_9510287d-c2ca-42ca-ad79-a20670f10d13">11,661,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzItMy0xLTEtMA_dd4ebdc1-fd04-4a04-85ec-6aee0091f35e">13,673,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzMtMS0xLTEtMA_da5e7da4-1afd-4963-8b4b-4e4a11e07c63">7,595,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e8e99c2015f49bb951bff3956b8fa43_I20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzMtMy0xLTEtMA_d03a4d99-c6aa-4c99-bb31-cb6236b29b8b">1,778,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzQtMS0xLTEtMA_a7859011-e130-400b-9ebc-1c47dcd2890d">19,257,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff87527ea3fc46fdacb3342226f9f0f9_I20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzQtMy0xLTEtMA_1e46c090-f6b3-4160-abcf-2a07842c6f1b">15,451,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosure of non-cash transactions:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Warrant Exchange Promissory Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NotesIssued1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzYtMS0xLTEtMA_efe694cb-a1c3-489f-ad08-85cb0ac235cc">5,625,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:NotesIssued1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzYtMy0xLTEtMA_358c72d7-494f-44e0-8353-62dcc61360b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Obligation settled with common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssued1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzctMS0xLTEtMA_773e3129-a5bd-47c1-a88e-fe243b6d4b36">331,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:StockIssued1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzctMy0xLTEtMA_d0d831ef-eb63-4f76-8ee0-1f173e3e914f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of convertible notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:DebtConversionOriginalDebtAmount1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzgtMS0xLTEtMA_4e158742-fb91-4fd0-939d-1c14035df383">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtConversionOriginalDebtAmount1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzgtMy0xLTEtMA_cc39e275-0d70-4278-a120-36f30c1f19df">13,979,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset related to operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:zerodash" name="ocgn:NoncashOrPartNoncashOperatingLeaseRightOfUseAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNDAtMS0xLTEtMA_91f1288a-f9ee-46e8-b940-4cd2e289338d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="ocgn:NoncashOrPartNoncashOperatingLeaseRightOfUseAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNDAtMy0xLTEtMA_0461419e-695d-443c-aaf5-7b801440b5cb">470,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity issuance costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="ocgn:NoncashOrPartNoncashAmountOfDeferredTransactionCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNDItMS0xLTEtMjg0MQ_49da5034-3ebb-462b-91ae-407f878751dd">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="ocgn:NoncashOrPartNoncashAmountOfDeferredTransactionCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNDItMy0xLTEtMjg0MQ_7f75d35d-fc34-49fa-966a-a82cf3a4b3e7">1,150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reverse asset acquisition costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:zerodash" name="ocgn:DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNDMtMS0xLTEtMzk0_192f3798-ae72-4ccb-a8c6-d8d51a63fd20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="ocgn:DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNDMtMy0xLTEtMzkw_330f8269-bfed-451a-9745-00e24cef2d74">2,711,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OCUGEN, INC.</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_34"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfNzM0MA_9b4968c8-6cc6-4553-81f7-a6fd886d96d7" continuedAt="ie0fdce61907f4f8aba919aa69307f784" escape="true">Nature of Business</ix:nonNumeric></span></div><ix:continuation id="ie0fdce61907f4f8aba919aa69307f784" continuedAt="ia37df2cb471b48c5a93074e20a68bf3b"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ocugen, Inc. (formerly known as Histogenics Corporation), together with its wholly owned subsidiaries (&#8220;Ocugen&#8221; or the &#8220;Company&#8221;), is a biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to cure blindness diseases. The Company is located in Malvern, Pennsylvania, and manages its business as <ix:nonFraction unitRef="segment" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfMzc1_151fd1eb-31d0-4aeb-83ad-f545400507a3">one</ix:nonFraction> operating segment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ocugen is developing a modifier gene therapy platform to generate therapies designed to fulfill unmet medical needs in the area of retinal diseases, including inherited retinal diseases ("IRDs") and dry age-related macular degeneration ("AMD"). Ocugen's modifier gene therapy platform is based on nuclear hormone receptors ("NHRs") which have the potential to restore homeostasis, the basic biological processes in the retina. Unlike single-gene replacement therapies, which only target one genetic mutation, Ocugen believes that its gene therapy platform, through its use of NHRs, represents a novel approach in that it may address multiple retinal diseases with one product. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ocugen's first gene therapy candidate, OCU400, is being developed to treat retinitis pigmentosa ("RP"), a group of rare genetic disorders that involves a breakdown and loss of cells in the retina and can lead to visual impairment and blindness. Ocugen has received <ix:nonFraction unitRef="orphan_drug_designation" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="ocgn:NumberOfOrphanDrugDesignations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfMTM0MA_3917f8a7-22d2-4d9a-9a27-bb7ebffaaa35">four</ix:nonFraction> Orphan Drug Designations ("ODDs") from the Food and Drug Administration ("FDA") for the treatment of certain disease genotypes: nuclear receptor subfamily 2 group E member 3 ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NR2E3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"), centrosomal protein 290 ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CEP290</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"), rhodopsin ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RHO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"), and phosphodiesterase 6B ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PDE6B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">") mutation-associated RP. Ocugen is planning to initiate <ix:nonFraction unitRef="clinical_trial" contextRef="id9576326dbf84d1db30189e963d4195f_D20210701-20211231" decimals="INF" format="ixt-sec:numwordsen" name="ocgn:NumberOfClinicalTrialsToBeInitiatedInTheFuture" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfMTgxNw_6cb03426-f016-4ba1-a1df-1787899af94e">two</ix:nonFraction> Phase 1/2a clinical trials for OCU400 in the second half of 2021. Ocugen's second gene therapy candidate, OCU410, is being developed to utilize the nuclear receptor genes RAR-related orphan receptor A ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RORA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">") for the treatment of dry AMD. This candidate is currently in preclinical development. Ocugen is planning to initiate a Phase 1/2a clinical trial for OCU410 in 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ocugen is also conducting preclinical development for its biologic product candidate, OCU200. OCU200 is a novel fusion protein designed to treat diabetic macular edema ("DME"), diabetic retinopathy ("DR") and wet AMD. Ocugen plans to expand the therapeutic applications of OCU200 beyond DME, DR and wet AMD to potentially include macular edema following retinal vein occlusion and myopic choroidal neovascularization. Ocugen expects to initiate Investigational New Drug ("IND") enabling preclinical studies for OCU200 in 2021 and a Phase 1/2a clinical trial for OCU200 in the first half of 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ocugen was developing OCU300, a small molecule therapeutic for the treatment of symptoms associated with ocular graft versus-host disease ("oGVHD"). On June 1, 2020, Ocugen announced that it had discontinued the Phase 3 trial of OCU300 based on results of a pre-planned interim sample size analysis conducted by an independent Data Monitoring Committee, which indicated the trial was unlikely to meet its co-primary endpoints upon completion. The trial was not stopped based on safety concerns. Ocugen is no longer pursuing the development of this product candidate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger with Histogenics</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2019, the Company completed its reverse merger with Ocugen OpCo, Inc. (&#8220;OpCo&#8221;) in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated as of April&#160;5, 2019, by and among Histogenics Corporation ("Histogenics"), OpCo and Restore Merger Sub,&#160;Inc., a wholly owned subsidiary of Histogenics (&#8220;Merger Sub&#8221;), as amended (the &#8220;Merger Agreement&#8221;), pursuant to which Merger Sub merged with and into OpCo, with OpCo surviving as a wholly owned subsidiary of Histogenics (the &#8220;Merger&#8221;). Immediately after completion of the Merger, Histogenics changed its name to Ocugen,&#160;Inc. and the business conducted by Ocugen,&#160;Inc. became the business conducted by OpCo. OpCo is deemed to be the accounting acquirer. Accordingly, the historical financial statements of OpCo became the Company&#8217;s historical financial statements, including the comparative prior periods. See Note 3 for additional information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reverse Stock Split</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with, and immediately prior to the completion of the Merger, Histogenics effected a reverse stock split of the common stock, at a ratio of 1-for-60 (the &#8216;&#8216;Reverse Stock Split&#8217;&#8217;). Under the terms of the Merger Agreement, the Company issued common stock to OpCo&#8217;s stockholders at an exchange rate of <ix:nonFraction unitRef="number" contextRef="i4b761e61f7dd46ec849abd0bd8bb9544_D20200101-20200930" decimals="4" name="ocgn:BusinessCombinationIssuedSharesExchangeRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfNDQ3MQ_af0b896b-9e49-4136-b3ba-42a75e0e013c">0.4794</ix:nonFraction> shares of common stock, after taking into account the Reverse Stock Split, for each share of OpCo&#8217;s common stock outstanding immediately prior to the Merger.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="ia37df2cb471b48c5a93074e20a68bf3b"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The capital structure, including the number of shares of common stock issued appearing in the condensed consolidated balance sheets for the periods presented, reflects that of Ocugen. All references in the condensed consolidated financial statements to the number of shares and per-share amounts of common stock have been retroactively restated to reflect the exchange rate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred recurring losses and negative cash flows from operations since inception and has funded its operating losses through the sale of common stock, warrants to purchase common stock, the issuance of convertible notes, debt, and grant proceeds. The Company incurred net losses of approximately $<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfNTMzNA_94f91a0a-4b26-4a89-b4c3-57950b9fa5ee">18.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfNTM0MQ_e981e2aa-96ef-4800-99ee-ebcb5779dbf5">32.6</ix:nonFraction> million for the nine months ended September 30, 2020 and 2019, respectively. As of September&#160;30, 2020, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfNTQyOQ_f8efcba3-e227-4271-a85c-aa19f97a9443">69.5</ix:nonFraction> million and cash, cash equivalents and restricted cash totaling $<ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfNTQ4OA_f5fb8e1e-e784-49d5-9d02-4e8e56168327">19.3</ix:nonFraction> million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a limited operating history and its prospects are subject to risks, expenses and uncertainties frequently encountered by companies in its industry. The Company intends to continue its research and development efforts for its product candidates, which will require significant funding. If the Company is unable to obtain additional financing in the future or research and development efforts require higher than anticipated capital, there may be a negative impact on the financial viability of the Company. The Company plans to increase working capital by raising additional capital through public and private placements of equity and/or debt, payments from potential strategic research and development arrangements, sale of assets, and licensing and/or collaboration arrangements with pharmaceutical companies or other institutions. Such financing may not be available at all, or on terms that are favorable to the Company. While management of the Company believes that it has a plan to fund ongoing operations, its plan may not be successfully implemented. Failure to generate sufficient cash flows from operations, raise additional capital through one or more financings, or appropriately manage certain discretionary spending could have a material adverse effect on the Company&#8217;s ability to achieve its intended business objectives.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of these factors, together with the anticipated increase in spending that will be necessary to continue to develop the Company&#8217;s product candidates, there is substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that these condensed consolidated financial statements are issued. The condensed consolidated financial statements do not contain any adjustments that might result from the resolution of any of the above uncertainties.</span></div></ix:continuation><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_40"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MTU_8fd6b496-27e4-4f3f-8b33-6577cee6e13b" continuedAt="i243c1d0d69554033ae3ca257672757bb" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i243c1d0d69554033ae3ca257672757bb" continuedAt="if0ef317b46a9435394840c7638935358"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MTk_43e00cc8-572d-43cc-a394-ad4e32403f9c" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements included herein have been prepared in conformity with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) and under the rules&#160;and regulations of the United States Securities and Exchange Commission (&#8220;SEC&#8221;) for interim reporting. The accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, that are necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows. The condensed consolidated results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosures of the Company normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted under the SEC&#8217;s rules and regulations. These condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes thereto for the year ended December&#160;31, 2019, included in the Company's 2019 Annual Report.</span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MjY_e0f63f8a-301b-4f77-9147-93c264c3e72b" escape="true">The condensed consolidated financial statements include the accounts of Ocugen, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform with current period presentation.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2Mjk_667a04d5-3d9e-4e95-a646-3789d1f01882" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing the condensed consolidated financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions primarily include those used in the accounting for clinical trial accruals, warrant transactions, asset held for sale, and the valuation of debt and equity instruments, including embedded derivatives and stock-based compensation.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="if0ef317b46a9435394840c7638935358" continuedAt="i2a7714d75d2f45939403fcf072d60c35"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:CollaborativeArrangementAccountingPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MzQ_6982f7d1-116f-4fa5-b04e-a5df7c33cc35" continuedAt="ieae44f10d73c483081b06b22273542ca" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses whether collaboration agreements are subject to the Financial Accounting Standards Board ("FASB") Accounting Standards Codification (&#8220;ASC&#8221;) Topic 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 808&#8221;), based on whether they involve joint operating activities and whether both parties have active participation in the arrangement and are exposed to significant risks and rewards. To the extent that the arrangement falls within the scope of ASC 808, the Company assesses whether the payments between the Company and the collaboration partner are subject to other accounting literature. If payments from the collaboration partner represent consideration from a customer, the Company accounts for those payments within the scope of ASC Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 606&#8221;). However, if the Company concludes that its collaboration partner is not a customer, the Company will determine if analogy to other authoritative literature is appropriate. </span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ieae44f10d73c483081b06b22273542ca">In April 2020, the Company entered into a collaboration agreement subject to ASC 808. Under this arrangement, the Company records cost reimbursements received as a reduction of research and development expense in the period incurred and royalty payments received as collaboration revenue in the period in which the underlying sale occurs.</ix:continuation> See Note 5 for additional information.</span></div><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MjI_116aeab5-0657-4bdf-9cb5-cb1063e3703a" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exit and Disposal Activities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records liabilities for one-time termination benefits in accordance with ASC Topic 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit and Disposal Cost Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 420"). In accordance with ASC 420, an arrangement for one-time termination benefits exists at the date the plan of the termination meets the following criteria: (i) management commits to a plan of termination, (ii) the plan identifies the impacted employees and expected completion date, (iii) the plan identifies the terms of the benefits arrangement, (iv) it is unlikely significant changes to the plan will be made or the plan will be withdrawn and (v) the plan has been communicated to employees. Costs for one-time termination benefits in which the employee is required to render service until termination in order to receive the benefits, are recognized ratably over the future service period. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records liabilities for employee termination benefits covered by ongoing benefit arrangements in accordance with ASC Topic 712, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nonretirement Postemployment Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 712"). In accordance with ASC 712, costs for termination benefits under ongoing benefits arrangements are recognized when management has committed to a plan of termination and the costs are probable and estimable.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Severance-related charges, once incurred, are recognized as either research and development expense or general and administrative expense within the condensed consolidated statements of operations and comprehensive loss depending on the job function of the employee.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="ocgn:AssetHeldForSalePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MjM_9e437044-1407-4514-838a-422b023b69f9" continuedAt="iac5c3d26aa4b4239b865075b18b91f07" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Asset Held for Sale</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An asset is considered to be held for sale when all of the following criteria are met: (i) management commits to a plan to sell the asset; (ii) it is unlikely that the disposal plan will be significantly modified or discontinued; (iii) the asset is available for immediate sale in its present condition; (iv) actions required to complete the sale of the asset have been initiated; (v) sale of the asset is probable and the completed sale is expected to occur within one year; and (vi) the asset is actively being marketed for sale at a price that is reasonable given its current market value.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A long-lived asset classified as held for sale is measured at the lower of its carrying amount or fair value less cost to sell. If the long-lived asset is newly acquired, the carrying amount of the long-lived asset is established based on its fair value less cost to sell at the acquisition date. A long-lived asset is not depreciated or amortized while it is classified as held for sale, and an impairment loss would be recognized to the extent the carrying amount exceeds the asset's fair value less cost to sell.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2019, the Company had an intangible asset held for sale, which it held prior to the Merger. The intangible asset qualified and was recorded as held for sale as of the date of the reverse asset acquisition and was carried at its original fair value less cost to sell of $<ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfNjc2NQ_a4d6c5c8-5c59-4e1d-a4cf-92789ae6db51">7.0</ix:nonFraction>&#160;million. The Company concluded during the three months ended September 30, 2020, that a sale of the intangible asset held for sale was no longer probable to be completed within one year from the date the intangible asset was initially recorded as held for sale. As such, the carrying value of the intangible asset was reduced to <ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfNzE0NjgyNTY0NzU3MA_1b291345-23c9-41fc-89c4-858cb9a9ebb2">zero</ix:nonFraction> with the corresponding charge of $<ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTA5OTUxMTY1MTUxNw_0905f6aa-29ac-430e-a7df-b59dd7f3bd3c"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTA5OTUxMTY1MTUxNw_6dc6cbda-d3a0-4c47-887d-5ef7edfef16f">7.0</ix:nonFraction></ix:nonFraction>&#160;million recognized as in-process research and development expense during the three and nine months ended September&#160;30, 2020 as the in-process research and development does not have an alternative future use.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company has concluded that a sale of the intangible asset is no longer probable to be completed within one year from the date the intangible asset was initially recorded as held for sale, the Company is party to an Asset Purchase Agreement </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="i2a7714d75d2f45939403fcf072d60c35" continuedAt="ice903b53767f4ed5b7dad6edbe10e155"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iac5c3d26aa4b4239b865075b18b91f07">(as defined within Note 3) related to the intangible asset as of September&#160;30, 2020, and continues to market the asset for sale. In the event of a sale of the intangible asset under the Asset Purchase Agreement or to another party, the Company will account for the sale in the period in which the sale occurs.</ix:continuation></span></div><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MzA_4159e53a-37bf-469d-9a57-a465013b7cc3" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company follows the provisions of the ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 820&#8221;), which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair measurements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of certain financial instruments, including cash and cash equivalents, accounts payable, and accrued expenses approximates their fair values due to the short-term nature of these instruments. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8212; quoted prices in active markets for identical assets or liabilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 &#8212; quoted prices for similar assets and liabilities in active markets or inputs that are observable</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 &#8212; inputs that are unobservable (for example cash flow modeling inputs based on assumptions)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had derivative instruments that were fair valued on a recurring basis using Level 3 inputs during the three and nine months ended September&#160;30, 2019. There were no derivative instruments fair valued on a recurring basis using Level 3 inputs during the three and nine months ended September&#160;30, 2020. As of September&#160;30, 2020, the Company estimates the fair value of the note with EB5 Life Sciences, L.P. was $<ix:nonFraction unitRef="usd" contextRef="i8c3c6f97b8e34fa1acfc3dcfa2747a64_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LinesOfCreditFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfODQ4NQ_aac69e20-ce49-4396-9f0f-ccf1bc3e554d">1.0</ix:nonFraction>&#160;million using Level 2 inputs. As of September&#160;30, 2020, the Company believes the fair values using Level 2 inputs of both the Warrant Exchange Promissory Notes (as defined in Note 9) and the loan received under the PPP of the CARES Act (as defined in Note 9) approximate their carrying values. See Note 9 for additional information.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MzU_c3552369-ec9b-4288-b431-f1be2fd6bdb3" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments that have maturities of three months or less when acquired to be cash equivalents. Cash and cash equivalents include bank demand deposits, marketable securities with maturities of three months or less at purchase, and money market funds that invest primarily in certificates of deposit, commercial paper and United States government and United States government agency obligations. The Company&#8217;s restricted cash balance consists of cash held to collateralize a corporate credit card account.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="ocgn:ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MTQ_8bf40e28-b073-42d1-a5e4-62bd81ea41b7" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents, and restricted cash in the condensed consolidated balance sheets to the total amount shown in the condensed consolidated statements of cash flows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RhYmxlOmI5ZjZlNmI1MTBhMTRiOTY5ODE5MWMyMTdkMGJjZGI0L3RhYmxlcmFuZ2U6YjlmNmU2YjUxMGExNGI5Njk4MTkxYzIxN2QwYmNkYjRfMi0xLTEtMS0w_c8da8289-9a1f-4740-9e86-a581ff60b5fa">19,105,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff87527ea3fc46fdacb3342226f9f0f9_I20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RhYmxlOmI5ZjZlNmI1MTBhMTRiOTY5ODE5MWMyMTdkMGJjZGI0L3RhYmxlcmFuZ2U6YjlmNmU2YjUxMGExNGI5Njk4MTkxYzIxN2QwYmNkYjRfMi0zLTEtMS0w_f54965fa-8cda-4ab1-9225-5b243e2b9270">15,301,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RhYmxlOmI5ZjZlNmI1MTBhMTRiOTY5ODE5MWMyMTdkMGJjZGI0L3RhYmxlcmFuZ2U6YjlmNmU2YjUxMGExNGI5Njk4MTkxYzIxN2QwYmNkYjRfMy0xLTEtMS0w_f68ae9bb-8f9d-426b-8ce1-073afc8eb4e1">151,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff87527ea3fc46fdacb3342226f9f0f9_I20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RhYmxlOmI5ZjZlNmI1MTBhMTRiOTY5ODE5MWMyMTdkMGJjZGI0L3RhYmxlcmFuZ2U6YjlmNmU2YjUxMGExNGI5Njk4MTkxYzIxN2QwYmNkYjRfMy0zLTEtMS0w_c0d63310-a6a8-41a9-9b3e-4f027f44d9ea">150,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RhYmxlOmI5ZjZlNmI1MTBhMTRiOTY5ODE5MWMyMTdkMGJjZGI0L3RhYmxlcmFuZ2U6YjlmNmU2YjUxMGExNGI5Njk4MTkxYzIxN2QwYmNkYjRfNC0xLTEtMS0w_31739621-1533-4497-8f7b-ab1fa1a7b11b">19,257,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff87527ea3fc46fdacb3342226f9f0f9_I20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RhYmxlOmI5ZjZlNmI1MTBhMTRiOTY5ODE5MWMyMTdkMGJjZGI0L3RhYmxlcmFuZ2U6YjlmNmU2YjUxMGExNGI5Njk4MTkxYzIxN2QwYmNkYjRfNC0zLTEtMS0w_6453ef52-041b-4c65-8f10-fc3f39814bb0">15,451,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MzE_35e542fe-d087-4f60-879c-748dce400048" continuedAt="i0c9a219294694df8af8677c8580a117a" escape="true"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys to the Company the right to control the use of an explicitly or implicitly identified fixed asset for a period of time in exchange for consideration. Control of an underlying asset is conveyed to the Company if the Company obtains the rights to direct the use of and to obtain substantially all of the economic benefits from using the underlying asset. The Company has lease agreements which include lease and&#160;non-lease&#160;components, which the Company has elected to account for as a single lease component for all classes of underlying assets. Lease expense for variable lease components are recognized when the obligation is probable.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="ice903b53767f4ed5b7dad6edbe10e155" continuedAt="id6dbcb7b708b46fa9aa28f50966d75e0"><ix:continuation id="i0c9a219294694df8af8677c8580a117a"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in other assets and lease obligations on the Company&#8217;s condensed consolidated balance sheets. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease payments are recognized as lease expense on a straight-line basis over the lease term. The Company primarily leases real estate, and leases for real estate are classified as operating leases. ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 842") requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As an implicit interest rate is not readily determinable in the Company&#8217;s leases, the incremental borrowing rate is used based on the information available at commencement date in determining the present value of lease payments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease term for all of the Company&#8217;s leases includes the&#160;non-cancellable&#160;period of the lease plus any additional periods covered by either a Company option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Options for lease renewals have been excluded from the lease term (and lease liability) for the majority of the Company&#8217;s leases as the reasonably certain threshold is not met.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease payments included in the measurement of the lease liability are comprised of fixed payments, variable payments that depend on index or rate, and amounts probable to be payable under the exercise of the Company option to purchase the underlying asset if reasonably certain.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease payments not dependent on a rate or index associated with the Company&#8217;s leases are recognized when the event, activity, or circumstance in the lease agreement on which those payments are assessed as probable. Variable lease payments include the Company's proportionate share of utilities and other operating expenses and are presented as operating expenses in the Company&#8217;s condensed consolidated statements of operations and comprehensive loss in the same line item as expense arising from fixed lease payments.</span></div></ix:continuation><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2Mjg_2637301a-94cd-465b-960e-0adefdfe12a5" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its stock-based compensation awards in accordance with ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation&#8212;Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 718&#8221;). ASC 718 requires all stock-based payments to employees, including grants of employee stock options and restricted stock units and modifications to existing agreements, to be recognized in the condensed consolidated statements of operations and comprehensive loss based on their fair values. The Company uses the Black-Scholes option-pricing model to determine the fair value of options granted. The Company recognizes forfeitures as they occur.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock-based awards are subject to service-based vesting conditions. Compensation expense related to awards to employees and directors with service-based vesting conditions is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. Stock-based awards generally vest over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2MTk_eb512e86-ca54-4b51-8e50-01fc17d11c9f">one</span> to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2MjU_8897e6c7-9303-4adc-88de-47d481ae6e6d">three</span> year requisite service period and have a contractual term of <ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2ODk_faddac5a-549d-4e41-ac16-4844095d5beb">10</ix:nonNumeric> years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimating the fair value of options requires the input of subjective assumptions, including expected life of the option, stock price volatility, the risk-free interest rate and expected dividends. The assumptions used in the Company&#8217;s Black-Scholes option-pricing model represent management&#8217;s best estimates and involve a number of variables, uncertainties and assumptions and the application of management&#8217;s judgment, as they are inherently subjective. If any assumptions change, the Company&#8217;s stock-based compensation expense could be materially different in the future.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MjQ_47c5d32d-92d5-4a22-bb82-b77a7d455b35" continuedAt="iea6bd3b556a740d090e2b7ea810349db" escape="true"><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued Accounting Standards Update ("ASU") No. 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework&#8212;Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard modifies certain disclosure requirements on fair value measurements and was effective for the Company on January 1, 2020. The adoption of this standard did not have a material impact on the Company's disclosures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, the FASB issued ASU No. 2018-18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under ASC 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In those situations, ASC 606 guidance should be applied, including recognition, measurement, presentation and disclosure requirements. The standard adds unit-of-account guidance to ASC 808 to align with the guidance in ASC 606 when an entity is assessing whether the collaborative arrangement or a part of the collaborative arrangement is within the scope of ASC 606. The standard also precludes a company from presenting transactions with collaborative arrangement participants that are not directly related to sales to third parties with revenue from contracts with customers recognized under ASC 606 if the collaborative arrangement participant is not a customer. This standard was effective for the Company on </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="id6dbcb7b708b46fa9aa28f50966d75e0"><ix:continuation id="iea6bd3b556a740d090e2b7ea810349db"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 1, 2020. Consistent with the guidance in this standard, the Company assesses whether collaboration arrangements are within the scope of ASC 606. For collaboration arrangements that are not within the scope of ASC 606, applicable transactions with collaborative arrangement participants are presented as collaboration revenue rather than revenue from contracts with customers. See above and Note 5 for additional information.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The FASB subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date of January 1, 2023. These standards require that credit losses be reported using an expected losses model rather than the incurred losses model that is currently used, and establishes additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, these standards now require allowances to be recorded instead of reducing the amortized cost of the investment. These standards limit the amount of credit losses to be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The Company does not currently expect the adoption of these standards to have a material impact on its condensed consolidated financial statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This standard will have an effective date and transition date of January 1, 2021. This standard removes certain exceptions for recognizing deferred taxes for investments, performing intraperiod allocations and calculating income taxes in interim periods. This standard also adds guidance to reduce complexity in certain areas, including recognizing franchise tax, recognizing deferred taxes for tax goodwill, allocating taxes to the members of a consolidated group and recognizing the effect of enacted changes in tax laws or rates during an interim period. The Company does not currently expect the adoption of this standard to have a material impact on its condensed consolidated financial statements.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity's Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard will have an effective and transition date of January 1, 2024. Early adoption is permitted beginning January 1, 2021. This standard simplifies an issuer's accounting for convertible instruments by eliminating two of the three models in ASC 470-20 that require separate accounting for embedded conversion features as well as simplifies the settlement assessment that entities are required to perform to determine whether a contract qualifies for equity classification. This standard also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of potential share settlement (if the effect is more dilutive) for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. The standard requires new disclosures about events that occur during the reporting period and cause conversion contingencies to be met and about the fair value of a public business entity's convertible debt at the instrument level, among other things. The Company does not currently expect the adoption of this standard to have a material impact on its condensed consolidated financial statements.</span></div></ix:continuation></ix:continuation><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_43"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfMzI5ODUzNDg5Njg3Nw_1a51c9e0-6961-4e89-b382-34a1aeae1882" continuedAt="if087342c00564eafbd0bbed905997aa3" escape="true">Merger and Financing</ix:nonNumeric></span></div><ix:continuation id="if087342c00564eafbd0bbed905997aa3" continuedAt="i0094f01b72ca416a98a2341e837520b3"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pre-Merger Financing</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, OpCo and Histogenics entered into a Securities Purchase Agreement (as amended, the "Financing SPA") with certain accredited investors (the "Investors"). Pursuant to the Financing SPA, among other things, (i) immediately prior to the Merger, OpCo issued <ix:nonFraction unitRef="shares" contextRef="i32e5f294ab464b6d83e4148060068867_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfMzE4_eba638ac-6488-4a8a-b36b-9079f6ec9c85">2.2</ix:nonFraction>&#160;million shares of common stock to the Investors, (ii)&#160;on October 4, 2019, the Company issued <ix:nonFraction unitRef="shares" contextRef="i48a7b850f34d4e93a932a1250a70dcdc_I20191004" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfNDA2_12eecccf-c3e8-4fdd-be0d-5047bba9857e">2.2</ix:nonFraction>&#160;million shares of the Company's common stock to the Investors and (iii)&#160;on October 4, 2019, the Company issued <ix:nonFraction unitRef="series" contextRef="ie03e503b087545748223eb40f7381d1f_D20191004-20191004" decimals="INF" format="ixt-sec:numwordsen" name="ocgn:NumberOfSeriesOfWarrantsIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfNTEy_e14f491f-a36b-4c4a-b24d-bb1c59c9f04b">three</ix:nonFraction> series of warrants to purchase shares of the Company&#8217;s common stock (the &#8220;Series&#160;A Warrants,&#8221; the &#8220;Series&#160;B Warrants&#8221; and the &#8220;Series&#160;C Warrants&#8221; and collectively, the &#8220;Pre-Merger Financing Warrants&#8221;) in exchange for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i1524a036f48541e08e32da279b7f7398_D20191004-20191004" decimals="-5" format="ixt:numdotdecimal" name="ocgn:SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfNzYz_793cf64d-c70e-46ad-987c-d549ce0f9b95">25.0</ix:nonFraction> million (the "Pre-Merger Financing"). See Note 12 for additional information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger with Histogenics</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;27, 2019, the Company completed the Merger in accordance with the terms of the Merger Agreement. The Merger was structured as a stock-for-stock transaction whereby all of OpCo&#8217;s outstanding shares of common stock and securities convertible into or exercisable for OpCo&#8217;s common stock were converted into the right to receive Histogenics&#8217; common stock and securities convertible into or exercisable for Histogenics&#8217; common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 805&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company concluded that, while Histogenics was the legal acquirer, OpCo was the accounting acquirer due to the fact that (i)&#160;OpCo&#8217;s shareholders had the majority of the voting </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="i0094f01b72ca416a98a2341e837520b3"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rights in Ocugen, (ii)&#160;OpCo held all of the board seats of the combined company and (iii)&#160;OpCo management held all key positions in the management of the combined company. The Company further concluded that Histogenics did not meet the definition of a business under ASC 805 due to the fact that substantially all of the fair value of the gross assets disposed of is concentrated in a single identifiable asset or a group of similar identifiable assets. Therefore, the Merger was accounted for as a reverse asset acquisition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, on May 8, 2019, Histogenics entered into an asset purchase agreement (the "Asset Purchase Agreement") with Medavate Corp., pursuant to which Histogenics agreed to sell substantially all of its assets relating to its NeoCart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> program for $<ix:nonFraction unitRef="usd" contextRef="i0feccca0bf2b43a1a54176fe040b711e_D20190508-20190508" decimals="-5" format="ixt:numdotdecimal" name="ocgn:AssetPurchaseAgreementCashConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfMjMyMw_e61aee36-2407-424b-a6df-d37f8b350fef">6.5</ix:nonFraction>&#160;million. The parties subsequently amended the Asset Purchase Agreement to increase the purchase price to $<ix:nonFraction unitRef="usd" contextRef="ibf034182282345c38684657f3ac357ca_D20191031-20191031" decimals="-5" format="ixt:numdotdecimal" name="ocgn:AssetPurchaseAgreementCashConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfMjQyMw_db1d78ad-c634-4620-a041-ce876bed8f43">7.0</ix:nonFraction>&#160;million with the purchase price increasing <ix:nonFraction unitRef="number" contextRef="ibf034182282345c38684657f3ac357ca_D20191031-20191031" decimals="INF" name="ocgn:PercentageOfIncreaseInPurchasePriceOfAssetPerMonth" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfMjQ2MQ_edeeb1c7-d1f0-453d-a3dc-658f4e56f95e">10</ix:nonFraction>% per month (or any portion thereof) starting October 31, 2019 if the closing date of the Asset Purchase Agreement did not occur prior to October 31, 2019. The Company may terminate the Asset Purchase Agreement at any time without recourse. The Asset Purchase Agreement closing date did not occur as of September&#160;30, 2020 and the Company has not terminated the Asset Purchase Agreement as of September&#160;30, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NeoCart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> asset was held for sale as of December&#160;31, 2019. The NeoCart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> asset qualified as held for sale as of the date of the reverse asset acquisition and was carried at its original fair value less cost to sell valued at the acquisition date based on a quoted price of $<ix:nonFraction unitRef="usd" contextRef="ic3cf544d14484496ac45a00e1654a708_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldForSaleLongLivedFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfMzE1NA_969aff8c-f00a-44da-9a13-0baadd418f82">7.0</ix:nonFraction>&#160;million, which was an observable Level 2 fair value input. The NeoCart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> asset did not qualify as held for sale as of September&#160;30, 2020. See Note 2 for additional information.</span></div></ix:continuation><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_46"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RleHRyZWdpb246MGFmM2I3NzQ0OGJiNGQ0ZmE3YjBiMTVkYjhkODI1NDNfMzU0_388ae5f5-8c2a-4970-ac6b-102a1c8be5ba" continuedAt="i8e77b126213f4a029b14846cb70dcc0d" escape="true">Net Loss Per Share of Common Stock</ix:nonNumeric></span></div><ix:continuation id="i8e77b126213f4a029b14846cb70dcc0d"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RleHRyZWdpb246MGFmM2I3NzQ0OGJiNGQ0ZmE3YjBiMTVkYjhkODI1NDNfMzU1_cf6b9d1d-674d-4e70-ab2a-497fc9348450" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share for the three and nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss&#8212;basic and diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMi0xLTEtMS0w_969fe6fb-64b6-4fc2-ba6b-c819ddd27595">10,473,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMi0zLTEtMS0w_d244f64a-6adf-4455-9ec5-d06fdd8878eb">22,773,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMi01LTEtMS0w_5eea4f30-7d78-4264-a529-7c4b151e1a43">18,031,641</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMi03LTEtMS0w_2b44f038-6dab-43e2-acc2-985cb5214162">32,624,697</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividend related to Warrant Exchange (Note 12)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:PreferredStockDividendsAndOtherAdjustments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMy0xLTEtMS0w_12aca3b5-6ae9-4b15-9f13-b3eaf80f658f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:PreferredStockDividendsAndOtherAdjustments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMy0zLTEtMS0w_40900e07-088d-4cd9-bfda-c2a8e89b7f52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PreferredStockDividendsAndOtherAdjustments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMy01LTEtMS0w_7bb618c6-c8ba-477f-b972-4d0eb5da6dcd">12,546,340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:PreferredStockDividendsAndOtherAdjustments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMy03LTEtMS0w_6f428baa-bc9b-433a-b5c3-5e1d0d5821ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNC0xLTEtMS0w_59c1d01d-0329-4e7e-8159-8ea1f1959131">10,473,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNC0zLTEtMS0w_3b83277c-689b-42e8-83d2-8403da3881eb">22,773,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNC01LTEtMS0w_bd2fedd4-1f19-4a01-8a31-de7e6512af91">30,577,981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNC03LTEtMS0w_4bfe8c8d-8e99-4490-aa66-e24f3a12009e">32,624,697</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in calculating net loss per common share&#8212;basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNS0xLTEtMS0w_f172534d-b5f2-4a20-bbed-d5d4568292e2">141,591,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNS0zLTEtMS0w_e334e3b4-63a5-4c14-a4ec-267a20cc9e23">6,411,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNS01LTEtMS0w_a9836d37-d272-4df4-812a-ee5835410be9">92,764,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNS03LTEtMS0w_eb5592b7-8a12-4290-882e-11d5d6466ccc">5,839,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share&#8212;basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNi0xLTEtMS0w_57d3d144-dccb-42c6-b5fd-fe90b0c3db6c">0.07</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNi0zLTEtMS0w_ed7221cf-53f6-45cc-9304-86fc636cf2e9">3.55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNi01LTEtMS0w_84b393fe-8077-4741-a6dc-c1dc521f0ddc">0.33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNi03LTEtMS0w_492424d1-9fee-4d40-95a6-73e21bb50794">5.59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RleHRyZWdpb246MGFmM2I3NzQ0OGJiNGQ0ZmE3YjBiMTVkYjhkODI1NDNfMzU3_fa691f54-9866-4432-9bff-f57cab724e70" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding, as their inclusion would have been antidilutive:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f29b990abbf4758b5d2b15e35483711_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMi0xLTEtMS0w_3193c54f-4faa-4e74-a6c9-6f9d4abd6f0f">4,268,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie506a5cab5e247de846540df1b463305_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMi0zLTEtMS0w_7a264eda-c1f3-44ee-87d5-2dd2a4ff3ffa">500,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i59df5d0c89234b009956f4c9f8f30808_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMi01LTEtMS0w_2bb8b911-221d-46db-9db9-deb70be5d77a">4,268,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f62ded661e54fefb3a9fd8f2ba1bb64_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMi03LTEtMS0w_a4d890d1-686f-4c3e-a0d3-c12b4217d2fa">500,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i538b5af19f0f4c5b8fc4c537c4a489d5_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMy0xLTEtMS0w_3cca1eca-1970-4ce0-9ecf-95be252bc1ad">870,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc346fbec3d24dd58a12ad9d869ecfb2_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMy0zLTEtMS0w_5b18f381-ffff-49bd-97f2-b80808d773ef">870,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2380e13fd027491a936f449e6aa74829_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMy01LTEtMS0w_a1ee5902-9d1c-444e-b91b-5ba3437df55c">870,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76069125bcf9493eba6f0ce4826c29c2_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMy03LTEtMS0w_4914b7d5-d29e-4df2-afaf-e93414c09f1f">870,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc8d8f8a93fc45e4b628285d72bb142a_D20200701-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC0xLTEtMS00MDU_59a403aa-e25f-49b0-8219-892d9f1cfd99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i468172d3afbc4db09fe88fcad9e0d420_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC0zLTEtMS00MDU_81eacffd-b6e5-4848-b1b0-d46d0398e172">8,771,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i25dbded407394e83baa18d6851c893f9_D20200101-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC01LTEtMS00MDU_a96fcfe2-e06a-4e41-a9e0-a86024d13fbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97cd3bc630954c2b9bcbbddafafde030_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC03LTEtMS00MDU_4e8b98a1-2d29-49e2-b10e-2c08d7e8596c">8,771,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Warrants (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibb251e6b072448dfa91521c08d3b3479_D20200701-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNS0xLTEtMS00MDU_c0b0ca61-dbf8-490b-aba9-e430e4648115">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e6b2ef153df4c9788cd72ba0651ecfd_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNS0zLTEtMS00MDU_1ebe2fbc-9eff-412a-b1d0-5d0274204470">8,007,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad1b963da04845bd956aea311c52d499_D20200101-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNS01LTEtMS00MDU_8affeee2-a137-4308-8517-5933882a0972">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65d9eeb822d646fb9f1053229278fa42_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNS03LTEtMS00MDU_2792a5b2-439b-426c-95f6-428bbd979224">8,007,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i402e841332864f65bad74eba8425cb79_D20200701-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNi0xLTEtMS00MDU_16140081-959c-4b25-8c1c-8306022e8b73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb41ad76fece4484ae14bc550e4c9795_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNi0zLTEtMS00MDU_08e3b7c4-f766-457d-876f-9ce91daa23c1">50,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idfc7128277d343d4a99ba1fe8819b89d_D20200101-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNi01LTEtMS00MDU_c3a23d34-87ce-45e0-abeb-7b31ef07a8fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7d146e73e6e42e3a301e33bac8cd8ed_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNi03LTEtMS00MDU_f2d0c58e-f5f4-41ce-8cc1-eaad0adfcc70">50,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC0xLTEtMS0w_1db25977-f564-4bc3-ba5d-fd82e16ea66a">5,138,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC0zLTEtMS0w_dc38170f-a893-41e3-9d8a-9f11f8576de7">68,150,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC01LTEtMS0w_0d30786f-f49e-4bc9-8312-254fa6195042">5,138,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC03LTEtMS0w_7aa24e65-b034-43fb-a370-09c1fce534bf">68,150,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Series B Warrants do not include the additional Series B Warrants that were contingent upon the reset pricing as discussed in Note 12.</span></div></ix:nonNumeric></ix:continuation><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80OS9mcmFnOjFmYjk3ZDkzOWYwZTRmYmRhNjliMWJiYTJhMzhlNzQ2L3RleHRyZWdpb246MWZiOTdkOTM5ZjBlNGZiZGE2OWIxYmJhMmEzOGU3NDZfMjk2Mw_a65cdf33-fe3d-4c28-afb0-e12c98ddc207" continuedAt="idc6122024f8f499ba04c79ab0643abda" escape="true">Collaboration Agreements</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idc6122024f8f499ba04c79ab0643abda" continuedAt="i66fdbda4f4eb4d62ab1750711badc899">In April 2020, the Company entered into a collaboration agreement (the &#8220;Advaite Agreement&#8221;) with Advaite, Inc. (&#8220;Advaite&#8221;) with respect to the development of Advaite&#8217;s RapCov COVID-19 Testing Kit (the &#8220;COVID-19 Test&#8221;). Advaite was co-founded and is being managed by Mr. Karthik Musunuri, the son of the Company's Chief Executive Officer, Chairman of the Board and co-founder, Dr. Shankar Musunuri. Pursuant to the Advaite Agreement, the Company will provide certain production, research and development, technical, regulatory and quality support services to Advaite in connection with the development and </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="i66fdbda4f4eb4d62ab1750711badc899" continuedAt="i3ef6995eb9b74f3abe13d1d6b5040b76"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commercialization of the COVID-19 Test (the &#8220;Ocugen Services&#8221;). Advaite will research, develop, and seek to obtain regulatory approval of the COVID-19 Test, and where regulatory approval is obtained, commercialize the COVID-19 Test.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advaite will solely own all data and materials, including the COVID-19 Test, generated by the Company and its representatives solely in the course of the performance of the Ocugen Services. Advaite is responsible for all preparation and submission of regulatory materials for the COVID-19 Test to regulatory authorities, and Advaite will hold all regulatory approvals of the COVID-19 Test in its name and own all related submissions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is entitled to receive cost reimbursements from Advaite, beginning as of April 1, 2020, for (a) costs incurred by the Company related to its personnel who are subject matter experts involved in providing the Ocugen Services ("SME Costs") and (b) Advaite's pro-rata share of all costs (other than SME Costs) incurred by the Company in providing the Ocugen Services. As partial consideration for the Company's performance of the Ocugen Services, Advaite will pay to the Company a quarterly royalty in the range of mid to high single digits based on net sales of the COVID-19 Tests.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Advaite Agreement expires on April 29, 2021, unless extended upon mutual agreement of both the Company and Advaite. Except as otherwise specified in the terms of the Advaite Agreement, Advaite&#8217;s obligation to make royalty payments to the Company will survive expiration of the Advaite Agreement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Advaite Agreement is considered to be within the scope of ASC 808 as the Advaite Agreement represents a joint operating activity and both Advaite and the Company are active participants and exposed to the risks and rewards. The Company has evaluated the Advaite Agreement and determined it is not within the scope of ASC 606 as Advaite does not meet the definition of a customer. </span></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3ef6995eb9b74f3abe13d1d6b5040b76">Cost reimbursements are recorded as a reduction in research and development expense in the period incurred. Royalty payments are recorded as collaboration revenue in the period in which the underlying sale occurs. For the three and nine months ended September&#160;30, 2020, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="id67b6ca4f8b24a43beb2890f097dc5c2_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="ocgn:CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80OS9mcmFnOjFmYjk3ZDkzOWYwZTRmYmRhNjliMWJiYTJhMzhlNzQ2L3RleHRyZWdpb246MWZiOTdkOTM5ZjBlNGZiZGE2OWIxYmJhMmEzOGU3NDZfMTA5OTUxMTYzMTU2Nw_68429a0a-390a-455e-8445-e4cf54b858ba">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ibac481b8f449420f822e23ad5e256c76_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="ocgn:CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80OS9mcmFnOjFmYjk3ZDkzOWYwZTRmYmRhNjliMWJiYTJhMzhlNzQ2L3RleHRyZWdpb246MWZiOTdkOTM5ZjBlNGZiZGE2OWIxYmJhMmEzOGU3NDZfMTA5OTUxMTYzODQwOA_a0e40ff4-4439-4be6-ada6-dd0f5e4974de">0.3</ix:nonFraction>&#160;million as a reduction of research and development expense, respectively. For the three months ended September 30, 2020, the Company recorded no collaboration revenue in connection with the Advaite Agreement. For the nine months ended September 30, 2020, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="ibac481b8f449420f822e23ad5e256c76_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80OS9mcmFnOjFmYjk3ZDkzOWYwZTRmYmRhNjliMWJiYTJhMzhlNzQ2L3RleHRyZWdpb246MWZiOTdkOTM5ZjBlNGZiZGE2OWIxYmJhMmEzOGU3NDZfMTA5OTUxMTYzMTU4Mw_9a8ee2ec-2dcf-4d01-b4ed-854608c38742">42,620</ix:nonFraction> as collaboration revenue in connection with the Advaite Agreement</ix:continuation>.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_52"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RleHRyZWdpb246ZGM5MjNiMmY0NWMxNDYwOGE3MDEwOTE1ZDljYjIxODlfMTY3_5f951059-609c-4c7e-8226-9172ef5e1b6e" continuedAt="i8d7d6335b1954c2387615ccf4a582735" escape="true">Accrued Expenses</ix:nonNumeric></span></div><ix:continuation id="i8d7d6335b1954c2387615ccf4a582735"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RleHRyZWdpb246ZGM5MjNiMmY0NWMxNDYwOGE3MDEwOTE1ZDljYjIxODlfMTY5_a259b86f-a670-4a9a-8589-8829fe9cb43d" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued Expenses are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research&#160;and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="ocgn:ResearchAndDevelopmentExpensesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfMi0xLTEtMS0w_24321ca0-75e1-4ec8-8e65-854ad5fd73bf">177,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="ocgn:ResearchAndDevelopmentExpensesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfMi0zLTEtMS0w_85bca7ff-3c26-456a-a0d8-0bcb564302d3">271,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="ocgn:AccruedLiabilitiesClinical" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfMy0xLTEtMS0w_3970cd4c-10fe-4eea-9db9-6106fe40773d">125,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="ocgn:AccruedLiabilitiesClinical" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfMy0zLTEtMS0w_c15c72eb-b0d3-4135-af7c-12856c1aa390">421,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="ocgn:AccruedLiabilitiesProfessionalFees" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNC0xLTEtMS0w_c985885a-c6d1-4bf6-85a8-ceda88977d45">396,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="ocgn:AccruedLiabilitiesProfessionalFees" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNC0zLTEtMS0w_cdfe0417-5297-4bd7-a44c-2f6582a7322f">917,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNS0xLTEtMS0w_b961112b-94f3-4842-a225-44becc0aec2e">688,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNS0zLTEtMS0w_c74304b8-09b8-4ffe-96d5-c42712a076e5">624,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="ocgn:AccruedSeveranceRelatedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNi0xLTEtMS0w_561fd2a6-f967-4d52-ae90-699d213e61a0">888,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:zerodash" name="ocgn:AccruedSeveranceRelatedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNi0zLTEtMS0w_04e28b34-b031-4a86-ab00-aabed108a7dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNy0xLTEtMS0w_cc823798-70f0-45a0-9385-a410b5250b98">57,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNy0zLTEtMS0w_3c974789-fecd-4c3f-8ffb-2ec0c6bb1783">34,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfOC0xLTEtMS0w_c80ba9a6-aee0-481d-b742-329152af0d7c">2,333,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfOC0zLTEtMS0w_f42eaf73-7482-4fc1-9a51-3bb3f78a8e70">2,270,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) See Note 7 for additional information regarding severance-related accrued expenses.</span></div></ix:nonNumeric></ix:continuation><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_55"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfOTg1_5a46b4bc-93c6-4c21-bf63-8788be328f9a" continuedAt="iaabe54971f394f41a1de1aa51ba57382" escape="true">Exit and Disposal Activities</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaabe54971f394f41a1de1aa51ba57382" continuedAt="id64e91a2d5ca4b1ba581e3675e45c482">On June 15, 2020, the Company, as part of its recent shift in focus toward its gene therapy platform and novel biologics program aimed at curing blindness diseases, communicated notice to <ix:nonFraction unitRef="employee" contextRef="i2cc0ad28c5724aca9234dcc6309e44c1_D20200615-20200615" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfMjI2_48726d25-9e6c-4a6a-aeac-348ee1c2855a">five</ix:nonFraction> employees of termination of their employment. This reduction represents one-third of the Company&#8217;s workforce. All terminations were &#8220;without cause&#8221; and each employee is </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="id64e91a2d5ca4b1ba581e3675e45c482"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">entitled to receive termination benefits upon departure. The termination dates vary for each employee and range from June 30, 2020 to December 31, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the workforce reduction, the Company recognized severance-related charges of $<ix:nonFraction unitRef="usd" contextRef="ib65216302269446e88de6bdca0d4d78d_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfMTY0OTI2NzQ0Mjg4OQ_2cab0eb1-c99c-4134-a55d-97026c2fd4ed">0.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="id3d9be1e13f34b61b21f7829259b9c08_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfMTY0OTI2NzQ0Mjg5NA_fe13d504-d304-4de0-95b2-345a80cb2690">1.1</ix:nonFraction>&#160;million during the three and nine months ended September&#160;30, 2020, respectively. The Company expects to pay severance benefits of $<ix:nonFraction unitRef="usd" contextRef="ifd5fda4627a342a0982c1661cf0a687a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfNzAw_b9be26c0-ce10-4c65-9b99-fb4746e53131">0.4</ix:nonFraction>&#160;million during 2020 and $<ix:nonFraction unitRef="usd" contextRef="ife4854f917da4de9b27b201328eadc2a_I20211231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfNzE3_0c78ae8d-4263-4954-9004-6d719e8a611e">0.7</ix:nonFraction>&#160;million during 2021. For the three months ended September 30, 2020, the Company recognized a de minimis amount of severance-related charges within general and administrative expense and $<ix:nonFraction unitRef="usd" contextRef="i1851644d82bf4fb2b634fbb231dff413_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfMTY0OTI2NzQ0Mjg3NA_2149dddf-290a-42e5-ace7-df307f7e6266">0.4</ix:nonFraction>&#160;million of severance-related charges within research and development expense. For the nine months ended September 30, 2020, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i0c0ebd16833c4d9fb7640ffa8d1c822f_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfMTA5OTUxMTYzMTMxNA_e98c44af-6d0e-4a84-a717-af791ca8b335">0.2</ix:nonFraction>&#160;million of severance-related charges within general and administrative expense and $<ix:nonFraction unitRef="usd" contextRef="i74b18383221c462a91314443a371c7b1_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfMTY0OTI2NzQ0Mjg4NA_4fad5ffb-5cb3-48fa-82c3-79f2fc771ad8">0.9</ix:nonFraction>&#160;million of severance-related charges within research and development expense.</span></div><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfOTg0_5f127af1-124e-40c2-bd7c-c9c784e29e3c" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table outlines the components of the severance-related charges:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.444%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Severance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7c6f3716ee34faa9aa88da0c9ae7781_I20191231" decimals="0" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RhYmxlOmYzYmY0ZmZiN2JlYjRiNjZhZjQwOTM3NmQwYTc0ZTZhL3RhYmxlcmFuZ2U6ZjNiZjRmZmI3YmViNGI2NmFmNDA5Mzc2ZDBhNzRlNmFfMS0xLTEtMS0w_5b830307-3b4c-4fe5-bda8-8daab7644f6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d9be1e13f34b61b21f7829259b9c08_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RhYmxlOmYzYmY0ZmZiN2JlYjRiNjZhZjQwOTM3NmQwYTc0ZTZhL3RhYmxlcmFuZ2U6ZjNiZjRmZmI3YmViNGI2NmFmNDA5Mzc2ZDBhNzRlNmFfMi0xLTEtMS0w_325f6728-e6ad-4d2c-80fb-26bab155a772">1,093,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3d9be1e13f34b61b21f7829259b9c08_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRestructuring" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RhYmxlOmYzYmY0ZmZiN2JlYjRiNjZhZjQwOTM3NmQwYTc0ZTZhL3RhYmxlcmFuZ2U6ZjNiZjRmZmI3YmViNGI2NmFmNDA5Mzc2ZDBhNzRlNmFfMy0xLTEtMS0xMDQ_e7615e09-0f00-423f-ae38-6bae53efce0e">205,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Severance at September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de6dd9388504be191f7056b17d3e22e_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RhYmxlOmYzYmY0ZmZiN2JlYjRiNjZhZjQwOTM3NmQwYTc0ZTZhL3RhYmxlcmFuZ2U6ZjNiZjRmZmI3YmViNGI2NmFmNDA5Mzc2ZDBhNzRlNmFfMy0xLTEtMS0w_e8a05737-5217-4924-ae92-91c6338de117">888,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt"><span><br/></span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_61"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMjA5Mw_31493328-74e9-4176-b19e-e1875ed23f26" continuedAt="i219f9b83cd2e4d1584d6bb3199b069e3" escape="true">Equity Transactions</ix:nonNumeric></span></div><ix:continuation id="i219f9b83cd2e4d1584d6bb3199b069e3" continuedAt="ief92cbb15de64608ad78b01d8a293bbd"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-the-Market Offerings</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2020, the Company sold an aggregate of <ix:nonFraction unitRef="shares" contextRef="i705cda31adfa47b8bf226fde1fda52d5_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTAx_84f688d1-0538-443d-9633-16b925c27991">27.0</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="ib7205f6b303a46ca881e1f5b3771db48_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTA5OTUxMTYzMDAxOA_fa1c6e95-95ae-4a37-853c-78bb6c059aac">86.2</ix:nonFraction>&#160;million shares of common stock, respectively, in separate at-the-market offerings (&#8220;ATMs&#8221;) commenced in May 2020, June 2020 and August 2020. The Company sold <ix:nonFraction unitRef="shares" contextRef="i6788e535d4e547eaad37605b59a5e359_D20200501-20200531" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTA5OTUxMTYzNjA0OA_1a29b758-1152-49a9-bc0e-349b543bf844">34.4</ix:nonFraction>&#160;million shares under the May 2020 ATM, <ix:nonFraction unitRef="shares" contextRef="i641bb5999b314e3e9ff26b630c0802c5_D20200601-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTA5OTUxMTYzNjA1OQ_fdd001c6-1529-4e55-a02d-05e4821c6cda">24.8</ix:nonFraction>&#160;million shares under the June 2020 ATM and <ix:nonFraction unitRef="shares" contextRef="i84a2946964c741a8929a7e3b1f4d5681_D20200801-20200831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTA5OTUxMTYzNjA3Mg_eb967262-07b7-41ca-8f8a-faa0f1c206c7">27.0</ix:nonFraction>&#160;million shares under the August 2020 ATM. During the three months ended September 30, 2020, the Company received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i705cda31adfa47b8bf226fde1fda52d5_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMjQ2_0f6f6d33-82d2-4c54-be08-5180a066ecf9">10.1</ix:nonFraction>&#160;million, after deducting commissions, fees and expenses of $<ix:nonFraction unitRef="usd" contextRef="i705cda31adfa47b8bf226fde1fda52d5_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMzAw_4b7b156a-6d1c-4e3c-b53a-013b90ff3825">0.4</ix:nonFraction>&#160;million. During the nine months ended September 30, 2020, the Company received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ib7205f6b303a46ca881e1f5b3771db48_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTA5OTUxMTYzMDM0MQ_2f9c7c85-54b5-4f28-a343-da31872173bb">25.6</ix:nonFraction>&#160;million, after deducting commissions, fees and expenses of $<ix:nonFraction unitRef="usd" contextRef="ib7205f6b303a46ca881e1f5b3771db48_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTA5OTUxMTYzMDM0MA_e106c1b7-2e19-4f74-bc44-27f67cd76163">1.1</ix:nonFraction>&#160;million. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The offerings were made pursuant to the Company's effective "shelf" registration statement on Form S-3 filed with the SEC on March 27, 2020, the base prospectus contained therein dated May 5, 2020, and the prospectus supplements related to the offerings dated May 8, 2020, June 12, 2020 and August 17, 2020. As of September&#160;30, 2020, the Company had sold all of the shares of common stock available for issuance under the prospectus supplements filed on May 8, 2020 and June 12, 2020 in connection with the May 2020 and June 2020 ATMs. As of September&#160;30, 2020, the Company had remaining capacity to issue up to $<ix:nonFraction unitRef="shares" contextRef="i3798aebd55684549850d5b6934cb938f_I20200930" decimals="-5" format="ixt:numdotdecimal" name="ocgn:SaleOfStockNumberOfSharesOutstandingRemainingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTA5OTUxMTYzNTQyNg_a7772087-2dce-4c80-b7a1-289ab4695b29">19.5</ix:nonFraction>&#160;million of common stock under the prospectus supplement filed on August 17, 2020 in connection with the August 2020 ATM.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subscription Agreements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2020, the Company entered into a subscription agreement with an accredited investor for the sale of <ix:nonFraction unitRef="shares" contextRef="i4c39808114c84938bdbf2cfbe7968dba_I20200422" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesSubscribedButUnissued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfOTE5_6378ff8e-3db2-4035-a954-728a236a052e">1,000</ix:nonFraction> shares of the Company's common stock in a private placement for an aggregate offering price of $<ix:nonFraction unitRef="usd" contextRef="i4c39808114c84938bdbf2cfbe7968dba_I20200422" decimals="0" name="us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTAxNw_5b02af85-bbfc-4f17-959c-6aed959a0089">395</ix:nonFraction>. This private placement constituted a Dilutive Issuance (as defined in Note 12) and resulted in adjustments to the Series A Warrants.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 6, 2020, the Company entered into a subscription agreement with an accredited investor for the issuance of <ix:nonFraction unitRef="shares" contextRef="i891a1948cbf344f09e76772040e3fa8e_D20200606-20200606" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTI2NA_01ce48c0-ca36-4d55-b73a-477849f87683">1.3</ix:nonFraction> million shares of the Company's common stock in a private placement. The shares of common stock were issued as part of a transaction in settlement of an outstanding obligation of the Company to the accredited investor, in which (i) the Company agreed to make certain cash payments, (ii) the Company issued the <ix:nonFraction unitRef="shares" contextRef="i891a1948cbf344f09e76772040e3fa8e_D20200606-20200606" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTU2OQ_01ce48c0-ca36-4d55-b73a-477849f87683">1.3</ix:nonFraction> million shares of common stock in exchange for the accredited investor's agreement to cancel $<ix:nonFraction unitRef="usd" contextRef="i36e49ecbf9c640919597478a362dc2c5_I20200606" decimals="-5" format="ixt:numdotdecimal" name="ocgn:SaleOfStockOutstandingObligationCancelledInExchangeForStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTY1Nw_5862aa32-4d7d-4509-a6ab-f0a8a8e712ee">0.3</ix:nonFraction> million of the outstanding obligation and (iii) the accredited investor agreed to cancel an additional portion of the amount owed by the Company representing a discount of $<ix:nonFraction unitRef="usd" contextRef="i36e49ecbf9c640919597478a362dc2c5_I20200606" decimals="-5" format="ixt:numdotdecimal" name="ocgn:SaleOfStockAdditionalDebtCancelledInExchangeForStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTgyNA_c13c373e-9c2d-4353-9dc1-e2014e3eaab2">0.2</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ief92cbb15de64608ad78b01d8a293bbd">On April 5, 2019, OpCo entered into a subscription agreement (the "April 2019 Subscription Agreement") with existing investors for the sale of <ix:nonFraction unitRef="shares" contextRef="i3b93323e957a4ce9b32abd082822d3d0_D20190405-20190405" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTk2MA_79508c25-ca62-4f7f-a14c-a03070db54a9">0.1</ix:nonFraction> million shares of common stock for $<ix:nonFraction unitRef="usd" contextRef="i3b93323e957a4ce9b32abd082822d3d0_D20190405-20190405" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTk5MA_a2827e95-2a9e-44d6-8f27-4feb3c1f20da">1.0</ix:nonFraction>&#160;million. This capital raise triggered the conversion features on the convertible debt described in Note 9 below.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTA0MzU_8c8b9170-19b5-42d6-8000-52a7d3ef0c25" continuedAt="i835c939d9fa6442d96750bac14594226" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="i835c939d9fa6442d96750bac14594226" continuedAt="i469a7b9158c54d859225d86af698feb7"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTA0MjU_0b277618-00be-42c3-8df5-fd9f0a483dfd" continuedAt="ied6e50db113f49f3955fb1a66bfa8013" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the carrying values for the components of debt as reflected on the condensed consolidated balance sheets:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP Note</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i954c5746ce5b45d1a940c37f489ee070_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfMS0xLTEtMS0w_6686f68d-ee56-4ff0-bedd-3f747a871ea5">421,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id35de39551be499fbe3da2455d22798c_I20191231" decimals="0" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfMS0zLTEtMS0w_1eccc091-31ca-4776-aa12-e0c015779bde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant Exchange Promissory Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6eb732ec634b628ad24bc33e7f1a58_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfMi0xLTEtMS0w_f26cda9f-09ff-42a4-a181-d6183762c0ff">1,116,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ef6579c4fd4fce993710b539ee1478_I20191231" decimals="0" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfMi0zLTEtMS0w_70bda707-36a3-46ee-83d8-a9387ce0e0d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EB-5 Loan Agreement borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if855a3da2e6d45e0828572b9b374ebc3_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfMy0xLTEtMS0w_4e641195-9475-487b-b287-cbbdcf28cd01">1,616,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae6ba8a4f7f84d6da2219724a513733f_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfMy0zLTEtMS0w_57284e23-2815-4175-a3fe-d2dbc4fbd0f2">1,072,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value of debt, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfNC0xLTEtMS0w_b1cd2370-2376-4301-a8d6-35390d667478">3,155,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfNC0zLTEtMS0w_5819dfda-8197-4a10-b039-02c4d428074c">1,072,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PPP Note</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2020, the Company was granted a loan from Silicon Valley Bank ("SVB"), in the aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="ib962316dd8ec4a45b707ea8ffe2cfdca_I20200430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMjcy_d942e989-87f9-48db-8af3-047fb5412cfd">0.4</ix:nonFraction>&#160;million, pursuant to the Paycheck Protection Program (the &#8220;PPP&#8221;) of the Coronavirus Aid, Relief and Economic Security Act of 2020 (the &#8220;CARES Act&#8221;). On June 5, 2020, the PPP Flexibility Act of 2020 (the "PPPFA") was signed into law amending the original terms of the PPP. Among other things, the PPPFA extends the deferral period for monthly principal and interest payments from six months to the time when the Small Business Administration (the "SBA") compensates the lender for amounts forgiven as well as extending the covered period for qualifying expenses from eight weeks to the earlier of 24 weeks or December 31, 2020. Certain amounts of the loan may be forgiven if they are used for qualifying expenses as described by the CARES Act.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loan was in the form of a promissory note dated April 30, 2020 in favor of SVB (the "PPP Note"). The PPP Note matures on April 30, 2022 and bears interest at a rate of <ix:nonFraction unitRef="number" contextRef="ib962316dd8ec4a45b707ea8ffe2cfdca_I20200430" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTEzMw_4aa6ee10-b65e-487b-8f58-adca46830bd8">1.0</ix:nonFraction>% per annum. Principal and interest payments are payable monthly commencing on the date the SBA compensates SVB for forgiven amounts or within 10 months following the expiration of the covered period if the Company has not applied for forgiveness. The Company did not provide any collateral or guarantees for the loan, nor did the Company pay any facility charge to obtain the loan. The PPP Note provides for customary events of default, including, among others, failure to make payment, bankruptcy, breaches of representations and material adverse events. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, the carrying value of the PPP Loan was $<ix:nonFraction unitRef="usd" contextRef="i8d689227ca8e441da7199a43bf5eb16a_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTczOA_7b2ca781-c7ef-4ab6-96be-4d95cab50640">0.4</ix:nonFraction> million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrant Exchange Promissory Notes</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2020, in connection with the Warrant Exchange as defined in Note 12, the Company issued to Investors certain promissory notes (the "Warrant Exchange Promissory Notes") with an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i82bf19a1e632417380b5fe0e427dd9b7_I20200422" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTk3OA_b9d61358-7da4-445e-ad95-3f118fcd867b">5.6</ix:nonFraction>&#160;million. The Warrant Exchange Promissory Notes have a maturity date of April 21, 2021 and do not bear interest. The Company may prepay the Warrant Exchange Promissory Notes in whole or in part at any time without penalty or premium. In the event that the Company consummates a financing transaction that generates cash to the Company, the Company is required to use <ix:nonFraction unitRef="number" contextRef="i202e82a2e6574f9395b0475edfae9fc0_I20200422" decimals="INF" name="ocgn:DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMjMyNw_673b7a11-535d-4711-a336-1d60b6479de5">20</ix:nonFraction>% of the net proceeds of such transaction to prepay a portion of the outstanding amount under each Warrant Exchange Promissory Note if the transaction occurs on or prior to August 22, 2020, and <ix:nonFraction unitRef="number" contextRef="i2ca8387e786e470e94c2d428dd8b08be_I20200422" decimals="INF" name="ocgn:DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMjUwOQ_7491b242-17f2-482a-a65c-d1c51399ac50">30</ix:nonFraction>% of the net proceeds to prepay a portion of the outstanding amount under each Warrant Exchange Promissory Note if that transaction occurs after August 22, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2020, the Warrant Exchange Promissory Notes were recorded at a fair value of $<ix:nonFraction unitRef="usd" contextRef="i82bf19a1e632417380b5fe0e427dd9b7_I20200422" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMjczOA_0d40539e-45d1-4a96-867d-3c5cb08e5572">5.0</ix:nonFraction>&#160;million. The difference of $<ix:nonFraction unitRef="usd" contextRef="i82bf19a1e632417380b5fe0e427dd9b7_I20200422" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMjc2MA_b5d45f02-d359-4331-898d-449dc969b7f1">0.6</ix:nonFraction>&#160;million between the fair value and the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i82bf19a1e632417380b5fe0e427dd9b7_I20200422" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMjgyNA_6bd38b93-9648-4272-b2e9-316a9d51237a">5.6</ix:nonFraction>&#160;million was recorded as a debt discount to be accreted to interest expense over the life of the Warrant Exchange Promissory Notes. The accretion amounted to $<ix:nonFraction unitRef="usd" contextRef="if8e397ca8e294216950367c054054ea4_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMjk3Ng_bc1c0e7d-52dd-4b03-863e-3031399470dc">0.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="idafa3d9adff54d838525f6e345d7b222_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTY0OTI2NzQ1NDc1Mg_b92c0e1f-2fd0-4cc7-b5bb-08597ecb2c75">0.5</ix:nonFraction>&#160;million for the three and nine months ended September&#160;30, 2020, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to use a percentage of the net proceeds of the ATMs discussed in Note 8 to redeem the outstanding amount under the Warrant Exchange Promissory Notes. During the three and nine months ended September&#160;30, 2020, the Company made payments to the Warrant Exchange Promissory Note holders of $<ix:nonFraction unitRef="usd" contextRef="if8e397ca8e294216950367c054054ea4_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMzI3NQ_547173b4-8802-4aba-88ab-3b14b34d0a76">3.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idafa3d9adff54d838525f6e345d7b222_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTY0OTI2NzQ1NTE1Ng_8b220f8d-8bea-49c1-82fd-7e7bbe11842c">4.4</ix:nonFraction> million, respectively. Subsequent to September&#160;30, 2020, the Company made payments to the Warrant Exchange Promissory Note holders of $<ix:nonFraction unitRef="usd" contextRef="iaa36c601f8de4816bb5ac175ca991a52_D20201001-20201106" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTA5OTUxMTY1OTQ3OQ_8dc2930f-4fe3-4390-9c36-ea3df4257e67">1.3</ix:nonFraction> million, causing the Warrant Exchange Promissory Notes to be repaid in full and no longer outstanding.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="i469a7b9158c54d859225d86af698feb7" continuedAt="ib7f2980384d64c528f45ae6a870a0ea8"><ix:continuation id="ied6e50db113f49f3955fb1a66bfa8013" continuedAt="i98fed1c1cd1d436581e9d9a527782bca"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the Warrant Exchange Promissory Notes at September&#160;30, 2020 and December&#160;31, 2019 are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6eb732ec634b628ad24bc33e7f1a58_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYyMzNiNzU3MTViNzRkOTI5NmZiNWRlMTMxNDdmNThlL3RhYmxlcmFuZ2U6ZjIzM2I3NTcxNWI3NGQ5Mjk2ZmI1ZGUxMzE0N2Y1OGVfMS0yLTEtMS0w_f57fa4f1-2b45-4fba-9078-0cbeae60507f">1,262,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ef6579c4fd4fce993710b539ee1478_I20191231" decimals="0" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYyMzNiNzU3MTViNzRkOTI5NmZiNWRlMTMxNDdmNThlL3RhYmxlcmFuZ2U6ZjIzM2I3NTcxNWI3NGQ5Mjk2ZmI1ZGUxMzE0N2Y1OGVfMS00LTEtMS0w_347184f4-c46d-4ca1-a014-d6912541551e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt discount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f6eb732ec634b628ad24bc33e7f1a58_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYyMzNiNzU3MTViNzRkOTI5NmZiNWRlMTMxNDdmNThlL3RhYmxlcmFuZ2U6ZjIzM2I3NTcxNWI3NGQ5Mjk2ZmI1ZGUxMzE0N2Y1OGVfMi0yLTEtMS0w_e4257ff6-ce27-4df1-8722-23801b167214">145,732</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ef6579c4fd4fce993710b539ee1478_I20191231" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredFinanceCostsNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYyMzNiNzU3MTViNzRkOTI5NmZiNWRlMTMxNDdmNThlL3RhYmxlcmFuZ2U6ZjIzM2I3NTcxNWI3NGQ5Mjk2ZmI1ZGUxMzE0N2Y1OGVfMi00LTEtMS0w_5286e335-93e9-43e3-bbbd-596e4c19a770">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6eb732ec634b628ad24bc33e7f1a58_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYyMzNiNzU3MTViNzRkOTI5NmZiNWRlMTMxNDdmNThlL3RhYmxlcmFuZ2U6ZjIzM2I3NTcxNWI3NGQ5Mjk2ZmI1ZGUxMzE0N2Y1OGVfMy0yLTEtMS0w_2e3a8f4b-cab3-4a7d-87e6-12c16747295f">1,116,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43ef6579c4fd4fce993710b539ee1478_I20191231" decimals="0" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYyMzNiNzU3MTViNzRkOTI5NmZiNWRlMTMxNDdmNThlL3RhYmxlcmFuZ2U6ZjIzM2I3NTcxNWI3NGQ5Mjk2ZmI1ZGUxMzE0N2Y1OGVfMy00LTEtMS0w_1ecf535f-bf05-414e-84c0-df15455abe10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:12pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EB-5 Loan Agreement Borrowings</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September&#160;2016, pursuant to the U.S. government&#8217;s Immigrant Investor Program, commonly known as the EB-5 program (the &#8220;EB-5 Program&#8221;), the Company entered into an arrangement (the &#8220;EB-5 Loan Agreement&#8221;) to borrow up to $<ix:nonFraction unitRef="usd" contextRef="i89af07cba55243ada1a697e372c93c26_I20160930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMzczMw_13c3e16e-843a-47ab-8540-6d9b96e60f91">10.0</ix:nonFraction>&#160;million from EB5 Life Sciences,&#160;L.P. (&#8220;EB-5 Life Sciences&#8221;) in $<ix:nonFraction unitRef="usd" contextRef="i616e252088514e97a1bc3f1b262dcd7b_D20160901-20160930" decimals="INF" format="ixt:numdotdecimal" name="ocgn:LineOfCreditBorrowingEachDraw" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMzc5MQ_5ff38da3-2978-4cab-852c-9bbbf595fdad">0.5</ix:nonFraction>&#160;million increments. Borrowing may be limited by the amount of funds raised by the EB-5 Life Sciences and are subject to certain job creation requirements by the Company. Borrowings are at a fixed interest rate of <ix:nonFraction unitRef="number" contextRef="i89af07cba55243ada1a697e372c93c26_I20160930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMzk5OQ_4d84f760-a303-43ac-927d-9c8d21795978">4.0</ix:nonFraction>% per annum and are to be utilized in the clinical development, manufacturing, and commercialization of the Company&#8217;s products and for the general working capital needs of the Company. Outstanding borrowings pursuant to the EB-5 Program, including accrued interest, become due upon the seventh anniversary of the final disbursement. Amounts repaid cannot be re-borrowed. The EB-5 Program borrowings are secured by substantially all assets of the Company, except for any patents, patent applications, pending patents, patent license, patent sublicense, trademarks, and other intellectual property rights.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms and conditions of the EB-5 Loan Agreement, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="i4b78b94d3f034ec7b1df0ad282714b18_I20161231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNDY4NA_2506697c-177c-4311-9c79-5bc9dcb435ad">1.0</ix:nonFraction> million in 2016 and an additional $<ix:nonFraction unitRef="usd" contextRef="i3b4ea6a10d05450090d47b47a43bceac_I20200326" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNDcxMw_8f613440-f5b5-4b49-b285-414f228c63fe">0.5</ix:nonFraction> million on March&#160;26, 2020. Issuance costs were recognized as a reduction to the loan balance and are amortized to interest expense over the term of the loan.</span></div><ix:continuation id="i98fed1c1cd1d436581e9d9a527782bca"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the EB-5 Loan Agreement borrowings as of September&#160;30, 2020 and December&#160;31, 2019 are summarized below:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if855a3da2e6d45e0828572b9b374ebc3_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfMS0yLTEtMS0w_9d8a69d2-846b-493e-bf3c-4ced62766844">1,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae6ba8a4f7f84d6da2219724a513733f_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfMS00LTEtMS0w_bd642415-c893-42c4-a4d5-248a46e8ec3c">1,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if855a3da2e6d45e0828572b9b374ebc3_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestPayableCurrentAndNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfMi0yLTEtMS0w_e8ca4cc0-e008-4e2b-8dab-40dcf9c87401">166,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae6ba8a4f7f84d6da2219724a513733f_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InterestPayableCurrentAndNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfMi00LTEtMS0w_1600ed59-c0d7-4b27-b9cf-76c78fba22c4">127,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if855a3da2e6d45e0828572b9b374ebc3_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfMy0yLTEtMS0w_338f9c20-7697-48c1-a843-a63bd3268372">49,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae6ba8a4f7f84d6da2219724a513733f_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfMy00LTEtMS0w_1715d270-e47b-4413-9420-bfdb0281d8c0">55,654</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if855a3da2e6d45e0828572b9b374ebc3_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfNC0yLTEtMS0w_137edfab-5008-4cff-8804-bb9203b9d20e">1,616,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae6ba8a4f7f84d6da2219724a513733f_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfNC00LTEtMS0w_559f5311-ba3f-4fca-91fc-86a06f0e43e1">1,072,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Secured Convertible Notes</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 21, 2019, the Company issued senior secured convertible notes to certain investors for $<ix:nonFraction unitRef="usd" contextRef="ic2e106364d89410d8fa73ea0a7ada5a2_I20190521" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTA2OQ_92294747-d870-4bf5-9aec-3b5096a2f5d7">2.4</ix:nonFraction> million at an original issue discount of $<ix:nonFraction unitRef="usd" contextRef="ic2e106364d89410d8fa73ea0a7ada5a2_I20190521" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTEwNQ_c8eaa84b-a928-4815-8d3e-6e4f89fdd571">0.5</ix:nonFraction> million, and on June 28, 2019, the Company entered into an agreement to issue additional senior secured convertible notes to the investors for $<ix:nonFraction unitRef="usd" contextRef="iec5ace5a1a5d48d78f81c3898beaf7cf_I20190628" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTIzMg_087ea55d-540c-4e44-ae4e-daedf88d4cf3">2.9</ix:nonFraction> million with an original issue discount of $<ix:nonFraction unitRef="usd" contextRef="iec5ace5a1a5d48d78f81c3898beaf7cf_I20190628" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTI3MA_551833f0-0fec-4eab-9246-1cf8b6a0055c">0.4</ix:nonFraction> million (together the "Senior Secured Convertible Notes"). Immediately prior to the Merger completed on September 27, 2019, the Investors offset $<ix:nonFraction unitRef="usd" contextRef="i9fe0b042d77c45bc9e7880606282df26_I20190927" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTU0MQ_3c581066-c9d9-4f92-bbc6-6afd72b91432">5.3</ix:nonFraction> million from the amount to be received under the Pre-Merger Financing and the Senior Secured Convertible Notes were deemed to have been repaid and cancelled. The accretion of the original issue discount to interest expense amounted to $<ix:nonFraction unitRef="usd" contextRef="i3a8ac0202f094c9288e4af258c9a7d6c_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTc3MQ_c50ef01b-e85a-4966-aeb3-471511bd7a2b">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3b33f5ec1c0e4138ae4e880885651fb9_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTY0OTI2NzQ1NzM1OQ_3e778c8c-7bcb-490d-8021-046f8ecd8705">0.8</ix:nonFraction> million during three and nine months ended September&#160;30, 2019, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Promissory Note</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2019, the Company issued a convertible promissory note (the "Convertible Promissory Note") to an existing stockholder for $<ix:nonFraction unitRef="usd" contextRef="i9836b63cfe2f4fe7b7c0325bd22c222e_I20190404" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTk1Mg_54b4263e-2a77-45f4-b415-9e6a3829c51f">0.9</ix:nonFraction>&#160;million at an interest rate of <ix:nonFraction unitRef="number" contextRef="i9836b63cfe2f4fe7b7c0325bd22c222e_I20190404" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTk3OA_e9c1abad-8091-454c-a068-0d4099c1af5f">5</ix:nonFraction>% per annum. On May 16, 2019, the Convertible Promissory Note was converted into equity. OpCo issued <ix:nonFraction unitRef="shares" contextRef="iba956723fd0740239620e5f29bcb4ca7_I20190516" decimals="-5" format="ixt:numdotdecimal" name="ocgn:CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjA3MA_9964895b-cc60-4d51-8bab-330044a15c88">0.1</ix:nonFraction>&#160;million shares of common stock at the conversion date to extinguish the debt at $<ix:nonFraction unitRef="usdPerShare" contextRef="iba956723fd0740239620e5f29bcb4ca7_I20190516" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjE0NQ_472b003d-070d-4123-b086-54db0f3b7931">12.41</ix:nonFraction> per share. This non-cash transaction resulted in an increase of $<ix:nonFraction unitRef="usd" contextRef="ie5d139f20a3148c98c5a49fbdcb7bc19_D20190516-20190516" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjIxMg_cd17e9e5-60ce-4a3b-b61b-a4f989703f53">0.9</ix:nonFraction>&#160;million in additional paid-in capital, which was based on the principal balance outstanding and the unpaid interest upon conversion.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="ib7f2980384d64c528f45ae6a870a0ea8" continuedAt="if971e1dfb7984f0ca5b57cdce15b1a46"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Notes</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2019 and 2018, the Company issued convertible notes (the &#8220;Convertible Notes&#8221;) to new and existing stockholders in the Company, including Convertible Notes in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i1a9a7d47ff164922b47b9474737d5697_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjU2OQ_a8eb574b-649d-4f96-85e9-83d4807b1a00"><ix:nonFraction unitRef="usd" contextRef="i97a56e3f53224d4ab82457b6f444f1f4_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjU2OQ_d6aa5c79-27cf-4ff0-843d-e34c32e96eb2">3.5</ix:nonFraction></ix:nonFraction>&#160;million to members of the Board of Directors. As of December&#160;31, 2019, all Notes had been converted and were <ix:nonFraction unitRef="usd" contextRef="i6e196fac2ce14f69a9c7145fc6153460_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjY1OA_90c65e66-0b84-41e5-a003-fb13bd7a4693">no</ix:nonFraction> longer outstanding. </span></div><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTA0MzM_cb1a5199-4cd6-4b97-a413-e3736df4548e" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At issuance, the following amounts were recorded:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Convertible Note&#160;Issuance&#160;Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Convertible Note<br/>Principal<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value of Embedded Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt<br/>Issuance<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value upon Issuance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c95e5d478a04f07aafab89ce80821a5_I20180131" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMS0yLTEtMS0w_5deb631c-d827-4c2d-8eb9-2279824c61d6">5,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92b0bfa510874f698e53c5abd86cfac8_I20180131" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMS00LTEtMS0w_3ce16e73-942d-478b-a509-651e0589b494">2,657,711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c95e5d478a04f07aafab89ce80821a5_I20180131" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMS02LTEtMS0w_5a9a7fdf-aa8d-44a6-add7-1482d8ac66bb">35,969</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c95e5d478a04f07aafab89ce80821a5_I20180131" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMS04LTEtMS0w_0666a6be-dd15-4266-993e-a44a6b7dd514">2,306,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4bd0c993144352beacd61bd76c907a_I20180630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMi0yLTEtMS0w_37ef70a4-0b32-492c-932e-89abfb615f3d">1,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1ef8269ce6849a8bbaaf6f1dd81d930_I20180630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMi00LTEtMS0w_409598b0-3bd0-46d4-8fe6-05500e60bcd3">724,216</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f4bd0c993144352beacd61bd76c907a_I20180630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMi02LTEtMS0w_91d0d612-c8e3-4369-8a45-9b52245f36b7">3,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4bd0c993144352beacd61bd76c907a_I20180630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMi04LTEtMS0w_cf39b263-ce27-42b7-8f01-a1d3141eeeb6">272,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07700165b6f44737af43f19cf18c3b61_I20181130" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMy0yLTEtMS0w_684c70e0-1025-40a7-91a6-66fe7353c881">1,150,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic60fd8eff73747ec9eaa1854872d27d4_I20181130" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMy00LTEtMS0w_36306b1b-3a30-446c-93c6-5fcf02fdbaa9">21,127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07700165b6f44737af43f19cf18c3b61_I20181130" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMy02LTEtMS0w_3872322b-6ca0-41e9-b26d-1e6d339eed59">50,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07700165b6f44737af43f19cf18c3b61_I20181130" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMy04LTEtMS0w_a4c31017-2f3f-490b-bf10-a7477f836da3">1,078,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8441ef9a2d3446daa0a9a5e613555095_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNC0yLTEtMS0w_05457451-bf2a-4a3a-8e7c-e6e1c2eba803">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31f6d3314ac41ffb1c478548ad440f7_I20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNC00LTEtMS0w_dd25ff15-f5c9-45e5-9658-a6bcf00b9717">2,857</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8441ef9a2d3446daa0a9a5e613555095_I20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNC02LTEtMS0w_e483c332-5a17-41ae-929d-0a0bae208149">14,310</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8441ef9a2d3446daa0a9a5e613555095_I20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNC04LTEtMS0w_6a4a255c-e813-488f-aa45-7f50b6de26b7">132,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5349b87b7d764f64a46780bb66baca10_I20190131" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNS0yLTEtMS0w_921a6cc7-81a6-4a30-891c-2c9c41efe3ad">450,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10b818c696fa4a59b0fd450672c2f045_I20190131" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNS00LTEtMS0w_ed31edc8-7482-4a97-9db9-d5e42bea9033">182,882</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5349b87b7d764f64a46780bb66baca10_I20190131" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNS02LTEtMS0w_9fa3f9f6-34b3-41bc-8ad8-2876cc234b3d">29,358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5349b87b7d764f64a46780bb66baca10_I20190131" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNS04LTEtMS0w_7dd5b75d-9188-4add-9c13-0af22d88272c">237,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b69bf96efa4d168b3abf899bb9cc37_I20190228" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNi0yLTEtMS0w_1b0ade9a-ca02-4178-ac47-de01d38542c3">1,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c4f1fd7901c4793a17e268f79e0bcd9_I20190228" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNi00LTEtMS0w_8b6223a8-60f5-475d-8b5e-28fd9a2095e5">302,379</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83b69bf96efa4d168b3abf899bb9cc37_I20190228" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNi02LTEtMS0w_f54d6535-8ab0-48f0-9b7a-a6f22b8c4145">55,875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b69bf96efa4d168b3abf899bb9cc37_I20190228" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNi04LTEtMS0w_3c4e659e-4a45-4685-82f2-f6f046e589d5">641,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e196fac2ce14f69a9c7145fc6153460_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNy0yLTEtMS0w_1e1a1dd7-4c1a-4ee7-ae3a-a78d953c0c08">8,750,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29b4f949ec244c099e380923e5e22554_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNy00LTEtMS0w_36088b95-4b6e-4bed-8988-395485b6bfc3">3,891,172</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e196fac2ce14f69a9c7145fc6153460_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNy02LTEtMS0w_f6282c12-326b-4dc5-ab1e-e6e7bc0a3f32">189,158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e196fac2ce14f69a9c7145fc6153460_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNy04LTEtMS0w_90837e16-5803-41bc-8506-8fae72de67fc">4,670,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Convertible Notes accrued interest at a rate of <ix:nonFraction unitRef="number" contextRef="i6e196fac2ce14f69a9c7145fc6153460_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjc4Ng_5001605e-be9b-49d8-b425-25e945c82b61">5</ix:nonFraction>% per annum and had scheduled maturity dates on the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjgzOQ_9250eb5b-b0ea-4f42-8cf2-a98505654eac">eighteen</span> month anniversary of the date of the issuance of the Convertible Notes (the &#8220;Maturity Date&#8221;). If prior to the Maturity Date, there was a consummation of the sale of all or substantially all of the assets of the Company, change in control or event of default, the Convertible Notes would become due and payable at an amount equal to <ix:nonFraction unitRef="number" contextRef="i6e196fac2ce14f69a9c7145fc6153460_I20191231" decimals="INF" name="ocgn:DebtRedemptionMultipleFeature" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNzE3NA_dda15be8-33cf-4e0b-9ca5-f94445f86885">1.5</ix:nonFraction> times the principal amount of the Convertible Notes together with all accrued interest (the &#8220;Change in Control Feature&#8221;).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company received equity financing from the issuance of stock of the Company from an investor or group of investors in a transaction or series of related transactions above a certain amount of gross proceeds, the principal amount and all interest accrued but not paid through the closing date of the qualified equity financing was to automatically convert into the same class of equity securities as those issued in the qualified equity financing ("Conversion Feature"). The price per share varied among the Convertible Notes ranging from a <ix:nonFraction unitRef="number" contextRef="i10c8c2503acb440f996a2813e4f347ab_I20191231" decimals="INF" name="ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNzg0Ng_0ea5a196-8cd3-4f29-8265-85c8be7603ef">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ie9f2b124c93c4651bbb19190ff92d0ef_I20191231" decimals="INF" name="ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNzg1Mg_0404e072-4617-4296-9ffb-5ce017a7ebc4">30</ix:nonFraction>% discount to the lowest price per share being paid by investors in the qualified equity financing.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company bifurcated the Conversion Feature for the January&#160;2018, June&#160;2018, January&#160;2019, and February&#160;2019 Convertible Notes and classified it as a derivative liability because the conversion feature did not have a fixed conversion price and conversion would be settled in a variable number of shares of common stock. There was no bifurcated conversion feature for the November&#160;2018 and December 2018 Convertible Notes as there is no discount to the lowest equity price triggering conversion. The Company also bifurcated the Change in Control Feature for all of the Convertible Notes because it was determined to be a redemption feature not clearly and closely related to the debt host. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of both of the embedded features was accounted for as a derivative liability and was recorded as a discount on the Convertible Notes. Inputs used in valuation were unobservable and therefore considered Level 3 in the fair value hierarchy. The debt discount was accreted into interest expense over the expected time until conversion of the Convertible Notes. The accretion amounted to <ix:nonFraction unitRef="usd" contextRef="iebb9183c07544982815cbf0318070f47_D20190701-20190930" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTA0NA_fc307dcb-9372-4dee-9bc5-f4e5d7eaa38d">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i8eb7409e74724c4aab7c90a052528902_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTA1MQ_df74d78a-40ce-4d73-a881-eac2dc2c3a16">0.5</ix:nonFraction> million for the three and nine months ended September&#160;30, 2019, respectively. There was <ix:nonFraction unitRef="usd" contextRef="ic2954e2e8a8d4d55987f92e0a1378c69_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTEwNg_7581ccd5-af64-4f5a-ae0f-599b9b113f50"><ix:nonFraction unitRef="usd" contextRef="i6f3b2b81985349648981b7c33c6a0e02_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTEwNg_c646bdd4-b6b0-4bb7-b58e-90af1fcfea26">no</ix:nonFraction></ix:nonFraction> accretion during the three and nine months ended September&#160;30, 2020 as all Convertible Notes had been converted and were <ix:nonFraction unitRef="usd" contextRef="i6e196fac2ce14f69a9c7145fc6153460_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTIwMg_90c65e66-0b84-41e5-a003-fb13bd7a4693">no</ix:nonFraction> longer outstanding as of December&#160;31, 2019.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the embedded features was classified as a liability in the Company&#8217;s condensed consolidated balance sheets at issuance, with subsequent changes in fair value recorded on the Company&#8217;s condensed consolidated statements of operations and comprehensive loss as a change in fair value of derivative liabilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the April 2019 Subscription Agreement as described and defined within Note 8, the triggers for conversion were met on the Convertible Notes. On April 5, 2019, the Convertible Notes were modified to change the discount percentage from the <ix:nonFraction unitRef="number" contextRef="ica44cf11121f47e6b6dc2650b6be2704_I20190405" decimals="INF" name="ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTgwOQ_b22a604b-fb14-4b0e-88a7-10803ba8f40c">0</ix:nonFraction>% discount per the terms of the November&#160;2018 and December 2018 Convertible Notes and the <ix:nonFraction unitRef="number" contextRef="i73acee8636ae4ab98d80f2c562867e27_I20190405" decimals="INF" name="ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTkwMA_b4f64f19-e45a-421e-8966-ab265fc841a7">15</ix:nonFraction>% discount per the terms of the January&#160;2019 and February&#160;2019 Convertible Notes to <ix:nonFraction unitRef="number" contextRef="i6fa755318529457aba279a74293b8181_I20190405" decimals="INF" name="ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTk4NQ_16dfccb5-b496-4979-a855-cc14e306dac5">30</ix:nonFraction>% at the time of conversion. The Company issued <ix:nonFraction unitRef="shares" contextRef="i7122180f242946d99ad29848b79e37be_I20190405" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTAwMzQ_ac92f441-e7bd-4d2e-9c69-51ddddd700cf">1.1</ix:nonFraction>&#160;million shares of common stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="i7122180f242946d99ad29848b79e37be_I20190405" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTAwNjM_790a2432-c0b4-4768-bdc5-4d0fd9d7b564">8.69</ix:nonFraction> per share on the date of conversion to extinguish the debt, which resulted in a loss of $<ix:nonFraction unitRef="usd" contextRef="i4bebf4b2ec794a58aac7839dd043db44_D20190405-20190405" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTAxNTQ_9c6ca06f-e41f-43ac-b29b-71d24298b678">0.3</ix:nonFraction>&#160;million. This non-cash conversion also resulted in an increase of $<ix:nonFraction unitRef="usd" contextRef="ia96a5be04b654077a75d8375d8a5d905_D20190405-20190405" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTAyMTU_33e6da54-324c-496c-ad3e-818f0d5c3667">13.0</ix:nonFraction> million in additional paid-in capital, which was based on the principal balance outstanding and the unpaid interest upon conversion.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="if971e1dfb7984f0ca5b57cdce15b1a46"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principal Maturities</span></div><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTA0Mjk_88c59570-3761-4453-86bf-320b120d3ae7" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt maturities (excluding interest) are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.343%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve months ending September 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Maturities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYxYTkyODU5NWE3NjQzZWI4ZmQzMDBiZDNjMzU3OWZkL3RhYmxlcmFuZ2U6ZjFhOTI4NTk1YTc2NDNlYjhmZDMwMGJkM2MzNTc5ZmRfMi0xLTEtMS0w_6141df0a-5f7e-48c5-89ac-b38535e363ed">1,356,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYxYTkyODU5NWE3NjQzZWI4ZmQzMDBiZDNjMzU3OWZkL3RhYmxlcmFuZ2U6ZjFhOTI4NTk1YTc2NDNlYjhmZDMwMGJkM2MzNTc5ZmRfMi0yLTEtMS0w_c99add4e-e48d-47f8-bcb2-ae186beb88da">327,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYxYTkyODU5NWE3NjQzZWI4ZmQzMDBiZDNjMzU3OWZkL3RhYmxlcmFuZ2U6ZjFhOTI4NTk1YTc2NDNlYjhmZDMwMGJkM2MzNTc5ZmRfMi0zLTEtMS0w_b5e88bb6-3c3e-4e42-93a7-efd2fe8ffc11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYxYTkyODU5NWE3NjQzZWI4ZmQzMDBiZDNjMzU3OWZkL3RhYmxlcmFuZ2U6ZjFhOTI4NTk1YTc2NDNlYjhmZDMwMGJkM2MzNTc5ZmRfMi00LTEtMS0w_a5babb7e-82d7-4ade-8a52-08d4a699056d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYxYTkyODU5NWE3NjQzZWI4ZmQzMDBiZDNjMzU3OWZkL3RhYmxlcmFuZ2U6ZjFhOTI4NTk1YTc2NDNlYjhmZDMwMGJkM2MzNTc5ZmRfMi01LTEtMS0w_e2476ce3-6176-4117-9050-20c1486f534d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="ocgn:LongTermDebtMaturityAfterYearFour" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYxYTkyODU5NWE3NjQzZWI4ZmQzMDBiZDNjMzU3OWZkL3RhYmxlcmFuZ2U6ZjFhOTI4NTk1YTc2NDNlYjhmZDMwMGJkM2MzNTc5ZmRfMi02LTEtMS0w_43ee1820-ed77-479e-ba86-a90183ff65b3">1,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYxYTkyODU5NWE3NjQzZWI4ZmQzMDBiZDNjMzU3OWZkL3RhYmxlcmFuZ2U6ZjFhOTI4NTk1YTc2NDNlYjhmZDMwMGJkM2MzNTc5ZmRfMi03LTEtMS0w_6ad19464-8bd0-4e46-b03d-32e598e2c110">3,184,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt"><span><br/></span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_67"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMjI2NQ_2a37dcbb-fffc-4fe7-be25-a6541268b355" continuedAt="i6af8c748b41646ddba86f34562e2ebbb" escape="true">Stock-based Compensation</ix:nonNumeric></span></div><ix:continuation id="i6af8c748b41646ddba86f34562e2ebbb" continuedAt="iad7da2827b7e4295966853195086cbda"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMjI2Ng_00bedbe7-7570-43d0-8736-d76d07723c42" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for options granted is reflected in the condensed consolidated statements of operations and comprehensive loss as follows:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc5453f20d4e4f35b4a834519b122ec4_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMi0xLTEtMS0w_1e42d903-43a6-4656-b418-a29cf921fb51">100,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic43825ac7a304ddf9c2216ba906f7289_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMi0zLTEtMS0w_b2d586ee-6769-4381-99c0-e8170ae02761">48,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i087644c141fc4d80854025dc438c16bd_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMi01LTEtMS0w_c16ac5a6-ecf0-4b16-9a52-5076521ef068">248,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3df75069d5314c0b83c03d93eff49c3b_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMi03LTEtMS0w_2dad2951-9c5e-4ef4-99c2-8fa81f7827f7">298,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162d13dc4b1545c696e798ebac5d4a90_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMy0xLTEtMS0w_fcdb6e90-7242-449d-9aad-d91ab5f6c9da">25,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i792572cf35bb4b92b612e3ff5498a49a_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMy0zLTEtMS0w_fb7a47e4-7d90-401e-9180-51848bf1c3b0">144,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic13576b5389d4b328a17a5d499ac4d69_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMy01LTEtMS0w_fad8c827-c558-4225-8be8-c523e721014f">249,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c53be1af7724b3faa590b77e842c7b7_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMy03LTEtMS0w_9618e716-194a-4091-b4dd-e5ddebe8bdf4">421,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfNC0xLTEtMS0w_459b190f-9622-405a-87c9-c47f720949e8">126,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfNC0zLTEtMS0w_20e937da-e67b-47e5-bb05-49842aee38f8">193,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfNC01LTEtMS0w_4c8cef39-cc0a-44b1-ab68-0675b40b3fac">498,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfNC03LTEtMS0w_2d968deb-7e33-4307-93c4-f7cd1eef9fdc">720,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMjE4_cb69159f-113f-434f-a3ca-8d0d19b473e5">1.3</ix:nonFraction>&#160;million of unrecognized compensation expense related to options outstanding under its equity plans. This expense is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i4c8969ef77c1411c9bf6a611f2e2d36e_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMzg5_ea9f928b-47a2-4f3c-b3d6-bdcc8139fe07">2.2</ix:nonNumeric> years as of September&#160;30, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Plans</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains <ix:nonFraction unitRef="segment" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="ocgn:NumberOfEquityCompensationPlans" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMjI2Nw_ebf4fb40-5a17-4762-a642-05613d702444">two</ix:nonFraction> equity compensation plans, the 2014 Ocugen OpCo, Inc. Stock Option Plan (the &#8220;2014 Plan&#8221;) and the Ocugen, Inc. 2019 Equity Incentive Plan (the &#8220;2019 Plan&#8221;, collectively with the 2014 Plan, the "Plans"), which replaced the Histogenics Corporation 2013 Equity Incentive Plan (the "2013 Plan"). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, Ocugen&#8217;s stockholders approved the adoption of the 2019 Plan and the 2013 Plan was frozen. No additional awards have been or will be made under the 2013 Plan and any remaining authorized shares under the 2013 Plan were recycled into the 2019 Plan. On the first business day of each fiscal year, pursuant to the "Evergreen" provision of the 2019 Plan, the aggregate number of shares that may be issued under the 2019 Plan will automatically increase by a number equal to the lesser of <ix:nonFraction unitRef="number" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="INF" name="ocgn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMTIyNw_a157eeb8-c6e6-4310-849b-e019b2a6a0f6">4</ix:nonFraction>% of the total number of shares of Company common stock outstanding on December 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the prior year, or a number of shares of Company common stock determined by the Board. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, the 2014 Plan provides for the granting of up to <ix:nonFraction unitRef="shares" contextRef="i7bae26e5ec3b4d6e959ffe614c098254_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMTQ2Mw_84e2ba2f-3fc5-4a45-8167-ddfdae635277">0.8</ix:nonFraction>&#160;million equity awards in respect to Ocugen's common stock. As of September&#160;30, 2020, the 2019 Plan provides for the granting of up to <ix:nonFraction unitRef="shares" contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMTU3Ng_47f6252b-5df2-4f1e-a5d9-3be4e0992df0"><ix:nonFraction unitRef="shares" contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMTU3Ng_63881635-e616-4ef6-bfe8-89de560f16dd">4.2</ix:nonFraction></ix:nonFraction>&#160;million equity awards in respect of Ocugen's common stock, inclusive of equity awards that were previously available for issuance under the 2013 Plan and the additional shares authorized for issuance pursuant to the 2019 Plan's "Evergreen" provision on January 1, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, an aggregate of <ix:nonFraction unitRef="shares" contextRef="ie94bd56836134356a2b42c3d02bcd7b8_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMTg2OA_1f6fdc0f-5b73-4fd2-a7f3-aeb5e4f2461b">0.5</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="i132e89b796c1407695971319916c5052_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMTg3NQ_428587ca-c07a-49ee-9dd4-8021af1378a5">3.8</ix:nonFraction>&#160;million shares of Company common stock were issuable upon the exercise of outstanding stock options under the 2014 Plan and 2019 Plan, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="iad7da2827b7e4295966853195086cbda"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options to Purchase Common Stock</span></div><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMjI2NA_ccff5bcf-f07f-4a26-82b1-977cfd97615d" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the stock option activity under the Plans:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i112d9bfb269247e5a5787276fb3cd7ac_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMS0xLTEtMS0w_6a4fb162-9d0f-4de2-8336-3acced7c58b2">731,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i112d9bfb269247e5a5787276fb3cd7ac_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMS0zLTEtMS0w_e3fb7d05-9134-4476-ba17-6c7c9546843a">4.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i627461cada754117a3daf3d544a3877f_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMS01LTEtMS0w_22bde6ce-7d33-4416-b7fd-13fd34e251c3">8.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112d9bfb269247e5a5787276fb3cd7ac_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMS03LTEtMS0w_259c89ab-e515-4400-ad93-c3033e5632c9">24,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMi0xLTEtMS0w_751ce020-f4e8-4b8c-bc4a-07f1da25a2cf">4,064,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMi0zLTEtMS0w_fd9e43fd-39b5-48d0-ba5c-9538629f81c7">0.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMy0xLTEtMS0w_dc1bf8f8-7883-45cb-9f26-c349f3b20abd">527,862</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMy0zLTEtMS0w_1b3cdf1c-1069-48ed-bef5-e19c77bcc353">1.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September&#160;30, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNC0xLTEtMS0w_c81c4ced-0cba-46f8-aeca-18f1a2e1a3b7">4,268,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNC0zLTEtMS0w_a1e6f08e-9182-40e8-85da-036ba84901e5">0.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNC01LTEtMS0w_768a98e0-68cf-49ae-a86c-0b99535ac137">9.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNC03LTEtMS0w_3d061561-1755-4c1c-97e6-3461867f5544">7,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at September&#160;30, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNS0xLTEtMS0w_4701c55e-94ff-468c-8bd6-f5dae1b142b0">450,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNS0zLTEtMS0w_c66ad519-58b1-4f5c-87da-d261df5626b7">4.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNS01LTEtMS0w_012ebd18-d2d1-4cfd-a40b-9073a995078d">6.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNS03LTEtMS0w_4b99dbcf-1632-481d-bcd0-c0893b2a38bb">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of stock options granted during both the three and nine months ended September&#160;30, 2020 was $<ix:nonFraction unitRef="usdPerShare" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMjIzMQ_2d906255-d1c4-4245-9ddb-daab4f6b8668"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMjIzMQ_3466294d-afa1-426a-b36c-395b09a76084">0.34</ix:nonFraction></ix:nonFraction> per share.</span></div></ix:continuation><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_70"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfNzE0NjgyNTU4NjA5Mw_a17df76e-c8c6-4030-9558-ea28e5749022" continuedAt="i7f532aea44ab4b99a5f29e4829814888" escape="true">Commitments</ix:nonNumeric></span></div><ix:continuation id="i7f532aea44ab4b99a5f29e4829814888" continuedAt="i8198e96fc6764375aa6bcd9c70eb39e8"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has commitments under operating leases for certain facilities used in its operations. The Company&#8217;s leases have initial lease terms ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTk1_ae9976e8-4e79-4b4b-95fa-b8c561425fb1">one</span> to <ix:nonNumeric contextRef="ic33f61dc175243c98786068416fad0db_I20200930" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMjAx_e4543704-1de0-4352-85b4-e65fb6bd1921">five years</ix:nonNumeric>. Certain lease agreements contain provisions for future rent increases.</span></div><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI4Ng_2d619ce1-7645-4d16-adef-51ecc8211382" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.449%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMi0xLTEtMS0w_0e32971b-b9c2-4271-b674-8deb379b0332">47,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMi0zLTEtMS0w_de7c91c1-e4a7-4c03-b0ce-e2c757f47117">47,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMi01LTEtMS0w_2f199e5d-f313-4520-9f4d-5c9e8df036ae">142,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMi03LTEtMS0w_b6bf470f-74ad-442a-9968-24704bbc4b9f">202,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMy0xLTEtMS0w_81604f22-b25a-4900-8b57-d3ad1a4ef738">21,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMy0zLTEtMS0w_154336d1-5473-4914-ab2c-948b92d35924">21,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMy01LTEtMS0w_4a452609-e815-48bb-a98a-ae8a31007066">62,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMy03LTEtMS0w_abeffeec-21d5-464d-8c1f-8813a7c9709c">58,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfNC0xLTEtMS0w_f00c0ca3-439b-43a0-8835-eee29016805e">68,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfNC0zLTEtMS0w_d67bc170-5c7e-4698-b147-0104365bf9b1">68,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfNC01LTEtMS0w_1db1bc04-44a5-4bf8-8a6a-6d69b2482457">205,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfNC03LTEtMS0w_3968e609-d612-44c0-b42d-635fede844ce">260,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="ocgn:SupplementalBalanceSheetInformationLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfNzE0NjgyNTU4NjA5Mg_eb009733-9a56-4d19-8cc0-058bb1bc1fad" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfMS0xLTEtMS0w_198d601a-b23b-4bdb-9b37-4bc7328c08ac">217,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfMS0zLTEtMS0w_287906fa-3784-4464-ab2d-73033796f7bd">344,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfMy0xLTEtMS0w_6b3401d2-6529-485b-9743-16356c899f5c">164,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfMy0zLTEtMS0w_2481e56d-7d2c-42b3-a9ef-c9bd5b3b446a">172,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfNC0xLTEtMS0w_4d570017-c890-43b2-b726-32ba4772da27">42,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfNC0zLTEtMS0w_6aa1bed5-1e91-44e7-8593-b89f21271cdc">163,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfNS0xLTEtMS0w_426833b8-65ff-420a-805b-df1459ab8b6a">207,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfNS0zLTEtMS0w_43349fd1-2d69-4286-99cf-a175cb0e479b">335,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI3Mw_7bc703c5-3bdc-4aba-880e-7b2584cf2239" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease terms&#8212;operating leases (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjA1YWRlYTI1YjdkYTQ3NmRiMmQzZmY2MjVkOWU3OTA5L3RhYmxlcmFuZ2U6MDVhZGVhMjViN2RhNDc2ZGIyZDNmZjYyNWQ5ZTc5MDlfMi0xLTEtMS0w_49132242-025a-40d8-9a40-403dac244c65">1.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iff87527ea3fc46fdacb3342226f9f0f9_I20190930" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjA1YWRlYTI1YjdkYTQ3NmRiMmQzZmY2MjVkOWU3OTA5L3RhYmxlcmFuZ2U6MDVhZGVhMjViN2RhNDc2ZGIyZDNmZjYyNWQ5ZTc5MDlfMi0zLTEtMS0w_28e43f69-f1e5-495e-9709-8a9c7e8b3db9">2.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate&#8212;operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjA1YWRlYTI1YjdkYTQ3NmRiMmQzZmY2MjVkOWU3OTA5L3RhYmxlcmFuZ2U6MDVhZGVhMjViN2RhNDc2ZGIyZDNmZjYyNWQ5ZTc5MDlfMy0xLTEtMS0w_45e62fc0-c0d0-47ca-b85c-305c7c2282d6">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff87527ea3fc46fdacb3342226f9f0f9_I20190930" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjA1YWRlYTI1YjdkYTQ3NmRiMmQzZmY2MjVkOWU3OTA5L3RhYmxlcmFuZ2U6MDVhZGVhMjViN2RhNDc2ZGIyZDNmZjYyNWQ5ZTc5MDlfMy0zLTEtMS0w_20866b1c-9346-42cd-a314-cd9ddf2414dc">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="i8198e96fc6764375aa6bcd9c70eb39e8"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI4Nw_56a998e3-2fe4-4391-bb4f-77f9ba80ddcf" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum operating minimum lease payments for all leases, exclusive of taxes and other carrying charges, are approximately as follows:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjcwYjAwODhmN2ZjZTQxNTQ5ZDAyZDA5ZTU0MjYxZTRhL3RhYmxlcmFuZ2U6NzBiMDA4OGY3ZmNlNDE1NDlkMDJkMDllNTQyNjFlNGFfMS0yLTEtMS0w_3878a18e-ab97-4c59-a3bd-5d2f0f086f17">48,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjcwYjAwODhmN2ZjZTQxNTQ5ZDAyZDA5ZTU0MjYxZTRhL3RhYmxlcmFuZ2U6NzBiMDA4OGY3ZmNlNDE1NDlkMDJkMDllNTQyNjFlNGFfMi0yLTEtMS0w_bd3036b8-e3fe-453e-b948-4a5056a98f93">160,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjcwYjAwODhmN2ZjZTQxNTQ5ZDAyZDA5ZTU0MjYxZTRhL3RhYmxlcmFuZ2U6NzBiMDA4OGY3ZmNlNDE1NDlkMDJkMDllNTQyNjFlNGFfMy0yLTEtMS0w_c6f437f2-5f35-49bd-8287-c4821af201cb">11,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjcwYjAwODhmN2ZjZTQxNTQ5ZDAyZDA5ZTU0MjYxZTRhL3RhYmxlcmFuZ2U6NzBiMDA4OGY3ZmNlNDE1NDlkMDJkMDllNTQyNjFlNGFfNC0yLTEtMS0w_1effe2b3-4a84-46a5-8d4a-27628db33634">220,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: present value adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjcwYjAwODhmN2ZjZTQxNTQ5ZDAyZDA5ZTU0MjYxZTRhL3RhYmxlcmFuZ2U6NzBiMDA4OGY3ZmNlNDE1NDlkMDJkMDllNTQyNjFlNGFfNS0yLTEtMS0w_c53a338b-2dc1-4d94-91ad-f29b81aa78c9">12,765</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjcwYjAwODhmN2ZjZTQxNTQ5ZDAyZDA5ZTU0MjYxZTRhL3RhYmxlcmFuZ2U6NzBiMDA4OGY3ZmNlNDE1NDlkMDJkMDllNTQyNjFlNGFfNi0yLTEtMS0w_dd3e35ec-a6b9-41ac-a320-e79973649415">207,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Leases</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the Company leased specialized research equipment under a lease classified as a financing lease. The leased equipment is included in property and equipment, net and is amortized on a straight-line basis over <ix:nonNumeric contextRef="i2693db88967c4ff0a47ea33524803019_I20180630" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfODQ1_92546365-6630-451d-963e-ae5f2506dbab">five years</ix:nonNumeric>. Financing lease liabilities are included in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI3NQ_32d25827-fc2b-4183-a751-56c09cccc2ae"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI3NQ_939a82e3-172c-4a98-a538-b4e48e03f315">other liabilities</span></span> on the Company's condensed consolidated balance sheets. The interest rate related to the lease obligation is <ix:nonFraction unitRef="number" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="3" name="us-gaap:LesseeFinanceLeaseDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTAyMA_0be05c13-251e-4c48-9808-02c5826ce8fd">7.6</ix:nonFraction>% and the maturity date is July 2021.</span></div><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI3Ng_a8b3908e-b2ed-4425-ab70-9ee8460db39c" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for all financing leases, exclusive of taxes and other carrying charges, are approximately as follows:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmVhOGI1NjQyMTgwNzQ3N2U4NjAyN2ZjZDAxNzU4NzdlL3RhYmxlcmFuZ2U6ZWE4YjU2NDIxODA3NDc3ZTg2MDI3ZmNkMDE3NTg3N2VfMS0yLTEtMS0w_85b41b33-c4b8-41fe-a667-bf25b49a0fd1">5,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmVhOGI1NjQyMTgwNzQ3N2U4NjAyN2ZjZDAxNzU4NzdlL3RhYmxlcmFuZ2U6ZWE4YjU2NDIxODA3NDc3ZTg2MDI3ZmNkMDE3NTg3N2VfMi0yLTEtMS0w_e9fb1aac-6d06-41d8-b129-366def755cd5">9,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmVhOGI1NjQyMTgwNzQ3N2U4NjAyN2ZjZDAxNzU4NzdlL3RhYmxlcmFuZ2U6ZWE4YjU2NDIxODA3NDc3ZTg2MDI3ZmNkMDE3NTg3N2VfMy0yLTEtMS0w_4d4c48b8-6503-4777-b996-bda1d887e7f9">15,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: present value adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmVhOGI1NjQyMTgwNzQ3N2U4NjAyN2ZjZDAxNzU4NzdlL3RhYmxlcmFuZ2U6ZWE4YjU2NDIxODA3NDc3ZTg2MDI3ZmNkMDE3NTg3N2VfNC0yLTEtMS0w_61b8b05c-f238-4b10-85e4-0bc5f21a7be2">444</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmVhOGI1NjQyMTgwNzQ3N2U4NjAyN2ZjZDAxNzU4NzdlL3RhYmxlcmFuZ2U6ZWE4YjU2NDIxODA3NDc3ZTg2MDI3ZmNkMDE3NTg3N2VfNS0yLTEtMS0w_ab64d3f5-ae58-4191-8475-211e8cf0ef45">15,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to September&#160;30, 2020, the Company entered into a lease agreement for an expanded office and laboratory space located in Malvern, Pennsylvania. See Note 13 for additional information.</span></div></ix:continuation><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_73"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="ocgn:WarrantsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjk4Mg_2d2e2d97-cc0e-4f90-ba0d-41f010401e5f" continuedAt="id8ed7fd980834dee92d87ed1cd0389b4" escape="true">Warrants</ix:nonNumeric></span></div><ix:continuation id="id8ed7fd980834dee92d87ed1cd0389b4" continuedAt="ia0d7ce8c57b447869f1e0d95e8dc39b6"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pre-Merger Financing Warrants</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;27, 2019, Ocugen completed the Merger with OpCo. Immediately prior to the Merger, Ocugen and OpCo completed the Pre-Merger Financing, a previously announced private placement transaction with certain Investors pursuant to the Financing SPA, whereby, among other things, the Company agreed to issue Series&#160;A Warrants, Series&#160;B Warrants, and Series&#160;C Warrants.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 5, 2019, the Company entered into an agreement with each Investor that amended the terms of each of the Pre-Merger Financing Warrants held by each such Investor (collectively, the &#8220;Warrant Amendments&#8221;). The terms of the Pre-Merger Financing Warrants and the Warrant Amendments are discussed below. There were no Pre-Merger Financing Warrants outstanding at September&#160;30, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Series A Warrants</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series&#160;A Warrants had an initial exercise price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i2e5809e665eb4fa1bf1cecdf798b302a_I20200422" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfODUw_e1833215-59bc-40a6-b9c1-16aafc0f6f9d">7.13</ix:nonFraction>, were exercisable upon issuance and had a term of <ix:nonNumeric contextRef="i2e5809e665eb4fa1bf1cecdf798b302a_I20200422" format="ixt-sec:durmonth" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfOTAz_4e72ad94-2016-4f26-a5f6-1c0ff5852570">60</ix:nonNumeric> months from the date of issuance. The Series&#160;A Warrants were exercisable for up to <ix:nonFraction unitRef="shares" contextRef="i2e5809e665eb4fa1bf1cecdf798b302a_I20200422" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfOTgy_c200f384-9e58-4548-be05-088cd80500da">8.8</ix:nonFraction>&#160;million shares of Ocugen common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series&#160;A Warrants had an anti-dilution adjustment whereby if Ocugen issues or sells, enters into a definitive, binding agreement pursuant to which Ocugen is required to issue or sell or is deemed, pursuant to the provisions of the Series&#160;A Warrants, to have issued or sold, any common stock for a price per share lower than the exercise price then in effect (a &#8220;Dilutive Issuance&#8221;), subject to certain limited exceptions, then (i)&#160;the exercise price of the Series&#160;A Warrants shall be reduced </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="ia0d7ce8c57b447869f1e0d95e8dc39b6" continuedAt="ie5821e2da93e497eaac23b660f0ba5dc"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to such lower price per share and (ii)&#160;the number of shares issuable upon exercise of the Series&#160;A Warrants shall be increased to the number of shares of common stock determined by multiplying (a)&#160;the exercise price in effect immediately prior to such Dilutive Issuance by (b)&#160;the number of shares of common stock issuable upon exercise of the Series&#160;A Warrants immediately prior to such Dilutive Issuance (without giving effect to any limitation on exercise contained therein), and dividing the product thereof by the exercise price resulting from such Dilutive Issuance.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Series A Warrants were outstanding and exercisable as of December&#160;31, 2019. Pursuant to the Warrant Exchange (as defined below), no Series A Warrants were outstanding as of September&#160;30, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Series B Warrants</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series&#160;B Warrants had an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib4bee8b3a2e3430a8cbcbb7923b89e24_I20190927" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMjMyMw_5db77fa7-6cbc-4070-bf44-13b7c173cfe0">0.01</ix:nonFraction>, were exercisable after the completion of a <ix:nonNumeric contextRef="i72db3f74703449b199225c6a20600560_D20190927-20190927" format="ixt-sec:durday" name="ocgn:ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMjM3MA_84954a45-385a-493c-86e7-b5843ff64727">10</ix:nonNumeric> trading-day period following the effectiveness of a registration statement covering the resale of common stock into which such warrants were exercisable and were to expire on the date on which the Series&#160;B Warrants have been exercised in full (without giving effect to any limitation on exercise contained therein) and no shares remain issuable thereunder. The Series&#160;B Warrants were initially exercisable by the holders for <ix:nonFraction unitRef="shares" contextRef="ib4bee8b3a2e3430a8cbcbb7923b89e24_I20190927" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMjc5OA_44f3584f-9b8b-4243-8f22-87c3d3fe0ceb">8.0</ix:nonFraction> million shares of common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, each Series B Warrant included a Reset Period pursuant to which the number of shares issuable upon exercise of the Series B Warrants shall be increased during certain Reset Periods (as defined in the Series B Warrants). The Reset Period concluded in November 2019 and resulted in an aggregate of <ix:nonFraction unitRef="shares" contextRef="i37caa52256c84c01ad82bb794238bc10_I20191130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMzEzNQ_b5eda567-09ff-4780-8137-fc86dd01c76f">12.6</ix:nonFraction>&#160;million additional shares of common stock becoming issuable upon exercise of the Series B Warrants. There were <ix:nonFraction unitRef="shares" contextRef="i2639027910494f379046945f8a7d2bb9_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMzI0MQ_04f09fca-ee2a-4dfc-aa8d-26f9925963fe">1,000</ix:nonFraction> Series B Warrants outstanding at December&#160;31, 2019. There were <ix:nonFraction unitRef="shares" contextRef="ifa4ad77ecf7d4e6a9604ede41d7878a1_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMzI5ODUzNDkxNDM5Mw_4a0ee799-3c69-4d4b-be58-911bdd654308">no</ix:nonFraction> Series B Warrants outstanding at September&#160;30, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Series C Warrants</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series&#160;C Warrants were exercisable upon issuance for up to <ix:nonFraction unitRef="shares" contextRef="id84738694cfc4f48a8223bc4775059da_I20190927" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMzQyOA_e84f6dff-6de3-4062-96ac-96e4938dd273">50.0</ix:nonFraction> million shares of common stock at an initial exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="id84738694cfc4f48a8223bc4775059da_I20190927" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMzQ4Ng_47511d72-3607-4610-a7d6-769188248ecd">7.13</ix:nonFraction> per share. Each of the Series&#160;C Warrants was amended pursuant to the Warrant Amendments to permit the Investors, in lieu of making any cash payment otherwise contemplated to be made to the Company upon the exercise of the Series&#160;C Warrant, to elect instead to receive upon such exercise up to <ix:nonFraction unitRef="shares" contextRef="i41a7cddac3e8403d8a7b1b226753c6a6_I20191105" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMzc4Mg_e9261d5b-3ff8-4774-b48d-b664ec45f6ad">20.0</ix:nonFraction>&#160;million shares of common stock. Prior to the Warrant Amendments, the Series&#160;C Warrants had permitted the exercise without any cash payment of up to <ix:nonFraction unitRef="shares" contextRef="i5c449ee518aa4087bceac3f599d60b71_I20190927" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMzkyNQ_e524d2f6-e8fe-428f-91f1-abf4006682f4">50.0</ix:nonFraction> million shares of common stock in the event that the volume weighted-average price of the common stock on Nasdaq was less than or equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="i4e0e42f7805b40a7b369cb9a38e27242_D20190927-20190927" decimals="2" name="ocgn:ConvertedAdditionalSharesThresholdReleaseTriggerPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNDA1OQ_16edc5db-91c5-44f1-b1df-d71c36cb6746">1.20</ix:nonFraction> per share on any five trading days following the issuance of the Series&#160;C Warrants. There were <ix:nonFraction unitRef="shares" contextRef="i0391e6dd13e64542b9e6ef240aa2d783_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNDE1Nw_0f0a98ff-bc8c-4056-a54e-a54057f3272e">1,000</ix:nonFraction> Series C Warrants outstanding at December&#160;31, 2019. There were <ix:nonFraction unitRef="shares" contextRef="i09974af4f9294df7b673d1888259b853_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfOTM0NTg0ODg2NzI1NQ_6e28cc3e-b82d-4244-83f9-1a2f91cfffef">no</ix:nonFraction> Series C Warrants outstanding at September&#160;30, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for the Pre-Merger Financing Warrants</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2019, the Pre-Merger Financing Warrants were classified as equity. At issuance, the Series B Warrants were classified as a liability on the condensed consolidated balance sheet as they did not meet the derivative scope exception to be accounted for within stockholders' equity. The Series B Warrants were initially measured at fair value and marked to market each reporting period. Upon the completion of the Reset Period in November 2019, the Series B Warrants were reassessed and determined to meet the derivative scope exception allowing for equity classification. The Series B Warrants were marked to market a final time and the remaining liability balance was reclassified to equity.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Series B Warrants was calculated using a Monte Carlo simulation while estimating the stock price during the Reset Period, based on the terms described within the Financing SPA. Key fair value inputs included the starting stock price, expected stock volatility during the Reset Period, and additional shares issued from escrow. The methodology for measuring fair value was sensitive to the expected stock volatility assumption input mentioned above. The volatility used in the fair value estimate was <ix:nonFraction unitRef="number" contextRef="ibc6f5729ecb242e484fb2d858d328ec4_I20190927" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNzE0NjgyNTYxMTY3Nw_4a987897-7d71-4732-819f-604c2816f7ec">96.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i7dd696ce560e4f74960fe7452fda5bd9_I20190930" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNzE0NjgyNTYxMTY4NA_95125f0c-96ef-4c34-b36a-ecddc85e6bf9">97.0</ix:nonFraction>% as of September 27, 2019 and September&#160;30, 2019, respectively. Inputs used in the valuation were unobservable and were therefore classified as Level 3 fair value inputs. The fair value of the Series B Warrants upon the end of the Reset Period was based on a Black-Scholes valuation model, which is classified as Level 3 in the fair value hierarchy.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><ix:continuation id="ie5821e2da93e497eaac23b660f0ba5dc"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfOTM0NTg0ODg2NzI1NA_72476711-07a7-4eec-82ab-27c500eb23b2" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a roll-forward of the Series B Warrant liability:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.444%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief05580895fc46368234c7da5575be31_I20181231" decimals="0" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RhYmxlOmI1YmUyN2Q1ZTc3ODQ5ODhhYTUzODQzZTJlZjQ3NDFjL3RhYmxlcmFuZ2U6YjViZTI3ZDVlNzc4NDk4OGFhNTM4NDNlMmVmNDc0MWNfMS0xLTEtMS0xOTE4_e920387b-3a39-4581-ae17-5c9fca243b63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at issuance - September 27, 2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33032b532e54016bf273bdc3dc87946_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RhYmxlOmI1YmUyN2Q1ZTc3ODQ5ODhhYTUzODQzZTJlZjQ3NDFjL3RhYmxlcmFuZ2U6YjViZTI3ZDVlNzc4NDk4OGFhNTM4NDNlMmVmNDc0MWNfMi0xLTEtMS0xOTE4_3d1be9f2-d43b-4b72-b8e8-90b3850a6a47">9,387,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of embedded derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33032b532e54016bf273bdc3dc87946_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RhYmxlOmI1YmUyN2Q1ZTc3ODQ5ODhhYTUzODQzZTJlZjQ3NDFjL3RhYmxlcmFuZ2U6YjViZTI3ZDVlNzc4NDk4OGFhNTM4NDNlMmVmNDc0MWNfMy0xLTEtMS0xOTE4_16fc3784-03e5-4ec7-84be-b7be4340007a">18,577,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e68dccda8164000aaf8c597ab10b628_I20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RhYmxlOmI1YmUyN2Q1ZTc3ODQ5ODhhYTUzODQzZTJlZjQ3NDFjL3RhYmxlcmFuZ2U6YjViZTI3ZDVlNzc4NDk4OGFhNTM4NDNlMmVmNDc0MWNfNC0xLTEtMS0xOTE4_7047c357-2157-4c3a-bc8f-d47fa5ace493">27,964,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of embedded derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9c4014ea1664b28a89cbda4056472d5_D20191001-20191231" decimals="0" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RhYmxlOmI1YmUyN2Q1ZTc3ODQ5ODhhYTUzODQzZTJlZjQ3NDFjL3RhYmxlcmFuZ2U6YjViZTI3ZDVlNzc4NDk4OGFhNTM4NDNlMmVmNDc0MWNfNS0xLTEtMS0xOTQ3_f36cbbe8-fbcb-4978-9e0b-85c08c83d28c">16,709,246</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified to equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9c4014ea1664b28a89cbda4056472d5_D20191001-20191231" decimals="0" sign="-" format="ixt:numdotdecimal" name="ocgn:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RhYmxlOmI1YmUyN2Q1ZTc3ODQ5ODhhYTUzODQzZTJlZjQ3NDFjL3RhYmxlcmFuZ2U6YjViZTI3ZDVlNzc4NDk4OGFhNTM4NDNlMmVmNDc0MWNfNi0xLTEtMS0xOTQ3_ad38229d-b422-4853-b2b0-e6184981e073">11,255,740</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2639027910494f379046945f8a7d2bb9_I20191231" decimals="0" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RhYmxlOmI1YmUyN2Q1ZTc3ODQ5ODhhYTUzODQzZTJlZjQ3NDFjL3RhYmxlcmFuZ2U6YjViZTI3ZDVlNzc4NDk4OGFhNTM4NDNlMmVmNDc0MWNfNy0xLTEtMS0xOTQ3_b7eabb75-f0ee-456f-a80c-eb0147af0fcd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrant Exchange</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2020, the Company entered into a subscription agreement as discussed within Note 8. The subscription agreement constituted a Dilutive Issuance (as defined above) and resulted in adjustments to the number of issuable Series A Warrants and the exercise price under the Series A Warrants.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contemporaneously with the subscription agreement, the Company and OpCo entered into Amendment and Exchange Agreements (each an "Exchange Agreement" and collectively, the "Exchange Agreements") with the Investors. Pursuant to the Exchange Agreements, the Company, OpCo and the Investors agreed, among other things, after giving effect to the Dilutive Issuance, to amend the Series A Warrants to provide for an adjustment to the number of common stock issuable upon the exercise of the Series A Warrants. Concurrently with such amendments, the Investors exchanged the Series A Warrants for (i) an aggregate of <ix:nonFraction unitRef="shares" contextRef="i5d3016329c854e379eb39ead2fc7f7d1_D20200422-20200422" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNTE3Mg_ff3433bc-ae1f-4a0e-9f3b-f0e92ec0c1a7">21.9</ix:nonFraction>&#160;million shares of common stock and (ii) the Warrant Exchange Promissory Notes as defined in Note 9 (collectively the "Warrant Exchange"). Following the consummation of the Warrant Exchange and the concurrent exercise of the remaining Series B Warrants and Series C Warrants, there were no Pre-Merger Financing Warrants outstanding at September&#160;30, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the Warrant Exchange by recognizing the fair value of the consideration transferred in excess of the carrying value of the Series A Warrants as a reduction of additional paid-in capital. The fair value of the consideration transferred to settle the Series A Warrants was approximately $<ix:nonFraction unitRef="usd" contextRef="if5a1d88348ac442ca29916a0b2a044b7_D20200422-20200422" decimals="-5" format="ixt:numdotdecimal" name="ocgn:ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNTg1Mw_70007fda-9a4e-4d9b-91bb-fc7b5cb45c6d">13.6</ix:nonFraction>&#160;million, comprised of $<ix:nonFraction unitRef="usd" contextRef="if5a1d88348ac442ca29916a0b2a044b7_D20200422-20200422" decimals="-5" format="ixt:numdotdecimal" name="ocgn:ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNTg3MA_7d7a53fa-97c3-42d1-aea9-24601383e3e3">8.6</ix:nonFraction>&#160;million in shares of common stock and the fair value of the Warrant Exchange Promissory Notes of $<ix:nonFraction unitRef="usd" contextRef="if5a1d88348ac442ca29916a0b2a044b7_D20200422-20200422" decimals="-5" format="ixt:numdotdecimal" name="ocgn:ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNTk2Mg_0f9c34fb-d609-438f-9c65-3725bfb5a8d8">5.0</ix:nonFraction>&#160;million. The fair value of consideration transferred to settle the Series A warrants was in excess of the fair value of the Series A Warrants immediately prior to the transaction by approximately $<ix:nonFraction unitRef="usd" contextRef="ida7ba91283944cbaa8a66a0e1a833edb_D20200421-20200421" decimals="-5" format="ixt:numdotdecimal" name="ocgn:ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjE1Mw_7509a7ef-fe11-4cfb-b771-b7ed65baeb80">12.5</ix:nonFraction>&#160;million. The excess consideration was accounted for as a deemed dividend to the warrant holders and is reflected as an additional net loss attributed to common stockholders in the calculation of basic and diluted net loss per common share for the nine months ended September 30, 2020. The fair value of the Series A Warrants immediately prior to the Warrant Exchange was $<ix:nonFraction unitRef="usd" contextRef="ia5deeae01bef4c8e81884c72f6a8ce9d_I20200421" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjUwMQ_0e19b2da-24fe-4197-bc72-480625a46a50">1.1</ix:nonFraction>&#160;million, which was estimated using a Black-Scholes valuation model utilizing Level 3 inputs. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OpCo Warrants</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 2018, OpCo issued warrants to investors of the Company pursuant to a stockholders' agreement and to <ix:nonFraction unitRef="employee" contextRef="ia83d0c6aaf90427c82faff7bf369406a_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="ocgn:ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjcxMw_3ddd3bcd-ba43-441d-ac58-bf0dd62b9824">two</ix:nonFraction> employees of the Company pursuant to their respective employment agreements. As of September&#160;30, 2020 and December&#160;31, 2019, <ix:nonFraction unitRef="shares" contextRef="i5d1becb9d0b64817a37cabf28da5d1ee_I20191231" decimals="-5" format="ixt:numdotdecimal" name="ocgn:ClassOfWarrantOrRightExercisable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjgxMA_1a743e0b-3228-4a33-8e82-db8e28a5eb67"><ix:nonFraction unitRef="shares" contextRef="ib9adecc5943843fd91836c9fb0e2c80e_I20200930" decimals="-5" format="ixt:numdotdecimal" name="ocgn:ClassOfWarrantOrRightExercisable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjgxMA_743d6e24-d92e-4475-9100-62980fa05980">0.9</ix:nonFraction></ix:nonFraction>&#160;million warrants to purchase common stock were outstanding and exercisable and had a weighted average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5d1becb9d0b64817a37cabf28da5d1ee_I20191231" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjkyNQ_e34007ac-27cc-448e-bd84-a607075fdfc0"><ix:nonFraction unitRef="usdPerShare" contextRef="ib9adecc5943843fd91836c9fb0e2c80e_I20200930" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjkyNQ_f03e6acd-cb91-4d87-853a-538545108136">5.67</ix:nonFraction></ix:nonFraction> per share. The warrants expire between 2025 and 2027.</span></div></ix:continuation><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_1188"></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF85MzQ1ODQ4ODQxMTk2_a8698151-a080-4f1e-84e3-490a88d4b71d" continuedAt="i161112c5bd024cccaa9c88c71a05ec58" escape="true">Subsequent Events</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i161112c5bd024cccaa9c88c71a05ec58">On October 9, 2020, the Company entered into a lease agreement (the "Lease Agreement") with WPT Land 2 LP (the "Landlord") for an expanded office and laboratory space located in Malvern, Pennsylvania. The Lease Agreement has an expected commencement date in early 2021 and an initial term of <ix:nonNumeric contextRef="i6f2dc86eba1043a4b6a426c058150999_I20201009" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF8xNjQ5MjY3NDQ2MjQy_c0cab281-7ade-48be-8c4a-31582fcb7c9d">seven years</ix:nonNumeric>. The aggregate estimated base rent payments due over the initial <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF8xNjQ5MjY3NDQ2MzEx_c0cab281-7ade-48be-8c4a-31582fcb7c9d">seven</span> year term of the Lease Agreement is $<ix:nonFraction unitRef="usd" contextRef="i86c757f96f724d6b8aaa688ac26a295e_D20201009-20201009" decimals="0" format="ixt:numdotdecimal" name="ocgn:OperatingLeaseTotalBasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF8xNjQ5MjY3NDQ2Mjgw_5e66b0a2-6ad4-4b16-b9fb-fc39f5465293">1.8</ix:nonFraction>&#160;million. In addition, the Company will pay its pro rata share of the Landlord's annual operating expenses associated with the premises. The Company has the option to extend the Lease Agreement for <ix:nonFraction unitRef="numberofrenewaloptions" contextRef="i86c757f96f724d6b8aaa688ac26a295e_D20201009-20201009" decimals="INF" format="ixt-sec:numwordsen" name="ocgn:LesseeOperatingLeaseNumberOfRenewalOptions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF83MTQ2ODI1NTg1NzAw_1a056d8b-bcb9-49af-9ec4-e34d0c6a5eea">one</ix:nonFraction> additional <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF8xNjQ5MjY3NDQ2MjU0_e2515411-dba9-46d7-a836-2bb32ea59544">five</span> year term. The Company has an existing lease agreement with the Landlord for the Company's current office space. Provided that the Company is not under an event of default and surrenders the current office space pursuant to the terms of the Lease Agreement and in the condition required by the existing lease agreement, the existing lease agreement will be deemed terminated without penalty to the Company.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the financial statements and the notes thereto included elsewhere in this Quarterly Report on Form&#160;10-Q and with our audited financial statements for the year ended December&#160;31, 2019, included in our 2019 Annual Report. Some of the information contained in this discussion and analysis, including information with respect to our plans and strategy for our business and related financing, include forward-looking statements that involve risks, uncertainties and assumptions. These statements are based on our beliefs and expectations about future outcomes and are subject to risks and uncertainties that could cause our actual results to differ materially from anticipated results. We undertake no obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise. You should read the &#8220;Risk Factors&#8221; section included in our 2019 Annual Report and the "Risk Factors" and &#8220;Disclosure Regarding Forward-Looking Statements&#8221; sections of this Quarterly Report on Form&#160;10-Q for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_79"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to cure blindness diseases.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cutting-edge technology pipeline includes:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Modifier Gene Therapy Platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Based on NHRs, we believe our gene therapy platform has the potential to address many retinal diseases, including RP, with one product.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Novel Biologic Therapy for Retinal Diseases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;We are developing OCU200, which is being developed to treat DME, DR and wet AMD.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are developing a breakthrough modifier gene therapy platform to generate therapies designed to fulfill unmet medical needs in the area of retinal diseases, including IRDs, and dry AMD. Our modifier gene therapy platform is based on NHRs which have the potential to restore homeostasis, the basic biological processes in the retina. Unlike single-gene replacement therapies, which only target one genetic mutation, we believe that our gene therapy platform, through its use of NHRs, represents a novel approach in that it may address multiple retinal diseases with one product. IRDs such as RP, a group of rare genetic disorders that involves a breakdown and loss of cells in the retina and can lead to visual impairment and blindness, affect over 1.5 million people worldwide. Over 150 gene mutations have been associated with RP and this number represents only 60% of the RP population. The remaining 40% of RP patients cannot be genetically diagnosed, making it difficult to develop individual treatments. We believe our first gene therapy candidate, OCU400, has the potential to eliminate the need for developing more than 150 individual products and provide one treatment option for all RP patients. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OCU400 has received four ODDs from the FDA for the treatment of certain disease genotypes: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NR2E3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CEP290</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RHO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PDE6B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> mutation-associated RP. We are planning to initiate two Phase 1/2a clinical trials for OCU400 in the second half of 2021. Our second gene therapy candidate, OCU410, is being developed to utilize the nuclear receptor genes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RORA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of dry AMD. This candidate is currently in preclinical development. We are planning to initiate a Phase 1/2a clinical trial for OCU410 in 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also conducting preclinical development for our biologic product candidate, OCU200. OCU200 is a novel fusion protein designed to treat DME, DR and wet AMD. We plan to expand the therapeutic applications of OCU200 beyond DME, DR and wet AMD to potentially include macular edema following retinal vein occlusion and myopic choroidal neovascularization. We expect to initiate IND-enabling preclinical studies for OCU200 in 2021 and a Phase 1/2a clinical trial for OCU200 in the first half of 2022. In October 2020, we entered into an agreement with Kemwell Biopharma Pvt. Ltd. ("Kemwell") to manufacture OCU200. Under this agreement, Kemwell will manage all chemistry, manufacturing and control and clinical manufacturing activities as well as provide supplies for IND-enabling preclinical studies and our planned Phase 1/2a clinical trials. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were developing OCU300, a small molecule therapeutic for the treatment of symptoms associated with oGVHD. On June 1, 2020, we announced that we had discontinued the Phase 3 trial of OCU300 based on results of a pre-planned interim sample size analysis conducted by an independent Data Monitoring Committee, which indicated the trial was unlikely to meet its co-primary endpoints upon completion. The trial was not stopped based on safety concerns. We are no longer pursuing the development of this product candidate. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were previously developing OCU310 for patients with dry eye disease. We completed a Phase 3 clinical trial for OCU310 that was initiated in September 2018. Although the trial showed that OCU310 is safe and well-tolerated, it did not meet its co-primary endpoints for symptom and sign. We are no longer pursuing the development of this product candidate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no products approved for commercial sale and have not generated any revenue from product sales. We have never been profitable and have incurred operating losses in each year since inception. We incurred net losses of approximately $18.0&#160;million and $32.6&#160;million for the nine months ended September 30, 2020 and 2019, respectively. As of September&#160;30, 2020, we had an accumulated deficit of $69.5&#160;million and a cash, cash equivalents and restricted cash balance of $19.3&#160;million. Substantially all of our operating losses resulted from expenses incurred in connection with our research and development programs and from general and administrative costs associated with our operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have viewed our operations and manage our business as one operating segment. As of September&#160;30, 2020, all of our assets were located in the United States. Our headquarters and operations are located in Malvern, Pennsylvania.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_82"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Operations Overview</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration revenue</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue consists of royalty payments received in connection with agreements accounted for as collaborative arrangements under ASC 808. The Company assesses whether royalty payments from collaboration partners represent consideration from a customer. If the collaboration partner is considered a customer, the Company accounts for those payments within the scope of ASC 606. However, when the Company concludes that its collaboration partner is not a customer, the Company will record royalty payments received as collaboration revenue in the period in which the underlying sale occurs. See Note 5 to our condensed consolidated financial statements included in this report for additional information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development expense</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. These costs consist of internal and external expenses. Internal expenses include the cost of salaries, benefits, severance and other related costs, including stock-based compensation, for personnel serving in our research and development functions, as well as allocated rent and utilities expenses. External expenses include development, clinical trials, patent costs and regulatory compliance costs incurred with research organizations and other third-party vendors. License fees paid to acquire access to proprietary technology are expensed to research and development unless it is determined that the technology is expected to have an alternative future use. All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred to research and development expense due to the uncertainty about the recovery of the expenditure. We record costs for certain development activities, such as clinical trials, based on our evaluation of the progress to completion of specific tasks using data such as patient enrollment, clinical site activations, or information provided to us by our vendors on their actual costs incurred. Payments for these activities are based on the terms of the individual arrangements, which may differ from the pattern of costs incurred, and are reflected in the condensed consolidated financial statements as prepaid or accrued research and development expense, as the case may be.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that our research and development expenses, excluding charges to in-process research and development expense, will increase modestly as compared to prior periods as we conduct preclinical activities in preparation for Phase 1/2a trials with respect to OCU400, OCU410, and OCU200 that we plan to commence in 2021 and 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and administrative expense</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense consists primarily of personnel expenses, including salaries, benefits, severance and stock-based compensation expense, for employees in executive, accounting and other administrative functions. General and administrative expense also includes corporate facility costs, including rent and utilities, insurance premiums, legal fees related to corporate matters and fees for accounting and other consulting services.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that our general and administrative expenses will increase as a result of higher corporate infrastructure costs including, but not limited to accounting, legal, human resources, consulting, and investor relations fees, as well as increased director and officer insurance premiums, associated with operating as a public company.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Severance-related expense</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we communicated notice to five employees of termination of their employment. This reduction represents one-third of our workforce. All terminations were &#8220;without cause&#8221; and each employee is entitled to receive termination benefits upon departure. The termination dates vary for each employee and range from June&#160;30, 2020 to December&#160;31, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the workforce reduction, we recognized severance-related charges of $0.4&#160;million and $1.1&#160;million during the three and nine months ended September&#160;30, 2020, respectively. We expect to pay severance benefits of $0.4&#160;million during 2020 and $0.7&#160;million during 2021. For the three months ended September 30, 2020, we recognized a de minimis amount of severance-related charges within general and administrative expense and $0.4&#160;million of severance-related charges within research and development expense. For the nine months ended September 30, 2020, we recognized $0.2&#160;million of severance-related charges within general and administrative expense and $0.9&#160;million of severance-related charges within research and development expense. We expect that the workforce reduction will result in approximately $2.0&#160;million in annualized cost savings commencing in 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in fair value of derivative liabilities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value of derivative liabilities includes the change in fair value each reporting period of (a) the conversion and change in control features embedded in certain convertible notes, which were required to be bifurcated and recognized at fair value, and (b) the change in the fair value of the Company's Series B Warrants.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense primarily includes debt coupon interest, the amortization of debt issuance costs, and the accretion of debt discounts.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_85"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Significant Judgments and Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make judgments, estimates and assumptions in the preparation of our condensed consolidated financial statements. Actual results could differ from those estimates. There were no material changes to our critical accounting policies and estimates as reported in our 2019 Annual Report.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_88"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three Months Ended September&#160;30, 2020 and 2019</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the results of Ocugen&#8217;s operations for the three months ended September 30, 2020 and 2019:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,182)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,714)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,468)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(796)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(751)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,059)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,474)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,773)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,299&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expense</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense increased by $0.2&#160;million for the three months ended September 30, 2020 compared to the three months ended September 30, 2019 primarily as a result of an increase of $0.4&#160;million in severance-related charges related to the employee terminations announced in June 2020, partially offset by a decrease of $0.2&#160;million in employee-related expenses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In-process research and development expense</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development expense increased by $7.0&#160;million for the three months ended September 30, 2020 compared to the three months ended September 30, 2019 as a result of the NeoCart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> asset, which ceased to meet the criteria to be classified as held for sale during the three months ended September 30, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative expense</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased by $0.3 million for the three months ended September 30, 2020 compared to the three months ended September 30, 2019 primarily as a result of increases of $0.3&#160;million in insurance premiums, $0.2&#160;million in employee-related expenses, and $0.1&#160;million in consulting fees, partially offset by a decrease of $0.3&#160;million in professional fees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in fair value of derivative liability</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in fair value of derivative liability was zero&#160;for the three months ended September 30, 2020 compared to a loss of $18.5 million primarily due to the remeasurement of the Series B Warrant liability during the three months ended September 30, 2019.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $0.3&#160;million for the three months ended September 30, 2020 and $0.8 million for the three months ended September 30, 2019. The decrease in interest expense was primarily due to the conversions of all previously issued convertible debt during 2019. Interest expense for the three months ended September 30, 2020 primarily relates to the Warrant Exchange Promissory Notes.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense) was zero for the three months ended September 30, 2020 and $0.8&#160;million for the three months ended September 30, 2019. The decrease in other expense was primarily due to equity issuance costs related to the Series B Warrants which were expensed during the three months ended September 30, 2019 since the Series B Warrants were liability-classified.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Nine Months Ended September&#160;30, 2020 and 2019</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the results of Ocugen's operations for the nine months ended September 30, 2020 and 2019:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,578)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,520&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,883&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,637&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,477)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,883)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,594)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,897)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt conversion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(555)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,753)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(751)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(555)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,742)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,032)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,625)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,593&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaboration revenue</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue increased by $42,620 for the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019 as a result of collaboration revenue generated from Advaite Agreement, which commenced in April 2020. We did not have any collaboration revenue in 2019.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expense</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense decreased by $1.6&#160;million for the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019 primarily as a result of a decrease of $2.5&#160;million related to the discontinuation of OCU310 clinical trial activities in the first quarter of 2019 and $0.2&#160;million in employee-related expenses, partially offset by an increase of $0.9&#160;million in severance-related charges related to the employee terminations announced in June 2020 and $0.6&#160;million related to OCU300 clinical trial activities conducted in 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In-process research and development expense</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development expense increased by $7.0&#160;million for the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019 as a result of the NeoCart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> asset, which ceased to meet the criteria to be classified as held for sale during the nine months ended September 30, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative expense</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased by $2.2&#160;million for the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019 primarily as a result of an increase of $0.8&#160;million in insurance premiums, $0.5&#160;million in professional and consulting fees, $0.4&#160;million in employee-related expenses, $0.3&#160;million in Board of Director fees, and $0.2&#160;million in severance-related charges related to the employee terminations announced in June 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in fair value of derivative liability</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in fair value of derivative liability was zero&#160;for the nine months ended September 30, 2020 compared to a loss of $19.9&#160;million for the nine months ended September 30, 2019 primarily due to the remeasurement of the Series B Warrant liability during the nine months ended September 30, 2019.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on Debt Conversion </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss on debt conversion was zero for the nine months ended September 30, 2020 compared to a loss of $0.3&#160;million for the nine months ended September 30, 2019 relating to conversions in 2019 of all previously issued convertible debt.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $0.6&#160;million for the nine months ended September 30, 2020 compared to $1.8&#160;million for the nine months ended September 30, 2019. The decrease in interest expense was primarily due to the conversions of all previously issued convertible debt during 2019. Interest expense for the nine months ended September 30, 2020 primarily relates to the Warrant Exchange Promissory Notes.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense) was a de minimis amount for the nine months ended September 30, 2020 compared to $0.8&#160;million for the nine months ended September 30, 2019. The decrease in other income (expense) was primarily due to equity issuance costs related to the Series B Warrants which were expensed during the nine months ended September 30, 2019 since the Series B Warrants were liability-classified.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_91"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we had $19.3&#160;million in cash, cash equivalents and restricted cash. We have not generated any revenue from product sales to date and have primarily funded our operations to date through the sale of common stock, warrants to purchase common stock, the issuance of convertible notes, debt, and grant proceeds. Specifically, since our inception and through September&#160;30, 2020, we have raised an aggregate of $79.1&#160;million to fund our operations, of which $66.5&#160;million was from the sale of our common stock and warrants, $10.3&#160;million was from the issuance of convertible notes, $2.1&#160;million was from debt, and $0.2&#160;million from grant proceeds.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2020, we sold an aggregate of 86.2&#160;million shares of our common stock in separate at-the-market offerings (&#8220;ATMs&#8221;) commenced in May 2020, June 2020 and August 2020. We sold 34.4&#160;million shares under the May 2020 ATM, 24.8&#160;million shares under the June 2020 ATM and 27.0&#160;million shares under the August 2020 ATM. During the nine months ended September 30, 2020, we received net proceeds of $25.6&#160;million from the ATMs, after deducting commissions, fees and expenses of $1.1&#160;million. The offerings were made pursuant to our effective "shelf" registration statement on Form S-3 filed with the SEC on March 27, 2020, the base prospectus contained therein dated May 5, 2020, and the prospectus supplements related to the offerings dated May 8, 2020, June 12, 2020 and August 17, 2020. As of September&#160;30, 2020, we had sold all of the shares of common stock available for issuance under the prospectus supplements filed on May 8, 2020 and June 12, 2020 in connection with the May 2020 and June 2020 ATMs. As of September&#160;30, 2020, we had remaining capacity to issue up to $19.5&#160;million of common stock under the prospectus supplement filed on August 17, 2020 in connection with the August 2020 ATM.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have devoted substantial resources to research and development and have incurred significant net losses and expect to continue to incur net losses for the foreseeable future. We incurred net losses of approximately $18.0&#160;million and $32.6&#160;million for the nine months ended September 30, 2020 and 2019, respectively. As of September&#160;30, 2020, we had an accumulated deficit of $69.5&#160;million. In addition, as of September&#160;30, 2020, we had accounts payable and accrued expenses of $2.6&#160;million and indebtedness of $3.2&#160;million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a summary of our cash flows for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,426)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,150)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,662&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,673&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating activities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in operating activities was $10.4&#160;million for the nine months ended September 30, 2020 compared $8.1&#160;million for the nine months ended September 30, 2019. The increase in cash used in operating activities was primarily driven by the decrease in accounts payable and accrued expenses and the increase in prepayments, current and other assets during the nine months ended September 30, 2020 as compared to the nine months ended September 30, 2019.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing activities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities was $0.1&#160;million for the nine months ended September 30, 2020 compared with $2.3&#160;million for the nine months ended September 30, 2019. The decrease in cash used in investing activities was primarily driven by the payment of acquisition costs during the nine months ended September 30, 2019 with no comparable payments made during the nine months ended September 30, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing activities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by financing activities was $22.1&#160;million for the nine months ended September 30, 2020 compared to $24.2&#160;million for the nine months ended September 30, 2019. During the nine months ended September 30, 2020, cash provided by financing activities was primarily driven by gross proceeds of $26.7&#160;million received under May 2020, June 2020, and August 2020 ATMs and $0.9&#160;million in proceeds from the issuance of debt, partially offset by payments of equity issuance costs of $1.1&#160;million and repayments of debt of $4.4&#160;million. During the nine months ended September 30, 2019, cash provided by financing activities included proceeds from the Pre-Merger Financing of $22.4&#160;million, proceeds from the issuance of convertible debt of $6.8&#160;million, and proceeds from an April 2019 stock subscription agreement of $1.0&#160;million, partially offset by payments of equity issuance costs of $0.6&#160;million and repayments of debt of $5.3&#160;million </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indebtedness</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the President of the United States signed into law the CARES Act, a sweeping stimulus bill intended to bolster the U.S. economy, among other things, and provide emergency assistance to qualifying businesses and individuals. On April&#160;30, 2020, we were granted a loan from SVB in the aggregate amount of $0.4 million, pursuant to the PPP of the CARES Act. Certain amounts of the loan may be forgiven if they are used for qualifying expenses as described by the CARES Act. The loan was in the form of a promissory note which matures on April&#160;30, 2022 and bears interest at a rate of 1.0% per annum, payable monthly commencing on the date the SBA compensates SVB for amounts forgiven or within 10 months following the expiration of the 24-week covered period for qualifying expenses if we have not applied for forgiveness. At September&#160;30, 2020, there was $0.4&#160;million of principal outstanding under the PPP loan.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;22, 2020, we issued the Warrant Exchange Promissory Notes with an aggregate principal amount of $5.6&#160;million to existing investors in connection with an exchange of our Series A Warrants. The Warrant Exchange Promissory Notes had a maturity date of April 21, 2021 and did not bear interest. The Warrant Exchange Promissory Notes permitted prepayment in whole or in part at any time without penalty or premium. In the event that we consummated a financing transaction that generated cash to us, we were required to use 20% of the net proceeds of such transaction to prepay a portion of the outstanding amount under each Warrant Exchange Promissory Note if the transaction occurred on or prior to August&#160;22, 2020, and 30% of the net proceeds to prepay a portion of the outstanding amount under each Warrant Exchange Promissory Note if the transaction occurred after August&#160;22, 2020. As of September&#160;30, 2020, there was $1.3&#160;million of principal outstanding under the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrant Exchange Promissory Notes. On October 2, 2020, we made additional payments of $1.3&#160;million causing the Warrant Exchange Promissory Notes to be repaid in full and no longer outstanding.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2016, pursuant to the EB-5 Program, we entered into the EB-5 Loan Agreement to borrow up to $10.0&#160;million from EB5 Life Sciences in $0.5&#160;million increments. Borrowings are at a fixed interest rate of 4.0% and are to be utilized in the clinical development, manufacturing, and commercialization of our products and for our general working capital needs. Outstanding borrowings pursuant to the EB-5 Program become due upon the seventh anniversary of the final disbursement. Amounts repaid cannot be re-borrowed. Under the terms and conditions of the EB-5 Loan Agreement, we borrowed $0.5&#160;million on March&#160;26, 2020. At September&#160;30, 2020, there was $1.5&#160;million of principal outstanding under the EB-5 program.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Funding requirements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to incur significant expenses in connection with our ongoing activities, particularly as we continue research and development, including preclinical and clinical development activities of our product candidates, and add operational, financial and information systems to execute our business plan, maintain, expand and protect our patent portfolio, contract to manufacture our product candidates and operate as a public company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future funding requirements, both near- and long-term, will depend on many factors, including, but not limited to:</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">the initiation, progress, timing, costs and results of clinical trials for our product candidates;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">the outcome, timing and cost of the regulatory approval process for our product candidates by the FDA;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">future costs of manufacturing and commercialization;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">the cost of filing, prosecuting, defending and enforcing our patent claims and other intellectual property rights;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">the cost of defending intellectual property disputes, including patent infringement actions brought by third parties against us;</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">the costs of expanding infrastructure, as well as the higher corporate infrastructure costs associated with operating as a public company; and</span></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we in-license or acquire other products, product candidates or technologies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we had $19.3&#160;million in cash, cash equivalents and restricted cash. This amount is unlikely to meet our near-term capital requirements and will not meet our capital requirements over the next 12 months. Our management is currently evaluating different strategies to obtain the required funding for future operations. These strategies may include, but are not limited to: public and private placements of equity and/or debt, payments from potential strategic research and development, sale of assets, and licensing and/or collaboration arrangements with pharmaceutical companies or other institutions. There can be no assurance that these future funding efforts will be successful. If we cannot obtain the necessary funding, we will need to delay, scale back or eliminate some or all of our research and development programs&#894; consider other various strategic alternatives, including a merger or sale&#894; or cease operations. If we cannot expand our operations or otherwise capitalize on our business opportunities because we lack sufficient capital, our business, financial condition and results of operations could be materially adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, on December 27, 2019, we received a deficiency letter from the NASDAQ Capital Market ("Nasdaq") due to the bid price of our common stock falling below the minimum bid price for continued listing under Nasdaq listing rules for 30 consecutive days. In response to the COVID-19 pandemic and related extraordinary market conditions, Nasdaq tolled the compliance period for non-compliance with the minimum bid price listing requirement, effective April 16, 2020, until June 30, 2020 (the "Tolling Period"). Following the Tolling Period, we had until September 7, 2020 to regain compliance with the minimum bid price requirement. We did not regain compliance with the minimum bid price requirement as of September 7, 2020 and provided written notice to Nasdaq stating that we met the other continued listing requirements of Nasdaq and requesting an extension of the compliance period. On September 8, 2020, we received a written notice from the Nasdaq that we have been granted an additional 180 calendar days, or until March 8, 2021, to regain compliance with the minimum bid price requirement. If we are unable to regain compliance with Nasdaq listing rules regarding the price of our common stock in a timely manner, our common stock may become subject to delisting and we may find it difficult or impracticable to raise additional funds through public equity offerings.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of these factors, together with the anticipated increase in spending that will be necessary to continue to develop our products, we have concluded that there is substantial doubt about our ability to continue as a going concern within one year </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">after the date that the condensed consolidated financial statements included in this report are issued. See Note 1 to our condensed consolidated financial statements included in this report for additional information.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_94"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have off-balance sheet arrangements during the periods presented, and we do not currently have any off-balance sheet arrangements as defined in the rules&#160;and regulations of the SEC.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_97"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of recently adopted accounting pronouncements, see Note 2 to our condensed consolidated financial statements included in this report.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Company Information</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_103"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_106"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;Controls and Procedures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules&#160;13a-15(e)&#160;and 15d-15(e)&#160;under the Exchange Act, as of&#160;September&#160;30, 2020. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that (a)&#160;the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules&#160;and forms, and (b)&#160;such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rules&#160;13a-15(f)&#160;and 15d-15(f)&#160;under the Exchange Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II&#160;&#8212;&#160;OTHER INFORMATION</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_112"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Legal Proceedings.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are subject to claims in legal proceedings arising in the normal course of business. To our knowledge, there are no threatened or pending legal actions that could reasonably be expected to have a material adverse effect on our business, financial condition, results of operations or cash flows.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_115"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A.&#160;&#160;&#160;&#160;Risk Factors.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in our risk factors as previously disclosed in our 2019 Annual Report and in our Quarterly Report on Form 10-Q filed with the SEC on May 8, 2020. The risks described in our 2019 Annual Report and such Quarterly Report on Form 10-Q are not the only risks facing our company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_118"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no unregistered sales of equity securities during the three months ended September 30, 2020.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_121"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;Defaults Upon Senior Securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_124"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;Mine Safety Disclosures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_127"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5.&#160;&#160;&#160;&#160;Other Information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary;margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6.&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1372299/000110465920095729/tm2027637d2_ex10-1.htm">Controlled Equity Offering&#8480; Sales Agreement, dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1372299/000110465920095729/tm2027637d2_ex10-1.htm">August</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1372299/000110465920095729/tm2027637d2_ex10-1.htm"> 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1372299/000110465920095729/tm2027637d2_ex10-1.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1372299/000110465920095729/tm2027637d2_ex10-1.htm">, 2020, by and between Ocugen, Inc.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1372299/000110465920095729/tm2027637d2_ex10-1.htm">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1372299/000110465920095729/tm2027637d2_ex10-1.htm"> Cantor Fitzgerald &amp; Co.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1372299/000110465920095729/tm2027637d2_ex10-1.htm"> and Oppenheimer &amp; Co.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1372299/000110465920095729/tm2027637d2_ex10-1.htm"> (filed as exhibit 10.1 to the Registrant's Current Report on Form 8-K as filed on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1372299/000110465920095729/tm2027637d2_ex10-1.htm">August</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1372299/000110465920095729/tm2027637d2_ex10-1.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1372299/000110465920095729/tm2027637d2_ex10-1.htm">17</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1372299/000110465920095729/tm2027637d2_ex10-1.htm">, 2020, and incorporated herein by reference).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ocgn-20200930x10qxex311.htm">Certification of the Chief Executive Officer, as required by Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ocgn-20200930x10qxex312.htm">Certification of the Chief Financial Officer, as required by Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ocgn-20200930x10qxex321.htm">Certifications of the Chief Executive Officer and Chief Financial Officer as required by 18 U.S.C. 1350</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="ic4b88770ebf34f5b9ff4444c3fcf406a_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic4b88770ebf34f5b9ff4444c3fcf406a_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:6pt;margin-top:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ocugen, Inc.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: November 6, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Shankar Musunuri</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shankar Musunuri, Ph.D., MBA<br/>Chief Executive Officer&#160;and Chairman<br/>(Principal Executive Officer)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: November 6, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sanjay Subramanian</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanjay Subramanian<br/>Chief Financial Officer<br/>(Principal Financial Officer and Accounting Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ocgn-20200930x10qxex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i96e2907b523a422386e4dd7bca8d1f6c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Shankar Musunuri, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form&#160;10-Q of Ocugen,&#160;Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s)&#160;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s)&#160;and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:21pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;6, 2020</font></div></td><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Shankar Musunuri, Ph.D., MBA</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shankar Musunuri, Ph.D., MBA</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Chairman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="margin-top:12pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ocgn-20200930x10qxex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i7eff18dd149c495297c21c5d1b9bd511_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Sanjay Subramanian, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form&#160;10-Q of Ocugen,&#160;Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s)&#160;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s)&#160;and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:21pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.217%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;6, 2020</font></div></td><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sanjay Subramanian</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanjay Subramanian</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Accounting Officer)</font></td></tr></table></div><div style="margin-top:12pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ocgn-20200930x10qxex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="id1ac0ec57b4149db949f29e5a62cc699_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Ocugen,&#160;Inc. (the Company), does hereby certify, to the best of such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-bottom:18pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Quarterly Report on Form&#160;10-Q for the quarter ended September&#160;30, 2020 (the Form&#160;10-Q) of the Company fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934, and the information contained in the Form&#160;10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.681%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;6, 2020</font></div></td><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Shankar Musunuri, Ph.D., MBA</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shankar Musunuri, Ph.D., MBA</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Chairman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;6, 2020</font></div></td><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sanjay Subramanian</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanjay Subramanian</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Accounting Officer)</font></td></tr></table></div><div style="margin-top:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. This certification &#8220;accompanies&#8221; the Form&#160;10-Q to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form&#160;10-Q), irrespective of any general incorporation language contained in such filing.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>ocgn-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b98bd97b-267b-467c-adde-600f3c3e2154,g:859d45a4-db6c-4e83-b642-d8014a2143ca-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ocgn="http://www.deitaxonomy.com/20200930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.deitaxonomy.com/20200930">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ocgn-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ocgn-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ocgn-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ocgn-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.deitaxonomy.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusiness" roleURI="http://www.deitaxonomy.com/role/NatureofBusiness">
        <link:definition>2101101 - Disclosure - Nature of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusinessAdditionalInformationDetails" roleURI="http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails">
        <link:definition>2402401 - Disclosure - Nature of Business - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusinessReverseStockSplitDetails" roleURI="http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails">
        <link:definition>2403402 - Disclosure - Nature of Business - Reverse Stock Split (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusinessGoingConcernDetails" roleURI="http://www.deitaxonomy.com/role/NatureofBusinessGoingConcernDetails">
        <link:definition>2404403 - Disclosure - Nature of Business - Going Concern (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2105102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2206201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2307301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2408404 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>2409405 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergerandFinancing" roleURI="http://www.deitaxonomy.com/role/MergerandFinancing">
        <link:definition>2110103 - Disclosure - Merger and Financing</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergerandFinancingDetails" roleURI="http://www.deitaxonomy.com/role/MergerandFinancingDetails">
        <link:definition>2411406 - Disclosure - Merger and Financing (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareofCommonStock" roleURI="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStock">
        <link:definition>2112104 - Disclosure - Net Loss Per Share of Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareofCommonStockTables" roleURI="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockTables">
        <link:definition>2313302 - Disclosure - Net Loss Per Share of Common Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareofCommonStockDetails" roleURI="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails">
        <link:definition>2414407 - Disclosure - Net Loss Per Share of Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreements" roleURI="http://www.deitaxonomy.com/role/CollaborationAgreements">
        <link:definition>2115105 - Disclosure - Collaboration Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsDetails" roleURI="http://www.deitaxonomy.com/role/CollaborationAgreementsDetails">
        <link:definition>2416408 - Disclosure - Collaboration Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpenses" roleURI="http://www.deitaxonomy.com/role/AccruedExpenses">
        <link:definition>2117106 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesTables" roleURI="http://www.deitaxonomy.com/role/AccruedExpensesTables">
        <link:definition>2318303 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesDetails" roleURI="http://www.deitaxonomy.com/role/AccruedExpensesDetails">
        <link:definition>2419409 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ExitandDisposalActivities" roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivities">
        <link:definition>2120107 - Disclosure - Exit and Disposal Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ExitandDisposalActivitiesTables" roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesTables">
        <link:definition>2321304 - Disclosure - Exit and Disposal Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ExitandDisposalActivitiesNarrativeDetails" roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails">
        <link:definition>2422410 - Disclosure - Exit and Disposal Activities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails" roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails">
        <link:definition>2423411 - Disclosure - Exit and Disposal Activities - Schedule of Severance-Related Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTransactions" roleURI="http://www.deitaxonomy.com/role/EquityTransactions">
        <link:definition>2124108 - Disclosure - Equity Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTransactionsDetails" roleURI="http://www.deitaxonomy.com/role/EquityTransactionsDetails">
        <link:definition>2425412 - Disclosure - Equity Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.deitaxonomy.com/role/Debt">
        <link:definition>2126109 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.deitaxonomy.com/role/DebtTables">
        <link:definition>2327305 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtPPPNoteDetails" roleURI="http://www.deitaxonomy.com/role/DebtPPPNoteDetails">
        <link:definition>2428413 - Disclosure - Debt - PPP Note (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtWarrantExchangePromissoryNotesDetails" roleURI="http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails">
        <link:definition>2429414 - Disclosure - Debt - Warrant Exchange Promissory Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtEB5LoanAgreementBorrowingsDetails" roleURI="http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails">
        <link:definition>2430415 - Disclosure - Debt - EB 5 Loan Agreement Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSeniorSecuredConvertibleNotesDetails" roleURI="http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails">
        <link:definition>2431416 - Disclosure - Debt - Senior Secured Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtConvertiblePromissoryNoteDetails" roleURI="http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails">
        <link:definition>2432417 - Disclosure - Debt - Convertible Promissory Note (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtConvertibleNotesDetails" roleURI="http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails">
        <link:definition>2433418 - Disclosure - Debt - Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofDebtMaturitiesExcludingInterestDetails" roleURI="http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails">
        <link:definition>2434419 - Disclosure - Debt - Schedule of Debt Maturities (Excluding Interest) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensation" roleURI="http://www.deitaxonomy.com/role/StockbasedCompensation">
        <link:definition>2135110 - Disclosure - Stock-based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensationTables" roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationTables">
        <link:definition>2336306 - Disclosure - Stock-based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails" roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails">
        <link:definition>2437420 - Disclosure - Stock-based Compensation - Schedule of Compensation Expense for Options Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensationNarrativeDetails" roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails">
        <link:definition>2438421 - Disclosure - Stock-based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails" roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails">
        <link:definition>2439422 - Disclosure - Stock-based Compensation - Schedule Options to Purchase Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Commitments" roleURI="http://www.deitaxonomy.com/role/Commitments">
        <link:definition>2140111 - Disclosure - Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsTables" roleURI="http://www.deitaxonomy.com/role/CommitmentsTables">
        <link:definition>2341307 - Disclosure - Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAdditionalInformationDetails" roleURI="http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails">
        <link:definition>2442423 - Disclosure - Commitments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsOperatingleasescomponentsofleaseexpenseDetails" roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails">
        <link:definition>2443424 - Disclosure - Commitments - Operating leases, components of lease expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsOperatingleasessupplementalbalancesheetinformationDetails" roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails">
        <link:definition>2444425 - Disclosure - Commitments - Operating leases, supplemental balance sheet information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsOperatingleasessupplementalcashflowinformationDetails" roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalcashflowinformationDetails">
        <link:definition>2445426 - Disclosure - Commitments - Operating leases, supplemental cash flow information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsOperatingleasesfutureminimumleasepaymentsDetails" roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails">
        <link:definition>2446427 - Disclosure - Commitments - Operating leases, future minimum lease payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsOperatingleasesfutureminimumleasepaymentsDetails_1" roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails_1">
        <link:definition>2446427 - Disclosure - Commitments - Operating leases, future minimum lease payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsFinanceleasesfutureminimumleasepaymentsDetails" roleURI="http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails">
        <link:definition>2447428 - Disclosure - Commitments - Finance leases, future minimum lease payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsFinanceleasesfutureminimumleasepaymentsDetails_1" roleURI="http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails_1">
        <link:definition>2447428 - Disclosure - Commitments - Finance leases, future minimum lease payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Warrants" roleURI="http://www.deitaxonomy.com/role/Warrants">
        <link:definition>2148112 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsTables" roleURI="http://www.deitaxonomy.com/role/WarrantsTables">
        <link:definition>2349308 - Disclosure - Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsAdditionalInformationDetails" roleURI="http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails">
        <link:definition>2450429 - Disclosure - Warrants - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails" roleURI="http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails">
        <link:definition>2451430 - Disclosure - Warrants - Schedule of Roll-forward of Series&#160;B Warrant Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.deitaxonomy.com/role/SubsequentEvents">
        <link:definition>2152113 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.deitaxonomy.com/role/SubsequentEventsDetails">
        <link:definition>2453431 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ocgn_ClassOfWarrantOrRightExercisable" abstract="false" name="ClassOfWarrantOrRightExercisable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ocgn_HistogenicsCorporationMember" abstract="true" name="HistogenicsCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_ConvertibleDebtJanuary2018Member" abstract="true" name="ConvertibleDebtJanuary2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth" abstract="false" name="PercentageOfIncreaseInPurchasePriceOfAssetPerMonth" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ocgn_IncreaseDecreaseInLeaseObligations" abstract="false" name="IncreaseDecreaseInLeaseObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_BusinessCombinationIssuedSharesExchangeRate" abstract="false" name="BusinessCombinationIssuedSharesExchangeRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ocgn_ConvertiblePromissoryNotesMember" abstract="true" name="ConvertiblePromissoryNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_WarrantsTextBlock" abstract="false" name="WarrantsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ocgn_A2014PlanMember" abstract="true" name="A2014PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_ControlledEquityOfferingSalesAgreementMember" abstract="true" name="ControlledEquityOfferingSalesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity" abstract="false" name="FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_WarrantsExchangedForCommonStockMember" abstract="true" name="WarrantsExchangedForCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_NonCashInterestExpense" abstract="false" name="NonCashInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_SeniorSecuredConvertibleNotesJune2019Member" abstract="true" name="SeniorSecuredConvertibleNotesJune2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_AdvaiteIncMember" abstract="true" name="AdvaiteIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_SeniorSecuredConvertibleNotesMay2019Member" abstract="true" name="SeniorSecuredConvertibleNotesMay2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_GainsLossesOnConversionOfDebt" abstract="false" name="GainsLossesOnConversionOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_FormerOcugenWarrantsMember" abstract="true" name="FormerOcugenWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity" abstract="false" name="SaleOfStockNumberOfSharesOutstandingRemainingCapacity" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ocgn_NumberOfSeriesOfWarrantsIssued" abstract="false" name="NumberOfSeriesOfWarrantsIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered" abstract="false" name="ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ocgn_ReverseMergerAndFinancingDisclosureTable" abstract="true" name="ReverseMergerAndFinancingDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock" abstract="false" name="SaleOfStockAdditionalDebtCancelledInExchangeForStock" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_ConvertibleDebtJune2018Member" abstract="true" name="ConvertibleDebtJune2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_A2019PlanMember" abstract="true" name="A2019PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_ConvertibleDebtDecember2018Member" abstract="true" name="ConvertibleDebtDecember2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_ConvertibleDebtConversionFeatureMember" abstract="true" name="ConvertibleDebtConversionFeatureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_NumberOfOrphanDrugDesignations" abstract="false" name="NumberOfOrphanDrugDesignations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction" abstract="false" name="DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_ConvertibleDebtNovember2018Member" abstract="true" name="ConvertibleDebtNovember2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense" abstract="false" name="CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock" abstract="false" name="ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice" abstract="false" name="ConvertedAdditionalSharesThresholdReleaseTriggerPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="ocgn_AssetPurchaseAgreementCashConsideration" abstract="false" name="AssetPurchaseAgreementCashConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_SecuritiesPurchaseAgreementMember" abstract="true" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_ConvertibleNotesBoardOfDirectorsMember" abstract="true" name="ConvertibleNotesBoardOfDirectorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_DebtRedemptionMultipleFeature" abstract="false" name="DebtRedemptionMultipleFeature" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ocgn_NumberOfEquityCompensationPlans" abstract="false" name="NumberOfEquityCompensationPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ocgn_AccruedLiabilitiesProfessionalFees" abstract="false" name="AccruedLiabilitiesProfessionalFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_PaycheckProtectionProgramLoanMember" abstract="true" name="PaycheckProtectionProgramLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_LineOfCreditBorrowingEachDraw" abstract="false" name="LineOfCreditBorrowingEachDraw" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_PreMergerFinancingMember" abstract="true" name="PreMergerFinancingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_LesseeOperatingLeaseNumberOfRenewalOptions" abstract="false" name="LesseeOperatingLeaseNumberOfRenewalOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ocgn_SeniorSecuredConvertibleNotesMember" abstract="true" name="SeniorSecuredConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_ReverseMergerAndFinancingDisclosureLineItems" abstract="true" name="ReverseMergerAndFinancingDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost" abstract="false" name="NoncashOrPartNoncashAmountOfDeferredTransactionCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_SeriesBWarrantsMember" abstract="true" name="SeriesBWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_ConvertibleDebtJanuary2019Member" abstract="true" name="ConvertibleDebtJanuary2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_November2018AndDecember2018NotesMember" abstract="true" name="November2018AndDecember2018NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock" abstract="false" name="SaleOfStockOutstandingObligationCancelledInExchangeForStock" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants" abstract="false" name="ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_NoncashLeaseExpense" abstract="false" name="NoncashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_WarrantExchangePromissoryNotesMember" abstract="true" name="WarrantExchangePromissoryNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_AssetHeldForSalePolicyTextBlock" abstract="false" name="AssetHeldForSalePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote" abstract="false" name="ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount" abstract="false" name="ConvertibleDebtEquityFinancingTriggeredDiscount" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture" abstract="false" name="NumberOfClinicalTrialsToBeInitiatedInTheFuture" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ocgn_SubscriptionAgreementsMember" abstract="true" name="SubscriptionAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_OperatingLeaseTotalBasePayments" abstract="false" name="OperatingLeaseTotalBasePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock" abstract="false" name="ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ocgn_SeriesCWarrantsMember" abstract="true" name="SeriesCWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction" abstract="false" name="ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ocgn_AccruedSeveranceRelatedLiabilitiesCurrent" abstract="false" name="AccruedSeveranceRelatedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_ATMTransactionsMember" abstract="true" name="ATMTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock" abstract="false" name="SupplementalBalanceSheetInformationLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue" abstract="false" name="ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement" abstract="false" name="CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ocgn_EB5ProgramBorrowingsMember" abstract="true" name="EB5ProgramBorrowingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_January2019AndFebruary2019NotesMember" abstract="true" name="January2019AndFebruary2019NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_AccruedLiabilitiesClinical" abstract="false" name="AccruedLiabilitiesClinical" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_LongTermDebtMaturityAfterYearFour" abstract="false" name="LongTermDebtMaturityAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction" abstract="false" name="SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset" abstract="false" name="NoncashOrPartNoncashOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_ResearchAndDevelopmentExpensesCurrent" abstract="false" name="ResearchAndDevelopmentExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_ConvertibleDebtFebruary2019Member" abstract="true" name="ConvertibleDebtFebruary2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_SeriesAWarrantsMember" abstract="true" name="SeriesAWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ocgn_ProceedsFromPreMergerFinancingFinancingActivities" abstract="false" name="ProceedsFromPreMergerFinancingFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction" abstract="false" name="DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ocgn_ReverseAssetAcquisitionMember" abstract="true" name="ReverseAssetAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>ocgn-20200930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b98bd97b-267b-467c-adde-600f3c3e2154,g:859d45a4-db6c-4e83-b642-d8014a2143ca-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/Cover" xlink:type="simple" xlink:href="ocgn-20200930.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5d255a35-a741-4bd2-b55f-e651c144dd2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_db88fc09-848d-4922-8a29-5af308efbac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5d255a35-a741-4bd2-b55f-e651c144dd2f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_db88fc09-848d-4922-8a29-5af308efbac8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c686b2cb-7cbc-4fc3-b45e-fe68fac588ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5d255a35-a741-4bd2-b55f-e651c144dd2f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c686b2cb-7cbc-4fc3-b45e-fe68fac588ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_4d116f38-f6f0-4c4e-9b06-b593e200d297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5d255a35-a741-4bd2-b55f-e651c144dd2f" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_4d116f38-f6f0-4c4e-9b06-b593e200d297" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_88498ead-87ea-4b25-8581-de4ecb83bf5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_95ef3d9b-2f88-40a1-99ee-7ad63c3d44cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_88498ead-87ea-4b25-8581-de4ecb83bf5c" xlink:to="loc_us-gaap_AssetsCurrent_95ef3d9b-2f88-40a1-99ee-7ad63c3d44cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3712770b-fefb-4a7b-880f-6995ed7cd986" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_88498ead-87ea-4b25-8581-de4ecb83bf5c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3712770b-fefb-4a7b-880f-6995ed7cd986" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_cfbb6279-5621-40eb-b7a6-1e4fd8ff413f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_88498ead-87ea-4b25-8581-de4ecb83bf5c" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_cfbb6279-5621-40eb-b7a6-1e4fd8ff413f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_48f49614-1d94-44d6-b556-7c87b7cc009a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_88498ead-87ea-4b25-8581-de4ecb83bf5c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_48f49614-1d94-44d6-b556-7c87b7cc009a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c25755e0-4bd3-4275-a129-3704949cf781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_8ef203c0-8853-4209-8886-fea778cc3ab0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c25755e0-4bd3-4275-a129-3704949cf781" xlink:to="loc_us-gaap_AdditionalPaidInCapital_8ef203c0-8853-4209-8886-fea778cc3ab0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_9bc0538c-bdcd-4619-a29f-9132fbe16184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c25755e0-4bd3-4275-a129-3704949cf781" xlink:to="loc_us-gaap_TreasuryStockValue_9bc0538c-bdcd-4619-a29f-9132fbe16184" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_da7969f2-3410-47a8-a9a8-5c0ff968c137" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c25755e0-4bd3-4275-a129-3704949cf781" xlink:to="loc_us-gaap_PreferredStockValue_da7969f2-3410-47a8-a9a8-5c0ff968c137" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_bf67b05f-cafb-4bd2-8c1b-96d5f648d2ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c25755e0-4bd3-4275-a129-3704949cf781" xlink:to="loc_us-gaap_CommonStockValue_bf67b05f-cafb-4bd2-8c1b-96d5f648d2ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_259f15e5-7e18-4524-9c1c-a4451f6155c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c25755e0-4bd3-4275-a129-3704949cf781" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_259f15e5-7e18-4524-9c1c-a4451f6155c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_fd604f5a-c34c-4dc7-a692-4860410bde07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_18974b58-18f1-45e3-977e-590983798c55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_fd604f5a-c34c-4dc7-a692-4860410bde07" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_18974b58-18f1-45e3-977e-590983798c55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4138788a-5968-41b2-88a0-7aa234148bf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_fd604f5a-c34c-4dc7-a692-4860410bde07" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_4138788a-5968-41b2-88a0-7aa234148bf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_42e75e80-4a65-4868-a7df-54a1d70a997f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_fd604f5a-c34c-4dc7-a692-4860410bde07" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_42e75e80-4a65-4868-a7df-54a1d70a997f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_22e0a997-40ee-47a1-86a6-a4bf6a7f7e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9d865696-f997-4e47-a283-cb14eae6d0e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_22e0a997-40ee-47a1-86a6-a4bf6a7f7e00" xlink:to="loc_us-gaap_LiabilitiesCurrent_9d865696-f997-4e47-a283-cb14eae6d0e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_b0d06732-d4b4-47c1-ae4f-f62d098e9ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_22e0a997-40ee-47a1-86a6-a4bf6a7f7e00" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_b0d06732-d4b4-47c1-ae4f-f62d098e9ec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b5940e64-7596-46f8-8feb-40fe2a7c3715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_d635b49a-ad2d-4eb5-bfc1-e9a45e3b6645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b5940e64-7596-46f8-8feb-40fe2a7c3715" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_d635b49a-ad2d-4eb5-bfc1-e9a45e3b6645" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f14b48ae-3420-492e-9048-df2a908f5c98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b5940e64-7596-46f8-8feb-40fe2a7c3715" xlink:to="loc_us-gaap_AccountsPayableCurrent_f14b48ae-3420-492e-9048-df2a908f5c98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_309b4c8d-369e-4ddc-b5aa-c4de7a51c130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b5940e64-7596-46f8-8feb-40fe2a7c3715" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_309b4c8d-369e-4ddc-b5aa-c4de7a51c130" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_909a0834-fe1a-4ed6-829b-19a687d080c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b5940e64-7596-46f8-8feb-40fe2a7c3715" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_909a0834-fe1a-4ed6-829b-19a687d080c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_a58fac2c-175a-4ec2-9c65-b3313b55ed12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b5940e64-7596-46f8-8feb-40fe2a7c3715" xlink:to="loc_us-gaap_ShortTermBorrowings_a58fac2c-175a-4ec2-9c65-b3313b55ed12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b9bfd6ad-62f9-4bcb-ada7-6b322e44401b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_094cc93d-1951-49cc-b3f2-e7ad399e46ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b9bfd6ad-62f9-4bcb-ada7-6b322e44401b" xlink:to="loc_us-gaap_Liabilities_094cc93d-1951-49cc-b3f2-e7ad399e46ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5ab2cf2b-5373-4d31-b571-7c8733e9dcc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b9bfd6ad-62f9-4bcb-ada7-6b322e44401b" xlink:to="loc_us-gaap_StockholdersEquity_5ab2cf2b-5373-4d31-b571-7c8733e9dcc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_0b74541b-fb70-419a-85c9-eeebc0aede83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b9bfd6ad-62f9-4bcb-ada7-6b322e44401b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_0b74541b-fb70-419a-85c9-eeebc0aede83" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9f9d71e0-7822-4c1a-b611-74ddf3035d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_cdcc0c77-37e3-468f-b28c-0adaffa59858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9f9d71e0-7822-4c1a-b611-74ddf3035d90" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_cdcc0c77-37e3-468f-b28c-0adaffa59858" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8d99b73f-52fd-4b78-b7b8-79100cce811e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9f9d71e0-7822-4c1a-b611-74ddf3035d90" xlink:to="loc_us-gaap_OperatingIncomeLoss_8d99b73f-52fd-4b78-b7b8-79100cce811e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7ccb68d9-c23d-46bf-904a-db9534498ddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_81cd44f5-1bba-45d2-b64f-59826fe66db8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7ccb68d9-c23d-46bf-904a-db9534498ddf" xlink:to="loc_us-gaap_Revenues_81cd44f5-1bba-45d2-b64f-59826fe66db8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6b6c48e0-d453-4bab-b9bf-86028c13548d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7ccb68d9-c23d-46bf-904a-db9534498ddf" xlink:to="loc_us-gaap_OperatingExpenses_6b6c48e0-d453-4bab-b9bf-86028c13548d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d049622a-f21c-4d83-bb5e-d3158799aa68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_19ae9e23-ca0e-4f5d-a653-77d8d7a96539" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d049622a-f21c-4d83-bb5e-d3158799aa68" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_19ae9e23-ca0e-4f5d-a653-77d8d7a96539" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_ef8676c5-23dd-4983-8bad-a412612d7a27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d049622a-f21c-4d83-bb5e-d3158799aa68" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_ef8676c5-23dd-4983-8bad-a412612d7a27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_3a06237e-35cc-4c76-8aed-931e5e5d1097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d049622a-f21c-4d83-bb5e-d3158799aa68" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_3a06237e-35cc-4c76-8aed-931e5e5d1097" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4213c077-84f5-4fba-8ec3-ce8f2d6be131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_b0bc95da-37ba-410a-b523-dc26ed4779e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4213c077-84f5-4fba-8ec3-ce8f2d6be131" xlink:to="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_b0bc95da-37ba-410a-b523-dc26ed4779e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c147929d-cda6-4f83-8df6-aea61449acdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4213c077-84f5-4fba-8ec3-ce8f2d6be131" xlink:to="loc_us-gaap_NetIncomeLoss_c147929d-cda6-4f83-8df6-aea61449acdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7b6502ca-2916-4ab8-a510-2289c1d165e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3f2ff2cc-360b-4891-ab53-7e7058ee741b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7b6502ca-2916-4ab8-a510-2289c1d165e0" xlink:to="loc_us-gaap_InterestExpense_3f2ff2cc-360b-4891-ab53-7e7058ee741b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_6f57a2a6-9ec9-4faa-a82f-90fe9f12bc6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7b6502ca-2916-4ab8-a510-2289c1d165e0" xlink:to="loc_us-gaap_InvestmentIncomeInterest_6f57a2a6-9ec9-4faa-a82f-90fe9f12bc6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_924cb2e4-3438-4e15-94c9-7c1048b86b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7b6502ca-2916-4ab8-a510-2289c1d165e0" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_924cb2e4-3438-4e15-94c9-7c1048b86b4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_201eeaa6-0c76-4f7f-af8a-398d9ca9f5f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7b6502ca-2916-4ab8-a510-2289c1d165e0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_201eeaa6-0c76-4f7f-af8a-398d9ca9f5f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_GainsLossesOnConversionOfDebt_5520dffa-4cc5-4d02-9fe3-4bfc66c5d776" xlink:href="ocgn-20200930.xsd#ocgn_GainsLossesOnConversionOfDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7b6502ca-2916-4ab8-a510-2289c1d165e0" xlink:to="loc_ocgn_GainsLossesOnConversionOfDebt_5520dffa-4cc5-4d02-9fe3-4bfc66c5d776" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b74e3eec-a73a-4a02-8a7d-aafdf114d302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_bf90e7b5-ca46-4e27-b989-8f5795f2ba41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_b74e3eec-a73a-4a02-8a7d-aafdf114d302" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_bf90e7b5-ca46-4e27-b989-8f5795f2ba41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5f7b2258-f615-4ac2-b04d-e6f922d4201f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6a739a31-984f-4830-88b2-57763e03d291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5f7b2258-f615-4ac2-b04d-e6f922d4201f" xlink:to="loc_us-gaap_NetIncomeLoss_6a739a31-984f-4830-88b2-57763e03d291" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5a40115a-0791-409e-b543-cabb4cc8eb8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5f7b2258-f615-4ac2-b04d-e6f922d4201f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5a40115a-0791-409e-b543-cabb4cc8eb8c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_73016af7-100c-49f5-a628-d926d08e6e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0f05871d-3fa7-4fdf-9f5b-4c1e3e6cd98e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_73016af7-100c-49f5-a628-d926d08e6e3b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0f05871d-3fa7-4fdf-9f5b-4c1e3e6cd98e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_873ba5f5-336b-4113-8e1b-3b19a1699841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_73016af7-100c-49f5-a628-d926d08e6e3b" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_873ba5f5-336b-4113-8e1b-3b19a1699841" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7ce4848f-229b-476d-b2c9-2b710fca31f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ee3f6014-6dc2-4aa6-961b-3532a5da30e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7ce4848f-229b-476d-b2c9-2b710fca31f5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ee3f6014-6dc2-4aa6-961b-3532a5da30e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a45bd076-5e3f-497b-94b6-61794692009e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7ce4848f-229b-476d-b2c9-2b710fca31f5" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a45bd076-5e3f-497b-94b6-61794692009e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58e8696b-6ab9-447f-96e7-af9088fe636b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7ce4848f-229b-476d-b2c9-2b710fca31f5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58e8696b-6ab9-447f-96e7-af9088fe636b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30e192e1-8f50-4a5a-b63d-7a12839324ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7ce4848f-229b-476d-b2c9-2b710fca31f5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_30e192e1-8f50-4a5a-b63d-7a12839324ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2615d930-340b-4251-b61b-95c9613e4bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_89c4ce5e-012f-489a-b8fd-669443214060" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2615d930-340b-4251-b61b-95c9613e4bb6" xlink:to="loc_us-gaap_ProfitLoss_89c4ce5e-012f-489a-b8fd-669443214060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_084721d1-7d2d-47ce-ba35-6b59510aec8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2615d930-340b-4251-b61b-95c9613e4bb6" xlink:to="loc_us-gaap_Depreciation_084721d1-7d2d-47ce-ba35-6b59510aec8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NonCashInterestExpense_e5b39f8d-7c34-40e7-a1e9-37ad6f20ffa9" xlink:href="ocgn-20200930.xsd#ocgn_NonCashInterestExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2615d930-340b-4251-b61b-95c9613e4bb6" xlink:to="loc_ocgn_NonCashInterestExpense_e5b39f8d-7c34-40e7-a1e9-37ad6f20ffa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NoncashLeaseExpense_e25ba5e3-ae78-4f79-a8aa-4fa92c24e28d" xlink:href="ocgn-20200930.xsd#ocgn_NoncashLeaseExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2615d930-340b-4251-b61b-95c9613e4bb6" xlink:to="loc_ocgn_NoncashLeaseExpense_e25ba5e3-ae78-4f79-a8aa-4fa92c24e28d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_e9be714d-70e1-4dce-840d-e610677017d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2615d930-340b-4251-b61b-95c9613e4bb6" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_e9be714d-70e1-4dce-840d-e610677017d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_351547c7-da19-4bf7-aee3-41411da3fe3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2615d930-340b-4251-b61b-95c9613e4bb6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_351547c7-da19-4bf7-aee3-41411da3fe3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e4a36613-562e-4450-9e3d-63f71b49dc07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2615d930-340b-4251-b61b-95c9613e4bb6" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e4a36613-562e-4450-9e3d-63f71b49dc07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_bc23d9a5-266d-41a7-9ddc-f20ab522e483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2615d930-340b-4251-b61b-95c9613e4bb6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_bc23d9a5-266d-41a7-9ddc-f20ab522e483" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_IncreaseDecreaseInLeaseObligations_72a82334-a205-4c35-8c4f-01b3f5c69685" xlink:href="ocgn-20200930.xsd#ocgn_IncreaseDecreaseInLeaseObligations"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2615d930-340b-4251-b61b-95c9613e4bb6" xlink:to="loc_ocgn_IncreaseDecreaseInLeaseObligations_72a82334-a205-4c35-8c4f-01b3f5c69685" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_GainsLossesOnConversionOfDebt_cc87ca01-579e-4b80-8ebc-4584a10e1eb3" xlink:href="ocgn-20200930.xsd#ocgn_GainsLossesOnConversionOfDebt"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2615d930-340b-4251-b61b-95c9613e4bb6" xlink:to="loc_ocgn_GainsLossesOnConversionOfDebt_cc87ca01-579e-4b80-8ebc-4584a10e1eb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_5410351d-ce49-4936-baff-31b6c5aeec49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2615d930-340b-4251-b61b-95c9613e4bb6" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_5410351d-ce49-4936-baff-31b6c5aeec49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_5892f87f-39cf-43de-9e2d-0502a4110a75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2615d930-340b-4251-b61b-95c9613e4bb6" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_5892f87f-39cf-43de-9e2d-0502a4110a75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f92eeb4e-f1a9-4aac-bd68-c44f77b553d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_95dc70c3-8bdb-46d7-abbe-b610a446a957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f92eeb4e-f1a9-4aac-bd68-c44f77b553d1" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_95dc70c3-8bdb-46d7-abbe-b610a446a957" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_4cf89ca4-aefa-4f16-9dd3-53beefdac91c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f92eeb4e-f1a9-4aac-bd68-c44f77b553d1" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_4cf89ca4-aefa-4f16-9dd3-53beefdac91c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_f5e172bf-d5f5-463e-ba24-4c074a8d8e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f92eeb4e-f1a9-4aac-bd68-c44f77b553d1" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_f5e172bf-d5f5-463e-ba24-4c074a8d8e3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e0e44a00-7502-46c5-b9d0-8ab57241ddb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f92eeb4e-f1a9-4aac-bd68-c44f77b553d1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e0e44a00-7502-46c5-b9d0-8ab57241ddb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_5597feec-14e5-4ab1-a56a-0f2c58a3e174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f92eeb4e-f1a9-4aac-bd68-c44f77b553d1" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_5597feec-14e5-4ab1-a56a-0f2c58a3e174" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherDebt_7964c6a0-72b1-429d-94ce-509e9ff1c921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfOtherDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f92eeb4e-f1a9-4aac-bd68-c44f77b553d1" xlink:to="loc_us-gaap_RepaymentsOfOtherDebt_7964c6a0-72b1-429d-94ce-509e9ff1c921" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ProceedsFromPreMergerFinancingFinancingActivities_cebfaed5-988b-494c-92ef-ce05ffc7b606" xlink:href="ocgn-20200930.xsd#ocgn_ProceedsFromPreMergerFinancingFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f92eeb4e-f1a9-4aac-bd68-c44f77b553d1" xlink:to="loc_ocgn_ProceedsFromPreMergerFinancingFinancingActivities_cebfaed5-988b-494c-92ef-ce05ffc7b606" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NatureofBusiness" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NatureofBusiness"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/NatureofBusiness" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NatureofBusinessAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NatureofBusinessReverseStockSplitDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NatureofBusinessGoingConcernDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NatureofBusinessGoingConcernDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/NatureofBusinessGoingConcernDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc122a68-b50d-4acf-93b1-c703998df1dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_183d9888-4003-4560-9b23-d5d0f5d7adaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc122a68-b50d-4acf-93b1-c703998df1dd" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_183d9888-4003-4560-9b23-d5d0f5d7adaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_bd0d914f-5bfb-474e-a8af-11a5e4346a98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dc122a68-b50d-4acf-93b1-c703998df1dd" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_bd0d914f-5bfb-474e-a8af-11a5e4346a98" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/MergerandFinancing" xlink:type="simple" xlink:href="ocgn-20200930.xsd#MergerandFinancing"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/MergerandFinancing" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/MergerandFinancingDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#MergerandFinancingDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/MergerandFinancingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStock" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NetLossPerShareofCommonStock"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStock" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NetLossPerShareofCommonStockTables"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NetLossPerShareofCommonStockDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CollaborationAgreements" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CollaborationAgreements"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CollaborationAgreements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CollaborationAgreementsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CollaborationAgreementsDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CollaborationAgreementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/AccruedExpenses" xlink:type="simple" xlink:href="ocgn-20200930.xsd#AccruedExpenses"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/AccruedExpenses" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#AccruedExpensesTables"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/AccruedExpensesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#AccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_23306a9f-dfee-47da-a4a8-4165e245b8e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AccruedLiabilitiesClinical_b2c9d2fa-73ac-42a3-a65c-83e4d193d3d1" xlink:href="ocgn-20200930.xsd#ocgn_AccruedLiabilitiesClinical"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_23306a9f-dfee-47da-a4a8-4165e245b8e9" xlink:to="loc_ocgn_AccruedLiabilitiesClinical_b2c9d2fa-73ac-42a3-a65c-83e4d193d3d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ResearchAndDevelopmentExpensesCurrent_4ddd332d-7c2f-4740-ac6b-44d41a6c688a" xlink:href="ocgn-20200930.xsd#ocgn_ResearchAndDevelopmentExpensesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_23306a9f-dfee-47da-a4a8-4165e245b8e9" xlink:to="loc_ocgn_ResearchAndDevelopmentExpensesCurrent_4ddd332d-7c2f-4740-ac6b-44d41a6c688a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_05de9ac3-8eea-4041-9072-6b7253343fba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_23306a9f-dfee-47da-a4a8-4165e245b8e9" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_05de9ac3-8eea-4041-9072-6b7253343fba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AccruedLiabilitiesProfessionalFees_942afc1f-728a-4b3f-bdd7-5cdc72cc147e" xlink:href="ocgn-20200930.xsd#ocgn_AccruedLiabilitiesProfessionalFees"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_23306a9f-dfee-47da-a4a8-4165e245b8e9" xlink:to="loc_ocgn_AccruedLiabilitiesProfessionalFees_942afc1f-728a-4b3f-bdd7-5cdc72cc147e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ae0c6393-15d1-4cad-8d69-6c0728612aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_23306a9f-dfee-47da-a4a8-4165e245b8e9" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ae0c6393-15d1-4cad-8d69-6c0728612aa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent_85f0c246-7fd2-45e3-a7c3-8a5e28557ed2" xlink:href="ocgn-20200930.xsd#ocgn_AccruedSeveranceRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_23306a9f-dfee-47da-a4a8-4165e245b8e9" xlink:to="loc_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent_85f0c246-7fd2-45e3-a7c3-8a5e28557ed2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivities" xlink:type="simple" xlink:href="ocgn-20200930.xsd#ExitandDisposalActivities"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/ExitandDisposalActivities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#ExitandDisposalActivitiesTables"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#ExitandDisposalActivitiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/EquityTransactions" xlink:type="simple" xlink:href="ocgn-20200930.xsd#EquityTransactions"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/EquityTransactions" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/EquityTransactionsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#EquityTransactionsDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/EquityTransactionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/Debt" xlink:type="simple" xlink:href="ocgn-20200930.xsd#Debt"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/Debt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtTables"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/DebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtPPPNoteDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtPPPNoteDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/DebtPPPNoteDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtWarrantExchangePromissoryNotesDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtEB5LoanAgreementBorrowingsDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ae036ac2-7685-4259-8ddd-68e9dba09fee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_b5d38c54-59dd-4515-a0c9-87902ef2868d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ae036ac2-7685-4259-8ddd-68e9dba09fee" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_b5d38c54-59dd-4515-a0c9-87902ef2868d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_ba3a27b6-0e0b-4d9b-a197-4300d9d86f08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ae036ac2-7685-4259-8ddd-68e9dba09fee" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_ba3a27b6-0e0b-4d9b-a197-4300d9d86f08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4da27e55-67f1-40e4-88a9-ae6b79fd4aab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ae036ac2-7685-4259-8ddd-68e9dba09fee" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_4da27e55-67f1-40e4-88a9-ae6b79fd4aab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtSeniorSecuredConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtConvertiblePromissoryNoteDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtScheduleofDebtMaturitiesExcludingInterestDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f35e6be6-551c-4679-a007-1461b0127cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_LongTermDebtMaturityAfterYearFour_de064ab0-4517-4f2c-8bc0-6777f4f00aef" xlink:href="ocgn-20200930.xsd#ocgn_LongTermDebtMaturityAfterYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f35e6be6-551c-4679-a007-1461b0127cec" xlink:to="loc_ocgn_LongTermDebtMaturityAfterYearFour_de064ab0-4517-4f2c-8bc0-6777f4f00aef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_6720b714-e8f2-45f3-a3c7-b422cc5c57bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f35e6be6-551c-4679-a007-1461b0127cec" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_6720b714-e8f2-45f3-a3c7-b422cc5c57bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_7c9d4e6b-51db-4470-a8d1-e04d5ff43f96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f35e6be6-551c-4679-a007-1461b0127cec" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_7c9d4e6b-51db-4470-a8d1-e04d5ff43f96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_b5455723-6607-4737-af83-d41fa5579caf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f35e6be6-551c-4679-a007-1461b0127cec" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_b5455723-6607-4737-af83-d41fa5579caf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_140a8d6b-3c63-4991-b514-ed5759858069" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f35e6be6-551c-4679-a007-1461b0127cec" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_140a8d6b-3c63-4991-b514-ed5759858069" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f10fc9e7-1a8f-4a1e-ab9d-c800f50867a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f35e6be6-551c-4679-a007-1461b0127cec" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f10fc9e7-1a8f-4a1e-ab9d-c800f50867a4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensation" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensation"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensationTables"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/Commitments" xlink:type="simple" xlink:href="ocgn-20200930.xsd#Commitments"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/Commitments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsTables"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsOperatingleasescomponentsofleaseexpenseDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_9d26246d-de8e-42b1-be69-33da38f73a37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_e3b9aa4a-41f4-41ea-b18d-8268e9bf5a29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_9d26246d-de8e-42b1-be69-33da38f73a37" xlink:to="loc_us-gaap_OperatingLeaseCost_e3b9aa4a-41f4-41ea-b18d-8268e9bf5a29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_1f31133c-5c4f-4b81-8400-1ac5c491f77b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_9d26246d-de8e-42b1-be69-33da38f73a37" xlink:to="loc_us-gaap_VariableLeaseCost_1f31133c-5c4f-4b81-8400-1ac5c491f77b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsOperatingleasessupplementalbalancesheetinformationDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c9b25dbf-7c31-429a-a79e-9bd78e9259c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7eadf45c-ccde-4a76-88fb-29408cbdc54b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_c9b25dbf-7c31-429a-a79e-9bd78e9259c0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7eadf45c-ccde-4a76-88fb-29408cbdc54b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_84efa30d-2fd8-454e-8624-89440cb0051a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_c9b25dbf-7c31-429a-a79e-9bd78e9259c0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_84efa30d-2fd8-454e-8624-89440cb0051a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalcashflowinformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsOperatingleasessupplementalcashflowinformationDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalcashflowinformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsOperatingleasesfutureminimumleasepaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_40cceb95-9c58-4354-84c1-b4f660b85cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a034dd05-9139-4836-a2ec-76bf2148f74c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_40cceb95-9c58-4354-84c1-b4f660b85cf5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a034dd05-9139-4836-a2ec-76bf2148f74c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_40c417bc-8bf9-4529-aff4-e345e36ee1cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_40cceb95-9c58-4354-84c1-b4f660b85cf5" xlink:to="loc_us-gaap_OperatingLeaseLiability_40c417bc-8bf9-4529-aff4-e345e36ee1cf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails_1" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsOperatingleasesfutureminimumleasepaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e8d3330-83e8-4de5-bf3d-c286bc3a0183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_23c2922d-5ec4-4b65-a7cb-702ca1eee5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e8d3330-83e8-4de5-bf3d-c286bc3a0183" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_23c2922d-5ec4-4b65-a7cb-702ca1eee5d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_75ec426f-5ecd-4773-bedc-f7e3b5612193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e8d3330-83e8-4de5-bf3d-c286bc3a0183" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_75ec426f-5ecd-4773-bedc-f7e3b5612193" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a3b81e42-e300-480b-ade4-80a596b88ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e8d3330-83e8-4de5-bf3d-c286bc3a0183" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a3b81e42-e300-480b-ade4-80a596b88ab9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsFinanceleasesfutureminimumleasepaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_967172c2-47e2-4d4d-b1b1-0b4ffc0c5072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_354c27c8-0962-481d-8926-d502749e771d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_967172c2-47e2-4d4d-b1b1-0b4ffc0c5072" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_354c27c8-0962-481d-8926-d502749e771d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_5cd0f93d-f877-4ab4-a896-6c7fd21741f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_967172c2-47e2-4d4d-b1b1-0b4ffc0c5072" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_5cd0f93d-f877-4ab4-a896-6c7fd21741f0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails_1" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsFinanceleasesfutureminimumleasepaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_99b42602-b6d7-40e3-8697-2f0372c11946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_12237c9e-b4b7-4187-b7dd-f79f00f2c770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_99b42602-b6d7-40e3-8697-2f0372c11946" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_12237c9e-b4b7-4187-b7dd-f79f00f2c770" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7e9c4740-7222-406d-81ad-9bdcecc8af47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_99b42602-b6d7-40e3-8697-2f0372c11946" xlink:to="loc_us-gaap_FinanceLeaseLiability_7e9c4740-7222-406d-81ad-9bdcecc8af47" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/Warrants" xlink:type="simple" xlink:href="ocgn-20200930.xsd#Warrants"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/Warrants" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/WarrantsTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#WarrantsTables"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/WarrantsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#WarrantsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants_16457d0e-0188-48ce-993b-5b4a73f89dc8" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock_5e895b6b-f27e-4506-a65e-2b15f076d5a2" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants_16457d0e-0188-48ce-993b-5b4a73f89dc8" xlink:to="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock_5e895b6b-f27e-4506-a65e-2b15f076d5a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote_7b5206a0-95a1-420d-b289-643025c35efb" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants_16457d0e-0188-48ce-993b-5b4a73f89dc8" xlink:to="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote_7b5206a0-95a1-420d-b289-643025c35efb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SubsequentEvents" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SubsequentEvents"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/SubsequentEvents" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SubsequentEventsDetails"/>
  <link:calculationLink xlink:role="http://www.deitaxonomy.com/role/SubsequentEventsDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>ocgn-20200930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b98bd97b-267b-467c-adde-600f3c3e2154,g:859d45a4-db6c-4e83-b642-d8014a2143ca-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/Cover" xlink:type="simple" xlink:href="ocgn-20200930.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/Cover" xlink:type="extended" id="i804664c316584f00bd9c8c8bd43608c3_Cover"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="i7cb0410d02b840d98c918c1351d75623_CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="i69813f7696af4a3db95f563105f97400_CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended" id="i7b2e8b94f4ed4fdbb863cb03eb86f6b6_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended" id="icd2adf6ad38d4a19852b59b9993dc293_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ee75b2d0-0758-481d-b514-55bc23c1c7c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ee75b2d0-0758-481d-b514-55bc23c1c7c0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_d71dc113-7f3e-4393-a753-a8b054e4efef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_SharesOutstanding_d71dc113-7f3e-4393-a753-a8b054e4efef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_51be35de-8465-4337-98f6-96606f9a5748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_StockholdersEquity_51be35de-8465-4337-98f6-96606f9a5748" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_44254335-c0d2-402d-8a85-8672ba46bda4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_44254335-c0d2-402d-8a85-8672ba46bda4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c9536acc-b04f-4669-931f-0b144d687009" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c9536acc-b04f-4669-931f-0b144d687009" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_969d97d0-6bc3-4922-97c2-a46d06567b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_969d97d0-6bc3-4922-97c2-a46d06567b03" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c4be5dd1-8608-46ca-a53d-441caecfa0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c4be5dd1-8608-46ca-a53d-441caecfa0b3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c22ee3ab-9dcb-4da4-bbbb-39fe1a872333" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c22ee3ab-9dcb-4da4-bbbb-39fe1a872333" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_5134b090-f100-4cce-bf54-14c3b2c1bd59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_5134b090-f100-4cce-bf54-14c3b2c1bd59" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c515a032-b683-4dd1-ba77-e0fc613ca29d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_NetIncomeLoss_c515a032-b683-4dd1-ba77-e0fc613ca29d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_c3e38e18-8698-4ea0-90e1-44268d465a17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2af418e0-d1b0-4691-ab10-48c4b29d61ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5bc34b38-bd43-4c07-9d6a-78017f3c301a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ee75b2d0-0758-481d-b514-55bc23c1c7c0" xlink:to="loc_us-gaap_StatementTable_5bc34b38-bd43-4c07-9d6a-78017f3c301a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_99e4887f-7f3d-4170-b205-446d61cd996a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5bc34b38-bd43-4c07-9d6a-78017f3c301a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_99e4887f-7f3d-4170-b205-446d61cd996a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_99e4887f-7f3d-4170-b205-446d61cd996a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_99e4887f-7f3d-4170-b205-446d61cd996a" xlink:to="loc_us-gaap_EquityComponentDomain_99e4887f-7f3d-4170-b205-446d61cd996a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_47f5b879-ef75-4dae-a079-db8f54236b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_99e4887f-7f3d-4170-b205-446d61cd996a" xlink:to="loc_us-gaap_EquityComponentDomain_47f5b879-ef75-4dae-a079-db8f54236b56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7291f3dc-13a5-4616-bcf9-5b8696392b1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_47f5b879-ef75-4dae-a079-db8f54236b56" xlink:to="loc_us-gaap_CommonStockMember_7291f3dc-13a5-4616-bcf9-5b8696392b1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_2c6600dd-e216-439e-a631-9a0ff9c7cfac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_47f5b879-ef75-4dae-a079-db8f54236b56" xlink:to="loc_us-gaap_TreasuryStockMember_2c6600dd-e216-439e-a631-9a0ff9c7cfac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_86a03cce-670f-444c-9c2f-6d1281ca2573" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_47f5b879-ef75-4dae-a079-db8f54236b56" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_86a03cce-670f-444c-9c2f-6d1281ca2573" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_84ef1aa3-d168-4310-8a46-0e5ffbfe3180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_47f5b879-ef75-4dae-a079-db8f54236b56" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_84ef1aa3-d168-4310-8a46-0e5ffbfe3180" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_ad7144dd-e455-4da3-afe4-0796cdac8f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_47f5b879-ef75-4dae-a079-db8f54236b56" xlink:to="loc_us-gaap_RetainedEarningsMember_ad7144dd-e455-4da3-afe4-0796cdac8f8e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f52703a3-deba-4fc4-84d7-5c793e16326c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5bc34b38-bd43-4c07-9d6a-78017f3c301a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f52703a3-deba-4fc4-84d7-5c793e16326c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f52703a3-deba-4fc4-84d7-5c793e16326c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f52703a3-deba-4fc4-84d7-5c793e16326c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f52703a3-deba-4fc4-84d7-5c793e16326c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a448329-8c02-4c45-9b06-230c48bfe71b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f52703a3-deba-4fc4-84d7-5c793e16326c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a448329-8c02-4c45-9b06-230c48bfe71b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SubscriptionAgreementsMember_b7638c62-d663-4987-96e0-4248ebcec8a4" xlink:href="ocgn-20200930.xsd#ocgn_SubscriptionAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a448329-8c02-4c45-9b06-230c48bfe71b" xlink:to="loc_ocgn_SubscriptionAgreementsMember_b7638c62-d663-4987-96e0-4248ebcec8a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ATMTransactionsMember_2de99a8b-71ab-4c32-b533-49cde11739b7" xlink:href="ocgn-20200930.xsd#ocgn_ATMTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a448329-8c02-4c45-9b06-230c48bfe71b" xlink:to="loc_ocgn_ATMTransactionsMember_2de99a8b-71ab-4c32-b533-49cde11739b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ReverseAssetAcquisitionMember_847d9a55-91da-4c16-8a88-fb8f0391980e" xlink:href="ocgn-20200930.xsd#ocgn_ReverseAssetAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a448329-8c02-4c45-9b06-230c48bfe71b" xlink:to="loc_ocgn_ReverseAssetAcquisitionMember_847d9a55-91da-4c16-8a88-fb8f0391980e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_PreMergerFinancingMember_07602386-e38d-4e92-be13-1422a3667ef0" xlink:href="ocgn-20200930.xsd#ocgn_PreMergerFinancingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a448329-8c02-4c45-9b06-230c48bfe71b" xlink:to="loc_ocgn_PreMergerFinancingMember_07602386-e38d-4e92-be13-1422a3667ef0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="extended" id="i3a55ce1df63d4f8182b28125102abdd5_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d4cd4b2d-5cb5-40d6-9b30-f6c8c428daa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_7b05bfcf-2d56-4abe-be4b-fb34f058a753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4cd4b2d-5cb5-40d6-9b30-f6c8c428daa5" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_7b05bfcf-2d56-4abe-be4b-fb34f058a753" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_90454d2f-bc9b-43fa-ab76-28255a7c9820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d4cd4b2d-5cb5-40d6-9b30-f6c8c428daa5" xlink:to="loc_us-gaap_StatementTable_90454d2f-bc9b-43fa-ab76-28255a7c9820" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_ecddaf32-b270-4623-be91-d5e74bd97932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_90454d2f-bc9b-43fa-ab76-28255a7c9820" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_ecddaf32-b270-4623-be91-d5e74bd97932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ecddaf32-b270-4623-be91-d5e74bd97932_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ecddaf32-b270-4623-be91-d5e74bd97932" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ecddaf32-b270-4623-be91-d5e74bd97932_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25226e3b-2c9d-4fc9-85fd-e55f75564aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ecddaf32-b270-4623-be91-d5e74bd97932" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25226e3b-2c9d-4fc9-85fd-e55f75564aaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ATMTransactionsMember_d76b3c6f-1f30-4199-a402-9740322aaefb" xlink:href="ocgn-20200930.xsd#ocgn_ATMTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25226e3b-2c9d-4fc9-85fd-e55f75564aaf" xlink:to="loc_ocgn_ATMTransactionsMember_d76b3c6f-1f30-4199-a402-9740322aaefb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ReverseAssetAcquisitionMember_87d60099-e18c-4d98-8374-2cff10cb9a92" xlink:href="ocgn-20200930.xsd#ocgn_ReverseAssetAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25226e3b-2c9d-4fc9-85fd-e55f75564aaf" xlink:to="loc_ocgn_ReverseAssetAcquisitionMember_87d60099-e18c-4d98-8374-2cff10cb9a92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_PreMergerFinancingMember_1e4505e0-822e-44f8-91e3-548d5d78a819" xlink:href="ocgn-20200930.xsd#ocgn_PreMergerFinancingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25226e3b-2c9d-4fc9-85fd-e55f75564aaf" xlink:to="loc_ocgn_PreMergerFinancingMember_1e4505e0-822e-44f8-91e3-548d5d78a819" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="ifce38e43f8e94180bfba3895c67fdfba_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NatureofBusiness" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NatureofBusiness"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/NatureofBusiness" xlink:type="extended" id="i0d2b1e39ca2644139db7c148777532ea_NatureofBusiness"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NatureofBusinessAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails" xlink:type="extended" id="i1aebec3b9bba47d98f30b53c1b1fe1dd_NatureofBusinessAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_d0936321-0764-4a17-a3f4-5ccdcc09efec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_fa19842d-16f2-49ea-89b1-078bdbf1e8e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_d0936321-0764-4a17-a3f4-5ccdcc09efec" xlink:to="loc_us-gaap_NumberOfOperatingSegments_fa19842d-16f2-49ea-89b1-078bdbf1e8e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NumberOfOrphanDrugDesignations_5de04c78-463a-4384-8e66-69bf5c7f9849" xlink:href="ocgn-20200930.xsd#ocgn_NumberOfOrphanDrugDesignations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_d0936321-0764-4a17-a3f4-5ccdcc09efec" xlink:to="loc_ocgn_NumberOfOrphanDrugDesignations_5de04c78-463a-4384-8e66-69bf5c7f9849" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture_2634d089-0fa4-4322-a41e-552c4ed93ce6" xlink:href="ocgn-20200930.xsd#ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_d0936321-0764-4a17-a3f4-5ccdcc09efec" xlink:to="loc_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture_2634d089-0fa4-4322-a41e-552c4ed93ce6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_f2534ed0-e0ab-45a8-a858-b59c2df7c4f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_d0936321-0764-4a17-a3f4-5ccdcc09efec" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_f2534ed0-e0ab-45a8-a858-b59c2df7c4f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_fb27ed69-1ee2-446b-824f-28a183261994" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_f2534ed0-e0ab-45a8-a858-b59c2df7c4f8" xlink:to="loc_srt_StatementScenarioAxis_fb27ed69-1ee2-446b-824f-28a183261994" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_fb27ed69-1ee2-446b-824f-28a183261994_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_fb27ed69-1ee2-446b-824f-28a183261994" xlink:to="loc_srt_ScenarioUnspecifiedDomain_fb27ed69-1ee2-446b-824f-28a183261994_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9be10c97-8fab-4e87-9286-ce5fe2077ce2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_fb27ed69-1ee2-446b-824f-28a183261994" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9be10c97-8fab-4e87-9286-ce5fe2077ce2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_88d49db7-4be9-4b01-9156-5616b22837ec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9be10c97-8fab-4e87-9286-ce5fe2077ce2" xlink:to="loc_srt_ScenarioForecastMember_88d49db7-4be9-4b01-9156-5616b22837ec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NatureofBusinessReverseStockSplitDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails" xlink:type="extended" id="i874fcd9ecc514fb4a7a2702bddcf249a_NatureofBusinessReverseStockSplitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_8f179f43-19a9-4974-84bf-b414f3df17d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_BusinessCombinationIssuedSharesExchangeRate_4ce812e2-b806-4cb8-8df6-973b471de78d" xlink:href="ocgn-20200930.xsd#ocgn_BusinessCombinationIssuedSharesExchangeRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_8f179f43-19a9-4974-84bf-b414f3df17d1" xlink:to="loc_ocgn_BusinessCombinationIssuedSharesExchangeRate_4ce812e2-b806-4cb8-8df6-973b471de78d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_adbfb4db-0e47-459f-ba6a-4e30f800898d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_8f179f43-19a9-4974-84bf-b414f3df17d1" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_adbfb4db-0e47-459f-ba6a-4e30f800898d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_3fd07943-ff6f-4752-ae6f-5c1166605c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_8f179f43-19a9-4974-84bf-b414f3df17d1" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_3fd07943-ff6f-4752-ae6f-5c1166605c29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_33bb098b-6625-467a-bf2a-a4ad3f65d0dc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_3fd07943-ff6f-4752-ae6f-5c1166605c29" xlink:to="loc_dei_LegalEntityAxis_33bb098b-6625-467a-bf2a-a4ad3f65d0dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_33bb098b-6625-467a-bf2a-a4ad3f65d0dc_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_33bb098b-6625-467a-bf2a-a4ad3f65d0dc" xlink:to="loc_dei_EntityDomain_33bb098b-6625-467a-bf2a-a4ad3f65d0dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_51e87153-b7d2-449e-b580-3f97bef18150" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_33bb098b-6625-467a-bf2a-a4ad3f65d0dc" xlink:to="loc_dei_EntityDomain_51e87153-b7d2-449e-b580-3f97bef18150" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_HistogenicsCorporationMember_71818665-e886-4d6a-902d-2b0f50a59066" xlink:href="ocgn-20200930.xsd#ocgn_HistogenicsCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_51e87153-b7d2-449e-b580-3f97bef18150" xlink:to="loc_ocgn_HistogenicsCorporationMember_71818665-e886-4d6a-902d-2b0f50a59066" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NatureofBusinessGoingConcernDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NatureofBusinessGoingConcernDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/NatureofBusinessGoingConcernDetails" xlink:type="extended" id="icedc1cec6c3c4213845e8ece1ce783e4_NatureofBusinessGoingConcernDetails"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended" id="ib8f86ff069f74dcbb9b9116f28c84d36_SummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="i2b48846efc854bffbd7711d46cda4c8e_SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended" id="i0b0daee56771470bbd071ff6a1dad97d_SummaryofSignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i337882c674934ae6b9a2aea783f0e477_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7b667b32-ba14-42f9-9dc0-3c7778684432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_4627300b-022e-467b-9861-ee815dd3e59a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7b667b32-ba14-42f9-9dc0-3c7778684432" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_4627300b-022e-467b-9861-ee815dd3e59a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_67dc6aca-9821-4ec1-b836-a9753f961234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7b667b32-ba14-42f9-9dc0-3c7778684432" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_67dc6aca-9821-4ec1-b836-a9753f961234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure_dfb0e548-b831-4553-a5e7-f884d8dba369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7b667b32-ba14-42f9-9dc0-3c7778684432" xlink:to="loc_us-gaap_LinesOfCreditFairValueDisclosure_dfb0e548-b831-4553-a5e7-f884d8dba369" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d451fc76-0cc6-4598-b618-9aaccd655b38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7b667b32-ba14-42f9-9dc0-3c7778684432" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d451fc76-0cc6-4598-b618-9aaccd655b38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_bc6761ac-54e9-4c03-8f1a-986e0a95c13d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7b667b32-ba14-42f9-9dc0-3c7778684432" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_bc6761ac-54e9-4c03-8f1a-986e0a95c13d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7b667b32-ba14-42f9-9dc0-3c7778684432" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b2eddb28-f6e9-41db-9c4d-db50bc340384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:to="loc_us-gaap_AwardTypeAxis_b2eddb28-f6e9-41db-9c4d-db50bc340384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b2eddb28-f6e9-41db-9c4d-db50bc340384_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b2eddb28-f6e9-41db-9c4d-db50bc340384" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b2eddb28-f6e9-41db-9c4d-db50bc340384_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d84c3d27-42b9-4d81-8234-f51d53a250c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b2eddb28-f6e9-41db-9c4d-db50bc340384" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d84c3d27-42b9-4d81-8234-f51d53a250c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_dc287187-cec7-463f-b9c2-1990396610eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d84c3d27-42b9-4d81-8234-f51d53a250c3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_dc287187-cec7-463f-b9c2-1990396610eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e4917d92-f0b2-4e86-a7b2-030b830f782a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:to="loc_srt_RangeAxis_e4917d92-f0b2-4e86-a7b2-030b830f782a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e4917d92-f0b2-4e86-a7b2-030b830f782a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e4917d92-f0b2-4e86-a7b2-030b830f782a" xlink:to="loc_srt_RangeMember_e4917d92-f0b2-4e86-a7b2-030b830f782a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d642cc25-5737-4ee6-aedc-debed60557a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e4917d92-f0b2-4e86-a7b2-030b830f782a" xlink:to="loc_srt_RangeMember_d642cc25-5737-4ee6-aedc-debed60557a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d80fa60b-341a-4ad5-a5bd-ae211095bb9e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d642cc25-5737-4ee6-aedc-debed60557a2" xlink:to="loc_srt_MinimumMember_d80fa60b-341a-4ad5-a5bd-ae211095bb9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5c47a497-71f6-4c6c-9803-e51e16cbb944" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d642cc25-5737-4ee6-aedc-debed60557a2" xlink:to="loc_srt_MaximumMember_5c47a497-71f6-4c6c-9803-e51e16cbb944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5d607ca5-b86e-4a73-9a45-8910cf3e9347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:to="loc_us-gaap_DebtInstrumentAxis_5d607ca5-b86e-4a73-9a45-8910cf3e9347" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5d607ca5-b86e-4a73-9a45-8910cf3e9347_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5d607ca5-b86e-4a73-9a45-8910cf3e9347" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5d607ca5-b86e-4a73-9a45-8910cf3e9347_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3eb6adde-149c-4c80-8d38-9fcb84b45339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5d607ca5-b86e-4a73-9a45-8910cf3e9347" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3eb6adde-149c-4c80-8d38-9fcb84b45339" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_EB5ProgramBorrowingsMember_e50a4010-86d8-4baa-9137-f9adf11e3d7b" xlink:href="ocgn-20200930.xsd#ocgn_EB5ProgramBorrowingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3eb6adde-149c-4c80-8d38-9fcb84b45339" xlink:to="loc_ocgn_EB5ProgramBorrowingsMember_e50a4010-86d8-4baa-9137-f9adf11e3d7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f5fd231e-a687-4734-b383-90d13a58a8f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f5fd231e-a687-4734-b383-90d13a58a8f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f5fd231e-a687-4734-b383-90d13a58a8f7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f5fd231e-a687-4734-b383-90d13a58a8f7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f5fd231e-a687-4734-b383-90d13a58a8f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_acfca040-14a0-46e3-b03a-35841c89b73c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f5fd231e-a687-4734-b383-90d13a58a8f7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_acfca040-14a0-46e3-b03a-35841c89b73c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_eb02ce63-1cec-40c9-844c-5608e11bcc21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_acfca040-14a0-46e3-b03a-35841c89b73c" xlink:to="loc_us-gaap_LoansPayableMember_eb02ce63-1cec-40c9-844c-5608e11bcc21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_955ad5db-a0e7-42db-8758-6a102392b756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_955ad5db-a0e7-42db-8758-6a102392b756" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_955ad5db-a0e7-42db-8758-6a102392b756_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_955ad5db-a0e7-42db-8758-6a102392b756" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_955ad5db-a0e7-42db-8758-6a102392b756_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11f3724f-84e8-4fe3-8ef7-ee32aa3a046e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_955ad5db-a0e7-42db-8758-6a102392b756" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11f3724f-84e8-4fe3-8ef7-ee32aa3a046e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_690f361c-0c5e-43e3-86ed-2c35bf026976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11f3724f-84e8-4fe3-8ef7-ee32aa3a046e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_690f361c-0c5e-43e3-86ed-2c35bf026976" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended" id="i9b29b292c1aa43b9882a2963154475a5_SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/MergerandFinancing" xlink:type="simple" xlink:href="ocgn-20200930.xsd#MergerandFinancing"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/MergerandFinancing" xlink:type="extended" id="i5905bd26bcec468e9043a4aada4aba64_MergerandFinancing"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/MergerandFinancingDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#MergerandFinancingDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/MergerandFinancingDetails" xlink:type="extended" id="ia41b3633230640f68b8310f0d5bf021b_MergerandFinancingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:href="ocgn-20200930.xsd#ocgn_ReverseMergerAndFinancingDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_f9af3e11-b22b-435a-ba3b-a253a4ddbcb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:to="loc_us-gaap_SharesIssued_f9af3e11-b22b-435a-ba3b-a253a4ddbcb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NumberOfSeriesOfWarrantsIssued_7d14fa81-8010-4691-9383-c7de18a385da" xlink:href="ocgn-20200930.xsd#ocgn_NumberOfSeriesOfWarrantsIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:to="loc_ocgn_NumberOfSeriesOfWarrantsIssued_7d14fa81-8010-4691-9383-c7de18a385da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction_c8b6808e-9377-488f-96ac-60029d433c2d" xlink:href="ocgn-20200930.xsd#ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:to="loc_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction_c8b6808e-9377-488f-96ac-60029d433c2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AssetPurchaseAgreementCashConsideration_0b3c4fb8-0d5f-42a4-be89-dcfde8c4ca47" xlink:href="ocgn-20200930.xsd#ocgn_AssetPurchaseAgreementCashConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:to="loc_ocgn_AssetPurchaseAgreementCashConsideration_0b3c4fb8-0d5f-42a4-be89-dcfde8c4ca47" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth_e94e51cb-ea3d-4ebd-9dda-35b464f1a05f" xlink:href="ocgn-20200930.xsd#ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:to="loc_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth_e94e51cb-ea3d-4ebd-9dda-35b464f1a05f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure_6024d28a-3688-4c3d-aaed-74b0c967071e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:to="loc_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure_6024d28a-3688-4c3d-aaed-74b0c967071e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ReverseMergerAndFinancingDisclosureTable_c42e1a32-0b5e-49d6-ba1d-29c1823156a1" xlink:href="ocgn-20200930.xsd#ocgn_ReverseMergerAndFinancingDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:to="loc_ocgn_ReverseMergerAndFinancingDisclosureTable_c42e1a32-0b5e-49d6-ba1d-29c1823156a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6e865bd4-e47b-4a24-a889-1d60634d76a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureTable_c42e1a32-0b5e-49d6-ba1d-29c1823156a1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6e865bd4-e47b-4a24-a889-1d60634d76a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6e865bd4-e47b-4a24-a889-1d60634d76a0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6e865bd4-e47b-4a24-a889-1d60634d76a0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6e865bd4-e47b-4a24-a889-1d60634d76a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_faafb94a-a196-4c3d-9f02-76b27b750870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6e865bd4-e47b-4a24-a889-1d60634d76a0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_faafb94a-a196-4c3d-9f02-76b27b750870" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SecuritiesPurchaseAgreementMember_f2e5f765-07c3-4076-8a17-941ca960f6bb" xlink:href="ocgn-20200930.xsd#ocgn_SecuritiesPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_faafb94a-a196-4c3d-9f02-76b27b750870" xlink:to="loc_ocgn_SecuritiesPurchaseAgreementMember_f2e5f765-07c3-4076-8a17-941ca960f6bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_70917477-a7ae-4daa-b1fb-2f1513229088" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureTable_c42e1a32-0b5e-49d6-ba1d-29c1823156a1" xlink:to="loc_dei_LegalEntityAxis_70917477-a7ae-4daa-b1fb-2f1513229088" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_70917477-a7ae-4daa-b1fb-2f1513229088_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_70917477-a7ae-4daa-b1fb-2f1513229088" xlink:to="loc_dei_EntityDomain_70917477-a7ae-4daa-b1fb-2f1513229088_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4994c4ce-963b-4b63-a049-37e842cba8f6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_70917477-a7ae-4daa-b1fb-2f1513229088" xlink:to="loc_dei_EntityDomain_4994c4ce-963b-4b63-a049-37e842cba8f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_HistogenicsCorporationMember_66ff0430-56fa-4694-a7ba-14408b6f02af" xlink:href="ocgn-20200930.xsd#ocgn_HistogenicsCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_4994c4ce-963b-4b63-a049-37e842cba8f6" xlink:to="loc_ocgn_HistogenicsCorporationMember_66ff0430-56fa-4694-a7ba-14408b6f02af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9fc70afe-f750-40f2-bfd2-4e1bc869faaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureTable_c42e1a32-0b5e-49d6-ba1d-29c1823156a1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9fc70afe-f750-40f2-bfd2-4e1bc869faaa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9fc70afe-f750-40f2-bfd2-4e1bc869faaa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9fc70afe-f750-40f2-bfd2-4e1bc869faaa" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9fc70afe-f750-40f2-bfd2-4e1bc869faaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7e6d6ea0-9bac-4b09-bd2c-9bf127dfb7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9fc70afe-f750-40f2-bfd2-4e1bc869faaa" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7e6d6ea0-9bac-4b09-bd2c-9bf127dfb7fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_HistogenicsCorporationMember_a827dac2-d0dc-400b-b860-f8e6a8deaf93" xlink:href="ocgn-20200930.xsd#ocgn_HistogenicsCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7e6d6ea0-9bac-4b09-bd2c-9bf127dfb7fa" xlink:to="loc_ocgn_HistogenicsCorporationMember_a827dac2-d0dc-400b-b860-f8e6a8deaf93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c06651e1-96e1-4c01-9f67-7a6263c70c0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureTable_c42e1a32-0b5e-49d6-ba1d-29c1823156a1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c06651e1-96e1-4c01-9f67-7a6263c70c0b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c06651e1-96e1-4c01-9f67-7a6263c70c0b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c06651e1-96e1-4c01-9f67-7a6263c70c0b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c06651e1-96e1-4c01-9f67-7a6263c70c0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31187ded-5e80-435d-997e-91e3c9780384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c06651e1-96e1-4c01-9f67-7a6263c70c0b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31187ded-5e80-435d-997e-91e3c9780384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f871745a-995a-4371-920e-f2deb3b8d727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31187ded-5e80-435d-997e-91e3c9780384" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f871745a-995a-4371-920e-f2deb3b8d727" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStock" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NetLossPerShareofCommonStock"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStock" xlink:type="extended" id="ic6a1a9651ba1411396c397722d98b150_NetLossPerShareofCommonStock"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NetLossPerShareofCommonStockTables"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockTables" xlink:type="extended" id="i4bff892132fa420e95f26d9e5edfc441_NetLossPerShareofCommonStockTables"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NetLossPerShareofCommonStockDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails" xlink:type="extended" id="i3617ea1f58c44f468ee401cff668de7b_NetLossPerShareofCommonStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_600c84e4-aba2-48c5-b87b-ed42d41d1258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:to="loc_us-gaap_NetIncomeLoss_600c84e4-aba2-48c5-b87b-ed42d41d1258" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_58e70ff0-287f-4b80-93b9-ecde9efd7596" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:to="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_58e70ff0-287f-4b80-93b9-ecde9efd7596" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e7ffef5d-8c13-4d31-a7da-f018692358d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e7ffef5d-8c13-4d31-a7da-f018692358d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_bbebbb66-fce9-408b-ae60-fe00a7c42cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_bbebbb66-fce9-408b-ae60-fe00a7c42cd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_ca3bef32-2b16-4540-b718-0f9586e83f1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_ca3bef32-2b16-4540-b718-0f9586e83f1b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_41f0b0c9-31b0-4778-b581-d10696120aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_41f0b0c9-31b0-4778-b581-d10696120aa1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dce02c38-dd87-4a3a-b8aa-31e2a20f4fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_41f0b0c9-31b0-4778-b581-d10696120aa1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dce02c38-dd87-4a3a-b8aa-31e2a20f4fec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b41e971e-2624-4dda-886c-c9148aa332dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b41e971e-2624-4dda-886c-c9148aa332dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5478f296-230a-49d9-86b1-e301478536a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b41e971e-2624-4dda-886c-c9148aa332dd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5478f296-230a-49d9-86b1-e301478536a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5478f296-230a-49d9-86b1-e301478536a4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5478f296-230a-49d9-86b1-e301478536a4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5478f296-230a-49d9-86b1-e301478536a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_129fb962-b1c5-4725-b378-10c20761637b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5478f296-230a-49d9-86b1-e301478536a4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_129fb962-b1c5-4725-b378-10c20761637b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_deef3d13-47b7-43ae-bed9-0fd84878b7bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_129fb962-b1c5-4725-b378-10c20761637b" xlink:to="loc_us-gaap_StockOptionMember_deef3d13-47b7-43ae-bed9-0fd84878b7bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_d549875e-583f-40ea-8117-7c756a8e35d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_129fb962-b1c5-4725-b378-10c20761637b" xlink:to="loc_us-gaap_WarrantMember_d549875e-583f-40ea-8117-7c756a8e35d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_bc960c1a-28ff-467b-86d5-c7c495364432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b41e971e-2624-4dda-886c-c9148aa332dd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_bc960c1a-28ff-467b-86d5-c7c495364432" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_bc960c1a-28ff-467b-86d5-c7c495364432_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_bc960c1a-28ff-467b-86d5-c7c495364432" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_bc960c1a-28ff-467b-86d5-c7c495364432_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_0f757172-179b-49a5-8e09-d67d9c7c5d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_bc960c1a-28ff-467b-86d5-c7c495364432" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_0f757172-179b-49a5-8e09-d67d9c7c5d32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesAWarrantsMember_b842f98b-0d1c-4cd9-a736-2f8d2b5646c1" xlink:href="ocgn-20200930.xsd#ocgn_SeriesAWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_0f757172-179b-49a5-8e09-d67d9c7c5d32" xlink:to="loc_ocgn_SeriesAWarrantsMember_b842f98b-0d1c-4cd9-a736-2f8d2b5646c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesBWarrantsMember_156c09ef-81b6-4b8f-acd5-9635c28bb68f" xlink:href="ocgn-20200930.xsd#ocgn_SeriesBWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_0f757172-179b-49a5-8e09-d67d9c7c5d32" xlink:to="loc_ocgn_SeriesBWarrantsMember_156c09ef-81b6-4b8f-acd5-9635c28bb68f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesCWarrantsMember_677285a7-a493-494d-a80b-122f2da3938e" xlink:href="ocgn-20200930.xsd#ocgn_SeriesCWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_0f757172-179b-49a5-8e09-d67d9c7c5d32" xlink:to="loc_ocgn_SeriesCWarrantsMember_677285a7-a493-494d-a80b-122f2da3938e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CollaborationAgreements" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CollaborationAgreements"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CollaborationAgreements" xlink:type="extended" id="idfd1014e712c4802b3f21b501877e54c_CollaborationAgreements"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CollaborationAgreementsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CollaborationAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CollaborationAgreementsDetails" xlink:type="extended" id="id0d16b64a5124f72b8fd0cb88389792c_CollaborationAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e9c7935f-be15-4e34-9d1e-9d9d9f7bd758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense_42eb3c9d-1a5e-47b3-af99-a517a3c11127" xlink:href="ocgn-20200930.xsd#ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e9c7935f-be15-4e34-9d1e-9d9d9f7bd758" xlink:to="loc_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense_42eb3c9d-1a5e-47b3-af99-a517a3c11127" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_7bad7e59-ac5a-4e3e-8bc1-9679036a7915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e9c7935f-be15-4e34-9d1e-9d9d9f7bd758" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_7bad7e59-ac5a-4e3e-8bc1-9679036a7915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c7755e4a-dd73-43b0-93a6-aebb639d93d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e9c7935f-be15-4e34-9d1e-9d9d9f7bd758" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c7755e4a-dd73-43b0-93a6-aebb639d93d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_b6586f3f-f572-408a-a317-fd40e66ce304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c7755e4a-dd73-43b0-93a6-aebb639d93d7" xlink:to="loc_us-gaap_TypeOfArrangementAxis_b6586f3f-f572-408a-a317-fd40e66ce304" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b6586f3f-f572-408a-a317-fd40e66ce304_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_b6586f3f-f572-408a-a317-fd40e66ce304" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b6586f3f-f572-408a-a317-fd40e66ce304_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_954fe712-b57a-4ec1-a12f-5856aac1a5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_b6586f3f-f572-408a-a317-fd40e66ce304" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_954fe712-b57a-4ec1-a12f-5856aac1a5cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_201d76dc-f07f-410a-9d74-30ae05f24e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_954fe712-b57a-4ec1-a12f-5856aac1a5cc" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_201d76dc-f07f-410a-9d74-30ae05f24e58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_0d2d0d24-4991-4340-9a60-e059cda55b46" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c7755e4a-dd73-43b0-93a6-aebb639d93d7" xlink:to="loc_srt_CounterpartyNameAxis_0d2d0d24-4991-4340-9a60-e059cda55b46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0d2d0d24-4991-4340-9a60-e059cda55b46_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_0d2d0d24-4991-4340-9a60-e059cda55b46" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0d2d0d24-4991-4340-9a60-e059cda55b46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_eaee33b3-bc81-4f84-a6ee-4c69c3a8880b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_0d2d0d24-4991-4340-9a60-e059cda55b46" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_eaee33b3-bc81-4f84-a6ee-4c69c3a8880b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AdvaiteIncMember_b12f415d-a241-4951-a92d-febf87561f4b" xlink:href="ocgn-20200930.xsd#ocgn_AdvaiteIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_eaee33b3-bc81-4f84-a6ee-4c69c3a8880b" xlink:to="loc_ocgn_AdvaiteIncMember_b12f415d-a241-4951-a92d-febf87561f4b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/AccruedExpenses" xlink:type="simple" xlink:href="ocgn-20200930.xsd#AccruedExpenses"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/AccruedExpenses" xlink:type="extended" id="idbbb73f88eeb411c96b54a34f2fb1257_AccruedExpenses"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#AccruedExpensesTables"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/AccruedExpensesTables" xlink:type="extended" id="if91b733bb7a14f95a938164c94ae78b2_AccruedExpensesTables"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#AccruedExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/AccruedExpensesDetails" xlink:type="extended" id="i7d7055511fa542e5b53bc24c195627e2_AccruedExpensesDetails"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivities" xlink:type="simple" xlink:href="ocgn-20200930.xsd#ExitandDisposalActivities"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/ExitandDisposalActivities" xlink:type="extended" id="i7a1f444b58df4bdc97ba1f99ee05558f_ExitandDisposalActivities"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#ExitandDisposalActivitiesTables"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesTables" xlink:type="extended" id="ic31157e1f774419fbf594666b9e1873a_ExitandDisposalActivitiesTables"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#ExitandDisposalActivitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails" xlink:type="extended" id="i06986f4eca534d9ba8c6c4f605b45858_ExitandDisposalActivitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_34ef1585-7c5a-4899-a95a-1dc3122e0594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_3011d946-9512-4c23-b124-98a03ec9d9e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_34ef1585-7c5a-4899-a95a-1dc3122e0594" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_3011d946-9512-4c23-b124-98a03ec9d9e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent_ab4374c2-20d8-41e8-a434-d8daefa03c36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_34ef1585-7c5a-4899-a95a-1dc3122e0594" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent_ab4374c2-20d8-41e8-a434-d8daefa03c36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_bee8a014-b8a9-442e-be5e-32ae4591e12a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_34ef1585-7c5a-4899-a95a-1dc3122e0594" xlink:to="loc_us-gaap_RestructuringCharges_bee8a014-b8a9-442e-be5e-32ae4591e12a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_466fefdc-b2ca-42d5-9ba4-095a3f36aafc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_34ef1585-7c5a-4899-a95a-1dc3122e0594" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_466fefdc-b2ca-42d5-9ba4-095a3f36aafc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1049b98b-2db9-4c67-ac4b-3729cdbe9a37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_34ef1585-7c5a-4899-a95a-1dc3122e0594" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1049b98b-2db9-4c67-ac4b-3729cdbe9a37" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_08cf6fb5-bec3-4f31-80fe-34e92579eb1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1049b98b-2db9-4c67-ac4b-3729cdbe9a37" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_08cf6fb5-bec3-4f31-80fe-34e92579eb1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_08cf6fb5-bec3-4f31-80fe-34e92579eb1b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_08cf6fb5-bec3-4f31-80fe-34e92579eb1b" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_08cf6fb5-bec3-4f31-80fe-34e92579eb1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_84145d4b-0220-4d80-b8ab-bcdc15bb04ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_08cf6fb5-bec3-4f31-80fe-34e92579eb1b" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_84145d4b-0220-4d80-b8ab-bcdc15bb04ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_14a851d9-04ca-4962-bd66-fb7cfe5e3912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_84145d4b-0220-4d80-b8ab-bcdc15bb04ca" xlink:to="loc_us-gaap_EmployeeSeveranceMember_14a851d9-04ca-4962-bd66-fb7cfe5e3912" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_e7873349-16c5-4f3b-99cb-bc18a1270780" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1049b98b-2db9-4c67-ac4b-3729cdbe9a37" xlink:to="loc_srt_StatementScenarioAxis_e7873349-16c5-4f3b-99cb-bc18a1270780" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e7873349-16c5-4f3b-99cb-bc18a1270780_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_e7873349-16c5-4f3b-99cb-bc18a1270780" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e7873349-16c5-4f3b-99cb-bc18a1270780_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4baa2b26-107c-4c72-9451-e7042b90e570" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_e7873349-16c5-4f3b-99cb-bc18a1270780" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4baa2b26-107c-4c72-9451-e7042b90e570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_b3888a6f-9290-4a9f-ace5-d09f99701c0f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_4baa2b26-107c-4c72-9451-e7042b90e570" xlink:to="loc_srt_ScenarioForecastMember_b3888a6f-9290-4a9f-ace5-d09f99701c0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8ee62107-2a6a-4577-a2a6-7542d19e5c17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1049b98b-2db9-4c67-ac4b-3729cdbe9a37" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8ee62107-2a6a-4577-a2a6-7542d19e5c17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8ee62107-2a6a-4577-a2a6-7542d19e5c17_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8ee62107-2a6a-4577-a2a6-7542d19e5c17" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8ee62107-2a6a-4577-a2a6-7542d19e5c17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d6de93c8-d667-4842-ba3d-cdd881416c40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8ee62107-2a6a-4577-a2a6-7542d19e5c17" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d6de93c8-d667-4842-ba3d-cdd881416c40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_d60c00cf-d1a4-4c41-adce-9f9c9973a8b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d6de93c8-d667-4842-ba3d-cdd881416c40" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_d60c00cf-d1a4-4c41-adce-9f9c9973a8b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_d316582e-47e2-43bc-98a5-a1456863deef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d6de93c8-d667-4842-ba3d-cdd881416c40" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_d316582e-47e2-43bc-98a5-a1456863deef" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails" xlink:type="extended" id="i21b6869b999e4a27ba08a5e77989069b_ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f1913b78-ec98-4ff8-98ee-b93ae955c8ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_f120cf20-6fe3-4464-8f3d-714c19f95c78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f1913b78-ec98-4ff8-98ee-b93ae955c8ce" xlink:to="loc_us-gaap_RestructuringReserveRollForward_f120cf20-6fe3-4464-8f3d-714c19f95c78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f4cc7b36-a2b1-4277-9c3a-85c74a595c61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_f120cf20-6fe3-4464-8f3d-714c19f95c78" xlink:to="loc_us-gaap_RestructuringReserve_f4cc7b36-a2b1-4277-9c3a-85c74a595c61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_ef03cc0c-f617-44c7-826a-5c34a7af749c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_f120cf20-6fe3-4464-8f3d-714c19f95c78" xlink:to="loc_us-gaap_RestructuringCharges_ef03cc0c-f617-44c7-826a-5c34a7af749c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_4205459e-fb00-40b3-a5ec-8275fe33d7f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_f120cf20-6fe3-4464-8f3d-714c19f95c78" xlink:to="loc_us-gaap_PaymentsForRestructuring_4205459e-fb00-40b3-a5ec-8275fe33d7f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_63211906-33c4-460f-88de-5b813741eadb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eb73c569-c701-4dfd-b2f9-fd53c11a2b23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f1913b78-ec98-4ff8-98ee-b93ae955c8ce" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eb73c569-c701-4dfd-b2f9-fd53c11a2b23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_319c6324-54aa-49aa-890b-a41c5f583777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eb73c569-c701-4dfd-b2f9-fd53c11a2b23" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_319c6324-54aa-49aa-890b-a41c5f583777" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_319c6324-54aa-49aa-890b-a41c5f583777_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_319c6324-54aa-49aa-890b-a41c5f583777" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_319c6324-54aa-49aa-890b-a41c5f583777_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_56be0e84-2200-44cc-bedf-d8309ae34bb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_319c6324-54aa-49aa-890b-a41c5f583777" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_56be0e84-2200-44cc-bedf-d8309ae34bb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_4887b081-db94-456a-8667-93c085397bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_56be0e84-2200-44cc-bedf-d8309ae34bb3" xlink:to="loc_us-gaap_EmployeeSeveranceMember_4887b081-db94-456a-8667-93c085397bca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/EquityTransactions" xlink:type="simple" xlink:href="ocgn-20200930.xsd#EquityTransactions"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/EquityTransactions" xlink:type="extended" id="i9b81001c020a47c28e7def3f60a1397c_EquityTransactions"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/EquityTransactionsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#EquityTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/EquityTransactionsDetails" xlink:type="extended" id="i0c2b232de3bd4b458e4008430206e994_EquityTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_cee2c8ce-c544-4763-ad88-1bfdbfca2b93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_cee2c8ce-c544-4763-ad88-1bfdbfca2b93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_feac96ef-2d6f-4b67-bcd7-d8e85060e66c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_feac96ef-2d6f-4b67-bcd7-d8e85060e66c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_4e13fc71-022a-487f-8936-5a286b39ec09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_4e13fc71-022a-487f-8936-5a286b39ec09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity_d2f9d0e1-8800-46bc-921b-159cdb1072e1" xlink:href="ocgn-20200930.xsd#ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity_d2f9d0e1-8800-46bc-921b-159cdb1072e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesSubscribedButUnissued_c68d0c41-b272-4fb2-ada3-b3d896fe4d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesSubscribedButUnissued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_us-gaap_CommonStockSharesSubscribedButUnissued_c68d0c41-b272-4fb2-ada3-b3d896fe4d15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_b1b979a2-5c09-494c-a182-eec7350c8ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_b1b979a2-5c09-494c-a182-eec7350c8ff7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock_fa82101b-3d23-41c5-8915-a8f32071e1ab" xlink:href="ocgn-20200930.xsd#ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock_fa82101b-3d23-41c5-8915-a8f32071e1ab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock_73db38f3-77ba-46ff-965d-52335a1ae168" xlink:href="ocgn-20200930.xsd#ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock_73db38f3-77ba-46ff-965d-52335a1ae168" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_0dabb829-f44a-4e5a-8a9e-aa0233a77328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_0dabb829-f44a-4e5a-8a9e-aa0233a77328" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b8f00823-6d95-454c-8614-5fd7d4206c97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_0dabb829-f44a-4e5a-8a9e-aa0233a77328" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b8f00823-6d95-454c-8614-5fd7d4206c97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b8f00823-6d95-454c-8614-5fd7d4206c97_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b8f00823-6d95-454c-8614-5fd7d4206c97" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b8f00823-6d95-454c-8614-5fd7d4206c97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7cc9efb6-f88a-40ed-9e89-395c6ba011cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b8f00823-6d95-454c-8614-5fd7d4206c97" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7cc9efb6-f88a-40ed-9e89-395c6ba011cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ControlledEquityOfferingSalesAgreementMember_d98fb6b6-d65f-4198-8b46-ced6ccd46b3a" xlink:href="ocgn-20200930.xsd#ocgn_ControlledEquityOfferingSalesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7cc9efb6-f88a-40ed-9e89-395c6ba011cb" xlink:to="loc_ocgn_ControlledEquityOfferingSalesAgreementMember_d98fb6b6-d65f-4198-8b46-ced6ccd46b3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SubscriptionAgreementsMember_b89f54e3-8dd3-4cf3-81c3-08c28ab6ac40" xlink:href="ocgn-20200930.xsd#ocgn_SubscriptionAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7cc9efb6-f88a-40ed-9e89-395c6ba011cb" xlink:to="loc_ocgn_SubscriptionAgreementsMember_b89f54e3-8dd3-4cf3-81c3-08c28ab6ac40" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/Debt" xlink:type="simple" xlink:href="ocgn-20200930.xsd#Debt"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/Debt" xlink:type="extended" id="idbbe2b4891214ad09cff2ddb20602025_Debt"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtTables"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/DebtTables" xlink:type="extended" id="ia0e4d52b268940a3bb1fb615385fc1b0_DebtTables"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtPPPNoteDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtPPPNoteDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/DebtPPPNoteDetails" xlink:type="extended" id="i9d318ffba21f43c5a82c217db34d3121_DebtPPPNoteDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e9d647de-6567-424c-813a-55a52977a808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b2557e47-ac36-48e9-aab9-bfbcb6ac154a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e9d647de-6567-424c-813a-55a52977a808" xlink:to="loc_us-gaap_LongTermDebt_b2557e47-ac36-48e9-aab9-bfbcb6ac154a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a6d856df-f64f-45fa-930c-1a020cadcbc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e9d647de-6567-424c-813a-55a52977a808" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a6d856df-f64f-45fa-930c-1a020cadcbc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8b39b644-2ade-423d-a686-c69ad6589094" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e9d647de-6567-424c-813a-55a52977a808" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8b39b644-2ade-423d-a686-c69ad6589094" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a8f63487-05fd-4be5-b1e2-a52729b3429e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e9d647de-6567-424c-813a-55a52977a808" xlink:to="loc_us-gaap_DebtInstrumentTable_a8f63487-05fd-4be5-b1e2-a52729b3429e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2101f64a-353a-4d6e-9072-950028b9d64b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a8f63487-05fd-4be5-b1e2-a52729b3429e" xlink:to="loc_us-gaap_DebtInstrumentAxis_2101f64a-353a-4d6e-9072-950028b9d64b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2101f64a-353a-4d6e-9072-950028b9d64b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2101f64a-353a-4d6e-9072-950028b9d64b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2101f64a-353a-4d6e-9072-950028b9d64b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_134ccf16-13a4-429f-b244-5ddce669f167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2101f64a-353a-4d6e-9072-950028b9d64b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_134ccf16-13a4-429f-b244-5ddce669f167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_PaycheckProtectionProgramLoanMember_db81de4c-e9fc-4a60-b580-14f486c7a56c" xlink:href="ocgn-20200930.xsd#ocgn_PaycheckProtectionProgramLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_134ccf16-13a4-429f-b244-5ddce669f167" xlink:to="loc_ocgn_PaycheckProtectionProgramLoanMember_db81de4c-e9fc-4a60-b580-14f486c7a56c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_WarrantExchangePromissoryNotesMember_b571550d-17d9-4cec-bd44-f9084e5511e5" xlink:href="ocgn-20200930.xsd#ocgn_WarrantExchangePromissoryNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_134ccf16-13a4-429f-b244-5ddce669f167" xlink:to="loc_ocgn_WarrantExchangePromissoryNotesMember_b571550d-17d9-4cec-bd44-f9084e5511e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_EB5ProgramBorrowingsMember_34d9ed85-91cc-4479-a4ee-0e303416657b" xlink:href="ocgn-20200930.xsd#ocgn_EB5ProgramBorrowingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_134ccf16-13a4-429f-b244-5ddce669f167" xlink:to="loc_ocgn_EB5ProgramBorrowingsMember_34d9ed85-91cc-4479-a4ee-0e303416657b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_18155827-d367-4f7f-a708-a2d59d70c2c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a8f63487-05fd-4be5-b1e2-a52729b3429e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_18155827-d367-4f7f-a708-a2d59d70c2c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_18155827-d367-4f7f-a708-a2d59d70c2c2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_18155827-d367-4f7f-a708-a2d59d70c2c2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_18155827-d367-4f7f-a708-a2d59d70c2c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_75853ad1-05d2-4ce2-bd40-84263c11b569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_18155827-d367-4f7f-a708-a2d59d70c2c2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_75853ad1-05d2-4ce2-bd40-84263c11b569" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_ebb74469-be51-4b42-bd63-ea71f61e8739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_75853ad1-05d2-4ce2-bd40-84263c11b569" xlink:to="loc_us-gaap_NotesPayableToBanksMember_ebb74469-be51-4b42-bd63-ea71f61e8739" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_9ce46625-6257-45fe-a3cf-9e0f518348a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_75853ad1-05d2-4ce2-bd40-84263c11b569" xlink:to="loc_us-gaap_LoansPayableMember_9ce46625-6257-45fe-a3cf-9e0f518348a4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtWarrantExchangePromissoryNotesDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails" xlink:type="extended" id="ibbb2effb2b994190bfc8cced4abf8c9c_DebtWarrantExchangePromissoryNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3b25df13-fff2-4bfd-a8c2-97895c3ff9cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3b25df13-fff2-4bfd-a8c2-97895c3ff9cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction_05774996-7b6a-4f07-94dd-7afacddd56eb" xlink:href="ocgn-20200930.xsd#ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction_05774996-7b6a-4f07-94dd-7afacddd56eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_2760a819-71db-4626-918a-553ce68c483b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_LongTermDebtFairValue_2760a819-71db-4626-918a-553ce68c483b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_875688ff-fc3b-4229-af3b-06f225322e76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_875688ff-fc3b-4229-af3b-06f225322e76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_856d738f-e959-4d34-acdc-1f82cb9927e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_InterestExpenseDebt_856d738f-e959-4d34-acdc-1f82cb9927e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_302d1606-cf4d-4ace-923a-a9b3e76289dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_302d1606-cf4d-4ace-923a-a9b3e76289dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_dfabce2d-7161-4eb6-8d98-814b330a334b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_dfabce2d-7161-4eb6-8d98-814b330a334b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4eb3dd78-3131-4ba7-b182-b00d1fdb9797" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_LongTermDebt_4eb3dd78-3131-4ba7-b182-b00d1fdb9797" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_be9140a7-b6d2-45aa-ac39-b673eec51b48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_DebtInstrumentTable_be9140a7-b6d2-45aa-ac39-b673eec51b48" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_272f0a7b-b01d-4ab3-b915-f7db64300214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_be9140a7-b6d2-45aa-ac39-b673eec51b48" xlink:to="loc_us-gaap_DebtInstrumentAxis_272f0a7b-b01d-4ab3-b915-f7db64300214" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_272f0a7b-b01d-4ab3-b915-f7db64300214_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_272f0a7b-b01d-4ab3-b915-f7db64300214" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_272f0a7b-b01d-4ab3-b915-f7db64300214_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c8d3227a-b96a-45f4-ad0b-996615c69c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_272f0a7b-b01d-4ab3-b915-f7db64300214" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c8d3227a-b96a-45f4-ad0b-996615c69c15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_WarrantExchangePromissoryNotesMember_5a921737-2ffb-4513-ac68-82f515ae402c" xlink:href="ocgn-20200930.xsd#ocgn_WarrantExchangePromissoryNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8d3227a-b96a-45f4-ad0b-996615c69c15" xlink:to="loc_ocgn_WarrantExchangePromissoryNotesMember_5a921737-2ffb-4513-ac68-82f515ae402c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e77c58fa-42a6-4f64-bcbc-8c4eb78ab129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_be9140a7-b6d2-45aa-ac39-b673eec51b48" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e77c58fa-42a6-4f64-bcbc-8c4eb78ab129" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e77c58fa-42a6-4f64-bcbc-8c4eb78ab129_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e77c58fa-42a6-4f64-bcbc-8c4eb78ab129" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e77c58fa-42a6-4f64-bcbc-8c4eb78ab129_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_06d76322-49c5-4c18-8f3b-3647b6ce0ce9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e77c58fa-42a6-4f64-bcbc-8c4eb78ab129" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_06d76322-49c5-4c18-8f3b-3647b6ce0ce9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_0e0f3c3b-b96e-4f7a-993e-2f8b6e558bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_06d76322-49c5-4c18-8f3b-3647b6ce0ce9" xlink:to="loc_us-gaap_NotesPayableToBanksMember_0e0f3c3b-b96e-4f7a-993e-2f8b6e558bf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2f2ce204-e136-4270-b36a-566e013e4ec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_be9140a7-b6d2-45aa-ac39-b673eec51b48" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2f2ce204-e136-4270-b36a-566e013e4ec2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2f2ce204-e136-4270-b36a-566e013e4ec2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2f2ce204-e136-4270-b36a-566e013e4ec2" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2f2ce204-e136-4270-b36a-566e013e4ec2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_74754720-26e4-4193-a31a-bbbe4398acdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2f2ce204-e136-4270-b36a-566e013e4ec2" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_74754720-26e4-4193-a31a-bbbe4398acdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_ed2c4cbf-8fc2-4c07-b6b4-edb4d3e53896" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_74754720-26e4-4193-a31a-bbbe4398acdb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_ed2c4cbf-8fc2-4c07-b6b4-edb4d3e53896" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_abe79fde-f301-45d7-920e-ac8ac9993360" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_74754720-26e4-4193-a31a-bbbe4398acdb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_abe79fde-f301-45d7-920e-ac8ac9993360" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2815ae09-6b19-49cd-bb2a-1d29c2201239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_be9140a7-b6d2-45aa-ac39-b673eec51b48" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2815ae09-6b19-49cd-bb2a-1d29c2201239" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2815ae09-6b19-49cd-bb2a-1d29c2201239_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2815ae09-6b19-49cd-bb2a-1d29c2201239" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2815ae09-6b19-49cd-bb2a-1d29c2201239_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bf9fbae2-7a35-470a-aca8-b010bff84160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2815ae09-6b19-49cd-bb2a-1d29c2201239" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bf9fbae2-7a35-470a-aca8-b010bff84160" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_64eb2afa-ed83-4b53-957f-c519ab2cf746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_bf9fbae2-7a35-470a-aca8-b010bff84160" xlink:to="loc_us-gaap_SubsequentEventMember_64eb2afa-ed83-4b53-957f-c519ab2cf746" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtEB5LoanAgreementBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails" xlink:type="extended" id="i3dc3aa41c4dc4042956d1c7f3690fb26_DebtEB5LoanAgreementBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e7478c1e-7933-4bd3-b35f-fd181493b59e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e7478c1e-7933-4bd3-b35f-fd181493b59e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_LineOfCreditBorrowingEachDraw_ea25157c-bb78-4b54-b952-30e00e8557bd" xlink:href="ocgn-20200930.xsd#ocgn_LineOfCreditBorrowingEachDraw"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_ocgn_LineOfCreditBorrowingEachDraw_ea25157c-bb78-4b54-b952-30e00e8557bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_673cf57e-b4d1-4b59-b091-4266957021c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_673cf57e-b4d1-4b59-b091-4266957021c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_a348f323-f85f-4609-af58-0d9eeeafe50a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_LineOfCredit_a348f323-f85f-4609-af58-0d9eeeafe50a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d458951e-0669-4b67-a00c-486537933be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d458951e-0669-4b67-a00c-486537933be1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_b5c5a1e9-24d6-4774-ae63-b79e59fbe521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_b5c5a1e9-24d6-4774-ae63-b79e59fbe521" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_55481b38-3e01-4e2c-b30b-c8977084cbc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_55481b38-3e01-4e2c-b30b-c8977084cbc4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6dbbdfd0-cc54-45aa-be34-10b55f27d3fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_LongTermDebt_6dbbdfd0-cc54-45aa-be34-10b55f27d3fb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_424997ea-e584-4166-a0b0-46c8e9c5cbf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_DebtInstrumentTable_424997ea-e584-4166-a0b0-46c8e9c5cbf6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3bbf68da-9e3a-45a1-937c-29d16a2c9f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_424997ea-e584-4166-a0b0-46c8e9c5cbf6" xlink:to="loc_us-gaap_DebtInstrumentAxis_3bbf68da-9e3a-45a1-937c-29d16a2c9f0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3bbf68da-9e3a-45a1-937c-29d16a2c9f0d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3bbf68da-9e3a-45a1-937c-29d16a2c9f0d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3bbf68da-9e3a-45a1-937c-29d16a2c9f0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_122bdbd0-5961-4a9c-8bed-3f959324740c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3bbf68da-9e3a-45a1-937c-29d16a2c9f0d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_122bdbd0-5961-4a9c-8bed-3f959324740c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_EB5ProgramBorrowingsMember_9e28012b-6ca3-4458-975d-cbf5dec754c6" xlink:href="ocgn-20200930.xsd#ocgn_EB5ProgramBorrowingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_122bdbd0-5961-4a9c-8bed-3f959324740c" xlink:to="loc_ocgn_EB5ProgramBorrowingsMember_9e28012b-6ca3-4458-975d-cbf5dec754c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_65298381-1dfb-4e39-99c9-58124f4ea813" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_424997ea-e584-4166-a0b0-46c8e9c5cbf6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_65298381-1dfb-4e39-99c9-58124f4ea813" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_65298381-1dfb-4e39-99c9-58124f4ea813_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_65298381-1dfb-4e39-99c9-58124f4ea813" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_65298381-1dfb-4e39-99c9-58124f4ea813_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ea157207-5ed9-4f64-936f-401b2332f60a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_65298381-1dfb-4e39-99c9-58124f4ea813" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ea157207-5ed9-4f64-936f-401b2332f60a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_e2c3049f-18f2-4570-a593-697417578f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea157207-5ed9-4f64-936f-401b2332f60a" xlink:to="loc_us-gaap_LoansPayableMember_e2c3049f-18f2-4570-a593-697417578f05" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtSeniorSecuredConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails" xlink:type="extended" id="i42037f81415d46fb897056d6ff03e8c6_DebtSeniorSecuredConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5dc3e6af-441b-46b2-b8c1-d8c52086987a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5edb1adf-9eca-4027-953e-51cf8d819106" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dc3e6af-441b-46b2-b8c1-d8c52086987a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5edb1adf-9eca-4027-953e-51cf8d819106" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2b13fb9c-0673-4101-9fea-1185dbddb846" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dc3e6af-441b-46b2-b8c1-d8c52086987a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2b13fb9c-0673-4101-9fea-1185dbddb846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_64414d4b-3f73-4604-92c4-476b8b31b7c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dc3e6af-441b-46b2-b8c1-d8c52086987a" xlink:to="loc_us-gaap_InterestExpense_64414d4b-3f73-4604-92c4-476b8b31b7c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_837eb038-ed42-4c8c-9b2d-370ca20699c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dc3e6af-441b-46b2-b8c1-d8c52086987a" xlink:to="loc_us-gaap_DebtInstrumentTable_837eb038-ed42-4c8c-9b2d-370ca20699c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6bfa0e30-c492-479d-9b81-79943cd8f01f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_837eb038-ed42-4c8c-9b2d-370ca20699c3" xlink:to="loc_us-gaap_DebtInstrumentAxis_6bfa0e30-c492-479d-9b81-79943cd8f01f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6bfa0e30-c492-479d-9b81-79943cd8f01f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6bfa0e30-c492-479d-9b81-79943cd8f01f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6bfa0e30-c492-479d-9b81-79943cd8f01f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5dfd23c7-9791-4731-a075-81f08e729ff1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6bfa0e30-c492-479d-9b81-79943cd8f01f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5dfd23c7-9791-4731-a075-81f08e729ff1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeniorSecuredConvertibleNotesMay2019Member_3e0685ac-9f4d-4915-8892-53a4f286a920" xlink:href="ocgn-20200930.xsd#ocgn_SeniorSecuredConvertibleNotesMay2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5dfd23c7-9791-4731-a075-81f08e729ff1" xlink:to="loc_ocgn_SeniorSecuredConvertibleNotesMay2019Member_3e0685ac-9f4d-4915-8892-53a4f286a920" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeniorSecuredConvertibleNotesJune2019Member_9d6875f1-fa9b-4fc2-8949-2940b9365584" xlink:href="ocgn-20200930.xsd#ocgn_SeniorSecuredConvertibleNotesJune2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5dfd23c7-9791-4731-a075-81f08e729ff1" xlink:to="loc_ocgn_SeniorSecuredConvertibleNotesJune2019Member_9d6875f1-fa9b-4fc2-8949-2940b9365584" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeniorSecuredConvertibleNotesMember_3b17a970-8b05-44e2-97c9-ef43ee82582c" xlink:href="ocgn-20200930.xsd#ocgn_SeniorSecuredConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5dfd23c7-9791-4731-a075-81f08e729ff1" xlink:to="loc_ocgn_SeniorSecuredConvertibleNotesMember_3b17a970-8b05-44e2-97c9-ef43ee82582c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtConvertiblePromissoryNoteDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails" xlink:type="extended" id="i56e8cb85f2254a28b8dc4dc5f7733057_DebtConvertiblePromissoryNoteDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_015c9da9-35e3-43f8-8923-f0e0cba05c93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_55519170-fb06-4c95-a11c-605977057e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_015c9da9-35e3-43f8-8923-f0e0cba05c93" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_55519170-fb06-4c95-a11c-605977057e34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e76eafc2-adbe-44b3-996b-9139b102c0c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_015c9da9-35e3-43f8-8923-f0e0cba05c93" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e76eafc2-adbe-44b3-996b-9139b102c0c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement_bc6c9655-88b4-461c-b577-061fe6d95751" xlink:href="ocgn-20200930.xsd#ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_015c9da9-35e3-43f8-8923-f0e0cba05c93" xlink:to="loc_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement_bc6c9655-88b4-461c-b577-061fe6d95751" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_2faa8d38-8438-490c-a0f8-2b829db1379d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_015c9da9-35e3-43f8-8923-f0e0cba05c93" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_2faa8d38-8438-490c-a0f8-2b829db1379d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_3be3b607-7779-4384-b92e-9278319b7c0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_015c9da9-35e3-43f8-8923-f0e0cba05c93" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_3be3b607-7779-4384-b92e-9278319b7c0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_18a55a87-8414-41f5-ba2d-7a7e668ed71a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_015c9da9-35e3-43f8-8923-f0e0cba05c93" xlink:to="loc_us-gaap_DebtInstrumentTable_18a55a87-8414-41f5-ba2d-7a7e668ed71a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dc5d0fdd-2ebb-4584-b341-c0c2dd5adc60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_18a55a87-8414-41f5-ba2d-7a7e668ed71a" xlink:to="loc_us-gaap_DebtInstrumentAxis_dc5d0fdd-2ebb-4584-b341-c0c2dd5adc60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dc5d0fdd-2ebb-4584-b341-c0c2dd5adc60_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_dc5d0fdd-2ebb-4584-b341-c0c2dd5adc60" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dc5d0fdd-2ebb-4584-b341-c0c2dd5adc60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b3e13cf1-e013-4710-aa86-fd17ae41e05a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_dc5d0fdd-2ebb-4584-b341-c0c2dd5adc60" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b3e13cf1-e013-4710-aa86-fd17ae41e05a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertiblePromissoryNotesMember_500a5cae-f9fb-4f95-9ce5-309b48f46742" xlink:href="ocgn-20200930.xsd#ocgn_ConvertiblePromissoryNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3e13cf1-e013-4710-aa86-fd17ae41e05a" xlink:to="loc_ocgn_ConvertiblePromissoryNotesMember_500a5cae-f9fb-4f95-9ce5-309b48f46742" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails" xlink:type="extended" id="icd019fabf2f64f01bdff4692b8521a6b_DebtConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_cac5f619-ebb6-4ba2-af6e-21b267b4d79f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_cac5f619-ebb6-4ba2-af6e-21b267b4d79f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_f7e9ca24-ae99-483d-a123-1c1b4ca8076a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_ConvertibleDebt_f7e9ca24-ae99-483d-a123-1c1b4ca8076a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_60754164-c3fe-44dc-bcce-ea532ad68197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_60754164-c3fe-44dc-bcce-ea532ad68197" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_f737a9dd-68d3-4a06-856c-a188153a02d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_f737a9dd-68d3-4a06-856c-a188153a02d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_cf32e1da-2146-4a8a-b60b-a50e14440c46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_LongTermDebt_cf32e1da-2146-4a8a-b60b-a50e14440c46" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_008d80e3-3805-4af1-a74d-661955ccd4e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_008d80e3-3805-4af1-a74d-661955ccd4e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_6fabe028-8bf9-4449-8b4b-0fdfbb502783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_DebtInstrumentTerm_6fabe028-8bf9-4449-8b4b-0fdfbb502783" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_DebtRedemptionMultipleFeature_87902b41-f714-4c80-b969-56b38f68e173" xlink:href="ocgn-20200930.xsd#ocgn_DebtRedemptionMultipleFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_ocgn_DebtRedemptionMultipleFeature_87902b41-f714-4c80-b969-56b38f68e173" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount_94c4550a-f2d3-4baf-9ddd-9772c06ba44e" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount_94c4550a-f2d3-4baf-9ddd-9772c06ba44e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_1d5f5b89-9a3a-41c7-b2fa-e72eeaee6399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_1d5f5b89-9a3a-41c7-b2fa-e72eeaee6399" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_42493744-5c5a-4eae-9560-1053ad95cb04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_CommonStockSharesIssued_42493744-5c5a-4eae-9560-1053ad95cb04" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_06b15d73-cdee-434f-9254-2d4fa21cf5ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_06b15d73-cdee-434f-9254-2d4fa21cf5ef" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_46f3fbe9-07f4-4547-b1ff-ea1005ba9826" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_46f3fbe9-07f4-4547-b1ff-ea1005ba9826" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_b6d68127-be57-424b-80ed-61025abe0001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_b6d68127-be57-424b-80ed-61025abe0001" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_58b4db69-b853-49b8-a21d-b174bb43d8e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:to="loc_us-gaap_DebtInstrumentAxis_58b4db69-b853-49b8-a21d-b174bb43d8e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_58b4db69-b853-49b8-a21d-b174bb43d8e0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_58b4db69-b853-49b8-a21d-b174bb43d8e0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_58b4db69-b853-49b8-a21d-b174bb43d8e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6e2f9f0f-2d87-4a50-a55f-132550316387" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_58b4db69-b853-49b8-a21d-b174bb43d8e0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6e2f9f0f-2d87-4a50-a55f-132550316387" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e2f9f0f-2d87-4a50-a55f-132550316387" xlink:to="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleNotesBoardOfDirectorsMember_71478d2d-9dbf-4755-98c2-93bf9956f877" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleNotesBoardOfDirectorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_ConvertibleNotesBoardOfDirectorsMember_71478d2d-9dbf-4755-98c2-93bf9956f877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtJanuary2018Member_b2e25ad8-f957-4384-90fd-43b9a3346054" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtJanuary2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_ConvertibleDebtJanuary2018Member_b2e25ad8-f957-4384-90fd-43b9a3346054" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtJune2018Member_35252735-df0e-4fa7-bb2c-e5fe68b6867a" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtJune2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_ConvertibleDebtJune2018Member_35252735-df0e-4fa7-bb2c-e5fe68b6867a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtNovember2018Member_a5a9a4c1-3233-4803-87d8-1349defc4983" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtNovember2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_ConvertibleDebtNovember2018Member_a5a9a4c1-3233-4803-87d8-1349defc4983" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtDecember2018Member_82472e0d-b86f-47f6-9979-94ac0f8b820f" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtDecember2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_ConvertibleDebtDecember2018Member_82472e0d-b86f-47f6-9979-94ac0f8b820f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtJanuary2019Member_88592cf3-aea9-49f2-80d9-e0ae698547f7" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtJanuary2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_ConvertibleDebtJanuary2019Member_88592cf3-aea9-49f2-80d9-e0ae698547f7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtFebruary2019Member_b6063c88-25ac-487b-9e75-57de96399364" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtFebruary2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_ConvertibleDebtFebruary2019Member_b6063c88-25ac-487b-9e75-57de96399364" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_November2018AndDecember2018NotesMember_d07f2dc9-37d7-4367-ab9e-57c7aa21bafa" xlink:href="ocgn-20200930.xsd#ocgn_November2018AndDecember2018NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_November2018AndDecember2018NotesMember_d07f2dc9-37d7-4367-ab9e-57c7aa21bafa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_January2019AndFebruary2019NotesMember_2458d1c7-79a5-4f21-8398-2ade77b7899a" xlink:href="ocgn-20200930.xsd#ocgn_January2019AndFebruary2019NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_January2019AndFebruary2019NotesMember_2458d1c7-79a5-4f21-8398-2ade77b7899a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_4a3d1f55-0cde-47fa-96c8-8196fb88181a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:to="loc_srt_TitleOfIndividualAxis_4a3d1f55-0cde-47fa-96c8-8196fb88181a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4a3d1f55-0cde-47fa-96c8-8196fb88181a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_4a3d1f55-0cde-47fa-96c8-8196fb88181a" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4a3d1f55-0cde-47fa-96c8-8196fb88181a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_165194c7-402c-4392-8e46-caebc75edc88" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_4a3d1f55-0cde-47fa-96c8-8196fb88181a" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_165194c7-402c-4392-8e46-caebc75edc88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_8ef901e1-80ff-4fc0-9c8e-037e2aeb84ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_165194c7-402c-4392-8e46-caebc75edc88" xlink:to="loc_srt_DirectorMember_8ef901e1-80ff-4fc0-9c8e-037e2aeb84ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f1a29a59-e473-48f9-87f0-f50bec92b143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f1a29a59-e473-48f9-87f0-f50bec92b143" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f1a29a59-e473-48f9-87f0-f50bec92b143_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f1a29a59-e473-48f9-87f0-f50bec92b143" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f1a29a59-e473-48f9-87f0-f50bec92b143_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b24b40ee-3009-47d0-97ec-8a51d24c6ef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f1a29a59-e473-48f9-87f0-f50bec92b143" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b24b40ee-3009-47d0-97ec-8a51d24c6ef8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtConversionFeatureMember_8842c043-92b6-4b20-9254-30cc33f26e38" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtConversionFeatureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b24b40ee-3009-47d0-97ec-8a51d24c6ef8" xlink:to="loc_ocgn_ConvertibleDebtConversionFeatureMember_8842c043-92b6-4b20-9254-30cc33f26e38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_6272fb6d-9f49-4b7d-a894-98c5ba9aa3e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_6272fb6d-9f49-4b7d-a894-98c5ba9aa3e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_6272fb6d-9f49-4b7d-a894-98c5ba9aa3e2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_6272fb6d-9f49-4b7d-a894-98c5ba9aa3e2" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_6272fb6d-9f49-4b7d-a894-98c5ba9aa3e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_fa83cfd5-fea6-45dd-862a-de0f0894072d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_6272fb6d-9f49-4b7d-a894-98c5ba9aa3e2" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_fa83cfd5-fea6-45dd-862a-de0f0894072d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_0c982e19-ea34-46c0-9cbd-fe2392aee96e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_fa83cfd5-fea6-45dd-862a-de0f0894072d" xlink:to="loc_us-gaap_ConvertibleDebtMember_0c982e19-ea34-46c0-9cbd-fe2392aee96e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e8d14943-756a-472a-9a31-246f9ca6fd02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e8d14943-756a-472a-9a31-246f9ca6fd02" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e8d14943-756a-472a-9a31-246f9ca6fd02_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e8d14943-756a-472a-9a31-246f9ca6fd02" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e8d14943-756a-472a-9a31-246f9ca6fd02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6c4421e3-e075-4542-80f1-6b44b0bd75d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e8d14943-756a-472a-9a31-246f9ca6fd02" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6c4421e3-e075-4542-80f1-6b44b0bd75d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_545f2f0d-5165-4dbd-b750-d7e5674bfbc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6c4421e3-e075-4542-80f1-6b44b0bd75d3" xlink:to="loc_us-gaap_ConvertibleDebtMember_545f2f0d-5165-4dbd-b750-d7e5674bfbc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_95c9065f-e74e-49f5-be40-8afbe93c04fe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:to="loc_srt_RangeAxis_95c9065f-e74e-49f5-be40-8afbe93c04fe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_95c9065f-e74e-49f5-be40-8afbe93c04fe_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_95c9065f-e74e-49f5-be40-8afbe93c04fe" xlink:to="loc_srt_RangeMember_95c9065f-e74e-49f5-be40-8afbe93c04fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1949e4bc-7644-4801-ba69-24f1975f9a85" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_95c9065f-e74e-49f5-be40-8afbe93c04fe" xlink:to="loc_srt_RangeMember_1949e4bc-7644-4801-ba69-24f1975f9a85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9ef70bb8-8b9f-4040-ae68-491674b43419" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1949e4bc-7644-4801-ba69-24f1975f9a85" xlink:to="loc_srt_MinimumMember_9ef70bb8-8b9f-4040-ae68-491674b43419" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_08ff7bfd-f29c-4db2-80a0-fea7839f67b2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1949e4bc-7644-4801-ba69-24f1975f9a85" xlink:to="loc_srt_MaximumMember_08ff7bfd-f29c-4db2-80a0-fea7839f67b2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtScheduleofDebtMaturitiesExcludingInterestDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails" xlink:type="extended" id="idecf40c847d049219bd01463141bee2d_DebtScheduleofDebtMaturitiesExcludingInterestDetails"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensation" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensation"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensation" xlink:type="extended" id="i747f968953754d978540ead9c1d8245c_StockbasedCompensation"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensationTables"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensationTables" xlink:type="extended" id="i8e710f487c7e46f6bb343da5d59b1c4f_StockbasedCompensationTables"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails" xlink:type="extended" id="i0542fde709504e86ae003db592423a19_StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9c17fe3a-fe80-4c05-adc6-c74aeff00867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2e5f7a1d-2c54-49b6-8cb4-4c643fb06588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9c17fe3a-fe80-4c05-adc6-c74aeff00867" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2e5f7a1d-2c54-49b6-8cb4-4c643fb06588" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9fdc2b2d-7d91-4c78-8982-98f90eea80d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9c17fe3a-fe80-4c05-adc6-c74aeff00867" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9fdc2b2d-7d91-4c78-8982-98f90eea80d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_74cc6d6a-1ffb-4ddd-8492-a3235215daa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9fdc2b2d-7d91-4c78-8982-98f90eea80d8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_74cc6d6a-1ffb-4ddd-8492-a3235215daa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_74cc6d6a-1ffb-4ddd-8492-a3235215daa0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_74cc6d6a-1ffb-4ddd-8492-a3235215daa0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_74cc6d6a-1ffb-4ddd-8492-a3235215daa0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a29f4611-0200-472d-9d43-0a07369d2ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_74cc6d6a-1ffb-4ddd-8492-a3235215daa0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a29f4611-0200-472d-9d43-0a07369d2ee6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_0983287a-1c41-4325-8f6e-f305f481d6dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a29f4611-0200-472d-9d43-0a07369d2ee6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_0983287a-1c41-4325-8f6e-f305f481d6dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_18cd183a-671f-4c03-8698-092d96541ccf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a29f4611-0200-472d-9d43-0a07369d2ee6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_18cd183a-671f-4c03-8698-092d96541ccf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails" xlink:type="extended" id="i39516228538b46ceb12005369dcf49c7_StockbasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_4d28b6ea-767d-4d1c-bd52-e107e7141d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_4d28b6ea-767d-4d1c-bd52-e107e7141d26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e5973adb-d3de-447a-8c6b-0b37d87c703c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e5973adb-d3de-447a-8c6b-0b37d87c703c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NumberOfEquityCompensationPlans_5386940a-a0f7-4fc4-8879-267e40826638" xlink:href="ocgn-20200930.xsd#ocgn_NumberOfEquityCompensationPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_ocgn_NumberOfEquityCompensationPlans_5386940a-a0f7-4fc4-8879-267e40826638" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage_47a686d7-a768-4ec7-b6a0-3aa7555f1474" xlink:href="ocgn-20200930.xsd#ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage_47a686d7-a768-4ec7-b6a0-3aa7555f1474" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_97b0e78e-a593-4ea5-8494-2ebb2699288d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_97b0e78e-a593-4ea5-8494-2ebb2699288d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_54b80be3-8b91-4112-83b7-822e326ded1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_54b80be3-8b91-4112-83b7-822e326ded1d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_14a99f73-ec69-4eba-afdf-313ddb51a265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_14a99f73-ec69-4eba-afdf-313ddb51a265" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e0c7fcd7-4c72-41ea-bb2d-7657c0de9a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e0c7fcd7-4c72-41ea-bb2d-7657c0de9a2a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5597a65c-22e9-4614-92f2-c901012f7fcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e0c7fcd7-4c72-41ea-bb2d-7657c0de9a2a" xlink:to="loc_us-gaap_AwardTypeAxis_5597a65c-22e9-4614-92f2-c901012f7fcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5597a65c-22e9-4614-92f2-c901012f7fcb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5597a65c-22e9-4614-92f2-c901012f7fcb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5597a65c-22e9-4614-92f2-c901012f7fcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e6537be-8c04-4f74-99ca-d63b7214beae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5597a65c-22e9-4614-92f2-c901012f7fcb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e6537be-8c04-4f74-99ca-d63b7214beae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_A2014PlanMember_8d977f2b-1a88-401f-a2d0-944665daeb53" xlink:href="ocgn-20200930.xsd#ocgn_A2014PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e6537be-8c04-4f74-99ca-d63b7214beae" xlink:to="loc_ocgn_A2014PlanMember_8d977f2b-1a88-401f-a2d0-944665daeb53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_A2019PlanMember_1e76ba4e-3706-40f9-83cd-bc8f1a11dddb" xlink:href="ocgn-20200930.xsd#ocgn_A2019PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e6537be-8c04-4f74-99ca-d63b7214beae" xlink:to="loc_ocgn_A2019PlanMember_1e76ba4e-3706-40f9-83cd-bc8f1a11dddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ee5f8686-e2a1-45ab-ab8f-b71b9a832779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e6537be-8c04-4f74-99ca-d63b7214beae" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ee5f8686-e2a1-45ab-ab8f-b71b9a832779" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_bbfd4ad4-9edf-4153-8d25-6e8d7fabc361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e6537be-8c04-4f74-99ca-d63b7214beae" xlink:to="loc_us-gaap_StockOptionMember_bbfd4ad4-9edf-4153-8d25-6e8d7fabc361" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0dfc396d-9eb9-44e3-ac5f-c5b3715b9c58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e0c7fcd7-4c72-41ea-bb2d-7657c0de9a2a" xlink:to="loc_us-gaap_PlanNameAxis_0dfc396d-9eb9-44e3-ac5f-c5b3715b9c58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0dfc396d-9eb9-44e3-ac5f-c5b3715b9c58_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_0dfc396d-9eb9-44e3-ac5f-c5b3715b9c58" xlink:to="loc_us-gaap_PlanNameDomain_0dfc396d-9eb9-44e3-ac5f-c5b3715b9c58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_128c32b8-08e7-4d5e-9251-4ce9f6b44314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_0dfc396d-9eb9-44e3-ac5f-c5b3715b9c58" xlink:to="loc_us-gaap_PlanNameDomain_128c32b8-08e7-4d5e-9251-4ce9f6b44314" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_A2014PlanMember_c062c86f-fcf7-41ca-8d82-86a17d6ae575" xlink:href="ocgn-20200930.xsd#ocgn_A2014PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_128c32b8-08e7-4d5e-9251-4ce9f6b44314" xlink:to="loc_ocgn_A2014PlanMember_c062c86f-fcf7-41ca-8d82-86a17d6ae575" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_A2019PlanMember_15eea00f-7a48-476d-94d0-8eb6ce4a72a7" xlink:href="ocgn-20200930.xsd#ocgn_A2019PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_128c32b8-08e7-4d5e-9251-4ce9f6b44314" xlink:to="loc_ocgn_A2019PlanMember_15eea00f-7a48-476d-94d0-8eb6ce4a72a7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails" xlink:type="extended" id="i3c4825e24a5b430ca6e669ff9481b991_StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4cc6779-7940-4875-9862-38f88f71ac16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2e8d4e30-f394-448c-975a-4383aa2847dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4cc6779-7940-4875-9862-38f88f71ac16" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2e8d4e30-f394-448c-975a-4383aa2847dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6d466c93-8edc-4dce-a9e7-c28838970ede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2e8d4e30-f394-448c-975a-4383aa2847dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6d466c93-8edc-4dce-a9e7-c28838970ede" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e8160d8b-e2b1-4e8b-9cf7-b4fbac40af78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2e8d4e30-f394-448c-975a-4383aa2847dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e8160d8b-e2b1-4e8b-9cf7-b4fbac40af78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_69f51c4d-f584-4725-9128-ceb4db3a9059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2e8d4e30-f394-448c-975a-4383aa2847dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_69f51c4d-f584-4725-9128-ceb4db3a9059" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d7f55512-b2c4-45e0-b2a7-f977d06fda5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2c529907-3224-440c-b57a-89dd1ba1d5ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2e8d4e30-f394-448c-975a-4383aa2847dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2c529907-3224-440c-b57a-89dd1ba1d5ec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_54d84b15-b9b7-4674-bb19-d2adfa59520e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4cc6779-7940-4875-9862-38f88f71ac16" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_54d84b15-b9b7-4674-bb19-d2adfa59520e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_79c35fdd-30cc-4b49-916f-d0f46d6935c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_54d84b15-b9b7-4674-bb19-d2adfa59520e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_79c35fdd-30cc-4b49-916f-d0f46d6935c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_79e4b2c7-2c90-433d-ad8d-d9f6592b8558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_54d84b15-b9b7-4674-bb19-d2adfa59520e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_79e4b2c7-2c90-433d-ad8d-d9f6592b8558" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_757699d5-a45b-43f2-9638-b70f8faed279" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_54d84b15-b9b7-4674-bb19-d2adfa59520e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_757699d5-a45b-43f2-9638-b70f8faed279" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0993a36f-68c3-4b0a-adad-4219cb0831cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_65c6a6c6-b2e7-4fa7-b927-fee685eda95c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_54d84b15-b9b7-4674-bb19-d2adfa59520e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_65c6a6c6-b2e7-4fa7-b927-fee685eda95c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f470110b-808a-4b47-8c75-fea2f601c462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4cc6779-7940-4875-9862-38f88f71ac16" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f470110b-808a-4b47-8c75-fea2f601c462" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6a6bec7a-3ba3-4851-a912-f773f5b47500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f470110b-808a-4b47-8c75-fea2f601c462" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6a6bec7a-3ba3-4851-a912-f773f5b47500" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1b8a34f4-d2b3-46f1-8464-5e49420d02e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f470110b-808a-4b47-8c75-fea2f601c462" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1b8a34f4-d2b3-46f1-8464-5e49420d02e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c2bf0a30-baaf-4c8f-a09f-52c24c7f08ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f470110b-808a-4b47-8c75-fea2f601c462" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c2bf0a30-baaf-4c8f-a09f-52c24c7f08ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_20a3fa70-9955-43d9-b568-3d0d289e7661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_33a01ea2-ab2e-4574-88f0-208a2aca865b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f470110b-808a-4b47-8c75-fea2f601c462" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_33a01ea2-ab2e-4574-88f0-208a2aca865b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e5e34533-5522-4d6d-8c08-73b9a3d5ec2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4cc6779-7940-4875-9862-38f88f71ac16" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e5e34533-5522-4d6d-8c08-73b9a3d5ec2b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f83ac1e2-6e6f-42fd-b22c-0a3de7f3b8dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e5e34533-5522-4d6d-8c08-73b9a3d5ec2b" xlink:to="loc_us-gaap_AwardTypeAxis_f83ac1e2-6e6f-42fd-b22c-0a3de7f3b8dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f83ac1e2-6e6f-42fd-b22c-0a3de7f3b8dd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f83ac1e2-6e6f-42fd-b22c-0a3de7f3b8dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f83ac1e2-6e6f-42fd-b22c-0a3de7f3b8dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9f5eec98-3b91-4757-90dd-8b5436109dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f83ac1e2-6e6f-42fd-b22c-0a3de7f3b8dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9f5eec98-3b91-4757-90dd-8b5436109dec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_A2019PlanMember_3370a332-a201-4765-9afb-d67c18a2a6a3" xlink:href="ocgn-20200930.xsd#ocgn_A2019PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9f5eec98-3b91-4757-90dd-8b5436109dec" xlink:to="loc_ocgn_A2019PlanMember_3370a332-a201-4765-9afb-d67c18a2a6a3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/Commitments" xlink:type="simple" xlink:href="ocgn-20200930.xsd#Commitments"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/Commitments" xlink:type="extended" id="i46264f2b97a943e9956fa51899a9a0a6_Commitments"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsTables"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsTables" xlink:type="extended" id="i327c7e1c408c49fb9bb175dbb0873817_CommitmentsTables"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails" xlink:type="extended" id="id2fb0fbc1d374dfba01644c54cbca096_CommitmentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_3d80457c-938a-4631-a5bd-a6db3511a85f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_588f5ab2-0793-4475-8a96-c7ec3362de89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3d80457c-938a-4631-a5bd-a6db3511a85f" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_588f5ab2-0793-4475-8a96-c7ec3362de89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_34c32213-0309-45d7-9f57-655d51b4cd9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3d80457c-938a-4631-a5bd-a6db3511a85f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_34c32213-0309-45d7-9f57-655d51b4cd9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDiscountRate_b2d99cdb-80e2-43e0-96b7-f6fcbbde8285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3d80457c-938a-4631-a5bd-a6db3511a85f" xlink:to="loc_us-gaap_LesseeFinanceLeaseDiscountRate_b2d99cdb-80e2-43e0-96b7-f6fcbbde8285" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_78a00967-7e73-483b-a0d9-ba47a575e4c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3d80457c-938a-4631-a5bd-a6db3511a85f" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_78a00967-7e73-483b-a0d9-ba47a575e4c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7a5c9c01-aeb4-43f1-aaa5-c7db9e71d237" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_78a00967-7e73-483b-a0d9-ba47a575e4c0" xlink:to="loc_srt_RangeAxis_7a5c9c01-aeb4-43f1-aaa5-c7db9e71d237" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7a5c9c01-aeb4-43f1-aaa5-c7db9e71d237_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7a5c9c01-aeb4-43f1-aaa5-c7db9e71d237" xlink:to="loc_srt_RangeMember_7a5c9c01-aeb4-43f1-aaa5-c7db9e71d237_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7bda5401-138d-4183-b93a-e33b73bb2d4b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7a5c9c01-aeb4-43f1-aaa5-c7db9e71d237" xlink:to="loc_srt_RangeMember_7bda5401-138d-4183-b93a-e33b73bb2d4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ac5030e3-1cb1-4298-aee9-d67bdb26e007" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7bda5401-138d-4183-b93a-e33b73bb2d4b" xlink:to="loc_srt_MinimumMember_ac5030e3-1cb1-4298-aee9-d67bdb26e007" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e0283b65-68ce-495f-b19e-0945ebc4c353" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7bda5401-138d-4183-b93a-e33b73bb2d4b" xlink:to="loc_srt_MaximumMember_e0283b65-68ce-495f-b19e-0945ebc4c353" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsOperatingleasescomponentsofleaseexpenseDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails" xlink:type="extended" id="i804bcf7c81fc447a9a8a0b293931a53d_CommitmentsOperatingleasescomponentsofleaseexpenseDetails"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsOperatingleasessupplementalbalancesheetinformationDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails" xlink:type="extended" id="i0097f7bd1cb441a789dcd64a0f029154_CommitmentsOperatingleasessupplementalbalancesheetinformationDetails"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalcashflowinformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsOperatingleasessupplementalcashflowinformationDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalcashflowinformationDetails" xlink:type="extended" id="i8aca38a71d144514866f00e8965ecb93_CommitmentsOperatingleasessupplementalcashflowinformationDetails"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsOperatingleasesfutureminimumleasepaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails" xlink:type="extended" id="if489f61071044c69a437e62dd632c948_CommitmentsOperatingleasesfutureminimumleasepaymentsDetails"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsFinanceleasesfutureminimumleasepaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails" xlink:type="extended" id="i611a0b61f81e46de999103de2d961580_CommitmentsFinanceleasesfutureminimumleasepaymentsDetails"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/Warrants" xlink:type="simple" xlink:href="ocgn-20200930.xsd#Warrants"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/Warrants" xlink:type="extended" id="i8d423deb7d8149c0ae1ade5915646267_Warrants"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/WarrantsTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#WarrantsTables"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/WarrantsTables" xlink:type="extended" id="i6de1df98d4284f9f8244cc1d7c25bc51_WarrantsTables"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#WarrantsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails" xlink:type="extended" id="i610e81da51fd4fd581cb4421ff9d7728_WarrantsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6e0c07db-e26c-40f5-932a-00f3c57f70c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6e0c07db-e26c-40f5-932a-00f3c57f70c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_5b89a866-c59c-4d03-a59a-b9107ff9011e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_5b89a866-c59c-4d03-a59a-b9107ff9011e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_e13598b8-9e82-4ba7-9197-410959fb72a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_e13598b8-9e82-4ba7-9197-410959fb72a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered_1b1220db-acb2-46c5-b331-128dc1719309" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered_1b1220db-acb2-46c5-b331-128dc1719309" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_aca4cb38-f0de-4715-9581-d064517397ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_aca4cb38-f0de-4715-9581-d064517397ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice_36d0a4f1-2474-4650-a916-bb7d50e6615c" xlink:href="ocgn-20200930.xsd#ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice_36d0a4f1-2474-4650-a916-bb7d50e6615c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_5a497f5b-15e3-4107-86ad-14c65b0ee75a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_5a497f5b-15e3-4107-86ad-14c65b0ee75a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a82a1f9a-5c8a-41b5-946d-68ef8fc5ff18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a82a1f9a-5c8a-41b5-946d-68ef8fc5ff18" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants_035ad122-a21c-43f6-b3b9-12da57a163c9" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants_035ad122-a21c-43f6-b3b9-12da57a163c9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock_593c9a11-565a-48e8-b596-0c59a7cd7963" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock_593c9a11-565a-48e8-b596-0c59a7cd7963" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote_186a803a-e53b-4fad-9225-9f82d4b43e37" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote_186a803a-e53b-4fad-9225-9f82d4b43e37" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue_71f6ebfe-04ec-46c0-a037-f5efc03cc3d2" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue_71f6ebfe-04ec-46c0-a037-f5efc03cc3d2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_cda67a0a-e6b0-4089-be0c-40c94dd40420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_cda67a0a-e6b0-4089-be0c-40c94dd40420" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction_8e951dfd-2196-4609-ba3c-ea00a152d229" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction_8e951dfd-2196-4609-ba3c-ea00a152d229" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightExercisable_d626d888-5259-4ebc-85f7-fbef5b6e77a8" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightExercisable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ClassOfWarrantOrRightExercisable_d626d888-5259-4ebc-85f7-fbef5b6e77a8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_98b9670e-7b6e-48c8-ad75-cf804dc792e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_98b9670e-7b6e-48c8-ad75-cf804dc792e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_98b9670e-7b6e-48c8-ad75-cf804dc792e0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_98b9670e-7b6e-48c8-ad75-cf804dc792e0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_98b9670e-7b6e-48c8-ad75-cf804dc792e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1da6b6e6-03ae-4b01-8802-78148d49bab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_98b9670e-7b6e-48c8-ad75-cf804dc792e0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1da6b6e6-03ae-4b01-8802-78148d49bab7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesAWarrantsMember_a17fcb7a-2817-4317-bbd5-4b4262a3963e" xlink:href="ocgn-20200930.xsd#ocgn_SeriesAWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1da6b6e6-03ae-4b01-8802-78148d49bab7" xlink:to="loc_ocgn_SeriesAWarrantsMember_a17fcb7a-2817-4317-bbd5-4b4262a3963e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesBWarrantsMember_3700ae6b-d15a-4400-b060-9134530b6567" xlink:href="ocgn-20200930.xsd#ocgn_SeriesBWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1da6b6e6-03ae-4b01-8802-78148d49bab7" xlink:to="loc_ocgn_SeriesBWarrantsMember_3700ae6b-d15a-4400-b060-9134530b6567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesCWarrantsMember_062e63b0-dc20-4b64-b6f7-9fee508c6f25" xlink:href="ocgn-20200930.xsd#ocgn_SeriesCWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1da6b6e6-03ae-4b01-8802-78148d49bab7" xlink:to="loc_ocgn_SeriesCWarrantsMember_062e63b0-dc20-4b64-b6f7-9fee508c6f25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_FormerOcugenWarrantsMember_9bfc1311-3397-44fd-8956-6e603f241fef" xlink:href="ocgn-20200930.xsd#ocgn_FormerOcugenWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1da6b6e6-03ae-4b01-8802-78148d49bab7" xlink:to="loc_ocgn_FormerOcugenWarrantsMember_9bfc1311-3397-44fd-8956-6e603f241fef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_403db779-a775-43ff-bb06-9834bd6a7452" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:to="loc_srt_RangeAxis_403db779-a775-43ff-bb06-9834bd6a7452" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_403db779-a775-43ff-bb06-9834bd6a7452_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_403db779-a775-43ff-bb06-9834bd6a7452" xlink:to="loc_srt_RangeMember_403db779-a775-43ff-bb06-9834bd6a7452_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bf0cb494-7723-4055-902b-025da508c60a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_403db779-a775-43ff-bb06-9834bd6a7452" xlink:to="loc_srt_RangeMember_bf0cb494-7723-4055-902b-025da508c60a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_75dbeba2-2c15-4402-983f-c98ae3a4b14f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bf0cb494-7723-4055-902b-025da508c60a" xlink:to="loc_srt_MaximumMember_75dbeba2-2c15-4402-983f-c98ae3a4b14f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7c4c611d-91b8-4a8a-bb08-fd002dcfb18d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7c4c611d-91b8-4a8a-bb08-fd002dcfb18d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7c4c611d-91b8-4a8a-bb08-fd002dcfb18d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7c4c611d-91b8-4a8a-bb08-fd002dcfb18d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7c4c611d-91b8-4a8a-bb08-fd002dcfb18d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_664c201a-522a-4c46-86b8-eac1ef5552c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7c4c611d-91b8-4a8a-bb08-fd002dcfb18d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_664c201a-522a-4c46-86b8-eac1ef5552c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_4d4c104a-ad13-4ecf-80c3-1c33aa14910b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_664c201a-522a-4c46-86b8-eac1ef5552c3" xlink:to="loc_us-gaap_WarrantMember_4d4c104a-ad13-4ecf-80c3-1c33aa14910b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f05820a-7ed6-4015-a59a-ea069fdd7ab3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f05820a-7ed6-4015-a59a-ea069fdd7ab3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f05820a-7ed6-4015-a59a-ea069fdd7ab3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f05820a-7ed6-4015-a59a-ea069fdd7ab3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f05820a-7ed6-4015-a59a-ea069fdd7ab3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c0f9042f-6128-4fd9-b3da-4b5c2759810c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f05820a-7ed6-4015-a59a-ea069fdd7ab3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c0f9042f-6128-4fd9-b3da-4b5c2759810c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_86316546-5e3b-4c80-9d26-1de0c1f89d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c0f9042f-6128-4fd9-b3da-4b5c2759810c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_86316546-5e3b-4c80-9d26-1de0c1f89d1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_622b2260-5138-4581-b89d-9545f243f1c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_622b2260-5138-4581-b89d-9545f243f1c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_622b2260-5138-4581-b89d-9545f243f1c4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_622b2260-5138-4581-b89d-9545f243f1c4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_622b2260-5138-4581-b89d-9545f243f1c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3e67291d-31da-4753-bc23-c24e18931f46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_622b2260-5138-4581-b89d-9545f243f1c4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3e67291d-31da-4753-bc23-c24e18931f46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_WarrantsExchangedForCommonStockMember_4f07a427-01f9-4efd-8c99-3a8a3d5e9d4c" xlink:href="ocgn-20200930.xsd#ocgn_WarrantsExchangedForCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3e67291d-31da-4753-bc23-c24e18931f46" xlink:to="loc_ocgn_WarrantsExchangedForCommonStockMember_4f07a427-01f9-4efd-8c99-3a8a3d5e9d4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_863f53fb-3349-4ea8-8eec-e611ada2a283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_863f53fb-3349-4ea8-8eec-e611ada2a283" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_863f53fb-3349-4ea8-8eec-e611ada2a283_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_863f53fb-3349-4ea8-8eec-e611ada2a283" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_863f53fb-3349-4ea8-8eec-e611ada2a283_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_6d53c874-5b25-4808-827c-31c29e9917f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_863f53fb-3349-4ea8-8eec-e611ada2a283" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_6d53c874-5b25-4808-827c-31c29e9917f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_b237c264-df84-4eb7-9691-644b57050784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6d53c874-5b25-4808-827c-31c29e9917f4" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_b237c264-df84-4eb7-9691-644b57050784" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails" xlink:type="extended" id="i163fa33b7fd1420eab06f5f2708269b0_WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_62308dd8-0f58-4d36-8e6f-101febed1a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_25b4897c-37b6-4382-ab93-061ca076704e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_62308dd8-0f58-4d36-8e6f-101febed1a6e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_25b4897c-37b6-4382-ab93-061ca076704e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_09bf4964-3a5c-460a-94e7-71cde029d5d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_25b4897c-37b6-4382-ab93-061ca076704e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_09bf4964-3a5c-460a-94e7-71cde029d5d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_181840f8-8906-40bd-9347-989041e8fb02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_25b4897c-37b6-4382-ab93-061ca076704e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_181840f8-8906-40bd-9347-989041e8fb02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_d7087608-6dfd-486a-be7d-96cf8ec48963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_25b4897c-37b6-4382-ab93-061ca076704e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_d7087608-6dfd-486a-be7d-96cf8ec48963" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity_a0d68f41-e2a9-43a2-bc40-1bebd9ccb000" xlink:href="ocgn-20200930.xsd#ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_25b4897c-37b6-4382-ab93-061ca076704e" xlink:to="loc_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity_a0d68f41-e2a9-43a2-bc40-1bebd9ccb000" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_e290bdcb-4899-4498-b345-a458d05ff39d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_5534bf93-d55e-44c6-9bb7-9d64b0c6922c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_62308dd8-0f58-4d36-8e6f-101febed1a6e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_5534bf93-d55e-44c6-9bb7-9d64b0c6922c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_4c0c8b76-27be-4126-90a6-546e7f0b469a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_5534bf93-d55e-44c6-9bb7-9d64b0c6922c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_4c0c8b76-27be-4126-90a6-546e7f0b469a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_4c0c8b76-27be-4126-90a6-546e7f0b469a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4c0c8b76-27be-4126-90a6-546e7f0b469a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_4c0c8b76-27be-4126-90a6-546e7f0b469a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_8f995061-3d30-4881-a8b7-6ce7118a7342" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4c0c8b76-27be-4126-90a6-546e7f0b469a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_8f995061-3d30-4881-a8b7-6ce7118a7342" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesBWarrantsMember_9715a109-d7c8-4c4e-9ce8-4969d52576cf" xlink:href="ocgn-20200930.xsd#ocgn_SeriesBWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_8f995061-3d30-4881-a8b7-6ce7118a7342" xlink:to="loc_ocgn_SeriesBWarrantsMember_9715a109-d7c8-4c4e-9ce8-4969d52576cf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SubsequentEvents" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SubsequentEvents"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/SubsequentEvents" xlink:type="extended" id="i25b0687dbaa0473d8b5876308598f61a_SubsequentEvents"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.deitaxonomy.com/role/SubsequentEventsDetails" xlink:type="extended" id="i760da7501c2147f5b1160d785800fe20_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_b9790c27-5c7e-4ba3-a6a4-b19b7f2f0bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_04e172ca-0701-4cd5-a935-4671179f842e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_b9790c27-5c7e-4ba3-a6a4-b19b7f2f0bb8" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_04e172ca-0701-4cd5-a935-4671179f842e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_OperatingLeaseTotalBasePayments_1f5b2398-19d1-45c8-8c6b-19bc41da419a" xlink:href="ocgn-20200930.xsd#ocgn_OperatingLeaseTotalBasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_b9790c27-5c7e-4ba3-a6a4-b19b7f2f0bb8" xlink:to="loc_ocgn_OperatingLeaseTotalBasePayments_1f5b2398-19d1-45c8-8c6b-19bc41da419a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions_eb085bb5-343b-4d6d-adb7-a1aa4cf9701c" xlink:href="ocgn-20200930.xsd#ocgn_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_b9790c27-5c7e-4ba3-a6a4-b19b7f2f0bb8" xlink:to="loc_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions_eb085bb5-343b-4d6d-adb7-a1aa4cf9701c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_3fea75b8-d1d8-4ba9-bf14-7a449062bf58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_b9790c27-5c7e-4ba3-a6a4-b19b7f2f0bb8" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_3fea75b8-d1d8-4ba9-bf14-7a449062bf58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_47cb4bf8-6da3-4aad-88aa-4fe5c8db973e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_b9790c27-5c7e-4ba3-a6a4-b19b7f2f0bb8" xlink:to="loc_us-gaap_SubsequentEventTable_47cb4bf8-6da3-4aad-88aa-4fe5c8db973e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4a5ede42-00df-4b8d-a658-f7b74467e683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_47cb4bf8-6da3-4aad-88aa-4fe5c8db973e" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4a5ede42-00df-4b8d-a658-f7b74467e683" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4a5ede42-00df-4b8d-a658-f7b74467e683_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4a5ede42-00df-4b8d-a658-f7b74467e683" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4a5ede42-00df-4b8d-a658-f7b74467e683_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f9176b4b-1fc8-47e6-83af-eaaffc42dd30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4a5ede42-00df-4b8d-a658-f7b74467e683" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f9176b4b-1fc8-47e6-83af-eaaffc42dd30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f29247a5-ab40-4a51-b575-2e2b3d7df586" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f9176b4b-1fc8-47e6-83af-eaaffc42dd30" xlink:to="loc_us-gaap_SubsequentEventMember_f29247a5-ab40-4a51-b575-2e2b3d7df586" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>ocgn-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b98bd97b-267b-467c-adde-600f3c3e2154,g:859d45a4-db6c-4e83-b642-d8014a2143ca-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0641cd92-64cc-4cb8-b092-7a3471442387_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, beginning balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a771855f-02e5-4baf-97a9-14f4ff398084_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, ending balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_99e39f70-9d50-486e-acf2-a56d29c762b6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_AssetHeldForSalePolicyTextBlock_832d60af-7541-47f3-add6-1355e142f198_terseLabel_en-US" xlink:label="lab_ocgn_AssetHeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Held for Sale</link:label>
    <link:label id="lab_ocgn_AssetHeldForSalePolicyTextBlock_label_en-US" xlink:label="lab_ocgn_AssetHeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Held For Sale [Policy Text Block]</link:label>
    <link:label id="lab_ocgn_AssetHeldForSalePolicyTextBlock_documentation_en-US" xlink:label="lab_ocgn_AssetHeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents asset held for sale.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AssetHeldForSalePolicyTextBlock" xlink:href="ocgn-20200930.xsd#ocgn_AssetHeldForSalePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_AssetHeldForSalePolicyTextBlock" xlink:to="lab_ocgn_AssetHeldForSalePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b012f438-fb78-4aa1-8286-5abe0d11ebbd_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ac76c808-2ef8-4f38-a102-2d7d0f6a5f75_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_acfa8b7d-206e-4700-8eea-9acf9ac1861b_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_5a699985-2245-450d-afae-6cc0fc8b531a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_85bde79b-2fb9-476d-876a-f7f6d1098316_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_59a67acd-9302-4e9e-8386-2a2576882b03_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at issuance</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent_c2e861e0-75d8-43e4-a390-a5837b875079_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workforce reduction as a result of terminations (as a percent)</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_8eb4cab0-75fe-43e4-8ad2-8b4e8208059e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c6d2711e-b242-40df-8e7e-150aa0e65318_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_8c1dbbc7-a1da-4608-9a7a-7b08823f288b_negatedLabel_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Embedded Derivatives</link:label>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative, Fair Value of Embedded Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:to="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_086dc7da-998e-4145-9e6f-a9d3a82efc9c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_4d601f3b-3915-4a3e-84f3-d6e712166f10_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_fbe7cd5c-9c9a-479e-8b08-ff671fd1e4fb_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_42709bd9-df19-4192-ba99-c2f49bc16a53_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c50ca04-c6dc-42be-84cd-aad4ba5760f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_42f99252-d1c0-44be-bbe5-483ea34bb71c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_66720e52-35ec-4b72-b679-a8ce67efc3f2_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_e758bd71-b1cf-4b40-989e-8dbdb50ad157_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3cb50f9d-484f-4ca0-8d33-e86c7ee6df2a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_aa8178bb-668f-4b21-b1a6-a6608f4578e7_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2090d2c3-b2c7-4db9-b956-cc4ed183f2eb_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_WarrantsExchangedForCommonStockMember_fbab40c3-865f-40b6-ac88-2635f1411f3f_terseLabel_en-US" xlink:label="lab_ocgn_WarrantsExchangedForCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Exchange</link:label>
    <link:label id="lab_ocgn_WarrantsExchangedForCommonStockMember_label_en-US" xlink:label="lab_ocgn_WarrantsExchangedForCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Exchanged For Common Stock [Member]</link:label>
    <link:label id="lab_ocgn_WarrantsExchangedForCommonStockMember_documentation_en-US" xlink:label="lab_ocgn_WarrantsExchangedForCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Exchanged For Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_WarrantsExchangedForCommonStockMember" xlink:href="ocgn-20200930.xsd#ocgn_WarrantsExchangedForCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_WarrantsExchangedForCommonStockMember" xlink:to="lab_ocgn_WarrantsExchangedForCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_474ce482-066b-43b6-90d0-861e3bf096e9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 11)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_9954ac30-fea7-4c56-a999-050f4d8d5e01_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_0b532987-a9fd-4cbc-9d58-8c0c3ffadc9c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ConvertibleDebtNovember2018Member_a5cd524d-7b69-469c-ac97-e0a5d2b1c831_terseLabel_en-US" xlink:label="lab_ocgn_ConvertibleDebtNovember2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtNovember2018Member_label_en-US" xlink:label="lab_ocgn_ConvertibleDebtNovember2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt November2018 [Member]</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtNovember2018Member_documentation_en-US" xlink:label="lab_ocgn_ConvertibleDebtNovember2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in November 2018.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtNovember2018Member" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtNovember2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ConvertibleDebtNovember2018Member" xlink:to="lab_ocgn_ConvertibleDebtNovember2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_3fa760d7-18b2-4629-b7e6-e1e89f67c232_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advaite Agreement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4f13556f-e6db-430b-aba1-3e4d7e65e395_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_dbd7c977-4198-48f8-9f85-aa2704828794_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_ddaaa368-3715-4902-8e1c-9f616bdabe2f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_1730a1fd-205f-45a1-8b20-a64e787af8f8_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_06467bb9-5bc7-4761-a1f3-f59b4ea6fe39_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_32b18503-07ef-4a3e-87f0-a78f35922125_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_346b9675-407a-4aa2-af68-ebb7e850737a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3483a87b-e8a4-4a71-950b-16e499550363_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_1df62a44-7d01-4ba1-a823-f3e973c7d4e7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_7f3ef646-072a-489e-83da-5ca65e8ab538_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_14ccb2eb-28db-4eea-852b-d2987c6b9950_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_27081873-d154-4086-ab09-46011f9438e3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_AssetPurchaseAgreementCashConsideration_dcfe2179-5466-40d0-811d-9eda3d0a5a19_terseLabel_en-US" xlink:label="lab_ocgn_AssetPurchaseAgreementCashConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset purchase agreement, cash consideration</link:label>
    <link:label id="lab_ocgn_AssetPurchaseAgreementCashConsideration_label_en-US" xlink:label="lab_ocgn_AssetPurchaseAgreementCashConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset purchase agreement, cash consideration</link:label>
    <link:label id="lab_ocgn_AssetPurchaseAgreementCashConsideration_documentation_en-US" xlink:label="lab_ocgn_AssetPurchaseAgreementCashConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of cash consideration agreed under the asset purchase agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AssetPurchaseAgreementCashConsideration" xlink:href="ocgn-20200930.xsd#ocgn_AssetPurchaseAgreementCashConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_AssetPurchaseAgreementCashConsideration" xlink:to="lab_ocgn_AssetPurchaseAgreementCashConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_b5d70227-0210-489d-8a81-b0d045086c67_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt conversion</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_b11fa289-a8e5-487a-8a1c-b4fde2536a86_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original issue discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_BusinessCombinationIssuedSharesExchangeRate_de771e40-8f6c-47d8-b10d-d83d097a8ffb_terseLabel_en-US" xlink:label="lab_ocgn_BusinessCombinationIssuedSharesExchangeRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued exchange rate to former Ocugen's stockholders (in USD per share)</link:label>
    <link:label id="lab_ocgn_BusinessCombinationIssuedSharesExchangeRate_label_en-US" xlink:label="lab_ocgn_BusinessCombinationIssuedSharesExchangeRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Issued Shares Exchange Rate</link:label>
    <link:label id="lab_ocgn_BusinessCombinationIssuedSharesExchangeRate_documentation_en-US" xlink:label="lab_ocgn_BusinessCombinationIssuedSharesExchangeRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The exchange rate of share issued to shares surrendered by stockholder of the acquired entity in a business combination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_BusinessCombinationIssuedSharesExchangeRate" xlink:href="ocgn-20200930.xsd#ocgn_BusinessCombinationIssuedSharesExchangeRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_BusinessCombinationIssuedSharesExchangeRate" xlink:to="lab_ocgn_BusinessCombinationIssuedSharesExchangeRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_638738fd-0294-4107-8170-df5733cfa328_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_3d87088f-b2ef-4b78-8246-2524699165e2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bbeb5106-ab50-42fa-9bab-fae98c203934_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e027e313-4db0-4e6e-9f6e-4cfe4e6c40f8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares, options outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e25e9a63-05ef-47bc-8eac-5f3938a1deb7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares, options outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense_1e2e3e11-1fb0-4399-a262-c2491ab5a2a3_terseLabel_en-US" xlink:label="lab_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of research and development expense</link:label>
    <link:label id="lab_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, At-Cost Reimbursement Recorded As Reduction In Research And Development Expense</link:label>
    <link:label id="lab_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense_documentation_en-US" xlink:label="lab_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, At-Cost Reimbursement Recorded As Reduction In Research And Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense" xlink:href="ocgn-20200930.xsd#ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense" xlink:to="lab_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5eb8a714-03a3-4762-8cb3-3af1543f82ed_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING PRONOUNCEMENTS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock_29c55593-ff1f-43b9-a3e9-4972a1072823_terseLabel_en-US" xlink:label="lab_ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of supplemental balance sheet information related to leases</link:label>
    <link:label id="lab_ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock_label_en-US" xlink:label="lab_ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental balance sheet information leases [table text block]</link:label>
    <link:label id="lab_ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock_documentation_en-US" xlink:label="lab_ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of balance sheet information related to leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock" xlink:href="ocgn-20200930.xsd#ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock" xlink:to="lab_ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction_e912edd2-d3b1-4e8d-a627-c8f73dd97763_terseLabel_en-US" xlink:label="lab_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate purchase price</link:label>
    <link:label id="lab_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction_label_en-US" xlink:label="lab_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock And Issuance Of Warrants, Consideration Received Per Transaction</link:label>
    <link:label id="lab_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction_documentation_en-US" xlink:label="lab_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock And Issuance Of Warrants, Consideration Received Per Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction" xlink:href="ocgn-20200930.xsd#ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction" xlink:to="lab_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_d8352431-4d75-4f51-b037-90a946028e02_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_2e98f39c-8028-4e15-b4c6-ca12631a0f94_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_0ddba150-d6a8-4a10-8703-e313f45a7b75_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivative liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_19d6aa6d-be9d-4227-a183-61e543e9c179_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivative liability</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:to="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_53c5c162-19b3-4038-a048-92e951a58395_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock; $0.01 par value; 10,000,000 shares authorized; seven issued and outstanding at September&#160;30, 2020 and December&#160;31, 2019</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_796bf18f-eb11-4e00-8cd6-f50a7d6229f6_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_ed78a538-e4cf-420d-bba2-508686fbbccb_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_c7e4466a-f7aa-43da-8a7c-3801a01fac5c_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a6a9bd8c-eea5-4370-9035-6ab982744811_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_96baea9f-c63b-4a67-b8c8-af8b67150503_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_00b34b6d-703e-48f0-9793-8602ddc2dae4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_7b51c4c1-1ef2-49e9-80fe-48c629c420fa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_0c8c7beb-bfbd-477f-a2d5-0030548ffec1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, cancelled (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_6f72a7e8-82e9-45c8-9a68-da916f8d712b_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease principal payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8fe82532-9542-418e-b210-5bedd28e352d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0656fb63-10c8-412b-9e49-8878e223cad2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of changes in exchange rate on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_SeniorSecuredConvertibleNotesMay2019Member_623123d6-f2eb-466e-a183-66c60b4a84c5_terseLabel_en-US" xlink:label="lab_ocgn_SeniorSecuredConvertibleNotesMay2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2019 Senior Secured Convertible Notes</link:label>
    <link:label id="lab_ocgn_SeniorSecuredConvertibleNotesMay2019Member_label_en-US" xlink:label="lab_ocgn_SeniorSecuredConvertibleNotesMay2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Convertible Notes May2019 [Member]</link:label>
    <link:label id="lab_ocgn_SeniorSecuredConvertibleNotesMay2019Member_documentation_en-US" xlink:label="lab_ocgn_SeniorSecuredConvertibleNotesMay2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in May 2019.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeniorSecuredConvertibleNotesMay2019Member" xlink:href="ocgn-20200930.xsd#ocgn_SeniorSecuredConvertibleNotesMay2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_SeniorSecuredConvertibleNotesMay2019Member" xlink:to="lab_ocgn_SeniorSecuredConvertibleNotesMay2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1b011853-b8c4-47a0-87dd-b5c5fae8b890_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue_30238c07-30ab-4976-9953-90979c1e7e24_terseLabel_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of consideration transferred to settle warrants in excess of fair value of warrants</link:label>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue_label_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Consideration Transferred In Excess Of Fair Value</link:label>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue_documentation_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Consideration Transferred In Excess Of Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue" xlink:to="lab_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_4ad6f77e-d3aa-4382-8e42-1c1cb19fc3cd_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_AccruedLiabilitiesClinical_89e9c6eb-1027-4f5f-94b1-bd721bbc4f19_terseLabel_en-US" xlink:label="lab_ocgn_AccruedLiabilitiesClinical" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical</link:label>
    <link:label id="lab_ocgn_AccruedLiabilitiesClinical_label_en-US" xlink:label="lab_ocgn_AccruedLiabilitiesClinical" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Clinical</link:label>
    <link:label id="lab_ocgn_AccruedLiabilitiesClinical_documentation_en-US" xlink:label="lab_ocgn_AccruedLiabilitiesClinical" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Clinical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AccruedLiabilitiesClinical" xlink:href="ocgn-20200930.xsd#ocgn_AccruedLiabilitiesClinical"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_AccruedLiabilitiesClinical" xlink:to="lab_ocgn_AccruedLiabilitiesClinical" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_91a0e9a9-7e96-45e2-aab7-de24ce7b6c4c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_bc1721b5-3613-42a5-a386-608d41a55979_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesSubscribedButUnissued_b8e7adb6-4224-465f-8266-3436a05612c4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesSubscribedButUnissued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares sold in subscription agreement</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesSubscribedButUnissued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesSubscribedButUnissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Subscribed but Unissued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesSubscribedButUnissued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesSubscribedButUnissued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesSubscribedButUnissued" xlink:to="lab_us-gaap_CommonStockSharesSubscribedButUnissued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_fa981054-ab30-4dce-b675-1907715b8578_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_GainsLossesOnConversionOfDebt_9092b61c-94df-4f69-9494-8dd8198a91cd_terseLabel_en-US" xlink:label="lab_ocgn_GainsLossesOnConversionOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt conversion</link:label>
    <link:label id="lab_ocgn_GainsLossesOnConversionOfDebt_91080ee9-62fa-4596-b004-ff00f30dceb2_negatedTerseLabel_en-US" xlink:label="lab_ocgn_GainsLossesOnConversionOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt conversion</link:label>
    <link:label id="lab_ocgn_GainsLossesOnConversionOfDebt_label_en-US" xlink:label="lab_ocgn_GainsLossesOnConversionOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) on Conversion of Debt</link:label>
    <link:label id="lab_ocgn_GainsLossesOnConversionOfDebt_documentation_en-US" xlink:label="lab_ocgn_GainsLossesOnConversionOfDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain (loss) on conversion of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_GainsLossesOnConversionOfDebt" xlink:href="ocgn-20200930.xsd#ocgn_GainsLossesOnConversionOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_GainsLossesOnConversionOfDebt" xlink:to="lab_ocgn_GainsLossesOnConversionOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_05304b7a-5f1f-4e06-9f2f-85f6ebf3b342_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Potentially Dilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_33ed2c00-088a-4d3a-8787-177b6a2edd7b_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_SeriesAWarrantsMember_5600ef8f-0d21-4dcc-bcae-fc8f6c3e4bc3_terseLabel_en-US" xlink:label="lab_ocgn_SeriesAWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Warrants</link:label>
    <link:label id="lab_ocgn_SeriesAWarrantsMember_label_en-US" xlink:label="lab_ocgn_SeriesAWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Warrants [Member]</link:label>
    <link:label id="lab_ocgn_SeriesAWarrantsMember_documentation_en-US" xlink:label="lab_ocgn_SeriesAWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for Series A Warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesAWarrantsMember" xlink:href="ocgn-20200930.xsd#ocgn_SeriesAWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_SeriesAWarrantsMember" xlink:to="lab_ocgn_SeriesAWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_cba2a2b5-c03a-4b9b-a6bd-885b46211971_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity term (in months)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_084930d5-af7c-4f62-a28c-fecf1ba29076_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_244f456b-7579-4e4b-8387-93c3b3033e74_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_a6ca1244-022d-403c-b2ae-d2d1e652fe97_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_35a764d4-d0fa-4e17-be67-b55eb3782bda_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_8bc2954f-0cab-44e2-b231-a604744a0cda_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_2c474258-3e4d-4659-9b5b-be8ccd5a2451_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_639e6d17-bd39-4f9a-8cdd-e3002dfe0143_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_fca9ee6a-1c17-47ae-9795-7039a4d39e96_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_239204d8-107d-446e-a07f-e41eb363e17f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in additional paid-in capital from conversion</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7fbbf563-77f6-4b3b-8953-d3401e1d6402_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_db606309-f98f-48ba-ba96-d9fa4112b974_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_5a683553-4e4d-457d-bb38-74111e876631_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share of common stock - basic and diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_7d93d762-68be-403c-9731-98153fad72f7_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share of common share - basic and diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_383a599e-4aa9-43e0-a548-963eb441ec47_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7edc82aa-47e2-4c68-bf8d-bf32249444b8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8c7f834c-cb93-4cd5-90f1-b80aff1f4747_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued and sold</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_7bf297b8-a745-45d7-857a-073d2ca17f36_verboseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock exchanged for Series A Warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_9f817cda-78ca-4d82-b283-10eef0d025d6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dba67dc5-18a2-4398-b968-c6250c1a24d8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3112a983-4da1-47e5-bc94-0dd76475b87d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life, options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_NumberOfSeriesOfWarrantsIssued_579b694f-91c7-47ad-be57-d4ef2d0939fa_terseLabel_en-US" xlink:label="lab_ocgn_NumberOfSeriesOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of series of warrants issued</link:label>
    <link:label id="lab_ocgn_NumberOfSeriesOfWarrantsIssued_label_en-US" xlink:label="lab_ocgn_NumberOfSeriesOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Series Of Warrants Issued</link:label>
    <link:label id="lab_ocgn_NumberOfSeriesOfWarrantsIssued_documentation_en-US" xlink:label="lab_ocgn_NumberOfSeriesOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Series Of Warrants Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NumberOfSeriesOfWarrantsIssued" xlink:href="ocgn-20200930.xsd#ocgn_NumberOfSeriesOfWarrantsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_NumberOfSeriesOfWarrantsIssued" xlink:to="lab_ocgn_NumberOfSeriesOfWarrantsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_18796ac1-4459-4b80-80bb-6911fca25da1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_167cde24-362e-44f8-84cc-ea0340ebe562_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period one</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_f89fd2b8-fb79-4765-8be1-bdeb2d9b4f0e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ReverseMergerAndFinancingDisclosureLineItems_3f2df6c8-78c6-4d04-8055-7703a0a93bc7_terseLabel_en-US" xlink:label="lab_ocgn_ReverseMergerAndFinancingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Merger and Financing</link:label>
    <link:label id="lab_ocgn_ReverseMergerAndFinancingDisclosureLineItems_label_en-US" xlink:label="lab_ocgn_ReverseMergerAndFinancingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Merger And Financing Disclosure [Line Items]</link:label>
    <link:label id="lab_ocgn_ReverseMergerAndFinancingDisclosureLineItems_documentation_en-US" xlink:label="lab_ocgn_ReverseMergerAndFinancingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems" xlink:href="ocgn-20200930.xsd#ocgn_ReverseMergerAndFinancingDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems" xlink:to="lab_ocgn_ReverseMergerAndFinancingDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7184e4ed-faa4-4740-bcc7-e6f1084fc02a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_bb23797a-9cfa-4e6e-9a3c-d24a7d44ee3d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_4a2b317e-dc94-424d-9da1-445c9b0ad816_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_feca7dbe-24fa-4d45-98cc-b088fe10a254_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company borrowed</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ConvertibleNotesBoardOfDirectorsMember_721dbcb1-a2f8-45fc-8149-ea7edc82a471_terseLabel_en-US" xlink:label="lab_ocgn_ConvertibleNotesBoardOfDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes - Board Of Directors</link:label>
    <link:label id="lab_ocgn_ConvertibleNotesBoardOfDirectorsMember_label_en-US" xlink:label="lab_ocgn_ConvertibleNotesBoardOfDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes, Board Of Directors [Member]</link:label>
    <link:label id="lab_ocgn_ConvertibleNotesBoardOfDirectorsMember_documentation_en-US" xlink:label="lab_ocgn_ConvertibleNotesBoardOfDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes, Board Of Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleNotesBoardOfDirectorsMember" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleNotesBoardOfDirectorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ConvertibleNotesBoardOfDirectorsMember" xlink:to="lab_ocgn_ConvertibleNotesBoardOfDirectorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_c12275b9-d698-4082-ada1-d56763d3c905_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1c78fb61-b6f8-451b-acf6-6c5b2cebd1cc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_8d7cb1cc-1361-4c5c-ac3a-73087ed7cf18_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit and Disposal Activities</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_NonCashInterestExpense_3be2587c-9c78-4d64-a000-fd318daf6940_terseLabel_en-US" xlink:label="lab_ocgn_NonCashInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_ocgn_NonCashInterestExpense_label_en-US" xlink:label="lab_ocgn_NonCashInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Interest Expense</link:label>
    <link:label id="lab_ocgn_NonCashInterestExpense_documentation_en-US" xlink:label="lab_ocgn_NonCashInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of non-cash interest expense during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NonCashInterestExpense" xlink:href="ocgn-20200930.xsd#ocgn_NonCashInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_NonCashInterestExpense" xlink:to="lab_ocgn_NonCashInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_226cf2b8-5ea9-4a9f-850a-3b62ff6e5f54_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_ffe24db3-3394-4fb7-95a0-dbdebdb900d0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote_fa3d23fe-1dea-437b-b347-45ea15ce5cae_terseLabel_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred, Warrant Exchange Promissory Notes</link:label>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote_label_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants, Promissory Note</link:label>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote_documentation_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants, Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote" xlink:to="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2b756464-dfcd-430c-afdd-4ff28e7bb531_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_19a64430-a697-40d9-b457-e71b8e2f0867_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal, Embedded Derivatives and Carrying Value of Debts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_2fcef0f0-dec9-478c-bf51-ac4a45a09ffc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bba03ff1-1e6d-40df-a965-24c330d65ec5_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_215e768c-2b06-4dca-95fc-4cdff13b1767_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Series B Warrant liability</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_NumberOfEquityCompensationPlans_387fd926-c823-4c80-9d6b-8de1392c106f_terseLabel_en-US" xlink:label="lab_ocgn_NumberOfEquityCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of equity compensation plans</link:label>
    <link:label id="lab_ocgn_NumberOfEquityCompensationPlans_label_en-US" xlink:label="lab_ocgn_NumberOfEquityCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Equity Compensation Plans</link:label>
    <link:label id="lab_ocgn_NumberOfEquityCompensationPlans_documentation_en-US" xlink:label="lab_ocgn_NumberOfEquityCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Equity Compensation Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NumberOfEquityCompensationPlans" xlink:href="ocgn-20200930.xsd#ocgn_NumberOfEquityCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_NumberOfEquityCompensationPlans" xlink:to="lab_ocgn_NumberOfEquityCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_df0b9394-899f-4876-8184-876bacb875c2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease renewal term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_7577d360-f72f-4fee-bce2-0842c2bcec86_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_f5a584ef-cb01-4745-96cd-f226ccaf1529_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost_2d71c35f-efca-4714-9fa9-917e0a1bbe66_terseLabel_en-US" xlink:label="lab_ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity issuance costs</link:label>
    <link:label id="lab_ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost_label_en-US" xlink:label="lab_ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Or Part Noncash Amount of Deferred Transaction Cost</link:label>
    <link:label id="lab_ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost_documentation_en-US" xlink:label="lab_ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of noncash or part noncash amount of deferred transaction cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost" xlink:href="ocgn-20200930.xsd#ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost" xlink:to="lab_ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5dc91ee6-3666-47e7-b723-4e0e63932d8d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_7fa3611c-4ebd-4777-b89f-a480c2ea5a7a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_71df7ccd-ab0d-441b-bdfc-fb94419cfc29_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_600ce7b7-7063-40f6-935f-151d258c899d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ProceedsFromPreMergerFinancingFinancingActivities_277d96f0-2e3a-494d-bb11-ce30ab0a0670_terseLabel_en-US" xlink:label="lab_ocgn_ProceedsFromPreMergerFinancingFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Pre-Merger Financing</link:label>
    <link:label id="lab_ocgn_ProceedsFromPreMergerFinancingFinancingActivities_label_en-US" xlink:label="lab_ocgn_ProceedsFromPreMergerFinancingFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Pre Merger Financing, Financing Activities</link:label>
    <link:label id="lab_ocgn_ProceedsFromPreMergerFinancingFinancingActivities_documentation_en-US" xlink:label="lab_ocgn_ProceedsFromPreMergerFinancingFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Pre Merger Financing, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ProceedsFromPreMergerFinancingFinancingActivities" xlink:href="ocgn-20200930.xsd#ocgn_ProceedsFromPreMergerFinancingFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ProceedsFromPreMergerFinancingFinancingActivities" xlink:to="lab_ocgn_ProceedsFromPreMergerFinancingFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c013ba04-7f7e-496d-8cb0-ca11041e4452_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_d87bef2b-bcc4-4358-8cd4-ed4784797aae_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of components of lease expense</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_121151b5-4ac9-4330-ab95-9172c6a8d6a8_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_61f3db6a-c47e-4153-9c2a-b043f199e967_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_08ec620d-7678-4456-87bb-e60c5eb84e43_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_8f879a2a-077a-416f-be7c-acfbdddd434c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity transactions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_2ef74be2-7df8-4fc4-9219-3b1279d1e35f_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_56afb8a6-d913-4503-bf49-a4d2f66e1e5c_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_92a8b5a3-482f-43cb-b214-0b508799ff79_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_2451126c-09f5-4703-9cd6-76b588cc9157_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_78b0de2f-56ab-4ade-8aa1-ccd113252214_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ATMTransactionsMember_baf9394c-3a8a-440d-bba7-d41cffb8eb9b_terseLabel_en-US" xlink:label="lab_ocgn_ATMTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-the-market issuance</link:label>
    <link:label id="lab_ocgn_ATMTransactionsMember_label_en-US" xlink:label="lab_ocgn_ATMTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Transactions [Member]</link:label>
    <link:label id="lab_ocgn_ATMTransactionsMember_documentation_en-US" xlink:label="lab_ocgn_ATMTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ATMTransactionsMember" xlink:href="ocgn-20200930.xsd#ocgn_ATMTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ATMTransactionsMember" xlink:to="lab_ocgn_ATMTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8e04a864-395d-4351-8be5-9bbc6b396a85_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, grants in period, weighted average grant date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_1779d1cb-d415-47d3-9f6d-1bc0f78adb7d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount_9d78a14a-e1ce-4fd6-a522-9f40d7f435bd_terseLabel_en-US" xlink:label="lab_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price discount per original agreement (in a percentage)</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount_label_en-US" xlink:label="lab_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Equity Financing Triggered, Discount</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount_documentation_en-US" xlink:label="lab_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of discount of the convertible debt that automatically convert the same class of equity as those issued to the lowest price per share being paid by investors in the equity financing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount" xlink:to="lab_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b91b61a9-54eb-4b96-bda9-1e35e86d19c7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_0f4d4a38-9510-4a5e-bb0b-63c249431575_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_AccruedLiabilitiesProfessionalFees_286026c4-153d-4cfd-a8db-b0fab769facc_terseLabel_en-US" xlink:label="lab_ocgn_AccruedLiabilitiesProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_ocgn_AccruedLiabilitiesProfessionalFees_label_en-US" xlink:label="lab_ocgn_AccruedLiabilitiesProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Professional Fees</link:label>
    <link:label id="lab_ocgn_AccruedLiabilitiesProfessionalFees_documentation_en-US" xlink:label="lab_ocgn_AccruedLiabilitiesProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AccruedLiabilitiesProfessionalFees" xlink:href="ocgn-20200930.xsd#ocgn_AccruedLiabilitiesProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_AccruedLiabilitiesProfessionalFees" xlink:to="lab_ocgn_AccruedLiabilitiesProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_14127a42-0a91-4e39-9add-da0032a5ed85_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_9e27c8e2-07b8-4bc2-a89a-67aeb83969b1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of maturities of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_21788dee-a358-4031-a18e-0da898f11881_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus: accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_26d945ba-efc5-4740-85fd-50991cf97288_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_4d280bc3-2045-437d-9c7e-0df4b0222bc2_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4fd3420c-7097-4de9-86d7-c450699420df_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_52f2a74a-6d9d-4f2a-bda4-0474be4559b2_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger and Financing</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_94e9b90e-58a1-4256-9527-84d0ccf12495_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_a6bce229-97ce-492d-8385-3e974adbef5e_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6d5660db-434c-4ebd-befe-694cc21fc0c8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_a0be1a0f-eedf-4e92-a129-b1da6bf583fb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_a964d483-0f12-4b94-ae47-16343cc2e01d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense related to options outstanding, weighted average period for expense to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_837facfb-f9f6-4b38-a6d0-1c8594c112b7_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash transactions:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f3ffa7f2-253e-413d-b203-4f2361cf0b23_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: present value adjustment</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditFairValueDisclosure_f8775086-670a-4086-a120-db4093f44c46_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lines of credit</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lines of Credit, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditFairValueDisclosure" xlink:to="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ConvertibleDebtFebruary2019Member_93c5ab2f-1ee2-45b5-959e-ebf402a0da4c_terseLabel_en-US" xlink:label="lab_ocgn_ConvertibleDebtFebruary2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2019</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtFebruary2019Member_label_en-US" xlink:label="lab_ocgn_ConvertibleDebtFebruary2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt February2019 [Member]</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtFebruary2019Member_documentation_en-US" xlink:label="lab_ocgn_ConvertibleDebtFebruary2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in February 2019.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtFebruary2019Member" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtFebruary2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ConvertibleDebtFebruary2019Member" xlink:to="lab_ocgn_ConvertibleDebtFebruary2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure_0803f8a4-ae96-4db0-88d3-df6acdfa5cee_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted price of assets held for sale of NeoCart</link:label>
    <link:label id="lab_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-for-sale, Long Lived, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure" xlink:to="lab_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_54b1e5a4-a6dd-40cf-a6d0-94fc9e01048d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cbf28793-b44e-4da8-925a-0754f6c9b188_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2377eda0-76d0-4294-8327-ab2eafc068a8_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_af0547ff-37c9-416c-9028-f8f6f5b3a034_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_3bd7a1de-fc3f-4dd2-958b-b7046faf0299_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_fb2579e8-8ee9-4927-9a67-8e88f7cf08e3_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsAndOtherAdjustments_dcf17129-f007-4eae-bbcb-918f6e2db298_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed dividend related to Warrant Exchange</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsAndOtherAdjustments_0be8caab-a798-48bd-ae19-e1acdc46bc2d_negatedLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed dividend related to Warrant Exchange (Note 12)</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsAndOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Dividends and Other Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:to="lab_us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset_54555489-d392-403f-b7b9-fe44eb900bf4_terseLabel_en-US" xlink:label="lab_ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset related to operating leases</link:label>
    <link:label id="lab_ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash, Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-to-use asset recognized upon adoption of ASU 2018-11.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset" xlink:href="ocgn-20200930.xsd#ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset" xlink:to="lab_ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3be67a76-d550-4f05-b5ed-62390c48652a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent_519c11b8-69aa-4601-a89d-c94879c7db2a_terseLabel_en-US" xlink:label="lab_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance-related</link:label>
    <link:label id="lab_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Severance-Related Liabilities, Current</link:label>
    <link:label id="lab_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Severance-Related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent" xlink:href="ocgn-20200930.xsd#ocgn_AccruedSeveranceRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent" xlink:to="lab_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_e1b22d11-cd0f-442f-92df-92bf1e631c1f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock split, conversion ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_efd8b847-f25c-4fe5-a74c-4df23dfa28e3_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cfb8588a-de46-4914-aceb-b83b6ca9fb24_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a3eef1ff-b5df-45af-a35a-cc2f2dfcc565_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_bd4ae34b-2547-421b-ada9-1b1b0f444537_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock_f2e94997-3934-4008-89d9-9cc9e8b43a6a_terseLabel_en-US" xlink:label="lab_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accredited investors agreement to cancel outstanding obligation</link:label>
    <link:label id="lab_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock_label_en-US" xlink:label="lab_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Outstanding Obligation Cancelled In Exchange For Stock</link:label>
    <link:label id="lab_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock_documentation_en-US" xlink:label="lab_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Outstanding Obligation Cancelled In Exchange For Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock" xlink:href="ocgn-20200930.xsd#ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock" xlink:to="lab_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_A2014PlanMember_323bc028-7e5b-42cf-9c09-628c00c255a1_terseLabel_en-US" xlink:label="lab_ocgn_A2014PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Plan</link:label>
    <link:label id="lab_ocgn_A2014PlanMember_label_en-US" xlink:label="lab_ocgn_A2014PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Plan [Member]</link:label>
    <link:label id="lab_ocgn_A2014PlanMember_documentation_en-US" xlink:label="lab_ocgn_A2014PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_A2014PlanMember" xlink:href="ocgn-20200930.xsd#ocgn_A2014PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_A2014PlanMember" xlink:to="lab_ocgn_A2014PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_b61c8efc-0321-4368-b450-57e94090c594_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c8e291fc-5c2d-4e03-86cc-14802135cd5a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, weighted average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d9311449-4dc4-45e7-974b-1df146a3f69f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, weighted average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_2a70405d-bc60-4ebc-bedc-e78b4cb6ef08_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable to Banks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableToBanksMember" xlink:to="lab_us-gaap_NotesPayableToBanksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_9b38e9f8-fad0-42b4-831e-f860434a36d0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_1f5cbd59-a2c6-4f87-b94a-ff16feb94160_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity_a343630b-97c6-4725-add3-3037f7c573db_terseLabel_en-US" xlink:label="lab_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount reclassified to equity</link:label>
    <link:label id="lab_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity_label_en-US" xlink:label="lab_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Amount Reclassified To Equity</link:label>
    <link:label id="lab_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity_documentation_en-US" xlink:label="lab_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Amount Reclassified To Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity" xlink:href="ocgn-20200930.xsd#ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity" xlink:to="lab_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b635d0b1-c7c9-43ed-9a2a-0863d5832397_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0cc12f89-b34f-4126-9ca4-2af78382849e_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_b12da110-f140-40a3-a19d-02d75135bf6e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e652a400-dabe-4b3c-992a-d6c251b21bd0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_4fea400f-ab0b-4bc7-ba30-9ba41ab06698_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease obligation, less current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_66fe08c0-e542-46f8-94ea-e68cc38f66d5_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current lease obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4480f42b-8b51-4e0a-82ae-1d50da3796dc_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction_fe500d34-be26-4f32-9b72-ba63a14ed43d_terseLabel_en-US" xlink:label="lab_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of principal amount required to be redeemed - financing</link:label>
    <link:label id="lab_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction_label_en-US" xlink:label="lab_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Percentage of Principal Amount Required To Be Redeemed Upon Financing Transaction</link:label>
    <link:label id="lab_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction_documentation_en-US" xlink:label="lab_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Percentage of Principal Amount Required To Be Redeemed Upon Financing Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction" xlink:href="ocgn-20200930.xsd#ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction" xlink:to="lab_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_d78169cb-57b6-4b20-8e1e-b6f78c92b610_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_0509bc40-8ddf-405d-a4fb-ced356671014_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_59190298-abf5-4d83-ba77-43a887cdf7e5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_0532e5e3-a908-4636-ad8b-208fb1a697dc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of embedded derivatives</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture_72cbfc6a-4edf-4fc1-bff7-66b2c13a04d0_terseLabel_en-US" xlink:label="lab_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of clinical trials to be initiated in the future</link:label>
    <link:label id="lab_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture_label_en-US" xlink:label="lab_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Clinical Trials To Be Initiated In The Future</link:label>
    <link:label id="lab_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture_documentation_en-US" xlink:label="lab_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Clinical Trials To Be Initiated In The Future</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture" xlink:href="ocgn-20200930.xsd#ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture" xlink:to="lab_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_NoncashLeaseExpense_ab52d09a-bcb3-4cae-a105-6a0bcf152dc6_terseLabel_en-US" xlink:label="lab_ocgn_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_ocgn_NoncashLeaseExpense_label_en-US" xlink:label="lab_ocgn_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:label id="lab_ocgn_NoncashLeaseExpense_documentation_en-US" xlink:label="lab_ocgn_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NoncashLeaseExpense" xlink:href="ocgn-20200930.xsd#ocgn_NoncashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_NoncashLeaseExpense" xlink:to="lab_ocgn_NoncashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_WarrantExchangePromissoryNotesMember_607b26c3-8a3a-4cee-b555-cab5272a9d34_verboseLabel_en-US" xlink:label="lab_ocgn_WarrantExchangePromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Exchange Promissory Notes</link:label>
    <link:label id="lab_ocgn_WarrantExchangePromissoryNotesMember_45be60a2-8e6d-447d-8b46-324bf5595413_terseLabel_en-US" xlink:label="lab_ocgn_WarrantExchangePromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Exchange Promissory Notes</link:label>
    <link:label id="lab_ocgn_WarrantExchangePromissoryNotesMember_label_en-US" xlink:label="lab_ocgn_WarrantExchangePromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Exchange Promissory Notes [Member]</link:label>
    <link:label id="lab_ocgn_WarrantExchangePromissoryNotesMember_documentation_en-US" xlink:label="lab_ocgn_WarrantExchangePromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Exchange Promissory Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_WarrantExchangePromissoryNotesMember" xlink:href="ocgn-20200930.xsd#ocgn_WarrantExchangePromissoryNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_WarrantExchangePromissoryNotesMember" xlink:to="lab_ocgn_WarrantExchangePromissoryNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_a2d1555b-0110-46cc-b7c9-0d4db85c3d61_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity_87b1b0b1-a5bf-4847-8d75-469a7d6030a6_terseLabel_en-US" xlink:label="lab_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares outstanding, remaining capacity</link:label>
    <link:label id="lab_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity_label_en-US" xlink:label="lab_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Outstanding, Remaining Capacity</link:label>
    <link:label id="lab_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity_documentation_en-US" xlink:label="lab_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Outstanding, Remaining Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity" xlink:href="ocgn-20200930.xsd#ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity" xlink:to="lab_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_aa282470-d063-470d-a316-04870377ac22_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_ae40dcb4-3c41-4fee-88db-8e3ce9980235_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_56d8dd34-32b8-4800-9af9-4c6b875b487e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_77115cc4-cb36-4f70-9e1a-5f9ac767e643_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_6a1645d4-16e3-4358-87c3-182f063f558b_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_60e8939f-8da6-4ff7-a8f8-6c12bbd895bd_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction_20186098-48c1-41dd-81e0-25b4fa65ceb2_terseLabel_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of employees issued warrants</link:label>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction_label_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Number Of Employees Issued Stock In Transaction</link:label>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction_documentation_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Number Of Employees Issued Stock In Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction" xlink:to="lab_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_cb7970ed-6226-4204-ac17-37a54f965615_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_95f09ad9-00a3-4e94-9dd2-e0673ff3a21d_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board members</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_fdff8a2d-3e80-4f05-b234-f78db45aee6f_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_3c4fa238-d86e-40de-bbfb-f9e035f41196_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_7b4d823d-69be-46ba-ba23-c62b50ae02ec_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, term of contract (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_WarrantsTextBlock_7a262f08-fe73-412d-8ce1-b735b22e62ce_terseLabel_en-US" xlink:label="lab_ocgn_WarrantsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_ocgn_WarrantsTextBlock_label_en-US" xlink:label="lab_ocgn_WarrantsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants [Text Block]</link:label>
    <link:label id="lab_ocgn_WarrantsTextBlock_documentation_en-US" xlink:label="lab_ocgn_WarrantsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_WarrantsTextBlock" xlink:href="ocgn-20200930.xsd#ocgn_WarrantsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_WarrantsTextBlock" xlink:to="lab_ocgn_WarrantsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_d435ffe7-7156-4e74-adef-011d3a72c3c6_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_21db5e2d-f3f1-41b8-afa6-0c59af72c123_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_ce40fc49-6e4b-4d89-adfa-ce2388e56f92_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_SeniorSecuredConvertibleNotesJune2019Member_95fc337e-7577-4926-bcd7-ab936c66a8a7_terseLabel_en-US" xlink:label="lab_ocgn_SeniorSecuredConvertibleNotesJune2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2019 Senior Secured Convertible Notes</link:label>
    <link:label id="lab_ocgn_SeniorSecuredConvertibleNotesJune2019Member_label_en-US" xlink:label="lab_ocgn_SeniorSecuredConvertibleNotesJune2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Convertible Notes June2019 [Member]</link:label>
    <link:label id="lab_ocgn_SeniorSecuredConvertibleNotesJune2019Member_documentation_en-US" xlink:label="lab_ocgn_SeniorSecuredConvertibleNotesJune2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in June 2019.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeniorSecuredConvertibleNotesJune2019Member" xlink:href="ocgn-20200930.xsd#ocgn_SeniorSecuredConvertibleNotesJune2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_SeniorSecuredConvertibleNotesJune2019Member" xlink:to="lab_ocgn_SeniorSecuredConvertibleNotesJune2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_cab5ae2c-7687-40de-8019-c9bf5ff553c3_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ResearchAndDevelopmentExpensesCurrent_f2c52625-2426-4fe5-96f8-f275488d65af_terseLabel_en-US" xlink:label="lab_ocgn_ResearchAndDevelopmentExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research&#160;and development</link:label>
    <link:label id="lab_ocgn_ResearchAndDevelopmentExpensesCurrent_label_en-US" xlink:label="lab_ocgn_ResearchAndDevelopmentExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Expenses Current</link:label>
    <link:label id="lab_ocgn_ResearchAndDevelopmentExpensesCurrent_documentation_en-US" xlink:label="lab_ocgn_ResearchAndDevelopmentExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ResearchAndDevelopmentExpensesCurrent" xlink:href="ocgn-20200930.xsd#ocgn_ResearchAndDevelopmentExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ResearchAndDevelopmentExpensesCurrent" xlink:to="lab_ocgn_ResearchAndDevelopmentExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_ee40943b-9233-4c53-a384-e90a16385950_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_e1fb586c-06a8-4986-8d7f-f07b255e154e_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans payable</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_b4ae0e29-a4ae-4d51-8533-4e78e34e958b_netLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total carrying value of debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_cf33e111-ec10-47bb-9652-0a97a1359d99_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value upon Issuance</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_d433db96-0bea-4a5f-9dc4-11b0565a4d01_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_04bcd6f6-c1aa-44ae-96b8-2b2cb1c7912d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ConvertiblePromissoryNotesMember_c780f982-857f-4fd8-99db-fd896696b1d9_terseLabel_en-US" xlink:label="lab_ocgn_ConvertiblePromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Promissory Notes</link:label>
    <link:label id="lab_ocgn_ConvertiblePromissoryNotesMember_label_en-US" xlink:label="lab_ocgn_ConvertiblePromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Promissory Notes [Member]</link:label>
    <link:label id="lab_ocgn_ConvertiblePromissoryNotesMember_documentation_en-US" xlink:label="lab_ocgn_ConvertiblePromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promissory notes which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertiblePromissoryNotesMember" xlink:href="ocgn-20200930.xsd#ocgn_ConvertiblePromissoryNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ConvertiblePromissoryNotesMember" xlink:to="lab_ocgn_ConvertiblePromissoryNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_HistogenicsCorporationMember_a58dc207-ffb9-45b3-b0ce-b94b0fb7f959_terseLabel_en-US" xlink:label="lab_ocgn_HistogenicsCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Histogenics</link:label>
    <link:label id="lab_ocgn_HistogenicsCorporationMember_label_en-US" xlink:label="lab_ocgn_HistogenicsCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Histogenics Corporation [Member]</link:label>
    <link:label id="lab_ocgn_HistogenicsCorporationMember_documentation_en-US" xlink:label="lab_ocgn_HistogenicsCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents Histogenics Corporation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_HistogenicsCorporationMember" xlink:href="ocgn-20200930.xsd#ocgn_HistogenicsCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_HistogenicsCorporationMember" xlink:to="lab_ocgn_HistogenicsCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_de39d9fc-4631-4293-8c64-4fc1df534fdd_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_ad093334-0ca2-440f-9206-20d1d3d145a2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_68a1ede2-5646-46a9-be20-57893d977641_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_07d15238-96f7-43ad-89b3-1e97f83f884c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_52202ba9-f008-4db7-99d2-eca7b7418961_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_29aa4f24-24b9-404b-882c-15475ddcc93d_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to note holders</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_4a6bf323-0198-4b92-8119-098f3a1d005c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease obligation</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_9a5a25a7-9ce3-41e1-9f30-bdffb8dd1885_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_OperatingLeaseTotalBasePayments_296a4c1d-84fd-4b77-8714-0fab8dcda56c_terseLabel_en-US" xlink:label="lab_ocgn_OperatingLeaseTotalBasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base payments</link:label>
    <link:label id="lab_ocgn_OperatingLeaseTotalBasePayments_label_en-US" xlink:label="lab_ocgn_OperatingLeaseTotalBasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Total Base Payments</link:label>
    <link:label id="lab_ocgn_OperatingLeaseTotalBasePayments_documentation_en-US" xlink:label="lab_ocgn_OperatingLeaseTotalBasePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Total Base Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_OperatingLeaseTotalBasePayments" xlink:href="ocgn-20200930.xsd#ocgn_OperatingLeaseTotalBasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_OperatingLeaseTotalBasePayments" xlink:to="lab_ocgn_OperatingLeaseTotalBasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_621008a0-0e67-46fd-abde-91a2d4cda3e5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_SeniorSecuredConvertibleNotesMember_0a29fa74-9c8b-4ed0-8bcb-5eac7dfcf358_terseLabel_en-US" xlink:label="lab_ocgn_SeniorSecuredConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Convertible Notes</link:label>
    <link:label id="lab_ocgn_SeniorSecuredConvertibleNotesMember_label_en-US" xlink:label="lab_ocgn_SeniorSecuredConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Convertible Notes [Member]</link:label>
    <link:label id="lab_ocgn_SeniorSecuredConvertibleNotesMember_documentation_en-US" xlink:label="lab_ocgn_SeniorSecuredConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeniorSecuredConvertibleNotesMember" xlink:href="ocgn-20200930.xsd#ocgn_SeniorSecuredConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_SeniorSecuredConvertibleNotesMember" xlink:to="lab_ocgn_SeniorSecuredConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_SecuritiesPurchaseAgreementMember_1699506d-55c2-4ee3-aab3-db18e1287c91_terseLabel_en-US" xlink:label="lab_ocgn_SecuritiesPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing SPA</link:label>
    <link:label id="lab_ocgn_SecuritiesPurchaseAgreementMember_label_en-US" xlink:label="lab_ocgn_SecuritiesPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
    <link:label id="lab_ocgn_SecuritiesPurchaseAgreementMember_documentation_en-US" xlink:label="lab_ocgn_SecuritiesPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to Securities Purchase Agreement entered with several investors.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SecuritiesPurchaseAgreementMember" xlink:href="ocgn-20200930.xsd#ocgn_SecuritiesPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_SecuritiesPurchaseAgreementMember" xlink:to="lab_ocgn_SecuritiesPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth_bec66d17-73c7-49fb-8b83-3736b1bbad03_terseLabel_en-US" xlink:label="lab_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of increase in purchase price of asset per month (in percentage)</link:label>
    <link:label id="lab_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth_label_en-US" xlink:label="lab_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Increase In Purchase Price Of Asset Per Month</link:label>
    <link:label id="lab_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth_documentation_en-US" xlink:label="lab_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of asset purchase agreement that the purchase price increases per month between October 31, 2019 and the closing date if agreement is not terminated.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth" xlink:href="ocgn-20200930.xsd#ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth" xlink:to="lab_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d7774407-16ee-4d1f-94f5-8c9f2a97b5aa_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_88a9f759-7040-4609-887f-c7c8e6788860_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Transactions</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_de3f3ebb-f559-4879-9416-f98b20903a07_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_99cee749-a7e9-4ce6-8564-e8cc4e56dd46_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ConvertibleDebtJune2018Member_c291e4da-40f7-48c7-893b-32717a808f92_terseLabel_en-US" xlink:label="lab_ocgn_ConvertibleDebtJune2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2018</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtJune2018Member_label_en-US" xlink:label="lab_ocgn_ConvertibleDebtJune2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt June2018 [Member]</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtJune2018Member_documentation_en-US" xlink:label="lab_ocgn_ConvertibleDebtJune2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in June 2018.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtJune2018Member" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtJune2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ConvertibleDebtJune2018Member" xlink:to="lab_ocgn_ConvertibleDebtJune2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_a48f33ed-5b32-4c53-9ff3-f1091b477e26_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_97521526-74c2-494c-94b6-d875fa62260a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_91055cba-286a-453a-af38-704bc2bb48d5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_44abd625-35d6-46a4-b99a-99384ae9bd8b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate&#8212;operating leases (in percentage)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_7660ea24-e390-4827-bab6-ab5ef134ff33_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Business</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_f2f76b03-6362-4cce-a4ce-390bea53ee04_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c5819db8-6b27-4d6a-9579-619f21f33211_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_075261a6-7604-407b-a350-9028def06da6_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_e8384434-c7d8-404b-874c-d8b90ad30083_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: present value adjustment</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_71284183-989a-42dc-9528-2c8b67a5ca16_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_3f61b0df-7e74-411d-9a27-66ae65391d22_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_adce1b8c-43b4-4d2a-8817-b3e1fd3c8883_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive securities</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_DebtRedemptionMultipleFeature_7d8fa695-68e4-43c9-b6fa-c8a156873de9_terseLabel_en-US" xlink:label="lab_ocgn_DebtRedemptionMultipleFeature" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption multiple upon default</link:label>
    <link:label id="lab_ocgn_DebtRedemptionMultipleFeature_label_en-US" xlink:label="lab_ocgn_DebtRedemptionMultipleFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Redemption Multiple Feature</link:label>
    <link:label id="lab_ocgn_DebtRedemptionMultipleFeature_documentation_en-US" xlink:label="lab_ocgn_DebtRedemptionMultipleFeature" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption multiple of debt's principal and unpaid interest upon consummation of the sale of all or substantially all of the assets of the Company, change in control or event of default</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_DebtRedemptionMultipleFeature" xlink:href="ocgn-20200930.xsd#ocgn_DebtRedemptionMultipleFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_DebtRedemptionMultipleFeature" xlink:to="lab_ocgn_DebtRedemptionMultipleFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1810e0d4-5649-4604-a45e-594d069fe3c3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of debt</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c568658d-53ec-4a27-ab91-041a9258d89c_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_70f5bb5c-4bd2-4396-a1c9-c618d1dbaad8_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued, price per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_ce360650-25ce-41cf-9b3c-f73e2cd7dde4_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Severance, beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_2fc6ab4e-054e-4b0a-8824-cd7aff298ee5_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Severance, ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants_ac592597-e0e7-44eb-8c79-6c4c28df7771_totalLabel_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of consideration transferred to settle warrants</link:label>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants_label_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants</link:label>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants_documentation_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants" xlink:to="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_LongTermDebtMaturityAfterYearFour_de0450b2-8e98-4b1a-b1d7-ce92b9c638c2_terseLabel_en-US" xlink:label="lab_ocgn_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_ocgn_LongTermDebtMaturityAfterYearFour_label_en-US" xlink:label="lab_ocgn_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, After Year Four</link:label>
    <link:label id="lab_ocgn_LongTermDebtMaturityAfterYearFour_documentation_en-US" xlink:label="lab_ocgn_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_LongTermDebtMaturityAfterYearFour" xlink:href="ocgn-20200930.xsd#ocgn_LongTermDebtMaturityAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_LongTermDebtMaturityAfterYearFour" xlink:to="lab_ocgn_LongTermDebtMaturityAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cecb30b-9895-4f3d-8963-7bc75b366c6c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_6b363c41-7639-46fe-80e0-4ffdc1c7b811_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_6db4a316-2589-4891-9e72-a119c85bcb8b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_61860af0-fec2-4e2f-bad8-25db97f16069_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in calculating net loss per common share&#8212;basic and diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_a290993b-dc9e-4041-950d-45f035095008_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in calculating net loss per common share&#8212;basic and diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_3f4bccca-935c-4a6e-a689-c93fb577266a_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ff61cd50-0b55-4540-9df6-838b2c1c670a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_bdf36aad-35b7-4384-94da-57e08e6c5684_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_a3e4106d-3ce1-4598-8b72-1d09244e2e63_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_1fdf1730-cf86-4443-b706-0258628df617_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage_69b24578-efb4-4b3d-bdbb-83f43a61426e_terseLabel_en-US" xlink:label="lab_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Automatic increase in shares to be issued (in percentage)</link:label>
    <link:label id="lab_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage_label_en-US" xlink:label="lab_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Automatic Increase In Shares To Be Issue, Percentage</link:label>
    <link:label id="lab_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage_documentation_en-US" xlink:label="lab_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Automatic Increase In Shares To Be Issue, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage" xlink:href="ocgn-20200930.xsd#ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage" xlink:to="lab_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_043a8ea1-fd43-4165-9267-7ceb36534a20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance-related payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_bd6b7e78-bb67-421f-b210-42c230ac546f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_87e0c35e-823e-47dd-90af-04ae061cc19d_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b1d062c2-cf7d-455e-84d7-f635b62e621b_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_eb7de52a-5b42-40ca-bb35-5ee5c7502c68_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_e5ca1945-70c9-4a6b-8353-ab874c1d592c_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock_1b9067fa-2007-4b96-9751-b928a072e465_terseLabel_en-US" xlink:label="lab_ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents, and Restricted Cash</link:label>
    <link:label id="lab_ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock_label_en-US" xlink:label="lab_ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents, Restricted Cash [Table Text Block]</link:label>
    <link:label id="lab_ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock_documentation_en-US" xlink:label="lab_ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the components of cash and cash equivalents, restricted cash.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock" xlink:href="ocgn-20200930.xsd#ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock" xlink:to="lab_ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_140743ce-e08d-4969-a508-96502202e24f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_12ffb124-d180-439a-ada6-ce02d5696c8a_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_627c70d1-2f78-4ae1-a0d3-b8fc6e5f05f0_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_801f5033-88ce-499d-b77b-0ce660668420_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Note Principal Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_57424fc1-c40e-4b28-be5b-895f99bb05ee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_11bbf844-85e7-4694-9201-f08391245a4b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_3fae7bcb-01ab-4aa2-9b5b-9248a6b397d0_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_bd05f4b7-808d-473e-b429-3f1ee3bf4746_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commissions and equity issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2fd75fb1-88f2-40b2-ab03-591fbc803620_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commissions, fees and expenses</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_November2018AndDecember2018NotesMember_64194389-0ae5-4981-bb95-dc506ba6c961_terseLabel_en-US" xlink:label="lab_ocgn_November2018AndDecember2018NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November&#160;2018 and December 2018 Notes</link:label>
    <link:label id="lab_ocgn_November2018AndDecember2018NotesMember_label_en-US" xlink:label="lab_ocgn_November2018AndDecember2018NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November&#160;2018 And December 2018 Notes [Member]</link:label>
    <link:label id="lab_ocgn_November2018AndDecember2018NotesMember_documentation_en-US" xlink:label="lab_ocgn_November2018AndDecember2018NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November&#160;2018 And December 2018 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_November2018AndDecember2018NotesMember" xlink:href="ocgn-20200930.xsd#ocgn_November2018AndDecember2018NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_November2018AndDecember2018NotesMember" xlink:to="lab_ocgn_November2018AndDecember2018NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_97d109e9-b01c-4b88-aeb2-8018752c403e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_489c112d-ba8f-4800-9b5d-d03c70052273_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b115d8c8-de67-4f86-b2c4-9fac2d32ecde_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_d7d6d526-d1b9-42c5-9995-abd91b3af71c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c4dab4c7-5788-4c29-a082-ef4c78bd830f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_19287990-54b3-4d36-9a5f-23eabaf508de_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_7ebbe161-5089-4da5-ac25-b8b8985d7641_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_7baea7e1-2bb5-4ca3-bcd1-bf90bf6ecd51_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_564491fa-20ad-400b-acd1-646c616a74f0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease terms&#8212;operating leases (years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_d26969a6-7785-448c-9bc6-9b8669d6f25d_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_8ba75d02-436b-4d4d-87dd-b4b9c49efe9f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_NumberOfOrphanDrugDesignations_98b3ac9b-a532-4778-830c-99ba31380023_terseLabel_en-US" xlink:label="lab_ocgn_NumberOfOrphanDrugDesignations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of ODDs received (orphan drug designation)</link:label>
    <link:label id="lab_ocgn_NumberOfOrphanDrugDesignations_label_en-US" xlink:label="lab_ocgn_NumberOfOrphanDrugDesignations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Orphan Drug Designations</link:label>
    <link:label id="lab_ocgn_NumberOfOrphanDrugDesignations_documentation_en-US" xlink:label="lab_ocgn_NumberOfOrphanDrugDesignations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Orphan Drug Designations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NumberOfOrphanDrugDesignations" xlink:href="ocgn-20200930.xsd#ocgn_NumberOfOrphanDrugDesignations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_NumberOfOrphanDrugDesignations" xlink:to="lab_ocgn_NumberOfOrphanDrugDesignations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_6d016e8e-465b-40b9-bf53-1eee3e25da86_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate offering price</link:label>
    <link:label id="lab_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_label_en-US" xlink:label="lab_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Share Subscribed but Unissued, Subscriptions Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:to="lab_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6363c37-d19b-4d6b-bd53-2f82d9aeab42_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_PaycheckProtectionProgramLoanMember_fc7cfb35-784c-4e2a-9e06-672327437a36_verboseLabel_en-US" xlink:label="lab_ocgn_PaycheckProtectionProgramLoanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP Note</link:label>
    <link:label id="lab_ocgn_PaycheckProtectionProgramLoanMember_label_en-US" xlink:label="lab_ocgn_PaycheckProtectionProgramLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loan [Member]</link:label>
    <link:label id="lab_ocgn_PaycheckProtectionProgramLoanMember_documentation_en-US" xlink:label="lab_ocgn_PaycheckProtectionProgramLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_PaycheckProtectionProgramLoanMember" xlink:href="ocgn-20200930.xsd#ocgn_PaycheckProtectionProgramLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_PaycheckProtectionProgramLoanMember" xlink:to="lab_ocgn_PaycheckProtectionProgramLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b6aac9dc-ae4c-48f6-b4d0-875b3b8056b3_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_ffcd6b58-a192-4fb6-acaa-cb6472017b7e_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_beaa6965-b269-4004-a9e8-03fc185d9e3a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock; $0.01 par value; 200,000,000 authorized; 162,147,973 and 52,746,728 shares issued at September&#160;30, 2020 and December&#160;31, 2019, respectively; 162,026,473 and 52,625,228 shares outstanding at September&#160;30, 2020 and December&#160;31, 2019, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ControlledEquityOfferingSalesAgreementMember_8f0e1586-fb37-499a-9f46-7348068b9e95_terseLabel_en-US" xlink:label="lab_ocgn_ControlledEquityOfferingSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATMs</link:label>
    <link:label id="lab_ocgn_ControlledEquityOfferingSalesAgreementMember_label_en-US" xlink:label="lab_ocgn_ControlledEquityOfferingSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Controlled Equity Offering Sales Agreement [Member]</link:label>
    <link:label id="lab_ocgn_ControlledEquityOfferingSalesAgreementMember_documentation_en-US" xlink:label="lab_ocgn_ControlledEquityOfferingSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Controlled Equity Offering Sales Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ControlledEquityOfferingSalesAgreementMember" xlink:href="ocgn-20200930.xsd#ocgn_ControlledEquityOfferingSalesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ControlledEquityOfferingSalesAgreementMember" xlink:to="lab_ocgn_ControlledEquityOfferingSalesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ReverseMergerAndFinancingDisclosureTable_690dfbc9-83f2-4ba4-ab81-cd7f6ad9cc94_terseLabel_en-US" xlink:label="lab_ocgn_ReverseMergerAndFinancingDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Merger And Financing Disclosure [Table]</link:label>
    <link:label id="lab_ocgn_ReverseMergerAndFinancingDisclosureTable_label_en-US" xlink:label="lab_ocgn_ReverseMergerAndFinancingDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Merger And Financing Disclosure [Table]</link:label>
    <link:label id="lab_ocgn_ReverseMergerAndFinancingDisclosureTable_documentation_en-US" xlink:label="lab_ocgn_ReverseMergerAndFinancingDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of information about reverse merger and financing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ReverseMergerAndFinancingDisclosureTable" xlink:href="ocgn-20200930.xsd#ocgn_ReverseMergerAndFinancingDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureTable" xlink:to="lab_ocgn_ReverseMergerAndFinancingDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_934e902a-586a-4f22-96ed-922991874f3d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_c85ffffd-d40a-4df6-be48-8b71ccd1e971_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_655d83b5-e89e-4dbe-84cf-0287c3626ee3_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected severance benefits to be paid</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_ed310377-6ac0-4514-a643-949581180575_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price Volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_8ba4b86a-be29-421a-9f4a-53280fd128cf_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_43d821cc-74e5-4146-a758-980946b50352_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice_4841c043-8cf5-4ba5-b8db-0ee2f932792c_terseLabel_en-US" xlink:label="lab_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price over which trading price of common stock as quoted on the Nasdaq Capital Market was considered for the release of converted additional shares (in USD per share)</link:label>
    <link:label id="lab_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice_label_en-US" xlink:label="lab_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Converted Additional Shares, Threshold Release Trigger Price</link:label>
    <link:label id="lab_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice_documentation_en-US" xlink:label="lab_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The price over which 80% of the arithmetic average of the two lowest dollar volume-weighted average prices of a share of common stock on the NASDAQ Capital Market during the applicable Reset Period immediately preceding the applicable Reset Date to date to release converted additional shares is determined.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice" xlink:href="ocgn-20200930.xsd#ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice" xlink:to="lab_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_c0fc67ac-322a-4cfb-9745-f24807c8c855_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt, net</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_c51fe76c-59b5-4a0e-8fe2-dcfd1f0f07a8_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_33c04f5e-acfa-4915-9b11-30164019e7b2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_2da81c0c-383b-458d-a1c6-052a0ef5c792_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0571ad95-986e-422b-bca8-d6016c49e12c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered_9334ad6e-9378-4512-867b-63a1cf41111c_terseLabel_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, exercise price determination, number of trading days</link:label>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered_label_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercise Price Determination, Number Of Trading Days Considered</link:label>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered_documentation_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of trading days considered for determination of exercise price of warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered" xlink:to="lab_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_f44eb7bf-e553-42c5-8881-8baec8319420_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_60b3eaf2-93d0-42d5-a082-5621b5e01ac7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_b178684b-84ef-49a9-8d07-4c782c85e688_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_07dfbf0b-409f-428a-a80b-56c94004c664_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_35c3ff28-5858-4ccf-84bb-46f130e74e50_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_787683b1-0807-4fd5-bff0-5c1f9792c9c0_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_ca2cceb2-86e9-4420-b1b5-a135c192512f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5af876dd-108a-4a64-b29b-eff2d97c7877_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_50076482-e0f4-4988-82bc-c6e0db6a3d1c_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_769a6252-a0ea-4373-9f4c-58aecf53eb7a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of equity issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_51af313f-1422-41f1-93ff-b716eff6600a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of employees given notice of termination</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_3105861d-2de9-4e71-9977-e4211eb98020_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_1d3f94f9-e16d-431a-b8ae-547db2fec246_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_70582757-3815-484c-82f6-b0b4741ce328_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_fbd47273-5e8d-4d89-88db-af454f5de451_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_94cf5b0d-0b97-47cd-8ac9-4e852bf20bc4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_fa0df410-eadc-471f-9887-f0e32e1577c2_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_080ebca1-8dbf-425a-b77d-bdfb594f132b_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6f01e324-d33e-4bf7-992b-4fcf18a0ed34_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive securities outstanding excluded from the computation of diluted weighted average shares outstanding</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_725788c9-1dfd-446d-82ea-479162cceeed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_SeriesBWarrantsMember_d3757660-f4f5-49d6-8af7-c3e23285d95b_terseLabel_en-US" xlink:label="lab_ocgn_SeriesBWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Warrants</link:label>
    <link:label id="lab_ocgn_SeriesBWarrantsMember_label_en-US" xlink:label="lab_ocgn_SeriesBWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Warrants [Member]</link:label>
    <link:label id="lab_ocgn_SeriesBWarrantsMember_documentation_en-US" xlink:label="lab_ocgn_SeriesBWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for Series B Warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesBWarrantsMember" xlink:href="ocgn-20200930.xsd#ocgn_SeriesBWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_SeriesBWarrantsMember" xlink:to="lab_ocgn_SeriesBWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_4a31bafd-d749-4725-8c0e-0c48fefa1f1b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_90ae6a1d-261c-4d0f-b154-b5fc6f2dae22_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:to="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock_234f32ef-703e-49ad-8d36-b321e65529dc_terseLabel_en-US" xlink:label="lab_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accredited investors agreement to cancel additional portion owed representing a discount</link:label>
    <link:label id="lab_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock_label_en-US" xlink:label="lab_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Additional Debt Cancelled In Exchange For Stock</link:label>
    <link:label id="lab_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock_documentation_en-US" xlink:label="lab_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Additional Debt Cancelled In Exchange For Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock" xlink:href="ocgn-20200930.xsd#ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock" xlink:to="lab_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_65b9af2c-7062-497f-842f-30b8d56b5bf3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_e0d8e38c-8f2e-4378-aac1-c0d1d4388f53_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_LineOfCreditBorrowingEachDraw_82613d98-88db-42d8-b915-78d9f64045a7_terseLabel_en-US" xlink:label="lab_ocgn_LineOfCreditBorrowingEachDraw" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing increments</link:label>
    <link:label id="lab_ocgn_LineOfCreditBorrowingEachDraw_label_en-US" xlink:label="lab_ocgn_LineOfCreditBorrowingEachDraw" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Borrowing Each Draw</link:label>
    <link:label id="lab_ocgn_LineOfCreditBorrowingEachDraw_documentation_en-US" xlink:label="lab_ocgn_LineOfCreditBorrowingEachDraw" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of borrowing that can be borrowed each draw from a line of credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_LineOfCreditBorrowingEachDraw" xlink:href="ocgn-20200930.xsd#ocgn_LineOfCreditBorrowingEachDraw"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_LineOfCreditBorrowingEachDraw" xlink:to="lab_ocgn_LineOfCreditBorrowingEachDraw" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b77634a5-5cc9-4e70-aaa9-3b38f3ebc8e7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock_abbf116d-0a81-4a3a-81c3-ee431f9607a1_terseLabel_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred, common stock</link:label>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock_label_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants, Common Stock</link:label>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock_documentation_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock" xlink:to="lab_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_10691586-6f10-43bc-a318-cf5791a1c285_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and rights outstanding, term</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_d6db2754-a9c4-4b45-bf0a-183f6523c3d4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9c4a0d6d-e810-4887-ac5f-0a01515367a4_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_ba5b5df2-7001-4879-9a4d-67e530952031_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_5df2edf1-6880-4d2f-874a-ee7d5881d0dd_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_f4c79d40-8852-4c2b-9f96-51f4db6637f0_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss&#8212;basic and diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4f533032-53bf-4cec-b59c-f22163c97fdd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a556ed18-d149-43bb-a24b-b0b1c497e147_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_5bfbac2a-6496-42dd-9e16-3faf3e5cd19f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_e8844a11-bd3f-4891-8bb1-98f26358b297_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2020</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_a5c1667e-9b30-416b-b724-8ee89956b4f6_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_b718f895-33a9-4e23-adc0-77be8528f925_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_7ee0ee26-c4aa-4703-baae-99b49eced53b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_df568435-9016-479c-91f4-6d38a41cc195_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtAmount1_60fc1573-8e18-4de9-a1ad-4d035c914d73_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible notes</link:label>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Original Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_d5450ce9-7384-4061-b50d-6fc2da775286_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance-related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_bcc3900a-3cdb-4e55-b2a1-237a35f4e29c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance-related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_bd6c8bda-f5c1-48c6-919d-ec6eb7c58fe7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_2bd69b41-1863-46a4-bfe8-0ddbd11a93cb_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightExercisable_464122b6-7f0b-4643-8a41-e818951ba0e2_terseLabel_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightExercisable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of warrant or right, exercisable (in shares)</link:label>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightExercisable_label_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightExercisable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercisable</link:label>
    <link:label id="lab_ocgn_ClassOfWarrantOrRightExercisable_documentation_en-US" xlink:label="lab_ocgn_ClassOfWarrantOrRightExercisable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightExercisable" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightExercisable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ClassOfWarrantOrRightExercisable" xlink:to="lab_ocgn_ClassOfWarrantOrRightExercisable" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_A2019PlanMember_5814c418-06e4-4a19-9b50-23ad7ea6b82f_terseLabel_en-US" xlink:label="lab_ocgn_A2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Plan</link:label>
    <link:label id="lab_ocgn_A2019PlanMember_label_en-US" xlink:label="lab_ocgn_A2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Plan [Member]</link:label>
    <link:label id="lab_ocgn_A2019PlanMember_documentation_en-US" xlink:label="lab_ocgn_A2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_A2019PlanMember" xlink:href="ocgn-20200930.xsd#ocgn_A2019PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_A2019PlanMember" xlink:to="lab_ocgn_A2019PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_FormerOcugenWarrantsMember_209d12b5-dfd3-40df-b6fb-d2a0b9e35d52_terseLabel_en-US" xlink:label="lab_ocgn_FormerOcugenWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Ocugen Warrants</link:label>
    <link:label id="lab_ocgn_FormerOcugenWarrantsMember_label_en-US" xlink:label="lab_ocgn_FormerOcugenWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Ocugen Warrants [Member]</link:label>
    <link:label id="lab_ocgn_FormerOcugenWarrantsMember_documentation_en-US" xlink:label="lab_ocgn_FormerOcugenWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Ocugen Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_FormerOcugenWarrantsMember" xlink:href="ocgn-20200930.xsd#ocgn_FormerOcugenWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_FormerOcugenWarrantsMember" xlink:to="lab_ocgn_FormerOcugenWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_f1a78bb2-5543-4d2e-ac5f-2b10aa3af732_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7735ed3a-d0a7-40d3-a3eb-66293f765236_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common shares in to which the warrants are exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_948cfe17-6c79-412b-8b6a-e4e213310975_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1bbcd49d-3dd3-491c-9d04-02cfc2063dfa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b7bee88b-b308-4612-9eb4-f2e825230f9f_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebt_341bc133-4564-4f74-b53b-c84a62de2224_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note principal outstanding</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebt" xlink:to="lab_us-gaap_ConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_e8a13624-e524-4201-bdd9-eeb8eba56051_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction_b57eca98-51ae-4689-ab38-9b5f2b830038_terseLabel_en-US" xlink:label="lab_ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse asset acquisition costs</link:label>
    <link:label id="lab_ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction_label_en-US" xlink:label="lab_ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Equity Issuance Cost Incurred During Noncash Or Partial Noncash Transaction</link:label>
    <link:label id="lab_ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction_documentation_en-US" xlink:label="lab_ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of deferred equity issuance cost that were incurred during a noncash or partial noncash transaction.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction" xlink:href="ocgn-20200930.xsd#ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="lab_ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b3827439-3459-434f-8099-28491272fdb4_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement_52f14478-f92e-422d-bbea-d54d1511338f_terseLabel_en-US" xlink:label="lab_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares agreed to be sold</link:label>
    <link:label id="lab_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement_label_en-US" xlink:label="lab_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Agreed To Be Sold, Stock Subscription Agreement</link:label>
    <link:label id="lab_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement_documentation_en-US" xlink:label="lab_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Agreed To Be Sold, Stock Subscription Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement" xlink:href="ocgn-20200930.xsd#ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement" xlink:to="lab_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_510a5218-548f-4097-adad-28c81f14f449_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_3b9befdd-e59c-46fe-bdac-9852414d0a71_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset held for sale less cost to sell</link:label>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-for-sale, Not Part of Disposal Group, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:to="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_874dd36f-ff97-4138-b6c7-a413afbf0926_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_97b0502a-a0d9-4975-b4d0-22618bbc21e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock-based Compensation Expense for Options Granted Reflected in the Consolidate Statement of Operations and Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_a4b25921-e3e8-4c57-8cc5-cdda003b2c42_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common&#160;Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_January2019AndFebruary2019NotesMember_b44e987b-1d8c-411c-9e90-370b16285f4b_terseLabel_en-US" xlink:label="lab_ocgn_January2019AndFebruary2019NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January&#160;2019 and February&#160;2019 Notes</link:label>
    <link:label id="lab_ocgn_January2019AndFebruary2019NotesMember_label_en-US" xlink:label="lab_ocgn_January2019AndFebruary2019NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January&#160;2019 And February&#160;2019 Notes [Member]</link:label>
    <link:label id="lab_ocgn_January2019AndFebruary2019NotesMember_documentation_en-US" xlink:label="lab_ocgn_January2019AndFebruary2019NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January&#160;2019 And February&#160;2019 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_January2019AndFebruary2019NotesMember" xlink:href="ocgn-20200930.xsd#ocgn_January2019AndFebruary2019NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_January2019AndFebruary2019NotesMember" xlink:to="lab_ocgn_January2019AndFebruary2019NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_807fa2d7-964e-429b-ad06-6c68ff3a16aa_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a3ed8da8-45ad-4c06-8a8b-66cc5e3568bf_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity transactions (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_SeriesCWarrantsMember_fc7ce2b3-67c5-4446-bc43-6eb406ac48da_terseLabel_en-US" xlink:label="lab_ocgn_SeriesCWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Warrants</link:label>
    <link:label id="lab_ocgn_SeriesCWarrantsMember_label_en-US" xlink:label="lab_ocgn_SeriesCWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Warrants [Member]</link:label>
    <link:label id="lab_ocgn_SeriesCWarrantsMember_documentation_en-US" xlink:label="lab_ocgn_SeriesCWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for Series C Warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesCWarrantsMember" xlink:href="ocgn-20200930.xsd#ocgn_SeriesCWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_SeriesCWarrantsMember" xlink:to="lab_ocgn_SeriesCWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementAccountingPolicy_1c0aa6a5-a3fe-4e48-bb10-8e19bedea980_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementAccountingPolicy_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Accounting Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:to="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_8a212a6f-1039-489a-9d7d-89ab268c30cf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_IncreaseDecreaseInLeaseObligations_bddc59de-b685-4f67-a809-3485ca45d3c1_terseLabel_en-US" xlink:label="lab_ocgn_IncreaseDecreaseInLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease obligations</link:label>
    <link:label id="lab_ocgn_IncreaseDecreaseInLeaseObligations_label_en-US" xlink:label="lab_ocgn_IncreaseDecreaseInLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Lease Obligations</link:label>
    <link:label id="lab_ocgn_IncreaseDecreaseInLeaseObligations_documentation_en-US" xlink:label="lab_ocgn_IncreaseDecreaseInLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_IncreaseDecreaseInLeaseObligations" xlink:href="ocgn-20200930.xsd#ocgn_IncreaseDecreaseInLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_IncreaseDecreaseInLeaseObligations" xlink:to="lab_ocgn_IncreaseDecreaseInLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_d4df2bf6-5878-4ac7-9a68-2938ef263b21_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of debt (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_EB5ProgramBorrowingsMember_9240acb5-d476-408b-a45d-a449d6bd1d78_terseLabel_en-US" xlink:label="lab_ocgn_EB5ProgramBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EB-5 Loan</link:label>
    <link:label id="lab_ocgn_EB5ProgramBorrowingsMember_3cf0ec88-c4c0-4055-bca2-dd098943de3c_verboseLabel_en-US" xlink:label="lab_ocgn_EB5ProgramBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EB-5 Loan Agreement borrowings</link:label>
    <link:label id="lab_ocgn_EB5ProgramBorrowingsMember_label_en-US" xlink:label="lab_ocgn_EB5ProgramBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E B5 Program Borrowings [Member]</link:label>
    <link:label id="lab_ocgn_EB5ProgramBorrowingsMember_documentation_en-US" xlink:label="lab_ocgn_EB5ProgramBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents borrowings from the U.S. government's Immigrant Investor Program, commonly known as the EB 5 program (the "EB 5 Program").</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_EB5ProgramBorrowingsMember" xlink:href="ocgn-20200930.xsd#ocgn_EB5ProgramBorrowingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_EB5ProgramBorrowingsMember" xlink:to="lab_ocgn_EB5ProgramBorrowingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6133a328-abba-44a7-9f01-d4788dcce086_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_43c0a673-2258-4b00-9e06-0739519d2b28_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_7a1a9129-ba0e-400b-86e1-ec4579e48a1c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of maturities of operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_f751bdad-29d9-4647-9670-946415e9feb2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment arrangement, option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7430c7d3-0b04-413a-a33f-c66e12ac2f4c_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Consolidation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_845ad1f9-61be-440d-bcd3-51a3be72d5ee_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligation settled with common stock</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_PreMergerFinancingMember_7567fe9d-9e6a-45c6-96ea-c01236271a8c_terseLabel_en-US" xlink:label="lab_ocgn_PreMergerFinancingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Merger Financing</link:label>
    <link:label id="lab_ocgn_PreMergerFinancingMember_label_en-US" xlink:label="lab_ocgn_PreMergerFinancingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Merger Financing [Member]</link:label>
    <link:label id="lab_ocgn_PreMergerFinancingMember_documentation_en-US" xlink:label="lab_ocgn_PreMergerFinancingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Merger Financing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_PreMergerFinancingMember" xlink:href="ocgn-20200930.xsd#ocgn_PreMergerFinancingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_PreMergerFinancingMember" xlink:to="lab_ocgn_PreMergerFinancingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_5c1628e1-da4a-4f51-b433-362ccff85c99_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_189feb1c-3a37-4092-9769-3e7103649310_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_bda2c2e4-060f-4c6d-932e-c0060c458d7e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_5e7840fb-65a2-43e2-893b-0db0906a509f_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_442ecc34-23be-4e7f-bd79-4ccd4d526a54_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance-related charges</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_AdvaiteIncMember_853168e4-bebd-48ee-aaf1-866231b28648_terseLabel_en-US" xlink:label="lab_ocgn_AdvaiteIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advaite</link:label>
    <link:label id="lab_ocgn_AdvaiteIncMember_label_en-US" xlink:label="lab_ocgn_AdvaiteIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advaite, Inc. [Member]</link:label>
    <link:label id="lab_ocgn_AdvaiteIncMember_documentation_en-US" xlink:label="lab_ocgn_AdvaiteIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advaite, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AdvaiteIncMember" xlink:href="ocgn-20200930.xsd#ocgn_AdvaiteIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_AdvaiteIncMember" xlink:to="lab_ocgn_AdvaiteIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_aa59ed80-56b8-49b4-8490-316a51e7dfbf_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_c8b15b09-3a4f-44eb-8d2c-bf2a074ad429_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions_567676b3-b478-49c5-a7c7-49b8013074e9_terseLabel_en-US" xlink:label="lab_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of renewal options</link:label>
    <link:label id="lab_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions_label_en-US" xlink:label="lab_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:label id="lab_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions_documentation_en-US" xlink:label="lab_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:href="ocgn-20200930.xsd#ocgn_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:to="lab_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_b9b4bc79-ba1c-4ef1-937f-fee80e49c1d8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2020</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_864765f3-2c35-4f49-9eab-667f0c55fe39_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_5d49130a-c401-4f09-8588-9c11783198ea_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_3bd3d771-535f-4a46-a625-6ea6fb6a6070_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ConvertibleDebtDecember2018Member_805ec70e-bf16-402b-ab2b-6805cfe7cf3c_terseLabel_en-US" xlink:label="lab_ocgn_ConvertibleDebtDecember2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2018</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtDecember2018Member_label_en-US" xlink:label="lab_ocgn_ConvertibleDebtDecember2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt December2018 [Member]</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtDecember2018Member_documentation_en-US" xlink:label="lab_ocgn_ConvertibleDebtDecember2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in December 2018.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtDecember2018Member" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtDecember2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ConvertibleDebtDecember2018Member" xlink:to="lab_ocgn_ConvertibleDebtDecember2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3dfd56fc-fc01-405d-ab66-8096c0e6c473_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a9cebd1a-a999-48ee-81f8-3b8e4aeb5897_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b2847772-fd00-49d0-a42b-86e4db3375a2_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_75e11f73-d6aa-4643-b397-9bb11d2e4a02_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_df29c1a2-c4b0-484b-a4ec-529502869e2e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Maturities (Excluding Interest)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_a6793c6e-91d4-4b3e-8421-732ab3964f73_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a5c18350-087e-4723-a248-34a4e069742a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_5e473ae9-7f06-40d4-b377-06052c306afe_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_d14ec37d-105e-48ae-a406-a99811746779_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_df4427af-f9d9-4423-ba00-7d301236e399_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ConvertibleDebtConversionFeatureMember_a7d006f4-ebe8-41f1-9fa7-0f64a5b3afa1_terseLabel_en-US" xlink:label="lab_ocgn_ConvertibleDebtConversionFeatureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Embedded Derivatives</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtConversionFeatureMember_label_en-US" xlink:label="lab_ocgn_ConvertibleDebtConversionFeatureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Conversion Feature [Member]</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtConversionFeatureMember_documentation_en-US" xlink:label="lab_ocgn_ConvertibleDebtConversionFeatureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion feature of the convertible debt that is considered as an embedded derivative of the debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtConversionFeatureMember" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtConversionFeatureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ConvertibleDebtConversionFeatureMember" xlink:to="lab_ocgn_ConvertibleDebtConversionFeatureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_79b3808e-7d95-4a16-b982-dbeb9b07caad_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_60062a2c-a606-47c8-b8ef-351fd195dab7_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit and Disposal Activities</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_bfc67f9f-5805-4341-9c3c-fdbe0608a557_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants fair value estimate volatility (in percentage)</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_a865bd5b-bd4d-405b-9ab4-c83b5226876f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_1b46e81c-48d8-469f-a18b-f0e45ad2441b_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_df59280b-edcd-4e90-a49d-0f26e21cf027_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_457683ae-7c5c-4abb-83f4-89e1af91bbd2_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_9083f953-67ca-4bfb-9787-a687d00d574e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Roll-forward of Series B Warrant Liability</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_540d474e-815d-4324-a606-b07fb88d84a3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ConvertibleDebtJanuary2018Member_2b7b4d8a-0a4a-4417-87a1-de65eefd664c_terseLabel_en-US" xlink:label="lab_ocgn_ConvertibleDebtJanuary2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2018</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtJanuary2018Member_label_en-US" xlink:label="lab_ocgn_ConvertibleDebtJanuary2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt January2018 [Member]</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtJanuary2018Member_documentation_en-US" xlink:label="lab_ocgn_ConvertibleDebtJanuary2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in January 2018.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtJanuary2018Member" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtJanuary2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ConvertibleDebtJanuary2018Member" xlink:to="lab_ocgn_ConvertibleDebtJanuary2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_ee953faf-6ac5-4643-9208-d1afb94aaf1e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_SubscriptionAgreementsMember_2102b61f-df7d-4246-a559-d2c6868363d3_verboseLabel_en-US" xlink:label="lab_ocgn_SubscriptionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription agreements</link:label>
    <link:label id="lab_ocgn_SubscriptionAgreementsMember_7794f066-874c-4ba9-91c6-786f9869d6a3_terseLabel_en-US" xlink:label="lab_ocgn_SubscriptionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription Agreements</link:label>
    <link:label id="lab_ocgn_SubscriptionAgreementsMember_label_en-US" xlink:label="lab_ocgn_SubscriptionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription Agreements [Member]</link:label>
    <link:label id="lab_ocgn_SubscriptionAgreementsMember_documentation_en-US" xlink:label="lab_ocgn_SubscriptionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SubscriptionAgreementsMember" xlink:href="ocgn-20200930.xsd#ocgn_SubscriptionAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_SubscriptionAgreementsMember" xlink:to="lab_ocgn_SubscriptionAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_a23c258d-b872-496b-8444-45336c157cf7_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_02bc5445-0580-485b-90c4-1577679b1fe1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_ab715604-2036-4f19-bc7d-18ea876d6aa0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfOtherDebt_93071b7d-db4e-4ab9-9656-18940555950e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfOtherDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfOtherDebt" xlink:to="lab_us-gaap_RepaymentsOfOtherDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_f68b392d-d53b-4803-aa94-8b92142d36bf_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_d4b69ee5-4355-4ebb-bfab-7fe3b7ea4876_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_f8799b09-853f-42e1-8e05-3379ed213858_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_e2c3a635-862f-4734-8685-82b1adec155c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_5fcf0a90-0b6a-477c-b86b-b0490e0fd993_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of reverse asset acquisition costs</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDiscountRate_f71f8d77-b9ec-4c6e-920d-fbac2c59ac5f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDiscountRate_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:to="lab_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2cff9960-6a69-4d92-9ebd-08f955f4c2af_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_670d234c-fbad-4469-afa1-79980b5fe60d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, weighted average remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e36c52b7-67e6-45c1-849e-a6620f5def10_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_91176f1d-9ead-4563-8d68-881f41fec86b_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of warrants</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e86ef3ac-7608-4cff-9c35-fd13813c4067_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_0c136dfe-1993-4e21-a450-704818384506_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_d5e01a39-5c3b-47bd-844c-4c6ddd3486c6_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_a91e8147-68a9-40a9-a36f-8ae03e30925a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Severance-Related Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4ec1ecc5-c744-417b-bb0d-fb4972b7ab0b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, options exercisable (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesIssued1_90ba9e22-eea8-4f11-823a-c0756865b8d5_verboseLabel_en-US" xlink:label="lab_us-gaap_NotesIssued1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Warrant Exchange Promissory Notes</link:label>
    <link:label id="lab_us-gaap_NotesIssued1_label_en-US" xlink:label="lab_us-gaap_NotesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesIssued1" xlink:to="lab_us-gaap_NotesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ConvertibleDebtJanuary2019Member_58e68ae8-134d-4038-ba91-ebc379837ca9_terseLabel_en-US" xlink:label="lab_ocgn_ConvertibleDebtJanuary2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2019</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtJanuary2019Member_label_en-US" xlink:label="lab_ocgn_ConvertibleDebtJanuary2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt January2019 [Member]</link:label>
    <link:label id="lab_ocgn_ConvertibleDebtJanuary2019Member_documentation_en-US" xlink:label="lab_ocgn_ConvertibleDebtJanuary2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in January 2019.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtJanuary2019Member" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtJanuary2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ConvertibleDebtJanuary2019Member" xlink:to="lab_ocgn_ConvertibleDebtJanuary2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_e6c8366c-9691-4e6f-8654-c7f4b36b6204_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, at cost, 121,500 shares at September&#160;30, 2020 and December&#160;31, 2019</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_ca7096d3-e2a0-4926-805e-dd972ac1283a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share of Common Stock</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c2d77d26-104a-429f-bbc7-8cf58a37efe0_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ocgn_ReverseAssetAcquisitionMember_c136fd47-5353-4650-bd95-1e22dc127ead_terseLabel_en-US" xlink:label="lab_ocgn_ReverseAssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse asset acquisition</link:label>
    <link:label id="lab_ocgn_ReverseAssetAcquisitionMember_label_en-US" xlink:label="lab_ocgn_ReverseAssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Asset Acquisition [Member]</link:label>
    <link:label id="lab_ocgn_ReverseAssetAcquisitionMember_documentation_en-US" xlink:label="lab_ocgn_ReverseAssetAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Asset Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ReverseAssetAcquisitionMember" xlink:href="ocgn-20200930.xsd#ocgn_ReverseAssetAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ocgn_ReverseAssetAcquisitionMember" xlink:to="lab_ocgn_ReverseAssetAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_fd2e5c05-03ce-4155-a231-ed75fabafa3b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_bff17870-87a4-4196-9f24-e637a8a7c2d2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4e7bddea-f046-42a3-91e3-f0964b5d1074_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Standards and Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_bc375394-5d53-4864-ae8d-ff10d325616a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>ocgn-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b98bd97b-267b-467c-adde-600f3c3e2154,g:859d45a4-db6c-4e83-b642-d8014a2143ca-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/Cover" xlink:type="simple" xlink:href="ocgn-20200930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_be57b447-e990-4e67-9f10-fb38eef47a04" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_DocumentType_be57b447-e990-4e67-9f10-fb38eef47a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_8fe9e26b-1dbe-4155-a641-000a5fcb8ba8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_DocumentQuarterlyReport_8fe9e26b-1dbe-4155-a641-000a5fcb8ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_50f69620-d033-4b64-af6c-50744f84ba54" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_DocumentPeriodEndDate_50f69620-d033-4b64-af6c-50744f84ba54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b663f271-dd7a-456c-8c21-3e9124fe57c0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_DocumentTransitionReport_b663f271-dd7a-456c-8c21-3e9124fe57c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5b5991cb-82d8-4de9-aaa1-20d4a8824c5a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityFileNumber_5b5991cb-82d8-4de9-aaa1-20d4a8824c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9df13874-87bc-4153-b8d8-81c9aa887bfe" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityRegistrantName_9df13874-87bc-4153-b8d8-81c9aa887bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e70d8442-4c20-4bf4-a2f4-fd612be4b04a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e70d8442-4c20-4bf4-a2f4-fd612be4b04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6af2444f-3b4b-4c0a-bbca-9d87ee6b90b2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityTaxIdentificationNumber_6af2444f-3b4b-4c0a-bbca-9d87ee6b90b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_67afbfd8-4c9f-409d-a3ad-d3f4375acf16" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityAddressAddressLine1_67afbfd8-4c9f-409d-a3ad-d3f4375acf16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_24634777-1f22-4d1a-8a65-926213de0413" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityAddressAddressLine2_24634777-1f22-4d1a-8a65-926213de0413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_dac98be6-5506-45ac-90dd-356416880e37" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityAddressCityOrTown_dac98be6-5506-45ac-90dd-356416880e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_dd628390-56e4-4ff0-9cbc-affb926f9fb0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityAddressStateOrProvince_dd628390-56e4-4ff0-9cbc-affb926f9fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_94965fbd-b64d-4cb9-8766-2e2d57ca8f9d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityAddressPostalZipCode_94965fbd-b64d-4cb9-8766-2e2d57ca8f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fec9734e-7dac-41d6-b3cb-8b7538a6ef28" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_CityAreaCode_fec9734e-7dac-41d6-b3cb-8b7538a6ef28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_762fc2aa-8e60-4c87-a250-339808545fe7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_LocalPhoneNumber_762fc2aa-8e60-4c87-a250-339808545fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1a7eaec8-ab40-4e65-b3b5-0e7e5bb909cd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_Security12bTitle_1a7eaec8-ab40-4e65-b3b5-0e7e5bb909cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_6d50fdd9-e405-40b0-b1d3-c29679f64bea" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_TradingSymbol_6d50fdd9-e405-40b0-b1d3-c29679f64bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_0e32c88c-e354-4389-b205-4f29cef52f47" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_SecurityExchangeName_0e32c88c-e354-4389-b205-4f29cef52f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_a7e5da4a-34fa-457f-ae45-b73ce3a25548" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityCurrentReportingStatus_a7e5da4a-34fa-457f-ae45-b73ce3a25548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_7916defa-bf8d-4332-bf0c-4f9f70e0bd86" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityInteractiveDataCurrent_7916defa-bf8d-4332-bf0c-4f9f70e0bd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_327f2c01-49ff-44da-bce1-32fee583b8ee" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityFilerCategory_327f2c01-49ff-44da-bce1-32fee583b8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f7b95f1c-f516-4b37-94d1-dee60a833c7e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntitySmallBusiness_f7b95f1c-f516-4b37-94d1-dee60a833c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e8a84585-0393-4c0d-859c-fdb2f13040e4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityEmergingGrowthCompany_e8a84585-0393-4c0d-859c-fdb2f13040e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_091e3072-68ca-4d3c-8ef3-b524638f6787" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityShellCompany_091e3072-68ca-4d3c-8ef3-b524638f6787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_1ee9b43d-03ca-4af5-b343-33e64d2c37cf" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_1ee9b43d-03ca-4af5-b343-33e64d2c37cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e02cc2e6-3256-47d5-8683-2121ef89a308" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_EntityCentralIndexKey_e02cc2e6-3256-47d5-8683-2121ef89a308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_ef2c3f02-7721-41ec-8597-ce8b9fbbe75b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_CurrentFiscalYearEndDate_ef2c3f02-7721-41ec-8597-ce8b9fbbe75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5955e0bd-740f-4513-9538-d33d123ed188" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_DocumentFiscalYearFocus_5955e0bd-740f-4513-9538-d33d123ed188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_ad25e541-2e36-4fff-86c1-c29811dc8c7a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_DocumentFiscalPeriodFocus_ad25e541-2e36-4fff-86c1-c29811dc8c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_72cbfaf9-9c2f-4506-83b2-a5a0e2c81721" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8d743f40-73ff-457c-a9ec-73e1a5aaf07d" xlink:to="loc_dei_AmendmentFlag_72cbfaf9-9c2f-4506-83b2-a5a0e2c81721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_def070a8-23a9-40d0-b82b-4f1f9f71a6a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_02f612ba-326f-4bd1-bf9b-084f20e2c49c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_def070a8-23a9-40d0-b82b-4f1f9f71a6a1" xlink:to="loc_us-gaap_AssetsAbstract_02f612ba-326f-4bd1-bf9b-084f20e2c49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_2930e068-d880-4964-a050-6538fa1c6546" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_02f612ba-326f-4bd1-bf9b-084f20e2c49c" xlink:to="loc_us-gaap_AssetsCurrentAbstract_2930e068-d880-4964-a050-6538fa1c6546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_206b5fa7-da42-45db-ac08-e9f2c1daff1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2930e068-d880-4964-a050-6538fa1c6546" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_206b5fa7-da42-45db-ac08-e9f2c1daff1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fdc37ff6-64fb-45d3-918f-a503e3c7e5fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2930e068-d880-4964-a050-6538fa1c6546" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fdc37ff6-64fb-45d3-918f-a503e3c7e5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_bae056af-caf8-4dc8-8d44-89c6d9662439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2930e068-d880-4964-a050-6538fa1c6546" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_bae056af-caf8-4dc8-8d44-89c6d9662439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7c77817f-4a4e-4c81-8dea-271c384c38ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2930e068-d880-4964-a050-6538fa1c6546" xlink:to="loc_us-gaap_AssetsCurrent_7c77817f-4a4e-4c81-8dea-271c384c38ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_90062e39-d859-485d-aca9-63b8508e06db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_02f612ba-326f-4bd1-bf9b-084f20e2c49c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_90062e39-d859-485d-aca9-63b8508e06db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_5172cedc-496e-4570-825f-04a1642b322e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_02f612ba-326f-4bd1-bf9b-084f20e2c49c" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_5172cedc-496e-4570-825f-04a1642b322e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_683829e1-2769-4a1b-bcbb-c27778d5c429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_02f612ba-326f-4bd1-bf9b-084f20e2c49c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_683829e1-2769-4a1b-bcbb-c27778d5c429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0b1e34ea-f48a-47a5-a72d-c0bae4b42027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_02f612ba-326f-4bd1-bf9b-084f20e2c49c" xlink:to="loc_us-gaap_Assets_0b1e34ea-f48a-47a5-a72d-c0bae4b42027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_46fc860d-54ac-4274-9a8b-b235f63fe9d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_def070a8-23a9-40d0-b82b-4f1f9f71a6a1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_46fc860d-54ac-4274-9a8b-b235f63fe9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3aa6aa6e-1509-4845-b6dc-f140c87dc249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_46fc860d-54ac-4274-9a8b-b235f63fe9d9" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3aa6aa6e-1509-4845-b6dc-f140c87dc249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6af1b494-62a3-4275-aea2-6d5c6b28f328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3aa6aa6e-1509-4845-b6dc-f140c87dc249" xlink:to="loc_us-gaap_AccountsPayableCurrent_6af1b494-62a3-4275-aea2-6d5c6b28f328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_06eb3b78-7099-42ae-b3e7-935ecbce5171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3aa6aa6e-1509-4845-b6dc-f140c87dc249" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_06eb3b78-7099-42ae-b3e7-935ecbce5171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_646dbe71-25dd-4d13-9e70-fc3a17b94602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3aa6aa6e-1509-4845-b6dc-f140c87dc249" xlink:to="loc_us-gaap_ShortTermBorrowings_646dbe71-25dd-4d13-9e70-fc3a17b94602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9b67530e-d734-4ab3-aa35-176148eff052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3aa6aa6e-1509-4845-b6dc-f140c87dc249" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9b67530e-d734-4ab3-aa35-176148eff052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e97f4da8-4fea-4cd7-8556-f5a6d7467764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3aa6aa6e-1509-4845-b6dc-f140c87dc249" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e97f4da8-4fea-4cd7-8556-f5a6d7467764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_272c9851-4e10-4a40-a2d8-725c1357c4e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3aa6aa6e-1509-4845-b6dc-f140c87dc249" xlink:to="loc_us-gaap_LiabilitiesCurrent_272c9851-4e10-4a40-a2d8-725c1357c4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_37221858-3858-4112-b41f-962a813f6853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_46fc860d-54ac-4274-9a8b-b235f63fe9d9" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_37221858-3858-4112-b41f-962a813f6853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3f907b10-0de4-49da-b57e-f4811337b553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_37221858-3858-4112-b41f-962a813f6853" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3f907b10-0de4-49da-b57e-f4811337b553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_1bfc7dfa-e589-4aea-952f-44c47eeb1779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_37221858-3858-4112-b41f-962a813f6853" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_1bfc7dfa-e589-4aea-952f-44c47eeb1779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c32d2e41-803a-4049-8d65-a39db27bf3b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_37221858-3858-4112-b41f-962a813f6853" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c32d2e41-803a-4049-8d65-a39db27bf3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_c4eb0c71-9080-4c1b-a9c2-fa3542cfede3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_37221858-3858-4112-b41f-962a813f6853" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_c4eb0c71-9080-4c1b-a9c2-fa3542cfede3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2dab5d05-a010-449e-ac7d-934db5033232" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_46fc860d-54ac-4274-9a8b-b235f63fe9d9" xlink:to="loc_us-gaap_Liabilities_2dab5d05-a010-449e-ac7d-934db5033232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_5594576b-e255-460f-95c8-a65ff6da33f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_46fc860d-54ac-4274-9a8b-b235f63fe9d9" xlink:to="loc_us-gaap_CommitmentsAndContingencies_5594576b-e255-460f-95c8-a65ff6da33f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_22fca5c1-37b7-409f-b79b-4d8d436b14c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_46fc860d-54ac-4274-9a8b-b235f63fe9d9" xlink:to="loc_us-gaap_StockholdersEquityAbstract_22fca5c1-37b7-409f-b79b-4d8d436b14c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a1fef21c-0613-4a0f-8a9c-845d3b351822" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22fca5c1-37b7-409f-b79b-4d8d436b14c8" xlink:to="loc_us-gaap_PreferredStockValue_a1fef21c-0613-4a0f-8a9c-845d3b351822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3fa6266a-5044-4dcb-b6d8-38251d203a59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22fca5c1-37b7-409f-b79b-4d8d436b14c8" xlink:to="loc_us-gaap_CommonStockValue_3fa6266a-5044-4dcb-b6d8-38251d203a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_0fbce216-4a05-413d-a604-47b8d4913e4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22fca5c1-37b7-409f-b79b-4d8d436b14c8" xlink:to="loc_us-gaap_TreasuryStockValue_0fbce216-4a05-413d-a604-47b8d4913e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_612c82c5-1744-479c-97a7-bd7ca05bfec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22fca5c1-37b7-409f-b79b-4d8d436b14c8" xlink:to="loc_us-gaap_AdditionalPaidInCapital_612c82c5-1744-479c-97a7-bd7ca05bfec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7d69cfc5-59d1-4f87-91be-75cd86f997fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22fca5c1-37b7-409f-b79b-4d8d436b14c8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7d69cfc5-59d1-4f87-91be-75cd86f997fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4f7936cf-979f-43db-ac5f-abddd59e58f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22fca5c1-37b7-409f-b79b-4d8d436b14c8" xlink:to="loc_us-gaap_StockholdersEquity_4f7936cf-979f-43db-ac5f-abddd59e58f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_90c80c82-3c4f-407d-b07e-644f3e3fdf2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_46fc860d-54ac-4274-9a8b-b235f63fe9d9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_90c80c82-3c4f-407d-b07e-644f3e3fdf2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1ed972b5-830e-4f51-84bc-5a1d8c090637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_737953bc-fe7a-4abd-bb37-23f1613965db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1ed972b5-830e-4f51-84bc-5a1d8c090637" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_737953bc-fe7a-4abd-bb37-23f1613965db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_0e74adcd-8171-4a4f-906a-9e470bb78086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1ed972b5-830e-4f51-84bc-5a1d8c090637" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_0e74adcd-8171-4a4f-906a-9e470bb78086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_79901a58-308f-447a-9579-ef597d2c3982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1ed972b5-830e-4f51-84bc-5a1d8c090637" xlink:to="loc_us-gaap_PreferredStockSharesIssued_79901a58-308f-447a-9579-ef597d2c3982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_ea45a518-4007-440f-8357-3fc923d7796e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1ed972b5-830e-4f51-84bc-5a1d8c090637" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_ea45a518-4007-440f-8357-3fc923d7796e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3bf8ed17-360d-41e9-a395-eddf300c4422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1ed972b5-830e-4f51-84bc-5a1d8c090637" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3bf8ed17-360d-41e9-a395-eddf300c4422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_413e4476-0d30-40a5-8401-09f38e81e354" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1ed972b5-830e-4f51-84bc-5a1d8c090637" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_413e4476-0d30-40a5-8401-09f38e81e354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_dbc13866-b803-414c-bb1c-ef08198b008c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1ed972b5-830e-4f51-84bc-5a1d8c090637" xlink:to="loc_us-gaap_CommonStockSharesIssued_dbc13866-b803-414c-bb1c-ef08198b008c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6a569861-0b94-49ad-8bd9-2f90aac59817" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1ed972b5-830e-4f51-84bc-5a1d8c090637" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6a569861-0b94-49ad-8bd9-2f90aac59817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_a5934627-3875-4afe-aba3-4b604505ff07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1ed972b5-830e-4f51-84bc-5a1d8c090637" xlink:to="loc_us-gaap_TreasuryStockCommonShares_a5934627-3875-4afe-aba3-4b604505ff07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0467e2c2-2d95-47eb-b3f9-ea1e529d9a6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_93698a6d-2ae4-4286-ada6-f90a48fb4de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0467e2c2-2d95-47eb-b3f9-ea1e529d9a6c" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_93698a6d-2ae4-4286-ada6-f90a48fb4de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3697dbfd-408e-41fe-b2c7-ae89033d3f6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0467e2c2-2d95-47eb-b3f9-ea1e529d9a6c" xlink:to="loc_us-gaap_Revenues_3697dbfd-408e-41fe-b2c7-ae89033d3f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_183e9511-e944-4251-85e9-039b865aa870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0467e2c2-2d95-47eb-b3f9-ea1e529d9a6c" xlink:to="loc_us-gaap_OperatingExpensesAbstract_183e9511-e944-4251-85e9-039b865aa870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_b0941bd0-c65b-40a3-8227-5dca550e28da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_183e9511-e944-4251-85e9-039b865aa870" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_b0941bd0-c65b-40a3-8227-5dca550e28da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_0867c22d-8f81-4b67-903f-c95c78e5ad56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_183e9511-e944-4251-85e9-039b865aa870" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_0867c22d-8f81-4b67-903f-c95c78e5ad56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_8aeb4ebf-1519-4455-9cde-d5835a6a4815" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_183e9511-e944-4251-85e9-039b865aa870" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_8aeb4ebf-1519-4455-9cde-d5835a6a4815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6f84ff31-ec51-4d03-945d-b8f459d8f514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_183e9511-e944-4251-85e9-039b865aa870" xlink:to="loc_us-gaap_OperatingExpenses_6f84ff31-ec51-4d03-945d-b8f459d8f514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_eed8c845-e246-492b-a4f7-6e5efd9e120b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0467e2c2-2d95-47eb-b3f9-ea1e529d9a6c" xlink:to="loc_us-gaap_OperatingIncomeLoss_eed8c845-e246-492b-a4f7-6e5efd9e120b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ff84a397-97aa-4080-ac2d-5dfa3699aa23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0467e2c2-2d95-47eb-b3f9-ea1e529d9a6c" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ff84a397-97aa-4080-ac2d-5dfa3699aa23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_7a600bf1-cce2-4b92-bb5a-79448d25b09c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ff84a397-97aa-4080-ac2d-5dfa3699aa23" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_7a600bf1-cce2-4b92-bb5a-79448d25b09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_GainsLossesOnConversionOfDebt_1e96c60f-1c9f-4547-8399-2b42dec44cbf" xlink:href="ocgn-20200930.xsd#ocgn_GainsLossesOnConversionOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ff84a397-97aa-4080-ac2d-5dfa3699aa23" xlink:to="loc_ocgn_GainsLossesOnConversionOfDebt_1e96c60f-1c9f-4547-8399-2b42dec44cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c429e425-a050-43cd-a313-9d027803cbaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ff84a397-97aa-4080-ac2d-5dfa3699aa23" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c429e425-a050-43cd-a313-9d027803cbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a1eadebf-66a2-4b71-a4d8-f7b2a791a087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ff84a397-97aa-4080-ac2d-5dfa3699aa23" xlink:to="loc_us-gaap_InterestExpense_a1eadebf-66a2-4b71-a4d8-f7b2a791a087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_738132ca-01d7-4c79-be1b-254453440eae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ff84a397-97aa-4080-ac2d-5dfa3699aa23" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_738132ca-01d7-4c79-be1b-254453440eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1331477b-c128-496d-9a16-03cbf37772fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ff84a397-97aa-4080-ac2d-5dfa3699aa23" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1331477b-c128-496d-9a16-03cbf37772fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b014ff0b-6609-47b7-8c7b-68525d65826f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0467e2c2-2d95-47eb-b3f9-ea1e529d9a6c" xlink:to="loc_us-gaap_NetIncomeLoss_b014ff0b-6609-47b7-8c7b-68525d65826f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_a620eb84-62cb-49bc-9459-f422c15a3fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0467e2c2-2d95-47eb-b3f9-ea1e529d9a6c" xlink:to="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_a620eb84-62cb-49bc-9459-f422c15a3fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0fa45ccd-7160-4ae7-b242-bc78baef311e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0467e2c2-2d95-47eb-b3f9-ea1e529d9a6c" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0fa45ccd-7160-4ae7-b242-bc78baef311e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_53d07bbb-be6b-48cf-9b74-988a8cca5208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0467e2c2-2d95-47eb-b3f9-ea1e529d9a6c" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_53d07bbb-be6b-48cf-9b74-988a8cca5208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_26fd5f44-fec4-48b2-bfb0-5f3acfe2a3df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0467e2c2-2d95-47eb-b3f9-ea1e529d9a6c" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_26fd5f44-fec4-48b2-bfb0-5f3acfe2a3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_820afeb9-e0d5-4748-86fd-592602e077fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0467e2c2-2d95-47eb-b3f9-ea1e529d9a6c" xlink:to="loc_us-gaap_NetIncomeLoss_820afeb9-e0d5-4748-86fd-592602e077fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_b3a3a380-87aa-489f-a279-35b6742c332b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0467e2c2-2d95-47eb-b3f9-ea1e529d9a6c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_b3a3a380-87aa-489f-a279-35b6742c332b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f7acaaf5-4a78-4346-9765-6df6134c8430" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_b3a3a380-87aa-489f-a279-35b6742c332b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f7acaaf5-4a78-4346-9765-6df6134c8430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8e4f17cf-7ee0-4bcb-8269-b00f1892961d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0467e2c2-2d95-47eb-b3f9-ea1e529d9a6c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_8e4f17cf-7ee0-4bcb-8269-b00f1892961d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_291937f8-7638-45ac-9713-413ae5f120cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5bc34b38-bd43-4c07-9d6a-78017f3c301a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_291937f8-7638-45ac-9713-413ae5f120cc" xlink:to="loc_us-gaap_StatementTable_5bc34b38-bd43-4c07-9d6a-78017f3c301a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_99e4887f-7f3d-4170-b205-446d61cd996a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5bc34b38-bd43-4c07-9d6a-78017f3c301a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_99e4887f-7f3d-4170-b205-446d61cd996a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_47f5b879-ef75-4dae-a079-db8f54236b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_99e4887f-7f3d-4170-b205-446d61cd996a" xlink:to="loc_us-gaap_EquityComponentDomain_47f5b879-ef75-4dae-a079-db8f54236b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7291f3dc-13a5-4616-bcf9-5b8696392b1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_47f5b879-ef75-4dae-a079-db8f54236b56" xlink:to="loc_us-gaap_CommonStockMember_7291f3dc-13a5-4616-bcf9-5b8696392b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_2c6600dd-e216-439e-a631-9a0ff9c7cfac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_47f5b879-ef75-4dae-a079-db8f54236b56" xlink:to="loc_us-gaap_TreasuryStockMember_2c6600dd-e216-439e-a631-9a0ff9c7cfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_86a03cce-670f-444c-9c2f-6d1281ca2573" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_47f5b879-ef75-4dae-a079-db8f54236b56" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_86a03cce-670f-444c-9c2f-6d1281ca2573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_84ef1aa3-d168-4310-8a46-0e5ffbfe3180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_47f5b879-ef75-4dae-a079-db8f54236b56" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_84ef1aa3-d168-4310-8a46-0e5ffbfe3180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_ad7144dd-e455-4da3-afe4-0796cdac8f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_47f5b879-ef75-4dae-a079-db8f54236b56" xlink:to="loc_us-gaap_RetainedEarningsMember_ad7144dd-e455-4da3-afe4-0796cdac8f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f52703a3-deba-4fc4-84d7-5c793e16326c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5bc34b38-bd43-4c07-9d6a-78017f3c301a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f52703a3-deba-4fc4-84d7-5c793e16326c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a448329-8c02-4c45-9b06-230c48bfe71b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f52703a3-deba-4fc4-84d7-5c793e16326c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a448329-8c02-4c45-9b06-230c48bfe71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SubscriptionAgreementsMember_b7638c62-d663-4987-96e0-4248ebcec8a4" xlink:href="ocgn-20200930.xsd#ocgn_SubscriptionAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a448329-8c02-4c45-9b06-230c48bfe71b" xlink:to="loc_ocgn_SubscriptionAgreementsMember_b7638c62-d663-4987-96e0-4248ebcec8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ATMTransactionsMember_2de99a8b-71ab-4c32-b533-49cde11739b7" xlink:href="ocgn-20200930.xsd#ocgn_ATMTransactionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a448329-8c02-4c45-9b06-230c48bfe71b" xlink:to="loc_ocgn_ATMTransactionsMember_2de99a8b-71ab-4c32-b533-49cde11739b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ReverseAssetAcquisitionMember_847d9a55-91da-4c16-8a88-fb8f0391980e" xlink:href="ocgn-20200930.xsd#ocgn_ReverseAssetAcquisitionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a448329-8c02-4c45-9b06-230c48bfe71b" xlink:to="loc_ocgn_ReverseAssetAcquisitionMember_847d9a55-91da-4c16-8a88-fb8f0391980e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_PreMergerFinancingMember_07602386-e38d-4e92-be13-1422a3667ef0" xlink:href="ocgn-20200930.xsd#ocgn_PreMergerFinancingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8a448329-8c02-4c45-9b06-230c48bfe71b" xlink:to="loc_ocgn_PreMergerFinancingMember_07602386-e38d-4e92-be13-1422a3667ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ee75b2d0-0758-481d-b514-55bc23c1c7c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5bc34b38-bd43-4c07-9d6a-78017f3c301a" xlink:to="loc_us-gaap_StatementLineItems_ee75b2d0-0758-481d-b514-55bc23c1c7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ee75b2d0-0758-481d-b514-55bc23c1c7c0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_d71dc113-7f3e-4393-a753-a8b054e4efef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_SharesOutstanding_d71dc113-7f3e-4393-a753-a8b054e4efef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_51be35de-8465-4337-98f6-96606f9a5748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_StockholdersEquity_51be35de-8465-4337-98f6-96606f9a5748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_44254335-c0d2-402d-8a85-8672ba46bda4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_44254335-c0d2-402d-8a85-8672ba46bda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c9536acc-b04f-4669-931f-0b144d687009" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c9536acc-b04f-4669-931f-0b144d687009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_969d97d0-6bc3-4922-97c2-a46d06567b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_969d97d0-6bc3-4922-97c2-a46d06567b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c4be5dd1-8608-46ca-a53d-441caecfa0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c4be5dd1-8608-46ca-a53d-441caecfa0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c22ee3ab-9dcb-4da4-bbbb-39fe1a872333" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c22ee3ab-9dcb-4da4-bbbb-39fe1a872333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_5134b090-f100-4cce-bf54-14c3b2c1bd59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_5134b090-f100-4cce-bf54-14c3b2c1bd59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c515a032-b683-4dd1-ba77-e0fc613ca29d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_NetIncomeLoss_c515a032-b683-4dd1-ba77-e0fc613ca29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_c3e38e18-8698-4ea0-90e1-44268d465a17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_SharesOutstanding_c3e38e18-8698-4ea0-90e1-44268d465a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2af418e0-d1b0-4691-ab10-48c4b29d61ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae536b74-0f4f-4269-913b-37a7f219a85b" xlink:to="loc_us-gaap_StockholdersEquity_2af418e0-d1b0-4691-ab10-48c4b29d61ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_cc42092b-d215-4252-adbf-25133935e2d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_90454d2f-bc9b-43fa-ab76-28255a7c9820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_cc42092b-d215-4252-adbf-25133935e2d7" xlink:to="loc_us-gaap_StatementTable_90454d2f-bc9b-43fa-ab76-28255a7c9820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_ecddaf32-b270-4623-be91-d5e74bd97932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_90454d2f-bc9b-43fa-ab76-28255a7c9820" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_ecddaf32-b270-4623-be91-d5e74bd97932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25226e3b-2c9d-4fc9-85fd-e55f75564aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ecddaf32-b270-4623-be91-d5e74bd97932" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25226e3b-2c9d-4fc9-85fd-e55f75564aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ATMTransactionsMember_d76b3c6f-1f30-4199-a402-9740322aaefb" xlink:href="ocgn-20200930.xsd#ocgn_ATMTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25226e3b-2c9d-4fc9-85fd-e55f75564aaf" xlink:to="loc_ocgn_ATMTransactionsMember_d76b3c6f-1f30-4199-a402-9740322aaefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ReverseAssetAcquisitionMember_87d60099-e18c-4d98-8374-2cff10cb9a92" xlink:href="ocgn-20200930.xsd#ocgn_ReverseAssetAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25226e3b-2c9d-4fc9-85fd-e55f75564aaf" xlink:to="loc_ocgn_ReverseAssetAcquisitionMember_87d60099-e18c-4d98-8374-2cff10cb9a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_PreMergerFinancingMember_1e4505e0-822e-44f8-91e3-548d5d78a819" xlink:href="ocgn-20200930.xsd#ocgn_PreMergerFinancingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25226e3b-2c9d-4fc9-85fd-e55f75564aaf" xlink:to="loc_ocgn_PreMergerFinancingMember_1e4505e0-822e-44f8-91e3-548d5d78a819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d4cd4b2d-5cb5-40d6-9b30-f6c8c428daa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_90454d2f-bc9b-43fa-ab76-28255a7c9820" xlink:to="loc_us-gaap_StatementLineItems_d4cd4b2d-5cb5-40d6-9b30-f6c8c428daa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_7b05bfcf-2d56-4abe-be4b-fb34f058a753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4cd4b2d-5cb5-40d6-9b30-f6c8c428daa5" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_7b05bfcf-2d56-4abe-be4b-fb34f058a753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_be306db5-755a-4320-9856-59d35a42246b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ca3be0a8-1b2a-4e5a-b584-c7ebb9bc1fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_be306db5-755a-4320-9856-59d35a42246b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ca3be0a8-1b2a-4e5a-b584-c7ebb9bc1fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_30cf1da2-9336-40d5-9cdc-8e52784a6793" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ca3be0a8-1b2a-4e5a-b584-c7ebb9bc1fae" xlink:to="loc_us-gaap_ProfitLoss_30cf1da2-9336-40d5-9cdc-8e52784a6793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169073ca-92a4-4fb0-bfb7-f202022103ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ca3be0a8-1b2a-4e5a-b584-c7ebb9bc1fae" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169073ca-92a4-4fb0-bfb7-f202022103ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_a4c04589-77c2-45d6-9ae6-a4aefe3ea16c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169073ca-92a4-4fb0-bfb7-f202022103ba" xlink:to="loc_us-gaap_Depreciation_a4c04589-77c2-45d6-9ae6-a4aefe3ea16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NonCashInterestExpense_567e4e16-460d-45b0-a670-23fa681d53c8" xlink:href="ocgn-20200930.xsd#ocgn_NonCashInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169073ca-92a4-4fb0-bfb7-f202022103ba" xlink:to="loc_ocgn_NonCashInterestExpense_567e4e16-460d-45b0-a670-23fa681d53c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NoncashLeaseExpense_64681569-f922-4ffa-a92d-8f03e7a61cfc" xlink:href="ocgn-20200930.xsd#ocgn_NoncashLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169073ca-92a4-4fb0-bfb7-f202022103ba" xlink:to="loc_ocgn_NoncashLeaseExpense_64681569-f922-4ffa-a92d-8f03e7a61cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_ccd5227b-b34a-45cd-bc6a-6ecb50a190ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169073ca-92a4-4fb0-bfb7-f202022103ba" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_ccd5227b-b34a-45cd-bc6a-6ecb50a190ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_c9536279-6958-4938-89fa-6ba7e8c5c384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169073ca-92a4-4fb0-bfb7-f202022103ba" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_c9536279-6958-4938-89fa-6ba7e8c5c384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_12ce46c3-d2d0-4c55-84c6-0d277416cefb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169073ca-92a4-4fb0-bfb7-f202022103ba" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_12ce46c3-d2d0-4c55-84c6-0d277416cefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_GainsLossesOnConversionOfDebt_f4011ccb-383c-46f3-bee2-6405405919b1" xlink:href="ocgn-20200930.xsd#ocgn_GainsLossesOnConversionOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169073ca-92a4-4fb0-bfb7-f202022103ba" xlink:to="loc_ocgn_GainsLossesOnConversionOfDebt_f4011ccb-383c-46f3-bee2-6405405919b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_e74f5965-cc4f-4d08-8549-aa819c6227c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169073ca-92a4-4fb0-bfb7-f202022103ba" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_e74f5965-cc4f-4d08-8549-aa819c6227c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bfe6b8e6-ca07-430e-98f8-6d061c927716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_169073ca-92a4-4fb0-bfb7-f202022103ba" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bfe6b8e6-ca07-430e-98f8-6d061c927716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_bb1b2ffd-ad12-4bff-9fd5-9aa4dea1edc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bfe6b8e6-ca07-430e-98f8-6d061c927716" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_bb1b2ffd-ad12-4bff-9fd5-9aa4dea1edc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_94444fee-87a8-4fd1-bfa6-63b09ceb32ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bfe6b8e6-ca07-430e-98f8-6d061c927716" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_94444fee-87a8-4fd1-bfa6-63b09ceb32ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_IncreaseDecreaseInLeaseObligations_033c3d97-c998-4cb3-975c-27ed5cc0f461" xlink:href="ocgn-20200930.xsd#ocgn_IncreaseDecreaseInLeaseObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bfe6b8e6-ca07-430e-98f8-6d061c927716" xlink:to="loc_ocgn_IncreaseDecreaseInLeaseObligations_033c3d97-c998-4cb3-975c-27ed5cc0f461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_48e8b5e4-5aeb-43d7-96e4-1ae727db45f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bfe6b8e6-ca07-430e-98f8-6d061c927716" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_48e8b5e4-5aeb-43d7-96e4-1ae727db45f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9b21b47c-837e-4fa3-8367-ea887258ef45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_be306db5-755a-4320-9856-59d35a42246b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9b21b47c-837e-4fa3-8367-ea887258ef45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d145f593-c83f-41e1-8650-e3d9c793ecfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9b21b47c-837e-4fa3-8367-ea887258ef45" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d145f593-c83f-41e1-8650-e3d9c793ecfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_af172505-9e5b-43f3-b328-0acecfa2d933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9b21b47c-837e-4fa3-8367-ea887258ef45" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_af172505-9e5b-43f3-b328-0acecfa2d933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a0b391b5-c174-42c3-af02-7fc03e753ce6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9b21b47c-837e-4fa3-8367-ea887258ef45" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a0b391b5-c174-42c3-af02-7fc03e753ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3f4491a-4ef6-41c2-afbb-9dc83a935cf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_be306db5-755a-4320-9856-59d35a42246b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3f4491a-4ef6-41c2-afbb-9dc83a935cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_f91835ed-39e6-46df-852d-4591bc0fb92c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3f4491a-4ef6-41c2-afbb-9dc83a935cf9" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_f91835ed-39e6-46df-852d-4591bc0fb92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_d71f9662-6e7a-4d08-b3e7-46e8fe2e8fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3f4491a-4ef6-41c2-afbb-9dc83a935cf9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_d71f9662-6e7a-4d08-b3e7-46e8fe2e8fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_a665c46e-3330-4278-bac6-bdb798c580a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3f4491a-4ef6-41c2-afbb-9dc83a935cf9" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_a665c46e-3330-4278-bac6-bdb798c580a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_e141c81b-02be-4d98-872a-870201e2b5be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3f4491a-4ef6-41c2-afbb-9dc83a935cf9" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_e141c81b-02be-4d98-872a-870201e2b5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_66ce10df-4881-41f9-8deb-1a83fd661baa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3f4491a-4ef6-41c2-afbb-9dc83a935cf9" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_66ce10df-4881-41f9-8deb-1a83fd661baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherDebt_ba9cf42d-8925-4746-ade8-9c5e152943a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfOtherDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3f4491a-4ef6-41c2-afbb-9dc83a935cf9" xlink:to="loc_us-gaap_RepaymentsOfOtherDebt_ba9cf42d-8925-4746-ade8-9c5e152943a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ProceedsFromPreMergerFinancingFinancingActivities_9e753445-ba36-4c92-8e7f-6c82090201ee" xlink:href="ocgn-20200930.xsd#ocgn_ProceedsFromPreMergerFinancingFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3f4491a-4ef6-41c2-afbb-9dc83a935cf9" xlink:to="loc_ocgn_ProceedsFromPreMergerFinancingFinancingActivities_9e753445-ba36-4c92-8e7f-6c82090201ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ffdd72fd-641f-4d3b-94ba-3b9173c137f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3f4491a-4ef6-41c2-afbb-9dc83a935cf9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ffdd72fd-641f-4d3b-94ba-3b9173c137f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f67e2654-a711-49c8-b74b-274a31eea563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_be306db5-755a-4320-9856-59d35a42246b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f67e2654-a711-49c8-b74b-274a31eea563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3c705570-0e9f-49f8-8f46-68bebb2b0ce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_be306db5-755a-4320-9856-59d35a42246b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3c705570-0e9f-49f8-8f46-68bebb2b0ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_985fd6ea-4504-448a-8549-80b30e03d7c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_be306db5-755a-4320-9856-59d35a42246b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_985fd6ea-4504-448a-8549-80b30e03d7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e5cccb93-bacc-41a3-87f4-9f5cb103b5da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_be306db5-755a-4320-9856-59d35a42246b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e5cccb93-bacc-41a3-87f4-9f5cb103b5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_3e264f3d-bc9b-48fc-8440-d8e41c5d935f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_be306db5-755a-4320-9856-59d35a42246b" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_3e264f3d-bc9b-48fc-8440-d8e41c5d935f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesIssued1_31a96eb0-4b78-473e-99ef-9712026fe3fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesIssued1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_3e264f3d-bc9b-48fc-8440-d8e41c5d935f" xlink:to="loc_us-gaap_NotesIssued1_31a96eb0-4b78-473e-99ef-9712026fe3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_c04528eb-ec48-4e66-a06e-b0fbd3c00cf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_3e264f3d-bc9b-48fc-8440-d8e41c5d935f" xlink:to="loc_us-gaap_StockIssued1_c04528eb-ec48-4e66-a06e-b0fbd3c00cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_052c7125-b14d-4fac-9fa1-38c11405aa19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_3e264f3d-bc9b-48fc-8440-d8e41c5d935f" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_052c7125-b14d-4fac-9fa1-38c11405aa19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset_54ab42b6-921f-446c-b3b8-5e007d22c7ef" xlink:href="ocgn-20200930.xsd#ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_3e264f3d-bc9b-48fc-8440-d8e41c5d935f" xlink:to="loc_ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset_54ab42b6-921f-446c-b3b8-5e007d22c7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost_2d6bb5c1-a90c-4a56-9d95-83cac286ab06" xlink:href="ocgn-20200930.xsd#ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_3e264f3d-bc9b-48fc-8440-d8e41c5d935f" xlink:to="loc_ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost_2d6bb5c1-a90c-4a56-9d95-83cac286ab06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction_38ae39dd-1ddd-4a6c-a5c8-c6f72d79fd2b" xlink:href="ocgn-20200930.xsd#ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_3e264f3d-bc9b-48fc-8440-d8e41c5d935f" xlink:to="loc_ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction_38ae39dd-1ddd-4a6c-a5c8-c6f72d79fd2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NatureofBusiness" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NatureofBusiness"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/NatureofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2755edd5-5ea2-4761-a6ea-867a7b97262b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_5bb9f6e4-5ad8-4bde-a945-0c1c45a15194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2755edd5-5ea2-4761-a6ea-867a7b97262b" xlink:to="loc_us-gaap_NatureOfOperations_5bb9f6e4-5ad8-4bde-a945-0c1c45a15194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NatureofBusinessAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_061275d0-6bc1-4340-9712-33bce9142401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_f2534ed0-e0ab-45a8-a858-b59c2df7c4f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_061275d0-6bc1-4340-9712-33bce9142401" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_f2534ed0-e0ab-45a8-a858-b59c2df7c4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_fb27ed69-1ee2-446b-824f-28a183261994" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_f2534ed0-e0ab-45a8-a858-b59c2df7c4f8" xlink:to="loc_srt_StatementScenarioAxis_fb27ed69-1ee2-446b-824f-28a183261994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9be10c97-8fab-4e87-9286-ce5fe2077ce2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_fb27ed69-1ee2-446b-824f-28a183261994" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9be10c97-8fab-4e87-9286-ce5fe2077ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_88d49db7-4be9-4b01-9156-5616b22837ec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9be10c97-8fab-4e87-9286-ce5fe2077ce2" xlink:to="loc_srt_ScenarioForecastMember_88d49db7-4be9-4b01-9156-5616b22837ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_d0936321-0764-4a17-a3f4-5ccdcc09efec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_f2534ed0-e0ab-45a8-a858-b59c2df7c4f8" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_d0936321-0764-4a17-a3f4-5ccdcc09efec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_fa19842d-16f2-49ea-89b1-078bdbf1e8e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_d0936321-0764-4a17-a3f4-5ccdcc09efec" xlink:to="loc_us-gaap_NumberOfOperatingSegments_fa19842d-16f2-49ea-89b1-078bdbf1e8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NumberOfOrphanDrugDesignations_5de04c78-463a-4384-8e66-69bf5c7f9849" xlink:href="ocgn-20200930.xsd#ocgn_NumberOfOrphanDrugDesignations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_d0936321-0764-4a17-a3f4-5ccdcc09efec" xlink:to="loc_ocgn_NumberOfOrphanDrugDesignations_5de04c78-463a-4384-8e66-69bf5c7f9849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture_2634d089-0fa4-4322-a41e-552c4ed93ce6" xlink:href="ocgn-20200930.xsd#ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_d0936321-0764-4a17-a3f4-5ccdcc09efec" xlink:to="loc_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture_2634d089-0fa4-4322-a41e-552c4ed93ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NatureofBusinessReverseStockSplitDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_237b1f5c-0ff7-4be6-90d5-b88d0d4b0134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_3fd07943-ff6f-4752-ae6f-5c1166605c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_237b1f5c-0ff7-4be6-90d5-b88d0d4b0134" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_3fd07943-ff6f-4752-ae6f-5c1166605c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_33bb098b-6625-467a-bf2a-a4ad3f65d0dc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_3fd07943-ff6f-4752-ae6f-5c1166605c29" xlink:to="loc_dei_LegalEntityAxis_33bb098b-6625-467a-bf2a-a4ad3f65d0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_51e87153-b7d2-449e-b580-3f97bef18150" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_33bb098b-6625-467a-bf2a-a4ad3f65d0dc" xlink:to="loc_dei_EntityDomain_51e87153-b7d2-449e-b580-3f97bef18150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_HistogenicsCorporationMember_71818665-e886-4d6a-902d-2b0f50a59066" xlink:href="ocgn-20200930.xsd#ocgn_HistogenicsCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_51e87153-b7d2-449e-b580-3f97bef18150" xlink:to="loc_ocgn_HistogenicsCorporationMember_71818665-e886-4d6a-902d-2b0f50a59066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_8f179f43-19a9-4974-84bf-b414f3df17d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_3fd07943-ff6f-4752-ae6f-5c1166605c29" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_8f179f43-19a9-4974-84bf-b414f3df17d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_BusinessCombinationIssuedSharesExchangeRate_4ce812e2-b806-4cb8-8df6-973b471de78d" xlink:href="ocgn-20200930.xsd#ocgn_BusinessCombinationIssuedSharesExchangeRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_8f179f43-19a9-4974-84bf-b414f3df17d1" xlink:to="loc_ocgn_BusinessCombinationIssuedSharesExchangeRate_4ce812e2-b806-4cb8-8df6-973b471de78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_adbfb4db-0e47-459f-ba6a-4e30f800898d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_8f179f43-19a9-4974-84bf-b414f3df17d1" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_adbfb4db-0e47-459f-ba6a-4e30f800898d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NatureofBusinessGoingConcernDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NatureofBusinessGoingConcernDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/NatureofBusinessGoingConcernDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_148c6693-3323-448d-87be-38af7a4461dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9c77f1f8-23e3-4e9f-8258-9a7927e47889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_148c6693-3323-448d-87be-38af7a4461dd" xlink:to="loc_us-gaap_NetIncomeLoss_9c77f1f8-23e3-4e9f-8258-9a7927e47889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_73d91a5a-d525-4bec-be32-f456aef73b13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_148c6693-3323-448d-87be-38af7a4461dd" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_73d91a5a-d525-4bec-be32-f456aef73b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4c8a7535-2b00-4047-8ef8-4ef6c0195df3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_148c6693-3323-448d-87be-38af7a4461dd" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4c8a7535-2b00-4047-8ef8-4ef6c0195df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_84981809-e680-4044-b808-8e2ffecc1404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_86a0b3d2-d31d-44b5-96c3-bacc9d0490ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84981809-e680-4044-b808-8e2ffecc1404" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_86a0b3d2-d31d-44b5-96c3-bacc9d0490ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e4eb78e7-3819-4f8e-93af-85eb76e39f73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1db811b2-3b61-4021-a053-d5941a9f7922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e4eb78e7-3819-4f8e-93af-85eb76e39f73" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1db811b2-3b61-4021-a053-d5941a9f7922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_8c618bc1-f791-4a10-a252-6da6d338a544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e4eb78e7-3819-4f8e-93af-85eb76e39f73" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_8c618bc1-f791-4a10-a252-6da6d338a544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_341f312d-769d-4477-879b-bf41a58cbcb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e4eb78e7-3819-4f8e-93af-85eb76e39f73" xlink:to="loc_us-gaap_UseOfEstimates_341f312d-769d-4477-879b-bf41a58cbcb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy_a499eb38-b664-4a57-a849-4cc47da009c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e4eb78e7-3819-4f8e-93af-85eb76e39f73" xlink:to="loc_us-gaap_CollaborativeArrangementAccountingPolicy_a499eb38-b664-4a57-a849-4cc47da009c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_d3f3cca3-8cd4-45f3-a68b-ee06c71edab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e4eb78e7-3819-4f8e-93af-85eb76e39f73" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_d3f3cca3-8cd4-45f3-a68b-ee06c71edab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AssetHeldForSalePolicyTextBlock_fb14014e-e917-469e-9707-d6f6c4340444" xlink:href="ocgn-20200930.xsd#ocgn_AssetHeldForSalePolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e4eb78e7-3819-4f8e-93af-85eb76e39f73" xlink:to="loc_ocgn_AssetHeldForSalePolicyTextBlock_fb14014e-e917-469e-9707-d6f6c4340444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_54ce4a2c-1244-461d-9d58-f8a292b3f28c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e4eb78e7-3819-4f8e-93af-85eb76e39f73" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_54ce4a2c-1244-461d-9d58-f8a292b3f28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_84204514-5856-4f54-80b9-3e430d127699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e4eb78e7-3819-4f8e-93af-85eb76e39f73" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_84204514-5856-4f54-80b9-3e430d127699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_b35404f8-3e8f-451c-9a16-25db33332a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e4eb78e7-3819-4f8e-93af-85eb76e39f73" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_b35404f8-3e8f-451c-9a16-25db33332a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_22fd4ca1-60d2-4820-b95f-10e6a65880cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e4eb78e7-3819-4f8e-93af-85eb76e39f73" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_22fd4ca1-60d2-4820-b95f-10e6a65880cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6d0bee2c-5b9b-450e-b218-95f622c2e4a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e4eb78e7-3819-4f8e-93af-85eb76e39f73" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6d0bee2c-5b9b-450e-b218-95f622c2e4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ef2b9ca9-07b2-4b54-9430-6df5f4fa32a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock_6dbc58ca-c730-412b-8a28-78a50acbd386" xlink:href="ocgn-20200930.xsd#ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ef2b9ca9-07b2-4b54-9430-6df5f4fa32a7" xlink:to="loc_ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock_6dbc58ca-c730-412b-8a28-78a50acbd386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ba8909e7-1f0f-4ad2-8650-95c47adce72c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ba8909e7-1f0f-4ad2-8650-95c47adce72c" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b2eddb28-f6e9-41db-9c4d-db50bc340384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:to="loc_us-gaap_AwardTypeAxis_b2eddb28-f6e9-41db-9c4d-db50bc340384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d84c3d27-42b9-4d81-8234-f51d53a250c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b2eddb28-f6e9-41db-9c4d-db50bc340384" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d84c3d27-42b9-4d81-8234-f51d53a250c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_dc287187-cec7-463f-b9c2-1990396610eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d84c3d27-42b9-4d81-8234-f51d53a250c3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_dc287187-cec7-463f-b9c2-1990396610eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e4917d92-f0b2-4e86-a7b2-030b830f782a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:to="loc_srt_RangeAxis_e4917d92-f0b2-4e86-a7b2-030b830f782a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d642cc25-5737-4ee6-aedc-debed60557a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e4917d92-f0b2-4e86-a7b2-030b830f782a" xlink:to="loc_srt_RangeMember_d642cc25-5737-4ee6-aedc-debed60557a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d80fa60b-341a-4ad5-a5bd-ae211095bb9e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d642cc25-5737-4ee6-aedc-debed60557a2" xlink:to="loc_srt_MinimumMember_d80fa60b-341a-4ad5-a5bd-ae211095bb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5c47a497-71f6-4c6c-9803-e51e16cbb944" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d642cc25-5737-4ee6-aedc-debed60557a2" xlink:to="loc_srt_MaximumMember_5c47a497-71f6-4c6c-9803-e51e16cbb944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5d607ca5-b86e-4a73-9a45-8910cf3e9347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:to="loc_us-gaap_DebtInstrumentAxis_5d607ca5-b86e-4a73-9a45-8910cf3e9347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3eb6adde-149c-4c80-8d38-9fcb84b45339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5d607ca5-b86e-4a73-9a45-8910cf3e9347" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3eb6adde-149c-4c80-8d38-9fcb84b45339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_EB5ProgramBorrowingsMember_e50a4010-86d8-4baa-9137-f9adf11e3d7b" xlink:href="ocgn-20200930.xsd#ocgn_EB5ProgramBorrowingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3eb6adde-149c-4c80-8d38-9fcb84b45339" xlink:to="loc_ocgn_EB5ProgramBorrowingsMember_e50a4010-86d8-4baa-9137-f9adf11e3d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f5fd231e-a687-4734-b383-90d13a58a8f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f5fd231e-a687-4734-b383-90d13a58a8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_acfca040-14a0-46e3-b03a-35841c89b73c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f5fd231e-a687-4734-b383-90d13a58a8f7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_acfca040-14a0-46e3-b03a-35841c89b73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_eb02ce63-1cec-40c9-844c-5608e11bcc21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_acfca040-14a0-46e3-b03a-35841c89b73c" xlink:to="loc_us-gaap_LoansPayableMember_eb02ce63-1cec-40c9-844c-5608e11bcc21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_955ad5db-a0e7-42db-8758-6a102392b756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_955ad5db-a0e7-42db-8758-6a102392b756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11f3724f-84e8-4fe3-8ef7-ee32aa3a046e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_955ad5db-a0e7-42db-8758-6a102392b756" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11f3724f-84e8-4fe3-8ef7-ee32aa3a046e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_690f361c-0c5e-43e3-86ed-2c35bf026976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_11f3724f-84e8-4fe3-8ef7-ee32aa3a046e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_690f361c-0c5e-43e3-86ed-2c35bf026976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7b667b32-ba14-42f9-9dc0-3c7778684432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_206aa92c-9765-4aa8-bfef-ab4f36f79226" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7b667b32-ba14-42f9-9dc0-3c7778684432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_4627300b-022e-467b-9861-ee815dd3e59a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7b667b32-ba14-42f9-9dc0-3c7778684432" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_4627300b-022e-467b-9861-ee815dd3e59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_67dc6aca-9821-4ec1-b836-a9753f961234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7b667b32-ba14-42f9-9dc0-3c7778684432" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_67dc6aca-9821-4ec1-b836-a9753f961234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure_dfb0e548-b831-4553-a5e7-f884d8dba369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7b667b32-ba14-42f9-9dc0-3c7778684432" xlink:to="loc_us-gaap_LinesOfCreditFairValueDisclosure_dfb0e548-b831-4553-a5e7-f884d8dba369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d451fc76-0cc6-4598-b618-9aaccd655b38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7b667b32-ba14-42f9-9dc0-3c7778684432" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d451fc76-0cc6-4598-b618-9aaccd655b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_bc6761ac-54e9-4c03-8f1a-986e0a95c13d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7b667b32-ba14-42f9-9dc0-3c7778684432" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_bc6761ac-54e9-4c03-8f1a-986e0a95c13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fc998bc4-de29-48e3-a001-816338145521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7223686b-8666-46c7-81bc-e2f1a349a78d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc998bc4-de29-48e3-a001-816338145521" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7223686b-8666-46c7-81bc-e2f1a349a78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_ff21c82d-ecbd-45b8-a12a-66b8f64b0b04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc998bc4-de29-48e3-a001-816338145521" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_ff21c82d-ecbd-45b8-a12a-66b8f64b0b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c07b643e-9617-402b-af10-b9dbd682af99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fc998bc4-de29-48e3-a001-816338145521" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c07b643e-9617-402b-af10-b9dbd682af99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/MergerandFinancing" xlink:type="simple" xlink:href="ocgn-20200930.xsd#MergerandFinancing"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/MergerandFinancing" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e851978b-56e0-417f-888f-9891e6a93797" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_e827c053-8ca3-4568-90ba-f71a0f039874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e851978b-56e0-417f-888f-9891e6a93797" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_e827c053-8ca3-4568-90ba-f71a0f039874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/MergerandFinancingDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#MergerandFinancingDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/MergerandFinancingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_039c3641-2e36-4cd0-aaed-617ee38bdffb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ReverseMergerAndFinancingDisclosureTable_c42e1a32-0b5e-49d6-ba1d-29c1823156a1" xlink:href="ocgn-20200930.xsd#ocgn_ReverseMergerAndFinancingDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_039c3641-2e36-4cd0-aaed-617ee38bdffb" xlink:to="loc_ocgn_ReverseMergerAndFinancingDisclosureTable_c42e1a32-0b5e-49d6-ba1d-29c1823156a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6e865bd4-e47b-4a24-a889-1d60634d76a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureTable_c42e1a32-0b5e-49d6-ba1d-29c1823156a1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6e865bd4-e47b-4a24-a889-1d60634d76a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_faafb94a-a196-4c3d-9f02-76b27b750870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6e865bd4-e47b-4a24-a889-1d60634d76a0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_faafb94a-a196-4c3d-9f02-76b27b750870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SecuritiesPurchaseAgreementMember_f2e5f765-07c3-4076-8a17-941ca960f6bb" xlink:href="ocgn-20200930.xsd#ocgn_SecuritiesPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_faafb94a-a196-4c3d-9f02-76b27b750870" xlink:to="loc_ocgn_SecuritiesPurchaseAgreementMember_f2e5f765-07c3-4076-8a17-941ca960f6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_70917477-a7ae-4daa-b1fb-2f1513229088" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureTable_c42e1a32-0b5e-49d6-ba1d-29c1823156a1" xlink:to="loc_dei_LegalEntityAxis_70917477-a7ae-4daa-b1fb-2f1513229088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4994c4ce-963b-4b63-a049-37e842cba8f6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_70917477-a7ae-4daa-b1fb-2f1513229088" xlink:to="loc_dei_EntityDomain_4994c4ce-963b-4b63-a049-37e842cba8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_HistogenicsCorporationMember_66ff0430-56fa-4694-a7ba-14408b6f02af" xlink:href="ocgn-20200930.xsd#ocgn_HistogenicsCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4994c4ce-963b-4b63-a049-37e842cba8f6" xlink:to="loc_ocgn_HistogenicsCorporationMember_66ff0430-56fa-4694-a7ba-14408b6f02af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9fc70afe-f750-40f2-bfd2-4e1bc869faaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureTable_c42e1a32-0b5e-49d6-ba1d-29c1823156a1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9fc70afe-f750-40f2-bfd2-4e1bc869faaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7e6d6ea0-9bac-4b09-bd2c-9bf127dfb7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9fc70afe-f750-40f2-bfd2-4e1bc869faaa" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7e6d6ea0-9bac-4b09-bd2c-9bf127dfb7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_HistogenicsCorporationMember_a827dac2-d0dc-400b-b860-f8e6a8deaf93" xlink:href="ocgn-20200930.xsd#ocgn_HistogenicsCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7e6d6ea0-9bac-4b09-bd2c-9bf127dfb7fa" xlink:to="loc_ocgn_HistogenicsCorporationMember_a827dac2-d0dc-400b-b860-f8e6a8deaf93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c06651e1-96e1-4c01-9f67-7a6263c70c0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureTable_c42e1a32-0b5e-49d6-ba1d-29c1823156a1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c06651e1-96e1-4c01-9f67-7a6263c70c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31187ded-5e80-435d-997e-91e3c9780384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c06651e1-96e1-4c01-9f67-7a6263c70c0b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31187ded-5e80-435d-997e-91e3c9780384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f871745a-995a-4371-920e-f2deb3b8d727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31187ded-5e80-435d-997e-91e3c9780384" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f871745a-995a-4371-920e-f2deb3b8d727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:href="ocgn-20200930.xsd#ocgn_ReverseMergerAndFinancingDisclosureLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureTable_c42e1a32-0b5e-49d6-ba1d-29c1823156a1" xlink:to="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_f9af3e11-b22b-435a-ba3b-a253a4ddbcb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:to="loc_us-gaap_SharesIssued_f9af3e11-b22b-435a-ba3b-a253a4ddbcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NumberOfSeriesOfWarrantsIssued_7d14fa81-8010-4691-9383-c7de18a385da" xlink:href="ocgn-20200930.xsd#ocgn_NumberOfSeriesOfWarrantsIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:to="loc_ocgn_NumberOfSeriesOfWarrantsIssued_7d14fa81-8010-4691-9383-c7de18a385da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction_c8b6808e-9377-488f-96ac-60029d433c2d" xlink:href="ocgn-20200930.xsd#ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:to="loc_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction_c8b6808e-9377-488f-96ac-60029d433c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AssetPurchaseAgreementCashConsideration_0b3c4fb8-0d5f-42a4-be89-dcfde8c4ca47" xlink:href="ocgn-20200930.xsd#ocgn_AssetPurchaseAgreementCashConsideration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:to="loc_ocgn_AssetPurchaseAgreementCashConsideration_0b3c4fb8-0d5f-42a4-be89-dcfde8c4ca47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth_e94e51cb-ea3d-4ebd-9dda-35b464f1a05f" xlink:href="ocgn-20200930.xsd#ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:to="loc_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth_e94e51cb-ea3d-4ebd-9dda-35b464f1a05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure_6024d28a-3688-4c3d-aaed-74b0c967071e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ocgn_ReverseMergerAndFinancingDisclosureLineItems_deee6dc3-844f-4702-9b38-5002ac2cd9da" xlink:to="loc_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure_6024d28a-3688-4c3d-aaed-74b0c967071e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStock" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NetLossPerShareofCommonStock"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_12393de3-ca50-4a83-870e-ef7413ee42d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_3d379a74-12a2-4620-a36d-ae2e6b799904" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12393de3-ca50-4a83-870e-ef7413ee42d2" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_3d379a74-12a2-4620-a36d-ae2e6b799904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NetLossPerShareofCommonStockTables"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4ca8490b-fcde-408e-b8bf-0d6c5fedcf55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7cb8aabd-9f3e-4ea5-8606-1390798cdb65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4ca8490b-fcde-408e-b8bf-0d6c5fedcf55" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7cb8aabd-9f3e-4ea5-8606-1390798cdb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_a8a4d6b1-bba1-456e-b96e-727cd04908e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4ca8490b-fcde-408e-b8bf-0d6c5fedcf55" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_a8a4d6b1-bba1-456e-b96e-727cd04908e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#NetLossPerShareofCommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_16b8d07a-5bb7-4138-939a-37685ebeba94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b41e971e-2624-4dda-886c-c9148aa332dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_16b8d07a-5bb7-4138-939a-37685ebeba94" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b41e971e-2624-4dda-886c-c9148aa332dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5478f296-230a-49d9-86b1-e301478536a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b41e971e-2624-4dda-886c-c9148aa332dd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5478f296-230a-49d9-86b1-e301478536a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_129fb962-b1c5-4725-b378-10c20761637b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5478f296-230a-49d9-86b1-e301478536a4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_129fb962-b1c5-4725-b378-10c20761637b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_deef3d13-47b7-43ae-bed9-0fd84878b7bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_129fb962-b1c5-4725-b378-10c20761637b" xlink:to="loc_us-gaap_StockOptionMember_deef3d13-47b7-43ae-bed9-0fd84878b7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_d549875e-583f-40ea-8117-7c756a8e35d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_129fb962-b1c5-4725-b378-10c20761637b" xlink:to="loc_us-gaap_WarrantMember_d549875e-583f-40ea-8117-7c756a8e35d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_bc960c1a-28ff-467b-86d5-c7c495364432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b41e971e-2624-4dda-886c-c9148aa332dd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_bc960c1a-28ff-467b-86d5-c7c495364432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_0f757172-179b-49a5-8e09-d67d9c7c5d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_bc960c1a-28ff-467b-86d5-c7c495364432" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_0f757172-179b-49a5-8e09-d67d9c7c5d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesAWarrantsMember_b842f98b-0d1c-4cd9-a736-2f8d2b5646c1" xlink:href="ocgn-20200930.xsd#ocgn_SeriesAWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_0f757172-179b-49a5-8e09-d67d9c7c5d32" xlink:to="loc_ocgn_SeriesAWarrantsMember_b842f98b-0d1c-4cd9-a736-2f8d2b5646c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesBWarrantsMember_156c09ef-81b6-4b8f-acd5-9635c28bb68f" xlink:href="ocgn-20200930.xsd#ocgn_SeriesBWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_0f757172-179b-49a5-8e09-d67d9c7c5d32" xlink:to="loc_ocgn_SeriesBWarrantsMember_156c09ef-81b6-4b8f-acd5-9635c28bb68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesCWarrantsMember_677285a7-a493-494d-a80b-122f2da3938e" xlink:href="ocgn-20200930.xsd#ocgn_SeriesCWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_0f757172-179b-49a5-8e09-d67d9c7c5d32" xlink:to="loc_ocgn_SeriesCWarrantsMember_677285a7-a493-494d-a80b-122f2da3938e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b41e971e-2624-4dda-886c-c9148aa332dd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_600c84e4-aba2-48c5-b87b-ed42d41d1258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:to="loc_us-gaap_NetIncomeLoss_600c84e4-aba2-48c5-b87b-ed42d41d1258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_58e70ff0-287f-4b80-93b9-ecde9efd7596" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:to="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_58e70ff0-287f-4b80-93b9-ecde9efd7596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e7ffef5d-8c13-4d31-a7da-f018692358d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e7ffef5d-8c13-4d31-a7da-f018692358d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_bbebbb66-fce9-408b-ae60-fe00a7c42cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_bbebbb66-fce9-408b-ae60-fe00a7c42cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_ca3bef32-2b16-4540-b718-0f9586e83f1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_ca3bef32-2b16-4540-b718-0f9586e83f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_41f0b0c9-31b0-4778-b581-d10696120aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0aac4991-527e-4398-a272-e70ba6f00458" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_41f0b0c9-31b0-4778-b581-d10696120aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dce02c38-dd87-4a3a-b8aa-31e2a20f4fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_41f0b0c9-31b0-4778-b581-d10696120aa1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dce02c38-dd87-4a3a-b8aa-31e2a20f4fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CollaborationAgreements" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CollaborationAgreements"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CollaborationAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_25d50a85-fe40-4561-a4b4-906f6529393f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_9eecf5ab-92c6-4ffa-b970-f086bdff76f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_25d50a85-fe40-4561-a4b4-906f6529393f" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_9eecf5ab-92c6-4ffa-b970-f086bdff76f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CollaborationAgreementsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CollaborationAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CollaborationAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_195c1399-15be-4ada-b63a-d88485663353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c7755e4a-dd73-43b0-93a6-aebb639d93d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_195c1399-15be-4ada-b63a-d88485663353" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c7755e4a-dd73-43b0-93a6-aebb639d93d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_b6586f3f-f572-408a-a317-fd40e66ce304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c7755e4a-dd73-43b0-93a6-aebb639d93d7" xlink:to="loc_us-gaap_TypeOfArrangementAxis_b6586f3f-f572-408a-a317-fd40e66ce304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_954fe712-b57a-4ec1-a12f-5856aac1a5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_b6586f3f-f572-408a-a317-fd40e66ce304" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_954fe712-b57a-4ec1-a12f-5856aac1a5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_201d76dc-f07f-410a-9d74-30ae05f24e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_954fe712-b57a-4ec1-a12f-5856aac1a5cc" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_201d76dc-f07f-410a-9d74-30ae05f24e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_0d2d0d24-4991-4340-9a60-e059cda55b46" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c7755e4a-dd73-43b0-93a6-aebb639d93d7" xlink:to="loc_srt_CounterpartyNameAxis_0d2d0d24-4991-4340-9a60-e059cda55b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_eaee33b3-bc81-4f84-a6ee-4c69c3a8880b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_0d2d0d24-4991-4340-9a60-e059cda55b46" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_eaee33b3-bc81-4f84-a6ee-4c69c3a8880b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AdvaiteIncMember_b12f415d-a241-4951-a92d-febf87561f4b" xlink:href="ocgn-20200930.xsd#ocgn_AdvaiteIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_eaee33b3-bc81-4f84-a6ee-4c69c3a8880b" xlink:to="loc_ocgn_AdvaiteIncMember_b12f415d-a241-4951-a92d-febf87561f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e9c7935f-be15-4e34-9d1e-9d9d9f7bd758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c7755e4a-dd73-43b0-93a6-aebb639d93d7" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e9c7935f-be15-4e34-9d1e-9d9d9f7bd758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense_42eb3c9d-1a5e-47b3-af99-a517a3c11127" xlink:href="ocgn-20200930.xsd#ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e9c7935f-be15-4e34-9d1e-9d9d9f7bd758" xlink:to="loc_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense_42eb3c9d-1a5e-47b3-af99-a517a3c11127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_7bad7e59-ac5a-4e3e-8bc1-9679036a7915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e9c7935f-be15-4e34-9d1e-9d9d9f7bd758" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_7bad7e59-ac5a-4e3e-8bc1-9679036a7915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/AccruedExpenses" xlink:type="simple" xlink:href="ocgn-20200930.xsd#AccruedExpenses"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/AccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_afce6d92-3052-4d90-8766-8523b370cec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_77a7796e-e023-4181-b283-ca8f6723a0b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_afce6d92-3052-4d90-8766-8523b370cec4" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_77a7796e-e023-4181-b283-ca8f6723a0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#AccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/AccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_2f079a4f-dc18-40b9-a873-ed2d6face6e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_cc892c16-0ba2-47a6-b686-edc296990b53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_2f079a4f-dc18-40b9-a873-ed2d6face6e2" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_cc892c16-0ba2-47a6-b686-edc296990b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#AccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e633bf64-8018-4e7d-9aab-e1bec0ab7a3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ResearchAndDevelopmentExpensesCurrent_5170e1da-f12c-4405-bc72-b1d9966e17f1" xlink:href="ocgn-20200930.xsd#ocgn_ResearchAndDevelopmentExpensesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e633bf64-8018-4e7d-9aab-e1bec0ab7a3b" xlink:to="loc_ocgn_ResearchAndDevelopmentExpensesCurrent_5170e1da-f12c-4405-bc72-b1d9966e17f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AccruedLiabilitiesClinical_cc821380-750c-4bb9-bf50-99ddc1a7aa28" xlink:href="ocgn-20200930.xsd#ocgn_AccruedLiabilitiesClinical"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e633bf64-8018-4e7d-9aab-e1bec0ab7a3b" xlink:to="loc_ocgn_AccruedLiabilitiesClinical_cc821380-750c-4bb9-bf50-99ddc1a7aa28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AccruedLiabilitiesProfessionalFees_5e100c51-ef58-48a9-b70e-cb9e0e98d1a7" xlink:href="ocgn-20200930.xsd#ocgn_AccruedLiabilitiesProfessionalFees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e633bf64-8018-4e7d-9aab-e1bec0ab7a3b" xlink:to="loc_ocgn_AccruedLiabilitiesProfessionalFees_5e100c51-ef58-48a9-b70e-cb9e0e98d1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_27d2b533-9769-4085-b545-8d747f57dd27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e633bf64-8018-4e7d-9aab-e1bec0ab7a3b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_27d2b533-9769-4085-b545-8d747f57dd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent_9dbd2eaa-8b43-41ee-b7cb-e8c93ed63a69" xlink:href="ocgn-20200930.xsd#ocgn_AccruedSeveranceRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e633bf64-8018-4e7d-9aab-e1bec0ab7a3b" xlink:to="loc_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent_9dbd2eaa-8b43-41ee-b7cb-e8c93ed63a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f055ea42-473b-4e5e-a4a3-66ee9e10aa4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e633bf64-8018-4e7d-9aab-e1bec0ab7a3b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f055ea42-473b-4e5e-a4a3-66ee9e10aa4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9990e094-0ff3-46ca-a502-82f22d561c91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e633bf64-8018-4e7d-9aab-e1bec0ab7a3b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9990e094-0ff3-46ca-a502-82f22d561c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivities" xlink:type="simple" xlink:href="ocgn-20200930.xsd#ExitandDisposalActivities"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/ExitandDisposalActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6f56d125-2258-4f42-a4fc-32b9fe0d5d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2ba90d4c-566f-4db9-8e31-70f1e0ac4556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6f56d125-2258-4f42-a4fc-32b9fe0d5d14" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2ba90d4c-566f-4db9-8e31-70f1e0ac4556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#ExitandDisposalActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d1c9d576-1a1f-4a41-aad8-564f3e34fc2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_55fa533c-0644-4171-8a6f-6815d4f447b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d1c9d576-1a1f-4a41-aad8-564f3e34fc2c" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_55fa533c-0644-4171-8a6f-6815d4f447b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#ExitandDisposalActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9912190f-55b5-4c95-8420-9ea5dbbfe2fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1049b98b-2db9-4c67-ac4b-3729cdbe9a37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9912190f-55b5-4c95-8420-9ea5dbbfe2fe" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1049b98b-2db9-4c67-ac4b-3729cdbe9a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_08cf6fb5-bec3-4f31-80fe-34e92579eb1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1049b98b-2db9-4c67-ac4b-3729cdbe9a37" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_08cf6fb5-bec3-4f31-80fe-34e92579eb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_84145d4b-0220-4d80-b8ab-bcdc15bb04ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_08cf6fb5-bec3-4f31-80fe-34e92579eb1b" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_84145d4b-0220-4d80-b8ab-bcdc15bb04ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_14a851d9-04ca-4962-bd66-fb7cfe5e3912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_84145d4b-0220-4d80-b8ab-bcdc15bb04ca" xlink:to="loc_us-gaap_EmployeeSeveranceMember_14a851d9-04ca-4962-bd66-fb7cfe5e3912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_e7873349-16c5-4f3b-99cb-bc18a1270780" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1049b98b-2db9-4c67-ac4b-3729cdbe9a37" xlink:to="loc_srt_StatementScenarioAxis_e7873349-16c5-4f3b-99cb-bc18a1270780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4baa2b26-107c-4c72-9451-e7042b90e570" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_e7873349-16c5-4f3b-99cb-bc18a1270780" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4baa2b26-107c-4c72-9451-e7042b90e570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_b3888a6f-9290-4a9f-ace5-d09f99701c0f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_4baa2b26-107c-4c72-9451-e7042b90e570" xlink:to="loc_srt_ScenarioForecastMember_b3888a6f-9290-4a9f-ace5-d09f99701c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8ee62107-2a6a-4577-a2a6-7542d19e5c17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1049b98b-2db9-4c67-ac4b-3729cdbe9a37" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8ee62107-2a6a-4577-a2a6-7542d19e5c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d6de93c8-d667-4842-ba3d-cdd881416c40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8ee62107-2a6a-4577-a2a6-7542d19e5c17" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d6de93c8-d667-4842-ba3d-cdd881416c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_d60c00cf-d1a4-4c41-adce-9f9c9973a8b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d6de93c8-d667-4842-ba3d-cdd881416c40" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_d60c00cf-d1a4-4c41-adce-9f9c9973a8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_d316582e-47e2-43bc-98a5-a1456863deef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d6de93c8-d667-4842-ba3d-cdd881416c40" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_d316582e-47e2-43bc-98a5-a1456863deef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_34ef1585-7c5a-4899-a95a-1dc3122e0594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1049b98b-2db9-4c67-ac4b-3729cdbe9a37" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_34ef1585-7c5a-4899-a95a-1dc3122e0594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_3011d946-9512-4c23-b124-98a03ec9d9e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_34ef1585-7c5a-4899-a95a-1dc3122e0594" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_3011d946-9512-4c23-b124-98a03ec9d9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent_ab4374c2-20d8-41e8-a434-d8daefa03c36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_34ef1585-7c5a-4899-a95a-1dc3122e0594" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent_ab4374c2-20d8-41e8-a434-d8daefa03c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_bee8a014-b8a9-442e-be5e-32ae4591e12a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_34ef1585-7c5a-4899-a95a-1dc3122e0594" xlink:to="loc_us-gaap_RestructuringCharges_bee8a014-b8a9-442e-be5e-32ae4591e12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_466fefdc-b2ca-42d5-9ba4-095a3f36aafc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_34ef1585-7c5a-4899-a95a-1dc3122e0594" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_466fefdc-b2ca-42d5-9ba4-095a3f36aafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_bf16a4b5-bcb5-45ad-9f73-4674062fb425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eb73c569-c701-4dfd-b2f9-fd53c11a2b23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_bf16a4b5-bcb5-45ad-9f73-4674062fb425" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eb73c569-c701-4dfd-b2f9-fd53c11a2b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_319c6324-54aa-49aa-890b-a41c5f583777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eb73c569-c701-4dfd-b2f9-fd53c11a2b23" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_319c6324-54aa-49aa-890b-a41c5f583777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_56be0e84-2200-44cc-bedf-d8309ae34bb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_319c6324-54aa-49aa-890b-a41c5f583777" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_56be0e84-2200-44cc-bedf-d8309ae34bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_4887b081-db94-456a-8667-93c085397bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_56be0e84-2200-44cc-bedf-d8309ae34bb3" xlink:to="loc_us-gaap_EmployeeSeveranceMember_4887b081-db94-456a-8667-93c085397bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f1913b78-ec98-4ff8-98ee-b93ae955c8ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eb73c569-c701-4dfd-b2f9-fd53c11a2b23" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_f1913b78-ec98-4ff8-98ee-b93ae955c8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_f120cf20-6fe3-4464-8f3d-714c19f95c78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f1913b78-ec98-4ff8-98ee-b93ae955c8ce" xlink:to="loc_us-gaap_RestructuringReserveRollForward_f120cf20-6fe3-4464-8f3d-714c19f95c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f4cc7b36-a2b1-4277-9c3a-85c74a595c61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_f120cf20-6fe3-4464-8f3d-714c19f95c78" xlink:to="loc_us-gaap_RestructuringReserve_f4cc7b36-a2b1-4277-9c3a-85c74a595c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_ef03cc0c-f617-44c7-826a-5c34a7af749c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_f120cf20-6fe3-4464-8f3d-714c19f95c78" xlink:to="loc_us-gaap_RestructuringCharges_ef03cc0c-f617-44c7-826a-5c34a7af749c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_4205459e-fb00-40b3-a5ec-8275fe33d7f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_f120cf20-6fe3-4464-8f3d-714c19f95c78" xlink:to="loc_us-gaap_PaymentsForRestructuring_4205459e-fb00-40b3-a5ec-8275fe33d7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_63211906-33c4-460f-88de-5b813741eadb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_f120cf20-6fe3-4464-8f3d-714c19f95c78" xlink:to="loc_us-gaap_RestructuringReserve_63211906-33c4-460f-88de-5b813741eadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/EquityTransactions" xlink:type="simple" xlink:href="ocgn-20200930.xsd#EquityTransactions"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/EquityTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d7aec9d8-18d0-495d-9a53-dbfd269b0b2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b40e9cdc-0a78-4f76-a85e-8912ede43a71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d7aec9d8-18d0-495d-9a53-dbfd269b0b2a" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b40e9cdc-0a78-4f76-a85e-8912ede43a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/EquityTransactionsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#EquityTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/EquityTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_fcb12a88-8826-451d-b65e-1d1b76ca6ae6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_0dabb829-f44a-4e5a-8a9e-aa0233a77328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fcb12a88-8826-451d-b65e-1d1b76ca6ae6" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_0dabb829-f44a-4e5a-8a9e-aa0233a77328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b8f00823-6d95-454c-8614-5fd7d4206c97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_0dabb829-f44a-4e5a-8a9e-aa0233a77328" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b8f00823-6d95-454c-8614-5fd7d4206c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7cc9efb6-f88a-40ed-9e89-395c6ba011cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b8f00823-6d95-454c-8614-5fd7d4206c97" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7cc9efb6-f88a-40ed-9e89-395c6ba011cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ControlledEquityOfferingSalesAgreementMember_d98fb6b6-d65f-4198-8b46-ced6ccd46b3a" xlink:href="ocgn-20200930.xsd#ocgn_ControlledEquityOfferingSalesAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7cc9efb6-f88a-40ed-9e89-395c6ba011cb" xlink:to="loc_ocgn_ControlledEquityOfferingSalesAgreementMember_d98fb6b6-d65f-4198-8b46-ced6ccd46b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SubscriptionAgreementsMember_b89f54e3-8dd3-4cf3-81c3-08c28ab6ac40" xlink:href="ocgn-20200930.xsd#ocgn_SubscriptionAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7cc9efb6-f88a-40ed-9e89-395c6ba011cb" xlink:to="loc_ocgn_SubscriptionAgreementsMember_b89f54e3-8dd3-4cf3-81c3-08c28ab6ac40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_0dabb829-f44a-4e5a-8a9e-aa0233a77328" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_cee2c8ce-c544-4763-ad88-1bfdbfca2b93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_cee2c8ce-c544-4763-ad88-1bfdbfca2b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_feac96ef-2d6f-4b67-bcd7-d8e85060e66c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_feac96ef-2d6f-4b67-bcd7-d8e85060e66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_4e13fc71-022a-487f-8936-5a286b39ec09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_4e13fc71-022a-487f-8936-5a286b39ec09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity_d2f9d0e1-8800-46bc-921b-159cdb1072e1" xlink:href="ocgn-20200930.xsd#ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity_d2f9d0e1-8800-46bc-921b-159cdb1072e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesSubscribedButUnissued_c68d0c41-b272-4fb2-ada3-b3d896fe4d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesSubscribedButUnissued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_us-gaap_CommonStockSharesSubscribedButUnissued_c68d0c41-b272-4fb2-ada3-b3d896fe4d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_b1b979a2-5c09-494c-a182-eec7350c8ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_b1b979a2-5c09-494c-a182-eec7350c8ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock_fa82101b-3d23-41c5-8915-a8f32071e1ab" xlink:href="ocgn-20200930.xsd#ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock_fa82101b-3d23-41c5-8915-a8f32071e1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock_73db38f3-77ba-46ff-965d-52335a1ae168" xlink:href="ocgn-20200930.xsd#ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_f025d295-59a6-4a49-87f1-ca68a0cc0133" xlink:to="loc_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock_73db38f3-77ba-46ff-965d-52335a1ae168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/Debt" xlink:type="simple" xlink:href="ocgn-20200930.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f4aa7a35-09ed-48f8-ac91-081f92ec804a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_bc6cc0b3-0dea-41af-9ec4-a90c6395f15f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f4aa7a35-09ed-48f8-ac91-081f92ec804a" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_bc6cc0b3-0dea-41af-9ec4-a90c6395f15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6ef31ae8-431c-4c68-b0c8-78d1c11b34a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_27cad212-6137-4a94-b53d-b919408b1ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6ef31ae8-431c-4c68-b0c8-78d1c11b34a9" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_27cad212-6137-4a94-b53d-b919408b1ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_b3637182-a695-411a-a2d3-40d2ae5d09e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6ef31ae8-431c-4c68-b0c8-78d1c11b34a9" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_b3637182-a695-411a-a2d3-40d2ae5d09e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_9bd1692f-fc95-494e-a6ca-b5263608a9b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6ef31ae8-431c-4c68-b0c8-78d1c11b34a9" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_9bd1692f-fc95-494e-a6ca-b5263608a9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtPPPNoteDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtPPPNoteDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/DebtPPPNoteDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_064d03fc-e5d0-4542-a121-b498f7a45311" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a8f63487-05fd-4be5-b1e2-a52729b3429e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_064d03fc-e5d0-4542-a121-b498f7a45311" xlink:to="loc_us-gaap_DebtInstrumentTable_a8f63487-05fd-4be5-b1e2-a52729b3429e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2101f64a-353a-4d6e-9072-950028b9d64b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a8f63487-05fd-4be5-b1e2-a52729b3429e" xlink:to="loc_us-gaap_DebtInstrumentAxis_2101f64a-353a-4d6e-9072-950028b9d64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_134ccf16-13a4-429f-b244-5ddce669f167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2101f64a-353a-4d6e-9072-950028b9d64b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_134ccf16-13a4-429f-b244-5ddce669f167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_PaycheckProtectionProgramLoanMember_db81de4c-e9fc-4a60-b580-14f486c7a56c" xlink:href="ocgn-20200930.xsd#ocgn_PaycheckProtectionProgramLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_134ccf16-13a4-429f-b244-5ddce669f167" xlink:to="loc_ocgn_PaycheckProtectionProgramLoanMember_db81de4c-e9fc-4a60-b580-14f486c7a56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_WarrantExchangePromissoryNotesMember_b571550d-17d9-4cec-bd44-f9084e5511e5" xlink:href="ocgn-20200930.xsd#ocgn_WarrantExchangePromissoryNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_134ccf16-13a4-429f-b244-5ddce669f167" xlink:to="loc_ocgn_WarrantExchangePromissoryNotesMember_b571550d-17d9-4cec-bd44-f9084e5511e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_EB5ProgramBorrowingsMember_34d9ed85-91cc-4479-a4ee-0e303416657b" xlink:href="ocgn-20200930.xsd#ocgn_EB5ProgramBorrowingsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_134ccf16-13a4-429f-b244-5ddce669f167" xlink:to="loc_ocgn_EB5ProgramBorrowingsMember_34d9ed85-91cc-4479-a4ee-0e303416657b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_18155827-d367-4f7f-a708-a2d59d70c2c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a8f63487-05fd-4be5-b1e2-a52729b3429e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_18155827-d367-4f7f-a708-a2d59d70c2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_75853ad1-05d2-4ce2-bd40-84263c11b569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_18155827-d367-4f7f-a708-a2d59d70c2c2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_75853ad1-05d2-4ce2-bd40-84263c11b569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_ebb74469-be51-4b42-bd63-ea71f61e8739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_75853ad1-05d2-4ce2-bd40-84263c11b569" xlink:to="loc_us-gaap_NotesPayableToBanksMember_ebb74469-be51-4b42-bd63-ea71f61e8739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_9ce46625-6257-45fe-a3cf-9e0f518348a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_75853ad1-05d2-4ce2-bd40-84263c11b569" xlink:to="loc_us-gaap_LoansPayableMember_9ce46625-6257-45fe-a3cf-9e0f518348a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e9d647de-6567-424c-813a-55a52977a808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a8f63487-05fd-4be5-b1e2-a52729b3429e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_e9d647de-6567-424c-813a-55a52977a808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b2557e47-ac36-48e9-aab9-bfbcb6ac154a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e9d647de-6567-424c-813a-55a52977a808" xlink:to="loc_us-gaap_LongTermDebt_b2557e47-ac36-48e9-aab9-bfbcb6ac154a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a6d856df-f64f-45fa-930c-1a020cadcbc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e9d647de-6567-424c-813a-55a52977a808" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a6d856df-f64f-45fa-930c-1a020cadcbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8b39b644-2ade-423d-a686-c69ad6589094" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e9d647de-6567-424c-813a-55a52977a808" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8b39b644-2ade-423d-a686-c69ad6589094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtWarrantExchangePromissoryNotesDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_68c0303e-d9a9-4993-97bf-7ee7c36d3185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_be9140a7-b6d2-45aa-ac39-b673eec51b48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_68c0303e-d9a9-4993-97bf-7ee7c36d3185" xlink:to="loc_us-gaap_DebtInstrumentTable_be9140a7-b6d2-45aa-ac39-b673eec51b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_272f0a7b-b01d-4ab3-b915-f7db64300214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_be9140a7-b6d2-45aa-ac39-b673eec51b48" xlink:to="loc_us-gaap_DebtInstrumentAxis_272f0a7b-b01d-4ab3-b915-f7db64300214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c8d3227a-b96a-45f4-ad0b-996615c69c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_272f0a7b-b01d-4ab3-b915-f7db64300214" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c8d3227a-b96a-45f4-ad0b-996615c69c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_WarrantExchangePromissoryNotesMember_5a921737-2ffb-4513-ac68-82f515ae402c" xlink:href="ocgn-20200930.xsd#ocgn_WarrantExchangePromissoryNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8d3227a-b96a-45f4-ad0b-996615c69c15" xlink:to="loc_ocgn_WarrantExchangePromissoryNotesMember_5a921737-2ffb-4513-ac68-82f515ae402c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e77c58fa-42a6-4f64-bcbc-8c4eb78ab129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_be9140a7-b6d2-45aa-ac39-b673eec51b48" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e77c58fa-42a6-4f64-bcbc-8c4eb78ab129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_06d76322-49c5-4c18-8f3b-3647b6ce0ce9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e77c58fa-42a6-4f64-bcbc-8c4eb78ab129" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_06d76322-49c5-4c18-8f3b-3647b6ce0ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_0e0f3c3b-b96e-4f7a-993e-2f8b6e558bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_06d76322-49c5-4c18-8f3b-3647b6ce0ce9" xlink:to="loc_us-gaap_NotesPayableToBanksMember_0e0f3c3b-b96e-4f7a-993e-2f8b6e558bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2f2ce204-e136-4270-b36a-566e013e4ec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_be9140a7-b6d2-45aa-ac39-b673eec51b48" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2f2ce204-e136-4270-b36a-566e013e4ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_74754720-26e4-4193-a31a-bbbe4398acdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2f2ce204-e136-4270-b36a-566e013e4ec2" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_74754720-26e4-4193-a31a-bbbe4398acdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_ed2c4cbf-8fc2-4c07-b6b4-edb4d3e53896" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_74754720-26e4-4193-a31a-bbbe4398acdb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_ed2c4cbf-8fc2-4c07-b6b4-edb4d3e53896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_abe79fde-f301-45d7-920e-ac8ac9993360" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_74754720-26e4-4193-a31a-bbbe4398acdb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_abe79fde-f301-45d7-920e-ac8ac9993360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2815ae09-6b19-49cd-bb2a-1d29c2201239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_be9140a7-b6d2-45aa-ac39-b673eec51b48" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2815ae09-6b19-49cd-bb2a-1d29c2201239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bf9fbae2-7a35-470a-aca8-b010bff84160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2815ae09-6b19-49cd-bb2a-1d29c2201239" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bf9fbae2-7a35-470a-aca8-b010bff84160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_64eb2afa-ed83-4b53-957f-c519ab2cf746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_bf9fbae2-7a35-470a-aca8-b010bff84160" xlink:to="loc_us-gaap_SubsequentEventMember_64eb2afa-ed83-4b53-957f-c519ab2cf746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_be9140a7-b6d2-45aa-ac39-b673eec51b48" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3b25df13-fff2-4bfd-a8c2-97895c3ff9cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3b25df13-fff2-4bfd-a8c2-97895c3ff9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction_05774996-7b6a-4f07-94dd-7afacddd56eb" xlink:href="ocgn-20200930.xsd#ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction_05774996-7b6a-4f07-94dd-7afacddd56eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_2760a819-71db-4626-918a-553ce68c483b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_LongTermDebtFairValue_2760a819-71db-4626-918a-553ce68c483b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_875688ff-fc3b-4229-af3b-06f225322e76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_875688ff-fc3b-4229-af3b-06f225322e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_856d738f-e959-4d34-acdc-1f82cb9927e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_InterestExpenseDebt_856d738f-e959-4d34-acdc-1f82cb9927e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_302d1606-cf4d-4ace-923a-a9b3e76289dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_302d1606-cf4d-4ace-923a-a9b3e76289dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_dfabce2d-7161-4eb6-8d98-814b330a334b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_dfabce2d-7161-4eb6-8d98-814b330a334b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4eb3dd78-3131-4ba7-b182-b00d1fdb9797" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce707952-d8cb-4b56-8a27-94917a37c514" xlink:to="loc_us-gaap_LongTermDebt_4eb3dd78-3131-4ba7-b182-b00d1fdb9797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtEB5LoanAgreementBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_203a18d3-b1ca-4f2e-81dc-e47a3a16641c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_424997ea-e584-4166-a0b0-46c8e9c5cbf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_203a18d3-b1ca-4f2e-81dc-e47a3a16641c" xlink:to="loc_us-gaap_DebtInstrumentTable_424997ea-e584-4166-a0b0-46c8e9c5cbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3bbf68da-9e3a-45a1-937c-29d16a2c9f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_424997ea-e584-4166-a0b0-46c8e9c5cbf6" xlink:to="loc_us-gaap_DebtInstrumentAxis_3bbf68da-9e3a-45a1-937c-29d16a2c9f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_122bdbd0-5961-4a9c-8bed-3f959324740c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3bbf68da-9e3a-45a1-937c-29d16a2c9f0d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_122bdbd0-5961-4a9c-8bed-3f959324740c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_EB5ProgramBorrowingsMember_9e28012b-6ca3-4458-975d-cbf5dec754c6" xlink:href="ocgn-20200930.xsd#ocgn_EB5ProgramBorrowingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_122bdbd0-5961-4a9c-8bed-3f959324740c" xlink:to="loc_ocgn_EB5ProgramBorrowingsMember_9e28012b-6ca3-4458-975d-cbf5dec754c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_65298381-1dfb-4e39-99c9-58124f4ea813" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_424997ea-e584-4166-a0b0-46c8e9c5cbf6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_65298381-1dfb-4e39-99c9-58124f4ea813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ea157207-5ed9-4f64-936f-401b2332f60a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_65298381-1dfb-4e39-99c9-58124f4ea813" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ea157207-5ed9-4f64-936f-401b2332f60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_e2c3049f-18f2-4570-a593-697417578f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea157207-5ed9-4f64-936f-401b2332f60a" xlink:to="loc_us-gaap_LoansPayableMember_e2c3049f-18f2-4570-a593-697417578f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_424997ea-e584-4166-a0b0-46c8e9c5cbf6" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e7478c1e-7933-4bd3-b35f-fd181493b59e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e7478c1e-7933-4bd3-b35f-fd181493b59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_LineOfCreditBorrowingEachDraw_ea25157c-bb78-4b54-b952-30e00e8557bd" xlink:href="ocgn-20200930.xsd#ocgn_LineOfCreditBorrowingEachDraw"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_ocgn_LineOfCreditBorrowingEachDraw_ea25157c-bb78-4b54-b952-30e00e8557bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_673cf57e-b4d1-4b59-b091-4266957021c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_673cf57e-b4d1-4b59-b091-4266957021c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_a348f323-f85f-4609-af58-0d9eeeafe50a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_LineOfCredit_a348f323-f85f-4609-af58-0d9eeeafe50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d458951e-0669-4b67-a00c-486537933be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d458951e-0669-4b67-a00c-486537933be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_b5c5a1e9-24d6-4774-ae63-b79e59fbe521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_b5c5a1e9-24d6-4774-ae63-b79e59fbe521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_55481b38-3e01-4e2c-b30b-c8977084cbc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_55481b38-3e01-4e2c-b30b-c8977084cbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6dbbdfd0-cc54-45aa-be34-10b55f27d3fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8f133ca-96e0-4650-a6f4-a5f5e8bec871" xlink:to="loc_us-gaap_LongTermDebt_6dbbdfd0-cc54-45aa-be34-10b55f27d3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtSeniorSecuredConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_987465ec-1015-4fd0-9919-2c1c6cc75aea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_837eb038-ed42-4c8c-9b2d-370ca20699c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_987465ec-1015-4fd0-9919-2c1c6cc75aea" xlink:to="loc_us-gaap_DebtInstrumentTable_837eb038-ed42-4c8c-9b2d-370ca20699c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6bfa0e30-c492-479d-9b81-79943cd8f01f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_837eb038-ed42-4c8c-9b2d-370ca20699c3" xlink:to="loc_us-gaap_DebtInstrumentAxis_6bfa0e30-c492-479d-9b81-79943cd8f01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5dfd23c7-9791-4731-a075-81f08e729ff1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6bfa0e30-c492-479d-9b81-79943cd8f01f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5dfd23c7-9791-4731-a075-81f08e729ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeniorSecuredConvertibleNotesMay2019Member_3e0685ac-9f4d-4915-8892-53a4f286a920" xlink:href="ocgn-20200930.xsd#ocgn_SeniorSecuredConvertibleNotesMay2019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5dfd23c7-9791-4731-a075-81f08e729ff1" xlink:to="loc_ocgn_SeniorSecuredConvertibleNotesMay2019Member_3e0685ac-9f4d-4915-8892-53a4f286a920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeniorSecuredConvertibleNotesJune2019Member_9d6875f1-fa9b-4fc2-8949-2940b9365584" xlink:href="ocgn-20200930.xsd#ocgn_SeniorSecuredConvertibleNotesJune2019Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5dfd23c7-9791-4731-a075-81f08e729ff1" xlink:to="loc_ocgn_SeniorSecuredConvertibleNotesJune2019Member_9d6875f1-fa9b-4fc2-8949-2940b9365584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeniorSecuredConvertibleNotesMember_3b17a970-8b05-44e2-97c9-ef43ee82582c" xlink:href="ocgn-20200930.xsd#ocgn_SeniorSecuredConvertibleNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5dfd23c7-9791-4731-a075-81f08e729ff1" xlink:to="loc_ocgn_SeniorSecuredConvertibleNotesMember_3b17a970-8b05-44e2-97c9-ef43ee82582c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5dc3e6af-441b-46b2-b8c1-d8c52086987a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_837eb038-ed42-4c8c-9b2d-370ca20699c3" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5dc3e6af-441b-46b2-b8c1-d8c52086987a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5edb1adf-9eca-4027-953e-51cf8d819106" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dc3e6af-441b-46b2-b8c1-d8c52086987a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5edb1adf-9eca-4027-953e-51cf8d819106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2b13fb9c-0673-4101-9fea-1185dbddb846" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dc3e6af-441b-46b2-b8c1-d8c52086987a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2b13fb9c-0673-4101-9fea-1185dbddb846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_64414d4b-3f73-4604-92c4-476b8b31b7c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5dc3e6af-441b-46b2-b8c1-d8c52086987a" xlink:to="loc_us-gaap_InterestExpense_64414d4b-3f73-4604-92c4-476b8b31b7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtConvertiblePromissoryNoteDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_548ea6a9-546d-4a06-a820-680828083c36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_18a55a87-8414-41f5-ba2d-7a7e668ed71a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_548ea6a9-546d-4a06-a820-680828083c36" xlink:to="loc_us-gaap_DebtInstrumentTable_18a55a87-8414-41f5-ba2d-7a7e668ed71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dc5d0fdd-2ebb-4584-b341-c0c2dd5adc60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_18a55a87-8414-41f5-ba2d-7a7e668ed71a" xlink:to="loc_us-gaap_DebtInstrumentAxis_dc5d0fdd-2ebb-4584-b341-c0c2dd5adc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b3e13cf1-e013-4710-aa86-fd17ae41e05a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_dc5d0fdd-2ebb-4584-b341-c0c2dd5adc60" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b3e13cf1-e013-4710-aa86-fd17ae41e05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertiblePromissoryNotesMember_500a5cae-f9fb-4f95-9ce5-309b48f46742" xlink:href="ocgn-20200930.xsd#ocgn_ConvertiblePromissoryNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b3e13cf1-e013-4710-aa86-fd17ae41e05a" xlink:to="loc_ocgn_ConvertiblePromissoryNotesMember_500a5cae-f9fb-4f95-9ce5-309b48f46742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_015c9da9-35e3-43f8-8923-f0e0cba05c93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_18a55a87-8414-41f5-ba2d-7a7e668ed71a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_015c9da9-35e3-43f8-8923-f0e0cba05c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_55519170-fb06-4c95-a11c-605977057e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_015c9da9-35e3-43f8-8923-f0e0cba05c93" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_55519170-fb06-4c95-a11c-605977057e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e76eafc2-adbe-44b3-996b-9139b102c0c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_015c9da9-35e3-43f8-8923-f0e0cba05c93" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e76eafc2-adbe-44b3-996b-9139b102c0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement_bc6c9655-88b4-461c-b577-061fe6d95751" xlink:href="ocgn-20200930.xsd#ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_015c9da9-35e3-43f8-8923-f0e0cba05c93" xlink:to="loc_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement_bc6c9655-88b4-461c-b577-061fe6d95751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_2faa8d38-8438-490c-a0f8-2b829db1379d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_015c9da9-35e3-43f8-8923-f0e0cba05c93" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_2faa8d38-8438-490c-a0f8-2b829db1379d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_3be3b607-7779-4384-b92e-9278319b7c0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_015c9da9-35e3-43f8-8923-f0e0cba05c93" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_3be3b607-7779-4384-b92e-9278319b7c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9fe919ef-cd0b-440f-b7ad-9702fcb30bab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9fe919ef-cd0b-440f-b7ad-9702fcb30bab" xlink:to="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_58b4db69-b853-49b8-a21d-b174bb43d8e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:to="loc_us-gaap_DebtInstrumentAxis_58b4db69-b853-49b8-a21d-b174bb43d8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6e2f9f0f-2d87-4a50-a55f-132550316387" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_58b4db69-b853-49b8-a21d-b174bb43d8e0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6e2f9f0f-2d87-4a50-a55f-132550316387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e2f9f0f-2d87-4a50-a55f-132550316387" xlink:to="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleNotesBoardOfDirectorsMember_71478d2d-9dbf-4755-98c2-93bf9956f877" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleNotesBoardOfDirectorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_ConvertibleNotesBoardOfDirectorsMember_71478d2d-9dbf-4755-98c2-93bf9956f877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtJanuary2018Member_b2e25ad8-f957-4384-90fd-43b9a3346054" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtJanuary2018Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_ConvertibleDebtJanuary2018Member_b2e25ad8-f957-4384-90fd-43b9a3346054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtJune2018Member_35252735-df0e-4fa7-bb2c-e5fe68b6867a" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtJune2018Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_ConvertibleDebtJune2018Member_35252735-df0e-4fa7-bb2c-e5fe68b6867a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtNovember2018Member_a5a9a4c1-3233-4803-87d8-1349defc4983" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtNovember2018Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_ConvertibleDebtNovember2018Member_a5a9a4c1-3233-4803-87d8-1349defc4983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtDecember2018Member_82472e0d-b86f-47f6-9979-94ac0f8b820f" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtDecember2018Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_ConvertibleDebtDecember2018Member_82472e0d-b86f-47f6-9979-94ac0f8b820f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtJanuary2019Member_88592cf3-aea9-49f2-80d9-e0ae698547f7" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtJanuary2019Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_ConvertibleDebtJanuary2019Member_88592cf3-aea9-49f2-80d9-e0ae698547f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtFebruary2019Member_b6063c88-25ac-487b-9e75-57de96399364" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtFebruary2019Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_ConvertibleDebtFebruary2019Member_b6063c88-25ac-487b-9e75-57de96399364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_November2018AndDecember2018NotesMember_d07f2dc9-37d7-4367-ab9e-57c7aa21bafa" xlink:href="ocgn-20200930.xsd#ocgn_November2018AndDecember2018NotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_November2018AndDecember2018NotesMember_d07f2dc9-37d7-4367-ab9e-57c7aa21bafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_January2019AndFebruary2019NotesMember_2458d1c7-79a5-4f21-8398-2ade77b7899a" xlink:href="ocgn-20200930.xsd#ocgn_January2019AndFebruary2019NotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConvertibleDebtMember_a3f0e70b-a8c8-4c1f-9a3d-a53d92ba8ad5" xlink:to="loc_ocgn_January2019AndFebruary2019NotesMember_2458d1c7-79a5-4f21-8398-2ade77b7899a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_4a3d1f55-0cde-47fa-96c8-8196fb88181a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:to="loc_srt_TitleOfIndividualAxis_4a3d1f55-0cde-47fa-96c8-8196fb88181a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_165194c7-402c-4392-8e46-caebc75edc88" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_4a3d1f55-0cde-47fa-96c8-8196fb88181a" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_165194c7-402c-4392-8e46-caebc75edc88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_8ef901e1-80ff-4fc0-9c8e-037e2aeb84ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_165194c7-402c-4392-8e46-caebc75edc88" xlink:to="loc_srt_DirectorMember_8ef901e1-80ff-4fc0-9c8e-037e2aeb84ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f1a29a59-e473-48f9-87f0-f50bec92b143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f1a29a59-e473-48f9-87f0-f50bec92b143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b24b40ee-3009-47d0-97ec-8a51d24c6ef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f1a29a59-e473-48f9-87f0-f50bec92b143" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b24b40ee-3009-47d0-97ec-8a51d24c6ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtConversionFeatureMember_8842c043-92b6-4b20-9254-30cc33f26e38" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtConversionFeatureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b24b40ee-3009-47d0-97ec-8a51d24c6ef8" xlink:to="loc_ocgn_ConvertibleDebtConversionFeatureMember_8842c043-92b6-4b20-9254-30cc33f26e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_6272fb6d-9f49-4b7d-a894-98c5ba9aa3e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_6272fb6d-9f49-4b7d-a894-98c5ba9aa3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_fa83cfd5-fea6-45dd-862a-de0f0894072d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_6272fb6d-9f49-4b7d-a894-98c5ba9aa3e2" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_fa83cfd5-fea6-45dd-862a-de0f0894072d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_0c982e19-ea34-46c0-9cbd-fe2392aee96e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_fa83cfd5-fea6-45dd-862a-de0f0894072d" xlink:to="loc_us-gaap_ConvertibleDebtMember_0c982e19-ea34-46c0-9cbd-fe2392aee96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e8d14943-756a-472a-9a31-246f9ca6fd02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e8d14943-756a-472a-9a31-246f9ca6fd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6c4421e3-e075-4542-80f1-6b44b0bd75d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e8d14943-756a-472a-9a31-246f9ca6fd02" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6c4421e3-e075-4542-80f1-6b44b0bd75d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_545f2f0d-5165-4dbd-b750-d7e5674bfbc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6c4421e3-e075-4542-80f1-6b44b0bd75d3" xlink:to="loc_us-gaap_ConvertibleDebtMember_545f2f0d-5165-4dbd-b750-d7e5674bfbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_95c9065f-e74e-49f5-be40-8afbe93c04fe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:to="loc_srt_RangeAxis_95c9065f-e74e-49f5-be40-8afbe93c04fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1949e4bc-7644-4801-ba69-24f1975f9a85" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_95c9065f-e74e-49f5-be40-8afbe93c04fe" xlink:to="loc_srt_RangeMember_1949e4bc-7644-4801-ba69-24f1975f9a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9ef70bb8-8b9f-4040-ae68-491674b43419" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1949e4bc-7644-4801-ba69-24f1975f9a85" xlink:to="loc_srt_MinimumMember_9ef70bb8-8b9f-4040-ae68-491674b43419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_08ff7bfd-f29c-4db2-80a0-fea7839f67b2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1949e4bc-7644-4801-ba69-24f1975f9a85" xlink:to="loc_srt_MaximumMember_08ff7bfd-f29c-4db2-80a0-fea7839f67b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a251a966-813d-491c-9dc8-917e50921cee" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_cac5f619-ebb6-4ba2-af6e-21b267b4d79f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_cac5f619-ebb6-4ba2-af6e-21b267b4d79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_f7e9ca24-ae99-483d-a123-1c1b4ca8076a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_ConvertibleDebt_f7e9ca24-ae99-483d-a123-1c1b4ca8076a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_60754164-c3fe-44dc-bcce-ea532ad68197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_60754164-c3fe-44dc-bcce-ea532ad68197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_f737a9dd-68d3-4a06-856c-a188153a02d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_f737a9dd-68d3-4a06-856c-a188153a02d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_cf32e1da-2146-4a8a-b60b-a50e14440c46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_LongTermDebt_cf32e1da-2146-4a8a-b60b-a50e14440c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_008d80e3-3805-4af1-a74d-661955ccd4e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_008d80e3-3805-4af1-a74d-661955ccd4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_6fabe028-8bf9-4449-8b4b-0fdfbb502783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_DebtInstrumentTerm_6fabe028-8bf9-4449-8b4b-0fdfbb502783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_DebtRedemptionMultipleFeature_87902b41-f714-4c80-b969-56b38f68e173" xlink:href="ocgn-20200930.xsd#ocgn_DebtRedemptionMultipleFeature"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_ocgn_DebtRedemptionMultipleFeature_87902b41-f714-4c80-b969-56b38f68e173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount_94c4550a-f2d3-4baf-9ddd-9772c06ba44e" xlink:href="ocgn-20200930.xsd#ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount_94c4550a-f2d3-4baf-9ddd-9772c06ba44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_1d5f5b89-9a3a-41c7-b2fa-e72eeaee6399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_1d5f5b89-9a3a-41c7-b2fa-e72eeaee6399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_42493744-5c5a-4eae-9560-1053ad95cb04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_CommonStockSharesIssued_42493744-5c5a-4eae-9560-1053ad95cb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_06b15d73-cdee-434f-9254-2d4fa21cf5ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_06b15d73-cdee-434f-9254-2d4fa21cf5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_46f3fbe9-07f4-4547-b1ff-ea1005ba9826" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_46f3fbe9-07f4-4547-b1ff-ea1005ba9826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_b6d68127-be57-424b-80ed-61025abe0001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d3dc03bd-0ccb-455c-8dc6-f307e1ba6a0b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_b6d68127-be57-424b-80ed-61025abe0001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#DebtScheduleofDebtMaturitiesExcludingInterestDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_daa99d4e-991c-4575-9205-7825babbb57b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_ce8c4ff3-7872-48e9-80fd-59013050f2a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_daa99d4e-991c-4575-9205-7825babbb57b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_ce8c4ff3-7872-48e9-80fd-59013050f2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_557a776a-171a-4ac6-a2ad-462ac95799ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_daa99d4e-991c-4575-9205-7825babbb57b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_557a776a-171a-4ac6-a2ad-462ac95799ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_fb9baf78-a313-4ffe-9a9a-c5b7a953a57f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_daa99d4e-991c-4575-9205-7825babbb57b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_fb9baf78-a313-4ffe-9a9a-c5b7a953a57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_6f1b68b8-779a-4c5c-b0aa-7bba2340e255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_daa99d4e-991c-4575-9205-7825babbb57b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_6f1b68b8-779a-4c5c-b0aa-7bba2340e255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e3a55499-0313-49e9-87fa-0984a26b1db2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_daa99d4e-991c-4575-9205-7825babbb57b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e3a55499-0313-49e9-87fa-0984a26b1db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_LongTermDebtMaturityAfterYearFour_4d918919-2560-4867-94e0-c654c4570988" xlink:href="ocgn-20200930.xsd#ocgn_LongTermDebtMaturityAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_daa99d4e-991c-4575-9205-7825babbb57b" xlink:to="loc_ocgn_LongTermDebtMaturityAfterYearFour_4d918919-2560-4867-94e0-c654c4570988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ee5b8058-7de4-41de-ba8b-a5c956cb0f89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_daa99d4e-991c-4575-9205-7825babbb57b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ee5b8058-7de4-41de-ba8b-a5c956cb0f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensation" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensation"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ca846768-755b-4cf7-ac6e-24471ccfdce0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ee9c0b2b-dc17-4c0c-98c0-8b68ad2e219d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ca846768-755b-4cf7-ac6e-24471ccfdce0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ee9c0b2b-dc17-4c0c-98c0-8b68ad2e219d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14e2ba1d-a43f-4c03-801a-815354a6ea60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_3ff4aafe-a319-43d1-bb1f-c4cb25747bad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14e2ba1d-a43f-4c03-801a-815354a6ea60" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_3ff4aafe-a319-43d1-bb1f-c4cb25747bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_c5de99e5-85b7-4969-bc41-2f5efd695f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14e2ba1d-a43f-4c03-801a-815354a6ea60" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_c5de99e5-85b7-4969-bc41-2f5efd695f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_78f71b02-8fe1-4b9d-8535-b9506b92a463" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9fdc2b2d-7d91-4c78-8982-98f90eea80d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_78f71b02-8fe1-4b9d-8535-b9506b92a463" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9fdc2b2d-7d91-4c78-8982-98f90eea80d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_74cc6d6a-1ffb-4ddd-8492-a3235215daa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9fdc2b2d-7d91-4c78-8982-98f90eea80d8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_74cc6d6a-1ffb-4ddd-8492-a3235215daa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a29f4611-0200-472d-9d43-0a07369d2ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_74cc6d6a-1ffb-4ddd-8492-a3235215daa0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a29f4611-0200-472d-9d43-0a07369d2ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_0983287a-1c41-4325-8f6e-f305f481d6dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a29f4611-0200-472d-9d43-0a07369d2ee6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_0983287a-1c41-4325-8f6e-f305f481d6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_18cd183a-671f-4c03-8698-092d96541ccf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a29f4611-0200-472d-9d43-0a07369d2ee6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_18cd183a-671f-4c03-8698-092d96541ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9c17fe3a-fe80-4c05-adc6-c74aeff00867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9fdc2b2d-7d91-4c78-8982-98f90eea80d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9c17fe3a-fe80-4c05-adc6-c74aeff00867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2e5f7a1d-2c54-49b6-8cb4-4c643fb06588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9c17fe3a-fe80-4c05-adc6-c74aeff00867" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2e5f7a1d-2c54-49b6-8cb4-4c643fb06588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_938a324d-1491-42f5-a2c3-4014c81a23e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e0c7fcd7-4c72-41ea-bb2d-7657c0de9a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_938a324d-1491-42f5-a2c3-4014c81a23e0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e0c7fcd7-4c72-41ea-bb2d-7657c0de9a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5597a65c-22e9-4614-92f2-c901012f7fcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e0c7fcd7-4c72-41ea-bb2d-7657c0de9a2a" xlink:to="loc_us-gaap_AwardTypeAxis_5597a65c-22e9-4614-92f2-c901012f7fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e6537be-8c04-4f74-99ca-d63b7214beae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5597a65c-22e9-4614-92f2-c901012f7fcb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e6537be-8c04-4f74-99ca-d63b7214beae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_A2014PlanMember_8d977f2b-1a88-401f-a2d0-944665daeb53" xlink:href="ocgn-20200930.xsd#ocgn_A2014PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e6537be-8c04-4f74-99ca-d63b7214beae" xlink:to="loc_ocgn_A2014PlanMember_8d977f2b-1a88-401f-a2d0-944665daeb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_A2019PlanMember_1e76ba4e-3706-40f9-83cd-bc8f1a11dddb" xlink:href="ocgn-20200930.xsd#ocgn_A2019PlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e6537be-8c04-4f74-99ca-d63b7214beae" xlink:to="loc_ocgn_A2019PlanMember_1e76ba4e-3706-40f9-83cd-bc8f1a11dddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ee5f8686-e2a1-45ab-ab8f-b71b9a832779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e6537be-8c04-4f74-99ca-d63b7214beae" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ee5f8686-e2a1-45ab-ab8f-b71b9a832779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_bbfd4ad4-9edf-4153-8d25-6e8d7fabc361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e6537be-8c04-4f74-99ca-d63b7214beae" xlink:to="loc_us-gaap_StockOptionMember_bbfd4ad4-9edf-4153-8d25-6e8d7fabc361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0dfc396d-9eb9-44e3-ac5f-c5b3715b9c58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e0c7fcd7-4c72-41ea-bb2d-7657c0de9a2a" xlink:to="loc_us-gaap_PlanNameAxis_0dfc396d-9eb9-44e3-ac5f-c5b3715b9c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_128c32b8-08e7-4d5e-9251-4ce9f6b44314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_0dfc396d-9eb9-44e3-ac5f-c5b3715b9c58" xlink:to="loc_us-gaap_PlanNameDomain_128c32b8-08e7-4d5e-9251-4ce9f6b44314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_A2014PlanMember_c062c86f-fcf7-41ca-8d82-86a17d6ae575" xlink:href="ocgn-20200930.xsd#ocgn_A2014PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_128c32b8-08e7-4d5e-9251-4ce9f6b44314" xlink:to="loc_ocgn_A2014PlanMember_c062c86f-fcf7-41ca-8d82-86a17d6ae575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_A2019PlanMember_15eea00f-7a48-476d-94d0-8eb6ce4a72a7" xlink:href="ocgn-20200930.xsd#ocgn_A2019PlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_128c32b8-08e7-4d5e-9251-4ce9f6b44314" xlink:to="loc_ocgn_A2019PlanMember_15eea00f-7a48-476d-94d0-8eb6ce4a72a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e0c7fcd7-4c72-41ea-bb2d-7657c0de9a2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_4d28b6ea-767d-4d1c-bd52-e107e7141d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_4d28b6ea-767d-4d1c-bd52-e107e7141d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e5973adb-d3de-447a-8c6b-0b37d87c703c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e5973adb-d3de-447a-8c6b-0b37d87c703c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_NumberOfEquityCompensationPlans_5386940a-a0f7-4fc4-8879-267e40826638" xlink:href="ocgn-20200930.xsd#ocgn_NumberOfEquityCompensationPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_ocgn_NumberOfEquityCompensationPlans_5386940a-a0f7-4fc4-8879-267e40826638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage_47a686d7-a768-4ec7-b6a0-3aa7555f1474" xlink:href="ocgn-20200930.xsd#ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage_47a686d7-a768-4ec7-b6a0-3aa7555f1474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_97b0e78e-a593-4ea5-8494-2ebb2699288d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_97b0e78e-a593-4ea5-8494-2ebb2699288d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_54b80be3-8b91-4112-83b7-822e326ded1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_54b80be3-8b91-4112-83b7-822e326ded1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_14a99f73-ec69-4eba-afdf-313ddb51a265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9dfaeffe-6696-42f9-9b1d-3f620705ce0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_14a99f73-ec69-4eba-afdf-313ddb51a265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d516b5dc-c92b-4edb-a000-eade633e57a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e5e34533-5522-4d6d-8c08-73b9a3d5ec2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d516b5dc-c92b-4edb-a000-eade633e57a6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e5e34533-5522-4d6d-8c08-73b9a3d5ec2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f83ac1e2-6e6f-42fd-b22c-0a3de7f3b8dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e5e34533-5522-4d6d-8c08-73b9a3d5ec2b" xlink:to="loc_us-gaap_AwardTypeAxis_f83ac1e2-6e6f-42fd-b22c-0a3de7f3b8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9f5eec98-3b91-4757-90dd-8b5436109dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f83ac1e2-6e6f-42fd-b22c-0a3de7f3b8dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9f5eec98-3b91-4757-90dd-8b5436109dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_A2019PlanMember_3370a332-a201-4765-9afb-d67c18a2a6a3" xlink:href="ocgn-20200930.xsd#ocgn_A2019PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9f5eec98-3b91-4757-90dd-8b5436109dec" xlink:to="loc_ocgn_A2019PlanMember_3370a332-a201-4765-9afb-d67c18a2a6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4cc6779-7940-4875-9862-38f88f71ac16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e5e34533-5522-4d6d-8c08-73b9a3d5ec2b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4cc6779-7940-4875-9862-38f88f71ac16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2e8d4e30-f394-448c-975a-4383aa2847dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4cc6779-7940-4875-9862-38f88f71ac16" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2e8d4e30-f394-448c-975a-4383aa2847dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6d466c93-8edc-4dce-a9e7-c28838970ede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2e8d4e30-f394-448c-975a-4383aa2847dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6d466c93-8edc-4dce-a9e7-c28838970ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e8160d8b-e2b1-4e8b-9cf7-b4fbac40af78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2e8d4e30-f394-448c-975a-4383aa2847dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e8160d8b-e2b1-4e8b-9cf7-b4fbac40af78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_69f51c4d-f584-4725-9128-ceb4db3a9059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2e8d4e30-f394-448c-975a-4383aa2847dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_69f51c4d-f584-4725-9128-ceb4db3a9059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d7f55512-b2c4-45e0-b2a7-f977d06fda5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2e8d4e30-f394-448c-975a-4383aa2847dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d7f55512-b2c4-45e0-b2a7-f977d06fda5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2c529907-3224-440c-b57a-89dd1ba1d5ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2e8d4e30-f394-448c-975a-4383aa2847dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2c529907-3224-440c-b57a-89dd1ba1d5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_54d84b15-b9b7-4674-bb19-d2adfa59520e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4cc6779-7940-4875-9862-38f88f71ac16" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_54d84b15-b9b7-4674-bb19-d2adfa59520e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_79c35fdd-30cc-4b49-916f-d0f46d6935c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_54d84b15-b9b7-4674-bb19-d2adfa59520e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_79c35fdd-30cc-4b49-916f-d0f46d6935c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_79e4b2c7-2c90-433d-ad8d-d9f6592b8558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_54d84b15-b9b7-4674-bb19-d2adfa59520e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_79e4b2c7-2c90-433d-ad8d-d9f6592b8558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_757699d5-a45b-43f2-9638-b70f8faed279" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_54d84b15-b9b7-4674-bb19-d2adfa59520e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_757699d5-a45b-43f2-9638-b70f8faed279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0993a36f-68c3-4b0a-adad-4219cb0831cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_54d84b15-b9b7-4674-bb19-d2adfa59520e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0993a36f-68c3-4b0a-adad-4219cb0831cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_65c6a6c6-b2e7-4fa7-b927-fee685eda95c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_54d84b15-b9b7-4674-bb19-d2adfa59520e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_65c6a6c6-b2e7-4fa7-b927-fee685eda95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f470110b-808a-4b47-8c75-fea2f601c462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4cc6779-7940-4875-9862-38f88f71ac16" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f470110b-808a-4b47-8c75-fea2f601c462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6a6bec7a-3ba3-4851-a912-f773f5b47500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f470110b-808a-4b47-8c75-fea2f601c462" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6a6bec7a-3ba3-4851-a912-f773f5b47500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1b8a34f4-d2b3-46f1-8464-5e49420d02e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f470110b-808a-4b47-8c75-fea2f601c462" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1b8a34f4-d2b3-46f1-8464-5e49420d02e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c2bf0a30-baaf-4c8f-a09f-52c24c7f08ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f470110b-808a-4b47-8c75-fea2f601c462" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c2bf0a30-baaf-4c8f-a09f-52c24c7f08ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_20a3fa70-9955-43d9-b568-3d0d289e7661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f470110b-808a-4b47-8c75-fea2f601c462" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_20a3fa70-9955-43d9-b568-3d0d289e7661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_33a01ea2-ab2e-4574-88f0-208a2aca865b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f470110b-808a-4b47-8c75-fea2f601c462" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_33a01ea2-ab2e-4574-88f0-208a2aca865b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/Commitments" xlink:type="simple" xlink:href="ocgn-20200930.xsd#Commitments"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/Commitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_520e68d1-a2bc-4644-81d2-d7cc84d2c16d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6f5d1797-0ea2-4ec8-9a3a-2d96372492ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_520e68d1-a2bc-4644-81d2-d7cc84d2c16d" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6f5d1797-0ea2-4ec8-9a3a-2d96372492ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsTables"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ab7ed106-69e5-4ff8-819c-9bb6286e0a70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_54267e10-2095-4343-9e12-a16cfa7bd423" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ab7ed106-69e5-4ff8-819c-9bb6286e0a70" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_54267e10-2095-4343-9e12-a16cfa7bd423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock_d7515b42-c5eb-4e5d-8963-09690c4ec735" xlink:href="ocgn-20200930.xsd#ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ab7ed106-69e5-4ff8-819c-9bb6286e0a70" xlink:to="loc_ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock_d7515b42-c5eb-4e5d-8963-09690c4ec735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_3dade082-f778-4df8-8ac1-75927154088d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ab7ed106-69e5-4ff8-819c-9bb6286e0a70" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_3dade082-f778-4df8-8ac1-75927154088d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d47cf243-aeaf-4fc5-8e15-cbf0e2de94fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ab7ed106-69e5-4ff8-819c-9bb6286e0a70" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d47cf243-aeaf-4fc5-8e15-cbf0e2de94fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_acbaf4e0-2e04-4d8b-9a29-3a4e495fe40d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ab7ed106-69e5-4ff8-819c-9bb6286e0a70" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_acbaf4e0-2e04-4d8b-9a29-3a4e495fe40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_65e673f6-c0b6-4a93-882b-5824fdcf63d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_78a00967-7e73-483b-a0d9-ba47a575e4c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_65e673f6-c0b6-4a93-882b-5824fdcf63d4" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_78a00967-7e73-483b-a0d9-ba47a575e4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7a5c9c01-aeb4-43f1-aaa5-c7db9e71d237" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_78a00967-7e73-483b-a0d9-ba47a575e4c0" xlink:to="loc_srt_RangeAxis_7a5c9c01-aeb4-43f1-aaa5-c7db9e71d237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7bda5401-138d-4183-b93a-e33b73bb2d4b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7a5c9c01-aeb4-43f1-aaa5-c7db9e71d237" xlink:to="loc_srt_RangeMember_7bda5401-138d-4183-b93a-e33b73bb2d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ac5030e3-1cb1-4298-aee9-d67bdb26e007" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7bda5401-138d-4183-b93a-e33b73bb2d4b" xlink:to="loc_srt_MinimumMember_ac5030e3-1cb1-4298-aee9-d67bdb26e007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e0283b65-68ce-495f-b19e-0945ebc4c353" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7bda5401-138d-4183-b93a-e33b73bb2d4b" xlink:to="loc_srt_MaximumMember_e0283b65-68ce-495f-b19e-0945ebc4c353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_3d80457c-938a-4631-a5bd-a6db3511a85f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_78a00967-7e73-483b-a0d9-ba47a575e4c0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_3d80457c-938a-4631-a5bd-a6db3511a85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_588f5ab2-0793-4475-8a96-c7ec3362de89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3d80457c-938a-4631-a5bd-a6db3511a85f" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_588f5ab2-0793-4475-8a96-c7ec3362de89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_34c32213-0309-45d7-9f57-655d51b4cd9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3d80457c-938a-4631-a5bd-a6db3511a85f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_34c32213-0309-45d7-9f57-655d51b4cd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDiscountRate_b2d99cdb-80e2-43e0-96b7-f6fcbbde8285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseDiscountRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3d80457c-938a-4631-a5bd-a6db3511a85f" xlink:to="loc_us-gaap_LesseeFinanceLeaseDiscountRate_b2d99cdb-80e2-43e0-96b7-f6fcbbde8285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsOperatingleasescomponentsofleaseexpenseDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_533887f4-2d1f-4306-b29e-9cebf118fb9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_bceb05bd-8e1c-4110-b2d6-34ff54c69d0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_533887f4-2d1f-4306-b29e-9cebf118fb9c" xlink:to="loc_us-gaap_OperatingLeaseCost_bceb05bd-8e1c-4110-b2d6-34ff54c69d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_143b6d8a-679c-4b67-9b17-1122f1d6be30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_533887f4-2d1f-4306-b29e-9cebf118fb9c" xlink:to="loc_us-gaap_VariableLeaseCost_143b6d8a-679c-4b67-9b17-1122f1d6be30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_7380fbe8-49af-47f8-a3c2-a0fb13b50b94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_533887f4-2d1f-4306-b29e-9cebf118fb9c" xlink:to="loc_us-gaap_LeaseCost_7380fbe8-49af-47f8-a3c2-a0fb13b50b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsOperatingleasessupplementalbalancesheetinformationDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_64cd1356-8db9-4dfa-9701-6a703243e87e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e46feb99-2458-4bf6-aa86-38b0c99ebc7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_64cd1356-8db9-4dfa-9701-6a703243e87e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e46feb99-2458-4bf6-aa86-38b0c99ebc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a9031fa7-1c94-412c-9806-d70f529839c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_64cd1356-8db9-4dfa-9701-6a703243e87e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a9031fa7-1c94-412c-9806-d70f529839c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a9e38e3d-db3e-46de-b1e8-f60c683bdccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_64cd1356-8db9-4dfa-9701-6a703243e87e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a9e38e3d-db3e-46de-b1e8-f60c683bdccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_16ec43e6-564a-4e6e-b2bf-078abb9d25dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_64cd1356-8db9-4dfa-9701-6a703243e87e" xlink:to="loc_us-gaap_OperatingLeaseLiability_16ec43e6-564a-4e6e-b2bf-078abb9d25dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalcashflowinformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsOperatingleasessupplementalcashflowinformationDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalcashflowinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_697e4479-0f1d-4d93-8259-2b75ac7135c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8b494140-1bc8-417b-97ed-f16109a29a96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_697e4479-0f1d-4d93-8259-2b75ac7135c7" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8b494140-1bc8-417b-97ed-f16109a29a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8d18b7ea-daba-4176-be50-dac316e4ecdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_697e4479-0f1d-4d93-8259-2b75ac7135c7" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8d18b7ea-daba-4176-be50-dac316e4ecdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsOperatingleasesfutureminimumleasepaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c44edbf2-e048-43ad-ac5e-b8fb1c39d10a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_662c72da-e8c3-4c5c-9c74-bbd352c5487a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c44edbf2-e048-43ad-ac5e-b8fb1c39d10a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_662c72da-e8c3-4c5c-9c74-bbd352c5487a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a0e32c70-a291-438b-b115-ac45839f71a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c44edbf2-e048-43ad-ac5e-b8fb1c39d10a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a0e32c70-a291-438b-b115-ac45839f71a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ed829495-2ac4-42af-b02c-c220b567c70a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c44edbf2-e048-43ad-ac5e-b8fb1c39d10a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ed829495-2ac4-42af-b02c-c220b567c70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_edce6d16-eff7-434f-9700-1cc1282222ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c44edbf2-e048-43ad-ac5e-b8fb1c39d10a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_edce6d16-eff7-434f-9700-1cc1282222ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_81b1bdec-fbba-47ca-b1a0-125e1227d5c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c44edbf2-e048-43ad-ac5e-b8fb1c39d10a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_81b1bdec-fbba-47ca-b1a0-125e1227d5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8a223786-1347-4ba9-830e-3348e3e68c9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c44edbf2-e048-43ad-ac5e-b8fb1c39d10a" xlink:to="loc_us-gaap_OperatingLeaseLiability_8a223786-1347-4ba9-830e-3348e3e68c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails_1" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsOperatingleasesfutureminimumleasepaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsFinanceleasesfutureminimumleasepaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_df4e468b-1a64-4424-a31e-17457549149b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_9bc4208f-e630-4956-935c-50e1a5ebdbef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_df4e468b-1a64-4424-a31e-17457549149b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_9bc4208f-e630-4956-935c-50e1a5ebdbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_413415fa-c6ea-42e5-99cd-fac3095735b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_df4e468b-1a64-4424-a31e-17457549149b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_413415fa-c6ea-42e5-99cd-fac3095735b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_579c2c9c-8e71-452a-a483-7eb2aaab07e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_df4e468b-1a64-4424-a31e-17457549149b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_579c2c9c-8e71-452a-a483-7eb2aaab07e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_90034575-0650-438e-8151-268c4b131d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_df4e468b-1a64-4424-a31e-17457549149b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_90034575-0650-438e-8151-268c4b131d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_3626a5e6-29c4-4216-a909-c8fc0584fcb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_df4e468b-1a64-4424-a31e-17457549149b" xlink:to="loc_us-gaap_FinanceLeaseLiability_3626a5e6-29c4-4216-a909-c8fc0584fcb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails_1" xlink:type="simple" xlink:href="ocgn-20200930.xsd#CommitmentsFinanceleasesfutureminimumleasepaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/Warrants" xlink:type="simple" xlink:href="ocgn-20200930.xsd#Warrants"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/Warrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_bbaa6dfd-35a9-4746-a3bc-c5d2f9bde3ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_WarrantsTextBlock_29a6f570-54e2-4cd1-909d-f17f804ffefb" xlink:href="ocgn-20200930.xsd#ocgn_WarrantsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_bbaa6dfd-35a9-4746-a3bc-c5d2f9bde3ab" xlink:to="loc_ocgn_WarrantsTextBlock_29a6f570-54e2-4cd1-909d-f17f804ffefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/WarrantsTables" xlink:type="simple" xlink:href="ocgn-20200930.xsd#WarrantsTables"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/WarrantsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_bc738967-7404-49a4-aac8-a8075ff6f6e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_1a830406-25ec-4e4a-a710-e799ba7f289c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_bc738967-7404-49a4-aac8-a8075ff6f6e4" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_1a830406-25ec-4e4a-a710-e799ba7f289c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#WarrantsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_becdf42d-5b30-4f5b-979f-c3952c6964b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_becdf42d-5b30-4f5b-979f-c3952c6964b1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_98b9670e-7b6e-48c8-ad75-cf804dc792e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_98b9670e-7b6e-48c8-ad75-cf804dc792e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1da6b6e6-03ae-4b01-8802-78148d49bab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_98b9670e-7b6e-48c8-ad75-cf804dc792e0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1da6b6e6-03ae-4b01-8802-78148d49bab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesAWarrantsMember_a17fcb7a-2817-4317-bbd5-4b4262a3963e" xlink:href="ocgn-20200930.xsd#ocgn_SeriesAWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1da6b6e6-03ae-4b01-8802-78148d49bab7" xlink:to="loc_ocgn_SeriesAWarrantsMember_a17fcb7a-2817-4317-bbd5-4b4262a3963e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesBWarrantsMember_3700ae6b-d15a-4400-b060-9134530b6567" xlink:href="ocgn-20200930.xsd#ocgn_SeriesBWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1da6b6e6-03ae-4b01-8802-78148d49bab7" xlink:to="loc_ocgn_SeriesBWarrantsMember_3700ae6b-d15a-4400-b060-9134530b6567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesCWarrantsMember_062e63b0-dc20-4b64-b6f7-9fee508c6f25" xlink:href="ocgn-20200930.xsd#ocgn_SeriesCWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1da6b6e6-03ae-4b01-8802-78148d49bab7" xlink:to="loc_ocgn_SeriesCWarrantsMember_062e63b0-dc20-4b64-b6f7-9fee508c6f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_FormerOcugenWarrantsMember_9bfc1311-3397-44fd-8956-6e603f241fef" xlink:href="ocgn-20200930.xsd#ocgn_FormerOcugenWarrantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1da6b6e6-03ae-4b01-8802-78148d49bab7" xlink:to="loc_ocgn_FormerOcugenWarrantsMember_9bfc1311-3397-44fd-8956-6e603f241fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_403db779-a775-43ff-bb06-9834bd6a7452" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:to="loc_srt_RangeAxis_403db779-a775-43ff-bb06-9834bd6a7452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bf0cb494-7723-4055-902b-025da508c60a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_403db779-a775-43ff-bb06-9834bd6a7452" xlink:to="loc_srt_RangeMember_bf0cb494-7723-4055-902b-025da508c60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_75dbeba2-2c15-4402-983f-c98ae3a4b14f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bf0cb494-7723-4055-902b-025da508c60a" xlink:to="loc_srt_MaximumMember_75dbeba2-2c15-4402-983f-c98ae3a4b14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7c4c611d-91b8-4a8a-bb08-fd002dcfb18d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7c4c611d-91b8-4a8a-bb08-fd002dcfb18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_664c201a-522a-4c46-86b8-eac1ef5552c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7c4c611d-91b8-4a8a-bb08-fd002dcfb18d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_664c201a-522a-4c46-86b8-eac1ef5552c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_4d4c104a-ad13-4ecf-80c3-1c33aa14910b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_664c201a-522a-4c46-86b8-eac1ef5552c3" xlink:to="loc_us-gaap_WarrantMember_4d4c104a-ad13-4ecf-80c3-1c33aa14910b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f05820a-7ed6-4015-a59a-ea069fdd7ab3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f05820a-7ed6-4015-a59a-ea069fdd7ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c0f9042f-6128-4fd9-b3da-4b5c2759810c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2f05820a-7ed6-4015-a59a-ea069fdd7ab3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c0f9042f-6128-4fd9-b3da-4b5c2759810c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_86316546-5e3b-4c80-9d26-1de0c1f89d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c0f9042f-6128-4fd9-b3da-4b5c2759810c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_86316546-5e3b-4c80-9d26-1de0c1f89d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_622b2260-5138-4581-b89d-9545f243f1c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_622b2260-5138-4581-b89d-9545f243f1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3e67291d-31da-4753-bc23-c24e18931f46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_622b2260-5138-4581-b89d-9545f243f1c4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3e67291d-31da-4753-bc23-c24e18931f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_WarrantsExchangedForCommonStockMember_4f07a427-01f9-4efd-8c99-3a8a3d5e9d4c" xlink:href="ocgn-20200930.xsd#ocgn_WarrantsExchangedForCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3e67291d-31da-4753-bc23-c24e18931f46" xlink:to="loc_ocgn_WarrantsExchangedForCommonStockMember_4f07a427-01f9-4efd-8c99-3a8a3d5e9d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_863f53fb-3349-4ea8-8eec-e611ada2a283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_863f53fb-3349-4ea8-8eec-e611ada2a283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_6d53c874-5b25-4808-827c-31c29e9917f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_863f53fb-3349-4ea8-8eec-e611ada2a283" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_6d53c874-5b25-4808-827c-31c29e9917f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_b237c264-df84-4eb7-9691-644b57050784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6d53c874-5b25-4808-827c-31c29e9917f4" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_b237c264-df84-4eb7-9691-644b57050784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_e9e2090d-ccf4-491c-8ee8-af098bddc7fc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6e0c07db-e26c-40f5-932a-00f3c57f70c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6e0c07db-e26c-40f5-932a-00f3c57f70c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_5b89a866-c59c-4d03-a59a-b9107ff9011e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_5b89a866-c59c-4d03-a59a-b9107ff9011e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_e13598b8-9e82-4ba7-9197-410959fb72a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_e13598b8-9e82-4ba7-9197-410959fb72a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered_1b1220db-acb2-46c5-b331-128dc1719309" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered_1b1220db-acb2-46c5-b331-128dc1719309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_aca4cb38-f0de-4715-9581-d064517397ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_aca4cb38-f0de-4715-9581-d064517397ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice_36d0a4f1-2474-4650-a916-bb7d50e6615c" xlink:href="ocgn-20200930.xsd#ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice_36d0a4f1-2474-4650-a916-bb7d50e6615c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_5a497f5b-15e3-4107-86ad-14c65b0ee75a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_5a497f5b-15e3-4107-86ad-14c65b0ee75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a82a1f9a-5c8a-41b5-946d-68ef8fc5ff18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a82a1f9a-5c8a-41b5-946d-68ef8fc5ff18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants_035ad122-a21c-43f6-b3b9-12da57a163c9" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants_035ad122-a21c-43f6-b3b9-12da57a163c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock_593c9a11-565a-48e8-b596-0c59a7cd7963" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock_593c9a11-565a-48e8-b596-0c59a7cd7963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote_186a803a-e53b-4fad-9225-9f82d4b43e37" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote_186a803a-e53b-4fad-9225-9f82d4b43e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue_71f6ebfe-04ec-46c0-a037-f5efc03cc3d2" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue_71f6ebfe-04ec-46c0-a037-f5efc03cc3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_cda67a0a-e6b0-4089-be0c-40c94dd40420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_cda67a0a-e6b0-4089-be0c-40c94dd40420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction_8e951dfd-2196-4609-ba3c-ea00a152d229" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction_8e951dfd-2196-4609-ba3c-ea00a152d229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_ClassOfWarrantOrRightExercisable_d626d888-5259-4ebc-85f7-fbef5b6e77a8" xlink:href="ocgn-20200930.xsd#ocgn_ClassOfWarrantOrRightExercisable"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_c2c12175-e9ef-4b80-b041-8efad039dc69" xlink:to="loc_ocgn_ClassOfWarrantOrRightExercisable_d626d888-5259-4ebc-85f7-fbef5b6e77a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6ce10110-b124-4a17-8cf2-37b1505e6713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_5534bf93-d55e-44c6-9bb7-9d64b0c6922c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6ce10110-b124-4a17-8cf2-37b1505e6713" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_5534bf93-d55e-44c6-9bb7-9d64b0c6922c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_4c0c8b76-27be-4126-90a6-546e7f0b469a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_5534bf93-d55e-44c6-9bb7-9d64b0c6922c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_4c0c8b76-27be-4126-90a6-546e7f0b469a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_8f995061-3d30-4881-a8b7-6ce7118a7342" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4c0c8b76-27be-4126-90a6-546e7f0b469a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_8f995061-3d30-4881-a8b7-6ce7118a7342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_SeriesBWarrantsMember_9715a109-d7c8-4c4e-9ce8-4969d52576cf" xlink:href="ocgn-20200930.xsd#ocgn_SeriesBWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_8f995061-3d30-4881-a8b7-6ce7118a7342" xlink:to="loc_ocgn_SeriesBWarrantsMember_9715a109-d7c8-4c4e-9ce8-4969d52576cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_62308dd8-0f58-4d36-8e6f-101febed1a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_5534bf93-d55e-44c6-9bb7-9d64b0c6922c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_62308dd8-0f58-4d36-8e6f-101febed1a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_25b4897c-37b6-4382-ab93-061ca076704e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_62308dd8-0f58-4d36-8e6f-101febed1a6e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_25b4897c-37b6-4382-ab93-061ca076704e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_09bf4964-3a5c-460a-94e7-71cde029d5d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_25b4897c-37b6-4382-ab93-061ca076704e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_09bf4964-3a5c-460a-94e7-71cde029d5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_181840f8-8906-40bd-9347-989041e8fb02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_25b4897c-37b6-4382-ab93-061ca076704e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_181840f8-8906-40bd-9347-989041e8fb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_d7087608-6dfd-486a-be7d-96cf8ec48963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_25b4897c-37b6-4382-ab93-061ca076704e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_d7087608-6dfd-486a-be7d-96cf8ec48963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity_a0d68f41-e2a9-43a2-bc40-1bebd9ccb000" xlink:href="ocgn-20200930.xsd#ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_25b4897c-37b6-4382-ab93-061ca076704e" xlink:to="loc_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity_a0d68f41-e2a9-43a2-bc40-1bebd9ccb000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_e290bdcb-4899-4498-b345-a458d05ff39d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_25b4897c-37b6-4382-ab93-061ca076704e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_e290bdcb-4899-4498-b345-a458d05ff39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SubsequentEvents" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_15e1e39e-d9ba-43df-b354-60b7933fec63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_b44e2d71-8489-407c-951f-eb27333b1cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_15e1e39e-d9ba-43df-b354-60b7933fec63" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_b44e2d71-8489-407c-951f-eb27333b1cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.deitaxonomy.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="ocgn-20200930.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.deitaxonomy.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_76fde575-24c8-4640-b347-af5b86a82e85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_47cb4bf8-6da3-4aad-88aa-4fe5c8db973e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_76fde575-24c8-4640-b347-af5b86a82e85" xlink:to="loc_us-gaap_SubsequentEventTable_47cb4bf8-6da3-4aad-88aa-4fe5c8db973e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4a5ede42-00df-4b8d-a658-f7b74467e683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_47cb4bf8-6da3-4aad-88aa-4fe5c8db973e" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4a5ede42-00df-4b8d-a658-f7b74467e683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f9176b4b-1fc8-47e6-83af-eaaffc42dd30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4a5ede42-00df-4b8d-a658-f7b74467e683" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f9176b4b-1fc8-47e6-83af-eaaffc42dd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f29247a5-ab40-4a51-b575-2e2b3d7df586" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f9176b4b-1fc8-47e6-83af-eaaffc42dd30" xlink:to="loc_us-gaap_SubsequentEventMember_f29247a5-ab40-4a51-b575-2e2b3d7df586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_b9790c27-5c7e-4ba3-a6a4-b19b7f2f0bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_47cb4bf8-6da3-4aad-88aa-4fe5c8db973e" xlink:to="loc_us-gaap_SubsequentEventLineItems_b9790c27-5c7e-4ba3-a6a4-b19b7f2f0bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_04e172ca-0701-4cd5-a935-4671179f842e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_b9790c27-5c7e-4ba3-a6a4-b19b7f2f0bb8" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_04e172ca-0701-4cd5-a935-4671179f842e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_OperatingLeaseTotalBasePayments_1f5b2398-19d1-45c8-8c6b-19bc41da419a" xlink:href="ocgn-20200930.xsd#ocgn_OperatingLeaseTotalBasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_b9790c27-5c7e-4ba3-a6a4-b19b7f2f0bb8" xlink:to="loc_ocgn_OperatingLeaseTotalBasePayments_1f5b2398-19d1-45c8-8c6b-19bc41da419a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions_eb085bb5-343b-4d6d-adb7-a1aa4cf9701c" xlink:href="ocgn-20200930.xsd#ocgn_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_b9790c27-5c7e-4ba3-a6a4-b19b7f2f0bb8" xlink:to="loc_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions_eb085bb5-343b-4d6d-adb7-a1aa4cf9701c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_3fea75b8-d1d8-4ba9-bf14-7a449062bf58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_b9790c27-5c7e-4ba3-a6a4-b19b7f2f0bb8" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_3fea75b8-d1d8-4ba9-bf14-7a449062bf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>ocgn-20200930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:ocgn="http://www.deitaxonomy.com/20200930"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ocgn-20200930.xsd" xlink:type="simple"/>
    <context id="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id9b6720c14554b3da72ba7b6c4c2146e_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="iafdd84fcd6fd4125bddedf4247bb3490_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id67dafc585b7439a9965e753932cfa64_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i336430b025bf42ab979315995a7658d8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i98e43846e414426d8a674b5b72c8ca6d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifd20a7846d8b4fc39d7c932264bb4ea1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9993a23cdf354d4e9040dbf206654bd0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4f8723a3bb064fb19050f09d0f6f3be8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i28157047c72a40388b8efc8371f6fcd9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i609c16341b0b455fb5cb9f1944534389_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i88dcd54d5b2b41e98760d2603e2e5b19_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i15660c6077044e16863b22305e9f8bf4_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i66618942a356454490c353406b315661_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6f1a10afb95b4de09f391c08ee58cb4a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie4a740be98724d9e987038a54f18720a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i31ecd93cc7af4dbaa563d03c878f6d01_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9669856efb5d4178a3b37eabd7255b5f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2dc4b283ea42412298190a0bb1c42842_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i394152742f2b46919b80f9aac6e0bdae_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i328e36f86432406a9c2335a6a30ed14e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iff5a8b4ad96a4423b5a5d8703b80fd89_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1d76dbaad2e54a01a5508dc7b046d2a2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1c5385b73d594d0cb6109dbeb0dd402f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2d3447d3ea544b67af6beab734e24ec1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i84ec37475ad1407b8afd9d013bad577a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ATMTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id7f4e1ed546c4dd3bbdecfae1575602d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ATMTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iafb9f9ece2254e5d96200b89c04d05ae_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ATMTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib3761ade97814636b361bfcc7c6b79e1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7c8324876bb7424fb4a9c74dbd244211_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5848bd936cb84e5c9b92ed98dc5efc4c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i21e4bdc375dc4ba88ea91dac7663985e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id0da0e17b44c4d069cb3178f2bcee63e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6525b0b5dc1b4d65ad83f61508bd23f7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i18aa74b3c07a4d74a32c957095f16197_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id9d5479720a7404bb1a1908a324dc51e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia40e42f6afba4d05aafce4ad7747ba3b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ATMTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifec1223b1319497b93668a034608cb1c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ATMTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2c44d34b710b4e7e85a02e804db3124f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ATMTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2890f5772ae94a0baf3455349ee0ef1e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9b195f0612774af0ac040960b61f8f93_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i893354ca24b44aea8098609fe2707967_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifcec84ede62e484c81eb25c7fadbd8fb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9fd67196ac9e4ddcbc7f6a1fe73988b1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id192bd6eec634f2999ed2c6284506bd2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib39682b0589a4563bb7ca6600d2c74bb_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if64358bdad2f49bb80ab64f710d95a09_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5ecffe72ae39480a8cc4dea5b165a9a9_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4cb32b18dd0a4067962fc9ab0625c09c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib2c738591a314487b302f77f09e6912a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4e8e99c2015f49bb951bff3956b8fa43_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1bd3fa288f1e4b63accc8a222321ed39_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i64c7a1ac8ad047eca985cb5ee6a0d2c2_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="iac9335d486854d3084e445a33994b49e_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i6958ed5917474f8296be96a2f1c58358_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i0540cef311b94b2cb1eaf0f5cb846d7c_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="icd37dadabb2844f9a10e911cb83f43c0_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i544370edaa6242a58ab1c22527f96140_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i8ec2583968c54b76b5925cc04d32749f_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ic9d5c4839f734f9d8af158d6419bc025_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i83bb706036a64f5ea79f154273a0ebe0_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i23ac27353df346c9933361da82476672_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6f2c719325c44e12b2d5790a34483527_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8aafdea70ac54f0092cc97d32f96a3a5_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib5a973efc1294d12ba97fd0f51a25d4a_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i856b691e765e44f8afa4a464a1e78d9e_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i83267470589c49dabfad039edd942ede_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i604296e53c7c4e829ae539a464ee39bf_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i5ba87472b7a74f70b1be08aa590ce293_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i428aecd8c23f42019007455d1a246411_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i92496e8c334d48b585f951d94a716b85_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i7ac0b7a5cf8e4897b11c2a3631e77ac0_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i1c82191e545a466984e92701810a3a95_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib0884c1459fe43f596eee437b5363a5a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ReverseAssetAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7760c1095dda43128a60a00128e94a57_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ReverseAssetAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9a53906430b5411ea8116131d4c97f45_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ReverseAssetAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2f73b959d8e14b9098644555fbd773bb_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:PreMergerFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i01d87cc2a4764d93ac0bdd0a8c59cb83_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:PreMergerFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8e43eec18c794fc481f0826a92482fc5_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:PreMergerFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i87973e4eacbb4326a84eb1f0a491f757_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i08862f2fb8e94c82b2e2dcbf7ad2b49f_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i3c1260fccbd4436ba5f9ed5d97ed88be_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ib7b469aa758f4755afe661f5ed2d8bf5_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i7bd31c10c4a3492e971d2489a2155990_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i2dc6aea499224e54b008c9eab809c76d_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="iff87527ea3fc46fdacb3342226f9f0f9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="id9576326dbf84d1db30189e963d4195f_D20210701-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4b761e61f7dd46ec849abd0bd8bb9544_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ocgn:HistogenicsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8c3c6f97b8e34fa1acfc3dcfa2747a64_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:EB5ProgramBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i93fa98ddee794faabb3a0a08669c9b82_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0cae5296d90e425585c0c15306000032_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i32e5f294ab464b6d83e4148060068867_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i48a7b850f34d4e93a932a1250a70dcdc_I20191004">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-04</instant>
        </period>
    </context>
    <context id="ie03e503b087545748223eb40f7381d1f_D20191004-20191004">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <startDate>2019-10-04</startDate>
            <endDate>2019-10-04</endDate>
        </period>
    </context>
    <context id="i1524a036f48541e08e32da279b7f7398_D20191004-20191004">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-04</startDate>
            <endDate>2019-10-04</endDate>
        </period>
    </context>
    <context id="i0feccca0bf2b43a1a54176fe040b711e_D20190508-20190508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ocgn:HistogenicsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-08</startDate>
            <endDate>2019-05-08</endDate>
        </period>
    </context>
    <context id="ibf034182282345c38684657f3ac357ca_D20191031-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ocgn:HistogenicsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-31</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ic3cf544d14484496ac45a00e1654a708_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ocgn:HistogenicsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1f29b990abbf4758b5d2b15e35483711_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie506a5cab5e247de846540df1b463305_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i59df5d0c89234b009956f4c9f8f30808_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5f62ded661e54fefb3a9fd8f2ba1bb64_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i538b5af19f0f4c5b8fc4c537c4a489d5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idc346fbec3d24dd58a12ad9d869ecfb2_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2380e13fd027491a936f449e6aa74829_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i76069125bcf9493eba6f0ce4826c29c2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifc8d8f8a93fc45e4b628285d72bb142a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i468172d3afbc4db09fe88fcad9e0d420_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i25dbded407394e83baa18d6851c893f9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i97cd3bc630954c2b9bcbbddafafde030_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibb251e6b072448dfa91521c08d3b3479_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0e6b2ef153df4c9788cd72ba0651ecfd_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iad1b963da04845bd956aea311c52d499_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i65d9eeb822d646fb9f1053229278fa42_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i402e841332864f65bad74eba8425cb79_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icb41ad76fece4484ae14bc550e4c9795_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="idfc7128277d343d4a99ba1fe8819b89d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id7d146e73e6e42e3a301e33bac8cd8ed_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id67b6ca4f8b24a43beb2890f097dc5c2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ocgn:AdvaiteIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibac481b8f449420f822e23ad5e256c76_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ocgn:AdvaiteIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2cc0ad28c5724aca9234dcc6309e44c1_D20200615-20200615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-15</startDate>
            <endDate>2020-06-15</endDate>
        </period>
    </context>
    <context id="ib65216302269446e88de6bdca0d4d78d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id3d9be1e13f34b61b21f7829259b9c08_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifd5fda4627a342a0982c1661cf0a687a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife4854f917da4de9b27b201328eadc2a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1851644d82bf4fb2b634fbb231dff413_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0c0ebd16833c4d9fb7640ffa8d1c822f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i74b18383221c462a91314443a371c7b1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic7c6f3716ee34faa9aa88da0c9ae7781_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3de6dd9388504be191f7056b17d3e22e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ieded657d1fda48e6b4c81175703563eb_I20200615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-15</instant>
        </period>
    </context>
    <context id="i705cda31adfa47b8bf226fde1fda52d5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ControlledEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib7205f6b303a46ca881e1f5b3771db48_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ControlledEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6788e535d4e547eaad37605b59a5e359_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ControlledEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="i641bb5999b314e3e9ff26b630c0802c5_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ControlledEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i84a2946964c741a8929a7e3b1f4d5681_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ControlledEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i3798aebd55684549850d5b6934cb938f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:ControlledEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4c39808114c84938bdbf2cfbe7968dba_I20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-22</instant>
        </period>
    </context>
    <context id="i891a1948cbf344f09e76772040e3fa8e_D20200606-20200606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-06</startDate>
            <endDate>2020-06-06</endDate>
        </period>
    </context>
    <context id="i36e49ecbf9c640919597478a362dc2c5_I20200606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-06</instant>
        </period>
    </context>
    <context id="i3b93323e957a4ce9b32abd082822d3d0_D20190405-20190405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-05</startDate>
            <endDate>2019-04-05</endDate>
        </period>
    </context>
    <context id="i954c5746ce5b45d1a940c37f489ee070_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id35de39551be499fbe3da2455d22798c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7f6eb732ec634b628ad24bc33e7f1a58_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i43ef6579c4fd4fce993710b539ee1478_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if855a3da2e6d45e0828572b9b374ebc3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:EB5ProgramBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iae6ba8a4f7f84d6da2219724a513733f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:EB5ProgramBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib962316dd8ec4a45b707ea8ffe2cfdca_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i8d689227ca8e441da7199a43bf5eb16a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i82bf19a1e632417380b5fe0e427dd9b7_I20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-22</instant>
        </period>
    </context>
    <context id="i202e82a2e6574f9395b0475edfae9fc0_I20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-22</instant>
        </period>
    </context>
    <context id="i2ca8387e786e470e94c2d428dd8b08be_I20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-22</instant>
        </period>
    </context>
    <context id="if8e397ca8e294216950367c054054ea4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idafa3d9adff54d838525f6e345d7b222_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaa36c601f8de4816bb5ac175ca991a52_D20201001-20201106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:WarrantExchangePromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-11-06</endDate>
        </period>
    </context>
    <context id="i89af07cba55243ada1a697e372c93c26_I20160930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:EB5ProgramBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-09-30</instant>
        </period>
    </context>
    <context id="i616e252088514e97a1bc3f1b262dcd7b_D20160901-20160930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:EB5ProgramBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-09-01</startDate>
            <endDate>2016-09-30</endDate>
        </period>
    </context>
    <context id="i4b78b94d3f034ec7b1df0ad282714b18_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:EB5ProgramBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i3b4ea6a10d05450090d47b47a43bceac_I20200326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:EB5ProgramBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-26</instant>
        </period>
    </context>
    <context id="ic2e106364d89410d8fa73ea0a7ada5a2_I20190521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:SeniorSecuredConvertibleNotesMay2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-21</instant>
        </period>
    </context>
    <context id="iec5ace5a1a5d48d78f81c3898beaf7cf_I20190628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:SeniorSecuredConvertibleNotesJune2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-28</instant>
        </period>
    </context>
    <context id="i9fe0b042d77c45bc9e7880606282df26_I20190927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:SeniorSecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-27</instant>
        </period>
    </context>
    <context id="i3a8ac0202f094c9288e4af258c9a7d6c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:SeniorSecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3b33f5ec1c0e4138ae4e880885651fb9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:SeniorSecuredConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9836b63cfe2f4fe7b7c0325bd22c222e_I20190404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-04</instant>
        </period>
    </context>
    <context id="iba956723fd0740239620e5f29bcb4ca7_I20190516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <instant>2019-05-16</instant>
        </period>
    </context>
    <context id="ie5d139f20a3148c98c5a49fbdcb7bc19_D20190516-20190516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <startDate>2019-05-16</startDate>
            <endDate>2019-05-16</endDate>
        </period>
    </context>
    <context id="i1a9a7d47ff164922b47b9474737d5697_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleNotesBoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i97a56e3f53224d4ab82457b6f444f1f4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleNotesBoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6e196fac2ce14f69a9c7145fc6153460_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5c95e5d478a04f07aafab89ce80821a5_I20180131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtJanuary2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-31</instant>
        </period>
    </context>
    <context id="i92b0bfa510874f698e53c5abd86cfac8_I20180131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtJanuary2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ocgn:ConvertibleDebtConversionFeatureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-31</instant>
        </period>
    </context>
    <context id="i3f4bd0c993144352beacd61bd76c907a_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtJune2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="if1ef8269ce6849a8bbaaf6f1dd81d930_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtJune2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ocgn:ConvertibleDebtConversionFeatureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i07700165b6f44737af43f19cf18c3b61_I20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtNovember2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="ic60fd8eff73747ec9eaa1854872d27d4_I20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtNovember2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ocgn:ConvertibleDebtConversionFeatureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="i8441ef9a2d3446daa0a9a5e613555095_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtDecember2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia31f6d3314ac41ffb1c478548ad440f7_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtDecember2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ocgn:ConvertibleDebtConversionFeatureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5349b87b7d764f64a46780bb66baca10_I20190131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtJanuary2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-31</instant>
        </period>
    </context>
    <context id="i10b818c696fa4a59b0fd450672c2f045_I20190131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtJanuary2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ocgn:ConvertibleDebtConversionFeatureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-31</instant>
        </period>
    </context>
    <context id="i83b69bf96efa4d168b3abf899bb9cc37_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtFebruary2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="i4c4f1fd7901c4793a17e268f79e0bcd9_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:ConvertibleDebtFebruary2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ocgn:ConvertibleDebtConversionFeatureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="i29b4f949ec244c099e380923e5e22554_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ocgn:ConvertibleDebtConversionFeatureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6eb84a90f81044ad8ec2490494674494_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i10c8c2503acb440f996a2813e4f347ab_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie9f2b124c93c4651bbb19190ff92d0ef_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iebb9183c07544982815cbf0318070f47_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8eb7409e74724c4aab7c90a052528902_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic2954e2e8a8d4d55987f92e0a1378c69_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6f3b2b81985349648981b7c33c6a0e02_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ica44cf11121f47e6b6dc2650b6be2704_I20190405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:November2018AndDecember2018NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-05</instant>
        </period>
    </context>
    <context id="i73acee8636ae4ab98d80f2c562867e27_I20190405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ocgn:January2019AndFebruary2019NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-05</instant>
        </period>
    </context>
    <context id="i6fa755318529457aba279a74293b8181_I20190405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-05</instant>
        </period>
    </context>
    <context id="i7122180f242946d99ad29848b79e37be_I20190405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-05</instant>
        </period>
    </context>
    <context id="i4bebf4b2ec794a58aac7839dd043db44_D20190405-20190405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-05</startDate>
            <endDate>2019-04-05</endDate>
        </period>
    </context>
    <context id="ia96a5be04b654077a75d8375d8a5d905_D20190405-20190405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <startDate>2019-04-05</startDate>
            <endDate>2019-04-05</endDate>
        </period>
    </context>
    <context id="icc5453f20d4e4f35b4a834519b122ec4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic43825ac7a304ddf9c2216ba906f7289_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i087644c141fc4d80854025dc438c16bd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3df75069d5314c0b83c03d93eff49c3b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i162d13dc4b1545c696e798ebac5d4a90_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i792572cf35bb4b92b612e3ff5498a49a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic13576b5389d4b328a17a5d499ac4d69_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0c53be1af7724b3faa590b77e842c7b7_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4c8969ef77c1411c9bf6a611f2e2d36e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7bae26e5ec3b4d6e959ffe614c098254_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ocgn:A2014PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ocgn:A2019PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie94bd56836134356a2b42c3d02bcd7b8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ocgn:A2014PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i132e89b796c1407695971319916c5052_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ocgn:A2019PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i112d9bfb269247e5a5787276fb3cd7ac_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ocgn:A2019PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i627461cada754117a3daf3d544a3877f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ocgn:A2019PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ocgn:A2019PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i98e284c9e1a54ade9b9c47c38c6b72d3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic33f61dc175243c98786068416fad0db_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2693db88967c4ff0a47ea33524803019_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i2e5809e665eb4fa1bf1cecdf798b302a_I20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-22</instant>
        </period>
    </context>
    <context id="ib4bee8b3a2e3430a8cbcbb7923b89e24_I20190927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-27</instant>
        </period>
    </context>
    <context id="i72db3f74703449b199225c6a20600560_D20190927-20190927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-27</startDate>
            <endDate>2019-09-27</endDate>
        </period>
    </context>
    <context id="i37caa52256c84c01ad82bb794238bc10_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i2639027910494f379046945f8a7d2bb9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifa4ad77ecf7d4e6a9604ede41d7878a1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id84738694cfc4f48a8223bc4775059da_I20190927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-27</instant>
        </period>
    </context>
    <context id="i41a7cddac3e8403d8a7b1b226753c6a6_I20191105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-05</instant>
        </period>
    </context>
    <context id="i5c449ee518aa4087bceac3f599d60b71_I20190927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-27</instant>
        </period>
    </context>
    <context id="i4e0e42f7805b40a7b369cb9a38e27242_D20190927-20190927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-27</startDate>
            <endDate>2019-09-27</endDate>
        </period>
    </context>
    <context id="i0391e6dd13e64542b9e6ef240aa2d783_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i09974af4f9294df7b673d1888259b853_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibc6f5729ecb242e484fb2d858d328ec4_I20190927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-27</instant>
        </period>
    </context>
    <context id="i7dd696ce560e4f74960fe7452fda5bd9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ief05580895fc46368234c7da5575be31_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if33032b532e54016bf273bdc3dc87946_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4e68dccda8164000aaf8c597ab10b628_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="if9c4014ea1664b28a89cbda4056472d5_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5d3016329c854e379eb39ead2fc7f7d1_D20200422-20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ocgn:WarrantsExchangedForCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-22</startDate>
            <endDate>2020-04-22</endDate>
        </period>
    </context>
    <context id="if5a1d88348ac442ca29916a0b2a044b7_D20200422-20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-22</startDate>
            <endDate>2020-04-22</endDate>
        </period>
    </context>
    <context id="ida7ba91283944cbaa8a66a0e1a833edb_D20200421-20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-21</startDate>
            <endDate>2020-04-21</endDate>
        </period>
    </context>
    <context id="ia5deeae01bef4c8e81884c72f6a8ce9d_I20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-21</instant>
        </period>
    </context>
    <context id="ia83d0c6aaf90427c82faff7bf369406a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:FormerOcugenWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5d1becb9d0b64817a37cabf28da5d1ee_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:FormerOcugenWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib9adecc5943843fd91836c9fb0e2c80e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ocgn:FormerOcugenWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6f2dc86eba1043a4b6a426c058150999_I20201009">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-09</instant>
        </period>
    </context>
    <context id="i86c757f96f724d6b8aaa688ac26a295e_D20201009-20201009">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001372299</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-09</startDate>
            <endDate>2020-10-09</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>ocgn:segment</measure>
    </unit>
    <unit id="orphan_drug_designation">
        <measure>ocgn:orphan_drug_designation</measure>
    </unit>
    <unit id="clinical_trial">
        <measure>ocgn:clinical_trial</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="series">
        <measure>ocgn:series</measure>
    </unit>
    <unit id="employee">
        <measure>ocgn:employee</measure>
    </unit>
    <unit id="numberofrenewaloptions">
        <measure>ocgn:numberOfRenewalOptions</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80L2ZyYWc6MjdlZTg2NTQ3OTI4NDQ5ZDhmYzM3ZmZhZjFmNWY4MjcvdGFibGU6NTQwNGRjODM4Y2U1NGRmN2I1ODFhNTRiMGQ1MTYzNWIvdGFibGVyYW5nZTo1NDA0ZGM4MzhjZTU0ZGY3YjU4MWE1NGIwZDUxNjM1Yl8xLTEtMS0xLTA_e0c61455-3b3a-4709-85ab-1036036459a3">0001372299</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80L2ZyYWc6MjdlZTg2NTQ3OTI4NDQ5ZDhmYzM3ZmZhZjFmNWY4MjcvdGFibGU6NTQwNGRjODM4Y2U1NGRmN2I1ODFhNTRiMGQ1MTYzNWIvdGFibGVyYW5nZTo1NDA0ZGM4MzhjZTU0ZGY3YjU4MWE1NGIwZDUxNjM1Yl8yLTEtMS0xLTA_69a8be51-4f1c-40a2-8ade-d0b7a0a3c8c6">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80L2ZyYWc6MjdlZTg2NTQ3OTI4NDQ5ZDhmYzM3ZmZhZjFmNWY4MjcvdGFibGU6NTQwNGRjODM4Y2U1NGRmN2I1ODFhNTRiMGQ1MTYzNWIvdGFibGVyYW5nZTo1NDA0ZGM4MzhjZTU0ZGY3YjU4MWE1NGIwZDUxNjM1Yl8zLTEtMS0xLTA_6bb39445-dd34-41c9-80c1-82b0c6a890e4">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80L2ZyYWc6MjdlZTg2NTQ3OTI4NDQ5ZDhmYzM3ZmZhZjFmNWY4MjcvdGFibGU6NTQwNGRjODM4Y2U1NGRmN2I1ODFhNTRiMGQ1MTYzNWIvdGFibGVyYW5nZTo1NDA0ZGM4MzhjZTU0ZGY3YjU4MWE1NGIwZDUxNjM1Yl80LTEtMS0xLTA_12e98aee-3076-454e-8b38-7105f6299772">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80L2ZyYWc6MjdlZTg2NTQ3OTI4NDQ5ZDhmYzM3ZmZhZjFmNWY4MjcvdGFibGU6NTQwNGRjODM4Y2U1NGRmN2I1ODFhNTRiMGQ1MTYzNWIvdGFibGVyYW5nZTo1NDA0ZGM4MzhjZTU0ZGY3YjU4MWE1NGIwZDUxNjM1Yl81LTEtMS0xLTA_644b869e-0eb4-4c20-a775-4b0a064eef6c">false</dei:AmendmentFlag>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="i4b761e61f7dd46ec849abd0bd8bb9544_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNy9mcmFnOjYzNmJhODY3ODRiNTRjYTg5ZTA1ODFkNjFhNTY3MDU0L3RhYmxlOjg2ODg3MDVlNDNkNDQ1YWM4MTBiYWRkNDU3MWIwZmI0L3RhYmxlcmFuZ2U6ODY4ODcwNWU0M2Q0NDVhYzgxMGJhZGQ0NTcxYjBmYjRfMy0xLTEtMS0w_a1255c8b-c3de-46f2-acb2-fc48c24c64f4"
      unitRef="number">0.0167</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i93fa98ddee794faabb3a0a08669c9b82_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2MTk_eb512e86-ca54-4b51-8e50-01fc17d11c9f">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i0cae5296d90e425585c0c15306000032_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2MjU_8897e6c7-9303-4adc-88de-47d481ae6e6d">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent
      contextRef="ieded657d1fda48e6b4c81175703563eb_I20200615"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81OC9mcmFnOjcwOTY4ZjYyZmZmNzQ2N2FiZjhjYjBlNzc5MTY4NTc3L3RhYmxlOjEwY2RmZjBlYWU5NjRmOWQ4NzI4YTJiN2VmZDY3NzgxL3RhYmxlcmFuZ2U6MTBjZGZmMGVhZTk2NGY5ZDg3MjhhMmI3ZWZkNjc3ODFfMC0wLTEtMS0w_2469c958-b145-4389-b4a3-afa770d75e80"
      unitRef="number">0.3333</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent>
    <us-gaap:DebtInstrumentTerm
      contextRef="i6eb84a90f81044ad8ec2490494674494_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjgzOQ_9250eb5b-b0ea-4f42-8cf2-a98505654eac">P18M</us-gaap:DebtInstrumentTerm>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i98e284c9e1a54ade9b9c47c38c6b72d3_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTk1_ae9976e8-4e79-4b4b-95fa-b8c561425fb1">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI3NQ_32d25827-fc2b-4183-a751-56c09cccc2ae">us-gaap:OtherLiabilities</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI3NQ_939a82e3-172c-4a98-a538-b4e48e03f315">us-gaap:OtherLiabilities</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i6f2dc86eba1043a4b6a426c058150999_I20201009"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF8xNjQ5MjY3NDQ2MzEx_c0cab281-7ade-48be-8c4a-31582fcb7c9d">P7Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i6f2dc86eba1043a4b6a426c058150999_I20201009"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF8xNjQ5MjY3NDQ2MjU0_e2515411-dba9-46d7-a836-2bb32ea59544">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <dei:DocumentType
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzA3_5a9e0755-b44f-42d1-839b-372e37d07f70">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6ODQ5MTEwOGNjNGMxNDMxYWFmYjQ3YTQ1YzZiMzVmYjYvdGFibGVyYW5nZTo4NDkxMTA4Y2M0YzE0MzFhYWZiNDdhNDVjNmIzNWZiNl8wLTAtMS0xLTA_7ddb30a1-6dbf-4ba9-841f-bfbcca63d7a5">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV83MTQ2ODI1NTgyOTA1_cb647f0b-ace7-489c-8dcd-5a1dc843a479">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6ZWNiMGVjZGM0NDRlNDU3NTkyNmFjMDFjNDAzNTkyMGUvdGFibGVyYW5nZTplY2IwZWNkYzQ0NGU0NTc1OTI2YWMwMWM0MDM1OTIwZV8wLTAtMS0xLTA_a16f4b33-9ff1-4bb9-8f70-9c27f36dfba2">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzAz_a9fd2248-b6ea-4e2f-9f33-a380fd51b41b">001-36751</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzA4_bc00191c-365b-4f39-bb0c-6991e03fd7db">OCUGEN, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6ZTA3MWZiNDViNGFiNGY4Mzk2MzgxZDgzMjk3MWZhZTgvdGFibGVyYW5nZTplMDcxZmI0NWI0YWI0ZjgzOTYzODFkODMyOTcxZmFlOF8wLTAtMS0xLTA_d21afb73-56bb-4fde-b165-76d5b46bb2fd">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6ZTA3MWZiNDViNGFiNGY4Mzk2MzgxZDgzMjk3MWZhZTgvdGFibGVyYW5nZTplMDcxZmI0NWI0YWI0ZjgzOTYzODFkODMyOTcxZmFlOF8wLTEtMS0xLTA_bdcc12ab-224c-4a02-b6d2-bc42fbddc9d4">04-3522315</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzA5_6cda0d5a-9d49-451e-a538-6a363bb9fdf4">5 Great Valley Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzEy_9e729cdf-a2b5-4a4d-a44c-b97ea59dbcd8">Suite 160</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzA0_429cc035-3ead-4f9e-888b-eb803d198466">Malvern</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzE0_715e2ebc-b2b9-4204-8145-0c169fe4a0be">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV81NDI_dc429b65-9a73-4232-b419-ff75bffe15d4">19355</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV82MDc_3464ea65-0ab5-4a16-9260-9d0f6e3d421f">484</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzE1_c0543009-8698-460e-84a3-7bb517e1e664">328-4701</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6ZjBiN2RhN2ZiYzQzNDFiMGI4Nzk3NmViN2UwMWMwOWUvdGFibGVyYW5nZTpmMGI3ZGE3ZmJjNDM0MWIwYjg3OTc2ZWI3ZTAxYzA5ZV8xLTAtMS0xLTA_01427a38-2708-409c-b485-3436786330f9">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6ZjBiN2RhN2ZiYzQzNDFiMGI4Nzk3NmViN2UwMWMwOWUvdGFibGVyYW5nZTpmMGI3ZGE3ZmJjNDM0MWIwYjg3OTc2ZWI3ZTAxYzA5ZV8xLTItMS0xLTA_1f55f834-1921-498c-9c10-d9cfb0d116fe">OCGN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6ZjBiN2RhN2ZiYzQzNDFiMGI4Nzk3NmViN2UwMWMwOWUvdGFibGVyYW5nZTpmMGI3ZGE3ZmJjNDM0MWIwYjg3OTc2ZWI3ZTAxYzA5ZV8xLTQtMS0xLTAvdGV4dHJlZ2lvbjo4MjRiNjZlYzFhNTI0ZTVlYjhjMzFjZWIyZTc1NjgyNF80_cb5d2835-0ae7-4a03-90b6-69b5766acabf">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzEw_e58e15bd-8f34-43a2-83de-b9a511c1d33a">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzEx_fffbcd61-4d98-4b97-b26e-934912a97302">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6Njk4NTEyNDQ1NjQzNGY4OWI2MjBkNWVhZTI4ODYyMGIvdGFibGVyYW5nZTo2OTg1MTI0NDU2NDM0Zjg5YjYyMGQ1ZWFlMjg4NjIwYl8xLTAtMS0xLTA_a0d752be-d19b-4c29-848d-4faae2b50d71">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6Njk4NTEyNDQ1NjQzNGY4OWI2MjBkNWVhZTI4ODYyMGIvdGFibGVyYW5nZTo2OTg1MTI0NDU2NDM0Zjg5YjYyMGQ1ZWFlMjg4NjIwYl8xLTMtMS0xLTA_16f62144-9d8b-4fac-9ed5-a4fc9947a219">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGFibGU6Njk4NTEyNDQ1NjQzNGY4OWI2MjBkNWVhZTI4ODYyMGIvdGFibGVyYW5nZTo2OTg1MTI0NDU2NDM0Zjg5YjYyMGQ1ZWFlMjg4NjIwYl8yLTMtMS0xLTA_6d76a311-c44f-43e3-8d6c-aca5a9bbeea5">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMzA2_3bdefdd4-8143-4af8-8ab5-f4df48f7a128">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="id9b6720c14554b3da72ba7b6c4c2146e_I20201030"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xL2ZyYWc6YzZiNDkzODY2YTE1NDViNGI5MmY3YjBiOGExNGE0OGEvdGV4dHJlZ2lvbjpjNmI0OTM4NjZhMTU0NWI0YjkyZjdiMGI4YTE0YTQ4YV8yMjE5_af355a16-bede-4424-8a52-2a33543203d7"
      unitRef="shares">162026473</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMy0xLTEtMS0w_dd8d4995-6dfc-456f-8592-2e3459ecc513"
      unitRef="usd">19105830</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMy0zLTEtMS0w_43590bac-b622-48ce-9184-7e16fc9b2428"
      unitRef="usd">7444052</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNC0xLTEtMS0w_1df691c7-256e-4d19-90cb-5ec0374182be"
      unitRef="usd">652893</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNC0zLTEtMS0w_d28b2a12-935b-4086-a8f9-32f8880ab0cb"
      unitRef="usd">1322167</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNS0xLTEtMS0w_6cd416e3-6f87-43a6-a378-c50c2d06f878"
      unitRef="usd">0</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNS0zLTEtMS0w_00db3b5f-14d6-46b6-9323-793f4c651ccb"
      unitRef="usd">7000000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNi0xLTEtMS0w_36fbadca-d0de-4bfb-9aac-44b65304ff11"
      unitRef="usd">19758723</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNi0zLTEtMS0w_5835f946-2462-42af-82b4-e34ab4c7c2ff"
      unitRef="usd">15766219</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNy0xLTEtMS0w_1eb796b9-bdc0-44d4-84eb-d50fc62f85f6"
      unitRef="usd">214100</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfNy0zLTEtMS0w_70913877-0546-4eb6-9c93-b654c56ae01c"
      unitRef="usd">222464</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfOC0xLTEtMS0w_0deaf608-9b25-44ba-b825-dd9db8f444c5"
      unitRef="usd">151196</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfOC0zLTEtMS0w_4ad0e26d-1bea-4e1f-a971-e9c549c9d15b"
      unitRef="usd">151016</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfOS0xLTEtMS0w_f2a9ccdc-6a13-40be-940c-f564ef032847"
      unitRef="usd">415555</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfOS0zLTEtMS0w_65e422f3-cc0e-4077-b3d9-9efc96da4cb3"
      unitRef="usd">667747</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTAtMS0xLTEtMA_0e610fb9-6cec-42a8-ba42-e31c6b7a5c37"
      unitRef="usd">20539574</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTAtMy0xLTEtMA_9c992799-8c29-49f2-bf22-40b9d7a857f7"
      unitRef="usd">16807446</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTMtMS0xLTEtMA_d38e014e-5fd2-4e2b-b500-e01c496931a9"
      unitRef="usd">222340</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTMtMy0xLTEtMA_6753ecb7-e657-4bea-946d-72a6c5b5d314"
      unitRef="usd">1895613</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTQtMS0xLTEtMA_23e1c75a-dc7d-4f6f-8326-0f13f6ea951e"
      unitRef="usd">2333733</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTQtMy0xLTEtMA_79ac7c66-c246-4941-b182-7979cca22ee9"
      unitRef="usd">2270045</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ShortTermBorrowings
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTUtMS0xLTEtMA_92b38b4f-9b1e-4258-8402-f1a45f4fd59a"
      unitRef="usd">1210645</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTUtMy0xLTEtMA_71c61994-0138-4896-a770-52e875b5b80a"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTYtMS0xLTEtMA_b1a7a804-2666-4cda-a02b-479fbfdaf2ed"
      unitRef="usd">164808</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTYtMy0xLTEtMA_19fad6e1-decf-4813-8815-f59978db351d"
      unitRef="usd">172310</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTctMS0xLTEtMA_3ac3a004-832e-41f3-8817-dbf97d8c0ae4"
      unitRef="usd">199261</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTctMy0xLTEtMA_32b86be6-7b90-4fe2-b685-eef5bb9a37d8"
      unitRef="usd">205991</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTgtMS0xLTEtMA_50d1649a-95a0-4972-9e7c-e6a1e7b49204"
      unitRef="usd">4130787</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMTgtMy0xLTEtMA_4d716eb2-4d6a-4fa9-9ae1-25f1dab680f6"
      unitRef="usd">4543959</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjAtMS0xLTEtMA_7b0bef14-429a-4aed-9474-f7cebd52c3fa"
      unitRef="usd">42746</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjAtMy0xLTEtMA_92b7a272-3ca9-4a86-85e9-305d8a0a21ec"
      unitRef="usd">163198</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjEtMS0xLTEtMA_794bcbb3-d27d-48d0-a54c-d4d5b39030e7"
      unitRef="usd">1944396</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjEtMy0xLTEtMA_6833dfdf-4bd3-4be6-a06a-cf6a447b3560"
      unitRef="usd">1072123</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjItMS0xLTEtMA_0cb8d086-02be-4310-8087-161b525aadf6"
      unitRef="usd">0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjItMy0xLTEtMA_c3f9f6e7-a4d5-4bad-bba2-f70e06d4b62a"
      unitRef="usd">9755</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjMtMS0xLTEtMA_8fd0d354-51f5-4844-9297-7af2cc171437"
      unitRef="usd">1987142</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjMtMy0xLTEtMA_783ad40d-b090-4d61-bb84-70b7f2cf07b2"
      unitRef="usd">1245076</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjQtMS0xLTEtMA_f151bd47-d6f3-4fed-9b98-57d50b2c86a6"
      unitRef="usd">6117929</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjQtMy0xLTEtMA_c33ac690-ffe6-4dee-82bd-7b8a3d82fe5f"
      unitRef="usd">5789035</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjUtMS0xLTEtMA_ab9cd5cd-d919-4ace-840f-a3fa45986c33"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjUtMy0xLTEtMA_1980226d-fe66-4716-973a-2e54a8dc9256"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzMz_2330f818-8e51-464b-ae12-dfcdc2b90d3d"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzMz_e3442711-63b2-472f-909f-f5e040cf82c1"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzQ3_5f8ce1a2-1f61-4ba7-9a3b-556bd99e68ea"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzQ3_8ad982fb-2ced-4189-b604-811396b7b3db"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzY5_1d8a2869-516b-445b-8bcf-d78cc6627d24"
      unitRef="shares">7</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzY5_22b03d8f-227b-4c28-b696-586ce3b5ce95"
      unitRef="shares">7</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzY5_40b05ce5-9cc5-4b07-87ab-0e0355202c4f"
      unitRef="shares">7</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmVlNzFlZGUyM2EyNDQ1NTk5ZTA0M2I1ODY4YjY2Y2IwXzY5_b1fc9df3-ae5c-47dd-9993-523cb5fa887e"
      unitRef="shares">7</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMS0xLTEtMA_226e8a7e-7590-48a6-95db-f2b2d8eaf099"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjctMy0xLTEtMA_16f9cf94-b982-46d6-9c64-10a864d1255c"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1XzE4_3468769f-fae9-4c13-a598-cb52913ce00b"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1XzE4_9c4d05ae-23d1-40c5-b341-728484078063"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1XzMy_b73ab170-0b2c-4835-ba58-7f7d72298183"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1XzMy_c9a65608-fe6d-434d-87ac-896b4fbe707c"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1XzQ3_d45a33c8-6276-48ea-bfd8-ad5ffb36719d"
      unitRef="shares">162147973</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1XzU0_c6035af3-6ef4-4722-9bb8-e830d002d9f7"
      unitRef="shares">52746728</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1Xzk5_5653a4e3-bddf-4de2-97c9-7e48f08a68c7"
      unitRef="shares">162026473</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmMzMzFlM2E1MDU5ZjRkNzE5MWY4MGNmOGZjMGUxOTk1XzEwNg_47e1015c-0c7d-46c6-adae-ea02b11e92e4"
      unitRef="shares">52625228</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMS0xLTEtMA_f75a2e5b-70c0-4d68-81a9-91a2df789002"
      unitRef="usd">1621480</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjgtMy0xLTEtMA_23fcbdae-c487-4a13-a615-8c6c82bb387d"
      unitRef="usd">527467</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmVlMjA3YTVmYTk0NTRjNGE5NGFkYmNmZmYzYjM2YTU4XzI5_1bda7c35-dba9-4992-99f4-b37c6c5bdefb"
      unitRef="shares">121500</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjktMC0xLTEtMC90ZXh0cmVnaW9uOmVlMjA3YTVmYTk0NTRjNGE5NGFkYmNmZmYzYjM2YTU4XzI5_7664b0c9-3e4d-42b7-90f0-a2e7591e5710"
      unitRef="shares">121500</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjktMS0xLTEtMA_50a3ccb0-69e1-43b7-96b1-75c900109098"
      unitRef="usd">47864</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMjktMy0xLTEtMA_76822ff4-5c0c-4f48-b48d-2ee036f6dd9d"
      unitRef="usd">47864</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzAtMS0xLTEtMA_f68ff825-d7d5-4b2e-99ae-0c01608db6f0"
      unitRef="usd">82359494</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzAtMy0xLTEtMA_42052fa9-bd69-4c7c-ba8a-a3d6eb828c36"
      unitRef="usd">62018632</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzEtMS0xLTEtMA_d8ac7205-e417-4efd-9b7a-c51594239f69"
      unitRef="usd">-69511465</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzEtMy0xLTEtMA_21ef4f7d-c213-4ad9-906a-7d4661e7edd0"
      unitRef="usd">-51479824</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzItMS0xLTEtMA_0f7e6960-e018-4d95-ad8e-d6e19b00d9bb"
      unitRef="usd">14421645</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzItMy0xLTEtMA_1bc07c42-77ac-459a-a818-7bf4f1bb1ca5"
      unitRef="usd">11018411</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzMtMS0xLTEtMA_8ccbf760-5979-4a3f-9718-27bae85070de"
      unitRef="usd">20539574</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xOS9mcmFnOjJhZDkwZmFhMjg3NzQ5MmY4MzNkY2ExZTk3OTQ1ZGRhL3RhYmxlOmMwYzA2ZmEzODI5MDQ0YzRhNGE3NDQwMjVjNGZmMTE5L3RhYmxlcmFuZ2U6YzBjMDZmYTM4MjkwNDRjNGE0YTc0NDAyNWM0ZmYxMTlfMzMtMy0xLTEtMA_21941542-fad2-4bc0-9172-2f29f181def4"
      unitRef="usd">16807446</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMy0xLTEtMS0w_75d83e8a-e1ad-423f-a59f-56102370e375"
      unitRef="usd">0</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMy0zLTEtMS0w_f63a4ea7-c8d4-4a4e-91f1-97400af88da2"
      unitRef="usd">0</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMy01LTEtMS0w_11493ce0-8cb4-4859-ac9f-79d083fc818b"
      unitRef="usd">42620</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMy03LTEtMS0w_4c628bc0-d699-4e04-be7d-01ad386158da"
      unitRef="usd">0</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:Revenues
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNC0xLTEtMS0w_e16dce20-783c-4cc5-ba8f-41eddc2bec2e"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNC0zLTEtMS0w_d0ef148f-564c-4b2f-9ee8-a00351fb9d6f"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNC01LTEtMS0w_b1efbba6-fd78-4684-84a5-43adf737b084"
      unitRef="usd">42620</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNC03LTEtMS0w_69ae3712-1e17-45f6-92ec-a6dab141ae84"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNi0xLTEtMS0w_01a8d579-f97c-40f9-811b-96c0dcbed9e3"
      unitRef="usd">1477382</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNi0zLTEtMS0w_9fd0cd28-e937-4a60-86b2-289f01a805a8"
      unitRef="usd">1305461</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNi01LTEtMS0w_9a8e739e-d3e9-46db-b118-05248198c32e"
      unitRef="usd">4759569</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNi03LTEtMS0w_dc6af499-d59a-49f4-80d9-2d0ab34dcb03"
      unitRef="usd">6338530</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNy0xLTEtMS0w_e90df425-0acf-4de6-bd0c-274e68edba53"
      unitRef="usd">7000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNy0zLTEtMS0w_61016a21-6c30-4466-bf26-610042cb306e"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNy01LTEtMS0w_44838579-a759-488e-91d9-ea21d1faa48e"
      unitRef="usd">7000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfNy03LTEtMS0w_656a9373-17fb-4daa-8d3b-d71d82fb1220"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOC0xLTEtMS0w_dda6fc11-ff0b-465e-9b4e-f92e47d1d906"
      unitRef="usd">1704598</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOC0zLTEtMS0w_dc9f100b-2fd9-4626-925e-8d0a63a61849"
      unitRef="usd">1408350</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOC01LTEtMS0w_97ff3626-0f2c-4576-b967-1915d6257325"
      unitRef="usd">5760398</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOC03LTEtMS0w_f34ee613-934e-4b37-924c-c2a38d766456"
      unitRef="usd">3544847</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOS0xLTEtMS0w_d6b28b30-53b6-4f87-937e-d70b2992c4cc"
      unitRef="usd">10181980</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOS0zLTEtMS0w_92d06b18-025c-4016-8c2f-9793756f3f8a"
      unitRef="usd">2713811</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOS01LTEtMS0w_96b6a419-79ed-47ca-a553-3baa0de9ca3b"
      unitRef="usd">17519967</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfOS03LTEtMS0w_fe0edbb5-7b63-4fed-a950-eced75b5702a"
      unitRef="usd">9883377</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTAtMS0xLTEtMA_c0ee4dca-a5fc-4526-853b-45faedcd7d74"
      unitRef="usd">-10181980</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTAtMy0xLTEtMA_f7c253dd-c13e-4e4a-a868-6d74245b7ad4"
      unitRef="usd">-2713811</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTAtNS0xLTEtMA_6542e5c6-42ca-4b8a-b338-806760dfef75"
      unitRef="usd">-17477347</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTAtNy0xLTEtMA_1d2abdd6-3e25-420f-b893-c998453fdff2"
      unitRef="usd">-9883377</us-gaap:OperatingIncomeLoss>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTItMS0xLTEtMA_d3293719-0865-47f5-a0bc-d227eabb2e95"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTItMy0xLTEtMA_a5944aed-1cfd-4e41-98b4-2ad8ace0b5fd"
      unitRef="usd">-18512204</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTItNS0xLTEtMA_7fbee6aa-c6ae-417b-8ee8-dd1b9a9a98e8"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTItNy0xLTEtMA_6b245f36-4e12-4b91-9a80-ed7f574ebd74"
      unitRef="usd">-19896626</us-gaap:LiabilitiesFairValueAdjustment>
    <ocgn:GainsLossesOnConversionOfDebt
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTMtMS0xLTEtMA_70a01538-7c78-4c19-8e64-ccd596f0ce93"
      unitRef="usd">0</ocgn:GainsLossesOnConversionOfDebt>
    <ocgn:GainsLossesOnConversionOfDebt
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTMtMy0xLTEtMA_1ae8aa2a-0a24-41e0-835e-86a5c2aad51e"
      unitRef="usd">0</ocgn:GainsLossesOnConversionOfDebt>
    <ocgn:GainsLossesOnConversionOfDebt
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTMtNS0xLTEtMA_43898244-c7a6-4b5d-a1ff-69824da3deaf"
      unitRef="usd">0</ocgn:GainsLossesOnConversionOfDebt>
    <ocgn:GainsLossesOnConversionOfDebt
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTMtNy0xLTEtMA_230f5fb2-014d-479b-b424-2fd8a9f322c6"
      unitRef="usd">-341136</ocgn:GainsLossesOnConversionOfDebt>
    <us-gaap:InvestmentIncomeInterest
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTQtMS0xLTEtMA_1d169ece-2b94-4c26-9ed9-a313c6baba57"
      unitRef="usd">42</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTQtMy0xLTEtMA_585f4b8e-a133-47b5-9361-a4bb6cae910d"
      unitRef="usd">136</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTQtNS0xLTEtMA_ad3f1fe0-f13e-4720-aea5-bf97c12f5271"
      unitRef="usd">594</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTQtNy0xLTEtMA_f1ca1fd2-a9cb-4a1f-ac15-bf91b537342f"
      unitRef="usd">1107</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTUtMS0xLTEtMA_60674d24-e350-47c5-b72a-993a473d1cad"
      unitRef="usd">291909</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTUtMy0xLTEtMA_abd1e343-b345-4185-827f-18115e1d188f"
      unitRef="usd">796141</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTUtNS0xLTEtMA_d1702f9f-b074-4f65-8410-211d7932f997"
      unitRef="usd">554801</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTUtNy0xLTEtMA_cf5db233-d292-475b-b36d-b089e06b27fe"
      unitRef="usd">1753172</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTYtMS0xLTEtMA_3ef3b64a-ebf8-401d-89b2-d8f96f33f7bc"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTYtMy0xLTEtMA_6e18d051-f4ef-4ad7-9b59-19da753162ee"
      unitRef="usd">-751261</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTYtNS0xLTEtMA_bea945c3-3c6c-4a57-90b0-eab61513924b"
      unitRef="usd">-87</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTYtNy0xLTEtMA_34c27295-30ba-480e-9372-8cdab07b3a30"
      unitRef="usd">-751493</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTctMS0xLTEtMA_21d70997-e9c2-4891-b5f4-16daaf3060cd"
      unitRef="usd">-291867</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTctMy0xLTEtMA_44d31c21-9806-4ce7-96a0-80df302b8764"
      unitRef="usd">-20059470</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTctNS0xLTEtMA_0c35729a-7d46-4313-90ce-836b1aa4a2be"
      unitRef="usd">-554294</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTctNy0xLTEtMA_89dbdaa4-ec84-482a-9d62-0e506cc2fa50"
      unitRef="usd">-22741320</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTgtMS0xLTEtMA_f39ff86b-e5f5-4d72-8a03-c5206b0b2432"
      unitRef="usd">-10473847</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTgtMy0xLTEtMA_a277f8ae-d5ba-476c-9ac6-4bf82021e65f"
      unitRef="usd">-22773281</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTgtNS0xLTEtMA_1a239651-46e5-44ff-81f0-01aafd5ffa89"
      unitRef="usd">-18031641</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTgtNy0xLTEtMA_85e132b4-64b8-420d-a0c0-4f2a40027464"
      unitRef="usd">-32624697</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTktMS0xLTEtMA_c35abf8d-2d5e-416c-9248-f11fbcb46aa4"
      unitRef="usd">0</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTktMy0xLTEtMA_451847c8-7d9b-40bf-ac2f-3e85482edca3"
      unitRef="usd">0</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTktNS0xLTEtMA_ada8ddfb-faaf-4a06-9657-9237f68e823b"
      unitRef="usd">12546340</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMTktNy0xLTEtMA_77f1062a-ac98-41a6-847a-b30a8d3d4048"
      unitRef="usd">0</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjAtMS0xLTEtMA_e693c6ec-fe9d-48e1-8978-1c5059404395"
      unitRef="usd">-10473847</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjAtMy0xLTEtMA_115e9260-0b9d-44a6-b8d9-aa560861a13f"
      unitRef="usd">-22773281</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjAtNS0xLTEtMA_2b739099-9b4c-4eaf-912b-b8abc4fa0e3b"
      unitRef="usd">-30577981</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjAtNy0xLTEtMA_f3a8031a-44a5-48a8-85fc-0c37a28ea35b"
      unitRef="usd">-32624697</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjItMS0xLTEtMA_966ac592-7b36-463e-b565-afff1ed2de53"
      unitRef="shares">141591218</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjItMy0xLTEtMA_e08c280f-bb58-4953-b940-c314a6adfac7"
      unitRef="shares">6411308</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjItNS0xLTEtMA_71006fb1-bc94-4ae4-af3a-23fa76faf536"
      unitRef="shares">92764157</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjItNy0xLTEtMA_d650297b-d7c6-40a8-b3e1-805dd1505066"
      unitRef="shares">5839840</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjMtMS0xLTEtMA_643f3ad2-56a4-45b8-b5ca-0203e7a5b4d8"
      unitRef="usdPerShare">-0.07</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjMtMy0xLTEtMA_956e6a0c-e8bd-433f-b78b-87ec9849a410"
      unitRef="usdPerShare">-3.55</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjMtNS0xLTEtMA_18d86f32-d6e8-44f0-81e1-50e229d1806c"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjMtNy0xLTEtMA_86ca969f-39ab-47b7-a38c-46c2ffd4997e"
      unitRef="usdPerShare">-5.59</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjUtMS0xLTEtMA_3dfb509d-ed0a-4d78-a54e-03e3e3759609"
      unitRef="usd">-10473847</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjUtMy0xLTEtMA_41c7eb3e-a1c2-4983-9e4c-8b37fc4c359c"
      unitRef="usd">-22773281</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjUtNS0xLTEtMA_7cc9079b-1665-42bf-81ba-001ec3ea9b30"
      unitRef="usd">-18031641</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjUtNy0xLTEtMA_d0ce2427-4714-4b47-927a-6ff6e2114c50"
      unitRef="usd">-32624697</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjctMS0xLTEtMA_99daaaaf-d947-4fb2-9bf8-8384593cb26c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjctMy0xLTEtMA_a4fc18d8-b37c-4a37-b659-8e0c9f389314"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjctNS0xLTEtMA_60c1e28b-ed91-4d83-80ed-7f82cc4d4d2d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjctNy0xLTEtMA_eaaa189f-73d1-4637-bae1-dbc47b0adaff"
      unitRef="usd">-451</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjgtMS0xLTEtMA_26d08803-73fb-4b0b-a941-9799ade2a171"
      unitRef="usd">-10473847</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjgtMy0xLTEtMA_5f1f4a74-4de1-4367-a7f1-223a0b4ee1f7"
      unitRef="usd">-22773281</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjgtNS0xLTEtMA_3cb5546b-45c6-4e5f-a370-083418104456"
      unitRef="usd">-18031641</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yMi9mcmFnOmZiZDFiZmU0ZjVkNjRmZjY5Zjk4NWZkMTg5NWNlZWQ5L3RhYmxlOjg4MTMyZTdiMThmZjRhZjRiODYwZjIxN2NhZTQxODJkL3RhYmxlcmFuZ2U6ODgxMzJlN2IxOGZmNGFmNGI4NjBmMjE3Y2FlNDE4MmRfMjgtNy0xLTEtMA_413eaba8-d4a2-408b-b854-51ceee27e299"
      unitRef="usd">-32625148</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="i98e43846e414426d8a674b5b72c8ca6d_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMi01LTEtMS0w_5cf0d292-3df6-4bd4-b19b-08417a7e7825"
      unitRef="shares">52746728</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i98e43846e414426d8a674b5b72c8ca6d_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMi03LTEtMS0w_6cf6941a-fa33-41e6-b52c-39499f1b28c8"
      unitRef="usd">527467</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifd20a7846d8b4fc39d7c932264bb4ea1_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMi05LTEtMS0w_da49646f-8613-43c2-8ba8-d3dc084613b8"
      unitRef="usd">-47864</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9993a23cdf354d4e9040dbf206654bd0_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMi0xMS0xLTEtMA_54720cbb-463a-4973-b328-6e19d986a6ec"
      unitRef="usd">62018632</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4f8723a3bb064fb19050f09d0f6f3be8_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMi0xMy0xLTEtMA_e31ded79-1298-4510-b39b-59b5cbeee2c9"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i28157047c72a40388b8efc8371f6fcd9_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMi0xNS0xLTEtMA_f36ef2cb-64b0-47ee-9fa8-3a83f3d96ef9"
      unitRef="usd">-51479824</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMi0xNy0xLTEtMA_81bb788b-14b5-4efe-b298-493299989b97"
      unitRef="usd">11018411</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i609c16341b0b455fb5cb9f1944534389_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMy0xMS0xLTEtMA_603a4879-bb05-47dd-b76b-cc971b591c40"
      unitRef="usd">222513</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i88dcd54d5b2b41e98760d2603e2e5b19_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMy0xNy0xLTEtMA_4f8e3bb9-7e72-4292-b8b1-6a54c29bf3db"
      unitRef="usd">222513</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i15660c6077044e16863b22305e9f8bf4_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNC0xNS0xLTEtMA_3969048b-ff1e-4222-bf89-2fb377c5e764"
      unitRef="usd">-3943819</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i88dcd54d5b2b41e98760d2603e2e5b19_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNC0xNy0xLTEtMA_e9162dbf-b1ee-4466-9545-92b2c16f123d"
      unitRef="usd">-3943819</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i66618942a356454490c353406b315661_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNS01LTEtMS0w_d3db942c-09e7-4829-8e76-5c0989ea9f2f"
      unitRef="shares">52746728</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i66618942a356454490c353406b315661_I20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNS03LTEtMS0w_63b160c8-3faf-480f-bba8-23dc4e7fd125"
      unitRef="usd">527467</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6f1a10afb95b4de09f391c08ee58cb4a_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNS05LTEtMS0w_5858f5b3-a534-4a00-ae89-106fbbc4ae63"
      unitRef="usd">-47864</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie4a740be98724d9e987038a54f18720a_I20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNS0xMS0xLTEtMA_422f827b-04f6-4cd0-ab0a-423d39f8d7c3"
      unitRef="usd">62241145</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i31ecd93cc7af4dbaa563d03c878f6d01_I20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNS0xMy0xLTEtMA_7d3a76eb-0b5d-4086-8d21-f98aa82e05ea"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9669856efb5d4178a3b37eabd7255b5f_I20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNS0xNS0xLTEtMA_1ee43c1f-84ae-4373-beb1-37e4c852a561"
      unitRef="usd">-55423643</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2dc4b283ea42412298190a0bb1c42842_I20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNS0xNy0xLTEtMA_f647fb3d-d0fd-4798-bcf5-a62fe30252b5"
      unitRef="usd">7297105</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i394152742f2b46919b80f9aac6e0bdae_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNi0xMS0xLTEtMA_d0909744-5bc4-49b8-b4ad-2a0671b43b1e"
      unitRef="usd">149209</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i328e36f86432406a9c2335a6a30ed14e_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNi0xNy0xLTEtMA_6ae179c7-090f-4c5c-84f0-c84fee822a12"
      unitRef="usd">149209</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="iff5a8b4ad96a4423b5a5d8703b80fd89_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNy01LTEtMS0w_f43e113a-155c-4899-835d-43b472a8d398"
      unitRef="shares">21920820</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="iff5a8b4ad96a4423b5a5d8703b80fd89_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNy03LTEtMS0w_96d99b71-a226-41f2-828a-b904dd4771d4"
      unitRef="usd">219208</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i394152742f2b46919b80f9aac6e0bdae_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNy0xMS0xLTEtMA_239d5803-455f-4514-8739-c54ff3a8483b"
      unitRef="usd">-5197084</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i328e36f86432406a9c2335a6a30ed14e_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfNy0xNy0xLTEtMA_af9c6a43-d861-4c7f-a727-97c36e1f75e7"
      unitRef="usd">-4977876</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i1d76dbaad2e54a01a5508dc7b046d2a2_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOC01LTEtMS0w_b089f9e0-25ff-473f-9e6b-2a9a4886f6a6"
      unitRef="shares">1328405</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i1d76dbaad2e54a01a5508dc7b046d2a2_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOC03LTEtMS0w_4ff7de06-f01b-4fb2-bd4f-100193979fed"
      unitRef="usd">13284</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i1c5385b73d594d0cb6109dbeb0dd402f_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOC0xMS0xLTEtMA_c27e48ab-9113-443d-82bc-70c5245819ca"
      unitRef="usd">318472</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i2d3447d3ea544b67af6beab734e24ec1_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOC0xNy0xLTEtMA_468ad7c1-62e3-402b-86ce-87877c2a0287"
      unitRef="usd">331756</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i84ec37475ad1407b8afd9d013bad577a_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOS0wLTEtMS0wL3RleHRyZWdpb246OWZmMGM5YjI3NDI5NDEwMmIyMDFlN2YzZDk4ODJlZDBfNDg_dac565ae-d96e-4ce9-993e-ded4de44f170"
      unitRef="usd">700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="id7f4e1ed546c4dd3bbdecfae1575602d_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOS01LTEtMS0w_1530f6e9-e00b-4d61-8309-efc44a423657"
      unitRef="shares">59132191</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="id7f4e1ed546c4dd3bbdecfae1575602d_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOS03LTEtMS0w_e2e51f3f-04a5-4b41-ac20-1863cffda0fb"
      unitRef="usd">591322</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="iafb9f9ece2254e5d96200b89c04d05ae_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOS0xMS0xLTEtMA_7422941f-ca18-47f6-b5d0-1970c9c111e5"
      unitRef="usd">14845486</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i84ec37475ad1407b8afd9d013bad577a_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfOS0xNy0xLTEtMA_cd51840c-a3b9-4a58-a769-8db92d3568fb"
      unitRef="usd">15436808</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="ib3761ade97814636b361bfcc7c6b79e1_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTAtMTUtMS0xLTA_505afa39-dc72-4b8f-b2b8-17ee192f2df2"
      unitRef="usd">-3613975</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i328e36f86432406a9c2335a6a30ed14e_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTAtMTctMS0xLTA_f351cd9e-989a-4716-9d8f-bc863b37cc41"
      unitRef="usd">-3613975</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i7c8324876bb7424fb4a9c74dbd244211_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTEtNS0xLTEtMA_ba928e3d-447a-4228-8e9e-bc36293abd4a"
      unitRef="shares">135128144</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7c8324876bb7424fb4a9c74dbd244211_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTEtNy0xLTEtMA_4632d845-a123-4c36-b27e-093d414b238d"
      unitRef="usd">1351281</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5848bd936cb84e5c9b92ed98dc5efc4c_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTEtOS0xLTEtMA_0e535c2e-eff9-46fe-9faf-a1690f04ae71"
      unitRef="usd">-47864</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i21e4bdc375dc4ba88ea91dac7663985e_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTEtMTEtMS0xLTA_3802c8d7-a875-4167-b50e-3f59b4349245"
      unitRef="usd">72357228</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id0da0e17b44c4d069cb3178f2bcee63e_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTEtMTMtMS0xLTA_49f5f5f4-420b-4087-baa0-a4f1317ff91c"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6525b0b5dc1b4d65ad83f61508bd23f7_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTEtMTUtMS0xLTA_d9a63688-533f-4e5a-bb9a-315f6251842d"
      unitRef="usd">-59037618</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i18aa74b3c07a4d74a32c957095f16197_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTEtMTctMS0xLTA_6cc9627a-7ecf-4520-8d1a-34e5d9f60e5b"
      unitRef="usd">14623027</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id9d5479720a7404bb1a1908a324dc51e_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTItMTEtMS0xLTA_eb23c322-16cc-46b2-ace1-395ce21919b1"
      unitRef="usd">126290</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTItMTctMS0xLTA_69352188-2a0a-402e-b0b9-3e882d4bd972"
      unitRef="usd">126290</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="ia40e42f6afba4d05aafce4ad7747ba3b_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTMtMC0xLTEtMzcvdGV4dHJlZ2lvbjpiOTg2MmFlYzcwMDA0YzRhOTJhMDdjY2NiNzdmY2ZhOF8xMDk5NTExNjI3ODg4_226c480e-78a4-4c98-9a7e-029befb87e19"
      unitRef="usd">400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ifec1223b1319497b93668a034608cb1c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTMtNS0xLTEtMzM_4dc96e93-98fe-45ce-a202-6e4627697935"
      unitRef="shares">27019829</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ifec1223b1319497b93668a034608cb1c_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTMtNy0xLTEtMzM_f6e22649-9bf5-49fd-8d04-f374c27f1c19"
      unitRef="usd">270199</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i2c44d34b710b4e7e85a02e804db3124f_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTMtMTEtMS0xLTMz_0b238359-d878-40f6-85da-4fbe982c96eb"
      unitRef="usd">9875976</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ia40e42f6afba4d05aafce4ad7747ba3b_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTMtMTctMS0xLTMz_401c26ef-ca29-4a4d-87d8-422bafb83802"
      unitRef="usd">10146175</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="i2890f5772ae94a0baf3455349ee0ef1e_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTMtMTUtMS0xLTA_06d4cb5f-57bd-4c22-89fd-5b384f981f68"
      unitRef="usd">-10473847</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTMtMTctMS0xLTA_c930be02-a669-48a0-8f3a-5b5a61bb1f1b"
      unitRef="usd">-10473847</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i9b195f0612774af0ac040960b61f8f93_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTQtNS0xLTEtMA_bd64b9e5-b985-4c5c-9f0f-a8249f176072"
      unitRef="shares">162147973</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i9b195f0612774af0ac040960b61f8f93_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTQtNy0xLTEtMA_ce6780d3-c3cd-4863-9acd-7a0e0be190e5"
      unitRef="usd">1621480</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i893354ca24b44aea8098609fe2707967_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTQtOS0xLTEtMA_25c0a65d-babc-4ff4-836e-08ca1019fea5"
      unitRef="usd">-47864</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifcec84ede62e484c81eb25c7fadbd8fb_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTQtMTEtMS0xLTA_e5be5645-b75a-4151-ae29-9ca684e205b3"
      unitRef="usd">82359494</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9fd67196ac9e4ddcbc7f6a1fe73988b1_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTQtMTMtMS0xLTA_4f6017a0-cabd-4bd2-80a0-bb0bea381d99"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id192bd6eec634f2999ed2c6284506bd2_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTQtMTUtMS0xLTA_25a9c709-e4cc-418d-b4f9-7b05680b5236"
      unitRef="usd">-69511465</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjgwNTdmNzEwMzIxMzQ0OWFiYTA1MjUwZjhlM2M4ZTUyL3RhYmxlcmFuZ2U6ODA1N2Y3MTAzMjEzNDQ5YWJhMDUyNTBmOGUzYzhlNTJfMTQtMTctMS0xLTA_ff397534-7ec4-4c8e-ab59-20998c2e2ad6"
      unitRef="usd">14421645</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ib39682b0589a4563bb7ca6600d2c74bb_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMi0xLTEtMS0w_f30e5125-8fcd-4ee8-a2a9-eee8960c6401"
      unitRef="shares">4960552</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib39682b0589a4563bb7ca6600d2c74bb_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMi0zLTEtMS0w_e4a37d98-0dfb-4e89-80d5-597c5966d52d"
      unitRef="usd">49606</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if64358bdad2f49bb80ab64f710d95a09_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMi01LTEtMS0w_9f147a67-0866-432d-b825-f7c2445201c3"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ecffe72ae39480a8cc4dea5b165a9a9_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMi03LTEtMS0w_66c6614c-9a05-490c-85e0-090b6a1b293f"
      unitRef="usd">18477598</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4cb32b18dd0a4067962fc9ab0625c09c_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMi05LTEtMS0w_6db2e1f3-66d4-46c4-a67b-e5bdab6ddc6c"
      unitRef="usd">451</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib2c738591a314487b302f77f09e6912a_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMi0xMS0xLTEtMA_f4bf0fd1-de3a-44c0-aaa2-b76da0f802cc"
      unitRef="usd">-31237194</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4e8e99c2015f49bb951bff3956b8fa43_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMi0xMy0xLTEtMA_c5a75f43-5c55-465e-ab96-513b450e4759"
      unitRef="usd">-12709539</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1bd3fa288f1e4b63accc8a222321ed39_D20190101-20190331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMy03LTEtMS0w_7b616f4b-cc19-414a-b633-42e29c549de8"
      unitRef="usd">415202</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i64c7a1ac8ad047eca985cb5ee6a0d2c2_D20190101-20190331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMy0xMy0xLTEtMA_4ad25ff4-30f9-44c7-beec-dcf1838f03b9"
      unitRef="usd">415202</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iac9335d486854d3084e445a33994b49e_D20190101-20190331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNC05LTEtMS0w_60dac18a-bceb-4abd-994d-c52fa102b24c"
      unitRef="usd">-282</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i64c7a1ac8ad047eca985cb5ee6a0d2c2_D20190101-20190331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNC0xMy0xLTEtMA_8e686025-e136-4f23-92e7-56d4a384832c"
      unitRef="usd">-282</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i6958ed5917474f8296be96a2f1c58358_D20190101-20190331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNS0xMS0xLTEtMA_79474c27-00fd-4aab-b2b0-3cf6af757692"
      unitRef="usd">-6312606</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i64c7a1ac8ad047eca985cb5ee6a0d2c2_D20190101-20190331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNS0xMy0xLTEtMA_49285a48-5517-4d1f-ad63-f452a682b7be"
      unitRef="usd">-6312606</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i0540cef311b94b2cb1eaf0f5cb846d7c_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNi0xLTEtMS0w_4c38acf9-2f05-4826-b049-6e3147682062"
      unitRef="shares">4960552</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i0540cef311b94b2cb1eaf0f5cb846d7c_I20190331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNi0zLTEtMS0w_1e0d7554-8ad4-4d60-a454-5b5e4ccdcaaf"
      unitRef="usd">49606</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icd37dadabb2844f9a10e911cb83f43c0_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNi01LTEtMS0w_d44d4537-6083-4c04-8e15-03e7f2873bb9"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i544370edaa6242a58ab1c22527f96140_I20190331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNi03LTEtMS0w_431946b1-9631-4596-afbe-86900f067750"
      unitRef="usd">18892800</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8ec2583968c54b76b5925cc04d32749f_I20190331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNi05LTEtMS0w_6bbc5019-7404-45dc-8ab7-7db52f289288"
      unitRef="usd">169</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic9d5c4839f734f9d8af158d6419bc025_I20190331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNi0xMS0xLTEtMA_9ecfda2d-454e-410e-9d11-cc281f03a762"
      unitRef="usd">-37549800</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i83bb706036a64f5ea79f154273a0ebe0_I20190331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNi0xMy0xLTEtMA_34f2c2a4-3848-43ff-9b09-f8555fa67cd9"
      unitRef="usd">-18607225</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i23ac27353df346c9933361da82476672_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNy03LTEtMS0w_a785ec32-208b-4cd1-bea4-15feb1734de0"
      unitRef="usd">111807</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6f2c719325c44e12b2d5790a34483527_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfNy0xMy0xLTEtMA_0f7df3ed-4cbf-4e38-8074-de8402409600"
      unitRef="usd">111807</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8aafdea70ac54f0092cc97d32f96a3a5_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfOC05LTEtMS0w_2a0efdb6-63e0-4225-8734-8d5107c438a6"
      unitRef="usd">-169</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6f2c719325c44e12b2d5790a34483527_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfOC0xMy0xLTEtMA_d12fecb7-9229-42bf-8e12-907a619fe521"
      unitRef="usd">-169</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="ib5a973efc1294d12ba97fd0f51a25d4a_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfOS0xLTEtMS0w_29f50417-f0f4-4d2c-a2cc-ad251dbc06d0"
      unitRef="shares">1125673</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ib5a973efc1294d12ba97fd0f51a25d4a_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfOS0zLTEtMS0w_b268c984-8dbf-4e02-877f-f700b0b869ac"
      unitRef="usd">11257</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i23ac27353df346c9933361da82476672_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfOS03LTEtMS0w_5e4ae3dc-4cea-473e-8db8-42e360855259"
      unitRef="usd">13968532</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i6f2c719325c44e12b2d5790a34483527_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfOS0xMy0xLTEtMA_3b57d191-1382-436c-abe3-173d977601b1"
      unitRef="usd">13979789</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ib5a973efc1294d12ba97fd0f51a25d4a_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTAtMS0xLTEtMA_570ac778-d9fb-437d-81ee-4b5e2412c70f"
      unitRef="shares">157743</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ib5a973efc1294d12ba97fd0f51a25d4a_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTAtMy0xLTEtMA_7407349e-28e3-4e50-b069-b1aef41edb19"
      unitRef="usd">1577</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i23ac27353df346c9933361da82476672_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTAtNy0xLTEtMA_d3f0cc62-3ee1-4cf4-bd74-09116c6dd2b3"
      unitRef="usd">1947308</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i6f2c719325c44e12b2d5790a34483527_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTAtMTMtMS0xLTA_8da56311-52fe-40fd-9b1d-ff32a450e54c"
      unitRef="usd">1948885</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="i856b691e765e44f8afa4a464a1e78d9e_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTEtMTEtMS0xLTA_7075a36f-95b8-4e21-8fe8-616f23e4955d"
      unitRef="usd">-3538810</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6f2c719325c44e12b2d5790a34483527_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTEtMTMtMS0xLTA_f4482302-2ff4-4883-bbe2-aeac729cb6b2"
      unitRef="usd">-3538810</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i83267470589c49dabfad039edd942ede_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTItMS0xLTEtMA_da074e63-2a1c-4bfc-943a-5582ed3ef6b4"
      unitRef="shares">6243968</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i83267470589c49dabfad039edd942ede_I20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTItMy0xLTEtMA_96450235-0015-4faf-98e8-2396e1740313"
      unitRef="usd">62440</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i604296e53c7c4e829ae539a464ee39bf_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTItNS0xLTEtMA_750dd02a-5ab1-4f16-865f-0ca38d9a4870"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ba87472b7a74f70b1be08aa590ce293_I20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTItNy0xLTEtMA_d31e89da-0358-4c10-bc22-fc95827d3283"
      unitRef="usd">34920447</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i428aecd8c23f42019007455d1a246411_I20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTItOS0xLTEtMA_432548b1-7ad0-42f2-b0a8-e208865b4dd2"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i92496e8c334d48b585f951d94a716b85_I20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTItMTEtMS0xLTA_015749c0-1813-4c06-8f6b-47652bd53419"
      unitRef="usd">-41088610</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7ac0b7a5cf8e4897b11c2a3631e77ac0_I20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTItMTMtMS0xLTA_0f9d2318-d6cd-4724-bf2e-d1acc307a13c"
      unitRef="usd">-6105723</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1c82191e545a466984e92701810a3a95_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTMtNy0xLTEtODI_47c45d8d-f231-4976-adaf-1da89cf7b1c2"
      unitRef="usd">193005</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTMtMTMtMS0xLTgy_0dda3811-0e14-4d9d-b700-01f5300f5668"
      unitRef="usd">193005</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="ib0884c1459fe43f596eee437b5363a5a_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTQtMC0xLTEtNTgvdGV4dHJlZ2lvbjpjYzA3Yjg2ZWJkMDI0YjVjYmZhYzFjODM1NTQ1ODAxY18xMDk5NTExNjI3ODY5_1e0ae699-88ad-4b53-bfaa-44ab7069416d"
      unitRef="usd">5000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i7760c1095dda43128a60a00128e94a57_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTQtMS0xLTEtODI_177d07bf-2e90-49f6-9b06-02445a6b67e4"
      unitRef="shares">1576655</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i7760c1095dda43128a60a00128e94a57_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTQtMy0xLTEtODI_1b9115e9-a649-49d1-80f2-ca42aeb936e7"
      unitRef="usd">15766</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i9a53906430b5411ea8116131d4c97f45_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTQtNy0xLTEtODI_7861e29d-045f-49e9-997a-15ca6ac8cf73"
      unitRef="usd">2325284</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ib0884c1459fe43f596eee437b5363a5a_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTQtMTMtMS0xLTgy_53ad25b3-c391-4330-ab29-f3a6557eaaec"
      unitRef="usd">2341050</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i2f73b959d8e14b9098644555fbd773bb_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTUtMC0xLTEtNTgvdGV4dHJlZ2lvbjpiOGJlNWVkYjM2YzM0MmI2OTE2ODFjMzlhYzEyYzE2MF8xMDk5NTExNjI3ODcz_eea71e58-384d-478e-9e97-3c3d8d49ba2f"
      unitRef="usd">1800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i01d87cc2a4764d93ac0bdd0a8c59cb83_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTUtMS0xLTEtODI_3af9bcfa-00d8-46e0-82b1-f31aa0516dfd"
      unitRef="shares">2192982</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i01d87cc2a4764d93ac0bdd0a8c59cb83_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTUtMy0xLTEtODI_019c68ec-a7f2-401d-892a-2b248c4d3b76"
      unitRef="usd">21930</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i8e43eec18c794fc481f0826a92482fc5_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTUtNy0xLTEtODI_4eb669bc-1878-424e-92ac-d5ed542db7ea"
      unitRef="usd">13229757</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i2f73b959d8e14b9098644555fbd773bb_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTUtMTMtMS0xLTgy_d4bf2f02-a560-4ef9-a565-86396e4812f1"
      unitRef="usd">13251687</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="i87973e4eacbb4326a84eb1f0a491f757_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTYtMTEtMS0xLTgy_84290494-5513-4ced-a01d-46dd995674fe"
      unitRef="usd">-22773281</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTYtMTMtMS0xLTgy_c8e8ea81-5813-4464-8938-d8356a3444c1"
      unitRef="usd">-22773281</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i08862f2fb8e94c82b2e2dcbf7ad2b49f_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTctMS0xLTEtODI_827640f4-c21e-4273-9ba0-f4304bbcfe15"
      unitRef="shares">10013605</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i08862f2fb8e94c82b2e2dcbf7ad2b49f_I20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTctMy0xLTEtODI_49012d64-4aa1-4108-925b-56474de1d84a"
      unitRef="usd">100136</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c1260fccbd4436ba5f9ed5d97ed88be_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTctNS0xLTEtODI_06027a25-327b-49cd-9583-e2794999d80a"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib7b469aa758f4755afe661f5ed2d8bf5_I20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTctNy0xLTEtODI_accc5237-2ec2-4c21-922a-ef35190f67d3"
      unitRef="usd">50668493</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7bd31c10c4a3492e971d2489a2155990_I20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTctOS0xLTEtODI_c9bf1a73-16ff-4635-9c4b-83de52eae501"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2dc6aea499224e54b008c9eab809c76d_I20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTctMTEtMS0xLTgy_4eab62aa-ae5e-40db-9699-55f6b6eb88aa"
      unitRef="usd">-63861891</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iff87527ea3fc46fdacb3342226f9f0f9_I20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yNS9mcmFnOjAyMDE5MDVhNmJmYjRiOWZhODhjM2UxYTYwNDU0YTRiL3RhYmxlOjBmN2UwMjU2NWVmNzQ4YzU5NDA4ZThkNjhlNDk0ODViL3RhYmxlcmFuZ2U6MGY3ZTAyNTY1ZWY3NDhjNTk0MDhlOGQ2OGU0OTQ4NWJfMTctMTMtMS0xLTgy_a933500f-dafc-4004-889f-bde5ab97ba5c"
      unitRef="usd">-13093262</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMy0xLTEtMS0w_42406fe5-08a1-48b2-b60c-31da1ea626e0"
      unitRef="usd">-18031641</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMy0zLTEtMS0w_201885b6-0bee-41e7-92ea-47622a3bc043"
      unitRef="usd">-32624697</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNS0xLTEtMS0w_2e1cae96-0461-4fe2-8566-742eb8b7bd3f"
      unitRef="usd">57565</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNS0zLTEtMS0w_eb55a2b8-a501-4789-8b69-42d3e6138ef5"
      unitRef="usd">34626</us-gaap:Depreciation>
    <ocgn:NonCashInterestExpense
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNi0xLTEtMS0w_8262651d-1d04-4196-be3e-f4720a834306"
      unitRef="usd">554801</ocgn:NonCashInterestExpense>
    <ocgn:NonCashInterestExpense
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNi0zLTEtMS0w_eabf43fd-08c1-4ea4-bd12-dc4f8b691e88"
      unitRef="usd">1718546</ocgn:NonCashInterestExpense>
    <ocgn:NoncashLeaseExpense
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNy0xLTEtMS0w_08017a28-9fe3-4787-8407-b1619b2ccc36"
      unitRef="usd">142947</ocgn:NoncashLeaseExpense>
    <ocgn:NoncashLeaseExpense
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNy0zLTEtMS0w_70916d78-ce02-4fc7-85ab-b7da5175f79d"
      unitRef="usd">202665</ocgn:NoncashLeaseExpense>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfOC0xLTEtMS0w_e956761a-27f6-4f3d-baef-c8700f2b4ad5"
      unitRef="usd">7000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfOC0zLTEtMS0w_e36c3c36-d410-4f6a-aafd-cd05546cb211"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfOS0xLTEtMS0w_3b51d234-5d48-42a1-8399-7acd85a3bd09"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfOS0zLTEtMS0w_0b1fa8eb-20a2-43b6-88c6-27cb45234455"
      unitRef="usd">-19896626</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTAtMS0xLTEtMA_b7a44d0f-cd77-4534-ae84-6243c7920303"
      unitRef="usd">498012</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTAtMy0xLTEtMA_b4e6ca0d-3553-480e-8a0f-f7ccdb51dcb0"
      unitRef="usd">720014</us-gaap:AllocatedShareBasedCompensationExpense>
    <ocgn:GainsLossesOnConversionOfDebt
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTEtMS0xLTEtMA_91177f01-472e-475d-b32f-85d8fccd0a82"
      unitRef="usd">0</ocgn:GainsLossesOnConversionOfDebt>
    <ocgn:GainsLossesOnConversionOfDebt
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTEtMy0xLTEtMA_99f84522-1402-4e0e-a3d4-ab6b48871292"
      unitRef="usd">-341136</ocgn:GainsLossesOnConversionOfDebt>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTItMS0xLTEtMA_fb25cfea-72c6-4741-a834-a55f4bff359d"
      unitRef="usd">165609</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTItMy0xLTEtMA_51c24b7b-e572-4085-a620-da26ba10a73a"
      unitRef="usd">0</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTQtMS0xLTEtMA_322b1289-8f50-4b22-b30b-ceef9fbdb8b5"
      unitRef="usd">-794398</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTQtMy0xLTEtMA_430b9c63-a266-4c03-beb7-93e99c6887bc"
      unitRef="usd">280838</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTYtMS0xLTEtMA_f9ee6d3d-ad4e-4407-b68b-01f1ca3f012c"
      unitRef="usd">-1133092</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTYtMy0xLTEtMA_639b0f54-aad1-464a-a589-191ddb0a13cf"
      unitRef="usd">2044901</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <ocgn:IncreaseDecreaseInLeaseObligations
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTctMS0xLTEtMA_8f3d4368-803d-4d97-a1ab-45231a4cc659"
      unitRef="usd">-143834</ocgn:IncreaseDecreaseInLeaseObligations>
    <ocgn:IncreaseDecreaseInLeaseObligations
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTctMy0xLTEtMA_1b47086a-7534-42c2-8d22-598b155ac639"
      unitRef="usd">-202338</ocgn:IncreaseDecreaseInLeaseObligations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTgtMS0xLTEtMA_c2355388-f5f9-4a47-82fc-54ce07cad8e5"
      unitRef="usd">-10426453</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMTgtMy0xLTEtMA_492e2255-5c33-449a-be31-786ce02f23b5"
      unitRef="usd">-8149359</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjAtMS0xLTEtMA_eb1828bd-13de-47ff-88d8-91ce8ff929b6"
      unitRef="usd">55488</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjAtMy0xLTEtMA_33d89cca-109e-4a7b-a89e-d085fe3e4566"
      unitRef="usd">2067</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjEtMS0xLTEtMA_fc7070e1-49b2-425f-8b61-b377c831619c"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjEtMy0xLTEtMA_c3585b17-c648-4179-bdae-c6bb1c68287c"
      unitRef="usd">2334063</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjItMS0xLTEtMA_6c58daf7-6e40-461e-ae36-9552406d7535"
      unitRef="usd">-55488</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjItMy0xLTEtMA_94e10a7a-bce6-41be-b06b-6d56ffd0b585"
      unitRef="usd">-2336130</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjQtMS0xLTEtMA_9b6cbabb-2d71-41b7-87fe-058bd328a5ef"
      unitRef="usd">17892</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjQtMy0xLTEtMA_ba1b3ac9-1091-4466-9ec4-76c0ef8e43ed"
      unitRef="usd">16985</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjUtMS0xLTEtMA_0d7689ac-3efc-4c56-9007-36f7c90c90a8"
      unitRef="usd">26692377</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjUtMy0xLTEtMA_9b570d0f-d93a-4e0a-9a5a-9c298f672ed6"
      unitRef="usd">999832</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjYtMS0xLTEtMA_fa135fa2-3ed0-4ab9-affd-92be421eeb0f"
      unitRef="usd">1083990</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjYtMy0xLTEtMA_c3877028-c0ae-4f8f-94ec-ab31647bdf0d"
      unitRef="usd">649254</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjctMS0xLTEtMA_4f9369e3-8c42-4a87-bc70-8672e2739a40"
      unitRef="usd">921415</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjctMy0xLTEtMA_42e0f859-61c7-4873-a75c-2a9b4c184fa8"
      unitRef="usd">6800000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjgtMS0xLTEtMA_2665cc9a-dcb0-45e7-8da8-9fd9ec666b7c"
      unitRef="usd">5740</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjgtMy0xLTEtMA_2b1ce09f-778b-4552-93a4-9cebda725a30"
      unitRef="usd">122262</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:RepaymentsOfOtherDebt
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjktMS0xLTEtMA_ec0ff976-0b99-47c5-8b2d-f3dc2255ffb4"
      unitRef="usd">4362271</us-gaap:RepaymentsOfOtherDebt>
    <us-gaap:RepaymentsOfOtherDebt
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMjktMy0xLTEtMA_1c2c1e01-ddaa-465c-bb44-09f85e8aa8f7"
      unitRef="usd">5290000</us-gaap:RepaymentsOfOtherDebt>
    <ocgn:ProceedsFromPreMergerFinancingFinancingActivities
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzAtMS0xLTEtMzc4_3e27cd24-ef76-4300-be81-0092b9285a42"
      unitRef="usd">0</ocgn:ProceedsFromPreMergerFinancingFinancingActivities>
    <ocgn:ProceedsFromPreMergerFinancingFinancingActivities
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzAtMy0xLTEtMzc4_920a4bb1-28f5-4478-a934-b0e16e05ae99"
      unitRef="usd">22437537</ocgn:ProceedsFromPreMergerFinancingFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzAtMS0xLTEtMA_3b8c15b9-20b7-4e07-975a-0ddec1b7b1df"
      unitRef="usd">22143899</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzAtMy0xLTEtMA_3daed63c-3d7d-4ca2-bb21-868251115038"
      unitRef="usd">24158868</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzEtMS0xLTEtMA_1c1f1b80-0d04-4939-822c-d09aa08d44dc"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzEtMy0xLTEtMA_0e28f499-5aa7-4d9f-a3a6-0a3610bfef95"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzItMS0xLTEtMA_9510287d-c2ca-42ca-ad79-a20670f10d13"
      unitRef="usd">11661958</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzItMy0xLTEtMA_dd4ebdc1-fd04-4a04-85ec-6aee0091f35e"
      unitRef="usd">13673379</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzMtMS0xLTEtMA_da5e7da4-1afd-4963-8b4b-4e4a11e07c63"
      unitRef="usd">7595068</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4e8e99c2015f49bb951bff3956b8fa43_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzMtMy0xLTEtMA_d03a4d99-c6aa-4c99-bb31-cb6236b29b8b"
      unitRef="usd">1778613</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzQtMS0xLTEtMA_a7859011-e130-400b-9ebc-1c47dcd2890d"
      unitRef="usd">19257026</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iff87527ea3fc46fdacb3342226f9f0f9_I20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzQtMy0xLTEtMA_1e46c090-f6b3-4160-abcf-2a07842c6f1b"
      unitRef="usd">15451992</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NotesIssued1
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzYtMS0xLTEtMA_efe694cb-a1c3-489f-ad08-85cb0ac235cc"
      unitRef="usd">5625000</us-gaap:NotesIssued1>
    <us-gaap:NotesIssued1
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzYtMy0xLTEtMA_358c72d7-494f-44e0-8353-62dcc61360b4"
      unitRef="usd">0</us-gaap:NotesIssued1>
    <us-gaap:StockIssued1
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzctMS0xLTEtMA_773e3129-a5bd-47c1-a88e-fe243b6d4b36"
      unitRef="usd">331218</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzctMy0xLTEtMA_d0d831ef-eb63-4f76-8ee0-1f173e3e914f"
      unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzgtMS0xLTEtMA_4e158742-fb91-4fd0-939d-1c14035df383"
      unitRef="usd">0</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfMzgtMy0xLTEtMA_cc39e275-0d70-4278-a120-36f30c1f19df"
      unitRef="usd">13979788</us-gaap:DebtConversionOriginalDebtAmount1>
    <ocgn:NoncashOrPartNoncashOperatingLeaseRightOfUseAsset
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNDAtMS0xLTEtMA_91f1288a-f9ee-46e8-b940-4cd2e289338d"
      unitRef="usd">0</ocgn:NoncashOrPartNoncashOperatingLeaseRightOfUseAsset>
    <ocgn:NoncashOrPartNoncashOperatingLeaseRightOfUseAsset
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNDAtMy0xLTEtMA_0461419e-695d-443c-aaf5-7b801440b5cb"
      unitRef="usd">470356</ocgn:NoncashOrPartNoncashOperatingLeaseRightOfUseAsset>
    <ocgn:NoncashOrPartNoncashAmountOfDeferredTransactionCost
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNDItMS0xLTEtMjg0MQ_49da5034-3ebb-462b-91ae-407f878751dd"
      unitRef="usd">25000</ocgn:NoncashOrPartNoncashAmountOfDeferredTransactionCost>
    <ocgn:NoncashOrPartNoncashAmountOfDeferredTransactionCost
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNDItMy0xLTEtMjg0MQ_7f75d35d-fc34-49fa-966a-a82cf3a4b3e7"
      unitRef="usd">1150000</ocgn:NoncashOrPartNoncashAmountOfDeferredTransactionCost>
    <ocgn:DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNDMtMS0xLTEtMzk0_192f3798-ae72-4ccb-a8c6-d8d51a63fd20"
      unitRef="usd">0</ocgn:DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction>
    <ocgn:DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8yOC9mcmFnOjk2NmE5YzY4ZmJmMjQ0ZWQ5NDkwOTEyM2RhZWU1ZjNhL3RhYmxlOjQ1ZWUyY2YyMzA3ZjQwYzlhZjBkMjk2N2VhNjk3MjVkL3RhYmxlcmFuZ2U6NDVlZTJjZjIzMDdmNDBjOWFmMGQyOTY3ZWE2OTcyNWRfNDMtMy0xLTEtMzkw_330f8269-bfed-451a-9745-00e24cef2d74"
      unitRef="usd">2711431</ocgn:DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:NatureOfOperations
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfNzM0MA_9b4968c8-6cc6-4553-81f7-a6fd886d96d7">Nature of Business&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ocugen, Inc. (formerly known as Histogenics Corporation), together with its wholly owned subsidiaries (&#x201c;Ocugen&#x201d; or the &#x201c;Company&#x201d;), is a biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to cure blindness diseases. The Company is located in Malvern, Pennsylvania, and manages its business as one operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ocugen is developing a modifier gene therapy platform to generate therapies designed to fulfill unmet medical needs in the area of retinal diseases, including inherited retinal diseases ("IRDs") and dry age-related macular degeneration ("AMD"). Ocugen's modifier gene therapy platform is based on nuclear hormone receptors ("NHRs") which have the potential to restore homeostasis, the basic biological processes in the retina. Unlike single-gene replacement therapies, which only target one genetic mutation, Ocugen believes that its gene therapy platform, through its use of NHRs, represents a novel approach in that it may address multiple retinal diseases with one product. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ocugen's first gene therapy candidate, OCU400, is being developed to treat retinitis pigmentosa ("RP"), a group of rare genetic disorders that involves a breakdown and loss of cells in the retina and can lead to visual impairment and blindness. Ocugen has received four Orphan Drug Designations ("ODDs") from the Food and Drug Administration ("FDA") for the treatment of certain disease genotypes: nuclear receptor subfamily 2 group E member 3 ("&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;NR2E3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;"), centrosomal protein 290 ("&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CEP290&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;"), rhodopsin ("&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;RHO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;"), and phosphodiesterase 6B ("&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;PDE6B&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;") mutation-associated RP. Ocugen is planning to initiate two Phase 1/2a clinical trials for OCU400 in the second half of 2021. Ocugen's second gene therapy candidate, OCU410, is being developed to utilize the nuclear receptor genes RAR-related orphan receptor A ("&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;RORA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;") for the treatment of dry AMD. This candidate is currently in preclinical development. Ocugen is planning to initiate a Phase 1/2a clinical trial for OCU410 in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ocugen is also conducting preclinical development for its biologic product candidate, OCU200. OCU200 is a novel fusion protein designed to treat diabetic macular edema ("DME"), diabetic retinopathy ("DR") and wet AMD. Ocugen plans to expand the therapeutic applications of OCU200 beyond DME, DR and wet AMD to potentially include macular edema following retinal vein occlusion and myopic choroidal neovascularization. Ocugen expects to initiate Investigational New Drug ("IND") enabling preclinical studies for OCU200 in 2021 and a Phase 1/2a clinical trial for OCU200 in the first half of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ocugen was developing OCU300, a small molecule therapeutic for the treatment of symptoms associated with ocular graft versus-host disease ("oGVHD"). On June 1, 2020, Ocugen announced that it had discontinued the Phase 3 trial of OCU300 based on results of a pre-planned interim sample size analysis conducted by an independent Data Monitoring Committee, which indicated the trial was unlikely to meet its co-primary endpoints upon completion. The trial was not stopped based on safety concerns. Ocugen is no longer pursuing the development of this product candidate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Merger with Histogenics&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 27, 2019, the Company completed its reverse merger with Ocugen OpCo, Inc. (&#x201c;OpCo&#x201d;) in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated as of April&#160;5, 2019, by and among Histogenics Corporation ("Histogenics"), OpCo and Restore Merger Sub,&#160;Inc., a wholly owned subsidiary of Histogenics (&#x201c;Merger Sub&#x201d;), as amended (the &#x201c;Merger Agreement&#x201d;), pursuant to which Merger Sub merged with and into OpCo, with OpCo surviving as a wholly owned subsidiary of Histogenics (the &#x201c;Merger&#x201d;). Immediately after completion of the Merger, Histogenics changed its name to Ocugen,&#160;Inc. and the business conducted by Ocugen,&#160;Inc. became the business conducted by OpCo. OpCo is deemed to be the accounting acquirer. Accordingly, the historical financial statements of OpCo became the Company&#x2019;s historical financial statements, including the comparative prior periods. See Note 3 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reverse Stock Split&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with, and immediately prior to the completion of the Merger, Histogenics effected a reverse stock split of the common stock, at a ratio of 1-for-60 (the &#x2018;&#x2018;Reverse Stock Split&#x2019;&#x2019;). Under the terms of the Merger Agreement, the Company issued common stock to OpCo&#x2019;s stockholders at an exchange rate of 0.4794 shares of common stock, after taking into account the Reverse Stock Split, for each share of OpCo&#x2019;s common stock outstanding immediately prior to the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The capital structure, including the number of shares of common stock issued appearing in the condensed consolidated balance sheets for the periods presented, reflects that of Ocugen. All references in the condensed consolidated financial statements to the number of shares and per-share amounts of common stock have been retroactively restated to reflect the exchange rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Going Concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has incurred recurring losses and negative cash flows from operations since inception and has funded its operating losses through the sale of common stock, warrants to purchase common stock, the issuance of convertible notes, debt, and grant proceeds. The Company incurred net losses of approximately $18.0 million and $32.6 million for the nine months ended September 30, 2020 and 2019, respectively. As of September&#160;30, 2020, the Company had an accumulated deficit of $69.5 million and cash, cash equivalents and restricted cash totaling $19.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a limited operating history and its prospects are subject to risks, expenses and uncertainties frequently encountered by companies in its industry. The Company intends to continue its research and development efforts for its product candidates, which will require significant funding. If the Company is unable to obtain additional financing in the future or research and development efforts require higher than anticipated capital, there may be a negative impact on the financial viability of the Company. The Company plans to increase working capital by raising additional capital through public and private placements of equity and/or debt, payments from potential strategic research and development arrangements, sale of assets, and licensing and/or collaboration arrangements with pharmaceutical companies or other institutions. Such financing may not be available at all, or on terms that are favorable to the Company. While management of the Company believes that it has a plan to fund ongoing operations, its plan may not be successfully implemented. Failure to generate sufficient cash flows from operations, raise additional capital through one or more financings, or appropriately manage certain discretionary spending could have a material adverse effect on the Company&#x2019;s ability to achieve its intended business objectives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of these factors, together with the anticipated increase in spending that will be necessary to continue to develop the Company&#x2019;s product candidates, there is substantial doubt about the Company&#x2019;s ability to continue as a going concern within one year after the date that these condensed consolidated financial statements are issued. The condensed consolidated financial statements do not contain any adjustments that might result from the resolution of any of the above uncertainties.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfMzc1_151fd1eb-31d0-4aeb-83ad-f545400507a3"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <ocgn:NumberOfOrphanDrugDesignations
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfMTM0MA_3917f8a7-22d2-4d9a-9a27-bb7ebffaaa35"
      unitRef="orphan_drug_designation">4</ocgn:NumberOfOrphanDrugDesignations>
    <ocgn:NumberOfClinicalTrialsToBeInitiatedInTheFuture
      contextRef="id9576326dbf84d1db30189e963d4195f_D20210701-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfMTgxNw_6cb03426-f016-4ba1-a1df-1787899af94e"
      unitRef="clinical_trial">2</ocgn:NumberOfClinicalTrialsToBeInitiatedInTheFuture>
    <ocgn:BusinessCombinationIssuedSharesExchangeRate
      contextRef="i4b761e61f7dd46ec849abd0bd8bb9544_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfNDQ3MQ_af0b896b-9e49-4136-b3ba-42a75e0e013c"
      unitRef="number">0.4794</ocgn:BusinessCombinationIssuedSharesExchangeRate>
    <us-gaap:NetIncomeLoss
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfNTMzNA_94f91a0a-4b26-4a89-b4c3-57950b9fa5ee"
      unitRef="usd">-18000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfNTM0MQ_e981e2aa-96ef-4800-99ee-ebcb5779dbf5"
      unitRef="usd">-32600000</us-gaap:NetIncomeLoss>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfNTQyOQ_f8efcba3-e227-4271-a85c-aa19f97a9443"
      unitRef="usd">-69500000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8zNC9mcmFnOjBiZjI3Y2NlYjQ1NzQ1YzZiYWI0YjZmZGVkYjJiMmNkL3RleHRyZWdpb246MGJmMjdjY2ViNDU3NDVjNmJhYjRiNmZkZWRiMmIyY2RfNTQ4OA_f5fb8e1e-e784-49d5-9d02-4e8e56168327"
      unitRef="usd">19300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MTU_8fd6b496-27e4-4f3f-8b33-6577cee6e13b">Summary of Significant Accounting Policies&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements included herein have been prepared in conformity with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) and under the rules&#160;and regulations of the United States Securities and Exchange Commission (&#x201c;SEC&#x201d;) for interim reporting. The accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, that are necessary to present fairly the Company&#x2019;s financial position, results of operations, and cash flows. The condensed consolidated results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosures of the Company normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted under the SEC&#x2019;s rules and regulations. These condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes thereto for the year ended December&#160;31, 2019, included in the Company's 2019 Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of Ocugen, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform with current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In preparing the condensed consolidated financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions primarily include those used in the accounting for clinical trial accruals, warrant transactions, asset held for sale, and the valuation of debt and equity instruments, including embedded derivatives and stock-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collaboration Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses whether collaboration agreements are subject to the Financial Accounting Standards Board ("FASB") Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 808, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 808&#x201d;), based on whether they involve joint operating activities and whether both parties have active participation in the arrangement and are exposed to significant risks and rewards. To the extent that the arrangement falls within the scope of ASC 808, the Company assesses whether the payments between the Company and the collaboration partner are subject to other accounting literature. If payments from the collaboration partner represent consideration from a customer, the Company accounts for those payments within the scope of ASC Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 606&#x201d;). However, if the Company concludes that its collaboration partner is not a customer, the Company will determine if analogy to other authoritative literature is appropriate. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, the Company entered into a collaboration agreement subject to ASC 808. Under this arrangement, the Company records cost reimbursements received as a reduction of research and development expense in the period incurred and royalty payments received as collaboration revenue in the period in which the underlying sale occurs. See Note 5 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Exit and Disposal Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records liabilities for one-time termination benefits in accordance with ASC Topic 420, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Exit and Disposal Cost Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC 420"). In accordance with ASC 420, an arrangement for one-time termination benefits exists at the date the plan of the termination meets the following criteria: (i) management commits to a plan of termination, (ii) the plan identifies the impacted employees and expected completion date, (iii) the plan identifies the terms of the benefits arrangement, (iv) it is unlikely significant changes to the plan will be made or the plan will be withdrawn and (v) the plan has been communicated to employees. Costs for one-time termination benefits in which the employee is required to render service until termination in order to receive the benefits, are recognized ratably over the future service period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records liabilities for employee termination benefits covered by ongoing benefit arrangements in accordance with ASC Topic 712, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nonretirement Postemployment Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC 712"). In accordance with ASC 712, costs for termination benefits under ongoing benefits arrangements are recognized when management has committed to a plan of termination and the costs are probable and estimable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Severance-related charges, once incurred, are recognized as either research and development expense or general and administrative expense within the condensed consolidated statements of operations and comprehensive loss depending on the job function of the employee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Asset Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An asset is considered to be held for sale when all of the following criteria are met: (i) management commits to a plan to sell the asset; (ii) it is unlikely that the disposal plan will be significantly modified or discontinued; (iii) the asset is available for immediate sale in its present condition; (iv) actions required to complete the sale of the asset have been initiated; (v) sale of the asset is probable and the completed sale is expected to occur within one year; and (vi) the asset is actively being marketed for sale at a price that is reasonable given its current market value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A long-lived asset classified as held for sale is measured at the lower of its carrying amount or fair value less cost to sell. If the long-lived asset is newly acquired, the carrying amount of the long-lived asset is established based on its fair value less cost to sell at the acquisition date. A long-lived asset is not depreciated or amortized while it is classified as held for sale, and an impairment loss would be recognized to the extent the carrying amount exceeds the asset's fair value less cost to sell.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2019, the Company had an intangible asset held for sale, which it held prior to the Merger. The intangible asset qualified and was recorded as held for sale as of the date of the reverse asset acquisition and was carried at its original fair value less cost to sell of $7.0&#160;million. The Company concluded during the three months ended September 30, 2020, that a sale of the intangible asset held for sale was no longer probable to be completed within one year from the date the intangible asset was initially recorded as held for sale. As such, the carrying value of the intangible asset was reduced to zero with the corresponding charge of $7.0&#160;million recognized as in-process research and development expense during the three and nine months ended September&#160;30, 2020 as the in-process research and development does not have an alternative future use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company has concluded that a sale of the intangible asset is no longer probable to be completed within one year from the date the intangible asset was initially recorded as held for sale, the Company is party to an Asset Purchase Agreement &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(as defined within Note 3) related to the intangible asset as of September&#160;30, 2020, and continues to market the asset for sale. In the event of a sale of the intangible asset under the Asset Purchase Agreement or to another party, the Company will account for the sale in the period in which the sale occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The company follows the provisions of the ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 820&#x201d;), which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair measurements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of certain financial instruments, including cash and cash equivalents, accounts payable, and accrued expenses approximates their fair values due to the short-term nature of these instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 &#x2014; quoted prices in active markets for identical assets or liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 &#x2014; quoted prices for similar assets and liabilities in active markets or inputs that are observable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 &#x2014; inputs that are unobservable (for example cash flow modeling inputs based on assumptions)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had derivative instruments that were fair valued on a recurring basis using Level 3 inputs during the three and nine months ended September&#160;30, 2019. There were no derivative instruments fair valued on a recurring basis using Level 3 inputs during the three and nine months ended September&#160;30, 2020. As of September&#160;30, 2020, the Company estimates the fair value of the note with EB5 Life Sciences, L.P. was $1.0&#160;million using Level 2 inputs. As of September&#160;30, 2020, the Company believes the fair values using Level 2 inputs of both the Warrant Exchange Promissory Notes (as defined in Note 9) and the loan received under the PPP of the CARES Act (as defined in Note 9) approximate their carrying values. See Note 9 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments that have maturities of three months or less when acquired to be cash equivalents. Cash and cash equivalents include bank demand deposits, marketable securities with maturities of three months or less at purchase, and money market funds that invest primarily in certificates of deposit, commercial paper and United States government and United States government agency obligations. The Company&#x2019;s restricted cash balance consists of cash held to collateralize a corporate credit card account.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents, and restricted cash in the condensed consolidated balance sheets to the total amount shown in the condensed consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,105,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,301,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,257,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,451,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys to the Company the right to control the use of an explicitly or implicitly identified fixed asset for a period of time in exchange for consideration. Control of an underlying asset is conveyed to the Company if the Company obtains the rights to direct the use of and to obtain substantially all of the economic benefits from using the underlying asset. The Company has lease agreements which include lease and&#160;non-lease&#160;components, which the Company has elected to account for as a single lease component for all classes of underlying assets. Lease expense for variable lease components are recognized when the obligation is probable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases are included in other assets and lease obligations on the Company&#x2019;s condensed consolidated balance sheets. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease payments are recognized as lease expense on a straight-line basis over the lease term. The Company primarily leases real estate, and leases for real estate are classified as operating leases. ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC 842") requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As an implicit interest rate is not readily determinable in the Company&#x2019;s leases, the incremental borrowing rate is used based on the information available at commencement date in determining the present value of lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The lease term for all of the Company&#x2019;s leases includes the&#160;non-cancellable&#160;period of the lease plus any additional periods covered by either a Company option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Options for lease renewals have been excluded from the lease term (and lease liability) for the majority of the Company&#x2019;s leases as the reasonably certain threshold is not met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease payments included in the measurement of the lease liability are comprised of fixed payments, variable payments that depend on index or rate, and amounts probable to be payable under the exercise of the Company option to purchase the underlying asset if reasonably certain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease payments not dependent on a rate or index associated with the Company&#x2019;s leases are recognized when the event, activity, or circumstance in the lease agreement on which those payments are assessed as probable. Variable lease payments include the Company's proportionate share of utilities and other operating expenses and are presented as operating expenses in the Company&#x2019;s condensed consolidated statements of operations and comprehensive loss in the same line item as expense arising from fixed lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its stock-based compensation awards in accordance with ASC Topic 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation&#x2014;Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 718&#x201d;). ASC 718 requires all stock-based payments to employees, including grants of employee stock options and restricted stock units and modifications to existing agreements, to be recognized in the condensed consolidated statements of operations and comprehensive loss based on their fair values. The Company uses the Black-Scholes option-pricing model to determine the fair value of options granted. The Company recognizes forfeitures as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s stock-based awards are subject to service-based vesting conditions. Compensation expense related to awards to employees and directors with service-based vesting conditions is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. Stock-based awards generally vest over a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2MTk_eb512e86-ca54-4b51-8e50-01fc17d11c9f"&gt;one&lt;/span&gt; to &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2MjU_8897e6c7-9303-4adc-88de-47d481ae6e6d"&gt;three&lt;/span&gt; year requisite service period and have a contractual term of 10 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimating the fair value of options requires the input of subjective assumptions, including expected life of the option, stock price volatility, the risk-free interest rate and expected dividends. The assumptions used in the Company&#x2019;s Black-Scholes option-pricing model represent management&#x2019;s best estimates and involve a number of variables, uncertainties and assumptions and the application of management&#x2019;s judgment, as they are inherently subjective. If any assumptions change, the Company&#x2019;s stock-based compensation expense could be materially different in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued Accounting Standards Update ("ASU") No. 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Disclosure Framework&#x2014;Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard modifies certain disclosure requirements on fair value measurements and was effective for the Company on January 1, 2020. The adoption of this standard did not have a material impact on the Company's disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, the FASB issued ASU No. 2018-18, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under ASC 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In those situations, ASC 606 guidance should be applied, including recognition, measurement, presentation and disclosure requirements. The standard adds unit-of-account guidance to ASC 808 to align with the guidance in ASC 606 when an entity is assessing whether the collaborative arrangement or a part of the collaborative arrangement is within the scope of ASC 606. The standard also precludes a company from presenting transactions with collaborative arrangement participants that are not directly related to sales to third parties with revenue from contracts with customers recognized under ASC 606 if the collaborative arrangement participant is not a customer. This standard was effective for the Company on &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;January 1, 2020. Consistent with the guidance in this standard, the Company assesses whether collaboration arrangements are within the scope of ASC 606. For collaboration arrangements that are not within the scope of ASC 606, applicable transactions with collaborative arrangement participants are presented as collaboration revenue rather than revenue from contracts with customers. See above and Note 5 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The FASB subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date of January 1, 2023. These standards require that credit losses be reported using an expected losses model rather than the incurred losses model that is currently used, and establishes additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, these standards now require allowances to be recorded instead of reducing the amortized cost of the investment. These standards limit the amount of credit losses to be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The Company does not currently expect the adoption of these standards to have a material impact on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; This standard will have an effective date and transition date of January 1, 2021. This standard removes certain exceptions for recognizing deferred taxes for investments, performing intraperiod allocations and calculating income taxes in interim periods. This standard also adds guidance to reduce complexity in certain areas, including recognizing franchise tax, recognizing deferred taxes for tax goodwill, allocating taxes to the members of a consolidated group and recognizing the effect of enacted changes in tax laws or rates during an interim period. The Company does not currently expect the adoption of this standard to have a material impact on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity's Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard will have an effective and transition date of January 1, 2024. Early adoption is permitted beginning January 1, 2021. This standard simplifies an issuer's accounting for convertible instruments by eliminating two of the three models in ASC 470-20 that require separate accounting for embedded conversion features as well as simplifies the settlement assessment that entities are required to perform to determine whether a contract qualifies for equity classification. This standard also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of potential share settlement (if the effect is more dilutive) for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. The standard requires new disclosures about events that occur during the reporting period and cause conversion contingencies to be met and about the fair value of a public business entity's convertible debt at the instrument level, among other things. The Company does not currently expect the adoption of this standard to have a material impact on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MTk_43e00cc8-572d-43cc-a394-ad4e32403f9c">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements included herein have been prepared in conformity with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) and under the rules&#160;and regulations of the United States Securities and Exchange Commission (&#x201c;SEC&#x201d;) for interim reporting. The accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, that are necessary to present fairly the Company&#x2019;s financial position, results of operations, and cash flows. The condensed consolidated results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosures of the Company normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted under the SEC&#x2019;s rules and regulations. These condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes thereto for the year ended December&#160;31, 2019, included in the Company's 2019 Annual Report.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MjY_e0f63f8a-301b-4f77-9147-93c264c3e72b">The condensed consolidated financial statements include the accounts of Ocugen, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform with current period presentation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2Mjk_667a04d5-3d9e-4e95-a646-3789d1f01882">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In preparing the condensed consolidated financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions primarily include those used in the accounting for clinical trial accruals, warrant transactions, asset held for sale, and the valuation of debt and equity instruments, including embedded derivatives and stock-based compensation.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CollaborativeArrangementAccountingPolicy
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MzQ_6982f7d1-116f-4fa5-b04e-a5df7c33cc35">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collaboration Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses whether collaboration agreements are subject to the Financial Accounting Standards Board ("FASB") Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 808, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 808&#x201d;), based on whether they involve joint operating activities and whether both parties have active participation in the arrangement and are exposed to significant risks and rewards. To the extent that the arrangement falls within the scope of ASC 808, the Company assesses whether the payments between the Company and the collaboration partner are subject to other accounting literature. If payments from the collaboration partner represent consideration from a customer, the Company accounts for those payments within the scope of ASC Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 606&#x201d;). However, if the Company concludes that its collaboration partner is not a customer, the Company will determine if analogy to other authoritative literature is appropriate. &lt;/span&gt;&lt;/div&gt;In April 2020, the Company entered into a collaboration agreement subject to ASC 808. Under this arrangement, the Company records cost reimbursements received as a reduction of research and development expense in the period incurred and royalty payments received as collaboration revenue in the period in which the underlying sale occurs.</us-gaap:CollaborativeArrangementAccountingPolicy>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MjI_116aeab5-0657-4bdf-9cb5-cb1063e3703a">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Exit and Disposal Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records liabilities for one-time termination benefits in accordance with ASC Topic 420, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Exit and Disposal Cost Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC 420"). In accordance with ASC 420, an arrangement for one-time termination benefits exists at the date the plan of the termination meets the following criteria: (i) management commits to a plan of termination, (ii) the plan identifies the impacted employees and expected completion date, (iii) the plan identifies the terms of the benefits arrangement, (iv) it is unlikely significant changes to the plan will be made or the plan will be withdrawn and (v) the plan has been communicated to employees. Costs for one-time termination benefits in which the employee is required to render service until termination in order to receive the benefits, are recognized ratably over the future service period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records liabilities for employee termination benefits covered by ongoing benefit arrangements in accordance with ASC Topic 712, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nonretirement Postemployment Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC 712"). In accordance with ASC 712, costs for termination benefits under ongoing benefits arrangements are recognized when management has committed to a plan of termination and the costs are probable and estimable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Severance-related charges, once incurred, are recognized as either research and development expense or general and administrative expense within the condensed consolidated statements of operations and comprehensive loss depending on the job function of the employee.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <ocgn:AssetHeldForSalePolicyTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MjM_9e437044-1407-4514-838a-422b023b69f9">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Asset Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An asset is considered to be held for sale when all of the following criteria are met: (i) management commits to a plan to sell the asset; (ii) it is unlikely that the disposal plan will be significantly modified or discontinued; (iii) the asset is available for immediate sale in its present condition; (iv) actions required to complete the sale of the asset have been initiated; (v) sale of the asset is probable and the completed sale is expected to occur within one year; and (vi) the asset is actively being marketed for sale at a price that is reasonable given its current market value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A long-lived asset classified as held for sale is measured at the lower of its carrying amount or fair value less cost to sell. If the long-lived asset is newly acquired, the carrying amount of the long-lived asset is established based on its fair value less cost to sell at the acquisition date. A long-lived asset is not depreciated or amortized while it is classified as held for sale, and an impairment loss would be recognized to the extent the carrying amount exceeds the asset's fair value less cost to sell.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2019, the Company had an intangible asset held for sale, which it held prior to the Merger. The intangible asset qualified and was recorded as held for sale as of the date of the reverse asset acquisition and was carried at its original fair value less cost to sell of $7.0&#160;million. The Company concluded during the three months ended September 30, 2020, that a sale of the intangible asset held for sale was no longer probable to be completed within one year from the date the intangible asset was initially recorded as held for sale. As such, the carrying value of the intangible asset was reduced to zero with the corresponding charge of $7.0&#160;million recognized as in-process research and development expense during the three and nine months ended September&#160;30, 2020 as the in-process research and development does not have an alternative future use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company has concluded that a sale of the intangible asset is no longer probable to be completed within one year from the date the intangible asset was initially recorded as held for sale, the Company is party to an Asset Purchase Agreement &lt;/span&gt;&lt;/div&gt;(as defined within Note 3) related to the intangible asset as of September&#160;30, 2020, and continues to market the asset for sale. In the event of a sale of the intangible asset under the Asset Purchase Agreement or to another party, the Company will account for the sale in the period in which the sale occurs.</ocgn:AssetHeldForSalePolicyTextBlock>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfNjc2NQ_a4d6c5c8-5c59-4e1d-a4cf-92789ae6db51"
      unitRef="usd">7000000.0</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfNzE0NjgyNTY0NzU3MA_1b291345-23c9-41fc-89c4-858cb9a9ebb2"
      unitRef="usd">0</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTA5OTUxMTY1MTUxNw_0905f6aa-29ac-430e-a7df-b59dd7f3bd3c"
      unitRef="usd">7000000.0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTA5OTUxMTY1MTUxNw_6dc6cbda-d3a0-4c47-887d-5ef7edfef16f"
      unitRef="usd">7000000.0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MzA_4159e53a-37bf-469d-9a57-a465013b7cc3">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The company follows the provisions of the ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 820&#x201d;), which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair measurements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of certain financial instruments, including cash and cash equivalents, accounts payable, and accrued expenses approximates their fair values due to the short-term nature of these instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 &#x2014; quoted prices in active markets for identical assets or liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 &#x2014; quoted prices for similar assets and liabilities in active markets or inputs that are observable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 &#x2014; inputs that are unobservable (for example cash flow modeling inputs based on assumptions)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had derivative instruments that were fair valued on a recurring basis using Level 3 inputs during the three and nine months ended September&#160;30, 2019. There were no derivative instruments fair valued on a recurring basis using Level 3 inputs during the three and nine months ended September&#160;30, 2020. As of September&#160;30, 2020, the Company estimates the fair value of the note with EB5 Life Sciences, L.P. was $1.0&#160;million using Level 2 inputs. As of September&#160;30, 2020, the Company believes the fair values using Level 2 inputs of both the Warrant Exchange Promissory Notes (as defined in Note 9) and the loan received under the PPP of the CARES Act (as defined in Note 9) approximate their carrying values. See Note 9 for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="i8c3c6f97b8e34fa1acfc3dcfa2747a64_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfODQ4NQ_aac69e20-ce49-4396-9f0f-ccf1bc3e554d"
      unitRef="usd">1000000.0</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MzU_c3552369-ec9b-4288-b431-f1be2fd6bdb3">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments that have maturities of three months or less when acquired to be cash equivalents. Cash and cash equivalents include bank demand deposits, marketable securities with maturities of three months or less at purchase, and money market funds that invest primarily in certificates of deposit, commercial paper and United States government and United States government agency obligations. The Company&#x2019;s restricted cash balance consists of cash held to collateralize a corporate credit card account.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <ocgn:ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MTQ_8bf40e28-b073-42d1-a5e4-62bd81ea41b7">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents, and restricted cash in the condensed consolidated balance sheets to the total amount shown in the condensed consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,105,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,301,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,257,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,451,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ocgn:ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RhYmxlOmI5ZjZlNmI1MTBhMTRiOTY5ODE5MWMyMTdkMGJjZGI0L3RhYmxlcmFuZ2U6YjlmNmU2YjUxMGExNGI5Njk4MTkxYzIxN2QwYmNkYjRfMi0xLTEtMS0w_c8da8289-9a1f-4740-9e86-a581ff60b5fa"
      unitRef="usd">19105830</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iff87527ea3fc46fdacb3342226f9f0f9_I20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RhYmxlOmI5ZjZlNmI1MTBhMTRiOTY5ODE5MWMyMTdkMGJjZGI0L3RhYmxlcmFuZ2U6YjlmNmU2YjUxMGExNGI5Njk4MTkxYzIxN2QwYmNkYjRfMi0zLTEtMS0w_f54965fa-8cda-4ab1-9225-5b243e2b9270"
      unitRef="usd">15301082</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RhYmxlOmI5ZjZlNmI1MTBhMTRiOTY5ODE5MWMyMTdkMGJjZGI0L3RhYmxlcmFuZ2U6YjlmNmU2YjUxMGExNGI5Njk4MTkxYzIxN2QwYmNkYjRfMy0xLTEtMS0w_f68ae9bb-8f9d-426b-8ce1-073afc8eb4e1"
      unitRef="usd">151196</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="iff87527ea3fc46fdacb3342226f9f0f9_I20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RhYmxlOmI5ZjZlNmI1MTBhMTRiOTY5ODE5MWMyMTdkMGJjZGI0L3RhYmxlcmFuZ2U6YjlmNmU2YjUxMGExNGI5Njk4MTkxYzIxN2QwYmNkYjRfMy0zLTEtMS0w_c0d63310-a6a8-41a9-9b3e-4f027f44d9ea"
      unitRef="usd">150910</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RhYmxlOmI5ZjZlNmI1MTBhMTRiOTY5ODE5MWMyMTdkMGJjZGI0L3RhYmxlcmFuZ2U6YjlmNmU2YjUxMGExNGI5Njk4MTkxYzIxN2QwYmNkYjRfNC0xLTEtMS0w_31739621-1533-4497-8f7b-ab1fa1a7b11b"
      unitRef="usd">19257026</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iff87527ea3fc46fdacb3342226f9f0f9_I20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RhYmxlOmI5ZjZlNmI1MTBhMTRiOTY5ODE5MWMyMTdkMGJjZGI0L3RhYmxlcmFuZ2U6YjlmNmU2YjUxMGExNGI5Njk4MTkxYzIxN2QwYmNkYjRfNC0zLTEtMS0w_6453ef52-041b-4c65-8f10-fc3f39814bb0"
      unitRef="usd">15451992</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MzE_35e542fe-d087-4f60-879c-748dce400048">&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys to the Company the right to control the use of an explicitly or implicitly identified fixed asset for a period of time in exchange for consideration. Control of an underlying asset is conveyed to the Company if the Company obtains the rights to direct the use of and to obtain substantially all of the economic benefits from using the underlying asset. The Company has lease agreements which include lease and&#160;non-lease&#160;components, which the Company has elected to account for as a single lease component for all classes of underlying assets. Lease expense for variable lease components are recognized when the obligation is probable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases are included in other assets and lease obligations on the Company&#x2019;s condensed consolidated balance sheets. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease payments are recognized as lease expense on a straight-line basis over the lease term. The Company primarily leases real estate, and leases for real estate are classified as operating leases. ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC 842") requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As an implicit interest rate is not readily determinable in the Company&#x2019;s leases, the incremental borrowing rate is used based on the information available at commencement date in determining the present value of lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The lease term for all of the Company&#x2019;s leases includes the&#160;non-cancellable&#160;period of the lease plus any additional periods covered by either a Company option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Options for lease renewals have been excluded from the lease term (and lease liability) for the majority of the Company&#x2019;s leases as the reasonably certain threshold is not met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease payments included in the measurement of the lease liability are comprised of fixed payments, variable payments that depend on index or rate, and amounts probable to be payable under the exercise of the Company option to purchase the underlying asset if reasonably certain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease payments not dependent on a rate or index associated with the Company&#x2019;s leases are recognized when the event, activity, or circumstance in the lease agreement on which those payments are assessed as probable. Variable lease payments include the Company's proportionate share of utilities and other operating expenses and are presented as operating expenses in the Company&#x2019;s condensed consolidated statements of operations and comprehensive loss in the same line item as expense arising from fixed lease payments.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2Mjg_2637301a-94cd-465b-960e-0adefdfe12a5">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its stock-based compensation awards in accordance with ASC Topic 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation&#x2014;Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 718&#x201d;). ASC 718 requires all stock-based payments to employees, including grants of employee stock options and restricted stock units and modifications to existing agreements, to be recognized in the condensed consolidated statements of operations and comprehensive loss based on their fair values. The Company uses the Black-Scholes option-pricing model to determine the fair value of options granted. The Company recognizes forfeitures as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s stock-based awards are subject to service-based vesting conditions. Compensation expense related to awards to employees and directors with service-based vesting conditions is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. Stock-based awards generally vest over a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2MTk_eb512e86-ca54-4b51-8e50-01fc17d11c9f"&gt;one&lt;/span&gt; to &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2MjU_8897e6c7-9303-4adc-88de-47d481ae6e6d"&gt;three&lt;/span&gt; year requisite service period and have a contractual term of 10 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimating the fair value of options requires the input of subjective assumptions, including expected life of the option, stock price volatility, the risk-free interest rate and expected dividends. The assumptions used in the Company&#x2019;s Black-Scholes option-pricing model represent management&#x2019;s best estimates and involve a number of variables, uncertainties and assumptions and the application of management&#x2019;s judgment, as they are inherently subjective. If any assumptions change, the Company&#x2019;s stock-based compensation expense could be materially different in the future.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2ODk_faddac5a-549d-4e41-ac16-4844095d5beb">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTk2MjQ_47c5d32d-92d5-4a22-bb82-b77a7d455b35">&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued Accounting Standards Update ("ASU") No. 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Disclosure Framework&#x2014;Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard modifies certain disclosure requirements on fair value measurements and was effective for the Company on January 1, 2020. The adoption of this standard did not have a material impact on the Company's disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, the FASB issued ASU No. 2018-18, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under ASC 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In those situations, ASC 606 guidance should be applied, including recognition, measurement, presentation and disclosure requirements. The standard adds unit-of-account guidance to ASC 808 to align with the guidance in ASC 606 when an entity is assessing whether the collaborative arrangement or a part of the collaborative arrangement is within the scope of ASC 606. The standard also precludes a company from presenting transactions with collaborative arrangement participants that are not directly related to sales to third parties with revenue from contracts with customers recognized under ASC 606 if the collaborative arrangement participant is not a customer. This standard was effective for the Company on &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;January 1, 2020. Consistent with the guidance in this standard, the Company assesses whether collaboration arrangements are within the scope of ASC 606. For collaboration arrangements that are not within the scope of ASC 606, applicable transactions with collaborative arrangement participants are presented as collaboration revenue rather than revenue from contracts with customers. See above and Note 5 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The FASB subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date of January 1, 2023. These standards require that credit losses be reported using an expected losses model rather than the incurred losses model that is currently used, and establishes additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, these standards now require allowances to be recorded instead of reducing the amortized cost of the investment. These standards limit the amount of credit losses to be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The Company does not currently expect the adoption of these standards to have a material impact on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; This standard will have an effective date and transition date of January 1, 2021. This standard removes certain exceptions for recognizing deferred taxes for investments, performing intraperiod allocations and calculating income taxes in interim periods. This standard also adds guidance to reduce complexity in certain areas, including recognizing franchise tax, recognizing deferred taxes for tax goodwill, allocating taxes to the members of a consolidated group and recognizing the effect of enacted changes in tax laws or rates during an interim period. The Company does not currently expect the adoption of this standard to have a material impact on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity's Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard will have an effective and transition date of January 1, 2024. Early adoption is permitted beginning January 1, 2021. This standard simplifies an issuer's accounting for convertible instruments by eliminating two of the three models in ASC 470-20 that require separate accounting for embedded conversion features as well as simplifies the settlement assessment that entities are required to perform to determine whether a contract qualifies for equity classification. This standard also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of potential share settlement (if the effect is more dilutive) for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. The standard requires new disclosures about events that occur during the reporting period and cause conversion contingencies to be met and about the fair value of a public business entity's convertible debt at the instrument level, among other things. The Company does not currently expect the adoption of this standard to have a material impact on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfMzI5ODUzNDg5Njg3Nw_1a51c9e0-6961-4e89-b382-34a1aeae1882">Merger and Financing&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pre-Merger Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2019, OpCo and Histogenics entered into a Securities Purchase Agreement (as amended, the "Financing SPA") with certain accredited investors (the "Investors"). Pursuant to the Financing SPA, among other things, (i) immediately prior to the Merger, OpCo issued 2.2&#160;million shares of common stock to the Investors, (ii)&#160;on October 4, 2019, the Company issued 2.2&#160;million shares of the Company's common stock to the Investors and (iii)&#160;on October 4, 2019, the Company issued three series of warrants to purchase shares of the Company&#x2019;s common stock (the &#x201c;Series&#160;A Warrants,&#x201d; the &#x201c;Series&#160;B Warrants&#x201d; and the &#x201c;Series&#160;C Warrants&#x201d; and collectively, the &#x201c;Pre-Merger Financing Warrants&#x201d;) in exchange for an aggregate purchase price of $25.0 million (the "Pre-Merger Financing"). See Note 12 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Merger with Histogenics&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;27, 2019, the Company completed the Merger in accordance with the terms of the Merger Agreement. The Merger was structured as a stock-for-stock transaction whereby all of OpCo&#x2019;s outstanding shares of common stock and securities convertible into or exercisable for OpCo&#x2019;s common stock were converted into the right to receive Histogenics&#x2019; common stock and securities convertible into or exercisable for Histogenics&#x2019; common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC Topic 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 805&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the Company concluded that, while Histogenics was the legal acquirer, OpCo was the accounting acquirer due to the fact that (i)&#160;OpCo&#x2019;s shareholders had the majority of the voting &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rights in Ocugen, (ii)&#160;OpCo held all of the board seats of the combined company and (iii)&#160;OpCo management held all key positions in the management of the combined company. The Company further concluded that Histogenics did not meet the definition of a business under ASC 805 due to the fact that substantially all of the fair value of the gross assets disposed of is concentrated in a single identifiable asset or a group of similar identifiable assets. Therefore, the Merger was accounted for as a reverse asset acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger, on May 8, 2019, Histogenics entered into an asset purchase agreement (the "Asset Purchase Agreement") with Medavate Corp., pursuant to which Histogenics agreed to sell substantially all of its assets relating to its NeoCart&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; program for $6.5&#160;million. The parties subsequently amended the Asset Purchase Agreement to increase the purchase price to $7.0&#160;million with the purchase price increasing 10% per month (or any portion thereof) starting October 31, 2019 if the closing date of the Asset Purchase Agreement did not occur prior to October 31, 2019. The Company may terminate the Asset Purchase Agreement at any time without recourse. The Asset Purchase Agreement closing date did not occur as of September&#160;30, 2020 and the Company has not terminated the Asset Purchase Agreement as of September&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The NeoCart&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; asset was held for sale as of December&#160;31, 2019. The NeoCart&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; asset qualified as held for sale as of the date of the reverse asset acquisition and was carried at its original fair value less cost to sell valued at the acquisition date based on a quoted price of $7.0&#160;million, which was an observable Level 2 fair value input. The NeoCart&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; asset did not qualify as held for sale as of September&#160;30, 2020. See Note 2 for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:SharesIssued
      contextRef="i32e5f294ab464b6d83e4148060068867_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfMzE4_eba638ac-6488-4a8a-b36b-9079f6ec9c85"
      unitRef="shares">2200000</us-gaap:SharesIssued>
    <us-gaap:SharesIssued
      contextRef="i48a7b850f34d4e93a932a1250a70dcdc_I20191004"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfNDA2_12eecccf-c3e8-4fdd-be0d-5047bba9857e"
      unitRef="shares">2200000</us-gaap:SharesIssued>
    <ocgn:NumberOfSeriesOfWarrantsIssued
      contextRef="ie03e503b087545748223eb40f7381d1f_D20191004-20191004"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfNTEy_e14f491f-a36b-4c4a-b24d-bb1c59c9f04b"
      unitRef="series">3</ocgn:NumberOfSeriesOfWarrantsIssued>
    <ocgn:SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction
      contextRef="i1524a036f48541e08e32da279b7f7398_D20191004-20191004"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfNzYz_793cf64d-c70e-46ad-987c-d549ce0f9b95"
      unitRef="usd">25000000.0</ocgn:SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction>
    <ocgn:AssetPurchaseAgreementCashConsideration
      contextRef="i0feccca0bf2b43a1a54176fe040b711e_D20190508-20190508"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfMjMyMw_e61aee36-2407-424b-a6df-d37f8b350fef"
      unitRef="usd">6500000</ocgn:AssetPurchaseAgreementCashConsideration>
    <ocgn:AssetPurchaseAgreementCashConsideration
      contextRef="ibf034182282345c38684657f3ac357ca_D20191031-20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfMjQyMw_db1d78ad-c634-4620-a041-ce876bed8f43"
      unitRef="usd">7000000.0</ocgn:AssetPurchaseAgreementCashConsideration>
    <ocgn:PercentageOfIncreaseInPurchasePriceOfAssetPerMonth
      contextRef="ibf034182282345c38684657f3ac357ca_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfMjQ2MQ_edeeb1c7-d1f0-453d-a3dc-658f4e56f95e"
      unitRef="number">0.10</ocgn:PercentageOfIncreaseInPurchasePriceOfAssetPerMonth>
    <us-gaap:AssetsHeldForSaleLongLivedFairValueDisclosure
      contextRef="ic3cf544d14484496ac45a00e1654a708_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80My9mcmFnOjA3YTM0ODRjOGVmNTQyOGM5OTllOTdjZGY5MzA1Nzc2L3RleHRyZWdpb246MDdhMzQ4NGM4ZWY1NDI4Yzk5OWU5N2NkZjkzMDU3NzZfMzE1NA_969aff8c-f00a-44da-9a13-0baadd418f82"
      unitRef="usd">7000000.0</us-gaap:AssetsHeldForSaleLongLivedFairValueDisclosure>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RleHRyZWdpb246MGFmM2I3NzQ0OGJiNGQ0ZmE3YjBiMTVkYjhkODI1NDNfMzU0_388ae5f5-8c2a-4970-ac6b-102a1c8be5ba">Net Loss Per Share of Common Stock&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted earnings per share for the three and nine months ended September&#160;30, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&#x2014;basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,473,847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,773,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,031,641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,624,697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividend related to Warrant Exchange (Note 12)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,546,340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,473,847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,773,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,577,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,624,697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in calculating net loss per common share&#x2014;basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,591,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,411,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,764,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,839,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per common share&#x2014;basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding, as their inclusion would have been antidilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,268,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,268,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,771,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,771,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Warrants (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,007,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,007,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series C Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,138,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,150,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,138,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,150,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Series B Warrants do not include the additional Series B Warrants that were contingent upon the reset pricing as discussed in Note 12.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RleHRyZWdpb246MGFmM2I3NzQ0OGJiNGQ0ZmE3YjBiMTVkYjhkODI1NDNfMzU1_cf6b9d1d-674d-4e70-ab2a-497fc9348450">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted earnings per share for the three and nine months ended September&#160;30, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&#x2014;basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,473,847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,773,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,031,641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,624,697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividend related to Warrant Exchange (Note 12)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,546,340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,473,847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,773,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,577,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,624,697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in calculating net loss per common share&#x2014;basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,591,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,411,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,764,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,839,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per common share&#x2014;basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMi0xLTEtMS0w_969fe6fb-64b6-4fc2-ba6b-c819ddd27595"
      unitRef="usd">-10473847</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMi0zLTEtMS0w_d244f64a-6adf-4455-9ec5-d06fdd8878eb"
      unitRef="usd">-22773281</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMi01LTEtMS0w_5eea4f30-7d78-4264-a529-7c4b151e1a43"
      unitRef="usd">-18031641</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMi03LTEtMS0w_2b44f038-6dab-43e2-acc2-985cb5214162"
      unitRef="usd">-32624697</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMy0xLTEtMS0w_12aca3b5-6ae9-4b15-9f13-b3eaf80f658f"
      unitRef="usd">0</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMy0zLTEtMS0w_40900e07-088d-4cd9-bfda-c2a8e89b7f52"
      unitRef="usd">0</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMy01LTEtMS0w_7bb618c6-c8ba-477f-b972-4d0eb5da6dcd"
      unitRef="usd">12546340</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfMy03LTEtMS0w_6f428baa-bc9b-433a-b5c3-5e1d0d5821ce"
      unitRef="usd">0</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNC0xLTEtMS0w_59c1d01d-0329-4e7e-8159-8ea1f1959131"
      unitRef="usd">-10473847</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNC0zLTEtMS0w_3b83277c-689b-42e8-83d2-8403da3881eb"
      unitRef="usd">-22773281</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNC01LTEtMS0w_bd2fedd4-1f19-4a01-8a31-de7e6512af91"
      unitRef="usd">-30577981</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNC03LTEtMS0w_4bfe8c8d-8e99-4490-aa66-e24f3a12009e"
      unitRef="usd">-32624697</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNS0xLTEtMS0w_f172534d-b5f2-4a20-bbed-d5d4568292e2"
      unitRef="shares">141591218</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNS0zLTEtMS0w_e334e3b4-63a5-4c14-a4ec-267a20cc9e23"
      unitRef="shares">6411308</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNS01LTEtMS0w_a9836d37-d272-4df4-812a-ee5835410be9"
      unitRef="shares">92764157</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNS03LTEtMS0w_eb5592b7-8a12-4290-882e-11d5d6466ccc"
      unitRef="shares">5839840</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNi0xLTEtMS0w_57d3d144-dccb-42c6-b5fd-fe90b0c3db6c"
      unitRef="usdPerShare">-0.07</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNi0zLTEtMS0w_ed7221cf-53f6-45cc-9304-86fc636cf2e9"
      unitRef="usdPerShare">-3.55</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNi01LTEtMS0w_84b393fe-8077-4741-a6dc-c1dc521f0ddc"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmRmNGYzY2IyYzgyMjQ5NGU4YzVlN2RlNTBjOTY2MjA2L3RhYmxlcmFuZ2U6ZGY0ZjNjYjJjODIyNDk0ZThjNWU3ZGU1MGM5NjYyMDZfNi03LTEtMS0w_492424d1-9fee-4d40-95a6-73e21bb50794"
      unitRef="usdPerShare">-5.59</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RleHRyZWdpb246MGFmM2I3NzQ0OGJiNGQ0ZmE3YjBiMTVkYjhkODI1NDNfMzU3_fa691f54-9866-4432-9bff-f57cab724e70">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding, as their inclusion would have been antidilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,268,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,268,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,771,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,771,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Warrants (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,007,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,007,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series C Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,138,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,150,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,138,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,150,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Series B Warrants do not include the additional Series B Warrants that were contingent upon the reset pricing as discussed in Note 12.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1f29b990abbf4758b5d2b15e35483711_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMi0xLTEtMS0w_3193c54f-4faa-4e74-a6c9-6f9d4abd6f0f"
      unitRef="shares">4268277</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie506a5cab5e247de846540df1b463305_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMi0zLTEtMS0w_7a264eda-c1f3-44ee-87d5-2dd2a4ff3ffa"
      unitRef="shares">500933</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i59df5d0c89234b009956f4c9f8f30808_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMi01LTEtMS0w_2bb8b911-221d-46db-9db9-deb70be5d77a"
      unitRef="shares">4268277</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5f62ded661e54fefb3a9fd8f2ba1bb64_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMi03LTEtMS0w_a4d890d1-686f-4c3e-a0d3-c12b4217d2fa"
      unitRef="shares">500933</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i538b5af19f0f4c5b8fc4c537c4a489d5_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMy0xLTEtMS0w_3cca1eca-1970-4ce0-9ecf-95be252bc1ad"
      unitRef="shares">870017</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idc346fbec3d24dd58a12ad9d869ecfb2_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMy0zLTEtMS0w_5b18f381-ffff-49bd-97f2-b80808d773ef"
      unitRef="shares">870017</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2380e13fd027491a936f449e6aa74829_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMy01LTEtMS0w_a1ee5902-9d1c-444e-b91b-5ba3437df55c"
      unitRef="shares">870017</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i76069125bcf9493eba6f0ce4826c29c2_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfMy03LTEtMS0w_4914b7d5-d29e-4df2-afaf-e93414c09f1f"
      unitRef="shares">870017</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ifc8d8f8a93fc45e4b628285d72bb142a_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC0xLTEtMS00MDU_59a403aa-e25f-49b0-8219-892d9f1cfd99"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i468172d3afbc4db09fe88fcad9e0d420_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC0zLTEtMS00MDU_81eacffd-b6e5-4848-b1b0-d46d0398e172"
      unitRef="shares">8771928</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i25dbded407394e83baa18d6851c893f9_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC01LTEtMS00MDU_a96fcfe2-e06a-4e41-a9e0-a86024d13fbc"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i97cd3bc630954c2b9bcbbddafafde030_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC03LTEtMS00MDU_4e8b98a1-2d29-49e2-b10e-2c08d7e8596c"
      unitRef="shares">8771928</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibb251e6b072448dfa91521c08d3b3479_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNS0xLTEtMS00MDU_c0b0ca61-dbf8-490b-aba9-e430e4648115"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0e6b2ef153df4c9788cd72ba0651ecfd_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNS0zLTEtMS00MDU_1ebe2fbc-9eff-412a-b1d0-5d0274204470"
      unitRef="shares">8007461</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iad1b963da04845bd956aea311c52d499_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNS01LTEtMS00MDU_8affeee2-a137-4308-8517-5933882a0972"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i65d9eeb822d646fb9f1053229278fa42_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNS03LTEtMS00MDU_2792a5b2-439b-426c-95f6-428bbd979224"
      unitRef="shares">8007461</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i402e841332864f65bad74eba8425cb79_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNi0xLTEtMS00MDU_16140081-959c-4b25-8c1c-8306022e8b73"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icb41ad76fece4484ae14bc550e4c9795_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNi0zLTEtMS00MDU_08e3b7c4-f766-457d-876f-9ce91daa23c1"
      unitRef="shares">50000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idfc7128277d343d4a99ba1fe8819b89d_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNi01LTEtMS00MDU_c3a23d34-87ce-45e0-abeb-7b31ef07a8fb"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id7d146e73e6e42e3a301e33bac8cd8ed_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNi03LTEtMS00MDU_f2d0c58e-f5f4-41ce-8cc1-eaad0adfcc70"
      unitRef="shares">50000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC0xLTEtMS0w_1db25977-f564-4bc3-ba5d-fd82e16ea66a"
      unitRef="shares">5138294</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC0zLTEtMS0w_dc38170f-a893-41e3-9d8a-9f11f8576de7"
      unitRef="shares">68150339</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC01LTEtMS0w_0d30786f-f49e-4bc9-8312-254fa6195042"
      unitRef="shares">5138294</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80Ni9mcmFnOjBhZjNiNzc0NDhiYjRkNGZhN2IwYjE1ZGI4ZDgyNTQzL3RhYmxlOmE5Njk0YmQyMmNmZjQ2NzVhZjIzZjZhOTBmYTJlYTc3L3RhYmxlcmFuZ2U6YTk2OTRiZDIyY2ZmNDY3NWFmMjNmNmE5MGZhMmVhNzdfNC03LTEtMS0w_7aa24e65-b034-43fb-a370-09c1fce534bf"
      unitRef="shares">68150339</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80OS9mcmFnOjFmYjk3ZDkzOWYwZTRmYmRhNjliMWJiYTJhMzhlNzQ2L3RleHRyZWdpb246MWZiOTdkOTM5ZjBlNGZiZGE2OWIxYmJhMmEzOGU3NDZfMjk2Mw_a65cdf33-fe3d-4c28-afb0-e12c98ddc207">Collaboration AgreementsIn April 2020, the Company entered into a collaboration agreement (the &#x201c;Advaite Agreement&#x201d;) with Advaite, Inc. (&#x201c;Advaite&#x201d;) with respect to the development of Advaite&#x2019;s RapCov COVID-19 Testing Kit (the &#x201c;COVID-19 Test&#x201d;). Advaite was co-founded and is being managed by Mr. Karthik Musunuri, the son of the Company's Chief Executive Officer, Chairman of the Board and co-founder, Dr. Shankar Musunuri. Pursuant to the Advaite Agreement, the Company will provide certain production, research and development, technical, regulatory and quality support services to Advaite in connection with the development and &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;commercialization of the COVID-19 Test (the &#x201c;Ocugen Services&#x201d;). Advaite will research, develop, and seek to obtain regulatory approval of the COVID-19 Test, and where regulatory approval is obtained, commercialize the COVID-19 Test.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advaite will solely own all data and materials, including the COVID-19 Test, generated by the Company and its representatives solely in the course of the performance of the Ocugen Services. Advaite is responsible for all preparation and submission of regulatory materials for the COVID-19 Test to regulatory authorities, and Advaite will hold all regulatory approvals of the COVID-19 Test in its name and own all related submissions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is entitled to receive cost reimbursements from Advaite, beginning as of April 1, 2020, for (a) costs incurred by the Company related to its personnel who are subject matter experts involved in providing the Ocugen Services ("SME Costs") and (b) Advaite's pro-rata share of all costs (other than SME Costs) incurred by the Company in providing the Ocugen Services. As partial consideration for the Company's performance of the Ocugen Services, Advaite will pay to the Company a quarterly royalty in the range of mid to high single digits based on net sales of the COVID-19 Tests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Advaite Agreement expires on April 29, 2021, unless extended upon mutual agreement of both the Company and Advaite. Except as otherwise specified in the terms of the Advaite Agreement, Advaite&#x2019;s obligation to make royalty payments to the Company will survive expiration of the Advaite Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Advaite Agreement is considered to be within the scope of ASC 808 as the Advaite Agreement represents a joint operating activity and both Advaite and the Company are active participants and exposed to the risks and rewards. The Company has evaluated the Advaite Agreement and determined it is not within the scope of ASC 606 as Advaite does not meet the definition of a customer. &lt;/span&gt;&lt;/div&gt;Cost reimbursements are recorded as a reduction in research and development expense in the period incurred. Royalty payments are recorded as collaboration revenue in the period in which the underlying sale occurs. For the three and nine months ended September&#160;30, 2020, the Company recorded $0.1&#160;million and $0.3&#160;million as a reduction of research and development expense, respectively. For the three months ended September 30, 2020, the Company recorded no collaboration revenue in connection with the Advaite Agreement. For the nine months ended September 30, 2020, the Company recorded $42,620 as collaboration revenue in connection with the Advaite Agreement</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <ocgn:CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense
      contextRef="id67b6ca4f8b24a43beb2890f097dc5c2_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80OS9mcmFnOjFmYjk3ZDkzOWYwZTRmYmRhNjliMWJiYTJhMzhlNzQ2L3RleHRyZWdpb246MWZiOTdkOTM5ZjBlNGZiZGE2OWIxYmJhMmEzOGU3NDZfMTA5OTUxMTYzMTU2Nw_68429a0a-390a-455e-8445-e4cf54b858ba"
      unitRef="usd">100000</ocgn:CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense>
    <ocgn:CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense
      contextRef="ibac481b8f449420f822e23ad5e256c76_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80OS9mcmFnOjFmYjk3ZDkzOWYwZTRmYmRhNjliMWJiYTJhMzhlNzQ2L3RleHRyZWdpb246MWZiOTdkOTM5ZjBlNGZiZGE2OWIxYmJhMmEzOGU3NDZfMTA5OTUxMTYzODQwOA_a0e40ff4-4439-4be6-ada6-dd0f5e4974de"
      unitRef="usd">300000</ocgn:CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
      contextRef="ibac481b8f449420f822e23ad5e256c76_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80OS9mcmFnOjFmYjk3ZDkzOWYwZTRmYmRhNjliMWJiYTJhMzhlNzQ2L3RleHRyZWdpb246MWZiOTdkOTM5ZjBlNGZiZGE2OWIxYmJhMmEzOGU3NDZfMTA5OTUxMTYzMTU4Mw_9a8ee2ec-2dcf-4d01-b4ed-854608c38742"
      unitRef="usd">42620</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RleHRyZWdpb246ZGM5MjNiMmY0NWMxNDYwOGE3MDEwOTE1ZDljYjIxODlfMTY3_5f951059-609c-4c7e-8226-9172ef5e1b6e">Accrued Expenses&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued Expenses are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research&#160;and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance-related (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,270,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) See Note 7 for additional information regarding severance-related accrued expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RleHRyZWdpb246ZGM5MjNiMmY0NWMxNDYwOGE3MDEwOTE1ZDljYjIxODlfMTY5_a259b86f-a670-4a9a-8589-8829fe9cb43d">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued Expenses are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research&#160;and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance-related (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,270,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) See Note 7 for additional information regarding severance-related accrued expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <ocgn:ResearchAndDevelopmentExpensesCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfMi0xLTEtMS0w_24321ca0-75e1-4ec8-8e65-854ad5fd73bf"
      unitRef="usd">177802</ocgn:ResearchAndDevelopmentExpensesCurrent>
    <ocgn:ResearchAndDevelopmentExpensesCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfMi0zLTEtMS0w_85bca7ff-3c26-456a-a0d8-0bcb564302d3"
      unitRef="usd">271322</ocgn:ResearchAndDevelopmentExpensesCurrent>
    <ocgn:AccruedLiabilitiesClinical
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfMy0xLTEtMS0w_3970cd4c-10fe-4eea-9db9-6106fe40773d"
      unitRef="usd">125463</ocgn:AccruedLiabilitiesClinical>
    <ocgn:AccruedLiabilitiesClinical
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfMy0zLTEtMS0w_c15c72eb-b0d3-4135-af7c-12856c1aa390"
      unitRef="usd">421788</ocgn:AccruedLiabilitiesClinical>
    <ocgn:AccruedLiabilitiesProfessionalFees
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNC0xLTEtMS0w_c985885a-c6d1-4bf6-85a8-ceda88977d45"
      unitRef="usd">396914</ocgn:AccruedLiabilitiesProfessionalFees>
    <ocgn:AccruedLiabilitiesProfessionalFees
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNC0zLTEtMS0w_cdfe0417-5297-4bd7-a44c-2f6582a7322f"
      unitRef="usd">917568</ocgn:AccruedLiabilitiesProfessionalFees>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNS0xLTEtMS0w_b961112b-94f3-4842-a225-44becc0aec2e"
      unitRef="usd">688251</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNS0zLTEtMS0w_c74304b8-09b8-4ffe-96d5-c42712a076e5"
      unitRef="usd">624420</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <ocgn:AccruedSeveranceRelatedLiabilitiesCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNi0xLTEtMS0w_561fd2a6-f967-4d52-ae90-699d213e61a0"
      unitRef="usd">888096</ocgn:AccruedSeveranceRelatedLiabilitiesCurrent>
    <ocgn:AccruedSeveranceRelatedLiabilitiesCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNi0zLTEtMS0w_04e28b34-b031-4a86-ab00-aabed108a7dc"
      unitRef="usd">0</ocgn:AccruedSeveranceRelatedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNy0xLTEtMS0w_cc823798-70f0-45a0-9385-a410b5250b98"
      unitRef="usd">57207</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfNy0zLTEtMS0w_3c974789-fecd-4c3f-8ffb-2ec0c6bb1783"
      unitRef="usd">34947</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfOC0xLTEtMS0w_c80ba9a6-aee0-481d-b742-329152af0d7c"
      unitRef="usd">2333733</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81Mi9mcmFnOmRjOTIzYjJmNDVjMTQ2MDhhNzAxMDkxNWQ5Y2IyMTg5L3RhYmxlOmRkMzA4NDRkZDdhODQ2OWU4MGRlNzQzNTZlNjEwMmQxL3RhYmxlcmFuZ2U6ZGQzMDg0NGRkN2E4NDY5ZTgwZGU3NDM1NmU2MTAyZDFfOC0zLTEtMS0w_f42eaf73-7482-4fc1-9a51-3bb3f78a8e70"
      unitRef="usd">2270045</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfOTg1_5a46b4bc-93c6-4c21-bf63-8788be328f9a">Exit and Disposal ActivitiesOn June 15, 2020, the Company, as part of its recent shift in focus toward its gene therapy platform and novel biologics program aimed at curing blindness diseases, communicated notice to five employees of termination of their employment. This reduction represents one-third of the Company&#x2019;s workforce. All terminations were &#x201c;without cause&#x201d; and each employee is &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;entitled to receive termination benefits upon departure. The termination dates vary for each employee and range from June 30, 2020 to December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the workforce reduction, the Company recognized severance-related charges of $0.4&#160;million and $1.1&#160;million during the three and nine months ended September&#160;30, 2020, respectively. The Company expects to pay severance benefits of $0.4&#160;million during 2020 and $0.7&#160;million during 2021. For the three months ended September 30, 2020, the Company recognized a de minimis amount of severance-related charges within general and administrative expense and $0.4&#160;million of severance-related charges within research and development expense. For the nine months ended September 30, 2020, the Company recognized $0.2&#160;million of severance-related charges within general and administrative expense and $0.9&#160;million of severance-related charges within research and development expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table outlines the components of the severance-related charges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Severance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,093,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance-related payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Severance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="i2cc0ad28c5724aca9234dcc6309e44c1_D20200615-20200615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfMjI2_48726d25-9e6c-4a6a-aeac-348ee1c2855a"
      unitRef="employee">5</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <us-gaap:RestructuringCharges
      contextRef="ib65216302269446e88de6bdca0d4d78d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfMTY0OTI2NzQ0Mjg4OQ_2cab0eb1-c99c-4134-a55d-97026c2fd4ed"
      unitRef="usd">400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id3d9be1e13f34b61b21f7829259b9c08_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfMTY0OTI2NzQ0Mjg5NA_fe13d504-d304-4de0-95b2-345a80cb2690"
      unitRef="usd">1100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="ifd5fda4627a342a0982c1661cf0a687a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfNzAw_b9be26c0-ce10-4c65-9b99-fb4746e53131"
      unitRef="usd">400000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="ife4854f917da4de9b27b201328eadc2a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfNzE3_0c78ae8d-4263-4954-9004-6d719e8a611e"
      unitRef="usd">700000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringCharges
      contextRef="i1851644d82bf4fb2b634fbb231dff413_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfMTY0OTI2NzQ0Mjg3NA_2149dddf-290a-42e5-ace7-df307f7e6266"
      unitRef="usd">400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0c0ebd16833c4d9fb7640ffa8d1c822f_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfMTA5OTUxMTYzMTMxNA_e98c44af-6d0e-4a84-a717-af791ca8b335"
      unitRef="usd">200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i74b18383221c462a91314443a371c7b1_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfMTY0OTI2NzQ0Mjg4NA_4fad5ffb-5cb3-48fa-82c3-79f2fc771ad8"
      unitRef="usd">900000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RleHRyZWdpb246MGJjYTQ2YjhmMDhhNGYyZmEzNjlmYWRlZTdlNWI5MGJfOTg0_5f127af1-124e-40c2-bd7c-c9c784e29e3c">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table outlines the components of the severance-related charges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Severance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,093,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance-related payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Severance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="ic7c6f3716ee34faa9aa88da0c9ae7781_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RhYmxlOmYzYmY0ZmZiN2JlYjRiNjZhZjQwOTM3NmQwYTc0ZTZhL3RhYmxlcmFuZ2U6ZjNiZjRmZmI3YmViNGI2NmFmNDA5Mzc2ZDBhNzRlNmFfMS0xLTEtMS0w_5b830307-3b4c-4fe5-bda8-8daab7644f6d"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="id3d9be1e13f34b61b21f7829259b9c08_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RhYmxlOmYzYmY0ZmZiN2JlYjRiNjZhZjQwOTM3NmQwYTc0ZTZhL3RhYmxlcmFuZ2U6ZjNiZjRmZmI3YmViNGI2NmFmNDA5Mzc2ZDBhNzRlNmFfMi0xLTEtMS0w_325f6728-e6ad-4d2c-80fb-26bab155a772"
      unitRef="usd">1093255</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="id3d9be1e13f34b61b21f7829259b9c08_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RhYmxlOmYzYmY0ZmZiN2JlYjRiNjZhZjQwOTM3NmQwYTc0ZTZhL3RhYmxlcmFuZ2U6ZjNiZjRmZmI3YmViNGI2NmFmNDA5Mzc2ZDBhNzRlNmFfMy0xLTEtMS0xMDQ_e7615e09-0f00-423f-ae38-6bae53efce0e"
      unitRef="usd">205159</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i3de6dd9388504be191f7056b17d3e22e_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV81NS9mcmFnOjBiY2E0NmI4ZjA4YTRmMmZhMzY5ZmFkZWU3ZTViOTBiL3RhYmxlOmYzYmY0ZmZiN2JlYjRiNjZhZjQwOTM3NmQwYTc0ZTZhL3RhYmxlcmFuZ2U6ZjNiZjRmZmI3YmViNGI2NmFmNDA5Mzc2ZDBhNzRlNmFfMy0xLTEtMS0w_e8a05737-5217-4924-ae92-91c6338de117"
      unitRef="usd">888096</us-gaap:RestructuringReserve>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMjA5Mw_31493328-74e9-4176-b19e-e1875ed23f26">Equity Transactions&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;At-the-Market Offerings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2020, the Company sold an aggregate of 27.0&#160;million and 86.2&#160;million shares of common stock, respectively, in separate at-the-market offerings (&#x201c;ATMs&#x201d;) commenced in May 2020, June 2020 and August 2020. The Company sold 34.4&#160;million shares under the May 2020 ATM, 24.8&#160;million shares under the June 2020 ATM and 27.0&#160;million shares under the August 2020 ATM. During the three months ended September 30, 2020, the Company received net proceeds of $10.1&#160;million, after deducting commissions, fees and expenses of $0.4&#160;million. During the nine months ended September 30, 2020, the Company received net proceeds of $25.6&#160;million, after deducting commissions, fees and expenses of $1.1&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The offerings were made pursuant to the Company's effective "shelf" registration statement on Form S-3 filed with the SEC on March 27, 2020, the base prospectus contained therein dated May 5, 2020, and the prospectus supplements related to the offerings dated May 8, 2020, June 12, 2020 and August 17, 2020. As of September&#160;30, 2020, the Company had sold all of the shares of common stock available for issuance under the prospectus supplements filed on May 8, 2020 and June 12, 2020 in connection with the May 2020 and June 2020 ATMs. As of September&#160;30, 2020, the Company had remaining capacity to issue up to $19.5&#160;million of common stock under the prospectus supplement filed on August 17, 2020 in connection with the August 2020 ATM.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subscription Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 22, 2020, the Company entered into a subscription agreement with an accredited investor for the sale of 1,000 shares of the Company's common stock in a private placement for an aggregate offering price of $395. This private placement constituted a Dilutive Issuance (as defined in Note 12) and resulted in adjustments to the Series A Warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 6, 2020, the Company entered into a subscription agreement with an accredited investor for the issuance of 1.3 million shares of the Company's common stock in a private placement. The shares of common stock were issued as part of a transaction in settlement of an outstanding obligation of the Company to the accredited investor, in which (i) the Company agreed to make certain cash payments, (ii) the Company issued the 1.3 million shares of common stock in exchange for the accredited investor's agreement to cancel $0.3 million of the outstanding obligation and (iii) the accredited investor agreed to cancel an additional portion of the amount owed by the Company representing a discount of $0.2&#160;million.&lt;/span&gt;&lt;/div&gt;On April 5, 2019, OpCo entered into a subscription agreement (the "April 2019 Subscription Agreement") with existing investors for the sale of 0.1 million shares of common stock for $1.0&#160;million. This capital raise triggered the conversion features on the convertible debt described in Note 9 below.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i705cda31adfa47b8bf226fde1fda52d5_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTAx_84f688d1-0538-443d-9633-16b925c27991"
      unitRef="shares">27000000.0</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ib7205f6b303a46ca881e1f5b3771db48_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTA5OTUxMTYzMDAxOA_fa1c6e95-95ae-4a37-853c-78bb6c059aac"
      unitRef="shares">86200000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i6788e535d4e547eaad37605b59a5e359_D20200501-20200531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTA5OTUxMTYzNjA0OA_1a29b758-1152-49a9-bc0e-349b543bf844"
      unitRef="shares">34400000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i641bb5999b314e3e9ff26b630c0802c5_D20200601-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTA5OTUxMTYzNjA1OQ_fdd001c6-1529-4e55-a02d-05e4821c6cda"
      unitRef="shares">24800000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i84a2946964c741a8929a7e3b1f4d5681_D20200801-20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTA5OTUxMTYzNjA3Mg_eb967262-07b7-41ca-8f8a-faa0f1c206c7"
      unitRef="shares">27000000.0</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i705cda31adfa47b8bf226fde1fda52d5_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMjQ2_0f6f6d33-82d2-4c54-be08-5180a066ecf9"
      unitRef="usd">10100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i705cda31adfa47b8bf226fde1fda52d5_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMzAw_4b7b156a-6d1c-4e3c-b53a-013b90ff3825"
      unitRef="usd">400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ib7205f6b303a46ca881e1f5b3771db48_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTA5OTUxMTYzMDM0MQ_2f9c7c85-54b5-4f28-a343-da31872173bb"
      unitRef="usd">25600000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="ib7205f6b303a46ca881e1f5b3771db48_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTA5OTUxMTYzMDM0MA_e106c1b7-2e19-4f74-bc44-27f67cd76163"
      unitRef="usd">1100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <ocgn:SaleOfStockNumberOfSharesOutstandingRemainingCapacity
      contextRef="i3798aebd55684549850d5b6934cb938f_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTA5OTUxMTYzNTQyNg_a7772087-2dce-4c80-b7a1-289ab4695b29"
      unitRef="shares">19500000</ocgn:SaleOfStockNumberOfSharesOutstandingRemainingCapacity>
    <us-gaap:CommonStockSharesSubscribedButUnissued
      contextRef="i4c39808114c84938bdbf2cfbe7968dba_I20200422"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfOTE5_6378ff8e-3db2-4035-a954-728a236a052e"
      unitRef="shares">1000</us-gaap:CommonStockSharesSubscribedButUnissued>
    <us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
      contextRef="i4c39808114c84938bdbf2cfbe7968dba_I20200422"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTAxNw_5b02af85-bbfc-4f17-959c-6aed959a0089"
      unitRef="usd">395</us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i891a1948cbf344f09e76772040e3fa8e_D20200606-20200606"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTI2NA_01ce48c0-ca36-4d55-b73a-477849f87683"
      unitRef="shares">1300000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i891a1948cbf344f09e76772040e3fa8e_D20200606-20200606"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTU2OQ_01ce48c0-ca36-4d55-b73a-477849f87683"
      unitRef="shares">1300000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <ocgn:SaleOfStockOutstandingObligationCancelledInExchangeForStock
      contextRef="i36e49ecbf9c640919597478a362dc2c5_I20200606"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTY1Nw_5862aa32-4d7d-4509-a6ab-f0a8a8e712ee"
      unitRef="usd">300000</ocgn:SaleOfStockOutstandingObligationCancelledInExchangeForStock>
    <ocgn:SaleOfStockAdditionalDebtCancelledInExchangeForStock
      contextRef="i36e49ecbf9c640919597478a362dc2c5_I20200606"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTgyNA_c13c373e-9c2d-4353-9dc1-e2014e3eaab2"
      unitRef="usd">200000</ocgn:SaleOfStockAdditionalDebtCancelledInExchangeForStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i3b93323e957a4ce9b32abd082822d3d0_D20190405-20190405"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTk2MA_79508c25-ca62-4f7f-a14c-a03070db54a9"
      unitRef="shares">100000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i3b93323e957a4ce9b32abd082822d3d0_D20190405-20190405"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82MS9mcmFnOjY4NjA0MTVmZDIwZDQwYTI4MGI3NjVjZWI2NGE1ZTVmL3RleHRyZWdpb246Njg2MDQxNWZkMjBkNDBhMjgwYjc2NWNlYjY0YTVlNWZfMTk5MA_a2827e95-2a9e-44d6-8f27-4feb3c1f20da"
      unitRef="usd">1000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTA0MzU_8c8b9170-19b5-42d6-8000-52a7d3ef0c25">Debt&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of the carrying values for the components of debt as reflected on the condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PPP Note&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant Exchange Promissory Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EB-5 Loan Agreement borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,616,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,072,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total carrying value of debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,155,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,072,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PPP Note&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 30, 2020, the Company was granted a loan from Silicon Valley Bank ("SVB"), in the aggregate amount of $0.4&#160;million, pursuant to the Paycheck Protection Program (the &#x201c;PPP&#x201d;) of the Coronavirus Aid, Relief and Economic Security Act of 2020 (the &#x201c;CARES Act&#x201d;). On June 5, 2020, the PPP Flexibility Act of 2020 (the "PPPFA") was signed into law amending the original terms of the PPP. Among other things, the PPPFA extends the deferral period for monthly principal and interest payments from six months to the time when the Small Business Administration (the "SBA") compensates the lender for amounts forgiven as well as extending the covered period for qualifying expenses from eight weeks to the earlier of 24 weeks or December 31, 2020. Certain amounts of the loan may be forgiven if they are used for qualifying expenses as described by the CARES Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loan was in the form of a promissory note dated April 30, 2020 in favor of SVB (the "PPP Note"). The PPP Note matures on April 30, 2022 and bears interest at a rate of 1.0% per annum. Principal and interest payments are payable monthly commencing on the date the SBA compensates SVB for forgiven amounts or within 10 months following the expiration of the covered period if the Company has not applied for forgiveness. The Company did not provide any collateral or guarantees for the loan, nor did the Company pay any facility charge to obtain the loan. The PPP Note provides for customary events of default, including, among others, failure to make payment, bankruptcy, breaches of representations and material adverse events. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020, the carrying value of the PPP Loan was $0.4 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrant Exchange Promissory Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 22, 2020, in connection with the Warrant Exchange as defined in Note 12, the Company issued to Investors certain promissory notes (the "Warrant Exchange Promissory Notes") with an aggregate principal amount of $5.6&#160;million. The Warrant Exchange Promissory Notes have a maturity date of April 21, 2021 and do not bear interest. The Company may prepay the Warrant Exchange Promissory Notes in whole or in part at any time without penalty or premium. In the event that the Company consummates a financing transaction that generates cash to the Company, the Company is required to use 20% of the net proceeds of such transaction to prepay a portion of the outstanding amount under each Warrant Exchange Promissory Note if the transaction occurs on or prior to August 22, 2020, and 30% of the net proceeds to prepay a portion of the outstanding amount under each Warrant Exchange Promissory Note if that transaction occurs after August 22, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 22, 2020, the Warrant Exchange Promissory Notes were recorded at a fair value of $5.0&#160;million. The difference of $0.6&#160;million between the fair value and the aggregate principal amount of $5.6&#160;million was recorded as a debt discount to be accreted to interest expense over the life of the Warrant Exchange Promissory Notes. The accretion amounted to $0.3&#160;million and $0.5&#160;million for the three and nine months ended September&#160;30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to use a percentage of the net proceeds of the ATMs discussed in Note 8 to redeem the outstanding amount under the Warrant Exchange Promissory Notes. During the three and nine months ended September&#160;30, 2020, the Company made payments to the Warrant Exchange Promissory Note holders of $3.2 million and $4.4 million, respectively. Subsequent to September&#160;30, 2020, the Company made payments to the Warrant Exchange Promissory Note holders of $1.3 million, causing the Warrant Exchange Promissory Notes to be repaid in full and no longer outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of the Warrant Exchange Promissory Notes at September&#160;30, 2020 and December&#160;31, 2019 are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145,732)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;EB-5 Loan Agreement Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September&#160;2016, pursuant to the U.S. government&#x2019;s Immigrant Investor Program, commonly known as the EB-5 program (the &#x201c;EB-5 Program&#x201d;), the Company entered into an arrangement (the &#x201c;EB-5 Loan Agreement&#x201d;) to borrow up to $10.0&#160;million from EB5 Life Sciences,&#160;L.P. (&#x201c;EB-5 Life Sciences&#x201d;) in $0.5&#160;million increments. Borrowing may be limited by the amount of funds raised by the EB-5 Life Sciences and are subject to certain job creation requirements by the Company. Borrowings are at a fixed interest rate of 4.0% per annum and are to be utilized in the clinical development, manufacturing, and commercialization of the Company&#x2019;s products and for the general working capital needs of the Company. Outstanding borrowings pursuant to the EB-5 Program, including accrued interest, become due upon the seventh anniversary of the final disbursement. Amounts repaid cannot be re-borrowed. The EB-5 Program borrowings are secured by substantially all assets of the Company, except for any patents, patent applications, pending patents, patent license, patent sublicense, trademarks, and other intellectual property rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms and conditions of the EB-5 Loan Agreement, the Company borrowed $1.0 million in 2016 and an additional $0.5 million on March&#160;26, 2020. Issuance costs were recognized as a reduction to the loan balance and are amortized to interest expense over the term of the loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of the EB-5 Loan Agreement borrowings as of September&#160;30, 2020 and December&#160;31, 2019 are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,616,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,072,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Secured Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 21, 2019, the Company issued senior secured convertible notes to certain investors for $2.4 million at an original issue discount of $0.5 million, and on June 28, 2019, the Company entered into an agreement to issue additional senior secured convertible notes to the investors for $2.9 million with an original issue discount of $0.4 million (together the "Senior Secured Convertible Notes"). Immediately prior to the Merger completed on September 27, 2019, the Investors offset $5.3 million from the amount to be received under the Pre-Merger Financing and the Senior Secured Convertible Notes were deemed to have been repaid and cancelled. The accretion of the original issue discount to interest expense amounted to $0.7 million and $0.8 million during three and nine months ended September&#160;30, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Promissory Note&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 4, 2019, the Company issued a convertible promissory note (the "Convertible Promissory Note") to an existing stockholder for $0.9&#160;million at an interest rate of 5% per annum. On May 16, 2019, the Convertible Promissory Note was converted into equity. OpCo issued 0.1&#160;million shares of common stock at the conversion date to extinguish the debt at $12.41 per share. This non-cash transaction resulted in an increase of $0.9&#160;million in additional paid-in capital, which was based on the principal balance outstanding and the unpaid interest upon conversion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2019 and 2018, the Company issued convertible notes (the &#x201c;Convertible Notes&#x201d;) to new and existing stockholders in the Company, including Convertible Notes in the aggregate principal amount of $3.5&#160;million to members of the Board of Directors. As of December&#160;31, 2019, all Notes had been converted and were no longer outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At issuance, the following amounts were recorded:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Convertible Note&#160;Issuance&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Convertible Note&lt;br/&gt;Principal&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value of Embedded Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;Issuance&lt;br/&gt;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value upon Issuance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,657,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,969)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,306,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(724,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182,882)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,750,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,891,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,670,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All Convertible Notes accrued interest at a rate of 5% per annum and had scheduled maturity dates on the &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjgzOQ_9250eb5b-b0ea-4f42-8cf2-a98505654eac"&gt;eighteen&lt;/span&gt; month anniversary of the date of the issuance of the Convertible Notes (the &#x201c;Maturity Date&#x201d;). If prior to the Maturity Date, there was a consummation of the sale of all or substantially all of the assets of the Company, change in control or event of default, the Convertible Notes would become due and payable at an amount equal to 1.5 times the principal amount of the Convertible Notes together with all accrued interest (the &#x201c;Change in Control Feature&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company received equity financing from the issuance of stock of the Company from an investor or group of investors in a transaction or series of related transactions above a certain amount of gross proceeds, the principal amount and all interest accrued but not paid through the closing date of the qualified equity financing was to automatically convert into the same class of equity securities as those issued in the qualified equity financing ("Conversion Feature"). The price per share varied among the Convertible Notes ranging from a 0% to 30% discount to the lowest price per share being paid by investors in the qualified equity financing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company bifurcated the Conversion Feature for the January&#160;2018, June&#160;2018, January&#160;2019, and February&#160;2019 Convertible Notes and classified it as a derivative liability because the conversion feature did not have a fixed conversion price and conversion would be settled in a variable number of shares of common stock. There was no bifurcated conversion feature for the November&#160;2018 and December 2018 Convertible Notes as there is no discount to the lowest equity price triggering conversion. The Company also bifurcated the Change in Control Feature for all of the Convertible Notes because it was determined to be a redemption feature not clearly and closely related to the debt host. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of both of the embedded features was accounted for as a derivative liability and was recorded as a discount on the Convertible Notes. Inputs used in valuation were unobservable and therefore considered Level 3 in the fair value hierarchy. The debt discount was accreted into interest expense over the expected time until conversion of the Convertible Notes. The accretion amounted to zero and $0.5 million for the three and nine months ended September&#160;30, 2019, respectively. There was no accretion during the three and nine months ended September&#160;30, 2020 as all Convertible Notes had been converted and were no longer outstanding as of December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the embedded features was classified as a liability in the Company&#x2019;s condensed consolidated balance sheets at issuance, with subsequent changes in fair value recorded on the Company&#x2019;s condensed consolidated statements of operations and comprehensive loss as a change in fair value of derivative liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the April 2019 Subscription Agreement as described and defined within Note 8, the triggers for conversion were met on the Convertible Notes. On April 5, 2019, the Convertible Notes were modified to change the discount percentage from the 0% discount per the terms of the November&#160;2018 and December 2018 Convertible Notes and the 15% discount per the terms of the January&#160;2019 and February&#160;2019 Convertible Notes to 30% at the time of conversion. The Company issued 1.1&#160;million shares of common stock at $8.69 per share on the date of conversion to extinguish the debt, which resulted in a loss of $0.3&#160;million. This non-cash conversion also resulted in an increase of $13.0 million in additional paid-in capital, which was based on the principal balance outstanding and the unpaid interest upon conversion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principal Maturities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt maturities (excluding interest) are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Twelve months ending September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal Maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,356,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,184,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTA0MjU_0b277618-00be-42c3-8df5-fd9f0a483dfd">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of the carrying values for the components of debt as reflected on the condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PPP Note&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant Exchange Promissory Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EB-5 Loan Agreement borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,616,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,072,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total carrying value of debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,155,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,072,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of the Warrant Exchange Promissory Notes at September&#160;30, 2020 and December&#160;31, 2019 are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145,732)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of the EB-5 Loan Agreement borrowings as of September&#160;30, 2020 and December&#160;31, 2019 are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,616,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,072,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i954c5746ce5b45d1a940c37f489ee070_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfMS0xLTEtMS0w_6686f68d-ee56-4ff0-bedd-3f747a871ea5"
      unitRef="usd">421415</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id35de39551be499fbe3da2455d22798c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfMS0zLTEtMS0w_1eccc091-31ca-4776-aa12-e0c015779bde"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i7f6eb732ec634b628ad24bc33e7f1a58_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfMi0xLTEtMS0w_f26cda9f-09ff-42a4-a181-d6183762c0ff"
      unitRef="usd">1116997</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i43ef6579c4fd4fce993710b539ee1478_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfMi0zLTEtMS0w_70bda707-36a3-46ee-83d8-a9387ce0e0d4"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if855a3da2e6d45e0828572b9b374ebc3_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfMy0xLTEtMS0w_4e641195-9475-487b-b287-cbbdcf28cd01"
      unitRef="usd">1616629</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iae6ba8a4f7f84d6da2219724a513733f_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfMy0zLTEtMS0w_57284e23-2815-4175-a3fe-d2dbc4fbd0f2"
      unitRef="usd">1072123</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfNC0xLTEtMS0w_b1cd2370-2376-4301-a8d6-35390d667478"
      unitRef="usd">3155041</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjE3Mzc2YzllZTBkMzQxOGI4OTE4OWY2ZThhNTdjOTgyL3RhYmxlcmFuZ2U6MTczNzZjOWVlMGQzNDE4Yjg5MTg5ZjZlOGE1N2M5ODJfNC0zLTEtMS0w_5819dfda-8197-4a10-b039-02c4d428074c"
      unitRef="usd">1072123</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib962316dd8ec4a45b707ea8ffe2cfdca_I20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMjcy_d942e989-87f9-48db-8af3-047fb5412cfd"
      unitRef="usd">400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib962316dd8ec4a45b707ea8ffe2cfdca_I20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTEzMw_4aa6ee10-b65e-487b-8f58-adca46830bd8"
      unitRef="number">0.010</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i8d689227ca8e441da7199a43bf5eb16a_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTczOA_7b2ca781-c7ef-4ab6-96be-4d95cab50640"
      unitRef="usd">400000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i82bf19a1e632417380b5fe0e427dd9b7_I20200422"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTk3OA_b9d61358-7da4-445e-ad95-3f118fcd867b"
      unitRef="usd">5600000</us-gaap:DebtInstrumentCarryingAmount>
    <ocgn:DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction
      contextRef="i202e82a2e6574f9395b0475edfae9fc0_I20200422"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMjMyNw_673b7a11-535d-4711-a336-1d60b6479de5"
      unitRef="number">0.20</ocgn:DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction>
    <ocgn:DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction
      contextRef="i2ca8387e786e470e94c2d428dd8b08be_I20200422"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMjUwOQ_7491b242-17f2-482a-a65c-d1c51399ac50"
      unitRef="number">0.30</ocgn:DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction>
    <us-gaap:LongTermDebtFairValue
      contextRef="i82bf19a1e632417380b5fe0e427dd9b7_I20200422"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMjczOA_0d40539e-45d1-4a96-867d-3c5cb08e5572"
      unitRef="usd">5000000.0</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i82bf19a1e632417380b5fe0e427dd9b7_I20200422"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMjc2MA_b5d45f02-d359-4331-898d-449dc969b7f1"
      unitRef="usd">600000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i82bf19a1e632417380b5fe0e427dd9b7_I20200422"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMjgyNA_6bd38b93-9648-4272-b2e9-316a9d51237a"
      unitRef="usd">5600000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:InterestExpenseDebt
      contextRef="if8e397ca8e294216950367c054054ea4_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMjk3Ng_bc1c0e7d-52dd-4b03-863e-3031399470dc"
      unitRef="usd">300000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="idafa3d9adff54d838525f6e345d7b222_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTY0OTI2NzQ1NDc1Mg_b92c0e1f-2fd0-4cc7-b5bb-08597ecb2c75"
      unitRef="usd">500000</us-gaap:InterestExpenseDebt>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="if8e397ca8e294216950367c054054ea4_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMzI3NQ_547173b4-8802-4aba-88ab-3b14b34d0a76"
      unitRef="usd">3200000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="idafa3d9adff54d838525f6e345d7b222_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTY0OTI2NzQ1NTE1Ng_8b220f8d-8bea-49c1-82fd-7e7bbe11842c"
      unitRef="usd">4400000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="iaa36c601f8de4816bb5ac175ca991a52_D20201001-20201106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTA5OTUxMTY1OTQ3OQ_8dc2930f-4fe3-4390-9c36-ea3df4257e67"
      unitRef="usd">1300000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7f6eb732ec634b628ad24bc33e7f1a58_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYyMzNiNzU3MTViNzRkOTI5NmZiNWRlMTMxNDdmNThlL3RhYmxlcmFuZ2U6ZjIzM2I3NTcxNWI3NGQ5Mjk2ZmI1ZGUxMzE0N2Y1OGVfMS0yLTEtMS0w_f57fa4f1-2b45-4fba-9078-0cbeae60507f"
      unitRef="usd">1262729</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i43ef6579c4fd4fce993710b539ee1478_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYyMzNiNzU3MTViNzRkOTI5NmZiNWRlMTMxNDdmNThlL3RhYmxlcmFuZ2U6ZjIzM2I3NTcxNWI3NGQ5Mjk2ZmI1ZGUxMzE0N2Y1OGVfMS00LTEtMS0w_347184f4-c46d-4ca1-a014-d6912541551e"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i7f6eb732ec634b628ad24bc33e7f1a58_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYyMzNiNzU3MTViNzRkOTI5NmZiNWRlMTMxNDdmNThlL3RhYmxlcmFuZ2U6ZjIzM2I3NTcxNWI3NGQ5Mjk2ZmI1ZGUxMzE0N2Y1OGVfMi0yLTEtMS0w_e4257ff6-ce27-4df1-8722-23801b167214"
      unitRef="usd">145732</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i43ef6579c4fd4fce993710b539ee1478_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYyMzNiNzU3MTViNzRkOTI5NmZiNWRlMTMxNDdmNThlL3RhYmxlcmFuZ2U6ZjIzM2I3NTcxNWI3NGQ5Mjk2ZmI1ZGUxMzE0N2Y1OGVfMi00LTEtMS0w_5286e335-93e9-43e3-bbbd-596e4c19a770"
      unitRef="usd">0</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i7f6eb732ec634b628ad24bc33e7f1a58_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYyMzNiNzU3MTViNzRkOTI5NmZiNWRlMTMxNDdmNThlL3RhYmxlcmFuZ2U6ZjIzM2I3NTcxNWI3NGQ5Mjk2ZmI1ZGUxMzE0N2Y1OGVfMy0yLTEtMS0w_2e3a8f4b-cab3-4a7d-87e6-12c16747295f"
      unitRef="usd">1116997</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i43ef6579c4fd4fce993710b539ee1478_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYyMzNiNzU3MTViNzRkOTI5NmZiNWRlMTMxNDdmNThlL3RhYmxlcmFuZ2U6ZjIzM2I3NTcxNWI3NGQ5Mjk2ZmI1ZGUxMzE0N2Y1OGVfMy00LTEtMS0w_1ecf535f-bf05-414e-84c0-df15455abe10"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i89af07cba55243ada1a697e372c93c26_I20160930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMzczMw_13c3e16e-843a-47ab-8540-6d9b96e60f91"
      unitRef="usd">10000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <ocgn:LineOfCreditBorrowingEachDraw
      contextRef="i616e252088514e97a1bc3f1b262dcd7b_D20160901-20160930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMzc5MQ_5ff38da3-2978-4cab-852c-9bbbf595fdad"
      unitRef="usd">500000</ocgn:LineOfCreditBorrowingEachDraw>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i89af07cba55243ada1a697e372c93c26_I20160930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMzk5OQ_4d84f760-a303-43ac-927d-9c8d21795978"
      unitRef="number">0.040</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCredit
      contextRef="i4b78b94d3f034ec7b1df0ad282714b18_I20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNDY4NA_2506697c-177c-4311-9c79-5bc9dcb435ad"
      unitRef="usd">1000000.0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i3b4ea6a10d05450090d47b47a43bceac_I20200326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNDcxMw_8f613440-f5b5-4b49-b285-414f228c63fe"
      unitRef="usd">500000</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if855a3da2e6d45e0828572b9b374ebc3_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfMS0yLTEtMS0w_9d8a69d2-846b-493e-bf3c-4ced62766844"
      unitRef="usd">1500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iae6ba8a4f7f84d6da2219724a513733f_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfMS00LTEtMS0w_bd642415-c893-42c4-a4d5-248a46e8ec3c"
      unitRef="usd">1000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="if855a3da2e6d45e0828572b9b374ebc3_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfMi0yLTEtMS0w_e8ca4cc0-e008-4e2b-8dab-40dcf9c87401"
      unitRef="usd">166053</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="iae6ba8a4f7f84d6da2219724a513733f_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfMi00LTEtMS0w_1600ed59-c0d7-4b27-b9cf-76c78fba22c4"
      unitRef="usd">127777</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="if855a3da2e6d45e0828572b9b374ebc3_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfMy0yLTEtMS0w_338f9c20-7697-48c1-a843-a63bd3268372"
      unitRef="usd">49424</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="iae6ba8a4f7f84d6da2219724a513733f_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfMy00LTEtMS0w_1715d270-e47b-4413-9420-bfdb0281d8c0"
      unitRef="usd">55654</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="if855a3da2e6d45e0828572b9b374ebc3_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfNC0yLTEtMS0w_137edfab-5008-4cff-8804-bb9203b9d20e"
      unitRef="usd">1616629</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iae6ba8a4f7f84d6da2219724a513733f_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjNlMTcwMzgwYzBkMDQxN2NiMTI1MzY4ODY0OTUzYzYzL3RhYmxlcmFuZ2U6M2UxNzAzODBjMGQwNDE3Y2IxMjUzNjg4NjQ5NTNjNjNfNC00LTEtMS0w_559f5311-ba3f-4fca-91fc-86a06f0e43e1"
      unitRef="usd">1072123</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic2e106364d89410d8fa73ea0a7ada5a2_I20190521"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTA2OQ_92294747-d870-4bf5-9aec-3b5096a2f5d7"
      unitRef="usd">2400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ic2e106364d89410d8fa73ea0a7ada5a2_I20190521"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTEwNQ_c8eaa84b-a928-4815-8d3e-6e4f89fdd571"
      unitRef="usd">500000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iec5ace5a1a5d48d78f81c3898beaf7cf_I20190628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTIzMg_087ea55d-540c-4e44-ae4e-daedf88d4cf3"
      unitRef="usd">2900000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="iec5ace5a1a5d48d78f81c3898beaf7cf_I20190628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTI3MA_551833f0-0fec-4eab-9246-1cf8b6a0055c"
      unitRef="usd">400000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9fe0b042d77c45bc9e7880606282df26_I20190927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTU0MQ_3c581066-c9d9-4f92-bbc6-6afd72b91432"
      unitRef="usd">5300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestExpense
      contextRef="i3a8ac0202f094c9288e4af258c9a7d6c_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTc3MQ_c50ef01b-e85a-4966-aeb3-471511bd7a2b"
      unitRef="usd">700000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3b33f5ec1c0e4138ae4e880885651fb9_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTY0OTI2NzQ1NzM1OQ_3e778c8c-7bcb-490d-8021-046f8ecd8705"
      unitRef="usd">800000</us-gaap:InterestExpense>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9836b63cfe2f4fe7b7c0325bd22c222e_I20190404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTk1Mg_54b4263e-2a77-45f4-b415-9e6a3829c51f"
      unitRef="usd">900000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9836b63cfe2f4fe7b7c0325bd22c222e_I20190404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNTk3OA_e9c1abad-8091-454c-a068-0d4099c1af5f"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <ocgn:CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement
      contextRef="iba956723fd0740239620e5f29bcb4ca7_I20190516"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjA3MA_9964895b-cc60-4d51-8bab-330044a15c88"
      unitRef="shares">100000</ocgn:CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="iba956723fd0740239620e5f29bcb4ca7_I20190516"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjE0NQ_472b003d-070d-4123-b086-54db0f3b7931"
      unitRef="usdPerShare">12.41</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="ie5d139f20a3148c98c5a49fbdcb7bc19_D20190516-20190516"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjIxMg_cd17e9e5-60ce-4a3b-b61b-a4f989703f53"
      unitRef="usd">900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1a9a7d47ff164922b47b9474737d5697_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjU2OQ_a8eb574b-649d-4f96-85e9-83d4807b1a00"
      unitRef="usd">3500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i97a56e3f53224d4ab82457b6f444f1f4_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjU2OQ_d6aa5c79-27cf-4ff0-843d-e34c32e96eb2"
      unitRef="usd">3500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ConvertibleDebt
      contextRef="i6e196fac2ce14f69a9c7145fc6153460_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjY1OA_90c65e66-0b84-41e5-a003-fb13bd7a4693"
      unitRef="usd">0</us-gaap:ConvertibleDebt>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTA0MzM_cb1a5199-4cd6-4b97-a413-e3736df4548e">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At issuance, the following amounts were recorded:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Convertible Note&#160;Issuance&#160;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Convertible Note&lt;br/&gt;Principal&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value of Embedded Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;Issuance&lt;br/&gt;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value upon Issuance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,657,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,969)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,306,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(724,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182,882)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,750,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,891,172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,670,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5c95e5d478a04f07aafab89ce80821a5_I20180131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMS0yLTEtMS0w_5deb631c-d827-4c2d-8eb9-2279824c61d6"
      unitRef="usd">5000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="i92b0bfa510874f698e53c5abd86cfac8_I20180131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMS00LTEtMS0w_3ce16e73-942d-478b-a509-651e0589b494"
      unitRef="usd">2657711</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i5c95e5d478a04f07aafab89ce80821a5_I20180131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMS02LTEtMS0w_5a9a7fdf-aa8d-44a6-add7-1482d8ac66bb"
      unitRef="usd">35969</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LongTermDebt
      contextRef="i5c95e5d478a04f07aafab89ce80821a5_I20180131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMS04LTEtMS0w_0666a6be-dd15-4266-993e-a44a6b7dd514"
      unitRef="usd">2306320</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3f4bd0c993144352beacd61bd76c907a_I20180630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMi0yLTEtMS0w_37ef70a4-0b32-492c-932e-89abfb615f3d"
      unitRef="usd">1000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="if1ef8269ce6849a8bbaaf6f1dd81d930_I20180630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMi00LTEtMS0w_409598b0-3bd0-46d4-8fe6-05500e60bcd3"
      unitRef="usd">724216</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i3f4bd0c993144352beacd61bd76c907a_I20180630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMi02LTEtMS0w_91d0d612-c8e3-4369-8a45-9b52245f36b7"
      unitRef="usd">3000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LongTermDebt
      contextRef="i3f4bd0c993144352beacd61bd76c907a_I20180630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMi04LTEtMS0w_cf39b263-ce27-42b7-8f01-a1d3141eeeb6"
      unitRef="usd">272784</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i07700165b6f44737af43f19cf18c3b61_I20181130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMy0yLTEtMS0w_684c70e0-1025-40a7-91a6-66fe7353c881"
      unitRef="usd">1150400</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="ic60fd8eff73747ec9eaa1854872d27d4_I20181130"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMy00LTEtMS0w_36306b1b-3a30-446c-93c6-5fcf02fdbaa9"
      unitRef="usd">21127</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i07700165b6f44737af43f19cf18c3b61_I20181130"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMy02LTEtMS0w_3872322b-6ca0-41e9-b26d-1e6d339eed59"
      unitRef="usd">50646</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LongTermDebt
      contextRef="i07700165b6f44737af43f19cf18c3b61_I20181130"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfMy04LTEtMS0w_a4c31017-2f3f-490b-bf10-a7477f836da3"
      unitRef="usd">1078627</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8441ef9a2d3446daa0a9a5e613555095_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNC0yLTEtMS0w_05457451-bf2a-4a3a-8e7c-e6e1c2eba803"
      unitRef="usd">150000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="ia31f6d3314ac41ffb1c478548ad440f7_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNC00LTEtMS0w_dd25ff15-f5c9-45e5-9658-a6bcf00b9717"
      unitRef="usd">2857</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i8441ef9a2d3446daa0a9a5e613555095_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNC02LTEtMS0w_e483c332-5a17-41ae-929d-0a0bae208149"
      unitRef="usd">14310</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LongTermDebt
      contextRef="i8441ef9a2d3446daa0a9a5e613555095_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNC04LTEtMS0w_6a4a255c-e813-488f-aa45-7f50b6de26b7"
      unitRef="usd">132833</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5349b87b7d764f64a46780bb66baca10_I20190131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNS0yLTEtMS0w_921a6cc7-81a6-4a30-891c-2c9c41efe3ad"
      unitRef="usd">450000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="i10b818c696fa4a59b0fd450672c2f045_I20190131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNS00LTEtMS0w_ed31edc8-7482-4a97-9db9-d5e42bea9033"
      unitRef="usd">182882</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i5349b87b7d764f64a46780bb66baca10_I20190131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNS02LTEtMS0w_9fa3f9f6-34b3-41bc-8ad8-2876cc234b3d"
      unitRef="usd">29358</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LongTermDebt
      contextRef="i5349b87b7d764f64a46780bb66baca10_I20190131"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNS04LTEtMS0w_7dd5b75d-9188-4add-9c13-0af22d88272c"
      unitRef="usd">237760</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i83b69bf96efa4d168b3abf899bb9cc37_I20190228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNi0yLTEtMS0w_1b0ade9a-ca02-4178-ac47-de01d38542c3"
      unitRef="usd">1000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="i4c4f1fd7901c4793a17e268f79e0bcd9_I20190228"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNi00LTEtMS0w_8b6223a8-60f5-475d-8b5e-28fd9a2095e5"
      unitRef="usd">302379</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i83b69bf96efa4d168b3abf899bb9cc37_I20190228"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNi02LTEtMS0w_f54d6535-8ab0-48f0-9b7a-a6f22b8c4145"
      unitRef="usd">55875</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LongTermDebt
      contextRef="i83b69bf96efa4d168b3abf899bb9cc37_I20190228"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNi04LTEtMS0w_3c4e659e-4a45-4685-82f2-f6f046e589d5"
      unitRef="usd">641746</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6e196fac2ce14f69a9c7145fc6153460_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNy0yLTEtMS0w_1e1a1dd7-4c1a-4ee7-ae3a-a78d953c0c08"
      unitRef="usd">8750400</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="i29b4f949ec244c099e380923e5e22554_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNy00LTEtMS0w_36088b95-4b6e-4bed-8988-395485b6bfc3"
      unitRef="usd">3891172</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i6e196fac2ce14f69a9c7145fc6153460_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNy02LTEtMS0w_f6282c12-326b-4dc5-ab1e-e6e7bc0a3f32"
      unitRef="usd">189158</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LongTermDebt
      contextRef="i6e196fac2ce14f69a9c7145fc6153460_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOjQ0ZjljZjJlY2ZhNDQyYWZiMzNlMjIwNzFjNzI2ZDNhL3RhYmxlcmFuZ2U6NDRmOWNmMmVjZmE0NDJhZmIzM2UyMjA3MWM3MjZkM2FfNy04LTEtMS0w_90837e16-5803-41bc-8506-8fae72de67fc"
      unitRef="usd">4670070</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6e196fac2ce14f69a9c7145fc6153460_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjc4Ng_5001605e-be9b-49d8-b425-25e945c82b61"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <ocgn:DebtRedemptionMultipleFeature
      contextRef="i6e196fac2ce14f69a9c7145fc6153460_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNzE3NA_dda15be8-33cf-4e0b-9ca5-f94445f86885"
      unitRef="number">1.5</ocgn:DebtRedemptionMultipleFeature>
    <ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount
      contextRef="i10c8c2503acb440f996a2813e4f347ab_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNzg0Ng_0ea5a196-8cd3-4f29-8265-85c8be7603ef"
      unitRef="number">0</ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount>
    <ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount
      contextRef="ie9f2b124c93c4651bbb19190ff92d0ef_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNzg1Mg_0404e072-4617-4296-9ffb-5ce017a7ebc4"
      unitRef="number">0.30</ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="iebb9183c07544982815cbf0318070f47_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTA0NA_fc307dcb-9372-4dee-9bc5-f4e5d7eaa38d"
      unitRef="usd">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i8eb7409e74724c4aab7c90a052528902_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTA1MQ_df74d78a-40ce-4d73-a881-eac2dc2c3a16"
      unitRef="usd">500000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ic2954e2e8a8d4d55987f92e0a1378c69_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTEwNg_7581ccd5-af64-4f5a-ae0f-599b9b113f50"
      unitRef="usd">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i6f3b2b81985349648981b7c33c6a0e02_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTEwNg_c646bdd4-b6b0-4bb7-b58e-90af1fcfea26"
      unitRef="usd">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:ConvertibleDebt
      contextRef="i6e196fac2ce14f69a9c7145fc6153460_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTIwMg_90c65e66-0b84-41e5-a003-fb13bd7a4693"
      unitRef="usd">0</us-gaap:ConvertibleDebt>
    <ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount
      contextRef="ica44cf11121f47e6b6dc2650b6be2704_I20190405"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTgwOQ_b22a604b-fb14-4b0e-88a7-10803ba8f40c"
      unitRef="number">0</ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount>
    <ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount
      contextRef="i73acee8636ae4ab98d80f2c562867e27_I20190405"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTkwMA_b4f64f19-e45a-421e-8966-ab265fc841a7"
      unitRef="number">0.15</ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount>
    <ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount
      contextRef="i6fa755318529457aba279a74293b8181_I20190405"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfOTk4NQ_16dfccb5-b496-4979-a855-cc14e306dac5"
      unitRef="number">0.30</ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7122180f242946d99ad29848b79e37be_I20190405"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTAwMzQ_ac92f441-e7bd-4d2e-9c69-51ddddd700cf"
      unitRef="shares">1100000</us-gaap:CommonStockSharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i7122180f242946d99ad29848b79e37be_I20190405"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTAwNjM_790a2432-c0b4-4768-bdc5-4d0fd9d7b564"
      unitRef="usdPerShare">8.69</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i4bebf4b2ec794a58aac7839dd043db44_D20190405-20190405"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTAxNTQ_9c6ca06f-e41f-43ac-b29b-71d24298b678"
      unitRef="usd">-300000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
      contextRef="ia96a5be04b654077a75d8375d8a5d905_D20190405-20190405"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTAyMTU_33e6da54-324c-496c-ad3e-818f0d5c3667"
      unitRef="usd">13000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfMTA0Mjk_88c59570-3761-4453-86bf-320b120d3ae7">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt maturities (excluding interest) are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Twelve months ending September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal Maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,356,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,184,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYxYTkyODU5NWE3NjQzZWI4ZmQzMDBiZDNjMzU3OWZkL3RhYmxlcmFuZ2U6ZjFhOTI4NTk1YTc2NDNlYjhmZDMwMGJkM2MzNTc5ZmRfMi0xLTEtMS0w_6141df0a-5f7e-48c5-89ac-b38535e363ed"
      unitRef="usd">1356377</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYxYTkyODU5NWE3NjQzZWI4ZmQzMDBiZDNjMzU3OWZkL3RhYmxlcmFuZ2U6ZjFhOTI4NTk1YTc2NDNlYjhmZDMwMGJkM2MzNTc5ZmRfMi0yLTEtMS0w_c99add4e-e48d-47f8-bcb2-ae186beb88da"
      unitRef="usd">327767</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYxYTkyODU5NWE3NjQzZWI4ZmQzMDBiZDNjMzU3OWZkL3RhYmxlcmFuZ2U6ZjFhOTI4NTk1YTc2NDNlYjhmZDMwMGJkM2MzNTc5ZmRfMi0zLTEtMS0w_b5e88bb6-3c3e-4e42-93a7-efd2fe8ffc11"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYxYTkyODU5NWE3NjQzZWI4ZmQzMDBiZDNjMzU3OWZkL3RhYmxlcmFuZ2U6ZjFhOTI4NTk1YTc2NDNlYjhmZDMwMGJkM2MzNTc5ZmRfMi00LTEtMS0w_a5babb7e-82d7-4ade-8a52-08d4a699056d"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYxYTkyODU5NWE3NjQzZWI4ZmQzMDBiZDNjMzU3OWZkL3RhYmxlcmFuZ2U6ZjFhOTI4NTk1YTc2NDNlYjhmZDMwMGJkM2MzNTc5ZmRfMi01LTEtMS0w_e2476ce3-6176-4117-9050-20c1486f534d"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <ocgn:LongTermDebtMaturityAfterYearFour
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYxYTkyODU5NWE3NjQzZWI4ZmQzMDBiZDNjMzU3OWZkL3RhYmxlcmFuZ2U6ZjFhOTI4NTk1YTc2NDNlYjhmZDMwMGJkM2MzNTc5ZmRfMi02LTEtMS0w_43ee1820-ed77-479e-ba86-a90183ff65b3"
      unitRef="usd">1500000</ocgn:LongTermDebtMaturityAfterYearFour>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RhYmxlOmYxYTkyODU5NWE3NjQzZWI4ZmQzMDBiZDNjMzU3OWZkL3RhYmxlcmFuZ2U6ZjFhOTI4NTk1YTc2NDNlYjhmZDMwMGJkM2MzNTc5ZmRfMi03LTEtMS0w_6ad19464-8bd0-4e46-b03d-32e598e2c110"
      unitRef="usd">3184144</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMjI2NQ_2a37dcbb-fffc-4fe7-be25-a6541268b355">Stock-based Compensation&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense for options granted is reflected in the condensed consolidated statements of operations and comprehensive loss as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;720,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, the Company had $1.3&#160;million of unrecognized compensation expense related to options outstanding under its equity plans. This expense is expected to be recognized over a weighted average period of 2.2 years as of September&#160;30, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains two equity compensation plans, the 2014 Ocugen OpCo, Inc. Stock Option Plan (the &#x201c;2014 Plan&#x201d;) and the Ocugen, Inc. 2019 Equity Incentive Plan (the &#x201c;2019 Plan&#x201d;, collectively with the 2014 Plan, the "Plans"), which replaced the Histogenics Corporation 2013 Equity Incentive Plan (the "2013 Plan"). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, Ocugen&#x2019;s stockholders approved the adoption of the 2019 Plan and the 2013 Plan was frozen. No additional awards have been or will be made under the 2013 Plan and any remaining authorized shares under the 2013 Plan were recycled into the 2019 Plan. On the first business day of each fiscal year, pursuant to the "Evergreen" provision of the 2019 Plan, the aggregate number of shares that may be issued under the 2019 Plan will automatically increase by a number equal to the lesser of 4% of the total number of shares of Company common stock outstanding on December 31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the prior year, or a number of shares of Company common stock determined by the Board. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, the 2014 Plan provides for the granting of up to 0.8&#160;million equity awards in respect to Ocugen's common stock. As of September&#160;30, 2020, the 2019 Plan provides for the granting of up to 4.2&#160;million equity awards in respect of Ocugen's common stock, inclusive of equity awards that were previously available for issuance under the 2013 Plan and the additional shares authorized for issuance pursuant to the 2019 Plan's "Evergreen" provision on January 1, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, an aggregate of 0.5&#160;million and 3.8&#160;million shares of Company common stock were issuable upon the exercise of outstanding stock options under the 2014 Plan and 2019 Plan, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Options to Purchase Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the stock option activity under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,064,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(527,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at September&#160;30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,268,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at September&#160;30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average grant date fair value of stock options granted during both the three and nine months ended September&#160;30, 2020 was $0.34 per share.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMjI2Ng_00bedbe7-7570-43d0-8736-d76d07723c42">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense for options granted is reflected in the condensed consolidated statements of operations and comprehensive loss as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;720,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icc5453f20d4e4f35b4a834519b122ec4_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMi0xLTEtMS0w_1e42d903-43a6-4656-b418-a29cf921fb51"
      unitRef="usd">100903</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic43825ac7a304ddf9c2216ba906f7289_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMi0zLTEtMS0w_b2d586ee-6769-4381-99c0-e8170ae02761"
      unitRef="usd">48226</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i087644c141fc4d80854025dc438c16bd_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMi01LTEtMS0w_c16ac5a6-ecf0-4b16-9a52-5076521ef068"
      unitRef="usd">248942</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3df75069d5314c0b83c03d93eff49c3b_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMi03LTEtMS0w_2dad2951-9c5e-4ef4-99c2-8fa81f7827f7"
      unitRef="usd">298621</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i162d13dc4b1545c696e798ebac5d4a90_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMy0xLTEtMS0w_fcdb6e90-7242-449d-9aad-d91ab5f6c9da"
      unitRef="usd">25387</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i792572cf35bb4b92b612e3ff5498a49a_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMy0zLTEtMS0w_fb7a47e4-7d90-401e-9180-51848bf1c3b0"
      unitRef="usd">144779</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic13576b5389d4b328a17a5d499ac4d69_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMy01LTEtMS0w_fad8c827-c558-4225-8be8-c523e721014f"
      unitRef="usd">249070</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0c53be1af7724b3faa590b77e842c7b7_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfMy03LTEtMS0w_9618e716-194a-4091-b4dd-e5ddebe8bdf4"
      unitRef="usd">421393</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfNC0xLTEtMS0w_459b190f-9622-405a-87c9-c47f720949e8"
      unitRef="usd">126290</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfNC0zLTEtMS0w_20e937da-e67b-47e5-bb05-49842aee38f8"
      unitRef="usd">193005</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfNC01LTEtMS0w_4c8cef39-cc0a-44b1-ab68-0675b40b3fac"
      unitRef="usd">498012</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmI2NzI5ZTU5ODBjNTQ4YmU4ZGVkZjRjOGZmMmIyZGU4L3RhYmxlcmFuZ2U6YjY3MjllNTk4MGM1NDhiZThkZWRmNGM4ZmYyYjJkZThfNC03LTEtMS0w_2d968deb-7e33-4307-93c4-f7cd1eef9fdc"
      unitRef="usd">720014</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMjE4_cb69159f-113f-434f-a3ca-8d0d19b473e5"
      unitRef="usd">1300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i4c8969ef77c1411c9bf6a611f2e2d36e_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMzg5_ea9f928b-47a2-4f3c-b3d6-bdcc8139fe07">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <ocgn:NumberOfEquityCompensationPlans
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMjI2Nw_ebf4fb40-5a17-4762-a642-05613d702444"
      unitRef="segment">2</ocgn:NumberOfEquityCompensationPlans>
    <ocgn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMTIyNw_a157eeb8-c6e6-4310-849b-e019b2a6a0f6"
      unitRef="number">0.04</ocgn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i7bae26e5ec3b4d6e959ffe614c098254_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMTQ2Mw_84e2ba2f-3fc5-4a45-8167-ddfdae635277"
      unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMTU3Ng_47f6252b-5df2-4f1e-a5d9-3be4e0992df0"
      unitRef="shares">4200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMTU3Ng_63881635-e616-4ef6-bfe8-89de560f16dd"
      unitRef="shares">4200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ie94bd56836134356a2b42c3d02bcd7b8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMTg2OA_1f6fdc0f-5b73-4fd2-a7f3-aeb5e4f2461b"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i132e89b796c1407695971319916c5052_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMTg3NQ_428587ca-c07a-49ee-9dd4-8021af1378a5"
      unitRef="shares">3800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMjI2NA_ccff5bcf-f07f-4a26-82b1-977cfd97615d">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the stock option activity under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,064,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(527,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at September&#160;30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,268,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at September&#160;30, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i112d9bfb269247e5a5787276fb3cd7ac_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMS0xLTEtMS0w_6a4fb162-9d0f-4de2-8336-3acced7c58b2"
      unitRef="shares">731189</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i112d9bfb269247e5a5787276fb3cd7ac_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMS0zLTEtMS0w_e3fb7d05-9134-4476-ba17-6c7c9546843a"
      unitRef="usdPerShare">4.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i627461cada754117a3daf3d544a3877f_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMS01LTEtMS0w_22bde6ce-7d33-4416-b7fd-13fd34e251c3">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i112d9bfb269247e5a5787276fb3cd7ac_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMS03LTEtMS0w_259c89ab-e515-4400-ad93-c3033e5632c9"
      unitRef="usd">24028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMi0xLTEtMS0w_751ce020-f4e8-4b8c-bc4a-07f1da25a2cf"
      unitRef="shares">4064950</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMi0zLTEtMS0w_fd9e43fd-39b5-48d0-ba5c-9538629f81c7"
      unitRef="usdPerShare">0.41</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMy0xLTEtMS0w_dc1bf8f8-7883-45cb-9f26-c349f3b20abd"
      unitRef="shares">527862</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfMy0zLTEtMS0w_1b3cdf1c-1069-48ed-bef5-e19c77bcc353"
      unitRef="usdPerShare">1.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNC0xLTEtMS0w_c81c4ced-0cba-46f8-aeca-18f1a2e1a3b7"
      unitRef="shares">4268277</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNC0zLTEtMS0w_a1e6f08e-9182-40e8-85da-036ba84901e5"
      unitRef="usdPerShare">0.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNC01LTEtMS0w_768a98e0-68cf-49ae-a86c-0b99535ac137">P9Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNC03LTEtMS0w_3d061561-1755-4c1c-97e6-3461867f5544"
      unitRef="usd">7072</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNS0xLTEtMS0w_4701c55e-94ff-468c-8bd6-f5dae1b142b0"
      unitRef="shares">450405</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNS0zLTEtMS0w_c66ad519-58b1-4f5c-87da-d261df5626b7"
      unitRef="usdPerShare">4.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNS01LTEtMS0w_012ebd18-d2d1-4cfd-a40b-9073a995078d">P6Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ifb2c4509f3aa454793f7dab4d0b5e0d9_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RhYmxlOmFkNjQ3OTAwYmQ0OTRkODM4ODJlNjljYjQxMTlhN2JiL3RhYmxlcmFuZ2U6YWQ2NDc5MDBiZDQ5NGQ4Mzg4MmU2OWNiNDExOWE3YmJfNS03LTEtMS0w_4b99dbcf-1632-481d-bcd0-c0893b2a38bb"
      unitRef="usd">450</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMjIzMQ_2d906255-d1c4-4245-9ddb-daab4f6b8668"
      unitRef="usdPerShare">0.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82Ny9mcmFnOmJhZmZlNDcwYmJiZTQ1ZTNiZTc1YzVmMGQxMzlkMWE3L3RleHRyZWdpb246YmFmZmU0NzBiYmJlNDVlM2JlNzVjNWYwZDEzOWQxYTdfMjIzMQ_3466294d-afa1-426a-b36c-395b09a76084"
      unitRef="usdPerShare">0.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfNzE0NjgyNTU4NjA5Mw_a17df76e-c8c6-4030-9558-ea28e5749022">Commitments&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has commitments under operating leases for certain facilities used in its operations. The Company&#x2019;s leases have initial lease terms ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTk1_ae9976e8-4e79-4b4b-95fa-b8c561425fb1"&gt;one&lt;/span&gt; to five years. Certain lease agreements contain provisions for future rent increases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease terms&#x2014;operating leases (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&#x2014;operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum operating minimum lease payments for all leases, exclusive of taxes and other carrying charges, are approximately as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: present value adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financing Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2018, the Company leased specialized research equipment under a lease classified as a financing lease. The leased equipment is included in property and equipment, net and is amortized on a straight-line basis over five years. Financing lease liabilities are included in &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI3NQ_32d25827-fc2b-4183-a751-56c09cccc2ae"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI3NQ_939a82e3-172c-4a98-a538-b4e48e03f315"&gt;other liabilities&lt;/span&gt;&lt;/span&gt; on the Company's condensed consolidated balance sheets. The interest rate related to the lease obligation is 7.6% and the maturity date is July 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments for all financing leases, exclusive of taxes and other carrying charges, are approximately as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: present value adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to September&#160;30, 2020, the Company entered into a lease agreement for an expanded office and laboratory space located in Malvern, Pennsylvania. See Note 13 for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ic33f61dc175243c98786068416fad0db_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMjAx_e4543704-1de0-4352-85b4-e65fb6bd1921">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI4Ng_2d619ce1-7645-4d16-adef-51ecc8211382">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMi0xLTEtMS0w_0e32971b-b9c2-4271-b674-8deb379b0332"
      unitRef="usd">47696</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMi0zLTEtMS0w_de7c91c1-e4a7-4c03-b0ce-e2c757f47117"
      unitRef="usd">47696</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMi01LTEtMS0w_2f199e5d-f313-4520-9f4d-5c9e8df036ae"
      unitRef="usd">142947</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMi03LTEtMS0w_b6bf470f-74ad-442a-9968-24704bbc4b9f"
      unitRef="usd">202665</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMy0xLTEtMS0w_81604f22-b25a-4900-8b57-d3ad1a4ef738"
      unitRef="usd">21169</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMy0zLTEtMS0w_154336d1-5473-4914-ab2c-948b92d35924"
      unitRef="usd">21284</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMy01LTEtMS0w_4a452609-e815-48bb-a98a-ae8a31007066"
      unitRef="usd">62415</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfMy03LTEtMS0w_abeffeec-21d5-464d-8c1f-8813a7c9709c"
      unitRef="usd">58163</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="id67dafc585b7439a9965e753932cfa64_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfNC0xLTEtMS0w_f00c0ca3-439b-43a0-8835-eee29016805e"
      unitRef="usd">68865</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i336430b025bf42ab979315995a7658d8_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfNC0zLTEtMS0w_d67bc170-5c7e-4698-b147-0104365bf9b1"
      unitRef="usd">68980</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfNC01LTEtMS0w_1db1bc04-44a5-4bf8-8a6a-6d69b2482457"
      unitRef="usd">205362</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i49c74a32e7d447b7b8b82eca0786467d_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmJlYWU0YjdjMjcwNTRlMzJhZjI0OWE1Yjc1YWM2YWQ2L3RhYmxlcmFuZ2U6YmVhZTRiN2MyNzA1NGUzMmFmMjQ5YTViNzVhYzZhZDZfNC03LTEtMS0w_3968e609-d612-44c0-b42d-635fede844ce"
      unitRef="usd">260828</us-gaap:LeaseCost>
    <ocgn:SupplementalBalanceSheetInformationLeasesTableTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfNzE0NjgyNTU4NjA5Mg_eb009733-9a56-4d19-8cc0-058bb1bc1fad">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ocgn:SupplementalBalanceSheetInformationLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfMS0xLTEtMS0w_198d601a-b23b-4bdb-9b37-4bc7328c08ac"
      unitRef="usd">217508</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfMS0zLTEtMS0w_287906fa-3784-4464-ab2d-73033796f7bd"
      unitRef="usd">344574</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfMy0xLTEtMS0w_6b3401d2-6529-485b-9743-16356c899f5c"
      unitRef="usd">164808</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfMy0zLTEtMS0w_2481e56d-7d2c-42b3-a9ef-c9bd5b3b446a"
      unitRef="usd">172310</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfNC0xLTEtMS0w_4d570017-c890-43b2-b726-32ba4772da27"
      unitRef="usd">42746</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfNC0zLTEtMS0w_6aa1bed5-1e91-44e7-8593-b89f21271cdc"
      unitRef="usd">163198</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfNS0xLTEtMS0w_426833b8-65ff-420a-805b-df1459ab8b6a"
      unitRef="usd">207554</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ia02f18907a7d4f3ead8d53843ee2de3c_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjUxY2NhYzZlZDNhMTQ3ZjRiMzkwY2VmZjhjNzZmNTUxL3RhYmxlcmFuZ2U6NTFjY2FjNmVkM2ExNDdmNGIzOTBjZWZmOGM3NmY1NTFfNS0zLTEtMS0w_43349fd1-2d69-4286-99cf-a175cb0e479b"
      unitRef="usd">335508</us-gaap:OperatingLeaseLiability>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI3Mw_7bc703c5-3bdc-4aba-880e-7b2584cf2239">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease terms&#x2014;operating leases (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&#x2014;operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjA1YWRlYTI1YjdkYTQ3NmRiMmQzZmY2MjVkOWU3OTA5L3RhYmxlcmFuZ2U6MDVhZGVhMjViN2RhNDc2ZGIyZDNmZjYyNWQ5ZTc5MDlfMi0xLTEtMS0w_49132242-025a-40d8-9a40-403dac244c65">P1Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iff87527ea3fc46fdacb3342226f9f0f9_I20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjA1YWRlYTI1YjdkYTQ3NmRiMmQzZmY2MjVkOWU3OTA5L3RhYmxlcmFuZ2U6MDVhZGVhMjViN2RhNDc2ZGIyZDNmZjYyNWQ5ZTc5MDlfMi0zLTEtMS0w_28e43f69-f1e5-495e-9709-8a9c7e8b3db9">P2Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjA1YWRlYTI1YjdkYTQ3NmRiMmQzZmY2MjVkOWU3OTA5L3RhYmxlcmFuZ2U6MDVhZGVhMjViN2RhNDc2ZGIyZDNmZjYyNWQ5ZTc5MDlfMy0xLTEtMS0w_45e62fc0-c0d0-47ca-b85c-305c7c2282d6"
      unitRef="number">0.076</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="iff87527ea3fc46fdacb3342226f9f0f9_I20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjA1YWRlYTI1YjdkYTQ3NmRiMmQzZmY2MjVkOWU3OTA5L3RhYmxlcmFuZ2U6MDVhZGVhMjViN2RhNDc2ZGIyZDNmZjYyNWQ5ZTc5MDlfMy0zLTEtMS0w_20866b1c-9346-42cd-a314-cd9ddf2414dc"
      unitRef="number">0.076</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI4Nw_56a998e3-2fe4-4391-bb4f-77f9ba80ddcf">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum operating minimum lease payments for all leases, exclusive of taxes and other carrying charges, are approximately as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: present value adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjcwYjAwODhmN2ZjZTQxNTQ5ZDAyZDA5ZTU0MjYxZTRhL3RhYmxlcmFuZ2U6NzBiMDA4OGY3ZmNlNDE1NDlkMDJkMDllNTQyNjFlNGFfMS0yLTEtMS0w_3878a18e-ab97-4c59-a3bd-5d2f0f086f17"
      unitRef="usd">48056</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjcwYjAwODhmN2ZjZTQxNTQ5ZDAyZDA5ZTU0MjYxZTRhL3RhYmxlcmFuZ2U6NzBiMDA4OGY3ZmNlNDE1NDlkMDJkMDllNTQyNjFlNGFfMi0yLTEtMS0w_bd3036b8-e3fe-453e-b948-4a5056a98f93"
      unitRef="usd">160909</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjcwYjAwODhmN2ZjZTQxNTQ5ZDAyZDA5ZTU0MjYxZTRhL3RhYmxlcmFuZ2U6NzBiMDA4OGY3ZmNlNDE1NDlkMDJkMDllNTQyNjFlNGFfMy0yLTEtMS0w_c6f437f2-5f35-49bd-8287-c4821af201cb"
      unitRef="usd">11354</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjcwYjAwODhmN2ZjZTQxNTQ5ZDAyZDA5ZTU0MjYxZTRhL3RhYmxlcmFuZ2U6NzBiMDA4OGY3ZmNlNDE1NDlkMDJkMDllNTQyNjFlNGFfNC0yLTEtMS0w_1effe2b3-4a84-46a5-8d4a-27628db33634"
      unitRef="usd">220319</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjcwYjAwODhmN2ZjZTQxNTQ5ZDAyZDA5ZTU0MjYxZTRhL3RhYmxlcmFuZ2U6NzBiMDA4OGY3ZmNlNDE1NDlkMDJkMDllNTQyNjFlNGFfNS0yLTEtMS0w_c53a338b-2dc1-4d94-91ad-f29b81aa78c9"
      unitRef="usd">12765</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOjcwYjAwODhmN2ZjZTQxNTQ5ZDAyZDA5ZTU0MjYxZTRhL3RhYmxlcmFuZ2U6NzBiMDA4OGY3ZmNlNDE1NDlkMDJkMDllNTQyNjFlNGFfNi0yLTEtMS0w_dd3e35ec-a6b9-41ac-a320-e79973649415"
      unitRef="usd">207554</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i2693db88967c4ff0a47ea33524803019_I20180630"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfODQ1_92546365-6630-451d-963e-ae5f2506dbab">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeFinanceLeaseDiscountRate
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTAyMA_0be05c13-251e-4c48-9808-02c5826ce8fd"
      unitRef="number">0.076</us-gaap:LesseeFinanceLeaseDiscountRate>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI3Ng_a8b3908e-b2ed-4425-ab70-9ee8460db39c">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments for all financing leases, exclusive of taxes and other carrying charges, are approximately as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: present value adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmVhOGI1NjQyMTgwNzQ3N2U4NjAyN2ZjZDAxNzU4NzdlL3RhYmxlcmFuZ2U6ZWE4YjU2NDIxODA3NDc3ZTg2MDI3ZmNkMDE3NTg3N2VfMS0yLTEtMS0w_85b41b33-c4b8-41fe-a667-bf25b49a0fd1"
      unitRef="usd">5964</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmVhOGI1NjQyMTgwNzQ3N2U4NjAyN2ZjZDAxNzU4NzdlL3RhYmxlcmFuZ2U6ZWE4YjU2NDIxODA3NDc3ZTg2MDI3ZmNkMDE3NTg3N2VfMi0yLTEtMS0w_e9fb1aac-6d06-41d8-b129-366def755cd5"
      unitRef="usd">9941</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmVhOGI1NjQyMTgwNzQ3N2U4NjAyN2ZjZDAxNzU4NzdlL3RhYmxlcmFuZ2U6ZWE4YjU2NDIxODA3NDc3ZTg2MDI3ZmNkMDE3NTg3N2VfMy0yLTEtMS0w_4d4c48b8-6503-4777-b996-bda1d887e7f9"
      unitRef="usd">15905</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmVhOGI1NjQyMTgwNzQ3N2U4NjAyN2ZjZDAxNzU4NzdlL3RhYmxlcmFuZ2U6ZWE4YjU2NDIxODA3NDc3ZTg2MDI3ZmNkMDE3NTg3N2VfNC0yLTEtMS0w_61b8b05c-f238-4b10-85e4-0bc5f21a7be2"
      unitRef="usd">444</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="iafdd84fcd6fd4125bddedf4247bb3490_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RhYmxlOmVhOGI1NjQyMTgwNzQ3N2U4NjAyN2ZjZDAxNzU4NzdlL3RhYmxlcmFuZ2U6ZWE4YjU2NDIxODA3NDc3ZTg2MDI3ZmNkMDE3NTg3N2VfNS0yLTEtMS0w_ab64d3f5-ae58-4191-8475-211e8cf0ef45"
      unitRef="usd">15461</us-gaap:FinanceLeaseLiability>
    <ocgn:WarrantsTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjk4Mg_2d2e2d97-cc0e-4f90-ba0d-41f010401e5f">Warrants&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pre-Merger Financing Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;27, 2019, Ocugen completed the Merger with OpCo. Immediately prior to the Merger, Ocugen and OpCo completed the Pre-Merger Financing, a previously announced private placement transaction with certain Investors pursuant to the Financing SPA, whereby, among other things, the Company agreed to issue Series&#160;A Warrants, Series&#160;B Warrants, and Series&#160;C Warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 5, 2019, the Company entered into an agreement with each Investor that amended the terms of each of the Pre-Merger Financing Warrants held by each such Investor (collectively, the &#x201c;Warrant Amendments&#x201d;). The terms of the Pre-Merger Financing Warrants and the Warrant Amendments are discussed below. There were no Pre-Merger Financing Warrants outstanding at September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Series A Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series&#160;A Warrants had an initial exercise price per share of $7.13, were exercisable upon issuance and had a term of 60 months from the date of issuance. The Series&#160;A Warrants were exercisable for up to 8.8&#160;million shares of Ocugen common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series&#160;A Warrants had an anti-dilution adjustment whereby if Ocugen issues or sells, enters into a definitive, binding agreement pursuant to which Ocugen is required to issue or sell or is deemed, pursuant to the provisions of the Series&#160;A Warrants, to have issued or sold, any common stock for a price per share lower than the exercise price then in effect (a &#x201c;Dilutive Issuance&#x201d;), subject to certain limited exceptions, then (i)&#160;the exercise price of the Series&#160;A Warrants shall be reduced &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to such lower price per share and (ii)&#160;the number of shares issuable upon exercise of the Series&#160;A Warrants shall be increased to the number of shares of common stock determined by multiplying (a)&#160;the exercise price in effect immediately prior to such Dilutive Issuance by (b)&#160;the number of shares of common stock issuable upon exercise of the Series&#160;A Warrants immediately prior to such Dilutive Issuance (without giving effect to any limitation on exercise contained therein), and dividing the product thereof by the exercise price resulting from such Dilutive Issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Series A Warrants were outstanding and exercisable as of December&#160;31, 2019. Pursuant to the Warrant Exchange (as defined below), no Series A Warrants were outstanding as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Series B Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series&#160;B Warrants had an exercise price of $0.01, were exercisable after the completion of a 10 trading-day period following the effectiveness of a registration statement covering the resale of common stock into which such warrants were exercisable and were to expire on the date on which the Series&#160;B Warrants have been exercised in full (without giving effect to any limitation on exercise contained therein) and no shares remain issuable thereunder. The Series&#160;B Warrants were initially exercisable by the holders for 8.0 million shares of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, each Series B Warrant included a Reset Period pursuant to which the number of shares issuable upon exercise of the Series B Warrants shall be increased during certain Reset Periods (as defined in the Series B Warrants). The Reset Period concluded in November 2019 and resulted in an aggregate of 12.6&#160;million additional shares of common stock becoming issuable upon exercise of the Series B Warrants. There were 1,000 Series B Warrants outstanding at December&#160;31, 2019. There were no Series B Warrants outstanding at September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Series C Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series&#160;C Warrants were exercisable upon issuance for up to 50.0 million shares of common stock at an initial exercise price of $7.13 per share. Each of the Series&#160;C Warrants was amended pursuant to the Warrant Amendments to permit the Investors, in lieu of making any cash payment otherwise contemplated to be made to the Company upon the exercise of the Series&#160;C Warrant, to elect instead to receive upon such exercise up to 20.0&#160;million shares of common stock. Prior to the Warrant Amendments, the Series&#160;C Warrants had permitted the exercise without any cash payment of up to 50.0 million shares of common stock in the event that the volume weighted-average price of the common stock on Nasdaq was less than or equal to $1.20 per share on any five trading days following the issuance of the Series&#160;C Warrants. There were 1,000 Series C Warrants outstanding at December&#160;31, 2019. There were no Series C Warrants outstanding at September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for the Pre-Merger Financing Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2019, the Pre-Merger Financing Warrants were classified as equity. At issuance, the Series B Warrants were classified as a liability on the condensed consolidated balance sheet as they did not meet the derivative scope exception to be accounted for within stockholders' equity. The Series B Warrants were initially measured at fair value and marked to market each reporting period. Upon the completion of the Reset Period in November 2019, the Series B Warrants were reassessed and determined to meet the derivative scope exception allowing for equity classification. The Series B Warrants were marked to market a final time and the remaining liability balance was reclassified to equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Series B Warrants was calculated using a Monte Carlo simulation while estimating the stock price during the Reset Period, based on the terms described within the Financing SPA. Key fair value inputs included the starting stock price, expected stock volatility during the Reset Period, and additional shares issued from escrow. The methodology for measuring fair value was sensitive to the expected stock volatility assumption input mentioned above. The volatility used in the fair value estimate was 96.0% and 97.0% as of September 27, 2019 and September&#160;30, 2019, respectively. Inputs used in the valuation were unobservable and were therefore classified as Level 3 fair value inputs. The fair value of the Series B Warrants upon the end of the Reset Period was based on a Black-Scholes valuation model, which is classified as Level 3 in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a roll-forward of the Series B Warrant liability:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at issuance - September 27, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,387,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of embedded derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,577,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,964,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of embedded derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,709,246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount reclassified to equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,255,740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Warrant Exchange&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 22, 2020, the Company entered into a subscription agreement as discussed within Note 8. The subscription agreement constituted a Dilutive Issuance (as defined above) and resulted in adjustments to the number of issuable Series A Warrants and the exercise price under the Series A Warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contemporaneously with the subscription agreement, the Company and OpCo entered into Amendment and Exchange Agreements (each an "Exchange Agreement" and collectively, the "Exchange Agreements") with the Investors. Pursuant to the Exchange Agreements, the Company, OpCo and the Investors agreed, among other things, after giving effect to the Dilutive Issuance, to amend the Series A Warrants to provide for an adjustment to the number of common stock issuable upon the exercise of the Series A Warrants. Concurrently with such amendments, the Investors exchanged the Series A Warrants for (i) an aggregate of 21.9&#160;million shares of common stock and (ii) the Warrant Exchange Promissory Notes as defined in Note 9 (collectively the "Warrant Exchange"). Following the consummation of the Warrant Exchange and the concurrent exercise of the remaining Series B Warrants and Series C Warrants, there were no Pre-Merger Financing Warrants outstanding at September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the Warrant Exchange by recognizing the fair value of the consideration transferred in excess of the carrying value of the Series A Warrants as a reduction of additional paid-in capital. The fair value of the consideration transferred to settle the Series A Warrants was approximately $13.6&#160;million, comprised of $8.6&#160;million in shares of common stock and the fair value of the Warrant Exchange Promissory Notes of $5.0&#160;million. The fair value of consideration transferred to settle the Series A warrants was in excess of the fair value of the Series A Warrants immediately prior to the transaction by approximately $12.5&#160;million. The excess consideration was accounted for as a deemed dividend to the warrant holders and is reflected as an additional net loss attributed to common stockholders in the calculation of basic and diluted net loss per common share for the nine months ended September 30, 2020. The fair value of the Series A Warrants immediately prior to the Warrant Exchange was $1.1&#160;million, which was estimated using a Black-Scholes valuation model utilizing Level 3 inputs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;OpCo Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to 2018, OpCo issued warrants to investors of the Company pursuant to a stockholders' agreement and to two employees of the Company pursuant to their respective employment agreements. As of September&#160;30, 2020 and December&#160;31, 2019, 0.9&#160;million warrants to purchase common stock were outstanding and exercisable and had a weighted average exercise price of $5.67 per share. The warrants expire between 2025 and 2027.&lt;/span&gt;&lt;/div&gt;</ocgn:WarrantsTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i2e5809e665eb4fa1bf1cecdf798b302a_I20200422"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfODUw_e1833215-59bc-40a6-b9c1-16aafc0f6f9d"
      unitRef="usdPerShare">7.13</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="i2e5809e665eb4fa1bf1cecdf798b302a_I20200422"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfOTAz_4e72ad94-2016-4f26-a5f6-1c0ff5852570">P60M</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i2e5809e665eb4fa1bf1cecdf798b302a_I20200422"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfOTgy_c200f384-9e58-4548-be05-088cd80500da"
      unitRef="shares">8800000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ib4bee8b3a2e3430a8cbcbb7923b89e24_I20190927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMjMyMw_5db77fa7-6cbc-4070-bf44-13b7c173cfe0"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ocgn:ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered
      contextRef="i72db3f74703449b199225c6a20600560_D20190927-20190927"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMjM3MA_84954a45-385a-493c-86e7-b5843ff64727">P10D</ocgn:ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ib4bee8b3a2e3430a8cbcbb7923b89e24_I20190927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMjc5OA_44f3584f-9b8b-4243-8f22-87c3d3fe0ceb"
      unitRef="shares">8000000.0</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i37caa52256c84c01ad82bb794238bc10_I20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMzEzNQ_b5eda567-09ff-4780-8137-fc86dd01c76f"
      unitRef="shares">12600000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i2639027910494f379046945f8a7d2bb9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMzI0MQ_04f09fca-ee2a-4dfc-aa8d-26f9925963fe"
      unitRef="shares">1000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="ifa4ad77ecf7d4e6a9604ede41d7878a1_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMzI5ODUzNDkxNDM5Mw_4a0ee799-3c69-4d4b-be58-911bdd654308"
      unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="id84738694cfc4f48a8223bc4775059da_I20190927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMzQyOA_e84f6dff-6de3-4062-96ac-96e4938dd273"
      unitRef="shares">50000000.0</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="id84738694cfc4f48a8223bc4775059da_I20190927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMzQ4Ng_47511d72-3607-4610-a7d6-769188248ecd"
      unitRef="usdPerShare">7.13</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i41a7cddac3e8403d8a7b1b226753c6a6_I20191105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMzc4Mg_e9261d5b-3ff8-4774-b48d-b664ec45f6ad"
      unitRef="shares">20000000.0</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i5c449ee518aa4087bceac3f599d60b71_I20190927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfMzkyNQ_e524d2f6-e8fe-428f-91f1-abf4006682f4"
      unitRef="shares">50000000.0</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <ocgn:ConvertedAdditionalSharesThresholdReleaseTriggerPrice
      contextRef="i4e0e42f7805b40a7b369cb9a38e27242_D20190927-20190927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNDA1OQ_16edc5db-91c5-44f1-b1df-d71c36cb6746"
      unitRef="usdPerShare">1.20</ocgn:ConvertedAdditionalSharesThresholdReleaseTriggerPrice>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i0391e6dd13e64542b9e6ef240aa2d783_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNDE1Nw_0f0a98ff-bc8c-4056-a54e-a54057f3272e"
      unitRef="shares">1000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i09974af4f9294df7b673d1888259b853_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfOTM0NTg0ODg2NzI1NQ_6e28cc3e-b82d-4244-83f9-1a2f91cfffef"
      unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ibc6f5729ecb242e484fb2d858d328ec4_I20190927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNzE0NjgyNTYxMTY3Nw_4a987897-7d71-4732-819f-604c2816f7ec"
      unitRef="number">0.960</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i7dd696ce560e4f74960fe7452fda5bd9_I20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNzE0NjgyNTYxMTY4NA_95125f0c-96ef-4c34-b36a-ecddc85e6bf9"
      unitRef="number">0.970</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfOTM0NTg0ODg2NzI1NA_72476711-07a7-4eec-82ab-27c500eb23b2">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a roll-forward of the Series B Warrant liability:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at issuance - September 27, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,387,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of embedded derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,577,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,964,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of embedded derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,709,246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount reclassified to equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,255,740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ief05580895fc46368234c7da5575be31_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RhYmxlOmI1YmUyN2Q1ZTc3ODQ5ODhhYTUzODQzZTJlZjQ3NDFjL3RhYmxlcmFuZ2U6YjViZTI3ZDVlNzc4NDk4OGFhNTM4NDNlMmVmNDc0MWNfMS0xLTEtMS0xOTE4_e920387b-3a39-4581-ae17-5c9fca243b63"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
      contextRef="if33032b532e54016bf273bdc3dc87946_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RhYmxlOmI1YmUyN2Q1ZTc3ODQ5ODhhYTUzODQzZTJlZjQ3NDFjL3RhYmxlcmFuZ2U6YjViZTI3ZDVlNzc4NDk4OGFhNTM4NDNlMmVmNDc0MWNfMi0xLTEtMS0xOTE4_3d1be9f2-d43b-4b72-b8e8-90b3850a6a47"
      unitRef="usd">9387760</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
      contextRef="if33032b532e54016bf273bdc3dc87946_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RhYmxlOmI1YmUyN2Q1ZTc3ODQ5ODhhYTUzODQzZTJlZjQ3NDFjL3RhYmxlcmFuZ2U6YjViZTI3ZDVlNzc4NDk4OGFhNTM4NDNlMmVmNDc0MWNfMy0xLTEtMS0xOTE4_16fc3784-03e5-4ec7-84be-b7be4340007a"
      unitRef="usd">18577226</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i4e68dccda8164000aaf8c597ab10b628_I20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RhYmxlOmI1YmUyN2Q1ZTc3ODQ5ODhhYTUzODQzZTJlZjQ3NDFjL3RhYmxlcmFuZ2U6YjViZTI3ZDVlNzc4NDk4OGFhNTM4NDNlMmVmNDc0MWNfNC0xLTEtMS0xOTE4_7047c357-2157-4c3a-bc8f-d47fa5ace493"
      unitRef="usd">27964986</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
      contextRef="if9c4014ea1664b28a89cbda4056472d5_D20191001-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RhYmxlOmI1YmUyN2Q1ZTc3ODQ5ODhhYTUzODQzZTJlZjQ3NDFjL3RhYmxlcmFuZ2U6YjViZTI3ZDVlNzc4NDk4OGFhNTM4NDNlMmVmNDc0MWNfNS0xLTEtMS0xOTQ3_f36cbbe8-fbcb-4978-9e0b-85c08c83d28c"
      unitRef="usd">-16709246</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease>
    <ocgn:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity
      contextRef="if9c4014ea1664b28a89cbda4056472d5_D20191001-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RhYmxlOmI1YmUyN2Q1ZTc3ODQ5ODhhYTUzODQzZTJlZjQ3NDFjL3RhYmxlcmFuZ2U6YjViZTI3ZDVlNzc4NDk4OGFhNTM4NDNlMmVmNDc0MWNfNi0xLTEtMS0xOTQ3_ad38229d-b422-4853-b2b0-e6184981e073"
      unitRef="usd">-11255740</ocgn:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i2639027910494f379046945f8a7d2bb9_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RhYmxlOmI1YmUyN2Q1ZTc3ODQ5ODhhYTUzODQzZTJlZjQ3NDFjL3RhYmxlcmFuZ2U6YjViZTI3ZDVlNzc4NDk4OGFhNTM4NDNlMmVmNDc0MWNfNy0xLTEtMS0xOTQ3_b7eabb75-f0ee-456f-a80c-eb0147af0fcd"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i5d3016329c854e379eb39ead2fc7f7d1_D20200422-20200422"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNTE3Mg_ff3433bc-ae1f-4a0e-9f3b-f0e92ec0c1a7"
      unitRef="shares">21900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <ocgn:ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants
      contextRef="if5a1d88348ac442ca29916a0b2a044b7_D20200422-20200422"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNTg1Mw_70007fda-9a4e-4d9b-91bb-fc7b5cb45c6d"
      unitRef="usd">13600000</ocgn:ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants>
    <ocgn:ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock
      contextRef="if5a1d88348ac442ca29916a0b2a044b7_D20200422-20200422"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNTg3MA_7d7a53fa-97c3-42d1-aea9-24601383e3e3"
      unitRef="usd">8600000</ocgn:ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock>
    <ocgn:ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote
      contextRef="if5a1d88348ac442ca29916a0b2a044b7_D20200422-20200422"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNTk2Mg_0f9c34fb-d609-438f-9c65-3725bfb5a8d8"
      unitRef="usd">5000000.0</ocgn:ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote>
    <ocgn:ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue
      contextRef="ida7ba91283944cbaa8a66a0e1a833edb_D20200421-20200421"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjE1Mw_7509a7ef-fe11-4cfb-b771-b7ed65baeb80"
      unitRef="usd">12500000</ocgn:ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="ia5deeae01bef4c8e81884c72f6a8ce9d_I20200421"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjUwMQ_0e19b2da-24fe-4197-bc72-480625a46a50"
      unitRef="usd">1100000</us-gaap:WarrantsAndRightsOutstanding>
    <ocgn:ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction
      contextRef="ia83d0c6aaf90427c82faff7bf369406a_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjcxMw_3ddd3bcd-ba43-441d-ac58-bf0dd62b9824"
      unitRef="employee">2</ocgn:ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction>
    <ocgn:ClassOfWarrantOrRightExercisable
      contextRef="i5d1becb9d0b64817a37cabf28da5d1ee_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjgxMA_1a743e0b-3228-4a33-8e82-db8e28a5eb67"
      unitRef="shares">900000</ocgn:ClassOfWarrantOrRightExercisable>
    <ocgn:ClassOfWarrantOrRightExercisable
      contextRef="ib9adecc5943843fd91836c9fb0e2c80e_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjgxMA_743d6e24-d92e-4475-9100-62980fa05980"
      unitRef="shares">900000</ocgn:ClassOfWarrantOrRightExercisable>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i5d1becb9d0b64817a37cabf28da5d1ee_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjkyNQ_e34007ac-27cc-448e-bd84-a607075fdfc0"
      unitRef="usdPerShare">5.67</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ib9adecc5943843fd91836c9fb0e2c80e_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83My9mcmFnOjJkYzNiMWNhZTA5NDRlMTY5NWVjNmNjMzNmZDBkZDI2L3RleHRyZWdpb246MmRjM2IxY2FlMDk0NGUxNjk1ZWM2Y2MzM2ZkMGRkMjZfNjkyNQ_f03e6acd-cb91-4d87-853a-538545108136"
      unitRef="usdPerShare">5.67</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i9e90316c630e40dabfbef63c327d160a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF85MzQ1ODQ4ODQxMTk2_a8698151-a080-4f1e-84e3-490a88d4b71d">Subsequent EventsOn October 9, 2020, the Company entered into a lease agreement (the "Lease Agreement") with WPT Land 2 LP (the "Landlord") for an expanded office and laboratory space located in Malvern, Pennsylvania. The Lease Agreement has an expected commencement date in early 2021 and an initial term of seven years. The aggregate estimated base rent payments due over the initial &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF8xNjQ5MjY3NDQ2MzEx_c0cab281-7ade-48be-8c4a-31582fcb7c9d"&gt;seven&lt;/span&gt; year term of the Lease Agreement is $1.8&#160;million. In addition, the Company will pay its pro rata share of the Landlord's annual operating expenses associated with the premises. The Company has the option to extend the Lease Agreement for one additional &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF8xNjQ5MjY3NDQ2MjU0_e2515411-dba9-46d7-a836-2bb32ea59544"&gt;five&lt;/span&gt; year term. The Company has an existing lease agreement with the Landlord for the Company's current office space. Provided that the Company is not under an event of default and surrenders the current office space pursuant to the terms of the Lease Agreement and in the condition required by the existing lease agreement, the existing lease agreement will be deemed terminated without penalty to the Company.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i6f2dc86eba1043a4b6a426c058150999_I20201009"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF8xNjQ5MjY3NDQ2MjQy_c0cab281-7ade-48be-8c4a-31582fcb7c9d">P7Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <ocgn:OperatingLeaseTotalBasePayments
      contextRef="i86c757f96f724d6b8aaa688ac26a295e_D20201009-20201009"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF8xNjQ5MjY3NDQ2Mjgw_5e66b0a2-6ad4-4b16-b9fb-fc39f5465293"
      unitRef="usd">1800000</ocgn:OperatingLeaseTotalBasePayments>
    <ocgn:LesseeOperatingLeaseNumberOfRenewalOptions
      contextRef="i86c757f96f724d6b8aaa688ac26a295e_D20201009-20201009"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF83MTQ2ODI1NTg1NzAw_1a056d8b-bcb9-49af-9ec4-e34d0c6a5eea"
      unitRef="numberofrenewaloptions">1</ocgn:LesseeOperatingLeaseNumberOfRenewalOptions>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710185260088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">OCUGEN, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3522315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5 Great Valley Parkway<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Malvern<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">328-4701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">OCGN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,026,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001372299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710189120328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 19,105,830<span></span>
</td>
<td class="nump">$ 7,444,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">652,893<span></span>
</td>
<td class="nump">1,322,167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent', window );">Asset held for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">19,758,723<span></span>
</td>
<td class="nump">15,766,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">214,100<span></span>
</td>
<td class="nump">222,464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">151,196<span></span>
</td>
<td class="nump">151,016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">415,555<span></span>
</td>
<td class="nump">667,747<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">20,539,574<span></span>
</td>
<td class="nump">16,807,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">222,340<span></span>
</td>
<td class="nump">1,895,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">2,333,733<span></span>
</td>
<td class="nump">2,270,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt, net</a></td>
<td class="nump">1,210,645<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease obligation</a></td>
<td class="nump">164,808<span></span>
</td>
<td class="nump">172,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">199,261<span></span>
</td>
<td class="nump">205,991<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,130,787<span></span>
</td>
<td class="nump">4,543,959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease obligation, less current portion</a></td>
<td class="nump">42,746<span></span>
</td>
<td class="nump">163,198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term debt, net</a></td>
<td class="nump">1,944,396<span></span>
</td>
<td class="nump">1,072,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,755<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">1,987,142<span></span>
</td>
<td class="nump">1,245,076<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">6,117,929<span></span>
</td>
<td class="nump">5,789,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 11)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Convertible preferred stock; $0.01 par value; 10,000,000 shares authorized; seven issued and outstanding at September&#160;30, 2020 and December&#160;31, 2019</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock; $0.01 par value; 200,000,000 authorized; 162,147,973 and 52,746,728 shares issued at September&#160;30, 2020 and December&#160;31, 2019, respectively; 162,026,473 and 52,625,228 shares outstanding at September&#160;30, 2020 and December&#160;31, 2019, respectively</a></td>
<td class="nump">1,621,480<span></span>
</td>
<td class="nump">527,467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury Stock, at cost, 121,500 shares at September&#160;30, 2020 and December&#160;31, 2019</a></td>
<td class="num">(47,864)<span></span>
</td>
<td class="num">(47,864)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">82,359,494<span></span>
</td>
<td class="nump">62,018,632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(69,511,465)<span></span>
</td>
<td class="num">(51,479,824)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">14,421,645<span></span>
</td>
<td class="nump">11,018,411<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 20,539,574<span></span>
</td>
<td class="nump">$ 16,807,446<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121558832&amp;loc=d3e400-110220<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710184512120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock, shares authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock, shares issued (in shares)</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">162,147,973<span></span>
</td>
<td class="nump">52,746,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">162,026,473<span></span>
</td>
<td class="nump">52,625,228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">121,500<span></span>
</td>
<td class="nump">121,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710185390888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer', window );">Collaboration revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 42,620<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">42,620<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">1,477,382<span></span>
</td>
<td class="nump">1,305,461<span></span>
</td>
<td class="nump">4,759,569<span></span>
</td>
<td class="nump">6,338,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">1,704,598<span></span>
</td>
<td class="nump">1,408,350<span></span>
</td>
<td class="nump">5,760,398<span></span>
</td>
<td class="nump">3,544,847<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">10,181,980<span></span>
</td>
<td class="nump">2,713,811<span></span>
</td>
<td class="nump">17,519,967<span></span>
</td>
<td class="nump">9,883,377<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(10,181,980)<span></span>
</td>
<td class="num">(2,713,811)<span></span>
</td>
<td class="num">(17,477,347)<span></span>
</td>
<td class="num">(9,883,377)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value of derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,512,204)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(19,896,626)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_GainsLossesOnConversionOfDebt', window );">Loss on debt conversion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(341,136)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">594<span></span>
</td>
<td class="nump">1,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(291,909)<span></span>
</td>
<td class="num">(796,141)<span></span>
</td>
<td class="num">(554,801)<span></span>
</td>
<td class="num">(1,753,172)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(751,261)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="num">(751,493)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(291,867)<span></span>
</td>
<td class="num">(20,059,470)<span></span>
</td>
<td class="num">(554,294)<span></span>
</td>
<td class="num">(22,741,320)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(10,473,847)<span></span>
</td>
<td class="num">(22,773,281)<span></span>
</td>
<td class="num">(18,031,641)<span></span>
</td>
<td class="num">(32,624,697)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsAndOtherAdjustments', window );">Deemed dividend related to Warrant Exchange</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,546,340)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss to common stockholders</a></td>
<td class="num">$ (10,473,847)<span></span>
</td>
<td class="num">$ (22,773,281)<span></span>
</td>
<td class="num">$ (30,577,981)<span></span>
</td>
<td class="num">$ (32,624,697)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares used in calculating net loss per common share&#8212;basic and diluted (in shares)</a></td>
<td class="nump">141,591,218<span></span>
</td>
<td class="nump">6,411,308<span></span>
</td>
<td class="nump">92,764,157<span></span>
</td>
<td class="nump">5,839,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share of common stock - basic and diluted (in USD per share)</a></td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (3.55)<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (5.59)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (10,473,847)<span></span>
</td>
<td class="num">$ (22,773,281)<span></span>
</td>
<td class="num">$ (18,031,641)<span></span>
</td>
<td class="num">$ (32,624,697)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(451)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (10,473,847)<span></span>
</td>
<td class="num">$ (22,773,281)<span></span>
</td>
<td class="num">$ (18,031,641)<span></span>
</td>
<td class="num">$ (32,625,148)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_GainsLossesOnConversionOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on conversion of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_GainsLossesOnConversionOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsAndOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsAndOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118644919&amp;loc=SL5834089-161433<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710175433608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Subscription agreements</div></th>
<th class="th"><div>At-the-market issuance</div></th>
<th class="th"><div>Reverse asset acquisition</div></th>
<th class="th"><div>Pre-Merger Financing</div></th>
<th class="th"><div>Common&#160;Stock</div></th>
<th class="th">
<div>Common&#160;Stock </div>
<div>Subscription agreements</div>
</th>
<th class="th">
<div>Common&#160;Stock </div>
<div>At-the-market issuance</div>
</th>
<th class="th">
<div>Common&#160;Stock </div>
<div>Reverse asset acquisition</div>
</th>
<th class="th">
<div>Common&#160;Stock </div>
<div>Pre-Merger Financing</div>
</th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Subscription agreements</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>At-the-market issuance</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Reverse asset acquisition</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Pre-Merger Financing</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,960,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="num">$ (12,709,539)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 18,477,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 451<span></span>
</td>
<td class="num">$ (31,237,194)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">415,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">415,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(282)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(282)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(6,312,606)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,312,606)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,960,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2019</a></td>
<td class="num">(18,607,225)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,892,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="num">(37,549,800)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,960,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="num">(12,709,539)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,477,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">451<span></span>
</td>
<td class="num">(31,237,194)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(451)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(32,624,697)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,013,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2019</a></td>
<td class="num">(13,093,262)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,668,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(63,861,891)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,960,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2019</a></td>
<td class="num">(18,607,225)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,892,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="num">(37,549,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">111,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(169)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of debt (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,125,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of debt</a></td>
<td class="nump">13,979,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,968,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Equity transactions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Equity transactions</a></td>
<td class="nump">1,948,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,947,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(3,538,810)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,538,810)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,243,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2019</a></td>
<td class="num">(6,105,723)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,920,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(41,088,610)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">193,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Equity transactions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,576,655<span></span>
</td>
<td class="nump">2,192,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Equity transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,341,050<span></span>
</td>
<td class="nump">$ 13,251,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,766<span></span>
</td>
<td class="nump">$ 21,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,325,284<span></span>
</td>
<td class="nump">$ 13,229,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(22,773,281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,773,281)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,013,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2019</a></td>
<td class="num">(13,093,262)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,668,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(63,861,891)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,746,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">11,018,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 527,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,864)<span></span>
</td>
<td class="nump">62,018,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(51,479,824)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">222,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(3,943,819)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,943,819)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,746,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="nump">7,297,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 527,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,864)<span></span>
</td>
<td class="nump">62,241,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(55,423,643)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,746,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">11,018,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 527,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,864)<span></span>
</td>
<td class="nump">62,018,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(51,479,824)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(18,031,641)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,147,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">14,421,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,621,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,864)<span></span>
</td>
<td class="nump">82,359,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(69,511,465)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,746,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">7,297,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 527,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,864)<span></span>
</td>
<td class="nump">62,241,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(55,423,643)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">149,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of debt (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,920,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of debt</a></td>
<td class="num">(4,977,876)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 219,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,197,084)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Equity transactions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,328,405<span></span>
</td>
<td class="nump">59,132,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Equity transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 331,756<span></span>
</td>
<td class="nump">$ 15,436,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,284<span></span>
</td>
<td class="nump">$ 591,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 318,472<span></span>
</td>
<td class="nump">$ 14,845,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(3,613,975)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,613,975)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,128,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">14,623,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,351,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,864)<span></span>
</td>
<td class="nump">72,357,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(59,037,618)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">126,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Equity transactions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,019,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Equity transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,146,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 270,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,875,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(10,473,847)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,473,847)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,147,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">$ 14,421,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,621,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (47,864)<span></span>
</td>
<td class="nump">$ 82,359,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (69,511,465)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710188756216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ocgn_ATMTransactionsMember', window );">At-the-market issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Commissions and equity issuance costs</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ocgn_ReverseAssetAcquisitionMember', window );">Reverse asset acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Commissions and equity issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ocgn_PreMergerFinancingMember', window );">Pre-Merger Financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Commissions and equity issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ocgn_ATMTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ocgn_ATMTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ocgn_ReverseAssetAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ocgn_ReverseAssetAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ocgn_PreMergerFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ocgn_PreMergerFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710268805432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (18,031,641)<span></span>
</td>
<td class="num">$ (32,624,697)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">57,565<span></span>
</td>
<td class="nump">34,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_NonCashInterestExpense', window );">Non-cash interest expense</a></td>
<td class="nump">554,801<span></span>
</td>
<td class="nump">1,718,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_NoncashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">142,947<span></span>
</td>
<td class="nump">202,665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value of derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,896,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">498,012<span></span>
</td>
<td class="nump">720,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_GainsLossesOnConversionOfDebt', window );">Loss on debt conversion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">341,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash</a></td>
<td class="num">(165,609)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">794,398<span></span>
</td>
<td class="num">(280,838)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(1,133,092)<span></span>
</td>
<td class="nump">2,044,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_IncreaseDecreaseInLeaseObligations', window );">Lease obligations</a></td>
<td class="num">(143,834)<span></span>
</td>
<td class="num">(202,338)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(10,426,453)<span></span>
</td>
<td class="num">(8,149,359)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(55,488)<span></span>
</td>
<td class="num">(2,067)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Payment of reverse asset acquisition costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,334,063)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(55,488)<span></span>
</td>
<td class="num">(2,336,130)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing lease principal payments</a></td>
<td class="num">(17,892)<span></span>
</td>
<td class="num">(16,985)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">26,692,377<span></span>
</td>
<td class="nump">999,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of equity issuance costs</a></td>
<td class="num">(1,083,990)<span></span>
</td>
<td class="num">(649,254)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from issuance of debt</a></td>
<td class="nump">921,415<span></span>
</td>
<td class="nump">6,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payments of debt issuance costs</a></td>
<td class="num">(5,740)<span></span>
</td>
<td class="num">(122,262)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherDebt', window );">Repayments of debt</a></td>
<td class="num">(4,362,271)<span></span>
</td>
<td class="num">(5,290,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ProceedsFromPreMergerFinancingFinancingActivities', window );">Proceeds from Pre-Merger Financing</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">22,437,537<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">22,143,899<span></span>
</td>
<td class="nump">24,158,868<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of changes in exchange rate on cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">11,661,958<span></span>
</td>
<td class="nump">13,673,379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">7,595,068<span></span>
</td>
<td class="nump">1,778,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">19,257,026<span></span>
</td>
<td class="nump">15,451,992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental disclosure of non-cash transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesIssued1', window );">Issuance of Warrant Exchange Promissory Notes</a></td>
<td class="nump">5,625,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Obligation settled with common stock</a></td>
<td class="nump">331,218<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Conversion of convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,979,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset', window );">Right-of-use asset related to operating leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">470,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost', window );">Equity issuance costs</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">1,150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction', window );">Reverse asset acquisition costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,711,431<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred equity issuance cost that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_GainsLossesOnConversionOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on conversion of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_GainsLossesOnConversionOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_IncreaseDecreaseInLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Lease Obligations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_IncreaseDecreaseInLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_NonCashInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of non-cash interest expense during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_NonCashInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_NoncashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_NoncashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash or part noncash amount of deferred transaction cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right-to-use asset recognized upon adoption of ASU 2018-11.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_ProceedsFromPreMergerFinancingFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Pre Merger Financing, Financing Activities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_ProceedsFromPreMergerFinancingFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of notes issued in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710184451256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Business</a></td>
<td class="text">Nature of Business<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ocugen, Inc. (formerly known as Histogenics Corporation), together with its wholly owned subsidiaries (&#8220;Ocugen&#8221; or the &#8220;Company&#8221;), is a biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to cure blindness diseases. The Company is located in Malvern, Pennsylvania, and manages its business as one operating segment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ocugen is developing a modifier gene therapy platform to generate therapies designed to fulfill unmet medical needs in the area of retinal diseases, including inherited retinal diseases ("IRDs") and dry age-related macular degeneration ("AMD"). Ocugen's modifier gene therapy platform is based on nuclear hormone receptors ("NHRs") which have the potential to restore homeostasis, the basic biological processes in the retina. Unlike single-gene replacement therapies, which only target one genetic mutation, Ocugen believes that its gene therapy platform, through its use of NHRs, represents a novel approach in that it may address multiple retinal diseases with one product. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ocugen's first gene therapy candidate, OCU400, is being developed to treat retinitis pigmentosa ("RP"), a group of rare genetic disorders that involves a breakdown and loss of cells in the retina and can lead to visual impairment and blindness. Ocugen has received four Orphan Drug Designations ("ODDs") from the Food and Drug Administration ("FDA") for the treatment of certain disease genotypes: nuclear receptor subfamily 2 group E member 3 ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NR2E3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"), centrosomal protein 290 ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CEP290</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"), rhodopsin ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RHO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"), and phosphodiesterase 6B ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PDE6B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">") mutation-associated RP. Ocugen is planning to initiate two Phase 1/2a clinical trials for OCU400 in the second half of 2021. Ocugen's second gene therapy candidate, OCU410, is being developed to utilize the nuclear receptor genes RAR-related orphan receptor A ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RORA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">") for the treatment of dry AMD. This candidate is currently in preclinical development. Ocugen is planning to initiate a Phase 1/2a clinical trial for OCU410 in 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ocugen is also conducting preclinical development for its biologic product candidate, OCU200. OCU200 is a novel fusion protein designed to treat diabetic macular edema ("DME"), diabetic retinopathy ("DR") and wet AMD. Ocugen plans to expand the therapeutic applications of OCU200 beyond DME, DR and wet AMD to potentially include macular edema following retinal vein occlusion and myopic choroidal neovascularization. Ocugen expects to initiate Investigational New Drug ("IND") enabling preclinical studies for OCU200 in 2021 and a Phase 1/2a clinical trial for OCU200 in the first half of 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ocugen was developing OCU300, a small molecule therapeutic for the treatment of symptoms associated with ocular graft versus-host disease ("oGVHD"). On June 1, 2020, Ocugen announced that it had discontinued the Phase 3 trial of OCU300 based on results of a pre-planned interim sample size analysis conducted by an independent Data Monitoring Committee, which indicated the trial was unlikely to meet its co-primary endpoints upon completion. The trial was not stopped based on safety concerns. Ocugen is no longer pursuing the development of this product candidate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger with Histogenics</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2019, the Company completed its reverse merger with Ocugen OpCo, Inc. (&#8220;OpCo&#8221;) in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated as of April&#160;5, 2019, by and among Histogenics Corporation ("Histogenics"), OpCo and Restore Merger Sub,&#160;Inc., a wholly owned subsidiary of Histogenics (&#8220;Merger Sub&#8221;), as amended (the &#8220;Merger Agreement&#8221;), pursuant to which Merger Sub merged with and into OpCo, with OpCo surviving as a wholly owned subsidiary of Histogenics (the &#8220;Merger&#8221;). Immediately after completion of the Merger, Histogenics changed its name to Ocugen,&#160;Inc. and the business conducted by Ocugen,&#160;Inc. became the business conducted by OpCo. OpCo is deemed to be the accounting acquirer. Accordingly, the historical financial statements of OpCo became the Company&#8217;s historical financial statements, including the comparative prior periods. See Note 3 for additional information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reverse Stock Split</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with, and immediately prior to the completion of the Merger, Histogenics effected a reverse stock split of the common stock, at a ratio of 1-for-60 (the &#8216;&#8216;Reverse Stock Split&#8217;&#8217;). Under the terms of the Merger Agreement, the Company issued common stock to OpCo&#8217;s stockholders at an exchange rate of 0.4794 shares of common stock, after taking into account the Reverse Stock Split, for each share of OpCo&#8217;s common stock outstanding immediately prior to the Merger.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The capital structure, including the number of shares of common stock issued appearing in the condensed consolidated balance sheets for the periods presented, reflects that of Ocugen. All references in the condensed consolidated financial statements to the number of shares and per-share amounts of common stock have been retroactively restated to reflect the exchange rate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred recurring losses and negative cash flows from operations since inception and has funded its operating losses through the sale of common stock, warrants to purchase common stock, the issuance of convertible notes, debt, and grant proceeds. The Company incurred net losses of approximately $18.0 million and $32.6 million for the nine months ended September 30, 2020 and 2019, respectively. As of September&#160;30, 2020, the Company had an accumulated deficit of $69.5 million and cash, cash equivalents and restricted cash totaling $19.3 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a limited operating history and its prospects are subject to risks, expenses and uncertainties frequently encountered by companies in its industry. The Company intends to continue its research and development efforts for its product candidates, which will require significant funding. If the Company is unable to obtain additional financing in the future or research and development efforts require higher than anticipated capital, there may be a negative impact on the financial viability of the Company. The Company plans to increase working capital by raising additional capital through public and private placements of equity and/or debt, payments from potential strategic research and development arrangements, sale of assets, and licensing and/or collaboration arrangements with pharmaceutical companies or other institutions. Such financing may not be available at all, or on terms that are favorable to the Company. While management of the Company believes that it has a plan to fund ongoing operations, its plan may not be successfully implemented. Failure to generate sufficient cash flows from operations, raise additional capital through one or more financings, or appropriately manage certain discretionary spending could have a material adverse effect on the Company&#8217;s ability to achieve its intended business objectives.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of these factors, together with the anticipated increase in spending that will be necessary to continue to develop the Company&#8217;s product candidates, there is substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that these condensed consolidated financial statements are issued. The condensed consolidated financial statements do not contain any adjustments that might result from the resolution of any of the above uncertainties.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710182740504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements included herein have been prepared in conformity with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) and under the rules&#160;and regulations of the United States Securities and Exchange Commission (&#8220;SEC&#8221;) for interim reporting. The accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, that are necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows. The condensed consolidated results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosures of the Company normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted under the SEC&#8217;s rules and regulations. These condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes thereto for the year ended December&#160;31, 2019, included in the Company's 2019 Annual Report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of Ocugen, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform with current period presentation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing the condensed consolidated financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions primarily include those used in the accounting for clinical trial accruals, warrant transactions, asset held for sale, and the valuation of debt and equity instruments, including embedded derivatives and stock-based compensation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses whether collaboration agreements are subject to the Financial Accounting Standards Board ("FASB") Accounting Standards Codification (&#8220;ASC&#8221;) Topic 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 808&#8221;), based on whether they involve joint operating activities and whether both parties have active participation in the arrangement and are exposed to significant risks and rewards. To the extent that the arrangement falls within the scope of ASC 808, the Company assesses whether the payments between the Company and the collaboration partner are subject to other accounting literature. If payments from the collaboration partner represent consideration from a customer, the Company accounts for those payments within the scope of ASC Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 606&#8221;). However, if the Company concludes that its collaboration partner is not a customer, the Company will determine if analogy to other authoritative literature is appropriate. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the Company entered into a collaboration agreement subject to ASC 808. Under this arrangement, the Company records cost reimbursements received as a reduction of research and development expense in the period incurred and royalty payments received as collaboration revenue in the period in which the underlying sale occurs. See Note 5 for additional information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exit and Disposal Activities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records liabilities for one-time termination benefits in accordance with ASC Topic 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit and Disposal Cost Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 420"). In accordance with ASC 420, an arrangement for one-time termination benefits exists at the date the plan of the termination meets the following criteria: (i) management commits to a plan of termination, (ii) the plan identifies the impacted employees and expected completion date, (iii) the plan identifies the terms of the benefits arrangement, (iv) it is unlikely significant changes to the plan will be made or the plan will be withdrawn and (v) the plan has been communicated to employees. Costs for one-time termination benefits in which the employee is required to render service until termination in order to receive the benefits, are recognized ratably over the future service period. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records liabilities for employee termination benefits covered by ongoing benefit arrangements in accordance with ASC Topic 712, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nonretirement Postemployment Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 712"). In accordance with ASC 712, costs for termination benefits under ongoing benefits arrangements are recognized when management has committed to a plan of termination and the costs are probable and estimable.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Severance-related charges, once incurred, are recognized as either research and development expense or general and administrative expense within the condensed consolidated statements of operations and comprehensive loss depending on the job function of the employee.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Asset Held for Sale</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An asset is considered to be held for sale when all of the following criteria are met: (i) management commits to a plan to sell the asset; (ii) it is unlikely that the disposal plan will be significantly modified or discontinued; (iii) the asset is available for immediate sale in its present condition; (iv) actions required to complete the sale of the asset have been initiated; (v) sale of the asset is probable and the completed sale is expected to occur within one year; and (vi) the asset is actively being marketed for sale at a price that is reasonable given its current market value.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A long-lived asset classified as held for sale is measured at the lower of its carrying amount or fair value less cost to sell. If the long-lived asset is newly acquired, the carrying amount of the long-lived asset is established based on its fair value less cost to sell at the acquisition date. A long-lived asset is not depreciated or amortized while it is classified as held for sale, and an impairment loss would be recognized to the extent the carrying amount exceeds the asset's fair value less cost to sell.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2019, the Company had an intangible asset held for sale, which it held prior to the Merger. The intangible asset qualified and was recorded as held for sale as of the date of the reverse asset acquisition and was carried at its original fair value less cost to sell of $7.0&#160;million. The Company concluded during the three months ended September 30, 2020, that a sale of the intangible asset held for sale was no longer probable to be completed within one year from the date the intangible asset was initially recorded as held for sale. As such, the carrying value of the intangible asset was reduced to zero with the corresponding charge of $7.0&#160;million recognized as in-process research and development expense during the three and nine months ended September&#160;30, 2020 as the in-process research and development does not have an alternative future use.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company has concluded that a sale of the intangible asset is no longer probable to be completed within one year from the date the intangible asset was initially recorded as held for sale, the Company is party to an Asset Purchase Agreement </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(as defined within Note 3) related to the intangible asset as of September&#160;30, 2020, and continues to market the asset for sale. In the event of a sale of the intangible asset under the Asset Purchase Agreement or to another party, the Company will account for the sale in the period in which the sale occurs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company follows the provisions of the ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 820&#8221;), which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair measurements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of certain financial instruments, including cash and cash equivalents, accounts payable, and accrued expenses approximates their fair values due to the short-term nature of these instruments. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8212; quoted prices in active markets for identical assets or liabilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 &#8212; quoted prices for similar assets and liabilities in active markets or inputs that are observable</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 &#8212; inputs that are unobservable (for example cash flow modeling inputs based on assumptions)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had derivative instruments that were fair valued on a recurring basis using Level 3 inputs during the three and nine months ended September&#160;30, 2019. There were no derivative instruments fair valued on a recurring basis using Level 3 inputs during the three and nine months ended September&#160;30, 2020. As of September&#160;30, 2020, the Company estimates the fair value of the note with EB5 Life Sciences, L.P. was $1.0&#160;million using Level 2 inputs. As of September&#160;30, 2020, the Company believes the fair values using Level 2 inputs of both the Warrant Exchange Promissory Notes (as defined in Note 9) and the loan received under the PPP of the CARES Act (as defined in Note 9) approximate their carrying values. See Note 9 for additional information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments that have maturities of three months or less when acquired to be cash equivalents. Cash and cash equivalents include bank demand deposits, marketable securities with maturities of three months or less at purchase, and money market funds that invest primarily in certificates of deposit, commercial paper and United States government and United States government agency obligations. The Company&#8217;s restricted cash balance consists of cash held to collateralize a corporate credit card account.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents, and restricted cash in the condensed consolidated balance sheets to the total amount shown in the condensed consolidated statements of cash flows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,105,830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,301,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,257,026&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,451,992&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys to the Company the right to control the use of an explicitly or implicitly identified fixed asset for a period of time in exchange for consideration. Control of an underlying asset is conveyed to the Company if the Company obtains the rights to direct the use of and to obtain substantially all of the economic benefits from using the underlying asset. The Company has lease agreements which include lease and&#160;non-lease&#160;components, which the Company has elected to account for as a single lease component for all classes of underlying assets. Lease expense for variable lease components are recognized when the obligation is probable.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in other assets and lease obligations on the Company&#8217;s condensed consolidated balance sheets. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease payments are recognized as lease expense on a straight-line basis over the lease term. The Company primarily leases real estate, and leases for real estate are classified as operating leases. ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 842") requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As an implicit interest rate is not readily determinable in the Company&#8217;s leases, the incremental borrowing rate is used based on the information available at commencement date in determining the present value of lease payments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease term for all of the Company&#8217;s leases includes the&#160;non-cancellable&#160;period of the lease plus any additional periods covered by either a Company option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Options for lease renewals have been excluded from the lease term (and lease liability) for the majority of the Company&#8217;s leases as the reasonably certain threshold is not met.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease payments included in the measurement of the lease liability are comprised of fixed payments, variable payments that depend on index or rate, and amounts probable to be payable under the exercise of the Company option to purchase the underlying asset if reasonably certain.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease payments not dependent on a rate or index associated with the Company&#8217;s leases are recognized when the event, activity, or circumstance in the lease agreement on which those payments are assessed as probable. Variable lease payments include the Company's proportionate share of utilities and other operating expenses and are presented as operating expenses in the Company&#8217;s condensed consolidated statements of operations and comprehensive loss in the same line item as expense arising from fixed lease payments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its stock-based compensation awards in accordance with ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation&#8212;Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 718&#8221;). ASC 718 requires all stock-based payments to employees, including grants of employee stock options and restricted stock units and modifications to existing agreements, to be recognized in the condensed consolidated statements of operations and comprehensive loss based on their fair values. The Company uses the Black-Scholes option-pricing model to determine the fair value of options granted. The Company recognizes forfeitures as they occur.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock-based awards are subject to service-based vesting conditions. Compensation expense related to awards to employees and directors with service-based vesting conditions is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. Stock-based awards generally vest over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2MTk_eb512e86-ca54-4b51-8e50-01fc17d11c9f">one</span> to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2MjU_8897e6c7-9303-4adc-88de-47d481ae6e6d">three</span> year requisite service period and have a contractual term of 10 years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimating the fair value of options requires the input of subjective assumptions, including expected life of the option, stock price volatility, the risk-free interest rate and expected dividends. The assumptions used in the Company&#8217;s Black-Scholes option-pricing model represent management&#8217;s best estimates and involve a number of variables, uncertainties and assumptions and the application of management&#8217;s judgment, as they are inherently subjective. If any assumptions change, the Company&#8217;s stock-based compensation expense could be materially different in the future.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued Accounting Standards Update ("ASU") No. 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework&#8212;Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard modifies certain disclosure requirements on fair value measurements and was effective for the Company on January 1, 2020. The adoption of this standard did not have a material impact on the Company's disclosures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, the FASB issued ASU No. 2018-18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under ASC 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In those situations, ASC 606 guidance should be applied, including recognition, measurement, presentation and disclosure requirements. The standard adds unit-of-account guidance to ASC 808 to align with the guidance in ASC 606 when an entity is assessing whether the collaborative arrangement or a part of the collaborative arrangement is within the scope of ASC 606. The standard also precludes a company from presenting transactions with collaborative arrangement participants that are not directly related to sales to third parties with revenue from contracts with customers recognized under ASC 606 if the collaborative arrangement participant is not a customer. This standard was effective for the Company on </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 1, 2020. Consistent with the guidance in this standard, the Company assesses whether collaboration arrangements are within the scope of ASC 606. For collaboration arrangements that are not within the scope of ASC 606, applicable transactions with collaborative arrangement participants are presented as collaboration revenue rather than revenue from contracts with customers. See above and Note 5 for additional information.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The FASB subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date of January 1, 2023. These standards require that credit losses be reported using an expected losses model rather than the incurred losses model that is currently used, and establishes additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, these standards now require allowances to be recorded instead of reducing the amortized cost of the investment. These standards limit the amount of credit losses to be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The Company does not currently expect the adoption of these standards to have a material impact on its condensed consolidated financial statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This standard will have an effective date and transition date of January 1, 2021. This standard removes certain exceptions for recognizing deferred taxes for investments, performing intraperiod allocations and calculating income taxes in interim periods. This standard also adds guidance to reduce complexity in certain areas, including recognizing franchise tax, recognizing deferred taxes for tax goodwill, allocating taxes to the members of a consolidated group and recognizing the effect of enacted changes in tax laws or rates during an interim period. The Company does not currently expect the adoption of this standard to have a material impact on its condensed consolidated financial statements.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity's Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard will have an effective and transition date of January 1, 2024. Early adoption is permitted beginning January 1, 2021. This standard simplifies an issuer's accounting for convertible instruments by eliminating two of the three models in ASC 470-20 that require separate accounting for embedded conversion features as well as simplifies the settlement assessment that entities are required to perform to determine whether a contract qualifies for equity classification. This standard also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of potential share settlement (if the effect is more dilutive) for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. The standard requires new disclosures about events that occur during the reporting period and cause conversion contingencies to be met and about the fair value of a public business entity's convertible debt at the instrument level, among other things. The Company does not currently expect the adoption of this standard to have a material impact on its condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710184474648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger and Financing<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Merger and Financing</a></td>
<td class="text">Merger and Financing<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pre-Merger Financing</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, OpCo and Histogenics entered into a Securities Purchase Agreement (as amended, the "Financing SPA") with certain accredited investors (the "Investors"). Pursuant to the Financing SPA, among other things, (i) immediately prior to the Merger, OpCo issued 2.2&#160;million shares of common stock to the Investors, (ii)&#160;on October 4, 2019, the Company issued 2.2&#160;million shares of the Company's common stock to the Investors and (iii)&#160;on October 4, 2019, the Company issued three series of warrants to purchase shares of the Company&#8217;s common stock (the &#8220;Series&#160;A Warrants,&#8221; the &#8220;Series&#160;B Warrants&#8221; and the &#8220;Series&#160;C Warrants&#8221; and collectively, the &#8220;Pre-Merger Financing Warrants&#8221;) in exchange for an aggregate purchase price of $25.0 million (the "Pre-Merger Financing"). See Note 12 for additional information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger with Histogenics</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;27, 2019, the Company completed the Merger in accordance with the terms of the Merger Agreement. The Merger was structured as a stock-for-stock transaction whereby all of OpCo&#8217;s outstanding shares of common stock and securities convertible into or exercisable for OpCo&#8217;s common stock were converted into the right to receive Histogenics&#8217; common stock and securities convertible into or exercisable for Histogenics&#8217; common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 805&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company concluded that, while Histogenics was the legal acquirer, OpCo was the accounting acquirer due to the fact that (i)&#160;OpCo&#8217;s shareholders had the majority of the voting </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rights in Ocugen, (ii)&#160;OpCo held all of the board seats of the combined company and (iii)&#160;OpCo management held all key positions in the management of the combined company. The Company further concluded that Histogenics did not meet the definition of a business under ASC 805 due to the fact that substantially all of the fair value of the gross assets disposed of is concentrated in a single identifiable asset or a group of similar identifiable assets. Therefore, the Merger was accounted for as a reverse asset acquisition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, on May 8, 2019, Histogenics entered into an asset purchase agreement (the "Asset Purchase Agreement") with Medavate Corp., pursuant to which Histogenics agreed to sell substantially all of its assets relating to its NeoCart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> program for $6.5&#160;million. The parties subsequently amended the Asset Purchase Agreement to increase the purchase price to $7.0&#160;million with the purchase price increasing 10% per month (or any portion thereof) starting October 31, 2019 if the closing date of the Asset Purchase Agreement did not occur prior to October 31, 2019. The Company may terminate the Asset Purchase Agreement at any time without recourse. The Asset Purchase Agreement closing date did not occur as of September&#160;30, 2020 and the Company has not terminated the Asset Purchase Agreement as of September&#160;30, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NeoCart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> asset was held for sale as of December&#160;31, 2019. The NeoCart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> asset qualified as held for sale as of the date of the reverse asset acquisition and was carried at its original fair value less cost to sell valued at the acquisition date based on a quoted price of $7.0&#160;million, which was an observable Level 2 fair value input. The NeoCart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> asset did not qualify as held for sale as of September&#160;30, 2020. See Note 2 for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710182825896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share of Common Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share of Common Stock</a></td>
<td class="text">Net Loss Per Share of Common Stock<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share for the three and nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss&#8212;basic and diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,473,847)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,773,281)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,031,641)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,624,697)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividend related to Warrant Exchange (Note 12)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,546,340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,473,847)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,773,281)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,577,981)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,624,697)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in calculating net loss per common share&#8212;basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,591,218&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,411,308&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,764,157&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,839,840&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share&#8212;basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.55)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.59)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding, as their inclusion would have been antidilutive:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,268,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,268,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,771,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,771,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Warrants (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,007,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,007,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,138,294&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,150,339&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,138,294&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,150,339&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Series B Warrants do not include the additional Series B Warrants that were contingent upon the reset pricing as discussed in Note 12.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710184385064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaboration Agreements</a></td>
<td class="text">Collaboration AgreementsIn April 2020, the Company entered into a collaboration agreement (the &#8220;Advaite Agreement&#8221;) with Advaite, Inc. (&#8220;Advaite&#8221;) with respect to the development of Advaite&#8217;s RapCov COVID-19 Testing Kit (the &#8220;COVID-19 Test&#8221;). Advaite was co-founded and is being managed by Mr. Karthik Musunuri, the son of the Company's Chief Executive Officer, Chairman of the Board and co-founder, Dr. Shankar Musunuri. Pursuant to the Advaite Agreement, the Company will provide certain production, research and development, technical, regulatory and quality support services to Advaite in connection with the development and <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commercialization of the COVID-19 Test (the &#8220;Ocugen Services&#8221;). Advaite will research, develop, and seek to obtain regulatory approval of the COVID-19 Test, and where regulatory approval is obtained, commercialize the COVID-19 Test.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advaite will solely own all data and materials, including the COVID-19 Test, generated by the Company and its representatives solely in the course of the performance of the Ocugen Services. Advaite is responsible for all preparation and submission of regulatory materials for the COVID-19 Test to regulatory authorities, and Advaite will hold all regulatory approvals of the COVID-19 Test in its name and own all related submissions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is entitled to receive cost reimbursements from Advaite, beginning as of April 1, 2020, for (a) costs incurred by the Company related to its personnel who are subject matter experts involved in providing the Ocugen Services ("SME Costs") and (b) Advaite's pro-rata share of all costs (other than SME Costs) incurred by the Company in providing the Ocugen Services. As partial consideration for the Company's performance of the Ocugen Services, Advaite will pay to the Company a quarterly royalty in the range of mid to high single digits based on net sales of the COVID-19 Tests.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Advaite Agreement expires on April 29, 2021, unless extended upon mutual agreement of both the Company and Advaite. Except as otherwise specified in the terms of the Advaite Agreement, Advaite&#8217;s obligation to make royalty payments to the Company will survive expiration of the Advaite Agreement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Advaite Agreement is considered to be within the scope of ASC 808 as the Advaite Agreement represents a joint operating activity and both Advaite and the Company are active participants and exposed to the risks and rewards. The Company has evaluated the Advaite Agreement and determined it is not within the scope of ASC 606 as Advaite does not meet the definition of a customer. </span></div>Cost reimbursements are recorded as a reduction in research and development expense in the period incurred. Royalty payments are recorded as collaboration revenue in the period in which the underlying sale occurs. For the three and nine months ended September&#160;30, 2020, the Company recorded $0.1&#160;million and $0.3&#160;million as a reduction of research and development expense, respectively. For the three months ended September 30, 2020, the Company recorded no collaboration revenue in connection with the Advaite Agreement. For the nine months ended September 30, 2020, the Company recorded $42,620 as collaboration revenue in connection with the Advaite Agreement<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710182794328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text">Accrued Expenses<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued Expenses are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research&#160;and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333,733&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270,045&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) See Note 7 for additional information regarding severance-related accrued expenses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710184398152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Exit and Disposal Activities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Exit and Disposal Activities</a></td>
<td class="text">Exit and Disposal ActivitiesOn June 15, 2020, the Company, as part of its recent shift in focus toward its gene therapy platform and novel biologics program aimed at curing blindness diseases, communicated notice to five employees of termination of their employment. This reduction represents one-third of the Company&#8217;s workforce. All terminations were &#8220;without cause&#8221; and each employee is <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">entitled to receive termination benefits upon departure. The termination dates vary for each employee and range from June 30, 2020 to December 31, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the workforce reduction, the Company recognized severance-related charges of $0.4&#160;million and $1.1&#160;million during the three and nine months ended September&#160;30, 2020, respectively. The Company expects to pay severance benefits of $0.4&#160;million during 2020 and $0.7&#160;million during 2021. For the three months ended September 30, 2020, the Company recognized a de minimis amount of severance-related charges within general and administrative expense and $0.4&#160;million of severance-related charges within research and development expense. For the nine months ended September 30, 2020, the Company recognized $0.2&#160;million of severance-related charges within general and administrative expense and $0.9&#160;million of severance-related charges within research and development expense.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table outlines the components of the severance-related charges:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Severance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Severance at September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888,096&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710182699800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity Transactions</a></td>
<td class="text">Equity Transactions<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-the-Market Offerings</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2020, the Company sold an aggregate of 27.0&#160;million and 86.2&#160;million shares of common stock, respectively, in separate at-the-market offerings (&#8220;ATMs&#8221;) commenced in May 2020, June 2020 and August 2020. The Company sold 34.4&#160;million shares under the May 2020 ATM, 24.8&#160;million shares under the June 2020 ATM and 27.0&#160;million shares under the August 2020 ATM. During the three months ended September 30, 2020, the Company received net proceeds of $10.1&#160;million, after deducting commissions, fees and expenses of $0.4&#160;million. During the nine months ended September 30, 2020, the Company received net proceeds of $25.6&#160;million, after deducting commissions, fees and expenses of $1.1&#160;million. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The offerings were made pursuant to the Company's effective "shelf" registration statement on Form S-3 filed with the SEC on March 27, 2020, the base prospectus contained therein dated May 5, 2020, and the prospectus supplements related to the offerings dated May 8, 2020, June 12, 2020 and August 17, 2020. As of September&#160;30, 2020, the Company had sold all of the shares of common stock available for issuance under the prospectus supplements filed on May 8, 2020 and June 12, 2020 in connection with the May 2020 and June 2020 ATMs. As of September&#160;30, 2020, the Company had remaining capacity to issue up to $19.5&#160;million of common stock under the prospectus supplement filed on August 17, 2020 in connection with the August 2020 ATM.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subscription Agreements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2020, the Company entered into a subscription agreement with an accredited investor for the sale of 1,000 shares of the Company's common stock in a private placement for an aggregate offering price of $395. This private placement constituted a Dilutive Issuance (as defined in Note 12) and resulted in adjustments to the Series A Warrants.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 6, 2020, the Company entered into a subscription agreement with an accredited investor for the issuance of 1.3 million shares of the Company's common stock in a private placement. The shares of common stock were issued as part of a transaction in settlement of an outstanding obligation of the Company to the accredited investor, in which (i) the Company agreed to make certain cash payments, (ii) the Company issued the 1.3 million shares of common stock in exchange for the accredited investor's agreement to cancel $0.3 million of the outstanding obligation and (iii) the accredited investor agreed to cancel an additional portion of the amount owed by the Company representing a discount of $0.2&#160;million.</span></div>On April 5, 2019, OpCo entered into a subscription agreement (the "April 2019 Subscription Agreement") with existing investors for the sale of 0.1 million shares of common stock for $1.0&#160;million. This capital raise triggered the conversion features on the convertible debt described in Note 9 below.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710185345144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the carrying values for the components of debt as reflected on the condensed consolidated balance sheets:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP Note</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant Exchange Promissory Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EB-5 Loan Agreement borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value of debt, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,155,041&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072,123&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PPP Note</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2020, the Company was granted a loan from Silicon Valley Bank ("SVB"), in the aggregate amount of $0.4&#160;million, pursuant to the Paycheck Protection Program (the &#8220;PPP&#8221;) of the Coronavirus Aid, Relief and Economic Security Act of 2020 (the &#8220;CARES Act&#8221;). On June 5, 2020, the PPP Flexibility Act of 2020 (the "PPPFA") was signed into law amending the original terms of the PPP. Among other things, the PPPFA extends the deferral period for monthly principal and interest payments from six months to the time when the Small Business Administration (the "SBA") compensates the lender for amounts forgiven as well as extending the covered period for qualifying expenses from eight weeks to the earlier of 24 weeks or December 31, 2020. Certain amounts of the loan may be forgiven if they are used for qualifying expenses as described by the CARES Act.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loan was in the form of a promissory note dated April 30, 2020 in favor of SVB (the "PPP Note"). The PPP Note matures on April 30, 2022 and bears interest at a rate of 1.0% per annum. Principal and interest payments are payable monthly commencing on the date the SBA compensates SVB for forgiven amounts or within 10 months following the expiration of the covered period if the Company has not applied for forgiveness. The Company did not provide any collateral or guarantees for the loan, nor did the Company pay any facility charge to obtain the loan. The PPP Note provides for customary events of default, including, among others, failure to make payment, bankruptcy, breaches of representations and material adverse events. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, the carrying value of the PPP Loan was $0.4 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrant Exchange Promissory Notes</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2020, in connection with the Warrant Exchange as defined in Note 12, the Company issued to Investors certain promissory notes (the "Warrant Exchange Promissory Notes") with an aggregate principal amount of $5.6&#160;million. The Warrant Exchange Promissory Notes have a maturity date of April 21, 2021 and do not bear interest. The Company may prepay the Warrant Exchange Promissory Notes in whole or in part at any time without penalty or premium. In the event that the Company consummates a financing transaction that generates cash to the Company, the Company is required to use 20% of the net proceeds of such transaction to prepay a portion of the outstanding amount under each Warrant Exchange Promissory Note if the transaction occurs on or prior to August 22, 2020, and 30% of the net proceeds to prepay a portion of the outstanding amount under each Warrant Exchange Promissory Note if that transaction occurs after August 22, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2020, the Warrant Exchange Promissory Notes were recorded at a fair value of $5.0&#160;million. The difference of $0.6&#160;million between the fair value and the aggregate principal amount of $5.6&#160;million was recorded as a debt discount to be accreted to interest expense over the life of the Warrant Exchange Promissory Notes. The accretion amounted to $0.3&#160;million and $0.5&#160;million for the three and nine months ended September&#160;30, 2020, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to use a percentage of the net proceeds of the ATMs discussed in Note 8 to redeem the outstanding amount under the Warrant Exchange Promissory Notes. During the three and nine months ended September&#160;30, 2020, the Company made payments to the Warrant Exchange Promissory Note holders of $3.2 million and $4.4 million, respectively. Subsequent to September&#160;30, 2020, the Company made payments to the Warrant Exchange Promissory Note holders of $1.3 million, causing the Warrant Exchange Promissory Notes to be repaid in full and no longer outstanding.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the Warrant Exchange Promissory Notes at September&#160;30, 2020 and December&#160;31, 2019 are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt discount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145,732)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116,997&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EB-5 Loan Agreement Borrowings</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September&#160;2016, pursuant to the U.S. government&#8217;s Immigrant Investor Program, commonly known as the EB-5 program (the &#8220;EB-5 Program&#8221;), the Company entered into an arrangement (the &#8220;EB-5 Loan Agreement&#8221;) to borrow up to $10.0&#160;million from EB5 Life Sciences,&#160;L.P. (&#8220;EB-5 Life Sciences&#8221;) in $0.5&#160;million increments. Borrowing may be limited by the amount of funds raised by the EB-5 Life Sciences and are subject to certain job creation requirements by the Company. Borrowings are at a fixed interest rate of 4.0% per annum and are to be utilized in the clinical development, manufacturing, and commercialization of the Company&#8217;s products and for the general working capital needs of the Company. Outstanding borrowings pursuant to the EB-5 Program, including accrued interest, become due upon the seventh anniversary of the final disbursement. Amounts repaid cannot be re-borrowed. The EB-5 Program borrowings are secured by substantially all assets of the Company, except for any patents, patent applications, pending patents, patent license, patent sublicense, trademarks, and other intellectual property rights.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms and conditions of the EB-5 Loan Agreement, the Company borrowed $1.0 million in 2016 and an additional $0.5 million on March&#160;26, 2020. Issuance costs were recognized as a reduction to the loan balance and are amortized to interest expense over the term of the loan.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the EB-5 Loan Agreement borrowings as of September&#160;30, 2020 and December&#160;31, 2019 are summarized below:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616,629&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072,123&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Secured Convertible Notes</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 21, 2019, the Company issued senior secured convertible notes to certain investors for $2.4 million at an original issue discount of $0.5 million, and on June 28, 2019, the Company entered into an agreement to issue additional senior secured convertible notes to the investors for $2.9 million with an original issue discount of $0.4 million (together the "Senior Secured Convertible Notes"). Immediately prior to the Merger completed on September 27, 2019, the Investors offset $5.3 million from the amount to be received under the Pre-Merger Financing and the Senior Secured Convertible Notes were deemed to have been repaid and cancelled. The accretion of the original issue discount to interest expense amounted to $0.7 million and $0.8 million during three and nine months ended September&#160;30, 2019, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Promissory Note</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2019, the Company issued a convertible promissory note (the "Convertible Promissory Note") to an existing stockholder for $0.9&#160;million at an interest rate of 5% per annum. On May 16, 2019, the Convertible Promissory Note was converted into equity. OpCo issued 0.1&#160;million shares of common stock at the conversion date to extinguish the debt at $12.41 per share. This non-cash transaction resulted in an increase of $0.9&#160;million in additional paid-in capital, which was based on the principal balance outstanding and the unpaid interest upon conversion.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Notes</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2019 and 2018, the Company issued convertible notes (the &#8220;Convertible Notes&#8221;) to new and existing stockholders in the Company, including Convertible Notes in the aggregate principal amount of $3.5&#160;million to members of the Board of Directors. As of December&#160;31, 2019, all Notes had been converted and were no longer outstanding. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At issuance, the following amounts were recorded:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Convertible Note&#160;Issuance&#160;Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Convertible Note<br/>Principal<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value of Embedded Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt<br/>Issuance<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value upon Issuance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,657,711)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,969)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,306,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(724,216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,857)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,310)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182,882)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302,379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,875)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,750,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,891,172)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189,158)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,670,070&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All Convertible Notes accrued interest at a rate of 5% per annum and had scheduled maturity dates on the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV82NC9mcmFnOmNkNzllZDQ3NGYwODQ2ZWI5OGNmZTdhODQwYTk4MDQwL3RleHRyZWdpb246Y2Q3OWVkNDc0ZjA4NDZlYjk4Y2ZlN2E4NDBhOTgwNDBfNjgzOQ_9250eb5b-b0ea-4f42-8cf2-a98505654eac">eighteen</span> month anniversary of the date of the issuance of the Convertible Notes (the &#8220;Maturity Date&#8221;). If prior to the Maturity Date, there was a consummation of the sale of all or substantially all of the assets of the Company, change in control or event of default, the Convertible Notes would become due and payable at an amount equal to 1.5 times the principal amount of the Convertible Notes together with all accrued interest (the &#8220;Change in Control Feature&#8221;).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company received equity financing from the issuance of stock of the Company from an investor or group of investors in a transaction or series of related transactions above a certain amount of gross proceeds, the principal amount and all interest accrued but not paid through the closing date of the qualified equity financing was to automatically convert into the same class of equity securities as those issued in the qualified equity financing ("Conversion Feature"). The price per share varied among the Convertible Notes ranging from a 0% to 30% discount to the lowest price per share being paid by investors in the qualified equity financing.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company bifurcated the Conversion Feature for the January&#160;2018, June&#160;2018, January&#160;2019, and February&#160;2019 Convertible Notes and classified it as a derivative liability because the conversion feature did not have a fixed conversion price and conversion would be settled in a variable number of shares of common stock. There was no bifurcated conversion feature for the November&#160;2018 and December 2018 Convertible Notes as there is no discount to the lowest equity price triggering conversion. The Company also bifurcated the Change in Control Feature for all of the Convertible Notes because it was determined to be a redemption feature not clearly and closely related to the debt host. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of both of the embedded features was accounted for as a derivative liability and was recorded as a discount on the Convertible Notes. Inputs used in valuation were unobservable and therefore considered Level 3 in the fair value hierarchy. The debt discount was accreted into interest expense over the expected time until conversion of the Convertible Notes. The accretion amounted to zero and $0.5 million for the three and nine months ended September&#160;30, 2019, respectively. There was no accretion during the three and nine months ended September&#160;30, 2020 as all Convertible Notes had been converted and were no longer outstanding as of December&#160;31, 2019.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the embedded features was classified as a liability in the Company&#8217;s condensed consolidated balance sheets at issuance, with subsequent changes in fair value recorded on the Company&#8217;s condensed consolidated statements of operations and comprehensive loss as a change in fair value of derivative liabilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the April 2019 Subscription Agreement as described and defined within Note 8, the triggers for conversion were met on the Convertible Notes. On April 5, 2019, the Convertible Notes were modified to change the discount percentage from the 0% discount per the terms of the November&#160;2018 and December 2018 Convertible Notes and the 15% discount per the terms of the January&#160;2019 and February&#160;2019 Convertible Notes to 30% at the time of conversion. The Company issued 1.1&#160;million shares of common stock at $8.69 per share on the date of conversion to extinguish the debt, which resulted in a loss of $0.3&#160;million. This non-cash conversion also resulted in an increase of $13.0 million in additional paid-in capital, which was based on the principal balance outstanding and the unpaid interest upon conversion.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principal Maturities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt maturities (excluding interest) are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:18.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.343%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve months ending September 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Maturities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,184,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710189115384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-based Compensation</a></td>
<td class="text">Stock-based Compensation<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for options granted is reflected in the condensed consolidated statements of operations and comprehensive loss as follows:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,621&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,290&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,005&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498,012&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720,014&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, the Company had $1.3&#160;million of unrecognized compensation expense related to options outstanding under its equity plans. This expense is expected to be recognized over a weighted average period of 2.2 years as of September&#160;30, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Plans</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains two equity compensation plans, the 2014 Ocugen OpCo, Inc. Stock Option Plan (the &#8220;2014 Plan&#8221;) and the Ocugen, Inc. 2019 Equity Incentive Plan (the &#8220;2019 Plan&#8221;, collectively with the 2014 Plan, the "Plans"), which replaced the Histogenics Corporation 2013 Equity Incentive Plan (the "2013 Plan"). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, Ocugen&#8217;s stockholders approved the adoption of the 2019 Plan and the 2013 Plan was frozen. No additional awards have been or will be made under the 2013 Plan and any remaining authorized shares under the 2013 Plan were recycled into the 2019 Plan. On the first business day of each fiscal year, pursuant to the "Evergreen" provision of the 2019 Plan, the aggregate number of shares that may be issued under the 2019 Plan will automatically increase by a number equal to the lesser of 4% of the total number of shares of Company common stock outstanding on December 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the prior year, or a number of shares of Company common stock determined by the Board. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, the 2014 Plan provides for the granting of up to 0.8&#160;million equity awards in respect to Ocugen's common stock. As of September&#160;30, 2020, the 2019 Plan provides for the granting of up to 4.2&#160;million equity awards in respect of Ocugen's common stock, inclusive of equity awards that were previously available for issuance under the 2013 Plan and the additional shares authorized for issuance pursuant to the 2019 Plan's "Evergreen" provision on January 1, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, an aggregate of 0.5&#160;million and 3.8&#160;million shares of Company common stock were issuable upon the exercise of outstanding stock options under the 2014 Plan and 2019 Plan, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options to Purchase Common Stock</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the stock option activity under the Plans:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,028&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,064,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(527,862)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September&#160;30, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,268,277&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.94&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,072&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at September&#160;30, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.34&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of stock options granted during both the three and nine months ended September&#160;30, 2020 was $0.34 per share.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710182794328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments</a></td>
<td class="text">Commitments<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has commitments under operating leases for certain facilities used in its operations. The Company&#8217;s leases have initial lease terms ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTk1_ae9976e8-4e79-4b4b-95fa-b8c561425fb1">one</span> to five years. Certain lease agreements contain provisions for future rent increases.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.449%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,947&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,865&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,362&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,828&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,554&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease terms&#8212;operating leases (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate&#8212;operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum operating minimum lease payments for all leases, exclusive of taxes and other carrying charges, are approximately as follows:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,319&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: present value adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,554&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Leases</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the Company leased specialized research equipment under a lease classified as a financing lease. The leased equipment is included in property and equipment, net and is amortized on a straight-line basis over five years. Financing lease liabilities are included in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI3NQ_32d25827-fc2b-4183-a751-56c09cccc2ae"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV83MC9mcmFnOjQzMGZjYmMzMTg0YTQzN2I4MGU3YzA0MTIxYWYxZDI3L3RleHRyZWdpb246NDMwZmNiYzMxODRhNDM3YjgwZTdjMDQxMjFhZjFkMjdfMTI3NQ_939a82e3-172c-4a98-a538-b4e48e03f315">other liabilities</span></span> on the Company's condensed consolidated balance sheets. The interest rate related to the lease obligation is 7.6% and the maturity date is July 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for all financing leases, exclusive of taxes and other carrying charges, are approximately as follows:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: present value adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,461&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to September&#160;30, 2020, the Company entered into a lease agreement for an expanded office and laboratory space located in Malvern, Pennsylvania. See Note 13 for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710182711912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_WarrantsTextBlock', window );">Warrants</a></td>
<td class="text">Warrants<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pre-Merger Financing Warrants</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;27, 2019, Ocugen completed the Merger with OpCo. Immediately prior to the Merger, Ocugen and OpCo completed the Pre-Merger Financing, a previously announced private placement transaction with certain Investors pursuant to the Financing SPA, whereby, among other things, the Company agreed to issue Series&#160;A Warrants, Series&#160;B Warrants, and Series&#160;C Warrants.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 5, 2019, the Company entered into an agreement with each Investor that amended the terms of each of the Pre-Merger Financing Warrants held by each such Investor (collectively, the &#8220;Warrant Amendments&#8221;). The terms of the Pre-Merger Financing Warrants and the Warrant Amendments are discussed below. There were no Pre-Merger Financing Warrants outstanding at September&#160;30, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Series A Warrants</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series&#160;A Warrants had an initial exercise price per share of $7.13, were exercisable upon issuance and had a term of 60 months from the date of issuance. The Series&#160;A Warrants were exercisable for up to 8.8&#160;million shares of Ocugen common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series&#160;A Warrants had an anti-dilution adjustment whereby if Ocugen issues or sells, enters into a definitive, binding agreement pursuant to which Ocugen is required to issue or sell or is deemed, pursuant to the provisions of the Series&#160;A Warrants, to have issued or sold, any common stock for a price per share lower than the exercise price then in effect (a &#8220;Dilutive Issuance&#8221;), subject to certain limited exceptions, then (i)&#160;the exercise price of the Series&#160;A Warrants shall be reduced </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to such lower price per share and (ii)&#160;the number of shares issuable upon exercise of the Series&#160;A Warrants shall be increased to the number of shares of common stock determined by multiplying (a)&#160;the exercise price in effect immediately prior to such Dilutive Issuance by (b)&#160;the number of shares of common stock issuable upon exercise of the Series&#160;A Warrants immediately prior to such Dilutive Issuance (without giving effect to any limitation on exercise contained therein), and dividing the product thereof by the exercise price resulting from such Dilutive Issuance.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Series A Warrants were outstanding and exercisable as of December&#160;31, 2019. Pursuant to the Warrant Exchange (as defined below), no Series A Warrants were outstanding as of September&#160;30, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Series B Warrants</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series&#160;B Warrants had an exercise price of $0.01, were exercisable after the completion of a 10 trading-day period following the effectiveness of a registration statement covering the resale of common stock into which such warrants were exercisable and were to expire on the date on which the Series&#160;B Warrants have been exercised in full (without giving effect to any limitation on exercise contained therein) and no shares remain issuable thereunder. The Series&#160;B Warrants were initially exercisable by the holders for 8.0 million shares of common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, each Series B Warrant included a Reset Period pursuant to which the number of shares issuable upon exercise of the Series B Warrants shall be increased during certain Reset Periods (as defined in the Series B Warrants). The Reset Period concluded in November 2019 and resulted in an aggregate of 12.6&#160;million additional shares of common stock becoming issuable upon exercise of the Series B Warrants. There were 1,000 Series B Warrants outstanding at December&#160;31, 2019. There were no Series B Warrants outstanding at September&#160;30, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Series C Warrants</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series&#160;C Warrants were exercisable upon issuance for up to 50.0 million shares of common stock at an initial exercise price of $7.13 per share. Each of the Series&#160;C Warrants was amended pursuant to the Warrant Amendments to permit the Investors, in lieu of making any cash payment otherwise contemplated to be made to the Company upon the exercise of the Series&#160;C Warrant, to elect instead to receive upon such exercise up to 20.0&#160;million shares of common stock. Prior to the Warrant Amendments, the Series&#160;C Warrants had permitted the exercise without any cash payment of up to 50.0 million shares of common stock in the event that the volume weighted-average price of the common stock on Nasdaq was less than or equal to $1.20 per share on any five trading days following the issuance of the Series&#160;C Warrants. There were 1,000 Series C Warrants outstanding at December&#160;31, 2019. There were no Series C Warrants outstanding at September&#160;30, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for the Pre-Merger Financing Warrants</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2019, the Pre-Merger Financing Warrants were classified as equity. At issuance, the Series B Warrants were classified as a liability on the condensed consolidated balance sheet as they did not meet the derivative scope exception to be accounted for within stockholders' equity. The Series B Warrants were initially measured at fair value and marked to market each reporting period. Upon the completion of the Reset Period in November 2019, the Series B Warrants were reassessed and determined to meet the derivative scope exception allowing for equity classification. The Series B Warrants were marked to market a final time and the remaining liability balance was reclassified to equity.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Series B Warrants was calculated using a Monte Carlo simulation while estimating the stock price during the Reset Period, based on the terms described within the Financing SPA. Key fair value inputs included the starting stock price, expected stock volatility during the Reset Period, and additional shares issued from escrow. The methodology for measuring fair value was sensitive to the expected stock volatility assumption input mentioned above. The volatility used in the fair value estimate was 96.0% and 97.0% as of September 27, 2019 and September&#160;30, 2019, respectively. Inputs used in the valuation were unobservable and were therefore classified as Level 3 fair value inputs. The fair value of the Series B Warrants upon the end of the Reset Period was based on a Black-Scholes valuation model, which is classified as Level 3 in the fair value hierarchy.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a roll-forward of the Series B Warrant liability:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at issuance - September 27, 2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,387,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of embedded derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,577,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,964,986&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of embedded derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,709,246)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified to equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,255,740)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrant Exchange</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2020, the Company entered into a subscription agreement as discussed within Note 8. The subscription agreement constituted a Dilutive Issuance (as defined above) and resulted in adjustments to the number of issuable Series A Warrants and the exercise price under the Series A Warrants.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contemporaneously with the subscription agreement, the Company and OpCo entered into Amendment and Exchange Agreements (each an "Exchange Agreement" and collectively, the "Exchange Agreements") with the Investors. Pursuant to the Exchange Agreements, the Company, OpCo and the Investors agreed, among other things, after giving effect to the Dilutive Issuance, to amend the Series A Warrants to provide for an adjustment to the number of common stock issuable upon the exercise of the Series A Warrants. Concurrently with such amendments, the Investors exchanged the Series A Warrants for (i) an aggregate of 21.9&#160;million shares of common stock and (ii) the Warrant Exchange Promissory Notes as defined in Note 9 (collectively the "Warrant Exchange"). Following the consummation of the Warrant Exchange and the concurrent exercise of the remaining Series B Warrants and Series C Warrants, there were no Pre-Merger Financing Warrants outstanding at September&#160;30, 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the Warrant Exchange by recognizing the fair value of the consideration transferred in excess of the carrying value of the Series A Warrants as a reduction of additional paid-in capital. The fair value of the consideration transferred to settle the Series A Warrants was approximately $13.6&#160;million, comprised of $8.6&#160;million in shares of common stock and the fair value of the Warrant Exchange Promissory Notes of $5.0&#160;million. The fair value of consideration transferred to settle the Series A warrants was in excess of the fair value of the Series A Warrants immediately prior to the transaction by approximately $12.5&#160;million. The excess consideration was accounted for as a deemed dividend to the warrant holders and is reflected as an additional net loss attributed to common stockholders in the calculation of basic and diluted net loss per common share for the nine months ended September 30, 2020. The fair value of the Series A Warrants immediately prior to the Warrant Exchange was $1.1&#160;million, which was estimated using a Black-Scholes valuation model utilizing Level 3 inputs. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OpCo Warrants</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 2018, OpCo issued warrants to investors of the Company pursuant to a stockholders' agreement and to two employees of the Company pursuant to their respective employment agreements. As of September&#160;30, 2020 and December&#160;31, 2019, 0.9&#160;million warrants to purchase common stock were outstanding and exercisable and had a weighted average exercise price of $5.67 per share. The warrants expire between 2025 and 2027.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_WarrantsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_WarrantsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710182796008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent EventsOn October 9, 2020, the Company entered into a lease agreement (the "Lease Agreement") with WPT Land 2 LP (the "Landlord") for an expanded office and laboratory space located in Malvern, Pennsylvania. The Lease Agreement has an expected commencement date in early 2021 and an initial term of seven years. The aggregate estimated base rent payments due over the initial <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF8xNjQ5MjY3NDQ2MzEx_c0cab281-7ade-48be-8c4a-31582fcb7c9d">seven</span> year term of the Lease Agreement is $1.8&#160;million. In addition, the Company will pay its pro rata share of the Landlord's annual operating expenses associated with the premises. The Company has the option to extend the Lease Agreement for one additional <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV8xMTg4L2ZyYWc6N2M5OTMwOWFiYzFkNDY2YzkxZTU4ZTE0MDdmZjg5MjgvdGV4dHJlZ2lvbjo3Yzk5MzA5YWJjMWQ0NjZjOTFlNThlMTQwN2ZmODkyOF8xNjQ5MjY3NDQ2MjU0_e2515411-dba9-46d7-a836-2bb32ea59544">five</span> year term. The Company has an existing lease agreement with the Landlord for the Company's current office space. Provided that the Company is not under an event of default and surrenders the current office space pursuant to the terms of the Lease Agreement and in the condition required by the existing lease agreement, the existing lease agreement will be deemed terminated without penalty to the Company.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710188593208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Consolidation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements included herein have been prepared in conformity with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) and under the rules&#160;and regulations of the United States Securities and Exchange Commission (&#8220;SEC&#8221;) for interim reporting. The accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, that are necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows. The condensed consolidated results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosures of the Company normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted under the SEC&#8217;s rules and regulations. These condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes thereto for the year ended December&#160;31, 2019, included in the Company's 2019 Annual Report.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">The condensed consolidated financial statements include the accounts of Ocugen, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform with current period presentation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing the condensed consolidated financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions primarily include those used in the accounting for clinical trial accruals, warrant transactions, asset held for sale, and the valuation of debt and equity instruments, including embedded derivatives and stock-based compensation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementAccountingPolicy', window );">Collaboration Arrangements</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Arrangements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses whether collaboration agreements are subject to the Financial Accounting Standards Board ("FASB") Accounting Standards Codification (&#8220;ASC&#8221;) Topic 808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 808&#8221;), based on whether they involve joint operating activities and whether both parties have active participation in the arrangement and are exposed to significant risks and rewards. To the extent that the arrangement falls within the scope of ASC 808, the Company assesses whether the payments between the Company and the collaboration partner are subject to other accounting literature. If payments from the collaboration partner represent consideration from a customer, the Company accounts for those payments within the scope of ASC Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 606&#8221;). However, if the Company concludes that its collaboration partner is not a customer, the Company will determine if analogy to other authoritative literature is appropriate. </span></div>In April 2020, the Company entered into a collaboration agreement subject to ASC 808. Under this arrangement, the Company records cost reimbursements received as a reduction of research and development expense in the period incurred and royalty payments received as collaboration revenue in the period in which the underlying sale occurs.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Exit and Disposal Activities</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exit and Disposal Activities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records liabilities for one-time termination benefits in accordance with ASC Topic 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit and Disposal Cost Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 420"). In accordance with ASC 420, an arrangement for one-time termination benefits exists at the date the plan of the termination meets the following criteria: (i) management commits to a plan of termination, (ii) the plan identifies the impacted employees and expected completion date, (iii) the plan identifies the terms of the benefits arrangement, (iv) it is unlikely significant changes to the plan will be made or the plan will be withdrawn and (v) the plan has been communicated to employees. Costs for one-time termination benefits in which the employee is required to render service until termination in order to receive the benefits, are recognized ratably over the future service period. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records liabilities for employee termination benefits covered by ongoing benefit arrangements in accordance with ASC Topic 712, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nonretirement Postemployment Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 712"). In accordance with ASC 712, costs for termination benefits under ongoing benefits arrangements are recognized when management has committed to a plan of termination and the costs are probable and estimable.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Severance-related charges, once incurred, are recognized as either research and development expense or general and administrative expense within the condensed consolidated statements of operations and comprehensive loss depending on the job function of the employee.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_AssetHeldForSalePolicyTextBlock', window );">Asset Held for Sale</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Asset Held for Sale</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An asset is considered to be held for sale when all of the following criteria are met: (i) management commits to a plan to sell the asset; (ii) it is unlikely that the disposal plan will be significantly modified or discontinued; (iii) the asset is available for immediate sale in its present condition; (iv) actions required to complete the sale of the asset have been initiated; (v) sale of the asset is probable and the completed sale is expected to occur within one year; and (vi) the asset is actively being marketed for sale at a price that is reasonable given its current market value.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A long-lived asset classified as held for sale is measured at the lower of its carrying amount or fair value less cost to sell. If the long-lived asset is newly acquired, the carrying amount of the long-lived asset is established based on its fair value less cost to sell at the acquisition date. A long-lived asset is not depreciated or amortized while it is classified as held for sale, and an impairment loss would be recognized to the extent the carrying amount exceeds the asset's fair value less cost to sell.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2019, the Company had an intangible asset held for sale, which it held prior to the Merger. The intangible asset qualified and was recorded as held for sale as of the date of the reverse asset acquisition and was carried at its original fair value less cost to sell of $7.0&#160;million. The Company concluded during the three months ended September 30, 2020, that a sale of the intangible asset held for sale was no longer probable to be completed within one year from the date the intangible asset was initially recorded as held for sale. As such, the carrying value of the intangible asset was reduced to zero with the corresponding charge of $7.0&#160;million recognized as in-process research and development expense during the three and nine months ended September&#160;30, 2020 as the in-process research and development does not have an alternative future use.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company has concluded that a sale of the intangible asset is no longer probable to be completed within one year from the date the intangible asset was initially recorded as held for sale, the Company is party to an Asset Purchase Agreement </span></div>(as defined within Note 3) related to the intangible asset as of September&#160;30, 2020, and continues to market the asset for sale. In the event of a sale of the intangible asset under the Asset Purchase Agreement or to another party, the Company will account for the sale in the period in which the sale occurs.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company follows the provisions of the ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 820&#8221;), which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair measurements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of certain financial instruments, including cash and cash equivalents, accounts payable, and accrued expenses approximates their fair values due to the short-term nature of these instruments. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8212; quoted prices in active markets for identical assets or liabilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 &#8212; quoted prices for similar assets and liabilities in active markets or inputs that are observable</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 &#8212; inputs that are unobservable (for example cash flow modeling inputs based on assumptions)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had derivative instruments that were fair valued on a recurring basis using Level 3 inputs during the three and nine months ended September&#160;30, 2019. There were no derivative instruments fair valued on a recurring basis using Level 3 inputs during the three and nine months ended September&#160;30, 2020. As of September&#160;30, 2020, the Company estimates the fair value of the note with EB5 Life Sciences, L.P. was $1.0&#160;million using Level 2 inputs. As of September&#160;30, 2020, the Company believes the fair values using Level 2 inputs of both the Warrant Exchange Promissory Notes (as defined in Note 9) and the loan received under the PPP of the CARES Act (as defined in Note 9) approximate their carrying values. See Note 9 for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments that have maturities of three months or less when acquired to be cash equivalents. Cash and cash equivalents include bank demand deposits, marketable securities with maturities of three months or less at purchase, and money market funds that invest primarily in certificates of deposit, commercial paper and United States government and United States government agency obligations. The Company&#8217;s restricted cash balance consists of cash held to collateralize a corporate credit card account.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys to the Company the right to control the use of an explicitly or implicitly identified fixed asset for a period of time in exchange for consideration. Control of an underlying asset is conveyed to the Company if the Company obtains the rights to direct the use of and to obtain substantially all of the economic benefits from using the underlying asset. The Company has lease agreements which include lease and&#160;non-lease&#160;components, which the Company has elected to account for as a single lease component for all classes of underlying assets. Lease expense for variable lease components are recognized when the obligation is probable.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in other assets and lease obligations on the Company&#8217;s condensed consolidated balance sheets. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease payments are recognized as lease expense on a straight-line basis over the lease term. The Company primarily leases real estate, and leases for real estate are classified as operating leases. ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 842") requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As an implicit interest rate is not readily determinable in the Company&#8217;s leases, the incremental borrowing rate is used based on the information available at commencement date in determining the present value of lease payments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease term for all of the Company&#8217;s leases includes the&#160;non-cancellable&#160;period of the lease plus any additional periods covered by either a Company option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Options for lease renewals have been excluded from the lease term (and lease liability) for the majority of the Company&#8217;s leases as the reasonably certain threshold is not met.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease payments included in the measurement of the lease liability are comprised of fixed payments, variable payments that depend on index or rate, and amounts probable to be payable under the exercise of the Company option to purchase the underlying asset if reasonably certain.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease payments not dependent on a rate or index associated with the Company&#8217;s leases are recognized when the event, activity, or circumstance in the lease agreement on which those payments are assessed as probable. Variable lease payments include the Company's proportionate share of utilities and other operating expenses and are presented as operating expenses in the Company&#8217;s condensed consolidated statements of operations and comprehensive loss in the same line item as expense arising from fixed lease payments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based compensation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its stock-based compensation awards in accordance with ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation&#8212;Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 718&#8221;). ASC 718 requires all stock-based payments to employees, including grants of employee stock options and restricted stock units and modifications to existing agreements, to be recognized in the condensed consolidated statements of operations and comprehensive loss based on their fair values. The Company uses the Black-Scholes option-pricing model to determine the fair value of options granted. The Company recognizes forfeitures as they occur.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock-based awards are subject to service-based vesting conditions. Compensation expense related to awards to employees and directors with service-based vesting conditions is recognized on a straight-line basis based on the grant date fair value over the associated service period of the award, which is generally the vesting term. Stock-based awards generally vest over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2MTk_eb512e86-ca54-4b51-8e50-01fc17d11c9f">one</span> to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM0Yjg4NzcwZWJmMzRmNWI5ZmY0NDQ0YzNmY2Y0MDZhL3NlYzpjNGI4ODc3MGViZjM0ZjViOWZmNDQ0NGMzZmNmNDA2YV80MC9mcmFnOjEzM2M0NGFjMGYwMDQyZTY5ZjNiYjRkYTY5ZDI0ZTY5L3RleHRyZWdpb246MTMzYzQ0YWMwZjAwNDJlNjlmM2JiNGRhNjlkMjRlNjlfMTM2MjU_8897e6c7-9303-4adc-88de-47d481ae6e6d">three</span> year requisite service period and have a contractual term of 10 years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimating the fair value of options requires the input of subjective assumptions, including expected life of the option, stock price volatility, the risk-free interest rate and expected dividends. The assumptions used in the Company&#8217;s Black-Scholes option-pricing model represent management&#8217;s best estimates and involve a number of variables, uncertainties and assumptions and the application of management&#8217;s judgment, as they are inherently subjective. If any assumptions change, the Company&#8217;s stock-based compensation expense could be materially different in the future.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Standards and Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued Accounting Standards Update ("ASU") No. 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework&#8212;Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard modifies certain disclosure requirements on fair value measurements and was effective for the Company on January 1, 2020. The adoption of this standard did not have a material impact on the Company's disclosures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, the FASB issued ASU No. 2018-18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under ASC 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In those situations, ASC 606 guidance should be applied, including recognition, measurement, presentation and disclosure requirements. The standard adds unit-of-account guidance to ASC 808 to align with the guidance in ASC 606 when an entity is assessing whether the collaborative arrangement or a part of the collaborative arrangement is within the scope of ASC 606. The standard also precludes a company from presenting transactions with collaborative arrangement participants that are not directly related to sales to third parties with revenue from contracts with customers recognized under ASC 606 if the collaborative arrangement participant is not a customer. This standard was effective for the Company on </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 1, 2020. Consistent with the guidance in this standard, the Company assesses whether collaboration arrangements are within the scope of ASC 606. For collaboration arrangements that are not within the scope of ASC 606, applicable transactions with collaborative arrangement participants are presented as collaboration revenue rather than revenue from contracts with customers. See above and Note 5 for additional information.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The FASB subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date of January 1, 2023. These standards require that credit losses be reported using an expected losses model rather than the incurred losses model that is currently used, and establishes additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, these standards now require allowances to be recorded instead of reducing the amortized cost of the investment. These standards limit the amount of credit losses to be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The Company does not currently expect the adoption of these standards to have a material impact on its condensed consolidated financial statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This standard will have an effective date and transition date of January 1, 2021. This standard removes certain exceptions for recognizing deferred taxes for investments, performing intraperiod allocations and calculating income taxes in interim periods. This standard also adds guidance to reduce complexity in certain areas, including recognizing franchise tax, recognizing deferred taxes for tax goodwill, allocating taxes to the members of a consolidated group and recognizing the effect of enacted changes in tax laws or rates during an interim period. The Company does not currently expect the adoption of this standard to have a material impact on its condensed consolidated financial statements.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity's Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard will have an effective and transition date of January 1, 2024. Early adoption is permitted beginning January 1, 2021. This standard simplifies an issuer's accounting for convertible instruments by eliminating two of the three models in ASC 470-20 that require separate accounting for embedded conversion features as well as simplifies the settlement assessment that entities are required to perform to determine whether a contract qualifies for equity classification. This standard also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of potential share settlement (if the effect is more dilutive) for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. The standard requires new disclosures about events that occur during the reporting period and cause conversion contingencies to be met and about the fair value of a public business entity's convertible debt at the instrument level, among other things. The Company does not currently expect the adoption of this standard to have a material impact on its condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_AssetHeldForSalePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents asset held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_AssetHeldForSalePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710182882056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock', window );">Schedule of Cash, Cash Equivalents, and Restricted Cash</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents, and restricted cash in the condensed consolidated balance sheets to the total amount shown in the condensed consolidated statements of cash flows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,105,830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,301,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,257,026&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,451,992&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents, restricted cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710182820408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share of Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share for the three and nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss&#8212;basic and diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,473,847)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,773,281)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,031,641)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,624,697)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividend related to Warrant Exchange (Note 12)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,546,340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,473,847)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,773,281)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,577,981)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,624,697)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in calculating net loss per common share&#8212;basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,591,218&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,411,308&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,764,157&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,839,840&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share&#8212;basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.55)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.59)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Potentially Dilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding, as their inclusion would have been antidilutive:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,268,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,268,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,771,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,771,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Warrants (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,007,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,007,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,138,294&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,150,339&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,138,294&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,150,339&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Series B Warrants do not include the additional Series B Warrants that were contingent upon the reset pricing as discussed in Note 12.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710186035960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued Expenses are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research&#160;and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333,733&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270,045&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) See Note 7 for additional information regarding severance-related accrued expenses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710182858984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Exit and Disposal Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Severance-Related Charges</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table outlines the components of the severance-related charges:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Severance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance-related payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Severance at September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888,096&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710184245384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the carrying values for the components of debt as reflected on the condensed consolidated balance sheets:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP Note</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant Exchange Promissory Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EB-5 Loan Agreement borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value of debt, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,155,041&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072,123&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the Warrant Exchange Promissory Notes at September&#160;30, 2020 and December&#160;31, 2019 are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt discount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145,732)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116,997&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the EB-5 Loan Agreement borrowings as of September&#160;30, 2020 and December&#160;31, 2019 are summarized below:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,616,629&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072,123&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Principal, Embedded Derivatives and Carrying Value of Debts</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At issuance, the following amounts were recorded:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Convertible Note&#160;Issuance&#160;Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Convertible Note<br/>Principal<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value of Embedded Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debt<br/>Issuance<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Value upon Issuance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,657,711)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,969)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,306,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(724,216)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,857)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,310)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182,882)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302,379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,875)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,750,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,891,172)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189,158)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,670,070&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Debt Maturities (Excluding Interest)</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt maturities (excluding interest) are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:18.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.343%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve months ending September 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Maturities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,184,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710182839288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-based Compensation Expense for Options Granted Reflected in the Consolidate Statement of Operations and Comprehensive Loss</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for options granted is reflected in the condensed consolidated statements of operations and comprehensive loss as follows:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,621&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,290&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,005&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498,012&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720,014&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the stock option activity under the Plans:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,028&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,064,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(527,862)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September&#160;30, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,268,277&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.94&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,072&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at September&#160;30, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.34&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710186082328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of components of lease expense</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.449%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,947&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,865&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,980&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,362&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,828&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock', window );">Schedule of supplemental balance sheet information related to leases</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,554&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental cash flow information</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease terms&#8212;operating leases (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate&#8212;operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of maturities of operating leases</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum operating minimum lease payments for all leases, exclusive of taxes and other carrying charges, are approximately as follows:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,319&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: present value adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,554&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of maturities of finance leases</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for all financing leases, exclusive of taxes and other carrying charges, are approximately as follows:</span></div><div style="margin-bottom:18pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,964&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: present value adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,461&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of balance sheet information related to leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710188368072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock', window );">Schedule of Roll-forward of Series B Warrant Liability</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a roll-forward of the Series B Warrant liability:</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at issuance - September 27, 2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,387,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of embedded derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,577,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,964,986&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of embedded derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,709,246)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified to equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,255,740)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710185737656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>clinical_trial</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>segment </div>
<div>orphan_drug_designation</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Nature of Business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_NumberOfOrphanDrugDesignations', window );">Number of ODDs received (orphan drug designation) | orphan_drug_designation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Nature of Business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture', window );">Number of clinical trials to be initiated in the future | clinical_trial</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Clinical Trials To Be Initiated In The Future</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_NumberOfOrphanDrugDesignations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Orphan Drug Designations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_NumberOfOrphanDrugDesignations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710184131640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business - Reverse Stock Split (Details) - Histogenics<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Nature of Business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_BusinessCombinationIssuedSharesExchangeRate', window );">Shares issued exchange rate to former Ocugen's stockholders (in USD per share)</a></td>
<td class="nump">0.4794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock split, conversion ratio</a></td>
<td class="nump">0.0167<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_BusinessCombinationIssuedSharesExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exchange rate of share issued to shares surrendered by stockholder of the acquired entity in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_BusinessCombinationIssuedSharesExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ocgn_HistogenicsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ocgn_HistogenicsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710186094744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business - Going Concern (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (10,473,847)<span></span>
</td>
<td class="num">$ (3,613,975)<span></span>
</td>
<td class="num">$ (3,943,819)<span></span>
</td>
<td class="num">$ (22,773,281)<span></span>
</td>
<td class="num">$ (3,538,810)<span></span>
</td>
<td class="num">$ (6,312,606)<span></span>
</td>
<td class="num">$ (18,031,641)<span></span>
</td>
<td class="num">$ (32,624,697)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">69,511,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,511,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,479,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 19,257,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,451,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,257,026<span></span>
</td>
<td class="nump">$ 15,451,992<span></span>
</td>
<td class="nump">$ 7,595,068<span></span>
</td>
<td class="nump">$ 1,778,613<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710269174760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>RECENT ACCOUNTING PRONOUNCEMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent', window );">Asset held for sale less cost to sell</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment charge</a></td>
<td class="nump">7,000,000.0<span></span>
</td>
<td class="nump">$ 7,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_EB5ProgramBorrowingsMember', window );">EB-5 Loan | Loans payable | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>RECENT ACCOUNTING PRONOUNCEMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditFairValueDisclosure', window );">Lines of credit</a></td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>RECENT ACCOUNTING PRONOUNCEMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>RECENT ACCOUNTING PRONOUNCEMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121558832&amp;loc=d3e400-110220<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_EB5ProgramBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_EB5ProgramBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710189423128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 19,105,830<span></span>
</td>
<td class="nump">$ 7,444,052<span></span>
</td>
<td class="nump">$ 15,301,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">151,196<span></span>
</td>
<td class="nump">151,016<span></span>
</td>
<td class="nump">150,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 19,257,026<span></span>
</td>
<td class="nump">$ 7,595,068<span></span>
</td>
<td class="nump">$ 15,451,992<span></span>
</td>
<td class="nump">$ 1,778,613<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710189491912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Merger and Financing (Details)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 04, 2019 </div>
<div>USD ($) </div>
<div>series </div>
<div>shares</div>
</th>
<th class="th">
<div>May 08, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ReverseMergerAndFinancingDisclosureLineItems', window );"><strong>Reverse Merger and Financing</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_NumberOfSeriesOfWarrantsIssued', window );">Number of series of warrants issued | series</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ocgn_HistogenicsCorporationMember', window );">Histogenics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ReverseMergerAndFinancingDisclosureLineItems', window );"><strong>Reverse Merger and Financing</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_AssetPurchaseAgreementCashConsideration', window );">Asset purchase agreement, cash consideration</a></td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth', window );">Percentage of increase in purchase price of asset per month (in percentage)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=ocgn_HistogenicsCorporationMember', window );">Histogenics | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ReverseMergerAndFinancingDisclosureLineItems', window );"><strong>Reverse Merger and Financing</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure', window );">Quoted price of assets held for sale of NeoCart</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ocgn_SecuritiesPurchaseAgreementMember', window );">Financing SPA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ReverseMergerAndFinancingDisclosureLineItems', window );"><strong>Reverse Merger and Financing</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_AssetPurchaseAgreementCashConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash consideration agreed under the asset purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_AssetPurchaseAgreementCashConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_NumberOfSeriesOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Series Of Warrants Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_NumberOfSeriesOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of asset purchase agreement that the purchase price increases per month between October 31, 2019 and the closing date if agreement is not terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_ReverseMergerAndFinancingDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_ReverseMergerAndFinancingDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock And Issuance Of Warrants, Consideration Received Per Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of assets classified as held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ocgn_HistogenicsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ocgn_HistogenicsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ocgn_HistogenicsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ocgn_HistogenicsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ocgn_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ocgn_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710175354712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share of Common Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Earnings Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss&#8212;basic and diluted</a></td>
<td class="num">$ (10,473,847)<span></span>
</td>
<td class="num">$ (3,613,975)<span></span>
</td>
<td class="num">$ (3,943,819)<span></span>
</td>
<td class="num">$ (22,773,281)<span></span>
</td>
<td class="num">$ (3,538,810)<span></span>
</td>
<td class="num">$ (6,312,606)<span></span>
</td>
<td class="num">$ (18,031,641)<span></span>
</td>
<td class="num">$ (32,624,697)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsAndOtherAdjustments', window );">Deemed dividend related to Warrant Exchange (Note 12)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,546,340)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss to common stockholders</a></td>
<td class="num">$ (10,473,847)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (22,773,281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30,577,981)<span></span>
</td>
<td class="num">$ (32,624,697)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares used in calculating net loss per common share&#8212;basic and diluted (in shares)</a></td>
<td class="nump">141,591,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,411,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,764,157<span></span>
</td>
<td class="nump">5,839,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share of common share - basic and diluted (in USD per share)</a></td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3.55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (5.59)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Potentially dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding excluded from the computation of diluted weighted average shares outstanding</a></td>
<td class="nump">5,138,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,150,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,138,294<span></span>
</td>
<td class="nump">68,150,339<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Potentially dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding excluded from the computation of diluted weighted average shares outstanding</a></td>
<td class="nump">4,268,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,268,277<span></span>
</td>
<td class="nump">500,933<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Potentially dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding excluded from the computation of diluted weighted average shares outstanding</a></td>
<td class="nump">870,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">870,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">870,017<span></span>
</td>
<td class="nump">870,017<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants | Series A Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Potentially dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding excluded from the computation of diluted weighted average shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,771,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,771,928<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants | Series B Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Potentially dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding excluded from the computation of diluted weighted average shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,007,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,007,461<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants | Series C Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Potentially dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding excluded from the computation of diluted weighted average shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsAndOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsAndOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesCWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesCWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710185889080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer', window );">Collaboration revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 42,620<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Advaite Agreement | Advaite</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense', window );">Reduction of research and development expense</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer', window );">Collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, At-Cost Reimbursement Recorded As Reduction In Research And Development Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118644919&amp;loc=SL5834089-161433<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ocgn_AdvaiteIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ocgn_AdvaiteIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710276942296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ResearchAndDevelopmentExpensesCurrent', window );">Research&#160;and development</a></td>
<td class="nump">$ 177,802<span></span>
</td>
<td class="nump">$ 271,322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_AccruedLiabilitiesClinical', window );">Clinical</a></td>
<td class="nump">125,463<span></span>
</td>
<td class="nump">421,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_AccruedLiabilitiesProfessionalFees', window );">Professional fees</a></td>
<td class="nump">396,914<span></span>
</td>
<td class="nump">917,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee-related</a></td>
<td class="nump">688,251<span></span>
</td>
<td class="nump">624,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent', window );">Severance-related</a></td>
<td class="nump">888,096<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">57,207<span></span>
</td>
<td class="nump">34,947<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 2,333,733<span></span>
</td>
<td class="nump">$ 2,270,045<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_AccruedLiabilitiesClinical">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Liabilities, Clinical</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_AccruedLiabilitiesClinical</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_AccruedLiabilitiesProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Liabilities, Professional Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_AccruedLiabilitiesProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_AccruedSeveranceRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Severance-Related Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_AccruedSeveranceRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_ResearchAndDevelopmentExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_ResearchAndDevelopmentExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710275099240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Exit and Disposal Activities - Narrative (Details) - Severance-related charges<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 15, 2020 </div>
<div>employee</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Number of employees given notice of termination | employee</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent', window );">Workforce reduction as a result of terminations (as a percent)</a></td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Severance-related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 1,093,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Severance-related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Severance-related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected severance benefits to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a result of restructuring activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the total number of positions eliminated as of the balance sheet date since inception of the restructuring plan(s).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710189425496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Exit and Disposal Activities - Schedule of Severance-Related Charges (Details) - Severance-related charges - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Accrued Severance, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Severance-related charges</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">1,093,255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Severance-related payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(205,159)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Accrued Severance, ending balance</a></td>
<td class="nump">$ 888,096<span></span>
</td>
<td class="nump">$ 888,096<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710268992632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 06, 2020</div></th>
<th class="th"><div>Apr. 05, 2019</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Apr. 22, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ocgn_ControlledEquityOfferingSalesAgreementMember', window );">ATMs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,000,000.0<span></span>
</td>
<td class="nump">24,800,000<span></span>
</td>
<td class="nump">34,400,000<span></span>
</td>
<td class="nump">27,000,000.0<span></span>
</td>
<td class="nump">86,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,100,000<span></span>
</td>
<td class="nump">$ 25,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Commissions, fees and expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity', window );">Number of shares outstanding, remaining capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,500,000<span></span>
</td>
<td class="nump">19,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ocgn_SubscriptionAgreementsMember', window );">Subscription Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscribedButUnissued', window );">Number of shares sold in subscription agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable', window );">Aggregate offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock', window );">Accredited investors agreement to cancel outstanding obligation</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock', window );">Accredited investors agreement to cancel additional portion owed representing a discount</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Additional Debt Cancelled In Exchange For Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Number of Shares Outstanding, Remaining Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Outstanding Obligation Cancelled In Exchange For Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of subscription receivable from investors who have been allocated common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesSubscribedButUnissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesSubscribedButUnissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ocgn_ControlledEquityOfferingSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ocgn_ControlledEquityOfferingSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ocgn_SubscriptionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ocgn_SubscriptionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710189178328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - PPP Note (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total carrying value of debt, net</a></td>
<td class="nump">$ 3,155,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,072,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_PaycheckProtectionProgramLoanMember', window );">PPP Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total carrying value of debt, net</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_PaycheckProtectionProgramLoanMember', window );">PPP Note | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total carrying value of debt, net</a></td>
<td class="nump">421,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_WarrantExchangePromissoryNotesMember', window );">Warrant Exchange Promissory Notes | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total carrying value of debt, net</a></td>
<td class="nump">1,116,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_EB5ProgramBorrowingsMember', window );">EB-5 Loan Agreement borrowings | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total carrying value of debt, net</a></td>
<td class="nump">$ 1,616,629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,072,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_PaycheckProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_PaycheckProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_WarrantExchangePromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_WarrantExchangePromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_EB5ProgramBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_EB5ProgramBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710189188792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Warrant Exchange Promissory Notes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 06, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Apr. 22, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,184,144<span></span>
</td>
<td class="nump">$ 3,184,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value upon Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,155,041<span></span>
</td>
<td class="nump">3,155,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,072,123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_WarrantExchangePromissoryNotesMember', window );">Warrant Exchange Promissory Notes | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,262,729<span></span>
</td>
<td class="nump">1,262,729<span></span>
</td>
<td class="nump">$ 5,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Payments to note holders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200,000<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Less: unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(145,732)<span></span>
</td>
<td class="num">(145,732)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value upon Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,116,997<span></span>
</td>
<td class="nump">$ 1,116,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_WarrantExchangePromissoryNotesMember', window );">Warrant Exchange Promissory Notes | Notes payable | Subsequent events</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Payments to note holders</a></td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_WarrantExchangePromissoryNotesMember', window );">Warrant Exchange Promissory Notes | Notes payable | Period one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction', window );">Percentage of principal amount required to be redeemed - financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_WarrantExchangePromissoryNotesMember', window );">Warrant Exchange Promissory Notes | Notes payable | Period two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction', window );">Percentage of principal amount required to be redeemed - financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Percentage of Principal Amount Required To Be Redeemed Upon Financing Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_WarrantExchangePromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_WarrantExchangePromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710269354840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - EB 5 Loan Agreement Borrowings (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 26, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,184,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,155,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,072,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_EB5ProgramBorrowingsMember', window );">EB-5 Loan | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing</a></td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_LineOfCreditBorrowingEachDraw', window );">Borrowing increments</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Company borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Plus: accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Less: unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49,424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,654)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,616,629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,072,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_LineOfCreditBorrowingEachDraw">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of borrowing that can be borrowed each draw from a line of credit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_LineOfCreditBorrowingEachDraw</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_EB5ProgramBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_EB5ProgramBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710269059064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Senior Secured Convertible Notes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 27, 2019</div></th>
<th class="th"><div>Jun. 28, 2019</div></th>
<th class="th"><div>May 21, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">$ 291,909<span></span>
</td>
<td class="nump">$ 796,141<span></span>
</td>
<td class="nump">$ 554,801<span></span>
</td>
<td class="nump">$ 1,753,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_SeniorSecuredConvertibleNotesMay2019Member', window );">May 2019 Senior Secured Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_SeniorSecuredConvertibleNotesJune2019Member', window );">June 2019 Senior Secured Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_SeniorSecuredConvertibleNotesMember', window );">Senior Secured Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_SeniorSecuredConvertibleNotesMay2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_SeniorSecuredConvertibleNotesMay2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_SeniorSecuredConvertibleNotesJune2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_SeniorSecuredConvertibleNotesJune2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_SeniorSecuredConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_SeniorSecuredConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710188333736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Convertible Promissory Note (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th"><div>May 16, 2019</div></th>
<th class="th"><div>Apr. 05, 2019</div></th>
<th class="th"><div>Apr. 04, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement', window );">Common stock, shares agreed to be sold</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in USD per share)</a></td>
<td class="nump">$ 12.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Increase in additional paid-in capital from conversion</a></td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">$ 13,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertiblePromissoryNotesMember', window );">Convertible Promissory Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Shares Agreed To Be Sold, Stock Subscription Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e34017-109320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertiblePromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_ConvertiblePromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710174637096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Convertible Notes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 16, 2019</div></th>
<th class="th"><div>Apr. 05, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Jan. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jan. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value upon Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,155,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,155,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,072,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,147,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,147,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,746,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Increase in additional paid-in capital from conversion</a></td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">$ 13,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount', window );">Conversion price discount per original agreement (in a percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount', window );">Conversion price discount per original agreement (in a percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible Note Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,750,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Note principal outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(189,158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value upon Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,670,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Maturity term (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_DebtRedemptionMultipleFeature', window );">Redemption multiple upon default</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Accretion of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes | Fair Value of Embedded Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair Value of Embedded Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,891,172)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleNotesBoardOfDirectorsMember', window );">Convertible Notes - Board Of Directors | Board members | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible Note Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtJanuary2018Member', window );">January 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible Note Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,969)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value upon Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,306,320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtJanuary2018Member', window );">January 2018 | Fair Value of Embedded Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair Value of Embedded Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,657,711)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtJune2018Member', window );">June 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible Note Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value upon Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtJune2018Member', window );">June 2018 | Fair Value of Embedded Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair Value of Embedded Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (724,216)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtNovember2018Member', window );">November 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible Note Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,150,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,646)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value upon Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,078,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtNovember2018Member', window );">November 2018 | Fair Value of Embedded Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair Value of Embedded Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (21,127)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtDecember2018Member', window );">December 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible Note Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,310)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value upon Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtDecember2018Member', window );">December 2018 | Fair Value of Embedded Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair Value of Embedded Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,857)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtJanuary2019Member', window );">January 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible Note Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value upon Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtJanuary2019Member', window );">January 2019 | Fair Value of Embedded Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair Value of Embedded Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (182,882)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtFebruary2019Member', window );">February 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible Note Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,875)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value upon Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtFebruary2019Member', window );">February 2019 | Fair Value of Embedded Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair Value of Embedded Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (302,379)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_November2018AndDecember2018NotesMember', window );">November&#160;2018 and December 2018 Notes | Convertible Notes | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount', window );">Conversion price discount per original agreement (in a percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ocgn_January2019AndFebruary2019NotesMember', window );">January&#160;2019 and February&#160;2019 Notes | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount', window );">Conversion price discount per original agreement (in a percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of discount of the convertible debt that automatically convert the same class of equity as those issued to the lowest price per share being paid by investors in the equity financing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_DebtRedemptionMultipleFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redemption multiple of debt's principal and unpaid interest upon consummation of the sale of all or substantially all of the assets of the Company, change in control or event of default</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_DebtRedemptionMultipleFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e34017-109320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ocgn_ConvertibleDebtConversionFeatureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ocgn_ConvertibleDebtConversionFeatureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleNotesBoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_ConvertibleNotesBoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtJanuary2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtJanuary2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtJune2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtJune2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtNovember2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtNovember2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtDecember2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtDecember2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtJanuary2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtJanuary2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtFebruary2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_ConvertibleDebtFebruary2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_November2018AndDecember2018NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_November2018AndDecember2018NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ocgn_January2019AndFebruary2019NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ocgn_January2019AndFebruary2019NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710182559416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Debt Maturities (Excluding Interest) (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2021</a></td>
<td class="nump">$ 1,356,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">327,767<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">$ 3,184,144<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_LongTermDebtMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_LongTermDebtMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710189386728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Schedule of Compensation Expense for Options Granted (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 126,290<span></span>
</td>
<td class="nump">$ 193,005<span></span>
</td>
<td class="nump">$ 498,012<span></span>
</td>
<td class="nump">$ 720,014<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">100,903<span></span>
</td>
<td class="nump">48,226<span></span>
</td>
<td class="nump">248,942<span></span>
</td>
<td class="nump">298,621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 25,387<span></span>
</td>
<td class="nump">$ 144,779<span></span>
</td>
<td class="nump">$ 249,070<span></span>
</td>
<td class="nump">$ 421,393<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710181178040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>segment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>segment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense | $</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_NumberOfEquityCompensationPlans', window );">Number of equity compensation plans | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage', window );">Automatic increase in shares to be issued (in percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options, grants in period, weighted average grant date fair value (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ocgn_A2014PlanMember', window );">2014 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ocgn_A2019PlanMember', window );">2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="nump">4,200,000<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, beginning balance (in shares)</a></td>
<td class="nump">4,268,277<span></span>
</td>
<td class="nump">4,268,277<span></span>
</td>
<td class="nump">731,189<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based payment arrangement, option | 2014 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, beginning balance (in shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based payment arrangement, option | 2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, beginning balance (in shares)</a></td>
<td class="nump">3,800,000<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense related to options outstanding, weighted average period for expense to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_NumberOfEquityCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Equity Compensation Plans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_NumberOfEquityCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Automatic Increase In Shares To Be Issue, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ocgn_A2014PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ocgn_A2014PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ocgn_A2019PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ocgn_A2019PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ocgn_A2014PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ocgn_A2014PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ocgn_A2019PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ocgn_A2019PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710189122664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Schedule Options to Purchase Common Stock (Details) - 2019 Plan - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares, options outstanding, beginning balance (in shares)</a></td>
<td class="nump">731,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">4,064,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(527,862)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares, options outstanding, ending balance (in shares)</a></td>
<td class="nump">4,268,277<span></span>
</td>
<td class="nump">731,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable (in shares)</a></td>
<td class="nump">450,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance, weighted average exercise price (in USD per share)</a></td>
<td class="nump">$ 4.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, granted (in USD per share)</a></td>
<td class="nump">0.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, cancelled (in USD per share)</a></td>
<td class="nump">1.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance, weighted average exercise price (in USD per share)</a></td>
<td class="nump">0.94<span></span>
</td>
<td class="nump">$ 4.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, options exercisable (in USD per share)</a></td>
<td class="nump">$ 4.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Beginning balance, weighted average remaining contractual life</a></td>
<td class="text">9 years 1 month 6 days<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life, options exercisable</a></td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, beginning balance</a></td>
<td class="nump">$ 24,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, ending balance</a></td>
<td class="nump">7,072<span></span>
</td>
<td class="nump">$ 24,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, options exercisable</a></td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ocgn_A2019PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ocgn_A2019PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710268873208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments - Additional Information (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Leases, term of contract (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:OtherLiabilities<span></span>
</td>
<td class="text">us-gaap:OtherLiabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDiscountRate', window );">Interest rate (as a percent)</a></td>
<td class="nump">7.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Leases, term of contract (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Leases, term of contract (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of finance lease payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710188899720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments - Operating leases, components of lease expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 47,696<span></span>
</td>
<td class="nump">$ 47,696<span></span>
</td>
<td class="nump">$ 142,947<span></span>
</td>
<td class="nump">$ 202,665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">21,169<span></span>
</td>
<td class="nump">21,284<span></span>
</td>
<td class="nump">62,415<span></span>
</td>
<td class="nump">58,163<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 68,865<span></span>
</td>
<td class="nump">$ 68,980<span></span>
</td>
<td class="nump">$ 205,362<span></span>
</td>
<td class="nump">$ 260,828<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710188307832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments - Operating leases, supplemental balance sheet information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, net</a></td>
<td class="nump">$ 217,508<span></span>
</td>
<td class="nump">$ 344,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current lease obligations</a></td>
<td class="nump">164,808<span></span>
</td>
<td class="nump">172,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current lease obligations</a></td>
<td class="nump">42,746<span></span>
</td>
<td class="nump">163,198<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 207,554<span></span>
</td>
<td class="nump">$ 335,508<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710184179128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments - Operating leases, supplemental cash flow information (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease terms&#8212;operating leases (years)</a></td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate&#8212;operating leases (in percentage)</a></td>
<td class="nump">7.60%<span></span>
</td>
<td class="nump">7.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710188718120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments - Operating leases, future minimum lease payments (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2020</a></td>
<td class="nump">$ 48,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">160,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">11,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">220,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: present value adjustment</a></td>
<td class="num">(12,765)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 207,554<span></span>
</td>
<td class="nump">$ 335,508<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710188909496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments - Finance leases, future minimum lease payments (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2020</a></td>
<td class="nump">$ 5,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">9,941<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">15,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: present value adjustment</a></td>
<td class="num">(444)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of minimum lease payments</a></td>
<td class="nump">$ 15,461<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710186260296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Additional Information (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 22, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 27, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>employee</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 05, 2019 </div>
<div>shares</div>
</th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Price Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants fair value estimate volatility (in percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.970<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ocgn_WarrantsExchangedForCommonStockMember', window );">Warrant Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock exchanged for Series A Warrants (in shares)</a></td>
<td class="nump">21,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrants | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesAWarrantsMember', window );">Series A Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Initial exercise price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 7.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding, term</a></td>
<td class="text">60 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common shares in to which the warrants are exercisable (in shares)</a></td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants', window );">Fair value of consideration transferred to settle warrants | $</a></td>
<td class="nump">$ 13.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock', window );">Consideration transferred, common stock | $</a></td>
<td class="nump">8.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote', window );">Consideration transferred, Warrant Exchange Promissory Notes | $</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue', window );">Fair value of consideration transferred to settle warrants in excess of fair value of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesBWarrantsMember', window );">Series B Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Initial exercise price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common shares in to which the warrants are exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered', window );">Warrants, exercise price determination, number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesCWarrantsMember', window );">Series C Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Initial exercise price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common shares in to which the warrants are exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice', window );">Price over which trading price of common stock as quoted on the Nasdaq Capital Market was considered for the release of converted additional shares (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesCWarrantsMember', window );">Series C Warrants | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of common shares in to which the warrants are exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ocgn_FormerOcugenWarrantsMember', window );">Former Ocugen Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Initial exercise price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.67<span></span>
</td>
<td class="nump">$ 5.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction', window );">Number of employees issued warrants | employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_ClassOfWarrantOrRightExercisable', window );">Class of warrant or right, exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Consideration Transferred In Excess Of Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_ClassOfWarrantOrRightExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Exercisable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_ClassOfWarrantOrRightExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of trading days considered for determination of exercise price of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants, Common Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants, Promissory Note</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Number Of Employees Issued Stock In Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price over which 80% of the arithmetic average of the two lowest dollar volume-weighted average prices of a share of common stock on the NASDAQ Capital Market during the applicable Reset Period immediately preceding the applicable Reset Date to date to release converted additional shares is determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ocgn_WarrantsExchangedForCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ocgn_WarrantsExchangedForCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesCWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesCWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ocgn_FormerOcugenWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ocgn_FormerOcugenWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710182604488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Schedule of Roll-forward of Series&#160;B Warrant Liability (Details) - Series B Warrants - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward', window );"><strong>Reconciliation of Series B Warrant liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Balance at beginning of period</a></td>
<td class="nump">$ 27,964,986<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues', window );">Fair value at issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,387,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease', window );">Change in fair value of embedded derivatives</a></td>
<td class="num">(16,709,246)<span></span>
</td>
<td class="nump">18,577,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity', window );">Amount reclassified to equity</a></td>
<td class="num">(11,255,740)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Balance at end of period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 27,964,986<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Amount Reclassified To Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ocgn_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139710188875096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details)<br></strong></div></th>
<th class="th">
<div>Oct. 09, 2020 </div>
<div>USD ($) </div>
<div>numberOfRenewalOptions</div>
</th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Leases, term of contract (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent events</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Leases, term of contract (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_OperatingLeaseTotalBasePayments', window );">Base payments | $</a></td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions', window );">Number of renewal options | numberOfRenewalOptions</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_LesseeOperatingLeaseNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Renewal Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_LesseeOperatingLeaseNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ocgn_OperatingLeaseTotalBasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Total Base Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ocgn_OperatingLeaseTotalBasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ocgn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>71
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M<ZBA2LDE<>AOB]_)G/N9@FS58N%*GHQC,,6YEO[+"4F8(J\LRCCYU3ZU'9+
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M^#$$9Q/$,94QEB1"R3GX"KX &XA8G8JN+94.'<V.RIQ714ZX)V>(LP9H.A<
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M./#5]=8@B8>IC]6TU[GT'!P$KJ=$0(,,?)]2KR\$!]($&T/PF4/6+PJ>[<+
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ME9!#FUS4CZSW=_<OJ6ZK5S/*_3M\.<::^Q-\&=:OH%KW]1NQAZA8)GF)4K:
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MX?'UC *[EV[SBA#3<N7C?M]E"9&?98FGYZ(#V6B8;+>KE2C:^E$,&P#QL[M
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MW+0?UX(OA3(&\/M*0HKL+\P-^M/LJ_\!4$L#!!0    ( "5 9E%P XL&Z T
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M">HM_SHA?@FVY5\$K&T(MN&/E9(8,6@![A<63)J^T ;#3T3>_@]02P,$%
M  @ )4!F4>J#,(1N&P  )5<  !@   !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6S-/&MOV\:6?X7P%EL;D&59SCMI ,=-MKEH&R-N[OVPV \C<B1-0G)4#FE9
M_?5[7O,@)=INT7T 16-)G#-GSOLU?+.US3>WUKK-[JJR=C\<K=MV\^KLS.5K
M72DWM1M=PR]+VU2JA8_-ZLQM&JT*6E259_/9[-E9I4Q]]/8-?7?=O'UCN[8T
MM;YN,M=5E6IV[W1IMS\<G1_Y+SZ;U;K%+\[>OMFHE;[1[9?-=0.?S@*4PE2Z
M=L;66:.7/QQ=GK]Z]P2?IP?^:?36)7]G>)*%M=_PP\?BAZ,9(J1+G;<(0<$_
MM_I*ER4" C1^%YA'84M<F/[MH7^@L\-9%LKI*UO^RQ3M^H>C%T=9H9>J*]O/
M=ON3EO,\17BY+1W]/]ORLT\NCK*\<ZVM9#%@4)F:_U5W0H=DP8O9R(*Y+)@3
MWKP18?FC:M7;-XW=9@T^#=#P#SHJK0;D3(U,N6D;^-7 NO;M#3,CL\OLQJQJ
MLS2YJMOL,L]M5[>F7F77MC2YT>[-60O[X:JS7&"_8]CS$=@OLU]LW:Y=]KXN
M=-%??P9X!F3G'MEW\WL!WNC--+N83;+Y;#Z[!]Y%./P%P;L8@7?@E-E_7BY<
MVX"P_-<]&SP)&SRA#9[\CU#W[X*=O5/..'SPNM%.UZUBA:B+[,K6#IXJ^)O?
MUAK4)+?51M4[A)!;X%SM=(%_R8/P86EJ5>=&E9D#6!ITM'69J?.R SYG:]UH
M4V=K=:NSA=9U!M9BHQKX!;X%.&A)3+L#06_7M)V@NVD A-F4@/!*U[I19;G#
MW_6FY;4MH/>E-OCI!O=UV?&__]N+^7SV^C\N+Z_IS_/7)W2N#O!N:$'3(4#\
MKM&KKJ2#$BWVH=WHO&M,:^3Y]W?Y6M4K#42J*N/(#/D-;]Y?A?W@/(!=JQM3
MP1X;V^!IIOO$[&K5%;3?7R!K!M3(5/$5+ )]/Z&EQA'EX#0UFJ@2]H<C-/A=
M[]EVK=H,6)#5.M?.H=BT%OF"TI ME6F U$B0*T87SW;^_+5+4-I89Y!V$]C#
M@<DC&H)O:)BB$R)9KMPZ6X*A=WS^D8,>A,#XV3;@:  G4Q<@UFBX/<O\6CI2
MI4#^<S@R,0%_7G9 IZ5Q.:"\TZJ99E>Z:<$Y 2AV85[TE]:VL)W."GBZM*X#
MR'X3(8-0E? 0X18Q/,BJ5,Z1\TT!SVB6<Y301"4B80!O"^J 9(E"*^)%+#@H
MP$1>-TK@@^BYM>W* O;/T'N+,G[M:G:/A"7N[87T( Q$HR?42$%D!N@\2)3G
M E(^TVCULQ^!F]4"SG5QCG;[_.5DCYA"[>\=_9Y=UG4'NWXF5;I7CNY5F%;T
MKZM9TC[E'9B52?:QSJ=T#@/?;]<6V6NW-8!SW<*9PH#D:2#P)0@2J;6<%IQ_
MB?QD(H"+J)W*67(C7W5IP$FK-AB[:%VC)(*A SJ!X!L+U*P8PP@#=+A48&Z6
M!J  4<5D,H=0O5%G9?4F,>C3[(LC-7D/5J$BB_;1&U]D5?NG";EGK5&*)Z!U
M-<1K^% &;J71OW>F850K]4UG.FQ/TN(@WMLPG=@,+9<0D8DN(XMU) (@#\]K
M$;32J(4IHT&.BHH/ FYH_!"+L36\"Q[1*_:A@X+I D'0:%_=*%KZ;H-T<UG1
M!6(&8R_<F&8_=AK)8&K4!T ,E(MYWJ()N;7E+0L&T F7!4I-,#KMR'ZS=0LH
MP,/+KL4C\QZ.;![H,),1GECL,O933O3))2R89I_0VF6V7EG<<8&1P*1GX_2M
M*CMB%RK$*/.\Q1GG+HAUY:VV5T$+*SH753UQ]V@K<@AJ#)KJMD&>P*\-4 $0
MW*JFP6@F5;,)\QGBB[*@U4Z5FOT.@N9CH"D#=A5ZT=(O*)Q$? CJ.F$WHT<,
M ,M4H"4"PVMNR<_PN2#NSK^=8KB/FE(A[[T2@\%0"\M.*[M$-%>B,+\E5$54
M\3^P,!JM(T!)UZE5H[U)!=Z"Y?E*2F'I*!^"E";1' 0I=:$:D(!W%O[)CH\^
M7-Z\.SHY_,R5+2@B;-.HY?(F1BV_V8W)LQ>S%Y/T2&"#>D=*5N*S?O4D8]*@
MWY#SP?^"C&=?0=A:[]LQ&,'<*RJR7[.P8%/ .M$/9  Y2>/O(!9D]+WL1,18
M]H!PH);6L>UQ21#<&/?-^\PMT@.DETFK[UI<3Y9H"'0)KMZ1H9,=70Y'0'&2
MX_<59X_%^.-&[9AR"]UNT9KW5HBH]F4!#POA[E 0+,%,% :L&M(3;,$T^[B,
M.RT;6]T#%DR)Q'D4,182;_$R)3FF;@9G\XZ3/3JJ<=AOC$ L4<]FSR;@NV]U
M#;:0]H <@Q(J7IE=R89]X8)E7KBFV4]V"P  )=,/Q^  9%C$DZ"].GQF<$L8
M28Z=;FO V!<:R G.6N,NX-%*N]HE=._@U) ,L$Y$TB-HM=DT%JP=6,$INMA+
M^+NDG'1@63%Z(-L'8-68!4AY+G(&GEQ"0=PM2F@?/,0)%E4]MPXD7IMJT35.
M]!9^TP:=#;@T!9^*+O>F$85!-?F:72K0N;0;PD-<G%<WB3# 6&+(4; VV9TJ
MP9P&64CWZ9^O$1$80@-M,3E'FA3OEA1&HBGG2!Y4]4;K[%>,S)^2^*FBH,Q#
ME6D,/X7\S+ A^-$XL )D+8.9^>T H=+8  ';6I^",P,_18+ >"\@]5P:#G^&
M07R4\B?(ZWT$KI 5GQ:E64E.<WR$:^#IHQ,2E4,0"1;XZ)XI>A ]?0?)7S_&
M(3J7JO;!3KJNTKKEZ&8);+);RNX;%&NC7F7'YB2-ZG),>/%Q%-L ,4*;P )8
M$?8#HP(F:FDX$\@,D)U"$UUM2KO38O51OO)6'&JI"2W$FZ#= PXW#IE9.']/
M+8[-[0F8 U3.KB[--PU!2.H/?( D_I5V(2, @52E(%*1O*7W S*H:-26T\7C
MVP3#M7(^CZNJ#D.8EIU0./&49.&1<A95PJ\?!M:-)H/@='-K<M2<%BQ."@Z@
M@&"AS;!>*7OTFI![04T JOR!.;AJU0)3GUOM,V>R;WX+'](^1I$"U@</F.,6
M'*B&,)1_2YGX@,(]/Y]/" \?B664(,]?@Z6H(?<$0I'H7@/5&1WZ^,XCP8H(
M4.Y11-HC#VP[>!C.T0?G</V##"@-X4&=:M>:;&4E2?^8CB7!@A.8X'46P#/-
MVD1Q.'Q">PD$QJ.<-KHD201Y;U:85E@\H#?A>S( B&A#[NY!IP#TD*(<QUX%
MX&FP4$K^T3^5A 8CF6:27PZJ/S4;AD:OL>2/3M<Z2+<T0*98W3+<KW8!HEH'
M=Y9J#23ME"'\Y#.$&W0KE[4D#L:%$(@)#TK>2R:855AI\^GBGJTD$E:Z?83-
MQ)@4LTH*,Q&!UVPV!W8JA**%]R(]*Y28,7BXHK">RT:8#E,.W.GB=6)#PV'5
MK3(E"0R5**M*%QBS\%&Q(L8U*Q\;LI=]S<;4ES92(R1VFPT+>^QELF.L8(!H
MM+@3H@6P]A\UKB_,+# ,O1#\7'08&)51E4_D"PPJE9A>BV7>.SAE$27FR<@[
MR$J_$># 9RQ#8+Z::XDD\:#*08R!&*U@,5/'5UL8 J68*&0@FO7JM)3 !S=-
M*C:@5'VA N 5 .\HB&)6@U"A%5GR)F \* CB<@.R%BNRO%M60H[!(9[($P7_
M#&2 !$:]>DM%<V8:QXM[\,>7@U$!"ABW1G/M,SS$\3Z$_*%H5RX2DU\_2"B)
MS M,2G*2$3PO8 8)'QM+@R1C91TG*J?]&"N 9S(-:2#9BVVL<08SUPY2OWV2
MZ+M<Z\)%*?K^_B.CH4$Z'BANIA'Z6C&.-:3E*T/"?JB"P>[?R/=<'12<?]%@
MQQOVPGM@?N]4*>3!I%HY<="'A%"%""HMAV&0#CF#P$L9Z"$BI0P++LH!I$0K
M@Y'XO0(!T+][/IUE%=@P"M73(,(G<45:2FO7D V!=:-V(1>.;[#OP\25CI_O
M8_0,ROW$I3/4EN00( 6CP\8_FIR!88DY=0BL]_9!R&SHL((\2GD2%=?EZX$R
M,NW&#L',A*R-Q?</W=A8H8>=P&IO+/M%]O5#F@_<O*E/X>S85WG8U>^Q!1^L
M,5%^@#^^?OJ8S0JKV1)PV0>]+OC7FL,)"44[A]0K(1'O5NN!8KE$CAXC%>;_
M6 SZA@']GVI:JC? V3EJN>Z 4&!TL\M0&CA6& $M31UQH\3XXB3SH9X8BCV\
M6.$/*1%'6APX.*[:DW>++C3*[D<.NC"7)\?Q )5C!VOT2&S;5,UE%J+"@>*,
MU)]"0\F'+&.EA%[]X /:IG^2?OW"CC?69WTSAR,[EE<0AUOCTKYPS#M>(,7&
M /:JH_-9K(XR8LRYGB<!KOAR>-U5H-6=Z[? ;6VQ:2"5ZNB/L8RS;%2E<<B%
MR,(Q!572$_B<9\,_;M NH8>J!'OIK.W9(^E8)*V2D>(Y-7M#UQ?C1( A#15?
M/MRH'2K:Q#<.FTX7L9="A;0[:2< W4T:^6"K17OQ=FL($$XQ/<IJKL,QIZA<
M%;";9L*)$=)S%"!=_23\2X,&+F=1W<GG#=BL4X95#?L12ZP/AB1X!UI:8SFF
M99 G04YYG@$(B-Q"_ZB*6PCC(6- MHO6>0D/6T6XAELW#57)TE9(*"X+C% N
MI[2*=T]8[:,QH8TJG1U*5B33VD!*!EJ[\U(L&0!F:%C1-&RU*@5\ ^_"A3SN
M.]H%%@_(L)IZTTE'#A/%X9-=O?\LI\D'A#KEJH,\;$'"@HZI1(="2BLPPE#
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MT#,,W6''[>%>=PY+C"#[F-B06..(JM0YC M+F8UQE)5+V6XP--$##,2^U;O
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M)*M2(8,.783%9&OWE,"R1 9Z9S#EOC*NK73-)EM8%8$#UIQ0:45-P9D@Z*)
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ML4\W+\&6\IT_MB'87!YGI-'#^ #V)Q97J%]80?O#S]F_4$L#!!0    ( "5
M9E&UJD30*00  $@*   9    >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;+56
M;6_;-A#^*X0W# E 6*1>;"ES#"1IA@Y8LZ#NU@_#,-#2V2)"B1I)U>F_WY&2
M'7=QL@+; CCBR]USS]T]$KG8:?-@:P!''AO5VLM)[5QW$46VK*$1=JH[:'%G
MHTTC'$[--K*= 5$%IT9%,6.SJ!&RG2P78>W>+!>Z=TJV<&^([9M&F,_7H/3N
M<L(G^X7W<EL[OQ M%YW8P@K<+]V]P5ET0*ED ZV5NB4&-I>3*WYQG7K[8/"K
MA)T]&A.?R5KK!S_YL;J<,$\(%)3.(PA\?((;4,H#(8T_1\S)(:1W/![OT7\(
MN6,N:V'A1JN/LG+UY22?D HVHE?NO=Z]A3&?S..56MGPG^P&VR2;D+*W3C>C
M,S)H9#L\Q>-8AR.'G+W@$(\.<> ]! HLWP@GE@NC=\1X:T3S@Y!J\$9RLO5-
M63F#NQ+]W/(.^_Z3MI;<@R&K6A@@>D-N=--@R59.EP^+R&$<;QV5(^;U@!F_
M@%F0=[IUM26W;075E_X1\CN0C/<DK^-7 5?034G"*(E9S%[!2PY))P$O>0'O
M5IA6MMOCI'^[6EMG4"._OX*?'O#3@)_^IT7]MYCD0PUDHQ6^9Y@<<6*M@%AP
M%A>-JXG#[5(W7>]$>"'0'?4L2R+:BE12]0XJ OO2=!C&AC#H'7Q=;0"",5H
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M#<J"SHEI;PW_1TZ?8DSY7A:I)S**9TV;B<]Q<8FM-KL01Y,C3GPG_OV0]-#
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M)Z7"!,Q&RW^(CL,'*@"=X3O;-4]6"KMI4W06#R<TJ)0*,Y>PG27#9'^1MT7
MAGUI._2:BARJ=G @#PZ@MO<=Z+BO6\);8YCA:M>&J(>&C_S =4K%O#O .P3X
M.:X.1@A1P!@//[SPF R!1O\1VO\$>2)B@K++TUM65!:B,HT.@3\=2"XRZC]N
M-TO]S!A%S@9X,/G0%T1:.^SA'[B]Q2XWA;!41:R=D[0R-3=0;_7 ^VVY.4&;
M<*7_"]?;^9Y_9;Y<3X51M*.$^A1KA=#M,"[0HQE%7=J.DK9E3GJ]@%6;XE66
MV2:$K*](FH//^C$YA[,P6I+T\B#X!9%D$)^/!^ET^H(,%7T5@'V7QM-!,CW_
M_F7/7V:.7,]F,S+]'E[Z5S<ZVBLJ)!R\/3D*!9%K5XS][7Y!6[5[R4&\W>X^
M$0U)DU1A0:K4;M,(;+LQM0=OZK"EK(VGG2=\EK1DHF4!>B^,\?V!'>S7UN6_
M4$L#!!0    ( "5 9E&_FOJ 5@4  'X.   9    >&PO=V]R:W-H965T<R]S
M:&5E=#$U+GAM;+5776_;-A3]*X07;"W@RK+LI&F;!'#2#.N K$73K0_#'FCI
MVN)"B2I)Q<F_W[F4+,N.DR(H]I!8$GDOSSGW@^3)RM@;EQ-Y<5?HTIT.<N^K
MMZ.12W,JI(M,125&%L86TN/5+D>NLB2S8%3H41+'1Z-"JG)P=A*^?;)G)Z;V
M6I7TR0I7%X6T]^>DS>IT,!ZL/WQ6R]SSA]'92267=$W^S^J3Q=NH\Y*I@DJG
M3"DL+4X'L_';\RG/#Q/^4K1RO6?!3.;&W/#+A^QT$#,@TI1Z]B#Q<TL7I#4[
M HQOK<]!MR0;]I_7WG\-W,%E+AU=&/U593X_'1P/1$8+66O_V:Q^HY;/(?M+
MC7;AOU@U<Y-X(-+:>5.TQD!0J++YE7>M#CV#X\<,DM8@";B;A0+*]]++LQ-K
M5L+R;'CCAT U6 .<*CDHU]YB5,'.GUU^JY6_%U^L+)T,0KF3D8=C'AZEK9/S
MQDGRB),WXLJ4/G?BLLPHV[8? 5"'*EFC.D^>='A-520F\5 D<1(_X6_2L9P$
M?Y.G6?X]FSMO0?.?)WQ..Y_3X'/Z8\H]VXF8^5<^IU=7TMZ@*#\N%F15N73B
M?<V_ F/XLT1"EIDHX5 4C?K$Z@MHYZF8D^T$' :;"U-4LKP7SN@,ID(NEY:6
MTI,P"Y&\CF*DE]:A4N#W^"A*N@\NEY8<STM-4? ';]*;(8K2513*2M\/A<)W
MJJ1EE[+A4#0<3,?AQ<\_'2=)_&[VY<J%Q_&[E\$IE2FPP\65O&]!_UZ#&C\&
M0+-ZB6H([Y'XLLMG,HVFNW!KR&$#];5/@64AR30Z?GSN9E5,#BMO:?-@?@\7
M6T0/P_2LZ%A*"7HBL-"MLB8ERH+R!^,X&J]A#(5<>/B QQKZ8SG64#ENE6XH
M%@2(#)WNT+Q=$[J#>"/1%LKGI]#C()/#Z.B'0(XW))LP;W)G118X94:BJJVK
M9>F%-WU<OP _9H>$% /T1+T8 .M2<=&'/<!Y)"=R#2E9"N[JXOK51"R4!I>5
M\GGP=GUYP<.HOS1'\/L"</]GPB'M:P="I<?&!VN,6D+Z9E@@"PEWN#9DCFS<
MLW-U5>D Q &@#C8MEPW?C:OC8;\DQLGP05F,6YB1F 4=OQ?!7&9M(]":Y_/8
M_BH7\E8J+>>:!(X  N&#\BGU*N 17HVJINPS")"W24 SJ%BVFW07A*YD.XMU
MA;GG<+3$!Y.0>[*2*?=:Z,PDP*#BYX/QF^BP*^]=\M]AN2&Y$X?':#WH%M?U
MW*5656':#!VY5>\CWBJKM$B2?=PP!_G&#1,4)!#UO,BUEV99;O5IBLG*!X-;
M C4;@AFB+G78 <;#.(Y[.;!=5UNB@)N$'NJ6.WVE9=IJ 8\[^TJ3RCPW#8L<
M3-X<<EDKM\<>>CFO?,TPI7BO=!T*^<,ZXUY(Q^>M4&Z \(?QG$8O0X8 -(YA
MS8#,_H7&C8QM45T#!VC-Q%=IL=7B&,L"A[0Z^G_E[>J%)8XF>[;49PO=],5'
MJC4TR9#?$!$J2\O;+]SXS1&CV:F];W.8AY'YM4=W+#..EYEKM6PZYC; M9Y[
M&(?]?Y4K],P7ZN6645 L-+A"WI!(R7+31$6Z' #O0Z2&L-HQ:UGPI_W*[6I%
M=VDNRR5UXN^!"8DW 02BE(.C>7.<])M Z,3[%>%T ]86[+[8;_BVWCE',DR"
MN=2B,K8OK2Q,S5%8P61^O[//XJ+E@)0A2)$IES9SPV[>G<^B?:?94>].4)!=
MAIL/YQ<<-->#[FMWN9HU=XK-].9FAIUPJ7 PU;2 :1R]/L2VVMQVFA=OJG##
MF!N/^TIXS'%!),L3,+XPJ-7VA1?HKIQG_P%02P,$%     @ )4!F46/-V E[
M$0  :S,  !D   !X;"]W;W)K<VAE971S+W-H965T,38N>&ULQ5MK;^.XU?XK
MA)LM$D#K6+YG=F: 9"[H%#-ML)G=?GCQ?J EVF8CBUY=XF1_?9]S2$J4[3C9
MHD6!04:61?+<SW/.D=_N3'%?KI6JQ.,FR\MWO755;=]<7I;)6FUDV3=;E>.;
MI2DVLL+'8G59;@LE4UZTR2Z'@\'T<B-UWGO_EN_=%N_?FKK*=*YN"U'6FXTL
MGFY49G;O>G'/W_A9K]85W;A\_W8K5^I.5;]L;PM\NFQV2?5&Y:4VN2C4\EWO
M.GYS,Z;G^8%?M=J5P;4@3A;&W-.'+^F[WH (4IE**MI!XK\']4%E&6T$,GYS
M>_::(VEA>.UW_\R\@Y>%+-4'D_U#I]7Z76_>$ZE:RCJK?C:[ORC'SX3V2TQ6
M\E^QL\\.9SV1U&5E-FXQ*-CHW/XO'YT<@@7SP3,+AF[!D.FV!S&5'V4EW[\M
MS$X4]#1VHPMFE5>#.)V34NZJ M]JK*O>?U2+ZNUEA9WH\V7B5MW85<-G5EV)
M;R:OUJ7XE*<J[:Z_! 4-&4-/QLWPY(9W:ML7HT$DAH/AX,1^HX:M$>\W.L&6
M^*C+)#-E72CQ?]>+LBI@ O]_8O-QL_F8-Q__09F=7$7>]:;<RD2]Z\%]2E4\
MJ)ZE\_M:B:7)X!\Z7XE*+C(EMH5YT*DJA?3^(LQ25'@RD47Q1 \^R*S& W!,
M>]]LMB97>572DREM+$OR&W( E0JX@'T,*LM+W,!5:3*=2OIV(3.9)TJP)95O
M!!12J<U"%:R5CRIQ'^)(W-[>BK^92HDS,1[&T3B>X.K/?YH/X^%/XA^@3N:5
M^/28K&6^4N*V,!M=E@8,T*)2Q%$<3Z.KJUFSYM/-CQ/QU<A<7*\*I>#RE5B8
MHF!YT((I%DR'5[@:S(91/!R)[Z:2V9XH/-N1R!',SL0HBB>3:#".<=VN;*C_
M.X[;%CIKS"YB^7R &&7^)'80WHI8@7"DR(BZ)5@1=SK3D)SX56:9>A(W,K\7
MY[V[7V]Z%Y'05L9R!3Y6D*N0&U.#&U!V-NB/X<!9AE@4B6U=E#7)J3*\XE8^
M(=PF]R2NR@4L7(* C3BG!TA6P\%/H)ZOXI\NO#U\,(7)Y8,NZE)<ZS02/ZM,
MJZ60>2H^@5*(/X$ZD[K0U9.X3I@:XK>S\8?KGS_=T;=^^SX)Z*]UKL0D% ^)
M[W.F'O4"<CBV7P]/?+[N7;  2[W*(3^=@\U,[B .E:=LY'C2%'JE<ZBQ4L6F
M].Q@>5]<;PP>,OA,MDU6T)S^^5JHQPK;E'P' 5C!XC*Q584V*7O#AF)3]@0?
MTGFBM_B29 $B%/RN$EOYM&$W87V6^M$N*+TN*B0=L5LKJ\N[#10M;NH2[EQ"
MPBF"L*98PCJR+-_=$,/D@/ L249.MS,0"?J)(FL&[*LK)*&</'.'3$3_6VZ\
M4!+S "K3D)W?:IGI)=NY>J03E".=,P[V4?<-[4H64'[!*AF[K[!%QW])5WWQ
M0145<G9#FA,_&_I&/HF%:JG5_-V3D(BD-86.Y\@".XA92:$7%%*>K'UZR^IS
MH.,#R#:<KQ"NH,,EA3P?*7)R4!N8NCY*JY;RP3"'<+K6YMBI>Q?VD,;)D;81
M_DL*?IV-AFP2"XBK; U#XI\HR&VQ>=P?_$!:P(-YO>G#&T\;$\D&'SAX>P.$
M1>#+A$3DHB_Q9,WJYKIC,,0+2;6U$*^7 HB ?$#$ V^H0;(@G3]NM3-'GR*Z
M1J27G<BVAO A8"&W6]A*VCD6)FXEZ!].=<H/NWPDZ!XP1P:BR>NP=%5+#I-!
M*B(=(PKC$RT/SX:$>(NE3&S\0)8HD"5@OF;!]NC7[RFRR8=TAL5%E!/50YOP
M&(E1#$ZRFOPI(AGZ,(( LI0Z(RR LS;R7GG51<A]^7U1;ZOD"== MHC$O&6A
M.%'G%0NW9,5OB'%-5I!"QJ5R%"!D57LYLXV9AVG*1]*OWAG"[-!_11)MDM=P
MZ$^"[!#M<Y<\R&;XF(.]V$>7VL9E*]QXV,U].*K&UQ#4E_P!5F[@)8F+%WM>
M6CH/?)%DR@A$$QANTV,0H=M$.>E/6U%\/\;"@3C6\@&,66\GJTJ=$SL9V: 7
MLP)3P_9,KM]X<=?D*?I!\62J1P5X<#JDLEN;C#(:76]E86,)]K*Y!'RC'H([
M(MN!.CR&_3>:PLH7:_%L1;B254<1!-$(_54,!*$T::,)T@_BAM4T+UK!=0M^
M+)'EVF<#M\V^<F'8O]6ZL!I&/(=P?O!62= )*DZ42MD'RCI9=X\S7CB(V*8(
MPPYX+"MI<YG39\TID%SJ13GZ,!4>9A+ %H[>+#--\<6(ZWJ% !"8/NEU] P/
M_V5Z26&'!,LE#&N?SOXQKWV=A>U@IM!:8HJ4X"CE*42SH@TH<)I!UVE2O00R
M4H3I+?ILG JV7P$9N/3;;D-2[*+7E]R30U=+%MDHUQTI"B]^'L('CI!)4JC*
MFEN3.!UF$)2J;-#7RR8VOB@1RZ/=F(M[IL\> 5Y'#87$%&Y,FAL^1U5KE!K\
M=8Y8Z#,K0;;T:" 'T5O%+83LJ1LOCCB4I-2;4.98J><\B^Y=?_]6LK3JL@SB
M\9SVP7:HA4X;ZBME]1%1T8&%/\IVU0F,J6H!CXLQ+[H)(B-(99;/1OUA5S/C
ML"CJBOBN7I00J[)F]-^G+6ZM)D(4)<"_>J5[6C.G**-9B<LZLS Q1]D#"$*
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M/YXX8S7JEL!0GU/MJ3G:[ZHP_YGYV6'=U?&M]OCTWQU4L3J/IOP_#!Q=!^H
MC1ZSS^?M,HA\;&FM)78!=],Q?M5[F8176DS+C8RR'9/9B5%IWY%JR&PLWORA
M@R&.RK7AP2@U/H.W8*A_4:@UO9M-7D:(@;E,FAC3E=,1E]3* G_IZKIF)&H'
MY)13: *8%-J&E;99V'G)C%_I<*^SN/>D[ @U<B\3<*QTKPT%R8'4OU&G'+\I
M_R?/U=%!AV1C4JML:J)9(7!P\ZX<C(,;^!?"@&VGC^Q$\6]D$U>FQI.7]NY
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M)R3O!=Y+L;&#-2-/%EI_I)>7Y<DH)(.$$H4C#1R/:W$AE")%,.-3KW.T/Y*
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M2TRZYJJ%:>7?N ;)4_8H I.R]#&[/)# >?=$YI92+V2-ZAJTTI<U^[4%0\"
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MLXEMGF>_VKI=N^Q=7>BBO_X!H!SP/O-XOSW;"_!*;^;9PY-9=G9R=K('WL-
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MCEP:&_R  CR\[%H\,N_AR V 66,RPA.+VXQ=MQ,3XQ(6S+-/Z  R6Z\L[KC
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M?/3G&D)FW> #\#N^J-%_P W"ZXC?_ ]02P,$%     @ )4!F48?:8VS1 @
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M7*/Q!K3?:LIW4GR ^0>P_1=02P,$%     @ )4!F46-2/$"1 @  D 4  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL?51M;]HP$/XK5C9-K<2:$* #
M!DC0%VT?*E70;1^F?3#)0:SZ);,OI?WW.SLA8Q/P);'/=\\]S]EWDYVQSZX
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MAYPZ/)E+8S[3P:VL6CR @]KMZWJC&]4X2R<+PD%:FB,:"%4 CD1W#"O76-Q
MR>JJ+"2]7<A*-KD"WUGV"K N3M4+97QQ'E3>+SB#^7P.OVJGX (BP5G$8Y1^
M_"$37/P,'S$ZV3AX_)2O9;-2,#>Z+JW5F  I6>",\X1-I^F@\WCW4PQOM&S@
M=F640@IPL-#&>#Q((4&%1$Q1"E+!N CA23M9?07%/FT&#9+;!82,QS$+(H[R
MD>8)"'MDOQ^[=%\!0UT+LBF^1$@$? H2NZ\K7?DW 4Q\>!Y74S9YN<&\D$RM
M0ZL4(L4N$L%2S/\ \QMEL4AM(VMMG+?O"UY@X^L64QCS*&9I*"X'C?LOL;HX
MJL/![!EPOE,DZ0_^'^#$0<""(.B*W,OSJD5X9)Z;%JV7C5,X; YXDK @#H&+
ME*5I^AR*6/+6#T.N+4[3.)JR2$27,,9V2F(43F"Y;]'C5CO#./' ./&_9IP!
M @:/B$N!!(P8F7(KZ4-G/=)#9!_V$T$\94\1U5G'IXGJ]H -\TUQ8"V$L"7J
MV2'22#JY-AC>%=SK9JL06Z(TSQFO]MCBUTM]^_JE+,TA]I-I>H8?\GPMFY;(
M$;LJ0_#CH04N8"RP6EAHSB]I%<9LFDQ)%"P,$A9B<[YN&]6I'GIGG(J("9Y@
MO4/:N 2!]4RS""/<=@W9:_ X8!%I( MB2U&#!"R)4)-Z(,-^2 ]-W.G$O0_!
MLI@4>,1"CBYXB#MA>)S.%*+]:9[AVPR'>2RF+(PS#"G$Q)( 7JJ%.2@<)1$&
MF&4Z[9HV2^-+2"+.TBCIJ?,",I;V\1,X+)MB$JGP4/%LBLEE)$<L2=%D&ISK
MYF3HYN0_?3_AK72M*5V)91TCZU:MG^I7_;R>O)^<]7"Z;;VK^LB5&ESMJ>'R
M&49ZVJEJJZ#N+CVJ8YUO6([30] CI$=$CYC(%*_-2W308W[@L*.\B3#"&-LQ
M)2(.B9F28TH^+1W3'G[GLHCQ*#I9HLG17;%69N5OQ!;\9Z*[-@Z[PZ7[MKMK
M'HYW-_:WTJS*QD*EEJ@:O$B10DQW"^X63F_\S7.A'=YCO;C&/P[*T %\O]0X
MX_V"' Q_16;_ %!+ P04    "  E0&91$IV+<?P#  #]"   &0   'AL+W=O
M<FMS:&5E=',O<VAE970R-RYX;6R55FUOXS8,_BN$L0\MX,6RXKRX2 *DO=OM
M@'L)VNX.P[ /BLW80FW+DY2FO5\_2G:]%&N"[4M"2>1#4GPH>G%0^L&4B!:>
MZJHQRZ"TMKV*(I.56 LS4BTV=+)3NA:6EKJ(3*M1Y-ZHKB+.V#2JA6R"U<+O
M;?1JH?:VD@UN-)A]70O]?(V5.BR#.'C9N)5%:=U&M%JTHL [M+^U&TVK:$#)
M98V-D:H!C;MEL(ZOKB=.WRM\DW@P1S*X3+9*/;C%QWP9,!<05IA9AR#H[Q%O
ML*H<$(7Q5X\9#"Z=X;'\@OZ+SYURV0J#-ZKZ+G-;+H-Y #GNQ+ZRM^KP*_;Y
M^  S51G_"X=>EP60[8U5=6],$=2RZ?[%4W\/_\6 ]P;<Q]TY\E&^$U:L%EH=
M0#MM0G."3]5;4W"R<46YLYI.)=G9U9U5V<//+J\<;E1-M3;"7]?%O=A6:"X7
MD24W3CG*>LCK#I*?@$SALVIL:>!]DV/^VCZB\(88^4N,U_PLX!VV(QBS$#CC
M[ S>>,AY[/'&I_!*H;'/>2.>B6(6UEJ+ID O_['>&JN)+W^><98,SA+O+#GE
MC-HHWU<(:@<G+_O]DY,1J,G@:^NV#'R@@"PIWN+.49@DV8 MD2P;HRJ9"XN$
M2+\^:(+_VJ(6G;%H.@\:2]= CPB?E#%OU?)L].Y)N#*MR' 9$)9!_8C!*\YD
MQVG@41JJ3Z/HTY#&]?#K3#)%#&DZF"&G',Q+4L9EI5YGE;W*JJ*L0!CR6-'S
M8J[@OM2(4'<$1$= (/H0W!:UY] 7RO#<N>,8_<3ID?0!&XJA\OY%3ETH'3_<
M<P(_0<Q8F+(Q2<D\Y'Q* B<I3;B3TGDXY3$5T:#06>DA<GRDQ[#U9>.3<#R?
M09PDX6Q&/I,T9#,&"8_#<3J&>V7)+SGATY"GS$GI.&1LXMP1-HN=EQEG)"5P
MAJZ3@:Z3_T?7GH^P=L^GM,]O<>@LY-L<NB^Q+YIL"K#NK>D'@_R!QK/#>/<=
MC[K7F]S#GFJF_?FF$@U5_,O>U\[%Z_K:P'?_$E-AUX]4M0*INU!GDGBYT3+#
M?Y_?HIM>+@YJ+=_X>[KT3W*'</$[E<U<PKHH-!:NXSZ2AB3R9?!-5'L<VI4&
M'O&VR1V,L/ .LYY3<=B1:$92/$]=X4:3%.8CYID2,CX?>IU6TR1,)^Z(C9(8
M:/+L4+JCBPF?A?,IOW0<&*734X[?8',2\BE1<S;SJ&D"Z2AVK"&F\0$&NTOR
MA3@!,V%ATC%O-$Y@.G)4I\TW:1<=C:0:=>$'KZ'NW3>VFT[#[C#;U]U(^T>]
M^S#X+'1!-PX5[LB4C69$-]T-VVYA5>L'W%99&I=>+.G[!+53H/.=4O9EX1P,
M7SRKOP%02P,$%     @ )4!F49ZP)269!   &0T  !D   !X;"]W;W)K<VAE
M971S+W-H965T,C@N>&ULS5?;;N,V$/V5@7K!!E!LW2VEMH$DNXL6Z&Z#)-U%
M4?2!EL:VNI2HDE3L_'V'E*/8K:TF^]07B:0X9RYGAD---T)^46M$#=N*UVKF
MK+5N+L9CE:^Q8FHD&JSIRU+(BFF:RM58-1)9884J/@X\+QE7K*R=^=2NW<CY
M5+2:ES7>2%!M53'Y>(5<;&:.[SPMW):KM38+X_FT82N\0_UK<R-I-NY1BK+"
M6I6B!HG+F7/I7URE9K_=\*G$C=H;@_%D(<07,_FIF#F>,0@YYMH@,'H]X#5R
M;H#(C+]VF$ZOT@CNCY_0WUO?R9<%4W@M^.>RT.N9DSI0X)*U7-^*S8^X\R<V
M>+G@RCYAT^U-,@?R5FE1[83)@JJLNS?;[N*P)Y!Z)P2"G4!@[>X462O?,LWF
M4RDV(,UN0C,#ZZJ5)N/*VI!RIR5]+4E.SZ]%596:HJP5O+EG"X[J;#K6A&R^
MC_,=RE6'$IQ R>"#J/5:P;NZP.)0?DP6]68%3V9=!8. =]B,(/1<"+S &\ +
M>S=#BQ>^P$U6%W!-YI;U"NN\1 5O2Y5SH5J)\/OE0FE)N?+'@-:HUQI9K=$I
M+ZB$BI8CB"7DHFI$;0V@&4?*), MU9;"8_$>!#:5>J$:EN/,H5)4*!_0F=^O
M<4@+;)#\8PJ6@E,IJ@NX7TM$J#KFT# '%'>-U0*E#?Y'4COTW9!##S_;&_W2
MH&0FMCOMN5 :OH5HXB99LC_PH\#-H@F-2-A-DA@^,5F:#-R7#'S73S+S"M((
MDL"-_!CBE!9#N!>:\4,U2>JFA&0'6>I9\-@-D\",$L]-@Q0&B(U[8N,7$ZO:
MIN%H4HN,63#.ZARA.U#+NCLUNP.,,TT1U**S6!UC?5#K<=;OOE(];"@5]K/A
M"+5O,=^M^&['KCVTS\7RO%4FEQ1JY4*-)O2!/W%C+Z51&$5N/(G@NI62[-HQ
M)!:\7%ECE&$_B=S4[O8G@1OZ'GP4]7E^4H*291(E)!:Z?I8>4,\I:4I>:E/)
MAF\R(XZ,&6%L#1K@.^GY3H;YW@]RSM0:EA2T_0 ?8_,5F*^CZN5U^=EV)2S.
MV0.5Y0H)W'3JY_+4*"OU_3=IX <_B,/2I8;PB$RJ,_!'$02C\-]H!1V<HB7"
M2 Y/H4Q&"7S7/0>HF/143%Y<>A2P5G;$T^R?BH]1,HA]O,#>M]HT!NJ]9=56
M>UJ>5KI -NRQ:R]$)#"^2TZJ#MSFO%5T]3 V:K;%K@,)O2:V<B;EHP'+UTRN
MS'9F#NFFD6);DGO('P^8IYL(D"#\9H@QW=;('I3I964)N;4\%[1(6FT^T-&;
MNEZ<F)E/A>2YF6</[@!\WPVI9+JBHA(*/*K(#'Y&12IM) CQ@?&63"O^I$N)
M\13>^%2327P&-P<[#"_'(_-<G -YD/9YD'YE'BS+VAZ"I[-@$/E%67""\T[U
M<PK^G]B/W2R).O(S:KQ^3[=/7[SX/]F.HN@U5!-JE/A'F1[O75<K),?-I5R!
M/4FZFVN_VM_[+[OK[O/V[J?A \6MI/; <4FBWFA"'51V%_%NHD5C+[\+H>DJ
M;8=K^G=!:3;0]Z40^FEB%/1_0_._ 5!+ P04    "  E0&91W]3;_MT"   I
M!@  &0   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6R55>MOTS 0_U=. :%-
MRI8T?8^VTKHQ 6)H6@?[@/C@)I?&FF,'VVFW_YZSDW:%/1!?&C_N]SC;=YUL
ME+XS!:*%^U)(,PT*:ZN3*#)I@24SQZI"23NYTB6S--6KR%0:6>9!I8B2.!Y$
M)>,RF$W\VI6>351M!9=XI<'49<GTPQR%VDR#3K!=N.:KPKJ%:#:IV H7:+]5
M5YIFT8XEXR5*PY4$C?DT..V<S'LNW@=\Y[@Q>V-PF2R5NG.33]DTB)TA%)A:
MQ\#HL\8S%,(1D8U?+6>PDW3 _?&6_<+G3KDLF<$S)6YY9HMI, H@PYS5PEZK
MS4=L\^D[OE0)XW]AT\3V^P&DM;&J;,'DH.2R^;+[]ASV */X!4#2 A+ONQ'R
M+L^99;.)5AO0+IK8W,"GZM%DCDMW*0NK:9<3SLYNF=9,6@,'-VPIT!Q.(DNT
M;C-*6XIY0Y&\0#&&2R5M8>"#S##[$Q^1G9VG9.MIGKQ*N,#J&+IQ"$F<Q*_P
M=7<Y=CU?]U\Y,IF!?W8&OBJ+<,Y-*I2I-<*/TZ6QFM[(SU<$>SO!GA?LO90
ME4Y6"P25P[42XHB*9\-TYN8+U!P-S*%U!5\X6W+![<-S)_^JCBO8$U.Q%*<!
M5:1!O<9@=E,@Y"2J-ERNP+I;A4JK-<](EH'^RX^E\">>Q-;3"9R6JJ:5.1-,
MI@C,PF<F:ZI?Z+@+ZHSA+;Q[,THZR7NX8%S#FHG:QW%C:H\Y(H'*8KE$#<FP
M18W#[F@8#@<QG!5,KA"XA/P13\X<(*,7146F^9JYZC70&87]X3!,DL&^I4?^
MYMD0/PF-![UP/!K\G\!!9Q .XW&8] :'V^0UIH(9PW-.P58!_JKI;"BT$R;]
M?CCLQ8?[;LXQ;<T\/:+G7E>T5[XEZI5O4@92I]U4\FYUUP=/F_)_#&^:Z"73
M*RX-",P)&A\/J>WHIC$U$ZLJWPR6RE)K\<.">CEJ%T#[N:+":"=.8/?O,/L-
M4$L#!!0    ( "5 9E'^TR7BI0(  #<'   9    >&PO=V]R:W-H965T<R]S
M:&5E=#,P+GAM;*U5RV[;,!#\E85."=!&MOQL8 N([1;-(6V0H.TQH*6U1(0B
M59**$R ?WR4EJT9BJS[T8O.Q,SL[I):SK=*/)D>T\%P(:>9!;FUY&88FR;%@
MYD*5*&EGHW3!+$UU%II2(TL]J!!AU.N-PX)Q&<0SOW:KXYFJK. 2;S68JBB8
M?EF@4-MYT ]V"W<\RZU;".-9R3*\1_NCO-4T"UN6E!<H#5<2-&[FP57_<CEU
M\3[@)\>MV1N#JV2MU*.;7*?SH.<$H<#$.@9&?T^X1"$<$<GXW7 &;4H'W!_O
MV+_XVJF6-3.X5.(73VT^#Z8!I+AAE;!W:OL5FWI&CB]1POA?V-:QDW$ 266L
M*AHP*2BXK/_9<^/#'B":'@%$#2!Z Q@.CP &#6#@"ZV5^;)6S+)XIM46M(LF
M-C?PWG@T5<.E.\5[JVF7$\[&WYBM-(+:P*(RM&<,?(2K-.7.9";@6M8WQ5E^
MMD++N##GL]!2:D<0)DV:19TF.I)F##=*VMS 9YEB>@"_[,9_ZL"'5');=[2K
M>Q%U$JXPN8!!_P-$O:B?T"Y/F'BPFC-Q2%TWV3V61-;S9#V#&=URJW29,_F0
MZBI[2-'P3'H3.Z0/VB,;^&R#DX^L@W38D@X]Z? 8:56L43M2:A":I,H,FDH,
MO.Z&AZRI>4>>U_6,I[@_"Y\.2!FU4D8G2OF^6AEJ%0G2EY["66TI.$MAS])S
MTG>2V[7>T3N]P\-ZQZW><:=>:B>8,&,[3F'24DW^W]%.6]+IB7[N[CGX>V[
M*E@CT)KES)+#7(+-$3:55_$*__PN%M-W9D9OS SW>E.!.O,MVT"B*FGK-M6N
MMJ_"E6^&X=_P^DFY83KCTH# #4%[%Q/*J^LV74^L*GVG6RM+?=,/<WK94+L
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M<VAE970S-"YX;6R-55UOVC 4_2M6M(=68L3YXJ,"I!:8MH=)J*S;P[0'DUS
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M8],-M^;J!&D!YOM:"/TVL6=G<QE/_@%02P,$%     @ )4!F4>GB9^!C P
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M7%Y^0"AO)-L6;Y<?F90L+2XWE"PIUP#U^XJI%%<WVD']&6?Z+U!+ P04
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M&T!3SC%-3/<1IO'!_K-,@2.98HH.0=]N%">ZEI"+[QT9^4U&OLG(/^DT<M@
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M*_M/MM79P<@A2:FTR&HP>I"QO'K2VUJ( T 0' $$-2"X#_"/ ,(:$#X6$-6
MZ+& N ;$CP7T:T#?:E^)996>4TVG8RFV1)K3R&8&-EP6C0*SW&360DO<98C3
MT_-;I@G-4S)GJA"*<O+6Q)II!HJ<DDLJ)36Q)R=ST)1Q]0I7%W #DN8)G$K@
M5$-*D@V5:U!C5Z-/AME-:OMGE?W@B/V/9=XC?OR:!%[@059P\1N@A6;63;.
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MN7B5.8!";P5E<NKE2I6/OB_3' HLN[P$IG=V7!18Z:G8^[(4@#-+*J@?!L'
M+S!A7C*Q:RN13'BE*&&P$DA618'%^QPH/TZ]GG=:6)-]KLR"GTQ*O(<-J)=R
M)?3,=RH9*8!)PAD2L)MZL][C8FCP%O"-P%&>C9&)9,OYJYE\S:9>8 P!A509
M!:P_!U@ I49(V_C1:'KN2$,\'Y_4/]O8=2Q;+&'!Z7>2J7SJC3R4P0Y75*WY
M\0LT\<1&+^54VG]T;+"!A])**EXT9.V@(*S^XK<F#V<$K=-."!M"^*^$J"%$
M-M#:F0UKB15.)H(?D3!HK68&-C>6K:,AS%1QHX3>)9JGDJ<WHA!F&5H267*)
M*9J9Q!)%0*(.VNA;DU44$-^A#1Q 8)9"9PT4*\C0(L=BKW%W2U"84'EO& XE
M&E3:H#KH9;-$=Y_N)[[2SLWY?MJXG-<NPRLN(_3,F<HE>F(99"W\Q6W^^ ;?
MUQES:0M/:9N'-P4W4'91%#R@, B#-C__3?_-3N2J&%F]Z(K>&J025:HJ0=@>
MZ1F( ]S0[3O=OM7M7]&=I:FH= E=41_0%O:$,7/,%E.SU!9]K3JPJJ:/'!(=
MY:'%2.R,Q#>-7+U5;7<IOCB]'YB?LU";K&'Q&:P7C*,PCMNM#IS5P0>MEOA=
M]SW5YG4QN##1"8.X%X_;30R=B>%'"P<LNUVU^? B;Z/1*!@/_LC;7V&U8_^L
M*16@:V5ZM40IKYBJ^Y-;=<_!S'9!_Q>\?DN>=:D)DXC"3E.#[E#G2]3]N9XH
M7MH6M^5*-TP[S/63!L( ]/Z.<W6:F /<(YG\!%!+ P04    "  E0&91]7SH
MUM\#  "(#@  &0   'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6RU5]MNXS80
M_15"Z,,ND$9WV5XX!A)GL\FB*8+U;OM0](&6QC812=225)S\?8>R(CL5Q:KH
M-@^Q+G,.SUS(&<WW7#S*'8 BST5>R@MGIU3UP75ENH."RG->08EO-EP45.&M
MV+JR$D"S!E3D;N!YB5M05CJ+>?/L02SFO%8Y*^%!$%D7!14O5Y#S_87C.Z\/
MOK#M3ND'[F)>T2VL0'VK'@3>N1U+Q@HH)>,E$;"Y<"[]#W=^K &-Q6\,]O+D
MFFA7UIP_ZIN[[,+QM"+((56:@N+/$RPASS43ZOC>DCK=FAIX>OW*?M,XC\ZL
MJ80ESW]GF=I=.%.'9+"A=:Z^\/TMM XU E.>R^8_V;>VGD/26BI>M&!44+#R
M\$N?VT"< /QH !"T@& L(&P!X5A U *BL8"X!<1_!X0#@*0%)&-7F+2 R5C
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M)\@C#I\]AQO%JV8F7G.%$W9SN<-/11#: -]O.%>O-WK,[CX^%W\!4$L#!!0
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MLYPYW,$_ "J; KB_$4(?3AJ!_C_%[&]02P,$%     @ )4!F47\BI/9C P
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M3IX/]_0XH[(&M+^5=)3EQ+;SZKF?_P%02P,$%     @ )4!F4<SRJ,1["
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M\.L:\8U5_Q!D;:BK1FZP0+(E:.QDOB5MN0>V-<,W&R8B\L>O:))\5I#*/RV
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M_2'6GB@?.,J.XKFY\L^YPE.\::Z 12"T /Z_X%SM.GJ"^IEI^@]02P,$%
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M:*\H7US;WP[0;H#M7RJ%^XJ[I^H?F=$?4$L#!!0    ( "5 9E%L:AKRW (
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M&#=],M<23AGP]&@BRI)IN'BMT$?TM:*2:,97J*!0?76!,E%6@MMCL:RMB+Y
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M(>6DD!SOO 'O3O"0H9]9#&,1<_7L@/1+2#^']!L@IS&5$F5S9*8090+E"N7
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M3T3L'Q2S%=_&F']B8O]T["MT3GF,V2<FMD\3//;88K%@<^U$-R#FG9C8.P?
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M4$L! A0#%     @ )4!F43Z9*&GN    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ )4!F49E<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  E0&91-4AV'T<%  #W%0  &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ )4!F4833 S1S!@  '!D
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M965T-BYX;6Q02P$"% ,4    "  E0&91%V0Z<Z\'  #9'@  &
M    @(%H+   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M)4!F47 #BP;H#0  +B(  !@              ("!330  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( "5 9E'J@S"$;AL  "57   8
M          " @6M"  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    "  E0&91117?(<$&   $$@  &0              @($/7@  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( "5 9E&UJD30*00  $@*
M   9              " @0=E  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ )4!F45&0^Q4#!@  W0X  !D              ("!9VD
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  E0&916P<Z
MNL\"   (!@  &0              @(&A;P  >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( "5 9E&>T"(/4 0  ,(*   9
M  " @:=R  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M)4!F4;^:^H!6!0  ?@X  !D              ("!+G<  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    "  E0&918\W8"7L1  !K,P  &0
M            @(&[?   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( "5 9E$\+49CNP8  %80   9              " @6V.  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ )4!F4=.,-YQ1!0
MU P  !D              ("!7Y4  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    "  E0&911IM-<K$,  #/*   &0              @('G
MF@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( "5 9E'N
M9=,:IP(  ,L%   9              " @<^G  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ )4!F44UR-UDA&P  FE@  !D
M     ("!K:H  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "5 9E''T4==$ 4  )8,   9              "
M@8#3  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ )4!F
M41*=BW'\ P  _0@  !D              ("!Q]@  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    "  E0&91GK E)9D$   9#0  &0
M        @('ZW   >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( "5 9E'?U-O^W0(  "D&   9              " @<KA  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ )4!F4?[3)>*E @  -P<
M !D              ("!WN0  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    "  E0&91*"3JF% "   =!0  &0              @(&ZYP
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( "5 9E'(!,C*
MD@,  #X,   9              " @4'J  !X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ )4!F42@*UQI& P  , L  !D
M ("!"NX  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    "  E
M0&910K(51*\"  "8!P  &0              @(&'\0  >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( "5 9E'IXF?@8P,  #@+   9
M          " @6WT  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#
M%     @ )4!F472-J.%A!0  TAD  !D              ("!!_@  'AL+W=O
M<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    "  E0&91N\42)\,"  #7
M"   &0              @(&?_0  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM
M;%!+ 0(4 Q0    ( "5 9E&+@$YTU@(   X(   9              " @9D
M 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ )4!F4<W)
M\OE> P  J L  !D              ("!I@,! 'AL+W=O<FMS:&5E=',O<VAE
M970S.2YX;6Q02P$"% ,4    "  E0&910H:F$I\"   P!P  &0
M    @($[!P$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M "5 9E'U?.C6WP,  (@.   9              " @1$* 0!X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ )4!F477E8BI% P  A@P  !D
M             ("!)PX! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    "  E0&914,GB[F8$   D$@  &0              @(&C$0$ >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( "5 9E&=8T'&E ,
M %\,   9              " @4 6 0!X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ )4!F47\BI/9C P  8PT  !D              ("!
M"QH! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    "  E0&91
MM'X-'-T"  #Z!P  &0              @(&E'0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    ( "5 9E',\JC$>P@  +8R   9
M      " @;D@ 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ )4!F42,\];]9 @  7P8  !D              ("!:RD! 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  E0&9181%MSS$#  #9"@
M&0              @('[*P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    ( "5 9E'X:37KA 0  '(2   9              " @6,O 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ )4!F43@WW8LS
M!   RP\  !D              ("!'C0! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    "  E0&91?>F.K+,"  #4"   &0
M@(&(. $ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( "5
M9E%L:AKRW (  )H(   9              " @7([ 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ )4!F44YE,ER@ @  I08  !D
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M=#4X+GAM;%!+ 0(4 Q0    ( "5 9E&(/[/9]0(  /4'   9
M  " @;I/ 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
M)4!F4;X;L*=P @  2P<  !D              ("!YE(! 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    "  E0&9156G8<5\"   @#0  #0
M            @ &-50$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( "5 9E&7
MBKL<P    !,"   +              "  1=8 0!?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( "5 9E%E#88'X 0  +0G   /              "  0!9 0!X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    "  E0&91F!M:GOL!  #+(P  &@
M        @ $-7@$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    "  E0&91=-+&8MX!  !:(P  $P              @ % 8 $ 6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     1 !$ ),2  !/8@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>244</ContextCount>
  <ElementCount>355</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>64</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Nature of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/NatureofBusiness</Role>
      <ShortName>Nature of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2105102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - Merger and Financing</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/MergerandFinancing</Role>
      <ShortName>Merger and Financing</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2112104 - Disclosure - Net Loss Per Share of Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/NetLossPerShareofCommonStock</Role>
      <ShortName>Net Loss Per Share of Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - Collaboration Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CollaborationAgreements</Role>
      <ShortName>Collaboration Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2117106 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2120107 - Disclosure - Exit and Disposal Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/ExitandDisposalActivities</Role>
      <ShortName>Exit and Disposal Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2124108 - Disclosure - Equity Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/EquityTransactions</Role>
      <ShortName>Equity Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2126109 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2135110 - Disclosure - Stock-based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/StockbasedCompensation</Role>
      <ShortName>Stock-based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2140111 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/Commitments</Role>
      <ShortName>Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2148112 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2152113 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2206201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2313302 - Disclosure - Net Loss Per Share of Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockTables</Role>
      <ShortName>Net Loss Per Share of Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/NetLossPerShareofCommonStock</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2318303 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/AccruedExpenses</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2321304 - Disclosure - Exit and Disposal Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/ExitandDisposalActivitiesTables</Role>
      <ShortName>Exit and Disposal Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/ExitandDisposalActivities</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2327305 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/Debt</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2336306 - Disclosure - Stock-based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/StockbasedCompensationTables</Role>
      <ShortName>Stock-based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/StockbasedCompensation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2341307 - Disclosure - Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CommitmentsTables</Role>
      <ShortName>Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/Commitments</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2349308 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/Warrants</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Nature of Business - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails</Role>
      <ShortName>Nature of Business - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Nature of Business - Reverse Stock Split (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails</Role>
      <ShortName>Nature of Business - Reverse Stock Split (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2404403 - Disclosure - Nature of Business - Going Concern (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/NatureofBusinessGoingConcernDetails</Role>
      <ShortName>Nature of Business - Going Concern (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2411406 - Disclosure - Merger and Financing (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/MergerandFinancingDetails</Role>
      <ShortName>Merger and Financing (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/MergerandFinancing</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - Net Loss Per Share of Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails</Role>
      <ShortName>Net Loss Per Share of Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Collaboration Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CollaborationAgreementsDetails</Role>
      <ShortName>Collaboration Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/CollaborationAgreements</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/AccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/AccruedExpensesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2422410 - Disclosure - Exit and Disposal Activities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails</Role>
      <ShortName>Exit and Disposal Activities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - Exit and Disposal Activities - Schedule of Severance-Related Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails</Role>
      <ShortName>Exit and Disposal Activities - Schedule of Severance-Related Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - Equity Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/EquityTransactionsDetails</Role>
      <ShortName>Equity Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/EquityTransactions</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2428413 - Disclosure - Debt - PPP Note (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/DebtPPPNoteDetails</Role>
      <ShortName>Debt - PPP Note (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2429414 - Disclosure - Debt - Warrant Exchange Promissory Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails</Role>
      <ShortName>Debt - Warrant Exchange Promissory Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2430415 - Disclosure - Debt - EB 5 Loan Agreement Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails</Role>
      <ShortName>Debt - EB 5 Loan Agreement Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2431416 - Disclosure - Debt - Senior Secured Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails</Role>
      <ShortName>Debt - Senior Secured Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2432417 - Disclosure - Debt - Convertible Promissory Note (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails</Role>
      <ShortName>Debt - Convertible Promissory Note (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2433418 - Disclosure - Debt - Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails</Role>
      <ShortName>Debt - Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - Debt - Schedule of Debt Maturities (Excluding Interest) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails</Role>
      <ShortName>Debt - Schedule of Debt Maturities (Excluding Interest) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2437420 - Disclosure - Stock-based Compensation - Schedule of Compensation Expense for Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails</Role>
      <ShortName>Stock-based Compensation - Schedule of Compensation Expense for Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2438421 - Disclosure - Stock-based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2439422 - Disclosure - Stock-based Compensation - Schedule Options to Purchase Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails</Role>
      <ShortName>Stock-based Compensation - Schedule Options to Purchase Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2442423 - Disclosure - Commitments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails</Role>
      <ShortName>Commitments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2443424 - Disclosure - Commitments - Operating leases, components of lease expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails</Role>
      <ShortName>Commitments - Operating leases, components of lease expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2444425 - Disclosure - Commitments - Operating leases, supplemental balance sheet information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails</Role>
      <ShortName>Commitments - Operating leases, supplemental balance sheet information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2445426 - Disclosure - Commitments - Operating leases, supplemental cash flow information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalcashflowinformationDetails</Role>
      <ShortName>Commitments - Operating leases, supplemental cash flow information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2446427 - Disclosure - Commitments - Operating leases, future minimum lease payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails</Role>
      <ShortName>Commitments - Operating leases, future minimum lease payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2447428 - Disclosure - Commitments - Finance leases, future minimum lease payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails</Role>
      <ShortName>Commitments - Finance leases, future minimum lease payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2450429 - Disclosure - Warrants - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails</Role>
      <ShortName>Warrants - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2451430 - Disclosure - Warrants - Schedule of Roll-forward of Series??B Warrant Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails</Role>
      <ShortName>Warrants - Schedule of Roll-forward of Series??B Warrant Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ocgn-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2453431 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.deitaxonomy.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.deitaxonomy.com/role/SubsequentEvents</ParentRole>
      <Position>60</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="ocgn-20200930.htm">ocgn-20200930.htm</File>
    <File>ocgn-20200930.xsd</File>
    <File>ocgn-20200930_cal.xml</File>
    <File>ocgn-20200930_def.xml</File>
    <File>ocgn-20200930_lab.xml</File>
    <File>ocgn-20200930_pre.xml</File>
    <File>ocgn-20200930x10qxex311.htm</File>
    <File>ocgn-20200930x10qxex312.htm</File>
    <File>ocgn-20200930x10qxex321.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>77
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ocgn-20200930.htm": {
   "axisCustom": 0,
   "axisStandard": 24,
   "contextCount": 244,
   "dts": {
    "calculationLink": {
     "local": [
      "ocgn-20200930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ocgn-20200930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "ocgn-20200930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ocgn-20200930_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ocgn-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "ocgn-20200930.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 460,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 10,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 15
   },
   "keyCustom": 46,
   "keyStandard": 309,
   "memberCustom": 32,
   "memberStandard": 25,
   "nsprefix": "ocgn",
   "nsuri": "http://www.deitaxonomy.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.deitaxonomy.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - Merger and Financing",
     "role": "http://www.deitaxonomy.com/role/MergerandFinancing",
     "shortName": "Merger and Financing",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112104 - Disclosure - Net Loss Per Share of Common Stock",
     "role": "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStock",
     "shortName": "Net Loss Per Share of Common Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - Collaboration Agreements",
     "role": "http://www.deitaxonomy.com/role/CollaborationAgreements",
     "shortName": "Collaboration Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117106 - Disclosure - Accrued Expenses",
     "role": "http://www.deitaxonomy.com/role/AccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120107 - Disclosure - Exit and Disposal Activities",
     "role": "http://www.deitaxonomy.com/role/ExitandDisposalActivities",
     "shortName": "Exit and Disposal Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124108 - Disclosure - Equity Transactions",
     "role": "http://www.deitaxonomy.com/role/EquityTransactions",
     "shortName": "Equity Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126109 - Disclosure - Debt",
     "role": "http://www.deitaxonomy.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135110 - Disclosure - Stock-based Compensation",
     "role": "http://www.deitaxonomy.com/role/StockbasedCompensation",
     "shortName": "Stock-based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140111 - Disclosure - Commitments",
     "role": "http://www.deitaxonomy.com/role/Commitments",
     "shortName": "Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ocgn:WarrantsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148112 - Disclosure - Warrants",
     "role": "http://www.deitaxonomy.com/role/Warrants",
     "shortName": "Warrants",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ocgn:WarrantsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ocgn:ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152113 - Disclosure - Subsequent Events",
     "role": "http://www.deitaxonomy.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2206201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ocgn:ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ocgn:ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313302 - Disclosure - Net Loss Per Share of Common Stock (Tables)",
     "role": "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockTables",
     "shortName": "Net Loss Per Share of Common Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318303 - Disclosure - Accrued Expenses (Tables)",
     "role": "http://www.deitaxonomy.com/role/AccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321304 - Disclosure - Exit and Disposal Activities (Tables)",
     "role": "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesTables",
     "shortName": "Exit and Disposal Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327305 - Disclosure - Debt (Tables)",
     "role": "http://www.deitaxonomy.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336306 - Disclosure - Stock-based Compensation (Tables)",
     "role": "http://www.deitaxonomy.com/role/StockbasedCompensationTables",
     "shortName": "Stock-based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341307 - Disclosure - Commitments (Tables)",
     "role": "http://www.deitaxonomy.com/role/CommitmentsTables",
     "shortName": "Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349308 - Disclosure - Warrants (Tables)",
     "role": "http://www.deitaxonomy.com/role/WarrantsTables",
     "shortName": "Warrants (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Nature of Business - Additional Information (Details)",
     "role": "http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails",
     "shortName": "Nature of Business - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i4b761e61f7dd46ec849abd0bd8bb9544_D20200101-20200930",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "ocgn:BusinessCombinationIssuedSharesExchangeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403402 - Disclosure - Nature of Business - Reverse Stock Split (Details)",
     "role": "http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails",
     "shortName": "Nature of Business - Reverse Stock Split (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i4b761e61f7dd46ec849abd0bd8bb9544_D20200101-20200930",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "ocgn:BusinessCombinationIssuedSharesExchangeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "id67dafc585b7439a9965e753932cfa64_D20200701-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404403 - Disclosure - Nature of Business - Going Concern (Details)",
     "role": "http://www.deitaxonomy.com/role/NatureofBusinessGoingConcernDetails",
     "shortName": "Nature of Business - Going Concern (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ocgn:AssetHeldForSalePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ocgn:AssetHeldForSalePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "id67dafc585b7439a9965e753932cfa64_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ocgn:ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)",
     "role": "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ocgn:ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iff87527ea3fc46fdacb3342226f9f0f9_I20190930",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "ie03e503b087545748223eb40f7381d1f_D20191004-20191004",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ocgn:NumberOfSeriesOfWarrantsIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "series",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411406 - Disclosure - Merger and Financing (Details)",
     "role": "http://www.deitaxonomy.com/role/MergerandFinancingDetails",
     "shortName": "Merger and Financing (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "ie03e503b087545748223eb40f7381d1f_D20191004-20191004",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ocgn:NumberOfSeriesOfWarrantsIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "series",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "id67dafc585b7439a9965e753932cfa64_D20200701-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - Net Loss Per Share of Common Stock (Details)",
     "role": "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails",
     "shortName": "Net Loss Per Share of Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "id67dafc585b7439a9965e753932cfa64_D20200701-20200930",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "id67dafc585b7439a9965e753932cfa64_D20200701-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Collaboration Agreements (Details)",
     "role": "http://www.deitaxonomy.com/role/CollaborationAgreementsDetails",
     "shortName": "Collaboration Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "id67b6ca4f8b24a43beb2890f097dc5c2_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "ocgn:CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "ocgn:ResearchAndDevelopmentExpensesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - Accrued Expenses (Details)",
     "role": "http://www.deitaxonomy.com/role/AccruedExpensesDetails",
     "shortName": "Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "ocgn:ResearchAndDevelopmentExpensesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i2cc0ad28c5724aca9234dcc6309e44c1_D20200615-20200615",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated",
      "reportCount": 1,
      "unique": true,
      "unitRef": "employee",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422410 - Disclosure - Exit and Disposal Activities - Narrative (Details)",
     "role": "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails",
     "shortName": "Exit and Disposal Activities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i2cc0ad28c5724aca9234dcc6309e44c1_D20200615-20200615",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated",
      "reportCount": 1,
      "unique": true,
      "unitRef": "employee",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "id67dafc585b7439a9965e753932cfa64_D20200701-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "role": "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "id67dafc585b7439a9965e753932cfa64_D20200701-20200930",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "ic7c6f3716ee34faa9aa88da0c9ae7781_I20191231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - Exit and Disposal Activities - Schedule of Severance-Related Charges (Details)",
     "role": "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails",
     "shortName": "Exit and Disposal Activities - Schedule of Severance-Related Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "ic7c6f3716ee34faa9aa88da0c9ae7781_I20191231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i84a2946964c741a8929a7e3b1f4d5681_D20200801-20200831",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - Equity Transactions (Details)",
     "role": "http://www.deitaxonomy.com/role/EquityTransactionsDetails",
     "shortName": "Equity Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i84a2946964c741a8929a7e3b1f4d5681_D20200801-20200831",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428413 - Disclosure - Debt - PPP Note (Details)",
     "role": "http://www.deitaxonomy.com/role/DebtPPPNoteDetails",
     "shortName": "Debt - PPP Note (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i8d689227ca8e441da7199a43bf5eb16a_I20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429414 - Disclosure - Debt - Warrant Exchange Promissory Notes (Details)",
     "role": "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails",
     "shortName": "Debt - Warrant Exchange Promissory Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i82bf19a1e632417380b5fe0e427dd9b7_I20200422",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430415 - Disclosure - Debt - EB 5 Loan Agreement Borrowings (Details)",
     "role": "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails",
     "shortName": "Debt - EB 5 Loan Agreement Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i89af07cba55243ada1a697e372c93c26_I20160930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "id67dafc585b7439a9965e753932cfa64_D20200701-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431416 - Disclosure - Debt - Senior Secured Convertible Notes (Details)",
     "role": "http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails",
     "shortName": "Debt - Senior Secured Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "ic2e106364d89410d8fa73ea0a7ada5a2_I20190521",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iba956723fd0740239620e5f29bcb4ca7_I20190516",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ocgn:CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432417 - Disclosure - Debt - Convertible Promissory Note (Details)",
     "role": "http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails",
     "shortName": "Debt - Convertible Promissory Note (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iba956723fd0740239620e5f29bcb4ca7_I20190516",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ocgn:CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433418 - Disclosure - Debt - Convertible Notes (Details)",
     "role": "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
     "shortName": "Debt - Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i10c8c2503acb440f996a2813e4f347ab_I20191231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "ocgn:ConvertibleDebtEquityFinancingTriggeredDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - Debt - Schedule of Debt Maturities (Excluding Interest) (Details)",
     "role": "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails",
     "shortName": "Debt - Schedule of Debt Maturities (Excluding Interest) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "id67dafc585b7439a9965e753932cfa64_D20200701-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437420 - Disclosure - Stock-based Compensation - Schedule of Compensation Expense for Options Granted (Details)",
     "role": "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails",
     "shortName": "Stock-based Compensation - Schedule of Compensation Expense for Options Granted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "id67dafc585b7439a9965e753932cfa64_D20200701-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "ib39682b0589a4563bb7ca6600d2c74bb_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)",
     "role": "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i64c7a1ac8ad047eca985cb5ee6a0d2c2_D20190101-20190331",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438421 - Disclosure - Stock-based Compensation - Narrative (Details)",
     "role": "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails",
     "shortName": "Stock-based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "ia02f18907a7d4f3ead8d53843ee2de3c_I20191231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "ocgn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i112d9bfb269247e5a5787276fb3cd7ac_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439422 - Disclosure - Stock-based Compensation - Schedule Options to Purchase Common Stock (Details)",
     "role": "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails",
     "shortName": "Stock-based Compensation - Schedule Options to Purchase Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "ic2cccbbd683349c48b4927e90fb68e74_D20200101-20200930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i2693db88967c4ff0a47ea33524803019_I20180630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442423 - Disclosure - Commitments - Additional Information (Details)",
     "role": "http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails",
     "shortName": "Commitments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeaseDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "id67dafc585b7439a9965e753932cfa64_D20200701-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443424 - Disclosure - Commitments - Operating leases, components of lease expense (Details)",
     "role": "http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails",
     "shortName": "Commitments - Operating leases, components of lease expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "id67dafc585b7439a9965e753932cfa64_D20200701-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ocgn:SupplementalBalanceSheetInformationLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444425 - Disclosure - Commitments - Operating leases, supplemental balance sheet information (Details)",
     "role": "http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails",
     "shortName": "Commitments - Operating leases, supplemental balance sheet information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ocgn:SupplementalBalanceSheetInformationLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445426 - Disclosure - Commitments - Operating leases, supplemental cash flow information (Details)",
     "role": "http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalcashflowinformationDetails",
     "shortName": "Commitments - Operating leases, supplemental cash flow information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446427 - Disclosure - Commitments - Operating leases, future minimum lease payments (Details)",
     "role": "http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails",
     "shortName": "Commitments - Operating leases, future minimum lease payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447428 - Disclosure - Commitments - Finance leases, future minimum lease payments (Details)",
     "role": "http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails",
     "shortName": "Commitments - Finance leases, future minimum lease payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "iafdd84fcd6fd4125bddedf4247bb3490_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "ibc6f5729ecb242e484fb2d858d328ec4_I20190927",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450429 - Disclosure - Warrants - Additional Information (Details)",
     "role": "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails",
     "shortName": "Warrants - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "ibc6f5729ecb242e484fb2d858d328ec4_I20190927",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i4e68dccda8164000aaf8c597ab10b628_I20190930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451430 - Disclosure - Warrants - Schedule of Roll-forward of Series\u00a0B Warrant Liability (Details)",
     "role": "http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails",
     "shortName": "Warrants - Schedule of Roll-forward of Series\u00a0B Warrant Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "ief05580895fc46368234c7da5575be31_I20181231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "ia40e42f6afba4d05aafce4ad7747ba3b_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "role": "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "ia40e42f6afba4d05aafce4ad7747ba3b_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i2693db88967c4ff0a47ea33524803019_I20180630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453431 - Disclosure - Subsequent Events (Details)",
     "role": "http://www.deitaxonomy.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i86c757f96f724d6b8aaa688ac26a295e_D20201009-20201009",
      "decimals": "0",
      "lang": "en-US",
      "name": "ocgn:OperatingLeaseTotalBasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Nature of Business",
     "role": "http://www.deitaxonomy.com/role/NatureofBusiness",
     "shortName": "Nature of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ocgn-20200930.htm",
      "contextRef": "i9e90316c630e40dabfbef63c327d160a_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 64,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails",
      "http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails",
      "http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ocgn_A2014PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2014 Plan",
        "label": "2014 Plan [Member]",
        "terseLabel": "2014 Plan"
       }
      }
     },
     "localname": "A2014PlanMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_A2019PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2019 Plan",
        "label": "2019 Plan [Member]",
        "terseLabel": "2019 Plan"
       }
      }
     },
     "localname": "A2019PlanMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails",
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_ATMTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ATM Transactions",
        "label": "ATM Transactions [Member]",
        "terseLabel": "At-the-market issuance"
       }
      }
     },
     "localname": "ATMTransactionsMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_AccruedLiabilitiesClinical": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/AccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Liabilities, Clinical",
        "label": "Accrued Liabilities, Clinical",
        "terseLabel": "Clinical"
       }
      }
     },
     "localname": "AccruedLiabilitiesClinical",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_AccruedLiabilitiesProfessionalFees": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/AccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Liabilities, Professional Fees",
        "label": "Accrued Liabilities, Professional Fees",
        "terseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedLiabilitiesProfessionalFees",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_AccruedSeveranceRelatedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/AccruedExpensesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Severance-Related Liabilities, Current",
        "label": "Accrued Severance-Related Liabilities, Current",
        "terseLabel": "Severance-related"
       }
      }
     },
     "localname": "AccruedSeveranceRelatedLiabilitiesCurrent",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_AdvaiteIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Advaite, Inc.",
        "label": "Advaite, Inc. [Member]",
        "terseLabel": "Advaite"
       }
      }
     },
     "localname": "AdvaiteIncMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_AssetHeldForSalePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents asset held for sale.",
        "label": "Asset Held For Sale [Policy Text Block]",
        "terseLabel": "Asset Held for Sale"
       }
      }
     },
     "localname": "AssetHeldForSalePolicyTextBlock",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ocgn_AssetPurchaseAgreementCashConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash consideration agreed under the asset purchase agreement.",
        "label": "Asset purchase agreement, cash consideration",
        "terseLabel": "Asset purchase agreement, cash consideration"
       }
      }
     },
     "localname": "AssetPurchaseAgreementCashConsideration",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_BusinessCombinationIssuedSharesExchangeRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exchange rate of share issued to shares surrendered by stockholder of the acquired entity in a business combination.",
        "label": "Business Combination, Issued Shares Exchange Rate",
        "terseLabel": "Shares issued exchange rate to former Ocugen's stockholders (in USD per share)"
       }
      }
     },
     "localname": "BusinessCombinationIssuedSharesExchangeRate",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ocgn_ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Consideration Transferred In Excess Of Fair Value",
        "label": "Class Of Warrant Or Right, Consideration Transferred In Excess Of Fair Value",
        "terseLabel": "Fair value of consideration transferred to settle warrants in excess of fair value of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightConsiderationTransferredInExcessOfFairValue",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_ClassOfWarrantOrRightExercisable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class of Warrant or Right, Exercisable",
        "label": "Class of Warrant or Right, Exercisable",
        "terseLabel": "Class of warrant or right, exercisable (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisable",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ocgn_ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of trading days considered for determination of exercise price of warrants.",
        "label": "Class Of Warrant Or Right, Exercise Price Determination, Number Of Trading Days Considered",
        "terseLabel": "Warrants, exercise price determination, number of trading days"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceDeterminationNumberOfTradingDaysConsidered",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants",
        "label": "Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants",
        "totalLabel": "Fair value of consideration transferred to settle warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails": {
       "order": 1.0,
       "parentTag": "ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants, Common Stock",
        "label": "Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants, Common Stock",
        "terseLabel": "Consideration transferred, common stock"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsCommonStock",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails": {
       "order": 2.0,
       "parentTag": "ocgn_ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrants",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants, Promissory Note",
        "label": "Class Of Warrant Or Right, Fair Value Of Consideration Transferred To Settle Warrants, Promissory Note",
        "terseLabel": "Consideration transferred, Warrant Exchange Promissory Notes"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightFairValueOfConsiderationTransferredToSettleWarrantsPromissoryNote",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Number Of Employees Issued Stock In Transaction",
        "label": "Class Of Warrant Or Right, Number Of Employees Issued Stock In Transaction",
        "terseLabel": "Number of employees issued warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfEmployeesIssuedStockInTransaction",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ocgn_CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative Arrangement, At-Cost Reimbursement Recorded As Reduction In Research And Development Expense",
        "label": "Collaborative Arrangement, At-Cost Reimbursement Recorded As Reduction In Research And Development Expense",
        "terseLabel": "Reduction of research and development expense"
       }
      }
     },
     "localname": "CollaborativeArrangementAtCostReimbursementRecordedAsReductionInResearchAndDevelopmentExpense",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock, Shares Agreed To Be Sold, Stock Subscription Agreement",
        "label": "Common Stock, Shares Agreed To Be Sold, Stock Subscription Agreement",
        "terseLabel": "Common stock, shares agreed to be sold"
       }
      }
     },
     "localname": "CommonStockSharesAgreedToBeSoldStockSubscriptionAgreement",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ocgn_ControlledEquityOfferingSalesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Controlled Equity Offering Sales Agreement",
        "label": "Controlled Equity Offering Sales Agreement [Member]",
        "terseLabel": "ATMs"
       }
      }
     },
     "localname": "ControlledEquityOfferingSalesAgreementMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/EquityTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_ConvertedAdditionalSharesThresholdReleaseTriggerPrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The price over which 80% of the arithmetic average of the two lowest dollar volume-weighted average prices of a share of common stock on the NASDAQ Capital Market during the applicable Reset Period immediately preceding the applicable Reset Date to date to release converted additional shares is determined.",
        "label": "Converted Additional Shares, Threshold Release Trigger Price",
        "terseLabel": "Price over which trading price of common stock as quoted on the Nasdaq Capital Market was considered for the release of converted additional shares (in USD per share)"
       }
      }
     },
     "localname": "ConvertedAdditionalSharesThresholdReleaseTriggerPrice",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ocgn_ConvertibleDebtConversionFeatureMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Conversion feature of the convertible debt that is considered as an embedded derivative of the debt.",
        "label": "Convertible Debt Conversion Feature [Member]",
        "terseLabel": "Fair Value of Embedded Derivatives"
       }
      }
     },
     "localname": "ConvertibleDebtConversionFeatureMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_ConvertibleDebtDecember2018Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in December 2018.",
        "label": "Convertible Debt December2018 [Member]",
        "terseLabel": "December 2018"
       }
      }
     },
     "localname": "ConvertibleDebtDecember2018Member",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_ConvertibleDebtEquityFinancingTriggeredDiscount": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of discount of the convertible debt that automatically convert the same class of equity as those issued to the lowest price per share being paid by investors in the equity financing.",
        "label": "Convertible Debt, Equity Financing Triggered, Discount",
        "terseLabel": "Conversion price discount per original agreement (in a percentage)"
       }
      }
     },
     "localname": "ConvertibleDebtEquityFinancingTriggeredDiscount",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ocgn_ConvertibleDebtFebruary2019Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in February 2019.",
        "label": "Convertible Debt February2019 [Member]",
        "terseLabel": "February 2019"
       }
      }
     },
     "localname": "ConvertibleDebtFebruary2019Member",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_ConvertibleDebtJanuary2018Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in January 2018.",
        "label": "Convertible Debt January2018 [Member]",
        "terseLabel": "January 2018"
       }
      }
     },
     "localname": "ConvertibleDebtJanuary2018Member",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_ConvertibleDebtJanuary2019Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in January 2019.",
        "label": "Convertible Debt January2019 [Member]",
        "terseLabel": "January 2019"
       }
      }
     },
     "localname": "ConvertibleDebtJanuary2019Member",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_ConvertibleDebtJune2018Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in June 2018.",
        "label": "Convertible Debt June2018 [Member]",
        "terseLabel": "June 2018"
       }
      }
     },
     "localname": "ConvertibleDebtJune2018Member",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_ConvertibleDebtNovember2018Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in November 2018.",
        "label": "Convertible Debt November2018 [Member]",
        "terseLabel": "November 2018"
       }
      }
     },
     "localname": "ConvertibleDebtNovember2018Member",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_ConvertibleNotesBoardOfDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Convertible Notes, Board Of Directors",
        "label": "Convertible Notes, Board Of Directors [Member]",
        "terseLabel": "Convertible Notes - Board Of Directors"
       }
      }
     },
     "localname": "ConvertibleNotesBoardOfDirectorsMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_ConvertiblePromissoryNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Promissory notes which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Promissory Notes [Member]",
        "terseLabel": "Convertible Promissory Notes"
       }
      }
     },
     "localname": "ConvertiblePromissoryNotesMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Percentage of Principal Amount Required To Be Redeemed Upon Financing Transaction",
        "label": "Debt Instrument, Percentage of Principal Amount Required To Be Redeemed Upon Financing Transaction",
        "terseLabel": "Percentage of principal amount required to be redeemed - financing"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfPrincipalAmountRequiredToBeRedeemedUponFinancingTransaction",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ocgn_DebtRedemptionMultipleFeature": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Redemption multiple of debt's principal and unpaid interest upon consummation of the sale of all or substantially all of the assets of the Company, change in control or event of default",
        "label": "Debt, Redemption Multiple Feature",
        "terseLabel": "Redemption multiple upon default"
       }
      }
     },
     "localname": "DebtRedemptionMultipleFeature",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ocgn_DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of deferred equity issuance cost that were incurred during a noncash or partial noncash transaction.",
        "label": "Deferred Equity Issuance Cost Incurred During Noncash Or Partial Noncash Transaction",
        "terseLabel": "Reverse asset acquisition costs"
       }
      }
     },
     "localname": "DeferredEquityIssuanceCostIncurredDuringNoncashOrPartialNoncashTransaction",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_EB5ProgramBorrowingsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents borrowings from the U.S. government's Immigrant Investor Program, commonly known as the EB 5 program (the \"EB 5 Program\").",
        "label": "E B5 Program Borrowings [Member]",
        "terseLabel": "EB-5 Loan",
        "verboseLabel": "EB-5 Loan Agreement borrowings"
       }
      }
     },
     "localname": "EB5ProgramBorrowingsMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails",
      "http://www.deitaxonomy.com/role/DebtPPPNoteDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Amount Reclassified To Equity",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Amount Reclassified To Equity",
        "terseLabel": "Amount reclassified to equity"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAmountReclassifiedToEquity",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_FormerOcugenWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Former Ocugen Warrants",
        "label": "Former Ocugen Warrants [Member]",
        "terseLabel": "Former Ocugen Warrants"
       }
      }
     },
     "localname": "FormerOcugenWarrantsMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_GainsLossesOnConversionOfDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on conversion of debt.",
        "label": "Gains (Losses) on Conversion of Debt",
        "negatedTerseLabel": "Loss on debt conversion",
        "terseLabel": "Loss on debt conversion"
       }
      }
     },
     "localname": "GainsLossesOnConversionOfDebt",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_HistogenicsCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents Histogenics Corporation.",
        "label": "Histogenics Corporation [Member]",
        "terseLabel": "Histogenics"
       }
      }
     },
     "localname": "HistogenicsCorporationMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails",
      "http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_IncreaseDecreaseInLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase (Decrease) In Lease Obligations",
        "label": "Increase (Decrease) In Lease Obligations",
        "terseLabel": "Lease obligations"
       }
      }
     },
     "localname": "IncreaseDecreaseInLeaseObligations",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_January2019AndFebruary2019NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "January\u00a02019 And February\u00a02019 Notes",
        "label": "January\u00a02019 And February\u00a02019 Notes [Member]",
        "terseLabel": "January\u00a02019 and February\u00a02019 Notes"
       }
      }
     },
     "localname": "January2019AndFebruary2019NotesMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_LesseeOperatingLeaseNumberOfRenewalOptions": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating Lease, Number Of Renewal Options",
        "label": "Lessee, Operating Lease, Number Of Renewal Options",
        "terseLabel": "Number of renewal options"
       }
      }
     },
     "localname": "LesseeOperatingLeaseNumberOfRenewalOptions",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ocgn_LineOfCreditBorrowingEachDraw": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of borrowing that can be borrowed each draw from a line of credit",
        "label": "Line Of Credit Borrowing Each Draw",
        "terseLabel": "Borrowing increments"
       }
      }
     },
     "localname": "LineOfCreditBorrowingEachDraw",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_LongTermDebtMaturityAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, After Year Four",
        "label": "Long-Term Debt, Maturity, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturityAfterYearFour",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_NonCashInterestExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of non-cash interest expense during the period.",
        "label": "Non-Cash Interest Expense",
        "terseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "NonCashInterestExpense",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_NoncashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Noncash Lease Expense",
        "label": "Noncash Lease Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "NoncashLeaseExpense",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_NoncashOrPartNoncashAmountOfDeferredTransactionCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash or part noncash amount of deferred transaction cost.",
        "label": "Noncash Or Part Noncash Amount of Deferred Transaction Cost",
        "terseLabel": "Equity issuance costs"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAmountOfDeferredTransactionCost",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_NoncashOrPartNoncashOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Right-to-use asset recognized upon adoption of ASU 2018-11.",
        "label": "Noncash or Part Noncash, Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use asset related to operating leases"
       }
      }
     },
     "localname": "NoncashOrPartNoncashOperatingLeaseRightOfUseAsset",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_November2018AndDecember2018NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "November\u00a02018 And December 2018 Notes",
        "label": "November\u00a02018 And December 2018 Notes [Member]",
        "terseLabel": "November\u00a02018 and December 2018 Notes"
       }
      }
     },
     "localname": "November2018AndDecember2018NotesMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_NumberOfClinicalTrialsToBeInitiatedInTheFuture": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number Of Clinical Trials To Be Initiated In The Future",
        "label": "Number Of Clinical Trials To Be Initiated In The Future",
        "terseLabel": "Number of clinical trials to be initiated in the future"
       }
      }
     },
     "localname": "NumberOfClinicalTrialsToBeInitiatedInTheFuture",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ocgn_NumberOfEquityCompensationPlans": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number Of Equity Compensation Plans",
        "label": "Number Of Equity Compensation Plans",
        "terseLabel": "Number of equity compensation plans"
       }
      }
     },
     "localname": "NumberOfEquityCompensationPlans",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ocgn_NumberOfOrphanDrugDesignations": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number Of Orphan Drug Designations",
        "label": "Number Of Orphan Drug Designations",
        "terseLabel": "Number of ODDs received (orphan drug designation)"
       }
      }
     },
     "localname": "NumberOfOrphanDrugDesignations",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ocgn_NumberOfSeriesOfWarrantsIssued": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number Of Series Of Warrants Issued",
        "label": "Number Of Series Of Warrants Issued",
        "terseLabel": "Number of series of warrants issued"
       }
      }
     },
     "localname": "NumberOfSeriesOfWarrantsIssued",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ocgn_OperatingLeaseTotalBasePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Lease, Total Base Payments",
        "label": "Operating Lease, Total Base Payments",
        "terseLabel": "Base payments"
       }
      }
     },
     "localname": "OperatingLeaseTotalBasePayments",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_PaycheckProtectionProgramLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Paycheck Protection Program Loan",
        "label": "Paycheck Protection Program Loan [Member]",
        "verboseLabel": "PPP Note"
       }
      }
     },
     "localname": "PaycheckProtectionProgramLoanMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtPPPNoteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_PercentageOfIncreaseInPurchasePriceOfAssetPerMonth": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of asset purchase agreement that the purchase price increases per month between October 31, 2019 and the closing date if agreement is not terminated.",
        "label": "Percentage of Increase In Purchase Price Of Asset Per Month",
        "terseLabel": "Percentage of increase in purchase price of asset per month (in percentage)"
       }
      }
     },
     "localname": "PercentageOfIncreaseInPurchasePriceOfAssetPerMonth",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ocgn_PreMergerFinancingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pre-Merger Financing",
        "label": "Pre-Merger Financing [Member]",
        "terseLabel": "Pre-Merger Financing"
       }
      }
     },
     "localname": "PreMergerFinancingMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_ProceedsFromPreMergerFinancingFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds from Pre Merger Financing, Financing Activities",
        "label": "Proceeds from Pre Merger Financing, Financing Activities",
        "terseLabel": "Proceeds from Pre-Merger Financing"
       }
      }
     },
     "localname": "ProceedsFromPreMergerFinancingFinancingActivities",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_ResearchAndDevelopmentExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/AccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Research And Development Expenses Current",
        "terseLabel": "Research\u00a0and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensesCurrent",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_ReverseAssetAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reverse Asset Acquisition",
        "label": "Reverse Asset Acquisition [Member]",
        "terseLabel": "Reverse asset acquisition"
       }
      }
     },
     "localname": "ReverseAssetAcquisitionMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_ReverseMergerAndFinancingDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reverse Merger And Financing Disclosure [Line Items]",
        "terseLabel": "Reverse Merger and Financing"
       }
      }
     },
     "localname": "ReverseMergerAndFinancingDisclosureLineItems",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ocgn_ReverseMergerAndFinancingDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about reverse merger and financing.",
        "label": "Reverse Merger And Financing Disclosure [Table]",
        "terseLabel": "Reverse Merger And Financing Disclosure [Table]"
       }
      }
     },
     "localname": "ReverseMergerAndFinancingDisclosureTable",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ocgn_SaleOfStockAdditionalDebtCancelledInExchangeForStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale Of Stock, Additional Debt Cancelled In Exchange For Stock",
        "label": "Sale Of Stock, Additional Debt Cancelled In Exchange For Stock",
        "terseLabel": "Accredited investors agreement to cancel additional portion owed representing a discount"
       }
      }
     },
     "localname": "SaleOfStockAdditionalDebtCancelledInExchangeForStock",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/EquityTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale of Stock And Issuance Of Warrants, Consideration Received Per Transaction",
        "label": "Sale of Stock And Issuance Of Warrants, Consideration Received Per Transaction",
        "terseLabel": "Aggregate purchase price"
       }
      }
     },
     "localname": "SaleOfStockAndIssuanceOfWarrantsConsiderationReceivedPerTransaction",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_SaleOfStockNumberOfSharesOutstandingRemainingCapacity": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale of Stock, Number of Shares Outstanding, Remaining Capacity",
        "label": "Sale of Stock, Number of Shares Outstanding, Remaining Capacity",
        "terseLabel": "Number of shares outstanding, remaining capacity"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesOutstandingRemainingCapacity",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/EquityTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ocgn_SaleOfStockOutstandingObligationCancelledInExchangeForStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale Of Stock, Outstanding Obligation Cancelled In Exchange For Stock",
        "label": "Sale Of Stock, Outstanding Obligation Cancelled In Exchange For Stock",
        "terseLabel": "Accredited investors agreement to cancel outstanding obligation"
       }
      }
     },
     "localname": "SaleOfStockOutstandingObligationCancelledInExchangeForStock",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/EquityTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ocgn_ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents, restricted cash.",
        "label": "Schedule of Cash and Cash Equivalents, Restricted Cash [Table Text Block]",
        "terseLabel": "Schedule of Cash, Cash Equivalents, and Restricted Cash"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsRestrictedCashTableTextBlock",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ocgn_SecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the information pertaining to Securities Purchase Agreement entered with several investors.",
        "label": "Securities Purchase Agreement [Member]",
        "terseLabel": "Financing SPA"
       }
      }
     },
     "localname": "SecuritiesPurchaseAgreementMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_SeniorSecuredConvertibleNotesJune2019Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior secured borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in June 2019.",
        "label": "Senior Secured Convertible Notes June2019 [Member]",
        "terseLabel": "June 2019 Senior Secured Convertible Notes"
       }
      }
     },
     "localname": "SeniorSecuredConvertibleNotesJune2019Member",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_SeniorSecuredConvertibleNotesMay2019Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior secured borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock, issued in May 2019.",
        "label": "Senior Secured Convertible Notes May2019 [Member]",
        "terseLabel": "May 2019 Senior Secured Convertible Notes"
       }
      }
     },
     "localname": "SeniorSecuredConvertibleNotesMay2019Member",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_SeniorSecuredConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior secured borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Senior Secured Convertible Notes [Member]",
        "terseLabel": "Senior Secured Convertible Notes"
       }
      }
     },
     "localname": "SeniorSecuredConvertibleNotesMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_SeriesAWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This member stands for Series A Warrants.",
        "label": "Series A Warrants [Member]",
        "terseLabel": "Series A Warrants"
       }
      }
     },
     "localname": "SeriesAWarrantsMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails",
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_SeriesBWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This member stands for Series B Warrants.",
        "label": "Series B Warrants [Member]",
        "terseLabel": "Series B Warrants"
       }
      }
     },
     "localname": "SeriesBWarrantsMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails",
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails",
      "http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_SeriesCWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This member stands for Series C Warrants.",
        "label": "Series C Warrants [Member]",
        "terseLabel": "Series C Warrants"
       }
      }
     },
     "localname": "SeriesCWarrantsMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails",
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Automatic Increase In Shares To Be Issue, Percentage",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Automatic Increase In Shares To Be Issue, Percentage",
        "terseLabel": "Automatic increase in shares to be issued (in percentage)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAutomaticIncreaseInSharesToBeIssuePercentage",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ocgn_SubscriptionAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Subscription Agreements",
        "label": "Subscription Agreements [Member]",
        "terseLabel": "Subscription Agreements",
        "verboseLabel": "Subscription agreements"
       }
      }
     },
     "localname": "SubscriptionAgreementsMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.deitaxonomy.com/role/EquityTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_SupplementalBalanceSheetInformationLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of balance sheet information related to leases.",
        "label": "Supplemental balance sheet information leases [table text block]",
        "terseLabel": "Schedule of supplemental balance sheet information related to leases"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationLeasesTableTextBlock",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ocgn_WarrantExchangePromissoryNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrant Exchange Promissory Notes",
        "label": "Warrant Exchange Promissory Notes [Member]",
        "terseLabel": "Warrant Exchange Promissory Notes",
        "verboseLabel": "Warrant Exchange Promissory Notes"
       }
      }
     },
     "localname": "WarrantExchangePromissoryNotesMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtPPPNoteDetails",
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_WarrantsExchangedForCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrants Exchanged For Common Stock",
        "label": "Warrants Exchanged For Common Stock [Member]",
        "terseLabel": "Warrant Exchange"
       }
      }
     },
     "localname": "WarrantsExchangedForCommonStockMember",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ocgn_WarrantsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrants",
        "label": "Warrants [Text Block]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantsTextBlock",
     "nsuri": "http://www.deitaxonomy.com/20200930",
     "presentation": [
      "http://www.deitaxonomy.com/role/Warrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r47",
      "r89"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Board members"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r228",
      "r231",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r372",
      "r401",
      "r402"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails",
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r228",
      "r231",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r372",
      "r401",
      "r402"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails",
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r218",
      "r228",
      "r231",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r372",
      "r401",
      "r402"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails",
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r218",
      "r228",
      "r231",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r372",
      "r401",
      "r402"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails",
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails",
      "http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails",
      "http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r195",
      "r229",
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails",
      "http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r150",
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/AccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/AccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/AccruedExpensesDetails",
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r49",
      "r50",
      "r51",
      "r93",
      "r94",
      "r95",
      "r288",
      "r405",
      "r406"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r24",
      "r261"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r258",
      "r259",
      "r260"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": {
     "auth_ref": [
      "r207",
      "r212",
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.",
        "label": "Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature",
        "terseLabel": "Increase in additional paid-in capital from conversion"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r232",
      "r234",
      "r263",
      "r264"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r207",
      "r212"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "terseLabel": "Commissions, fees and expenses",
        "verboseLabel": "Commissions and equity issuance costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://www.deitaxonomy.com/role/EquityTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r234",
      "r251",
      "r262"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r65",
      "r78",
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "verboseLabel": "Accretion of debt discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive securities outstanding excluded from the computation of diluted weighted average shares outstanding"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r88",
      "r136",
      "r139",
      "r145",
      "r154",
      "r283",
      "r290",
      "r307",
      "r378",
      "r391"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r46",
      "r88",
      "r154",
      "r283",
      "r290",
      "r307"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure": {
     "auth_ref": [
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of assets classified as held for sale.",
        "label": "Assets Held-for-sale, Long Lived, Fair Value Disclosure",
        "terseLabel": "Quoted price of assets held for sale of NeoCart"
       }
      }
     },
     "localname": "AssetsHeldForSaleLongLivedFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent": {
     "auth_ref": [
      "r171"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.",
        "label": "Assets Held-for-sale, Not Part of Disposal Group, Current",
        "terseLabel": "Asset held for sale",
        "verboseLabel": "Asset held for sale less cost to sell"
       }
      }
     },
     "localname": "AssetsHeldForSaleNotPartOfDisposalGroupCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r235",
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails",
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Consolidation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r227",
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r227",
      "r230",
      "r272",
      "r273"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r31",
      "r80"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r13",
      "r81",
      "r86",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r75",
      "r80",
      "r85"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "terseLabel": "Cash, cash equivalents and restricted cash",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.deitaxonomy.com/role/NatureofBusinessGoingConcernDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r75",
      "r308"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r216",
      "r233"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails",
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails",
      "http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails",
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails",
      "http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Initial exercise price (in USD per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class of Warrant or Right"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails",
      "http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Number of common shares in to which the warrants are exercisable (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Number of warrants outstanding (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r216",
      "r233"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails",
      "http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementAccountingPolicy": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for collaborative arrangements.",
        "label": "Collaborative Arrangement, Accounting Policy [Policy Text Block]",
        "terseLabel": "Collaboration Arrangements"
       }
      }
     },
     "localname": "CollaborativeArrangementAccountingPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r276",
      "r277",
      "r281"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaboration Agreements"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CollaborationAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement.",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "terseLabel": "Advaite Agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r42",
      "r194",
      "r383",
      "r397"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 11)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r196"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Commitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r93",
      "r94"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common\u00a0Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable": {
     "auth_ref": [
      "r23"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of subscription receivable from investors who have been allocated common stock.",
        "label": "Common Stock, Share Subscribed but Unissued, Subscriptions Receivable",
        "terseLabel": "Aggregate offering price"
       }
      }
     },
     "localname": "CommonStockShareSubscribedButUnissuedSubscriptionsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/EquityTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r23",
      "r207"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesSubscribedButUnissued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.",
        "label": "Common Stock, Shares Subscribed but Unissued",
        "terseLabel": "Number of shares sold in subscription agreement"
       }
      }
     },
     "localname": "CommonStockSharesSubscribedButUnissued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/EquityTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock; $0.01 par value; 200,000,000 authorized; 162,147,973 and 52,746,728 shares issued at September\u00a030, 2020 and December\u00a031, 2019, respectively; 162,026,473 and 52,625,228 shares outstanding at September\u00a030, 2020 and December\u00a031, 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r53",
      "r55",
      "r56",
      "r60",
      "r385",
      "r400"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "terseLabel": "Nature of Business"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails",
      "http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "auth_ref": [
      "r289",
      "r294"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails",
      "http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r86",
      "r285"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleDebt": {
     "auth_ref": [
      "r20",
      "r380",
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.",
        "label": "Convertible Debt",
        "terseLabel": "Note principal outstanding"
       }
      }
     },
     "localname": "ConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r86",
      "r181",
      "r182",
      "r189"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Exit and Disposal Activities"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtConversionOriginalDebtAmount1": {
     "auth_ref": [
      "r82",
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Original Debt, Amount",
        "terseLabel": "Conversion of convertible notes"
       }
      }
     },
     "localname": "DebtConversionOriginalDebtAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r379",
      "r380",
      "r390"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails",
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails",
      "http://www.deitaxonomy.com/role/DebtPPPNoteDetails",
      "http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r20",
      "r200",
      "r380",
      "r390"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Principal outstanding",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails",
      "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails",
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r318",
      "r320"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Convertible Note Principal Amount",
        "verboseLabel": "Aggregate amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails",
      "http://www.deitaxonomy.com/role/DebtPPPNoteDetails",
      "http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails",
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails",
      "http://www.deitaxonomy.com/role/DebtPPPNoteDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails",
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails",
      "http://www.deitaxonomy.com/role/DebtPPPNoteDetails",
      "http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails",
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails",
      "http://www.deitaxonomy.com/role/DebtPPPNoteDetails",
      "http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Period one"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Period two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r40",
      "r90",
      "r208",
      "r209",
      "r210",
      "r211",
      "r317",
      "r318",
      "r320",
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails",
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails",
      "http://www.deitaxonomy.com/role/DebtPPPNoteDetails",
      "http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Maturity term (in months)"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r317",
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Original issue discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r319"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "negatedLabel": "Debt Issuance Costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r32",
      "r319"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedLabel": "Less: unamortized debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails",
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r78",
      "r172"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r295",
      "r297",
      "r298",
      "r299"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Net loss per share of common stock - basic and diluted (in USD per share)",
        "verboseLabel": "Net loss per share of common share - basic and diluted (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r120"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share of Common Stock"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r308"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of changes in exchange rate on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.",
        "label": "Embedded Derivative, Fair Value of Embedded Derivative Liability",
        "negatedLabel": "Fair Value of Embedded Derivatives"
       }
      }
     },
     "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/AccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee-related"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation expense related to options outstanding, weighted average period for expense to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Severance-related charges"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails",
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based payment arrangement, option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r98",
      "r106",
      "r108",
      "r121",
      "r158",
      "r207",
      "r212",
      "r258",
      "r259",
      "r260",
      "r270",
      "r271",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r405",
      "r406",
      "r407"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.",
        "label": "Extinguishment of Debt [Axis]",
        "terseLabel": "Extinguishment of Debt [Axis]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of debt extinguished.",
        "label": "Extinguishment of Debt, Type [Domain]",
        "terseLabel": "Extinguishment of Debt, Type [Domain]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r301",
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r219",
      "r220",
      "r225",
      "r226",
      "r301",
      "r346"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r301",
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]",
        "terseLabel": "Reconciliation of Series B Warrant liability"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": {
     "auth_ref": [
      "r304",
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Roll-forward of Series B Warrant Liability"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues": {
     "auth_ref": [
      "r305",
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues",
        "terseLabel": "Fair value at issuance"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease": {
     "auth_ref": [
      "r304",
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease)",
        "terseLabel": "Change in fair value of embedded derivatives"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs": {
     "auth_ref": [
      "r300",
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsScheduleofRollforwardofSeriesBWarrantLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r322",
      "r335"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Schedule of maturities of finance leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2020"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease liability.",
        "label": "Finance Lease, Liability, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Liability, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: present value adjustment"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsFinanceleasesfutureminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r324",
      "r331"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedLabel": "Financing lease principal payments"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r152",
      "r153",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r78",
      "r203",
      "r204"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "terseLabel": "Loss on debt conversion"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails",
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r78",
      "r170"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Impairment charge"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails",
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails",
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r57",
      "r135",
      "r316",
      "r319",
      "r386"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.deitaxonomy.com/role/DebtSeniorSecuredConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r65",
      "r202"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r382",
      "r398"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable",
        "terseLabel": "Plus: accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r63",
      "r134"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r334",
      "r336"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of components of lease expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeFinanceLeaseDiscountRate": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discount rate used by lessee to determine present value of finance lease payments.",
        "label": "Lessee, Finance Lease, Discount Rate",
        "terseLabel": "Interest rate (as a percent)"
       }
      }
     },
     "localname": "LesseeFinanceLeaseDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of maturities of operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2020"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: present value adjustment"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lease renewal term (in years)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Leases, term of contract (in years)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsAdditionalInformationDetails",
      "http://www.deitaxonomy.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r36",
      "r88",
      "r140",
      "r154",
      "r284",
      "r290",
      "r291",
      "r307"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r28",
      "r88",
      "r154",
      "r307",
      "r381",
      "r395"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r38",
      "r88",
      "r154",
      "r284",
      "r290",
      "r291",
      "r307"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.",
        "label": "Liabilities, Fair Value Adjustment",
        "negatedLabel": "Change in fair value of derivative liability",
        "terseLabel": "Change in fair value of derivative liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r20",
      "r21",
      "r88",
      "r154",
      "r284",
      "r290",
      "r291",
      "r307"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r20",
      "r380",
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Company borrowed"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r35"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LinesOfCreditFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time.",
        "label": "Lines of Credit, Fair Value Disclosure",
        "terseLabel": "Lines of credit"
       }
      }
     },
     "localname": "LinesOfCreditFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Loans payable"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails",
      "http://www.deitaxonomy.com/role/DebtPPPNoteDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r20",
      "r201",
      "r380",
      "r393"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "netLabel": "Total carrying value of debt, net",
        "terseLabel": "Carrying Value upon Issuance",
        "totalLabel": "Carrying value"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails",
      "http://www.deitaxonomy.com/role/DebtPPPNoteDetails",
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r91",
      "r197"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r91",
      "r197"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r91",
      "r197"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r91",
      "r197"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtScheduleofDebtMaturitiesExcludingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long term debt, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails",
      "http://www.deitaxonomy.com/role/DebtPPPNoteDetails",
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r40",
      "r198"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails",
      "http://www.deitaxonomy.com/role/DebtEB5LoanAgreementBorrowingsDetails",
      "http://www.deitaxonomy.com/role/DebtPPPNoteDetails",
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Price Volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r1",
      "r274"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Merger and Financing"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancing"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r122",
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Nature of Business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NatureofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r75",
      "r76",
      "r79"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r52",
      "r54",
      "r59",
      "r79",
      "r88",
      "r97",
      "r102",
      "r103",
      "r104",
      "r105",
      "r107",
      "r108",
      "r111",
      "r136",
      "r138",
      "r141",
      "r144",
      "r146",
      "r154",
      "r307",
      "r384",
      "r399"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss\u2014basic and diluted"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.deitaxonomy.com/role/NatureofBusinessGoingConcernDetails",
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105",
      "r109",
      "r110",
      "r112",
      "r114",
      "r136",
      "r138",
      "r141",
      "r144",
      "r146"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net loss to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "RECENT ACCOUNTING PRONOUNCEMENTS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r96",
      "r97",
      "r98",
      "r99",
      "r100",
      "r101",
      "r104",
      "r119",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r268",
      "r269",
      "r270",
      "r271",
      "r374",
      "r375",
      "r376",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Standards and Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesIssued1": {
     "auth_ref": [
      "r82",
      "r83",
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fair value of notes issued in noncash investing and financing activities.",
        "label": "Notes Issued",
        "verboseLabel": "Issuance of Warrant Exchange Promissory Notes"
       }
      }
     },
     "localname": "NotesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableToBanksMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A written promise to pay a note to a bank.",
        "label": "Notes Payable to Banks [Member]",
        "terseLabel": "Notes payable"
       }
      }
     },
     "localname": "NotesPayableToBanksMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtPPPNoteDetails",
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NatureofBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r136",
      "r138",
      "r141",
      "r144",
      "r146"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r329",
      "r336"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r322"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasesfutureminimumleasepaymentsDetails",
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r322"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease obligation",
        "verboseLabel": "Current lease obligations"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r322"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      },
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease obligation, less current portion",
        "verboseLabel": "Non-current lease obligations"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalbalancesheetinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r333",
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate\u2014operating leases (in percentage)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalcashflowinformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r332",
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease terms\u2014operating leases (years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasessupplementalcashflowinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r37"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/AccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r37"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r73",
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Severance-related payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedLabel": "Payments of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Payment of equity issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedTerseLabel": "Payment of reverse asset acquisition costs"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r235",
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockDividendsAndOtherAdjustments": {
     "auth_ref": [
      "r110",
      "r115"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.",
        "label": "Preferred Stock Dividends and Other Adjustments",
        "negatedLabel": "Deemed dividend related to Warrant Exchange (Note 12)",
        "negatedTerseLabel": "Deemed dividend related to Warrant Exchange"
       }
      }
     },
     "localname": "PreferredStockDividendsAndOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Convertible preferred stock, par value (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Convertible preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Convertible preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Convertible preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Convertible preferred stock; $0.01 par value; 10,000,000 shares authorized; seven issued and outstanding at September\u00a030, 2020 and December\u00a031, 2019"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r3",
      "r29",
      "r30"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Proceeds from issuance of debt"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r0",
      "r52",
      "r54",
      "r74",
      "r88",
      "r97",
      "r107",
      "r108",
      "r136",
      "r138",
      "r141",
      "r144",
      "r146",
      "r154",
      "r282",
      "r286",
      "r287",
      "r292",
      "r293",
      "r307",
      "r387"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r14",
      "r15",
      "r173",
      "r396"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "terseLabel": "Payments to note holders"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfOtherDebt": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for the payment of debt classified as other.",
        "label": "Repayments of Other Debt",
        "negatedTerseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfOtherDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r266"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development",
        "verboseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails",
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research and Development in Process",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r5",
      "r16",
      "r85",
      "r415"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Exit and Disposal Activities"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r176",
      "r178",
      "r185",
      "r188"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected severance benefits to be paid"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of positions eliminated during the period as a result of restructuring activities.",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated",
        "terseLabel": "Number of employees given notice of termination"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminated",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the total number of positions eliminated as of the balance sheet date since inception of the restructuring plan(s).",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date Percent",
        "terseLabel": "Workforce reduction as a result of terminations (as a percent)"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r78",
      "r175",
      "r181",
      "r187"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Severance-related charges",
        "verboseLabel": "Severance-related charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails",
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails",
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails",
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r177",
      "r183"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Accrued Severance, ending balance",
        "periodStartLabel": "Accrued Severance, beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r25",
      "r212",
      "r261",
      "r394",
      "r409",
      "r414"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedTerseLabel": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.deitaxonomy.com/role/NatureofBusinessGoingConcernDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r98",
      "r106",
      "r108",
      "r158",
      "r258",
      "r259",
      "r260",
      "r270",
      "r271",
      "r405",
      "r407"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer": {
     "auth_ref": [
      "r275",
      "r279"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606.",
        "label": "Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer",
        "terseLabel": "Collaboration revenue",
        "verboseLabel": "Collaboration revenue"
       }
      }
     },
     "localname": "RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.deitaxonomy.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r58",
      "r88",
      "r132",
      "r133",
      "r137",
      "r142",
      "r143",
      "r147",
      "r148",
      "r149",
      "r154",
      "r307",
      "r387"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Proceeds from sale of stock"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/EquityTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://www.deitaxonomy.com/role/EquityTransactionsDetails",
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails",
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares issued and sold",
        "verboseLabel": "Common stock exchanged for Series A Warrants (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/EquityTransactionsDetails",
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Price per share (in USD per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertiblePromissoryNoteDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/AccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Potentially Dilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Principal, Embedded Derivatives and Carrying Value of Debts"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental cash flow information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r40",
      "r90",
      "r208",
      "r209",
      "r210",
      "r211",
      "r317",
      "r318",
      "r320",
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r234",
      "r250",
      "r262"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Stock-based Compensation Expense for Options Granted Reflected in the Consolidate Statement of Operations and Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt Maturities (Excluding Interest)"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r179",
      "r180",
      "r184"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails",
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r177",
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Severance-Related Charges"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r235",
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails",
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails",
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r240",
      "r245",
      "r247"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails",
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails",
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleofCompensationExpenseforOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Additional Disclosures"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, options exercisable (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, cancelled (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Options, grants in period, weighted average grant date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Aggregate intrinsic value, ending balance",
        "periodStartLabel": "Aggregate intrinsic value, beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r242",
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Number of shares, options outstanding, ending balance (in shares)",
        "periodStartLabel": "Number of shares, options outstanding, beginning balance (in shares)",
        "terseLabel": "Options outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails",
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance, weighted average exercise price (in USD per share)",
        "periodStartLabel": "Beginning balance, weighted average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r233",
      "r238"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails",
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails",
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, granted (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r86",
      "r235",
      "r239"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration period (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life, options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Beginning balance, weighted average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/StockbasedCompensationScheduleOptionstoPurchaseCommonStockDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Shares issued, price per share (in USD per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtConvertibleNotesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r17",
      "r379",
      "r392"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Short-term debt, net"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r45",
      "r93",
      "r94",
      "r95",
      "r98",
      "r106",
      "r108",
      "r121",
      "r158",
      "r207",
      "r212",
      "r258",
      "r259",
      "r260",
      "r270",
      "r271",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r405",
      "r406",
      "r407"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r121",
      "r373"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r82",
      "r83",
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Obligation settled with common stock"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r44",
      "r207",
      "r208",
      "r212"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of debt (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r22",
      "r23",
      "r207",
      "r212"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Equity transactions (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r45",
      "r207",
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of debt"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r22",
      "r23",
      "r207",
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Equity transactions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Options to purchase common stock"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails",
      "http://www.deitaxonomy.com/role/StockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r23",
      "r26",
      "r27",
      "r88",
      "r151",
      "r154",
      "r307"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r87",
      "r212",
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Equity Transactions"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/EquityTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "terseLabel": "Stock split, conversion ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NatureofBusinessReverseStockSplitDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r315",
      "r339"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent events"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails",
      "http://www.deitaxonomy.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r315",
      "r339"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r315",
      "r339"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails",
      "http://www.deitaxonomy.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r315",
      "r339"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/DebtWarrantExchangePromissoryNotesDetails",
      "http://www.deitaxonomy.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r338",
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/EquityTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://www.deitaxonomy.com/role/EquityTransactionsDetails",
      "http://www.deitaxonomy.com/role/MergerandFinancingDetails",
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/EquityTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash transactions:"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r152",
      "r153",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r43",
      "r214"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r43",
      "r214",
      "r215"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury Stock, at cost, 121,500 shares at September\u00a030, 2020 and December\u00a031, 2019"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesNarrativeDetails",
      "http://www.deitaxonomy.com/role/ExitandDisposalActivitiesScheduleofSeveranceRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r330",
      "r336"
     ],
     "calculation": {
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CommitmentsOperatingleasescomponentsofleaseexpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails",
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Warrants and Rights Note Disclosure [Abstract]"
       }
      }
     },
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Fair value of warrants"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.",
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "terseLabel": "Warrants fair value estimate volatility (in percentage)"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Warrants and rights outstanding, term"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/WarrantsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]",
        "terseLabel": "Potentially dilutive securities"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Shares used in calculating net loss per common share\u2014basic and diluted (in shares)",
        "verboseLabel": "Shares used in calculating net loss per common share\u2014basic and diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.deitaxonomy.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.deitaxonomy.com/role/NetLossPerShareofCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=121558832&loc=d3e400-110220"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "51",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e34017-109320"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=118644919&loc=SL5834089-161433"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918631-209977"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r416": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r417": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r418": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r419": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r421": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>78
<FILENAME>0001628280-20-015862-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-20-015862-xbrl.zip
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M.8TS28)X%)8B:IAPX,HP ,PME1)[R\J4]2L+R'.80RN5"IQRGS;.D<$83Z5
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M40N!F3 8>0C1.'!HY)FT3*9,M@O&C1,,E)2/"RV_'"1R3*MD&I,6'0G =ZF
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M[NSXZ>*RH!'ER'--96$$=T +0^!8&<.0DL4NG31RK;U 5N)?31,7%_&IZ7A
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ML9S_O B/[,?:L]@Z_"B!?O]Q8Z^YO??VH+*W_:ZQUZR\^[CWX>-&O5EI-BK
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M?5:EG!"*^2,$>[KV_>;0PQR%_"MF5 CY;X51K?3R2F_0@L#T>)AG?9^Y)(Y
ME19I?LO]+Y#=]!#%>^1'IIM=%M]_?RZKM=B8[J[OK7]8KXPWFL@7'\3;9K!2
M[ZW?A]RC1[-F$L ^=@+6L[N1#>_ST.^/_WD+#<"E="$_%<;RS\)Y@SPW5;#W
MNLHX#E7#J:H*0P6U5D<?P0_PRIL\F$'EDVFWPT7EG<F_G)F+NS[AQ?,GZ+Y&
MC?QRJ&U??-9!$NU\K!IB.7AOYJN&@1^W6@;#M;?.J[77'X89."GHV\7)/"R:
M^F_"QT;>[)UU?SDQVD"?&0B10Y17:3 >8AL=JDHI6PU6(>JQ5DR(M=<UTP8_
MWIV!MC\YT!VC6+"Q1OX.S@1B4\X(]Z<L OHL,0\D6# !Q((=)\#<%6:\BAP6
M.@8@^#:LO7X7NMW^1?L4J)[Y>B;!C'3N70]P;1]F)Z7-1OPP5G#?W<\>0BQM
M!:]J(RE 12'J8EA78Y3<QA@P3Z$7UI1_)^I:,$XZRAF/04X)XY,<M#$[,>U*
M. ]NF'9PAY^!KX;^BPH<:@]3\%"YS$Y V/SW9[,N'$G][1E5)GFF#2!=OYZ2
MD-J6^TR98,& DB!3,!PLJIH(!#0511&H9P3'M==,L;LJ\OMSVK&T47+[7:O7
M_55'B;?Q9X<XHVG1JA):59E 0!J8H55I+<<RX" $F"]*X)A$"S1(_&@+=CW.
M]5__J0B6?_0K@] .)PGVRFAUYTWS94!)OV._EG_D:XZF^7X4/X##R;-!!K?,
M"SQ#'GSE9)CWAVD <]"KP!DI;3*>>T-^L^-9-^"XTCS:#3<H\W ?I>N<Z1\:
M[OOV,2U^[*[?G#0I?WC6Y+>/4<6FWMC4L_QQ#5K*C/@#\]RRP6AY<S"N57&I
MW,:3L\BW%NH^N<M&[S^;R7^/[I7<I.86"[G[%QW;:__6__T),QR7KT<FDTD*
M,0GC8H-%__2ZE;-6!K]>V^NOIS8^K$QCDYL<$71#I=]K9_ZKI>"/[J0GS7LN
MS0#JV"E>8&(+?2TE?1V/F<+O=;+7JI/#[.#R_65]:Z>@J_7++[3>@>O)QS1'
M^:RQ_]6\Y@Z<1P_?;-/#SC_']:T:JNWOGL%[TD;3D<-].-;<.#^XW."'J8TW
MI@(@S(@T5%6)1,!ND780N"M>I8P*J02E*.K1W%60Y:)LYHO*B<DKIZG,6N7_
M!U^.TZ*<2K_UK9D"4[$**VWXOC:,C?.'PBZO5.$1JK![I0HX<AX5956L":XR
MK5Q5.XRJ7KMHD<=8Q)!F/[ZI+Z:<_^)S:NXFVI,C_CK'/G$7DYK I9WJ.VL]
M>3_1DSO9EAZK'>]E]>-#>.^=5KVYBPZ;G]H'QZWCVN7.,=SGXK#I</WXZ**^
MH]!G9[DGBJ8<6%HC:!"M:F1%56C+I1 F%4@$C@G!:MWTO?GWR.=44G6 ,*B\
M?;NYR,F7^R7]MQMOLVE.LH%IC]_GIZ8V?+N2U?-F(G:[/LW0"!5[47&M  !U
M4OF&LU8HI@ZE7$-^/;/Z-_Q[I67ZE9BU@Z^8=AL.IB5H*8WQ[V&6DAB#7L6&
M\0EPSW$>HX)IFL=3+!^JC',8-Y(@$QU.>8UT.*T<JG@XVCTJ3CW)@PM%/@N3
M2K&6MU_Y#>X'EJ+2'P(K[[=Z:7KW9%7QH&4&=]M^9FZW,C5Q=/'X'7Y_4:F8
MKJ_\1D8O:<'@P GV&%XA75"<"U>E9HQOE);C]8M6%*TT_4%%HXHW%_WU4;KF
MZ[^??1QK<YCGT*S1VL#$( 9F,.R7TC+^5"[X['/@*F!N?55%X *,&E)5-,V0
MU89C[+"GU*R]/@C]NY;H-FI%-8.O@:SWOCHMK1?\?B92E$7;DQ* _'>RP0!4
M)K1!#_)>-W&2]D4E #^YJ.PF<VQ<,7BV909FM"#NCC&XOL?-#.?>L!U&?<<0
M'Z_@&+9'D\4^5)O/K?ZC1ETI=>C_/C^5O=&+J1/'&OSKJ>SYYQBC=5X :?=I
M^,9J6;5$A"KX XV)T9(B\N,J^ZLH;M:OF$H;&AXJQCE0W-PD[4MBGK\ 'W?O
MKQ7HS>H]!_J=-*TN'WO)I(2NUX$^N'B1/#K<#+Q@ZJ*CRE'>.QNT)H?7P<&'
MHF4^Q*Q;+%@O!M[3N!6!EWR@?<5A_,?DM.^>\'#[)B<FISX^^8&V3L[,NH59
M C-CJV3"4VZ2DS(/NF"Y+OGTAT<P7==<37\@0Z\3/OT5882M"[KPM2JF.Q/[
M;=*TD;6[H4VC'PJ5FGY5@ZE6YGCL>]XUY?-YF^EBM_&K ;8T6C>3<A#Y)DC&
M42^_*"59'&6^ZL=?6+VY?0'WQ?7C]Y=I@5EC?Y?4CO_^4M__U#ILIG8<7 !A
MO%O)CC2:1[C6W(5W^$A2YNOP^(@?'*=SW^/#_9UV+;WS\>[90?OV8(E!7G)B
M0]5C;:O,D53)3J59QL8$8CD<QFNOZW<8T<Y(]YZ[),S\=%$LE_'\,**&(\-Y
MQ0]'7\?,;TG0FU]5JI$M*GKZ[V$?&M8O9ZYIUK:H=CU:):(@F+&J]BJMX3:N
MJH/G5<.BTYI)0[!^7%7-1_K.)\S;^+DI'@MF#K;'P=_( (PBP)4QF+XQF/3S
MFZ*'-T=]NS(*WS,*%S>-@O!2&(IQU145SFF@5>6% SIBN-'6AG!5:O<[5>H>
M/0PUS_16_$8B*4UGOC?[E<7[,M9%GAK(6K=7I)F'_5$2"C1@5&MV<%4^<9(N
M3FGD]*SV17KX60:/AL=6NO!RO917.LWZ1?)IO&5BREFE@B7IY+3]DC>Y[U?2
M0K#,?VL6K_S-_/X;^?VWOV]/Y;TQ#+;A!NN_1&ZRWPKM]@3?RF^ 6I$C')5K
MNAX8># -]W"N_B#TGREI_U1&E%ZQS+;OIU9ODL_4 J3>%PO]:)69J*HJ+9:)
MS$>FHC28J <-V!-2]V+1U6.C2'HWW*!G)Z'(I%SRBR38>:B<I;_& KM3# 2!
M<4I[;Q7B6DS( U)]2X2]MD(2Y##CG%GJC2362"L<Q+*8B3#95R])K@\N W[>
M_VMMM[YSNS9V=]CQO<'XA'O&DJ_WV/Y0M*(Q'!0F#VP?4"+@.7 Z^M7$^WB;
M?S:1<I[6?=G@0Y4Q H)N.*D20REGE"#JY=IK+,@+1,0+)NE$Q"?XOJ[TKOMR
M-.FR/S%U^==K?-QHWF9_-&]S/%OS:O;FU;S-]>7:<Z-T6W0]-%7I.[NEW=S]
M[J0W8B>O\I!&PT_#@_OAC5N.KB\QMM]K#P</7W+_K*/[6G=GT[='[N\GUR;7
MM/+KD.DH5&T>S)>JB= EKTS[S%STUUX^N D@69>K?0"GU99GVP?P 9E:F#+-
MMZN;+DPUT_L;^]5.(HUZI=A%;+2)U8*W'EI:% ._?HMWVWN[C:W*=GTK;0VX
M_:ZY7?M[>^_&1A%S'D?7>EV-]BQXJD^2Z^(9UNTIO$[I](>[4V/%-$>[YYH[
MG,L:P^^N7B[\TSMP<H^M.BB>=<.C*7F9^UYS7A[OB6UYO,?#%) #DS4*RW8+
MMDW^V-FM;]0W=S?>@NM(-GBC6>P*^I4C_,F%'U_3RF=9C#MS:C1'07EB6YX@
M*&+M]>X@=,9YJ?4G2<,*O/F#MW.5O2W*<8TF[O_VL6N&/AL$__L/ ?HC&CP;
MKSB^136=G^:\I7AJ]D'24@I3L8@6+NRF00'X5!CW8GK(WZ8-,A8J'UHA@'29
M(I]3"%997_1JA[=2O\55U%',!-X*;KQI'4Z_8CTK6WX/8\W3RZ[T<EI LP>@
M7)GF7T($"'G0--]P^FDPYB2,'M,O+$(:I<M#"RY+RYC>]OK72_H&\/!0G%1:
M"YAZI0N7E/H%)JN^QMO%EOE5RN]3"T!N^=25&UTF&\I7;O27%@'^2#=:S MH
M]=KPB/YXH+JR_>]A-KBH_+858N:RP>]+Y4EYV3TI7QY/RI?"D_*5)UUF,RI6
MGO27%@'U2$^Z:?JMRDZ[=W8=>9;7IJFR>TFU/%Y2+8675"LON<PF4JV\Y*\L
M K18:3V -@UZE0?<Y7W#MRL#L"SH/V3+5Y-B%AHZ>6M2#%E-BIE_6YX&7LUT
MS5%A3*_6F6QE?3?L]],"I$2T-KJF?='/BB#EV@8G(SU:09G.V0O]8?ONP-K*
M."^+D)"?3&*L%'Q.$R(0O6F>Z<H\S[\M3T3O?5I'G@V*56"%J84?VI/OR5*W
M>_UA6C>X87O#P:2T]E[6_[(ROTLC!/0G9S6M-'A>X-VBQVQE?^??EB>BEQ9!
MYH!-87O?Y3T7?#*W*^.Z- @_S;BN%FXMS,(MI&^MW)HLW6HT_[6]]\/+ME:Z
MNK"Z"G#3GYR7MH"Z^FN A\EJ\5RYT7L;CDQ[Q("*?3A6%&AYL%V9U;*"QV^9
MU8V579U_6YX(7TK557:,&_3RE4E='EA7)K6LX*G5B':YT?O8O=Z@O?+!M$=%
M%<>K4FZ4VDT9O8_]HM39F-:N#/#R2,'* )<4/()78];E1F\K1%-,!_IXDC;R
M#-VLE]\PO"LCNS1(KXQL6<%CJX'I<J-7@VN W<8 I/;&/*"5<5T:A%?&M:S@
MR9O&E:^,Z_S;\D3T&L6V-;O=T3X9<*N565T:;%=FM:3@4733K(J569U_6YZ(
MWO9Y*[/9:MGF$D%*G[0TJ!2S)W\1\.C:ZP_0M6:P"AN7"E0JOZ61C]D%%*OI
M;Y5WW0G%'5]E T#??;M;BGUE/G;;H=\OZN&,=[^K]!([/\OZ:9>T?P\S$-\7
M\"F&/'3=J(1 .CM-!R;HC_'^BR^*K_B/R<]GX>XOO6$^^:673WX<]B>_95VX
M:]:OC/80'STO/:KAAD>A^P*"!;=>#"F"?ZOTA[:?^<SD66I;^O5V^\9W;YQL
M]B;WOW/#2CHVNFNQ16!E_!Y7JW3/6KUV^Z+2.TM;9EX][^+A;8[N[*PURSW&
M;EJ(&6U2=+\PD6EL<(;1VN2BU0YG"]*67W:'LZW=#YMO&Q\^[FU7]K;?;.QM
M[=;?I%W#]N%C]6VC\3_I^X?F1G.[MEUO?GC,1JG?EK5GU<]FLK#OAR:'#@7C
MMC>RM;UN9:>73R8YHNK[2L=<%-[ @%6.O?S,Y+[:[O6^C/=CGI152_LX%W8[
M5#K!=-/15+/TYH[,1&Y4[MV%.?V*-:4OTB8.IC.J O;;#<=R^_2Q&?]]9.UO
M/P)OW_.(FWL9CY_%'GS6S9-O/*E8\COV%_>YGO5*LQ7 37ZCBTP>P+5-]L7N
M56QRLZ?%U!E[4;2Y;V*HM$QNP2O&T?\/W>QJ ^SQI>_R[#3M"GWCM=_"/T>%
M]@*Z*;UV_?Z:KR><O]72M*%W_U;9/!"802]/;+,2C1N,NM^!Y,*+0%.Z@RQF
MUPT:CJ;[W'T%D#:PS"#C1Q?0?ZZ58!CWO WM+)R&"0UX,?D]G)\ QE_]#()Y
M]Z>SK-V^^YOK#=O^[H_]UGV_0I\>W_>DDS;HV=T?CWKFJV<-0+/#/=?WDNG+
MOCX_] =9![KXZRORWFCCX*\:'L*7K\X>"=45?;JF5&D]N\M.;CRA,JYWV U'
MHW7MQ9;(@--X4W:3%P;[!DK?%)2LZ]I#'RK^JHY)(2EI-]U!.+IX<6,;]W'G
MIE->5(Z&F2\V;TDB=-4+E=]&]ROD!(Q57AEYG6*C>-/O#SLGQ?6@CS?:D,.K
MY,4U!4XO*CU;/.@T\<&1[(QW'RC>L=L'(CMBA]#24U#>WK _VJ;>3)J76G53
M'0KE3]T6ARF$2QL %^C 7>!Q5U587J27]$,W&$UX \-\FHV?\TW+L0^&P P+
M105F7.G?*/1<7%&0<'A/4_R2%!.L![PL]!]TT#!Q\W96=&?:LS@IU77CO[M%
M\9S=T$%O6!EI8_&"MXA_>O?4Z[[GAB,D8M:^MC!CFEZXGI')W]XLA+@=!@%<
M6KK\ZE@A25<;0 ]:9E#T-4 ^3/9LA&L^KJV3?!X8M224.<@NW,MGL0@J!I68
M]SH0$<#U9P#;,$\_P@DC05NO-."F=MB']^R/P;NQ^T4>QHUJM]/]00J2I"8T
M32&):8 9A"7/^E] F(: :)[\[M44RI$@Q-$,]O6B9ELAS-" %Y-7F;Q#H5G0
M*+AKDHST2E^]S^AE!JU>/TQ\/'1OEN3TXAO.9[WR(0G9XYHYZNO""B<IAR=]
MNZ'0&5\W;FP\BL85%N<%=/+@RD^ULT[:5@RN??58<9_L"SBJ,$BO=NC.4D&\
MP:OJ\P;FWU2)PE2+/R9O,OLFW.X;S-:+XHO%5NEI!44!Z-B@):G)NL-1J W8
M)/,%1!V8 ! # *;7[\.Q LG>[6U@[KFR&R97_/$8&.D*Q2FAF(P#*%]OF*(K
M4&A0?>"R<"#I)=@8T/*DDYD#A2W2+(65!8C';L^'-@3@-W3_2[=W-O)VP^[H
M\]@:K(!]3F"AAY*+ H4Z:V5@H5O!M,'_A1.@YYW,W40(&$V10BG8"<#9&78!
MS\3]@,L%4V!^BXV!O4[1]]6%Z3H#UO<TM N^!UYC''FY7M[KFM,L'_;'[2CL
M/CP]4:*";H%XG61@#7IY$5R.R]N-I:9?V6Q\VMVJ8CUV&]"B?'@RD=;_[C_D
M8%?"]9S"=<?/]_L]X/7)ZUYQ+ <W*\)##V%<NW>2R,(X(WLT;(_0-B<I<H5S
M0%C&;#G%D+ZH/'M+YJZBIHEY&:<7DK FII#N#@2_F_?:[:LGC>E?0:7C=8,&
MB?:LY./9Y*.@@I4BO3W*;22@(/2S63L;<=J;A!V.]VR14.H/DU?)"O3\R H
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M<43KIK9A":TT8OOM?GMG)3.62(QR44$R*EC:?H8K)*/TDE*MB&)-#-65S=3
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MW D$-&D#8)5!EC&%%!928!]#S(/WB!QU4+HBTEI(X(F3P/RNC$("#T("$T6
M^*3 >2\0"Y0G)L 16:49<EHKX"SZ&.G/_!K-XX"GD(6Q-SP*_5:G1D#KEW$.
MQB51+-2I6Z[1G&L\L;*CS:,\0"MM]U8TG7[KLSD^#:U>3"=)O_.Y3KIK'7>,
M[1QWAIWY!@NMX'G=N/%!?TY$\2*)ZY\LK0W_X70PS,62Y:R>Z:S>F?;<>48U
MDT0CK$0ZJV7DR&#KD*=4!F,M#7IQD[)+FG.#%>^'\, 57"\6UQ,=W' -8()'
MQ$6?G7$$:64!4>.5<0%;'GTRQ%7%":THAOF5\(+J!A[/BTT**L?S4F \Y4^3
M25Y!&(.<, $!D1:I/!#,>V*3LF6T"JH<SZL*Y*;[Q0JN%XOKR?$L+ 4>F4@G
M,Z$(K$['LU$8!9\T< G!C@+FNE):5(**9AS/3ZQ':9WDDU#I@QUF,*9[&Z2U
M+WU)'\89T'-I*5Z:3G>0!1,&>]W-<YGLQ:TDI,)(,S'2[K0C0&*#"6<*29<'
M$CJBDZ8A #GGN181NZ!9$]LEE;9GC2XA*B"^?Q!/1=Y,4,90@["AD$>#8Z18
M[D(B#'?4&,]):47Z%$!\OW9_ ?'"03QE\P-36E%(1Z\TR4"PW"-#8D0B_ZTW
MS >SN"'@!<3%YB^8OB=,3PYFRG#DT5*$">0R/VV1A71$T^B5T9%1ZG(#$B 5
M8?,8^Z4/Z=T'D@Q#/PR&XPR8$O&_/R/_HI-Q)[',R*$XRKX[$T2AFYGHYN]I
M8YXD)4\'%Q"U.MD!+G<C#%XCPPASPAIKN%Q;AS+ ]!'C='X[ON#T?G Z40L2
MB4:P*B0%G[&D%EB.-!,$&;!6.!,TP3E*?X5*4(#Z:( ZOZU>@'HO0)VRR8UG
MD<2 4:QKVR3%R 3#D<V#P@F-G$JRML[UY3R: M1' ]0E=MDH&%X4AJ?J4XDS
M)'J*C'8607J-C",UAHGE3#*@,;?H)O@1-@!=.3-\7(#RQ(+MR^V;,0,=C:12
M&A'?A85>3YOF @L)G@(*C./<\"L1D*0&:<T,2.832265GVI2I0.D&9[ XMAO
M7JY]@>ZRH#N54V\]"0P8L@PX J(X4E1&1!0A/!!/E$H*A-2B(C!/>XL"W09#
M=XEM-@MTYX/NE/WNB<0TZH@LEH @B@1=(!A10GSBWO26ELE^YU I7*#[2*&[
M5/N]0'<NZ$Y.71>YMY0QY*FF26'F-IV_PB<D*QVPL.D$#O6@/,XJ(B^'M$KP
MO'&](YZ\)W$Y5?.U5-J];N]B>YO"27?AI,-I(YZ%R*P @X*-*C?L]TAI2Y%7
M48O(6)36E;*\505RTZOF"ZX7B^NILKQ E,><H @A(C!>(FVY1D1[D^B9"!J2
MKB$YJ:A80 /+ NDF0GJ!;2@+;N\1MU/FO0U& W<,,2=<PBU/N$VDC(*Q@G#"
M- 6[MJX6T&JN0+:)D'V0II$%S0M%\^049N"HI)JCI%@9! J'/ J/(N42&6-I
MF4GBJT]AT*P9D'X*#2+'8SH79^J/U^ I=[M]B-D7A;,6PUENVB- B9=8:XF"
M=C1QEB;(\@B("&],9%A@-P[KJRN&>,WLHVQ,U^L%1A^>,@\\A!NA\,#">&"B
MNP!X1AS-W?:P0.!"LD2$P4AAGUB 6B5%'H*!*\QU!7*>23B%"AXE%3S$%(Q"
M!8NB@BFG!':,)S/&H&24)BI@A"&-74"*"4N, 4-M&.4<T"OJ!@H//'$>> B?
M1N&!A?' 1"50VMMD!  *3D$R#7*RKQ<4X<"Q<(Y&PW%2"6@E@52,KH)*\!1&
M?+;#L'7<&USJ_7_G820W$U;CUN"_[^GA'P]+/X@#)PS+H*([,O/[::=-9#I&
M)2P*/'($/ON8#6;(<8J%Q98"H_784I"L4O<ZK:Q)@:7"<(7A'M@U51AN'H:;
M*EFA4D9E O(\A]*D<$B;/)[11I7.(Q($CR/=,S$<5?<YE+4P7&&X9C+<@WC<
M"L/-P7!37C9B*$LZ-T$@0M+A($:D2,0($V.BYS$:I>M!-TG$E9BK+J\P7&&X
MYCQUXWV)A>'F8;@I_R$/A%$+2(!5>9RN1P8[C"!2D[8&E9!#BHQ6@D(E=..M
MU*>0*[45PDGP+=_YW/&AZUO]<&R&Z2^&O=8;T^^;[K"U_=75,T@7E#K%DC1\
M[]0>AUO2>/,8K7$%5'_U0PS]?O#[PY[[N#46YF"CZ^ODS\DHI,)OL_';QVDO
MG&,\J=S*(^IYGG&6;50*"D5"HG46A#&PZ'[GMP3.:H9*GQ85W.^\DD(%]T\%
M4]E3G"B03B'IM46 ;6[11B-B07%(&JMW9N%#B H5-)L*&MJ<I1#"O1'"A;ZK
M1GD?;=I:)A=D8H&2IB>3@L!D%"HHRNS:.J$5!U$Q6&SN1*&#!M+!@_5[*9K!
M\HE@HAE(&0D6U"1]0*MD)!B!DJ9@D&4X,03S@&%Q@Y"70P5/*8DJ.SY<[^2D
ME^\@P>2H=YR6MN16%:]UDW.K-CZ;SK%)H#_H;=:;=W]J[_YN!AU7*'T62O^P
M,>WW"4(S)X)#,6B/0 6"E)8*$<<QUXG0F>8E^ZIPX)/FP ?/OBH<N'@.G!K8
M2WC05&"$;>9 2&JM57E0E^$"*T$,824_JW#@T^; !\_/*ARX< Z<\O%1*UDZ
MN#32%AR"8"+2A-I$A,8ZB :'[.-CN.)25KIP8.' )\B!#Y[!53AP\1PX-9N*
M&97..)-50)YL8:.0XM$A[)@T5 7#N%W!'*^SNSC;]KQFN$7'0&YQC5NX<N>Y
M?+G%5;W%I^"$WS\R_72UTT'PK4ZWE>[*G1[7-?ZM[IE__E/HGSOH\Z^WQJ&4
MELW4WC+=G,QX?#H,OG1U'QW)]3(-'FXFVYOZ+H/?2*MEWH?VZ8D-_;U8"WOO
M=#@8)IFEM:Z/YHVNWQI)KQS2,QW2.],.:RV$<5Q3)"T3" 0+R'+!D4G$0X*G
M/G"VMDZ 5%R3BA)5.K\_:K O<8I; ?MRP#[1R -6CBH<D;5<(="<(:L!(\<(
M&&%\-$ZNK8L*"*D8+E!_W%!?8F)A@?I2H#[E@)1I1XAH";). P(3(!WIS"#*
M8F+R:")G8FU=TTH*J AOTG3H@O7%8WV)8^(*UI>#]<FQ[@7'5$N+O,QM,+!1
MR+*<>8*Y]X1CCD7".J\4TY6Z(I]XY0?!-]I3T9YV1XS\$+UX(7'P]GZ)^TR+
M;MS"W3Z ,N/3-YO8?QI!^2OT:R)=K(N&7CO>9]OTNVG=!F??6UA['M;>G?:\
M)#L[*62>(BY,TM"X3:S-G4%)/BQ(PRUXM;:.G^'%MM9O< %(8;?";E>QVYP^
MJ<)N2V.WB4ZJN0C"8(>"LAX!8Q%9J2Q2,CBM0!L@>&V=/>.\L%MAMZ?,;G.Z
MX0J[+8O=IANTI5-'1$:1%T'E!FT8*9(L;HX#I=H3A87+NAN;9Y1;8;?";HUZ
M[+NPVYR.Q\)N2V.WJ>9LPADM=$1,&XNRU)!ARB$0CL;H06N9A[P\X[KQ[+:0
MG+W;!AIN<8W[RC8KM[CBM[@@3_@(),\D;_@).O,@DBL>]Y'J"H]%(6A:X7O1
M"&;2"%Y/^ZJ9CY9C[5'PV.2A(@H9#@%A%M*_DFN!]8+*VG_&:\TT;0HG->G9
M5JH0O7#2K)PTU5>1.!DL"\B0/)U:*X9T (>493(Z<(QKMZ R\\))A9.>3&%X
MX:09.6DZZ]*Y=%QHBX@0' &U>7"'-2C)*S@6C+9)6HL9W%$XJ7#2DRG4+IPT
M*R=-98=B%RA0B4 20& A=YJ5!HD81:"$@,NC>A=2AKU 3GH*-:QU+]6<"?JI
M'XY"=]#Y'%J=>L^W?LG.L4L+OVPG9KG&DJZQ2.^O:+[W]T6OGW[LMMQIOQ^Z
M[EMKV$]7R^7;Z1PRY\V%YYDB\Y@J.AYJ5$S-3YO3]#0YD<<BW!Q+\" +<'3?
M&UU_,!'GI%5T.M#WXH'Y6L[RF<YR=Z%:6WMC<M=XK],Q#M%2I&U42#$%7#-G
M:<X[66S'Z 99&(4 ECL@IA! ,PA@:O8Q1)>3SY!ETJ%DDTED!==(!>QT9"KM
M@H7/E2H$T$ "6&SQ=B& 1A/ E(=18$<"518%KPD"KQA2.'@DHZ+.@0=/?2&
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M4YRF@XFLK7->)06N$G Y*;U8H(7;5H_;9ND;Y1U8JE@PD&P62K4B&AML+7%
M%=!B@3:!T2;Z6A0@HV4>>1R3OB:U0M9%CHR@,3!,.;5\;5U65,N*X-4P0)]
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MD"8*&TS2$B!0"(X4K:#A6L'TW$RAC)>.($%#T@HPM4@)%Y"22DI'#:9*)JV
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M%OT<V^/QU&'9E=0KZC<4UI..K'K/[#><.GBUW?:-VMU^:RLCI:<1[**J(K(
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MWFOW<GET- YX.M2,!WXT=^/I?#E+E01!/"3QWL4,;I#E-/_EFYIQU;/2$9<
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MH61W35X/[V8F+@:8=;R<$Z!]B]9"^VEK^L=__YV];Y/!?Y:PK; ASB%MW5"
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MY^4J3CPS"[7S,2/K5;[KITD+<=!I2YG@R;GWL!G6_D$<T2$*L9%<>ZH&_L:
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M FL2G$_.:#WE_SM/[P^V)Q.LH? BZ=,95+O+)#8.3+\SS5C;5WIRL?O^S=M
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MX4U,T ^#\+?C*+LHWVC]A<XG^VW@"MO WI,.AQ.L$KKDC+!"""*EKH#-59:
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MM>L2CJF;I*N!//':T3QM$BM?]K"F*YW]\V:[XG9-KO4ZINM^A>6\+CCUV]C
M%+UTP$[1LYT>E6"IP=3K$<OI)4.W,3K/J)#63$^:O^#7[],^:%*:" ;'<M92
MY>-<YGO32=5995FZ*ZM6=F0)\Z5]GP(GTZ;[?/T9+#*3JM4VG4&Q,DX7,9J-
MO%,0OKYN=[WF3B0I.#.=U=5P+KI1-LG:]7:N+VK-6D_"S-9X5]J-NZI#%^O;
M#];-T#3VMI?@O!-ZPW>;069_U\O3<[GZ>*K.D^YK!FO2Q]Y@9/29'(P\*,XO
M#X@GP%U>?7@;;,$X'OUTII!$PE]$A8(2RJ)CP,N8TW'K\732E/=,#=SZ":PG
M\/WKMTKI*I2N(D!7!9'&.Z*4#T167BIF0AE*O_4X59=JIC UKDD[S'R$ML3Z
MTD?=S V!LJ\"+*&E&6<' ZC%C3/LDXWR_'*& SR3>MN3U'M[%>K^[7CUD>=Y
ME]Q&-7SV^6B4MYOGZ0$?'"'?Y?M//[R-QGOC"D,*B:=^@F3$.%82J:2DNO"%
M#9@Q2D_&9=-JV7C/Y+-<^[3QLYZ]M;>D*CMRCY;)YU-O=L@].N5UNY2J[3D]
MQIJI]=:0+SJL^5,N,/YQBM'H\:AI( +6[ <2L:[;NL^Z+GN?+PISB1D5OJ8V
MG3&TM??/,LDOP7AFH?$WKWJ2M]^W.)I5R5@<TF@"#Y 4?[),E6[@41OG%DP(
M%OI/[J/6W= =:U.,TQRAF[XM>W7&G=\O_;O#[&2I^5,.SF$1WM30?"61U#DZ
MV2R=.^5TDN&9LW*N*=,0$]>4?\?'GN7$#R"\,=V[F>O<^^Q.2WF"7FRWC1:>
MK_59Z'NW-&Z&O][*RA5><$\T]P7L?IP3:Q7\J%+?XZ*PIWLV!5-:+VQ1E*8"
MZ5!- [=5,(I1 =AHK^"6:)(L"29T_R+*)EMDE#R4OQ!\96-<%R^"R_JU[0$N
M0$%6"PPK.TX\<M8-Q_F=R6![^6X)T,4I.AY06W_??OD;D//Y\IQ'&KP^2A8
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M900%L :E(-0F S8@PVVA5-LT"-@@X"M$P&?/>&H0\+$1<!J[Y"Y%[74 M]<
M G*#D;52HDAY8I;D#2T^44[4BTR(>@[EK3I*MDZ'XY;Q=>_ZX_W6\3C<>5(8
M]ZMX9_[Z7:LU[W,^,[.2#)8K]$\S#<K=]H'E@\3[-0Y]W-2I&['PGS+*&-9@
MMNQ^G#1^S,/:FO:WNL2:U$#B?2#Q\TQ@,!%%!<OM(D6B8!12C'++;!1$X$)J
M:FBDN;D,:0M#VI3H1SK2N:,ZO: #W-<,$(^;B-4 Q+,#Q#1N%AGCD3F.)+,"
M<4\XLCQZ1*4"L/#>1,I6WL@V)Z3-< ,/#3Q<A8<GS.EJX.$IX&$:5+)&,QF8
M0H&6K*[$D2;4HAB%9H(3[*)9>6-H6TG>)N*J2]7@0X,/CYL=UN##L^/#-.02
MG1"&.H6T)8 /U&"D86T1(>!AP.)*[_W*&]'6S+3U@O3/I82'5Y5+]J/!E3N&
MQFJRV<O+]! X7+JY_-&P^P/G9KFWB!NC\F-V[,<-1-&9Z/S--.\-_C\ _V<9
MM(0*++<=0<'[G';A98XT!93 )7#8L^ DX#]>Q8\7;'^8UKR,T\@&-1O4O#-J
M/C ZUZ#F$Z'F3- M*$J)3TBP)!$7WB-8%'"M9?*229]H]JK9JKC:6+1!S08U
M&]1\!-1\8-"R0<TG0LUI+%)S!YY BDACI1!7G.1NS!YY$KR@).$0BJW)6(.:
M#6HVJ/DS4/.!H=P&-9\(-6>2X@SEE >"3(H1\< Q L] (L4B)<X)K Q?>2-6
MA7GAJ%FBMO]5.E'-ME2<[23W5$W@UHY'W1(V[7Z+GZ,_'71'W3A\_]WW3D,,
M?P[Z1^^FS<&N]HQ[Q?WAV%ZRTI D.#):@F_$&47&I812;CGO%,T=XUY:?[B3
M_BB"2-A>[[PUEHO6<"(8K0,+?W<Q'K=B+2.M!$*RJ(W<N'G<67W0U;+525<5
MO!^V^M-#KG;N4@JWZ Y:W6.X[3#?XJQ_V@LS#[0SHGIKY[BF3=S=;]MT7ONU
M!MNTB6O:Q#5MXIJ.7B]IXIHV<8U0-6WB'AXIV3K)YG?A73HY'?@#.XQS!$P_
M5'CT*+S[RQ=5NE]J($G4.&.P=2YQ);03@3HB(A-<,T7((Y8>/= I7SN"Q1O]
M(G&H]V+S\"O>.?IXWH%[[AY^I)L7?\-]-BYV#W</MK;?'NUL_ZNWL^W9Y3C4
MSO97NK7]J;N[OG&^0_/8=MCF/^#C'\+8X+X=>';GZ.^#S8LPWVN-$<.\X GQ
M9&VF*.+(2F^03"9PZX),.*V\X6TJ=9NJ!R<2O[#N' UBW!4QHL#2"F^=B)2K
M$#67@N.0B..2,2P>L1:I08QG0(QIEH2R5/*86:))8HCS&)%602 : K4\)9:2
M77DC,&Z;!4=^#5XT>)'Q0IB01,!>&\JX PO"")FX-TDGAC76CUB<U.#%,^ %
MF6F)X[0S!-:1DH"X# Z9X P*T2GLH@A*V<;":!#C5L1(DH*^2DDBV*LQ.69-
M"CI19XES51;Z(Y4K-8CQ#(@Q/1NW/&B# T%22W!,/(O(XL# X*".4Z("?8$6
MQFM@C:G;9%VAO+Y/1>:OCV-,.V$3,>!9<R^<3A[^PY3GEFL31!-;><DX-MLQ
MBWEO2?06$:,PX%C$N;US0D:X2 5UGMBP\D8KW,;DL4JT7V@=]B^O]<$S+I.+
MG@7*0Q"Y,-<&$[3,(N%H$Q]YV5H_C8\(1\"'U01EP4;<N(",2A0YG?U:\'98
M3(W6OPZMITSC2%@*F"INB#5,)LY-E-8JKJEIHAPO6^MG&%E(C,)@BDP@'G'.
M(W*&."2<99RID(3PC=:_#JU7$DM#J' ^&6Y8=%8F[",HO/34>-I$*EZVUL]F
M\1/N\N%'H"9G\<,V;Y--*!K&"??8)+*4>_UKR [Y#)?!W=9:#XI*+'CQ7Q*S
MDM=!)PT62O)<1.XDU52+H*ASA%/[.'VZ&[AZ:KB:Z4<%[_EE3QC+,;,612J*
M=X*1IL0@;6@ M/(I&/-HC007H\9+.6[YY76>2TT4#<PFYWEPL%M%K9.WP40<
M.,5-3.)E*_[%K.)K$JU/*2 GHT!<<XT< >T/7 ;,C(X@"F"JM)4B;4,?S"C;
MJ/Y2JSX5P8'B<:R8X5$S9RW106I!O 83X)Z!B6:[7R*M)[-:;XU,/D6*(I8Y
MO3.3,P"Z(ZLESN7'#*"_V>Y?A\X;Y0-SN93:".ZI,\X[%T)V6$/$##=AB9>M
M^&Q6\0'4G=$6EC+DUK,&(, 1'!'U^0PB:F$R ^ R;O>O(5&BCDV\G<0F6K^1
M*[0.34QU!KR<HX)$Z;"BG.N0K"&"DBS,S#&N3!.?>*&X]7D^/N$S/ZF5! 67
M-. 6=L@Z:U#DF0%$<DV(>#2#I3E'66J=QZ#O-"8B6,BIX4IKG^.1%DN  I]"
M$Y]XV8H_%Y\@T44*W@@R,:=-Y&X6C@2,1#D[IYASA;/! AC?YO)JF]1&]7\E
MU;>!."-9L)AK+EPP0MIH&2%>T,!-$Y]XN5H_%Y_0-J48P3FQA"D$>[Q&6A"%
MA&%,:VJQR5')9KM_#3HO13 Q.DUI;E&2G$D$"T:IH4HGRYNTB1>N^'/Q":H,
MM<)1T'F3.Q1(V/A%9MVFV@'<PZ>4+^=V_XIR)]XUN1-W.D?%-&I.&*-:\B2%
MLT'QZ*SF5'C7Q"9>+&9UYV,31!(0%TT J8Q'W%&!M"<>:88EIB #3K'F,.5U
MZ+QWG(":RQ1]Y."CV$BX\T+@F",5IN&[>.&*/Q>;P#HRISQ'267R6Z$"TK#T
MR/AH2+"6,D]R02I8*^7?1O=_:=T/R2M"-54J,,X"M\8X2W+R%#%.F] $)UZL
MVL\%)SP#S88E!F7W$=0^YTVXZ)!RC,2$E=7)-?O]*]%Y%0B74;$H(Z>1689)
M9 PF1/N@XV,VRVT4_QD4?RXXD6C 7NB(DD@<<0+:K[TG*%H;L 7X]_DL8BGW
M^]>0/;'=']G>0[(E[MP08YX*Y!6@W,,ZO38HM]0H]VZ&FX($1X51"B!. L0Y
MSY"S(J 4-(U$1BMEYMAI$Z;;U/#'[1#^(,5[04<V#<Y<@S,/[(W:X,R2X\R4
M#2-XIHG""5EM&)A2D2$3M$4F$9*T4#)$M?)&ZC8!<XJQJ]VN&J!I@.8!.>\/
M:R?: ,V2 \V4@ ,'EKL=)I1X+L5WWB#-"$54<+!<B1&8T\:@:7#F)QT!/ZP!
M9X,S2XXS;(;^W%(>I4 .,W"<6'+(,H41-IXD'P7C+OUB!LV"%I[ECR=6R]+!
M<6_Q/W=ID2B?K>WD;^3WUM62G]!O'?='51/($$M7R;Q864AL;\'W1P=VU#J+
M@UB@!Q8U'H]:IR> 3?E2P*0X:IT,NCZWMK1P^^[0GPZ',< 36IO]46P1NCH_
M3Y<;L>:_5_<^+>A1S63!!\^=UDKAZ!+C23B3$H=_/$L^<2SM'C<K=^I0^7/G
M_TIWI#+_8O+>C_IT=J>'5_I^]<^?,J0[3LA/;KG[+C<:!4RR>8]:R^*['X]
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MUEF[[*-VX _*XV=F&VX3_<%Q-I+RE_9/>W;4'YR7K_W/*9A-H_/6\/3DI#\
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M&8]>.1(2MH%JJ@AWI/+:Y66O_<<-R%>[N6^N[_#-M3TJL(2MR".BX _." &
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M'>*&1>02 ^_/QR"IDE+SG#S<!B^L#<+V4@HE&J!K@.XG]4R.TEEM>5(I$Y0
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M!:PXILQ(BJ-(U(#\X]ZJL=>0R!NK&T4UQ[=%5=6_,M+]5;R_*(D2=KI_Q+\
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M?U"(-F?[I6LPH\[QI)3*N S93$F5B:]GV"D\-A,-JJB(.86T<Q;4I2?E(W.
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M[32/,?U"3=N! ?W1!J'YRC:_L;.)&V>-/0_20!!C$/=!(NZ, EN3,, 7Q60
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MA\ '0$VYIMZRIYG9I]6S'9\K^<'5[=/:26MP,!UJOJX<^5I)#_^JUTX.6OX
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MS[QQML\;1U_I]K=FJ[GU[M<VO O&DAI_S93TD)8G1R1%)F"P@4*D2#,F$;/
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MEA5:/A/_:H66MT3+F?Y*1NJ83T6")!0@TV/D. U(,I%BB!H^ 2N=2ES75+\
MM+Q&X=:'*233]3"6OX;'Q^VBU(UM_V';MN/C7P<Q#CYV2IJ'-2U+;;WJ*C,+
M)>+V]Z*#Q52,(6.%S!5G#-(>:!4+[;*X)\F&U:\X,[O]-5?N?ZV?":#6FE)
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MLA3[3:G]%4B[%RK3'EEE_T_+NMP%X'1$>I50NXE0FTUUE+ _F 2*I* &<2U
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MOZD0[5X0+>ML.R?="LAN F2G,T#F9>),)8I$8CD,!30V3;5"GFM*;**8> =
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M-$NI6^V" 1FE7K%4'O6\WNLUGWJ5U*>.Y$T[ZP,95&U@I:\695$O'B;1]'K
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M-LU2:=V7Y"'9KTN%(FY5H"P0$Z,1HD*FPA;@;,+% L\$V9'*);'Y#QT 73?
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M+FD4<1%%45YQ&P8K/F//580.Z#9/-R\646G0/F>HNX#U@.$\>;^E0K'BVVF
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MP]QOV-LO]+I28+@NY[[_:JF 7B6=?YWJ7^_GD70ZJPWL>KF)DEL&E&T4W-:
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MYV)J'(Z0P=DR<O"6.X$O!'Z D[82[8I//$)ZPD"CU<8AKB& GK9[SMB2ZY_
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M]G9"PT//C&LS/O9AC2<6XKU3][,V5/5+DBGW5)/N(9J>Z6 (C;>W<5L,_;)
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M@%[#*-6NV#776'B[Y%7PQ?V<C+NL(=V>3,I=M_U\@J>@3[TW7#P3].$H=>F
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M]@C ESPA+9L);VU<%?S5TZ\Y9G'*"A*6G:O*B0T7U>=U-5VH8(]?1TB>2>8
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M2S0'D$D5X\1BV!XLFB2I+%_XTCOO:1P(.YK>=K#&%WF#[-;T"DM-<FI&]M.
M1(&/0A<[/B4!9O>[E'7_=P;X\6_QM4Z6! A]:2QCTB=\%3Y/>MJ99(,%">=4
MMT/U:EB]ITTB)JN%SO_]1G5I+(J\9"VRH&]+*]BD5/-#P/SX48$Q!U)/.P(>
M9FCR3X7%+Y^@=TY!^CI4+7!)0CR@S^"\L#TREU#?E(Y;> 9@^'!D:$=(J<H[
M+]0+4%6HKI-8941]+F=%Z3N6_<D"Q"G#,@7J<E$'FT'@=3B+DZ(= $NQ#Y<L
M@\.434R^Q593V;23.S8D<2>WJH"-I*'8D"P)Y=KYFT/2NW THCI$ AY<02P'
M#_P-S3<XD-Y7HKR4*7Q%A=-!G#?DQ+\8%C &_P8O &&*$IOR@Y<"%C!P4ZJ)
M9;/9))!X4-L <NMIA^GRB@8JP5)&N54K[0'@ AQF.&(I2Y&J,7Y1JO%!,D+D
M-<"R7"=22H1B&"7^DIT>-FJ\("SRN:K* D(EUJN5]V&E_?= >!+"IXB(.FLE
M3[ V5V^7B>.R.OXPKXX7/+-^LU2J(GB%>O9(ZI?Z5B<8Z*+42'8J1J;)>6;3
MU\RP>5N:DH6AM"<>[>8JPJS^F.PNT-+$@R'P/R"6#@LD!5\.V00V!X_);G=4
MD4/\<8T+I5?PM1LN>MM-IZ+FNV3II+"[A D(TK-%:3C91P#Y+"D$:8SV@+29
M06H!"/Y#<5^U2C/)0-+,+1_)$Z)<BN(RYY:Y0]*!8!+.8)%U,)2R=.YED2O+
MKZ)0 "= <SZ2MFZ5CA&)YI*C[&;;HH)UT6[7EG&59))>M;LVD$EM\=2JXBFC
M+9YJBZ>:H937]SE"N_C,32/T>\LZFX)?JFH3!$'99ZO+#)>AY7VYH8H778)1
M8 84 O2SB>BN&H)? 4X MD$OY$[3#1_0I47H 'SL8=T5.'G3'2 8P,>8$G1)
M/BE7*G_B/=KH^?P#X2W%<723EX;W:YVTT4LY>0-?#7RPG-T FT*0U;.HG:TK
MF@\"TM_0NE3.C\X%F>Y^\%WL2)CSRI*WT)*G^XB82\QE:3 ! 'G*E\@[N)?J
MJ3M 06'F@\ZBF$M'=L\%JS]V Y#2/W*S' TPV5%&N&UH7>,?+V4?XILH_B9+
MYJEK3RB:MYR55)-3G&<5[&'SU+')HW)[Z7@D9 6A71@&V*Y,%A2*UOQ(^EZ0
M.+ HP0XTJW1#)/FZV$LW%?3<%=O@7@\<9Z4KL?%NHGH'"W;*O;X%6"?R4.LL
MP*+J "$5_C!7^)MY(/J"Y@+KM#WM<B8@V !FW#(J\S83YY%FZ53([UT?8K74
MYBL;#)3[$I0:<M<<'6HN%%Y&\]%*&<]SLPF+1?=L8?J+ERQKC]"104Y<"TS=
MG..)KA>P?SD\.L_CR#'@#+%4-;@&)5/T0&*3CO(\Y.I!B*$*V2?E-@$*3X2O
MQ]TL%7T@5-A'FTU8B((GH/8G'80.O4%$D5*$*.V$H18G2]V/@ LZ=/Z8"8 7
M<HLOV;>X8*4M<]%^?)8Y0(WBNB"\;0"3K';5X52B#05UH:IR1P?D#]Z* 2%T
MZ:BHD[LHQT X83S/XT!TY#9-T=M$8(&O72(16 $<3Y2+DV :B"XR:PNO<T->
MYG!T,>'GY<!2ICWV= C3EUW=W@9PO\-*N%KR<R"CSDO#'4YAF(>*;O4&8P2#
MR < /F.IND, 39( ,E* /&)"1.-E-F0V$1;<_,R5)%>Y=5I_M0G:S!9K6V,-
M="W:(@I1TD)(\M![S"^QNPI:S=00YAJ-<#F 93FZ5/3W[?%AB[D'P)P4F_D5
MUYR1N]C&;?'P0!RDN,4';P0E'7;#0J. ?O&XSV74#?LUH1$A;AL*_>].6"!-
M<]7/->63"?;3$KP&&CZ]U2ACL)6##XW% F&+T8!-53(R&DN6J$ DF(C(?CPW
M/-'%<JAI9RH$8A![PNQ%X^T2;$-X9];B]"%Q*E(#R  72/5CEJ1Q1H9U1_@=
M&/9)2%]=P;(<NV/&LXC,ZOGGE163)!%(UE0EII62+NM6^"OD[)U@^%Z-]0;B
M6:$9("3C5*I9-:"M"RB@3NUX9>N25R'%JPKR=!;9+7CUPMVK$(YT&32B_WHC
M.C)?7!7=SP-LGSH)OF%70#5]+:*&@^"HH7N61\C*WISH"(QN&_IC^9<6/HJ7
MXO)VZWNJZ8:\5<=86XRF#I,R%G8B<XUA*QRGLP@N] +L$HI/4&M3CIBD%J@.
MY3P(LU;>#BK/D^[2A555=$*FB]&$EY?!Y B9:"7<2XQ'5EQ,)0&$PX^38CC&
M!%Q>S56"!UY$<9Z-)D/;HKEUA$2-T0?U<G=%5$3U81:)UB*@(1A FA[XFOFA
MM!0>OY1;(C$VNV+Q%':944V"E%^!8 IEF21ID&8%;% D M4[" )\N1QG1M>S
M*8&NXN!S'P!-+P1*@*\EF8NNA)]->MH[RG*0D<P2KD*.CV \5*XB+GF)EKBX
MX/7XA&'K;!?A@#4=N&>.* D1^ E&6U$0B):N2'A+&W#*"",V.1Y;K^@V.L 0
MI(# -8MQ;D0)*6P"-!_2M>*<4<"TJ4BXDR,'Y7J(!S$4KD1E<R>7T:)*MW*%
M@YL >X\+K@%!09?&Y=A3-,-X4A:*F)?#\4H$;\2U":.$.Q];9)+9*=;HS'V]
M'/7*X\15K[VT*S?*)IB!@[D'.'D1L_.8A^%KE Z,V@TO;.7?-"E:&@B",W0G
M8,)['3$6R)57*B.5C5EN^,QDTU%*")OP%*_"\[S)T\/SX\-/>9O_#Z*G]K.#
M4Y9X[.^#Y^4A)4Y LL)=W$[=!\C2!0.0J4AXHY$4V;3T/9]87 10D?M%#HJ(
MGXLWYG^,LXEL"VOVB<+)7\&^M>PVH;0,[,:*?U?;.SK[][OC+@Z5 F+@4RG<
MBKF"P Y1#'2/7"I[AQ?W#!WU_A0DD,S 0>DR"<3PPR+Y*8S";NF3O#=P_;3Y
M40K%T2GUMQ:I+_I0:4)07/ [91/G6=7/<.6#BTB ]B/MXN!Y3WL[E[PU_WFN
M4\6"Q8V;:FY,O7W1M-<V.T=I_W.CQ.^Z2+6Q;;ZQ4@XC*.(8\WA"?%,@TA<E
MAK %N#BY2,:9RM&J0OK5R6M>;_MJ&4$<?V>JI"(41EI2RDBI$0#= 1?[MDM&
M3(G=*CLO>$U2F-PWY<HY'![,$RK#\CVR;@/AH\7CL9BHOH,25B!5I*2*]^N=
MG\.HD.R4.1G2]?WRU1;R*#X;>XH6EPL(3.6D?*L)\E\8\KA3?T@D=M+58Y(Y
M7^7-#NC.0*')$W?NE&#N:4%*IA1>TJ24WC6=X>T$6 ?J)#AIH@Q65-!)/JE"
MFD'2V,E;M^^!.JA,;48[1MTNI-$E)V;(20#[>^/%I9@07M07)3,921!$*2V>
MPIJIW*I)(V3N(KKH* Y/RNQ^95S%F-$XUV$<*U1! #B8;H>KJ!E^Y1>1ARHN
MXW!),%U4]FH$LO$6TP+;M*I5:55FFU;5IE4U0U")S,M2UCI+U< [3TSJ0ML.
M"]-)-A6F?3[HHU0T1,Y60 DE42S<6I$PW0.ES$4:J*X&B=S'&RB9OE =I0OV
MNX_^LIH[^NO,][MOV(3T_?D5QC\.2QYXPU4B&J81V:6DC$"5=QUYEH3.,A=-
M*!6KJL;G,_2WT0[K*"M#KE<$<&AEO,A?LSI5F?A!6"1^D:DDXEO"\*0KRW*&
MT_G)T=V):M1<HOK,70&\0R^:(0<>BA)^<ECB2(Q7WP<">XO"@%SO+%%>0JP.
MQ^3A6'&XV=SA.EJB1)1QCR+JSB0#^KNY-".&71Z)VPGP]7.QVW 2.04#]2<P
M8FZ D77W+_B7'6'M'="J#._WQ'_K_W["A-,@%8/)41)^PEHR^?NQ"&M1-9UP
M$60\ZG.0?&NZ2W:JJM[(]?P)*A@^%BJPEE(!FK%Q-!$W+A\Q5<=#I#<'Q8N/
M=B+O;X3L+ZA56W*>QAQGJ<4D_':P70(:/II2&"P_9:>4VIQD8"==!XD*MN>A
M!9$CB[&%4I9Z<0-6OF\080.50BWR4@-AJP4N5<!ZI<\+-2@_[RA3*8^AJJ%5
MHDL09ON6$DY+V_$*5+EE5,UR5&G/YFVVSX6]IINLJP^>\>>%^:8/O/*?2@G@
MJI)#E'GCYL0C2^X_>]H;AOI?IMB#<U2&_D_"JQ*040/%"((();]D_N9EOB()
M1)D7G4W!A[Y8$=H& ()=HTQL.-4S)D$ELC"+/.5R":3#BXL-W$>6EV"+S21Y
MZ!3G]M&E5>9,@U1;#'^-3N%B#S2OHQ("\4<Q"XG*,F27!5A<)DK(%U)9J'(,
M$C'[MC#FP53'7 -]]"JI&O9X,GFY^<R19Z;:S?*A\:*Z-!-.Y<)EH1B\I,S#
M!V(B#*]AFB0\1"YYA'>.>&4C0K,>'%8,HB\"NSF6"DJ@*QC!<WGJ6'&]O1G5
M="K')'3!>C]4"!&MOZ7?#3$!G6ZSKF#WE"(C]B-!*M/.O0[=_ZK>"%%(,^Y9
M$HE@=W$C3%V2K@)^K1Q#7"T6QCGN0(LH'BTN4=7U9VGS*FJ*O66P@J1,VF@8
MW&H!D/#7S+M41<DE@*E<H*X#0LT/4G%OA6BX"F94>A*!TX$;7@*/INO.(^)+
MXNAW(5U'3Y3:U,ZNBZ8O-&N<*H/#R\8<:>F\M5A6<F-?K.* 8N*F/&1./7C(
M@AUC=<CUFL>O:QY_I>9Y+K@G+W^N!3N62'OQ-;()RI?E\HJ<KI\8E:U+[KG5
M2CDVU2]TM@-#.V9R94C?6A[2W\:W&!^T%P%/_")@!S2]6"-\//Q\(:38NW?*
M.02CRI ^XMG%/T\^:^].WYY]_G!X\>[L],X>M6X\%H]:7^I1OP=;;2)<3^[M
MPPWV6\J*0#,;TW<"+.^160BE>W]9=P!:<4+GFQ7G@T>#1*1+BPP\M*Y1S6#]
M,7*(RA?K:1?"G/X61C<3[EUR5>8KTB(Q%8!C=CQZP+&F+L3%"U6*/"E&D4E6
MTGZ.JCX51IZX'<@UH<HRDWY1-0UN81Y;9TD26U0>V7KWV)(^>#2<<+B4%3!8
MJ+T5N1!-YP)A0A:90&%A2%4-RAB/)5,\-+8X'5 ]2_T+#\,PRZUI62!,GW[*
M&/B[6-(L/P/*?(M-SO1^]Q/YUJ7P#OBZHI+^5J4[B59,N)UR+[75;R87>/5[
M59(RI7*1DT9O@!,KAU+5#&N'Q96L> A?@3<MU#".LDKG[^V0]4/198G2YU4;
MI_P!C_.I#$$$TX*!)TE$J48K4D<WR$TMTK8E<_\$ ]O[S\":L91UOX0QOPP2
MT?'CG$U$2?R)2,XZYR[V#@MD5?D7(>:ERML33E?.8E8^:*(.*K/0DN*@)<\-
MU=1=FBIO2%F&OO^4M>[RZ9C[C)3K%PRWGO,0VY@59-5T$OJYVT5CD\23O4#P
M\GNE#]BJ^)SY'+BH=)G8?,2FVN$]7!T:FZ2![ 6*!TM1+%(#WJW,Q-HOY+9A
MKB+,-;B7,)?9_Q5A+CBDVZ6R$C=]*>Z4;E^UL:]&Q;Y6X6BO!.)PJ4 \^7X5
M.,%"IV)A/'8(;ZY+1IKA5$@4FAM%Q9BSA+]4/[S"S@(3=OLR"&FO]*7JA"A8
M5++,>-P;]4?(-7+.HEQ>,E2/&*HR[$HQ6V]H+O^XW]/O])D.^QG>\9O+=V,/
M>L;0VFC9-4,G[SI;DA!^K_1IKR-/DH:2]"H\N'R.WMI1I_<""K7$@RNUS8!T
MS//Y$0L )2FB8@28@B<7#R/<9*C;%A#>X-'M7WF_A XOWM5X/N#>I>.3?P5A
MBZ.O8O"'TMS]3:V(.1W+A4AXM?,-2M/B*DUGR<L7+VYN;GJPS]YE=/WB,':O
M,(OC!?<N6?S"8RE[H9LCPQB/7\!^=;UO#0=CH]\?#T;&^$4Z-?K&:&B./.,O
M_EWO=_7>50JR1F8O8+141JC.9/G@?_X?V[+[KV0$J]2P5.1WD]WRY,$GNK&W
ML$!8:'H+!X2#U8(!P:#*RIU;.3TFO<'+H3,WN^1A1WL7NKT64 2H%@PD/HY8
MF$:80I?^N,1&X)[VGVPZ>P6><DLH D+(1V>S&0]A1U,>M_"IP.>9N/9EB29/
MK:'IJUJK?*;+*NQ2\5^)=B1GYU8N<>WN_^+7Q3HTE*X%;&OES!%9"P8$@SYJ
MX5"V<D1F2M[/TM/PICR@P:RP!6R2Y_+GO07!WKO%3QXF1/*HHR"FWM/_NPV#
M['$8)'(OPRZR6W]L]H$'__[.OYNZ"F0@K'%*1GD:V]%5P'WM)"\O.BN5#^65
M+0YEY>#75%F;D;<S8+'#0IYTS[Y/^"W58\$GL &CY>2=<K+1<O+CXV1C+2<7
MY54M)S\*3C9 )[>L_.A8V5BDE),U6IELZ"5\7F5SW:9IXD<]33<'_9:%=WFY
MJ/?>G9XW@8EW<?QWE$2B_;\WG]]K[T(YI?XX<C.\*YN#24N-OX@:SX_^V5+C
M>^V"?8_":'H+@E9U!#YWK_B4M>2Y4_(\.GS?DN="\CQB$U<V%-3>!^$W!_O[
MML2Z2V(]/GG;$NM"8CW&9A=!2ZO-0!;2ZOO#-RVM+J35]\SADY9,=X\G)-./
MGT]:,EU(IA]%[^+6 &@(NO2^]40)]8(:F6&3)RRX4L-/@F1U]7]'$_5\8CZ%
M5J+V.NV^H+*34IW+;FK5_EK\OSN-430,'!4X7W8D_K:C0KS_7E9M]);2>_"&
M'CM$;%1[N0>G77[<+ Z#Y&JC(__* LZ-ZMH:4]4YO)^JSJ(]=MN\K"%[>;+-
MR\[?_>/T\.++YY/S3<O/Y^3=3L7=QRQ.L V[RNZL#DBC2]^B!\E<3UWX6!^;
MEN@B.Z4V)!VYB$H1U:ZPH64&BIX&.WKS'2:IQX[LTHJM<%.< 'G%)K[H1<E%
M,U_Y /7IRD*</(7KL2R]BJAQ[UV+7>T&%KM:=F_<OUNQZSTMNZ'5_8!EF[^8
MA0DN\^44._60'J@N>!?V_S&F<+[43L$%H,Y$<KSE%M[0/ISR1?)".P>I^(W%
MVH<LR4(0EHMHZ%<5W^X#S*KPZF@?KWK'O8[VX<WA_W7B%Z^7)#<4S8^/KE@
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MT"O2E6FD,GIKT#A)O6B1H5<" E5</_:OC;2O#F0GUJFE/;T$D=ZI^UA/Y]"
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MI.44=,I<:6GYO$"SH_OH920^E.$W,.\(X1-;75,FHE-)/>QEVZ%2/'8.<\A
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MU_YE]L$N11QKH+LRCI_9ZV8JOH[PX&,_\73!*VF QS16)1H>@-@C=#KTI?,
M'T':B=O$;H@>L7T%6L?M$4$PMR;2KVA)/\-A,RB:E^O8L]2C#=76NJ:+Y&!W
M%#F>JFY*.0+U&K ^\3R'1 []TO-,9=S@;64=;\\&NB;'R<+#"^*\P43^F##'
M[@4[10><CJ7Y5'& 9GQNQ&U?2X1*=A$O2JU8AJN8BZ2\>JTP"79FLPO3'ZNI
M5ODI=9U/JA5YZ:U<PB,PU<M9MWN&N=T=M2@GEL=X\15"+?7!FPE3I33U9*HN
M%GCR'8_.'!+ZC!I'1$NUGWQ.P47=R%$,G*3D10H0RN0[F)ET^VE5<0<S?%TD
M6L("[>%L1(10%O.!D.RV%2$]U@C\!<^M";&^R1I[1'DD\K<QQU.X85.OA85(
M#ZZ"C]0%!T%UXN*:T#:V)BV.WS(AS:$Z6M?AA8>YL45B+ ?#S/*'!TXJ$"&+
MTVIJFT]D17K$)6_8">]KR4:Q!(N#1[CZ5:DM%K2.!= "N5M0.^ DMLC_)GCL
M"=/"F=^E3$'X1[#% 1;BPA E3AM O*A;4B_/ZWA]V^0)@MS1O;;PP<=SYC;3
MG.7G?+J#-RV9WE%YB3BA6\ <%:4^>#,3BRF))=1X+^F6"S3E>1ZKE[BK_,O>
M$SQ'[)J%-ELY(07V3Z7+'JLQUS_:4&C_6P[MP0V%2B9](0YLSP,%?V$.M>;Y
MNW]SZ8YA+_"N=&\9O+VK^JJXHU7\E?D^R( L'-<PZTK@63D+W+F\1&YQ/KM.
MJ90[Y!$%6DV'NM3"CJR@;,V W9,.G/B"!^HZ[F!"'GQM,JPLF\/'<9*IQ:F*
M*^/GLW-<7"W-P<W?<@0]8!YV[N%L47@]1"9VN71'J[.+NVA'L&(@G5CX!S3N
M55IQ%[:M0Q!HP0N/L/0+;<B?#;9C>@Q311"*-<O$;:G"!Q_-:R>@17YZ.G/8
MG)!PGZ'RRSMND>T#V[(]N.$*T]BK3Y@FTMI-V 6AF:%*<#C62*<Q>$H^$9FS
MA6M]X8./\'[BEK_[H-_Z</ECXOX,99%%4<.U*;^CL%FPX'R_>MEX8J/&_3PN
M$DY-#;ARHN%[#!IGQ:=JPX5S<#Y C^.CM]E=]V.D'];56VOZLOQXE?<@4'[A
M])>SJ:48'ZV'D=B*$N"J_#X;T.TS)Y@AUKJ%FOA@8XX'/B+0OK\*EP[CA_ST
MEE='<7#SF\CHPA(%&?+HSP(9D8+$!V]D>M$[BM!*K)/'),?J#SPR&5H3/DV\
MYC5OC#S"_T4P?V ^SUY\S*<\UD8G#QFX=K03-CZ#LV2!>\0B]%5.7H07<9-W
MPOM84Z'K%NF6@V U@W5'7T5P8KK4<E\.IV/M%.T&U]R8HB#UL:K22M(N:<]+
MK1*N(SSX'!!$^(TRZ8!4X8,W0OH1EG23Q -GT_1VF,4O#6EZ7M6DE7T33WE.
MQZJS,.0Z4F&X#Y\GKQAZX52V8H:=Z*Z&[S[E@9<)>Q8E'_OKC+F)O'21DQ=[
MD7;8H"C<JJ*,<\.2]19J][5>27*(?IRRJ O5A#4A4_SYIW\#4$L#!!0    (
M "5 9E%BNY.WQ1\  &)' 0 5    ;V-G;BTR,#(P,#DS,%]C86PN>&ULW7W9
M=ALYDNA[?X6OYW50QK[4Z>HYLBQ7^5R7I;%<73-//%@"-F]3I#I)E>V_OP%J
ML192HI@ E?:+;%%)(+:,#1&!O__7EY/)L[^@FX]GTU^>LY_H\V<PC;,TGG[\
MY?D?'UX3^_R__O&WO_W]_Q#R/R_?OWWV:A;/3F"Z>+;?@5] >O9YO/CT[,\$
M\W\]R]WLY-F?L^Y?X[\\(?]8?FE_=OJU&W_\M'C&*:>W_]K]')P-R9E N,8?
M4IM(?$I -*591 &<*?F?'W^VRB6IO"0IZ$@D6$&"EIPD2YGTG$D1SQ>=C*?_
M^KG\"'X.SQ"YZ7SYZR_//RT6IS^_>/'Y\^>?OH1N\M.L^_B"4RI>7#[]_.+Q
M+W>>_RR63S/GW(OE7Z\>G8]7/8C+LA?_\_O;X_@)3CP93^<+/XUE@_GXY_GR
MP[>SZ!=+FC\(U[.U3Y3?R.5CI'Q$&">"_?1EGI[_XV_/GIV3HYM-X#WD9^7?
M/]Z_N;%E@O'"?YE-9R=??XJSDQ?EF1?[,Y0(A';Y[<774_CE^7Q\<CJ!R\\^
M=9!_>3Z+'Z>DL)4Z0<N>_W'^Q1??MHY^$L\F2TS?XN\77R^;; 4%?%G -$&Z
MOL7CL3M\]^K@W?'!*_S/\>';-Z_V/AR\>KGW=N_=_L'Q;P<''XZW0OWA56O1
MY9'P7Q&M;'\)P&06;SPT*?(XNR+WQ >8+#\=G<W)1^]/1WOS.2SF^V==AZ__
M2"6NE!>*>",9D2%Q$I3*!+1BD4F9$L\W27:!UE*"LY^'I1A?+/ZBD/(%3!;S
MRT^6Q"6474CS?ZR$XIRBVZ.T[^>?]J:I_'/P[S/42Q-<=+ZWV/==]Q4UX#_]
MY Q&*5B;(W7$2IN(=)P3Z[DCRF=!+>3@HVV!ZD;0W23!-;':Z^*S69>@0ZW^
M_-EG*#KX0L&?@^J[>$?>;JJ7BR=>S,].3I9KDO$"3BZ_7[1]+0E9S%HSYEPD
M$*.^,G/4P:D?IX,OIS"= P)YN/@$W4W4H[8Z\!B(B0&M58YHK:0"DD';[*.R
M"%P+B=D MDWDA7]W\E*;*=6DY1R$WV"27L^Z8Q3C=[/%D>\6A_G5>'XZF_O)
MK]WL[/021ID8TUE8DG6F1$8)Q 6JD1 .72%*$W>FG5;=%,Q-9$A\=S+4D%65
MQ6EDK706?"+6@$<TN2)664822(C!BI!5;"<F=9"XI*-3D$5R& !D:XFDGA'G
M (CQ26, D*2,NW8DAF!%'\7CU:*\#84KFLG9*72+KT<3/UV@0BYF_+0$CN]@
M,1*&<6-H0-V;,>CS&/E92S/1#F%-)B9G=1O[N!ZHX1G&7B)0C?[5).(]S!?=
M."Y@Z=:]FTWCI6'.(6ANT&_3')4VA4""\9HPD#G9G"43333 .H"&9]YZ24(5
MNE>3@FN.V350I,W2:28)2TX2M-/%CBJ-KIHUP<2(8;9O(0(KH=F$__+[X7]_
MBE=C_O%B%O_U:39!$LZ+0EI\'46NC%) B[,FB.0&?3>&,9PP5#KI8C:6M>#\
M75!ZNS4IC0M'_>0(0Y$WTWU_.E[XR0C#"DY%I*AB5<&PQ*O6:M2]WA@;H_"!
M-G%P5L,S)%>GISS<<7LJ<*":K'_HP,_/NJ]+',_S%2Y$JH2-)*28B-3,$<]=
M)HX)G@,PS:QL(0EW07FDLT.^)RGH2?B:B:(,J&S3-4"2-TZ[S(F0#)$SWA+O
M\(>*-&>G;62B27R_ I8A>3F5): OY:N)P/[LY&0VO09%R-H$JC*)OCC>)3^!
M.P?B=%)92YMX:.+GW 9D2"Y.9>;WHGG%8&?AQU-(![Z;CJ<?YWLQGIT4&D-Z
M!7D<QXL15RXS!8H88!B6*RZ)BRP2+Z5B63.EHF@3]CP$VB;2H;Y/Z:C,EVKR
M\G;LPWB"W@M<=])STE1FY4D4,A*9HB%>.TZDQ<\9#0EH$W.Q$IK>D=\I=,CQ
MZ<>W:)_A<HNOU]!EUAD9E"7,9@Q(%0CBC &B''56&&>C4DVBP(<@&Y+/W%]2
M[@2(51E3-U.P&EO)A#76>@1 XRO* JITZRDQWG.T[]*&S)NE"S9X.9XV>]A
M0NJPHIZVG$T_?H#NY!6$Q758.!@%%@V#UZH@ACZ>29DHZ5DRU#MGFB025X,S
M) >[ODA48$$+XSGB'):[E'PF%#^?$:N]1NN-?J WV0!MDFVY!D-%=*Z.<)+5
M2CM-\A(UD,@I;@6)@4GPH!.%UH[  $_*MN7['5GN1_#&3F"@B6HC.$DR2,0L
M,N)!9I(U3VA^P4%T3^0$#L;.U6+_EF1O(0&7DAB40YRT) 8M+)$Z6V(S8"!+
M,W!OHC"LB5/\T*O?WZ&[Q#!IH8)TGOC$$[YK09&0D=S@?'$U@]:RC=N_&IZ!
M:KAMY.$A/VX;#M2K98EQ=C9=S(_\5Q\F< E+9OB^60]$2.2:=!R(H]*2E+EW
MU&8579-JR]7@#%3?U1"&"O2O*0O=&:05& KJ@HPV$:$=*O:4(@G*H\LJ$QA?
MJKI$F].S=1 -U*VO)!$5N% O ; Z+W'EHE'GJ1629& >E5;2Q'(7"'->6Y.H
MI;%)$=']8 TILU[;>M3C1[V*@D^S;E'BT)>SKIM]+BG=D5>EGI='PHPJ@$1.
M7,1H- C!1% *$FN2'5H!RY RZ96EH2_E6_C,>].TXKP@N)"3]HEHGAV1(0;T
M<[PA.@@,&Z24E(7&'O1*P&JF/:B3,3J1\&U3#*UV1 4M,B>HG9-P#J3V32J"
MUZ8]!N,W]Y>)>^+%1]&]91F5\H''S -1P@@TT(*A@39L6<XE!+@48Y,$T4-2
M/1B/N;X8].1"U2*#\>)DV2 U3?NS:3'1,(U+\0Q&*LD"R<&@,X^FF%ATX D
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MBIGTW#MVY]7&NX=Y6#KN3Z(]6H-+9*]GY)G.WN/LU_$D3!*Y*I>@F#5,2&<
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MP'.4H)7+.EL7'/>=U'RO@G%[:[@7.6Z-M X>C'ORZ.W??GWQZI]M2D9^>_I
M(;4MTUF+FI54K["1Z>_0*^Y8+#%(YW4RMF3Z_NZHV<:)[:R=EV%Q,<-I>7PQ
M)W]V/M]'!S>>T8^D;X>V)D^6122J^Q2$48I+GZ--7#EKK98"P^@VD =+[5L
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M[T1X'-^]%WUVX,CARFC@N-\-U*+)!@,#'T.B191YB+E>DXB%"YM+M&6P=64
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M][7#75M57\6S\?NE-?BD;L1G9]6W>/8Y?:AM!'Z=SI:?'Y7@!&>TM,HL)-0
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M0-;B,I!5;T O-RONB&M.6,BRNCO%%@B6.0@B:Y\M2R(UZ?2S"<Q#L>P/%O0
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M^K^? C?[VE26F5#)!=RJES%%A*):9I$A382R:OJ&77/#*G'*1:I(]UCZZ0<
MZ>[T':"#%+/;K+-"$@F<\X'X< "<Y5__Y_?G.?C*JSHOBW_[R?^3]Q/@!2U9
M7CS^VT^_/;R'Z4__\]__Z9_^]?^!\'^_^?0!O"OI\ID7"_"VXGC!&?B6+Y[
MWQBO_PY$53Z#OY75W_.O&,)_UR^]+5]^5/GCTP($7N#M_K7Z,\E2PK*$P""6
M_T%Q0B%FC,/8\T1(0Q[X$;IZ_',:90Q%&$%&8@H13T-(8A1 EGH^PH&/0MHT
M.L^+O_]9_8?@F@.I7%'K'__MIZ?%XN7/O_SR[=NW/WTGU?Q/9?7X2^!YX2^K
MIW]J'_^^]_RW4#_M9UGVB_[K^M$Z/_2@;-;_Y7__^N$S?>+/&.9%O< %51W4
M^9]K_<L/)<4+C?E9N<#1)]1/</485+^"?@!#_T_?:_;3O_\3  T<53GGG[@
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MC9ZG KA^4I?.\G]4(IRO>*ZNBG3\<DY5GO.#?V^2<LX8PQB'<0K#1.7,S+P
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M ?G1UPWPM7:+E5^Z_"WYT?WT5RD,,?W',E=_YDT8G)P/&)#5F-(-0JZVRSW
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M^YHO%G+[\*U-$=N>RTGUU)O;^=Y6S]C4?KMTF UV<F,.WL!+C5:EDZX9W%5
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ML-GSO.[52#]J:\J<U=?T'\N\SG60B#0;W^7U2]G^J/SCYF6]E!_PYG F"D2
M$X2A- ,91$)EU6<800^I!)LHBC)B9;WT$V-J9-?6^<,%LZUF>>%PF-'=\" /
MS'NM E>@JX*&NZL$Z&@!O@QR:'89DBZYL*<DHY+B96CMLN.%K?7UTGJ?SWGU
M5FXS'\OJQRQ#/".9QV&48A^B((IA%@4)3!'S*!5^@#)++ZVM]J=&;*U+DI81
MK(2T]=+:1O T93G 96 NLH.DAY?60<4O]M+:;G5D+ZV#*NU[:1U^K&<]P8T3
MP@S'A/(@R&"6J'"R+& P#=,(ACR3I@PC7$3<)OUWIVVK"3M:#O#Y1D#+"H$=
MU,QLBYY8##Q)/Q@ 8%_V;U]5IZ7^.LV/6]YO7Z^]DGX''NF[H%XS)H>Z?BO_
M>5<]E-^*6<RB./88@:KH!T2<,"CG)(=QAB@-?$$]:EG!;Z^/B2ZLK9QR*Z]^
M*BN@9+5=7_<!-5UC+X)IG'76#J$>R^U1#"Y><O=;'GG9/:K:_M)[_%&'WC?K
M]+IWHMTFX_E]:[S??%_PHE8Q>Q_R>C'#'N$^]@3DG E)"5D L2]7<.(SN9J+
M* V%4?HY1_),C3Z.^Y&L=5+GA&NMP$HM\&6C&%":63H(7CJN9D;%B*,U,(N-
M,5!N7'_LX1W<'<A"I-=W$;+'S\AMJ$>S_1C[YOEE7O[@_#.OON:4'\XX]+'4
M8>^<Z>1"M=YM=/^NJCY_+!?_R1>?."T?B_R_.&MR#KTOJ_97ZCE_AK,8,92&
MT!-^H$*;$<0<)="/0Q1*JX][OE4NH''%G]IZ\%M1K076]>+76='::W=0\;ER
ME5 Y#LHF)Q0HEXMZ@0M5K>) -KTFS1X0TN1:M2'?):JE54]V2\?('YC92C/=
MSV;HJ\1#Z?$V^<1TK=Q&Z576/*6E_.T"_."J?/9*T:LV=Y[^4CK*NENN7F>,
M7*YN(VLPZF+X.J.SNW:^DA1]\^.]O,SU-)/]X_KI_;S\=M/\HKXF]:+"=#%+
MPT2H8JA09"*6"V280APS#_HTC3)$?3\@5KD_3#J=VK+6E5FG &IN=Y3%7)0%
MI%*-K>*I?[9-IV<P#H8>)8[1'9K]N\ J>8$2&*PD!E]6,CM-NV<.D=L<? ;]
MCIR0SQR)_>Q\%N_VO#KA=<WYW8OV/BD>M_<COQ6K5%RZV)E\]/I9)R<3H1 X
M$0$,HI!#Y(<,DL +E8](&/M4>"0([1R#>\EA-,E&=1]6:OP9O,@FE8W5)*7&
M[/\LZX4:-,O[F5Y#8WB3,QC<(]WY:/E5=N=6@P.'+ETU0*,':!1Q>$UT"8Y.
M+Y1Z"3+NU=,E6.U=4EW46-]KYH+7=^)MQ5F^6.=/WCBBS$2:))&7QC!./ R1
M^A?VY7 Q@KPL% A1%-N8<><ZG)H)I^55!AO5$MM>1Y]!U_2.VAUF@U]<MW U
MPEYUDLYWW-M<WFF;0>/VHOM,GR/??ILAL'\E;OC>Y?F2WW-2+7'U0]TTMH5S
MLI!&F 0"^IP'$$4D@EF4<<B)0%Z /8:1>9*AL]U-C516$@(E8O^$NP=P/4TH
M[M$:F$YV4QB#KK1]RCB=1[!_DN++D!PIM]";LJK*;\JZ_/:4TR= <:$.Q?EW
M^J3.3IMC4 SJ%TYSD<N?BZ721%$Z+LK%DTHGW*01_ %PDYNX.8]?93;6N8A5
M8F_]TU,YEYQQU1[#XV>Y][L"9+D LBTPSY_SYDS_JDE!K*_R_U"K&X!GV6+=
MA(FTV8WS FS-FX$2%!\?19N4Q =:>;4DQ,<U.I5V^,1;/1,-ZWKC_\'GZC12
MA8I\**61J^)"#EE&7NJ%(L7J5BV+(6+$@VG*0LA$C"D3.**<6Z4.MNE]:NO%
M_UJ6:IXT&;W53-3*@">IC9Y9J_"TC[Q\BRM+(]5N7,PLUL'0'GB]:>0&2G H
M@84*6+D!+]5F7$D_N#W;"SBGR7JM!!@W_6X?;/82ZO9JI.?F6C;]P*MG1:>_
MKG,1?>(OS7VEM+[OJ[R@^0N>WQ8J<\[#MW(6(>+S2!%?S)C<<%/1W)MD2-",
M>[Z'4BO'@CY"3(W_Y+<:6NZ\^T!ON!L?&-"A=^A2?*CD;VN"K/+Z7#6YFZ2P
M#G?G%T#E=,?>1XYQ=_$7(+6WL[^DK9Z)+:7!GB^:2YR"24M2'6!RV0?O!+6M
MKR0I$4&:9"$D"'%IV^$49D&$H9=$2,0T(WYJY"_?J_>I<5M'>!T1NB5^Q\8P
MN=-T,#9F'#@8XH.?)[@#VSZ=9A_0G*;8M!)@W+2;?;#92\79JY%^C/>1+VX+
M6CY+^[&NK[_B?*[SXI5O]=&%SH'0G'W4;W"=TUD0)@EGV(.),N90D"&8AD$"
M,0DX%M2+4YS:Q/!9]F_%>B/$^4GQ@1R/6OED=D][6IGM&,YV+,PX;D"$!V8Y
M!6XC.OA9"?]'L!9?X=TH +H:7 &M@SNNZPF>2[:S%6%4ONN)SR[C]6W&/O;Q
M77L\W>1Y55;C>_F;>H:%%Z%$"!@F-(/(CRG,O""%(A6QB$B(O1"9QCX>Z6-J
M%MM*S*V<MUI2\\C'8W">IB9'( U,/SWPL8I[/(/ !7&/QUH>+>[QC&K=N,=S
MC_8S:]2>\;:0%I)N6V?.#PE+L,\X%#04<K?& IA%*8$D\5 LY/P/LLQFM[;?
MQ>0FN+IIW(C8JQ+! 2#-S([+X!EZ:MLA8VTV'%?>I65PH)=1%__C6NZN[R>>
M['D)QY@. <#S>YRSV^(M?LFEM=_>?0L21$G&4YARGJE$(PG,<)S(']-4)%1X
M*0^M+MU.]3:U6;\1%BAI85Z 5E[+^[23$!O>G[D";NC[LJ.8G7?.L+\;,P'%
MZ5W8R0['O?LRT7WOKLOHI7Y$<B]QYE7%F=YDO,N_YHP73)V[W"DGD>NU@W@]
M8U3XB4I^(#PO@8AC51F2$ICY<H_  T:";)UR^\&<7,PE,)HPVS[U#Z.8&?R9
M,\!:R;LAKJO2/C>M6XX= UF,C4=X2C$F$"=9"E%*&,1<VL7<QY11%!,:,+NH
MAT&'93HC G[^6"XX\(,_#C8V9DN%8[S'63?60C>G4& MMCZ5UX*#CN3NUA![
MM%PN*!:]C[JZV*.RN]3T:*&'7[&J"H'KI[OJ'E>+U0];\1*Z^M:=^*WFVM%C
M%J$HBE":019F@2H>(^2^E<BEB"/$2>9Y1!@=3_7K?FHFKA8/E@(N:]XXD6WG
M55@%'MF4R.HY,*?);7BXASZ";\15;K!*>M#^?""Z:STF4@N@U1@4=POWYD'Q
M'\G=N4%W46Y]\>M,(\N7L@"8;1R8KS__IGR+4^C[KMR+>Z-XTMW8OM7QW(][
M:[SECMR_E9XG(\4B9_E\N<B_\L^-AWO.ZX_RVWI7/N.\F(6$QPE.8LBBR(-(
M>!$D$6<P#L+,HRB-HP!;'8Z<Z7!JBT=77K 1^ HHD<&71FC+4]*SH!L>ESB$
M<N@3D\M0M#\T,83&Z;G)N3['/3HQ1&#O],3TO1Z&;%MI^C-7R:JD%I\:*ZR3
MIK8MA3:+_(SZ/DEAG&$,42S1QFG&(,U0FF0T8<2,=>RZG1KWK"6&K;UJ7U#>
M &L#FW00!(>FG+9NY ;$5NKM O.MX(,@:V%U#H+P2-:F(Z3M#$QKP$X:EN:M
MC6=06FNX94C:O]TS*U;'V^;F'\M\\4.=$.K??GZ1'37Q=;6JAZ0^0W_&?1($
MS/<A99Z " 4"9@%3_R'"YW'H4]^NWIJE ),C>7T46"M1KP!="PMT$2G+S%BV
M8V%F9PZ)\,"+0%?T/X!&>)4-D5^U1["?&]PW*H!/)W&WSY_5$SRGN;1L91@W
MKU9/A/9R;/5MIR?QJ62%]:V.TIYQP5*2H@2*(*)RE\PCB!-5%8&)(&0"!Y8N
M!-W&)T=86K95?/K/>0%J_1O+*Z$M_ R)J"<J0Y.,%NL*-((YI(X#ZCJEA6[[
MXT[Y YKM3>=#S_1U_UG?PSR4*B-H0?,YW_(B?BA56K[[JE17..S-C]]JSFZ+
M]<G;-97[86TU;<*Y!$FC-,60<11#E/D(RL^#0)*&)*8X$R0PNF,94LBI44='
M1W7U4JVT!$4G,$+]6]\B+.LF_\7FA@:O-;3,&3K(%V!X2O?*XSKT-GM[2-<*
M@OUP#!6$H<9UI2@@/\#/OS6#_,?.%=%&WT$"TH8<$+=^6 /(.;+[UG!([WM]
M#=A7__#@-ARE6<SN-JG[9SCD7/A"0!*I4CD1%A"'$8:4!D)NARF-8J.2E":=
M36T9>+N5Z*BQ'KMU#?H;E2<A-^-K5T .S+O=<#:YF6U-T(ZL;B-XSR'B.F#W
M:'^CQ^>>T_Q0..[9=_H1RE]QE:M(-WT/K-+>SPA#F(>(P""2FT\4^ 1BAC/H
M$Y]X B$4A5;IYO=ZF!IUK 1LG'4 E2+:,<0^AF:T<!$R W/!&I36N>;M*52L
MI_]1S5W.^?U.1IWH1W7<G=W''^QQ'ZH2,=T)314=DK@C\_RQJ6RA#N[G<V6E
MK!QP5?HF]?Q,!#Q#69; , L11)Z7PC1C&<PHS7A*4(AC\QO2"P29&D&H>P^5
MVU7O*E3=D+*J 7ZL>%.U307>:V6V[(URK:G%/> EHV=PYSK2F Q]-J9R]-V)
ME9W2T01L5 %K7>2.<>-K+M5IWAMI4"RN:T<:G)$N<(<=)+M[70?(GKSIO:3]
M\>Y^':"P=1OLHKT^#C^!YZ-[^:VU88!A$!*J\B0D/"+27*5"KE=>!N,@I9Y'
M@RC"OKE;SW;C4UN(E'1 B6?C6K*#E\$R<0$* U/_&H ^&:MWD;!QI>F/R$A\
M>_[3L/2%.:SQ:8^7G7=&]&LY+.VV]\J19_I6;B,U_\=2#NS-5_F?]I,BL4]3
M+BCTPL"'*(Q32%#DP2B1EK67>33*K"YP#O8R-5;:" GXUY-!9A9(&M[>7HK/
MT*;J!AHMX "QW"<A<%L][5!'(Y=+.Z'K?GVT4P]?X*"Q5TVR4RWUS8_-(VTQ
M55UB\JZIM-LQE/[6EMF];JKLWGSG%<UK?J\RD\\DB029+WDDH@&#B'LA3&-*
MH8]2+_##B+((SYJZO)\7N%H8LLDXTMO,OUT=AIN*;_AC7A1J_T'P7)FF!RH=
M\U:--C^\NC+X[?,[50"YN3KHXXXRPM?"LM#W$<H@8A1!%/$$9@DBT&?"1S$.
M19R)]FNY*0R#SR?[K:PT&.Y+N6FVJ?_M/A/#)75Z S_T(MTI@-W5N5L%6_D5
M'"R4W53$;G7?.N>X BO]00L 6"$ - 2.O;K&&S/G#F,CB#Z^+]IXXW'0S6W$
M[GOF_2T7O):]-WDVW^#B[W5K^P<X\9 7,4AH[$GKAU!(.*.0)RE!E,1<>%99
MS8_V-+6=E!84O#226F;N/8JF&>T[P6A@HF[@:854URY:S 'V5&?!<)I=]VAG
MX^;1/:?S7L;<LR_TXP6=YD015\6?)'?E7WGC;O6^K"09%4V($?WQL*GV?ETP
M_=.\X;FUU]9'OK@3#_C[O38<92N5NF%]QYO_7?M<9B1,>292*+!.*$Y40G&?
M0Y'&'@H1#F/FV=#-V I,C<6:I$.T"P#(6Z]-Y9!K:1Z/_CV8$>:41WE@'FX&
M>$OW;;?<*]"B %8P@ X..C-5!XE.?JHK[>);"B#A&,11][5&S>6",;H.HZY#
MKS5"N\O;J\GAR#'X>KEX*BN5G&?FBX@2%F40!S2&2*0))!G"4 @_%ES^TX^M
M%K@3?4UM+3KH%HS7XCKT"N[@;;: .$)Q8*X_Y!,,-I(.Z!&\#\>@#L&=[E[7
M'WA?[[/NP =>Z>%9L2[;* GKG>2JKU@E;-$9H58A_C]^E92UK#B[*SZI1"Y5
M7CRJ>ACU;T5):EY]59N!V^)EN:A7\1)YPX;/Y;)8R-_-<5WK<L@/Y?^E[DV7
M(\>Q--%7@5G?6YUE)M1P 4%@ZI=BR6[-9(;B1JBZ;"Q^N&$-<<KEKG*Z(E+]
M]!?@XKO3 3I(L=IFLA02R7/.!_+# 7"6.J%VQE*4XC3BD.:6G?(D@TS*%*91
MFNM<9'DJN7, Q]O8,#76JS6UN7 ;5>UR657*>D1,O-$;X1"B,OUQ'IB7M]US
M:Y]Y"T)=^M!XXBT.?P8M$L#6(FBQJ!H5E3=@%PY0XP'V ;D!S0NUBPEX6#;%
M#Z;_0GE$^DS_Q1HIH.A?X07S"VEZVZ'MC)QZ(]7&"]!Z6^SWXL#>6)7^#<,^
MM^??']A:S3A.,QGQ&(JJ75BJ)*0L83 B.)4929.4.J5IG94P-:=FTPRKUA(8
M-8'5T[]5V#Z0W=Y&$'@&]@6\D>G5).RD]0%:A.T_=_0&82?-.M4>[/2%?7=K
MYN:?RU5-/=N#65OFW5;H/?/GG<VF\K=BH>[6ZJF<14+$B284\A1IB.($0RH8
M@@G3.4E)0A!5?ML[X92;&HGLV;87X&$WI7?_76]RKQ_9 NS?],T:!RKKO/M'
M!QQUUTVFMQG+P7>EQAG&'KM8X?$.N^T54+^1]\G"(WN\L3: #'^'[^-B;3S&
M+^I[88\&%FM;*7G&XT2R.(Z@CE$$4<12R&(J893(/(O3C&OLQ/+G!$R-J6L=
MP5;)JJZWN[-W$L3+OMZUT Q,?)ZH>#EZ7:9?X>>=?.QH;EZ74;M>7N=U/4O$
M">,XOE0E<L\=)C8A6LIV/$!1!*5Y$$0\%9!2LY:36"19S).8^T6@.$N>VD>_
MHSBX&&7@6:[->33</*M!,!Z8/6[OW]^!V_5Z5?"7=1M$]YFMALE,\D8H:*4S
M9^'CEB_SQ>2H)IGW WI&X>TUB-ELC%DOJ*E$C[2RG*4AXQ$WI"5RR%D:0<H9
MBLWO,*9>4;H7)4Z-K+;5!>O"0=N*'S?F-V4)&KW!\W+E7@?$?0 PUBHB(H(J
M0PE$6!-(D6)082)$2C3&,IO]4"N^?),AV)4\9$SP K8X'PZ#9R+J9<3=9H:@
M* X\(QPU4=NH>P.V"@>,OW/%)FC W$6AXT:XN6)P%)+F?&,_SC\,3;M;?%ZI
M9U;(#TU+RH]_V&P2M>E%:<],RAE")-(HX9#P++;)J@R2A"D8RRR2+,TIEL*O
M\VT_19P^JU&[X#9: U6K6_=D759^;=5!SY.@>HZ/&VL-B/DX5-8: 'YI3?BS
MK?3<CD&C_FY;W.XA\.:VZQ ,27@]-1F5!:]#ZY :KWQ:CVBY#XJO[Q;E>M4>
M#@D;D_%=W>O/JV(ABF<V;T^#__E2K.Q)\#OU1<FJ,?;?GI>+7XL%,]<MON]L
M'\ZTRJ)(I@ARE=A0W30Q_G2>&,\:IRQ&2J)4.@?##:+BU+SPK5DV;^"Y-0RP
M-@:N-LVN=+DR_ZRM Q#HUCB/^*5A!KV;H*<QE .3M[4/; V\ ?O#NC%R&RC4
M#.O#$KQ3H+446%/!QM;=K),W'V6/(+0W'^V18LS><-3]0L<&'9#.R+!A)(\7
M^#4H<GMQ7<-*ZK>B^EMIQ'\LU\6366V4,YF3&%/!899S,[MSX[P1%2O(L<Z)
MH G'L=<^__[CIS8SVS;LYBO>Z.>WV#F SFT1TQ^0@>>W0RP,U2WGA7@%WYK_
M?5!_K,$[\]G\(^ ._&DX0JXT#B2,NH(X;=WARN#,53V/]*IE0]/E<I,P'&41
MY0*9CUG:OANV<@5#FD.A9)IAG,=1[->VZ924J7W=C7J]-C).P^AX[G8M.$.?
ML57Z;5K3#M-NJ N#H*=H)P6->V+69>O1Z5CGQ7UW16W)=^M3U,=K=POS>9G?
MS#(:TRBA!#*N,X@D2<TR/<\A2ADAN9 Z5U[M=LX)FMJ7W^K5%'7PW<,\@Z;K
M+N7U& V^#]FJV(0KW(!6RY![C=TXA-U-/"-KY/W";HN/=P0O7-^/#8;,'CE=
M(,"X%VFB,I5"1B,"$4XQ9))P,UQ$\YAAFDOAPS/CFS U!GM?]QDH%D#;++<?
M%@SKGMO "6F[",H-+)Z>S1N\'F[$.>U!'YB2Q\UE;+)P3IQ'A>/_MQO.D#/+
M&U@QZISU=J-T.!N^H28]SM8^O=@(MGO]WEQ0"#9_6!5L7MK]NKM%L2[LR?W=
MXN%1_?JR-@K/\D1P+3"#2-GUMQ8QY%KG$&.>B#AE$7(+G^TA>VHS6ZV]G<M$
MHS]85P8TYU]%:X.=_-:/"NC*#(_#$<^Q<3C;&@[Q@:>5!NQ[#5K50:U[<SZQ
M4=]V-S(&@%\'!MOCB&DXT$<Z.PH-OM^!4#_X.D]Z/!\YWA%./UOWSF9Z/J+/
MU&$,8N5C%2'7Q'S,&,\2&5$&N> I1((IR.(H@YA%7.C8_%%@]_GA6,#D)@$;
M$VN[HM<!L4WTF0_MG #1A<BO@V9HMJZUJP-=VW"P*T'Q(=SKP!F+5;U \N3,
M\PAT$^.)^T9DO_-:[U-<QW4]>.SOS.:7KMO.>9^-4D59+E>O5=GE)E,)1SE/
ML$@A8:GQ?H52D&=99CY^PWAYPJA,D5L&@+-,GW=VG R 1NMM^\BMWJ!2W.,;
M=T(=95SAB"60*"PA0KF$A",,TP1QG64T0W'J/)V$QGR,^65TQ!WFGM X#CP9
M782P3X-#)RP]IJS0F(XTA_5_/?WF,Q]X.B<XIP>--^/YV+4W!7K=V+O,\6&Z
M8UM>><82&9O9C\/(EDE ME\:M[6Q(HDD)YE()8YGZ^6:S=W.23ID>3'R1N*
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MVA8?SZR-Y[FV+:OCF+BYQ^&1'GB*V2C<,IK1V;S2H-:Z#J:QD2XUOX5SC/V
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M59#R?[TLE)UTM@$0(DUS!?/,-O&C"89<R!PR3E,L,&:$Y>ZEW=P%3XTIK7;
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M^Z8I-&D+K"<T5D@RB");*H.('!*:<I@F>9PS$A%-G2K7718U-5)K.Y:3?K7
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MT5AS0:(4^VTQC35:XVQ#;<;J!FBEFA&K/[4Q!\EM)AH+^H$GJ!TS;,F;K2'
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M]CK*RK-&_S7#X^8FCP7ZP*Q>FU$7P[AILN:VI@#^L@:M,3=@SQRPM2=@+X
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MY;N_9%G[A5^\[NI3@:I)RXPKQC#%&>0)IC9&%$%&%8%1JD5,,DE5ZM4W\U#
M]+[E:C>YM K^%?P_T5^B&!B P0^K[%^!4>8FJO\_8"_KQ^6J^&\E_PIBG-S$
M*+^A>5I5>\V2FQSAFSPA=1YU">JM1L#6X*L9_IU"FVET ^PKN%<EMOE3;/\4
MTZJ#]K/U+'^H^6LM+4KP#=I*PTEVDVRE+5_6Y=K\J=HTNUYD[[.+^B7R/H_P
M?C5&/6-HVTI5(SK(R<&>_0.=!M0RWFJ'?\_"CEW[_>MZ[%Q542K+^5S)NFW-
M?7,H]Y7-57G[?:4J/[;9'B Z4G%&,-0\S6W'20:I1ACF*2(1)IPJFCG'F/A(
MGAH-WC[\[A,,X06RPV;64- -3A.MVJ!I0=4J#BK-P4;U/OM;7B![;'0-!?9(
M.U[NH ?:^^J#5^<FF-<#Q]L-ZV/GWK98KP?TH'@;D[BRW7]6W]7J=B$W9Q_;
M%*NZ/C&FD=1<4$A2V^V%,^/,<A)#(7.-F:1"4.1,[ZY2IT;MC=Z@5KPJ\;X]
M^=O-"?0I*.TW#@XSP!#H#LS^$P#6@_6' '@DQM_!<JE!L=#+U5.]P<NX6?A4
M:0IV()[J@;"+G$T(P5\"30*^\'5. ,X/&X_\?>W;(W[OFZ^H1L<[2@ U%8#X
MF0I 39$?J\F=F:F*15F(:KT1SVB*%(T2!LUB@$&DDP12K"2D24)I3'*D4^E=
M?&X05:<VO6S#'XM6T7KSY 8LF[ [M36F1WFY80;<;8MB&L,XXI'/N>)QKK7C
M=@RV?;C;%Z*R.7"9N$&')7A5N&&T';\(W*"HGZSY-JS$GC,1L\T8J@VKJF)<
MVU]A)DBFS?])*%%DYA%I#^05(I#P/!9"QHKF7D58S@F:VBQ0*;<M(WI]8=%S
M #OR=@#8AF9=5C>.:?:8:P W?6 "<N4%*((RW3E9X_+4!8N/6.;2]7WK#Y3K
MU8M8O]@M$.,4?U%S>S)O.S/:<WC1_!S/<)9)DO(,*D*5X0RN($%"PR@AN4AQ
M@I7R"N)Q%3PU#FF5 Z5=3E2M3;E:*%W4G5&YX1=6G#]_N6X0W'AE"&@'WZ78
M4;E:&S=*5WUCZW@>T?XS9'JX'U)A<[\=98^<V.V'R''6MN?]_6CK=\7L>MVZ
M4G>+YY=U18G_M32RBGFQ?FV.&Y1,XRC-<XB9B"#*8@091BFDB&8DCDF4Y4X'
M9UY2IT98]9R]U=*/FMR =N.EX/ -3$H[^H)*X=8!VNI\^<3,FY.\4 I)2&Z"
M1V4C+RP.J<COYB#-:.K];L(9XG:'CJO$-J*)J_-Z!K,T(9&6<4*$7X^($T*F
MQC+'/59Z=?X\!:?C8NI*D(9>2/GB<VW[F>$:89Z2\Y9M9[J;4G9=V[^R[=W"
MNCE/FW<4I9(DL1 P1[;#?(PP9'E&("4119AG49HEOF5M#V1,[HO?Z2O[VW+Q
M'=HZE*"JX;K5O.S' Z<@=J.!*X$;F@7"8-:KZNT95$*7O#T4,WJ]VS-VGBIV
M>^[2?@%]/]3*5HJ4LK#;NFQ>;<^4#P;@\G$YMRNAJFCDJOC^7:WJ;D&(H%A$
M9D5B/(+,AG[82OF2PTBI1-,TR6GBU+*NOPI38Y7:P5X:0\#/QT(\@O6*R4VU
M$OO=B)U8:,!*\,^7I=T8,+]:/RKPB962_1.\9\_%FLW![VSU#[4&/\UUYA4J
M"S.:MLOU<E5=O*KQJ)_:@ ?8!KTV;+GO-O$5+T8WV8TSW -SX49_L#6@WE8N
M;\#&!M 8 1HK+O1R"H6_7Z#BL.,P4OS*PZ-J/[+MUT>B_]=^'?9C8:MB_?BD
MUH78-&QK_K+^N03SY4]5KH&TE?I6X,=R;E2&/P\[O%7/+^U]K#F".?R@V\_X
M]NN'V__O\#.6]?9@I<WS\[P0EK7-&U*:O]4-DT#Q]*1DP=9J_FJD*:'DV3L^
MV'" ]1+(YG];-NBB@J($4ME)NU@H&2IJYZHWZ%(,9X\GCQK,V=_RPZC.*Y[4
M-])GN5K;(M#OEJO5\J=M83\3D18X9P*F2<(@$II#FJ,,Z@21*!=$D,QKR_&$
MC*E-V96*M2<KC5-U Q;J_!:],Y".J_[KX!G:W=\B8]W-D*$E9\T.&Q-R+&;D
M8(ZS=AY'89R_M&_6X>FJLSOA@NJ/]3NC[S]F(HNURK& &;5M;5BD(-$J@5)H
M&>M(1SDC?@F)SK*G1@?[Q;DW ?6>M;%\P'>CBH$@'=Q+/E-2>S]VVV@.*M4#
M;AKT "QL4J"[^)'S!;UQ.4XE]']$T'I_=\9;*M=[A;@VW:325$1(9PHRH8T+
M0^,,4AZ;\8EBC**8JIQ[[67ZJS Y2K/EZ;19XI1UU?JB53UTZ;^N87%CN6'!
M'ICL+I0"W!BQ4PIPD"9A_4$<H3I@EQ93J!+H@))CM4"7)X4I,UW66?.S1#(2
MB\BLWDC*(<J(A"P6&$998EPZG8F<>E'?&3F3X[>='9B;@](0=O.S_HUG<.PY
MC%V]M:N1&]PS.ZKP7 Y:?N$4#D/69&Y%O6FYY0-[+U52/KR\)ST8,KI=2/L_
M-D?X!YO;!<RM(:G5ZM7P45T_),KRF$EJO"."%41)PB$7C$")C:-D.S;%;H<W
M7E(G1QUVNK;QFE5]9+75VY,LG!!WI([0. Y-)"V$U0\[*M_8(CFMUJ&SD[Q0
M"DHS3H+')1T?+(XHR.OF/D?+<U:6]_KOS*X3U_>K+_90I4D:4M4^]H?F2*+:
M<FG[<SS4!Z<?V&OY?G/T.:-IBI@T?$73G-B0V 02G'.(4^/H:!2;__,X<0ZH
MV=2(K3'*?(1-8FA[.B9W3;H!BTT7I/:D6AJ[? XH0PZOR[GQ&PW:T"QJS;+=
M?QK#P/T*5*9MTCU5$[W[87\ MWV#&A.!M1%LC7RKL?0Y@WZC,1WQ:/KT=W88
MU;'W<=J+#SY>\YN?S8<=[/1V .R[#W5#"ASQK'< G/:/@(<0$*+I^6\%XU7(
M^4PCI'C.-519EIHE@\@@(22&A#,E2!I3E$0^+57.R/&:2T?HG_)@933=RN>-
MDMY;IN<P=5L4!$!JX GLJ,7X1LFAVH@?H3!<M_"MJ#=L"GYD;W?O[^/+^^>(
M%+)@J]?[55UR['>U?ES*>GM3J9W,WG>OQQ>WES7%PB*>*J83X[_+R#"(S""+
M2 (SG,0\4U',1.Z;6Q)*N:FY\%MUS7BU9?AJ\T"K^ W82W&O*HB<NJV]OG]>
M2[!7P(WPWFI@!V;)-QG37KDXH<$/G<,33+_1<W]"(WLJ9RBXC'YSATT2L4%-
M-GSLDT'H9;4RRZT9CW."">*0(*4AHHQ"(J,<(I&31)!,8>(5;G1:S-3XW&H)
MKHDS/(.F&Z%>C]' U+B?4&2W/9KNZ.!]K2OXG=F\_+ =]+IA"4E:9R2-2C_=
MUAX2R86K0Z0?_E8LU-U:/96S*)>:Z\@V/J:&$Q+"("/FGQD6U'9($!@[E9&]
M(&=JI'"0/ >^64U!I>I528=;8-WH(0!< _-#+Z2N3#4\PF&X=,.MJ#=,.3RR
MMSOM\/CRGDO,-5M7 83W^FXAED_*'D@MGYY7ZE$MRN*':GZ["?'+1*IU0F!&
M,F*\!J&-)\$-=6 =IY&R2<R1URK23_[4.&2COETS[.D-:L5=HLR"#(SCVFXX
MN(=>OH5 VG\YU@^OH"LN3Q7&753UP^=HW=3S,7TYSZR_;&*7(8AZX37+28Y)
MRF,8$;L8TC*#7.L(9B+6U.924^&UO7XL8IH[Z^6.GG_Z-Y+$^5^K4!S?8D\G
M(!4L$4)Q&R6@*$3(O-P\YAEDL9E#8IID<:)GSU7NI1G^U7H,8 _%#0?O._6]
M6"SL$HJSN:WU=S6>&=/F)942QI%QT!'#"/*$<JC,="QI;M;O>=[@^7$AQT.S
M%38<EA_KOE^A@'2=*:^!9O#)<*O<O[>;DK?K]:K@+^LJ47F]!)_9*DB3F,N(
MA)WNCJ2,/*.=L_)XTCI[9<^,&[O)HNYU<YBT7)2S+(IRC$@"5:011)002!(N
MH, JDARS5+H%79T7,36/NM;0.GGO7DJSR"E]\V..073[X*^#9N /?HO*5KV!
MDO?.XQ T1>58RK@I*&>M/$HQ.7]EO\^\*>1>-@<!-N[<SFNVN&DYRS%E.,D2
MR")E9ODT3VT%0&&6VTP)G:6*YVRVJ!I2.,[Q7>*<WG!:O^&[0H=[T=O&"S8
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MDP\A=SQ/?D#4]OS_(>7T6S6T3[3%7JTRY?TV$\QVOIS%$:9Q1C#$.HX@2KF
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M*,,((ITCR+.40T$0PXE429)XM3DZ>/[4:./3<JW \ZI8B.*9S7>[,WKNZAW
MZ+A+UQ^<H7?==E*(K6H!=\Y.VQQT)^Q Q+@[6Z?M.]JI.G-9ST7F"R\+6;#5
MZU<V5_>ZHHK?-E'XBK XQ0F"*C/_088I(9>20J4X49QE.,J<NJF[B9O:-[[5
MUDQG1M]J^6<U=@NN[P.XXY(N&(Q#+\VN0]!_:>4$3- E4K?$<9<Z3M8?+5G<
M[NH1ZO5!U9VDZ_/-N[)\L0EBMIW8W:(J02<_5&FCGXQYK'R\7WUFAMC8O/EW
MU8O:[JHM%S.>Y4HP2F 6,V76*(1"QE-BPU5UPDEJT"+.H6'A])H:8WVQ.>*E
MJ@O[ 2:,@651[84(V\3-(TPJX-AU<]H;CLC Y-<:U49AM&8!:Q=H#0.U9: Q
M!=RO0&/<YE<[YKW-"'H$QKW-2(X42/?P:#ZMJE*(G<AD.[YU-!(HVO&UWQI8
M/[(U^*E6"A3M2,MZI!E8- .[7('G9JS;7ZVW /PE4(1>^"'IC.@+*&Z\",#P
M&.U%# [P^/XGS6*Y>EZNJD^E:KOTWK[0J]?W2ZEF9DY-<I12F*+,MD-"&I*(
M4I@01.,D3[3D3JMX1WE3FS\W!ZD[.N]T!6LT!U9U_S/H+MS=CZ(#H3G6B?05
M0/8ZG7: )\ A=9>4T<^J'4P^=63M<EN?7-_#+<?;[RNEY,/RG?JZG,OZ#V;)
MT;9HK_[\5#4U2G2,4$Z@IHGQ\9-$0LX5@S)#,L[B.$V)>S9:;S6F1DG-KGI9
M[ZHWT8:L,J;IF%$:>WPR6GL/D(,C/PKL@V]AGCC'J.T #TOP3@%KRDVSD;%K
M#=B8,\IX^*0>CS$N8^4D#SD^GAG+U\+:G<K<^^DCYCA?B\!^\O/53[NF(\1_
MJKG\=;FRVV"?EFOK@M_K#T7YO"S9_#]6RY?G3?N].&)9$A.8(:(ABF@.F632
M>,F"Q&82TPA1KVI"7N*G-D-5VH-'HSW0QK<SVOH6#?)#/^64*RTE5+:G,\):
M02Z9@)1D"8J1S5N(_0IJ#H?_.*4V3XP F*NR;'8BEJ!4\_F@8^)V;C$<S@.[
M!+7BP&H.#<+0(GP#C/;57IW=#&H- )4%@[44\<4N?,\19PW>H"F)+SJGNY9X
M/Z7?G//NI2P6YB.]W>[25S^:&>W#TK8[FY$<29EB#;4V,PR*4P(Y%F:N,3\R
MS75$$Z]4K(L2IS:SM J#'8UO0*LS^%9K[7D">QEW-S(+BN; _'4MD-YLY0Q.
M2(*Z+'143G+&X)"&W&_L&?0A'I5\L6>]'Y^>Y\M7I;ZJU8]"J#/1J_-JO*OR
M<%^46'Y?%/^MY&>U*I;2;F&7#^J/]3MSS3]F-.=1%B4,LDA2B&B>06X<,I@D
M.":<BR3V*]([F*938[K6T$V Q*EX]J9Y3N7C-?'"QMU@"UL+_(O2<R7L3S83
M]=$>,B[*Y;R0=L>UVM^KXMW-XYM>//9FMJ@EK-2C>;!-&_IM6?KF-@SV,CG&
MPDSA%1DZC.94YL(VIORF?3-D/:)U"WIK5]M_ GQ[J)*/K7&@LBYDT,W0(Q T
M7F<P9<<-]1D:\Z,HH<$%]@U#WNP8-55\&.))1I,8JE01B$260R)$!H64S"#-
M$X&\*J4<29C:W%$K^*=_BW'TUTI-WPCD0P3=B/<J7$;<PK]<)*I'*/(9T\,&
M(Q\*&3D<^8R-QP')YR[L<7KXO]CBA:U>[='K_]_>E_8XCC-I?I]?0<P",]V
M^:X.B@<&&"#KZ$4M^JTL5%5/8]$?#%[*\J[3SK&<597SZY?48<N73,J44B\P
M:'16VBF)$0_%8$0PCKN5^DV+3?/1!MPWA;H$0II1(F"LJ#2&L<UAU2R"*8E$
MC!.:Y<BIFKO[D%-;\S71U:(OZQ?:G;\AOO7U1_<V7AX3X' 2&!S6@47&*:)W
M'8CVJ3SG!JW'H5YPB$<ZP/.#.M!1G1=8G<=R;D\:[PC.B[.#XS:_.X/DB=5O
M.8U(SA-%(,/(QGHP ;F*,,02TSQ/>8RY5Q6"LZ-,36BW<Z,\Y'(WDJ[*VHWX
M#*ZP'::-#:*T=4 P8!;9ZRAO';Q>R2@+5\G2QKDVD:V5Z5<=ZG_4/\H_%7.>
M:D45-V9:9KNN2B,!**>VV)RQV'2:82J<0K[\AIV:7*CS UJAWT7_,G&.R#LZ
MUX+C.;2GK+3X*HJ;S(J*YB92: 8,W=45 <NZ^0$5O 3F]9''+X?IC,;9TICN
M=_>P,K^8!^KB[5'YYUP2J1.10DQD!A%"& J)S$<M4(2Y1$92.5N59X>8FN"I
MB 1O^Q0=/X^A@V%X,S)#BY!C4/K8>N?1\;#M;D9IM)2H10$>2^I 60&A*(^G
M3D ,E<S4B4NGV7;^SO',M$[*#\RR[BO[FF%+\[&,]_^N6V='=U+: R(K9=?+
MA7R9QS+B'/,,\C0WEIE&% H11Y#JF FM-&<T\K/,W :>FFQLT7U82LS;:G,$
MWM60"P_GX+9=B^3#<\L]U: B&_Q5_SO(2:4O>&&M0L>Q1S84_1 YM1T][^\G
MO:Q=^F%E.TW;AY?E-G6Q_<RWN@QML >+TNYU#WI.>1(G'.<PCE(&$64<,D44
M-+^(!%.91M++I'0?>FH2K*$5F-GQC,CVP-M-; V#XL""JW1$[:F>@1VBEO Z
MG5&!/>WA))4_7B%EE<?HHTHK?U2.Y56/)_2P+S^LY,:VP7ZGJW\_K,JNV/=B
MN7BH0J_F0BF9,:6AP-08FSDFD-/(YEW33'*4J50Z559R'&]JLJFD#ZSW!'K8
M5@[H.IBA83$;6!(UQ()?&G)_-<*HZG(/[H="T<-<#8OF2+;KS:CZF:[N&'7:
ML0Z/&<^H=>?IP,+UN&V \X?JP*,H@]-:AQ_[-@]SA52>B!S#C!(*$9<$,HXI
M3%A*=9[@5"1^=>]N(F=JPGM/<%4&QVA)PQQ77)^H ,<80>&?P/'&X>RT#U;W
M+(UT\.$,[6@'(M<IFLY!B3-Z7@<H[D_MH?B^?Y-]VJP?-OSQS7JS6?\P8S>^
M;Y:@B$O;W!41#%%$!;1JKOF!F,)"Q8JX5_"[/,[49.7[-S #OZ^]VDYWH)C*
M/-*24BB1C R*60:%Y E4*F*4H53I5+KE/@?$<9PDYQV2^RH.0.RH#@.O@]T0
M!K*!]XGWX$T&:C+!GLX^)UD=:'G8!V%0&\DN^*R?S..LJ[_U@@$KO<O,JC_^
M]N5OX&%MWOJ5)>9?"_#A\7'Q4/:8^V $:F%VS ;\6=TF</D"_M]J_6,%>%$^
MX_T;D(&G>H)^L=_\<_E5?=L__QKJO.PZ\)W&1L?MXQD9UWDX,"X<+N]YAL:+
M;_9_&Z_SG2_M"_+9S/9F8?/N[!_N5NKPB]:5U1Y\:OC(Y;.M&O_^I_QFG>?6
M%?4^S[7<SG&<ICQ-*.1"<(@0-T9(;O0=LX%2JJ34$<7S[7K+EXXG<:.2[[41
M[Y@8;E%_U%M;B;,R^(VU8NLJSLJ?9?W.FLTRC'ZS Z'\N^=YW[@OB>.IX62G
M?NBSQW*6[4_0XF@&]LQ6?[33?OS=P0T5".",R\@>"]10@ :+\H  5&@$/+Y\
ME5D,>@@Z+@?C'J6^RNR<',B^#A7]-M2/Z]6ZRD9?/=B"E(^Z3F2>HU1&'),4
M)DE&(1)1!)F.,(Q(RK*8J40DU&?ONSC2U+:IKW8,L#8:X<9N5X90\(NN2/7T
MK%T&UVW/" +9P.*]32/X4,/U_AI<WH+W*A0A9>3EP4859U=Y/I8\UV_H)R1^
MUT6A]7WSZ/*@X/<%%XOE8OOR=[ZU;JN7LKS!OG0$X3%G<<*@X)&&*(H$I%C'
M4$N4$:81Y;'T\=_WH&%JCJAVA9''BF(;H6D^[5?0TO+E&=_69WK<!-# H \L
MFBKJ9V!'?W6N. ,[%F:@86+0\APWP!A2K/4A8U2!=P-.QZ+PED?U$Y*[HAS6
M]5_5!FJR&D@6B[(X*;,EF3"R.9?$J%/FUSC3+-?"JQS&Q9$F)_!:17.>ZJ(Y
MO!U\NGYR[ZAR'6<WF18$O:$/&:]5&ZKH'B!%\RHZ(072Y<%&%3M7>3X6+M=O
MZ%F/DA>+XCX_CMRM?K94*Y1&DJ@41B)"MB@EASQ-<RBQ4; 2+I,<>:E6;L-.
M3;B45%OEZ5-U4E!E"53UU)JZ:]["Q7$&W"1->%P'%CL[2/<DST;)"O!#*FC!
M2K>1QZU:Z87&2>E*O[MO#NZ*Y]2FCL<Y@S@6QM1#D8)"&O&4Q3P5FB0JT[IG
MJ%8\-:FSCX\#A=YNEV:#_K'8?JO/&*L>(;W#KV+_8"HO@(;66EJA48.$-\5#
M2("#Y[]6Z%%\:36?O:9'6)#9)/^N-P]Z\]MBQ5?2B(5::289)KEF"C*-.429
MQ,8XT1S**$Y2G)"84R=EHG.4J:UB0R>L" 4[2CT",BZ"V;U\@T$T\#H^ATZ?
MN)6+,'E$K82 :Z28%:^7RB^$Y!H*G0$D%V\>+WSD&OT'P2-7+^[?9UW_Y[-Y
M#]Y_MR=M=Z+8;KC<SC-I"Q;J&"J.C 3,LQ@*E*;02#\I\YQFDGFUDKDTT-2$
MX)Y.4!$*_FI([=%1_2RTCNI, ,"&5FWZ8-6K=WH7$*&[II\=:_1^Z5T<G^N4
MWGE]/]EP;P][#\JP5\=GMA;[;^N-7CRLJHXCQH+:EXBZ6ZGRT[*JMZS^[W.Q
MM?O,1[V]S[_RG_.86M]N+&'*4V*;5"60$<Q@JDD<I1BQ-/8JY# ,F5.32S4G
M0-:L5%6YEK5_9T>^GX@::(;=!-SKS]O XK%D\*B/01,+8)G\=0::66T8;;=4
M+[UV+5[!GEE;*ZSLF6 8#B=HAYV0D&)Z($I'%?+#HGV\10P\6K\-YJL-XWK>
MO)3F?%VNN\P%F@O%$YEH!",<Y1!);"SQ--'&_C9?2)111;R<9Q='FIJ8;PBM
M?&;]TQ<O0^LFG(, -K!\W6%5=URMR&P2#L/)Q:M8A!1MEP<;53I=Y?E8P%R_
MH:>!RFUOC_*I'\V[8,3.7CS5;=$R32B*<@%QQA.(4IU RE(!(R4B%F&>1<RO
M6.O5(:<F-2S%NPY-/=O/.0#M:+@&A6]H$]8/.7_CU1F,H&;L]5''-6B=43@Q
M;=WOO#% 27_7YM%2U]Y8A!(M98I@DMKC.TUR*!1A1A>1"JDL,6(%]0I/.AQG
M<I*D(0]N]+*L(B6-%'_P#;Z\A*J;! F U<!BHZ$0[$@<,NKH/ R#Q!P=#?4Z
M$4?G^;T8;W3A\A[G@7?J.U]LK6G4M(/(TAA38X<(+11$5&O(>1Y#BG&2QB*A
M&+D7!SA^^M36?DV?QUG6"5X.1WVWH##PJJY)*Q/G_M;G;.\$#X\SO5MP&>DL
M[P"?0(=XE]CN/+P[N6F\0[M+]!X<UEV\J)^.\LG,@M5^:C6<\XQI12.884$A
M8@)!BFR7L=@H);$F*O=K3G'X^*E))4L=L.3UM&N.P'/30/I#,K"(\D##6]\X
MSW1(->-HA%&UB_/<'2L5%ZZZ(1[P(!A?4A%GPI;3Y"B'"&D!J4HD%'G"(X*X
M0HG?J?K4DQV:=M#;-7@RS_QF4]1OC KLD=TPY:R&NLG.8+D+H^0LO'*N@G..
M0JC<A'*7/Y=-]?'9/M7V%E[I'WQ9O_[S#!/SGTBA0+9N(Y,9Y$02NWG3*$[-
MTM=.Z]YSW*E)@XI*ZV_;5'36N4X^5;(\4'>P1H;!<F"1<3&%L\;W/@<U[;58
M&0A?#^MF&)Q'LGL"XNUG'/FCUFDV>3QN/(/*G\<#4ZO'[?V4N2KN4A_FS-9I
MB,5G;=5%90?];5%(OOP_FF_FPIAF0A*;[1]+B'0>0Y:2'.9:TTB;72!63MZC
M_B1,;0/8$6GW /N"^NE_/>; 34$<%MF!MX.:^#-Y_$;K%AI\X@ME*TNUH*_X
M ):1<)IF?Q!#JJ(]J!A55^V/TK$R>\.3^HG .Z465I3RI7VE/JS>\J?%EB_G
M%"."LSR%B4QMSPC$(-/<=DLE>22S+->IEU5[89RI";,]F>#)T G+XGTEI7Y2
M[1*L;J(K %B#N]5W.%D2;9'#MU=P\I8]5U (*6 N#36J%+G"[[&HN'9YSPI(
MZ]7#5[UYM,UK?N.+S7_PY;.>9PHQ8])R*)$!#^41@S2C%!IU)R8TC1G57BW4
MSXXR-5E@"0/?+66>58K.0NBV\F\&9F@SU= '#?B/9>?T&2@Q^H].C/R+"'5A
M$+1,T-F!QBT$U,7K2:F?SHO[K??/^KM>V2;=J5"I(B2&69KE$'&$(<=)!K'F
M.!>8XXA$/E40FP=[K>K1BAYN:NK\5O8.++?%W >"@=?OYVM\>Z_68R9#+M#=
MLT==D\<<'2_#D[_W\#.WNF'8U?Q.R])UG40Q;<)4HDQ+$FDH\MCVL$@$Y,+\
MP.8/,M=$YJE[NOK5X::V]S84 DNBAZ?S.JX.#N2@: V\H-L]=\H>DFUJ^\2[
M7$?0PT4<%,F1/,.[0O[@Q[>%_&;LOY7UN.BZ(+$J>XYS4#QIN<@7YO-J=P+"
M5U4QW:)J</,"^+;LP%"=B-@K[*>%+7)AKM^4G[ZMET9FS,JGZI_\\6FI9T \
M;X%Y%E@N'A<V8'.[GI47&^[-8_^U.#AOG55/+(VP@W43*I['>18[/=77GS*>
M@]J9HP._M/M=K]#S89ZJ7&4XES"7UD:+;+\C@3&D$<,RTE@BDLZ?JNY,6[[9
MNJEQ-]'DL[J/*1M09#IW8[#K5^B'Q6IEQ8%9OA61(S9IF',FM5 QAYPQ5D6K
MTCBG,!54(ZY%1AFI9_7]2DUR3ANZIC*CVGS]*G,I$HH((0G,511!Q%0$.4K*
M<M%(B30E&?<JCSK:/([2Z'&*/5+F)--QG),4*LRYK6B;0I$R ID0<:P2LP2C
M9+2^.-,TI2?9W&:,7C53L@+"M)Z92/N8(5P)MQ'TC]/<Y9+3(LQ#>\;,UNT
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MMW__I^8;\\-FOOW[/_U_4$L#!!0    ( "5 9E%X6"=70HT  #A?!@ 5
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MOGLG+.C6L7 $/YO PWMT^^>HSCK&?T'^PYO9S70Y__YFEF $AB8KT>.6$<]
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M<3N$Q$C(+A!J9>9E0T@7:RSU(1G#]$:HAHE;[=,#SP<\?AY2OS;#[Q;!46<
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MJXDOKB$5-%A!L['<[P"WG:8!W+UUV-30TY_/A[.\!9S<PEM+'B-71!F!\ 9
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M%7D#&.]*Y!<;-?(?9\M/?KX\S[=-%_XRG]U<O[F9%\&-I.9&4!H(Y1S*+*A
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M2!.(]%P2;ZTC+&FJA4Q&^RJMJK=2- RL*DK_<;RW%U&T@*E[\DN%V'G^BD?
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M_#<)AKX/GC29,JL=%\JF*OV#]Z1SX-DQ+:"VIF1[FRUS1% ?BCD/Z0PUM[^
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MU2QH&^-&F2H%7A:O401DF +BI1<$[3EPJ)P]>J]5REY>)&O@LOBJRJI'@30
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M_:N9XY''C E*K!&C38'N@D!,"HU<")MURU;[@=2>TZ"19A =197#\>JO\;K
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MC,3_6]+8?+U>KK[6,6@S3DZ.8S( ZEK^2DH +P3=.L6)K**2*/>;G=*&OOW
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MS,_,/^>7'[^3S'K&?"QT\RB00=>W$Q; *[1@><K(!-U(N<VN]]%9Z63&5$>
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M*CT[OPS\)MN#WQF]RC'/*G\)1M&5:8J24(T1%[NFM)M7#QMP:OBYOMKS>,5
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M.3,P7V-A;"YX;6Q02P$"% ,4    "  E0&91OPLU-T]@  #\& 0 %0
M        @ &I"0( ;V-G;BTR,#(P,#DS,%]D968N>&UL4$L! A0#%     @
M)4!F4>?CJYMCX   10T) !4              ( !*VH" &]C9VXM,C R,# Y
M,S!?;&%B+GAM;%!+ 0(4 Q0    ( "5 9E%X6"=70HT  #A?!@ 5
M      "  <%* P!O8V=N+3(P,C P.3,P7W!R92YX;6Q02P$"% ,4    "  E
M0&91Z\>Q[-\'  "$)@  &P              @ $VV , ;V-G;BTR,#(P,#DS
M,'@Q,'%X97@S,3$N:'1M4$L! A0#%     @ )4!F43#4_!?3!P  ?"8  !L
M             ( !3N # &]C9VXM,C R,# Y,S!X,3!Q>&5X,S$R+FAT;5!+
M 0(4 Q0    ( "5 9E%-SS1_\04  .,9   ;              "  5KH P!O
M8V=N+3(P,C P.3,P>#$P<7AE>#,R,2YH=&U02P4&      D "0!E @  A.X#
#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
